0001564590-21-008934.txt : 20210225 0001564590-21-008934.hdr.sgml : 20210225 20210225171000 ACCESSION NUMBER: 0001564590-21-008934 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 97 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NUVASIVE INC CENTRAL INDEX KEY: 0001142596 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330768598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-50744 FILM NUMBER: 21681553 BUSINESS ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 909-1800 MAIL ADDRESS: STREET 1: 7475 LUSK BLVD. CITY: SAN DIEGO STATE: CA ZIP: 92121 10-K 1 nuva-10k_20201231.htm 10-K nuva-10k_20201231.htm
0001142596 false 2020 FY --12-31 true true true true true true true true true true true true 2020 P3Y P5Y P6M P4Y P5Y P7Y P3Y P7Y P2Y P15Y P3Y P7Y P10Y P20Y P8Y P13Y P9Y P9Y P8Y P8Y P13Y P9Y P9Y P9Y 2021 0.028 0.040 us-gaap:ValuationTechniqueDiscountedCashFlowMember P12Y9M18D P12Y4M24D P2Y2M12D P2Y3M18D P10M20D P6M P6M P6M 0001142596 2020-01-01 2020-12-31 xbrli:shares 0001142596 2021-02-23 iso4217:USD 0001142596 2020-06-30 0001142596 2020-12-31 0001142596 2019-12-31 iso4217:USD xbrli:shares 0001142596 us-gaap:ProductMember 2020-01-01 2020-12-31 0001142596 us-gaap:ProductMember 2019-01-01 2019-12-31 0001142596 us-gaap:ProductMember 2018-01-01 2018-12-31 0001142596 us-gaap:ServiceMember 2020-01-01 2020-12-31 0001142596 us-gaap:ServiceMember 2019-01-01 2019-12-31 0001142596 us-gaap:ServiceMember 2018-01-01 2018-12-31 0001142596 2019-01-01 2019-12-31 0001142596 2018-01-01 2018-12-31 0001142596 us-gaap:CommonStockMember 2017-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001142596 us-gaap:RetainedEarningsMember 2017-12-31 0001142596 us-gaap:TreasuryStockMember 2017-12-31 0001142596 us-gaap:ParentMember 2017-12-31 0001142596 us-gaap:NoncontrollingInterestMember 2017-12-31 0001142596 2017-12-31 0001142596 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001142596 us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0001142596 us-gaap:ParentMember 2018-01-01 2018-12-31 0001142596 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001142596 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001142596 us-gaap:CommonStockMember 2018-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001142596 us-gaap:RetainedEarningsMember 2018-12-31 0001142596 us-gaap:TreasuryStockMember 2018-12-31 0001142596 us-gaap:ParentMember 2018-12-31 0001142596 2018-12-31 0001142596 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001142596 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001142596 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001142596 us-gaap:CommonStockMember 2019-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001142596 us-gaap:RetainedEarningsMember 2019-12-31 0001142596 us-gaap:TreasuryStockMember 2019-12-31 0001142596 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001142596 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001142596 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001142596 us-gaap:CommonStockMember 2020-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001142596 us-gaap:RetainedEarningsMember 2020-12-31 0001142596 us-gaap:TreasuryStockMember 2020-12-31 0001142596 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember nuva:AccountingStandardsUpdate202006Member us-gaap:SubsequentEventMember 2021-01-01 0001142596 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201613Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201704Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201813Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201815Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201912Member 2020-12-31 0001142596 nuva:AccountingStandardsUpdateTwentyThousandTwentyZeroFourMember 2020-12-31 nuva:Customer nuva:segment 0001142596 2020-10-01 2020-10-01 0001142596 srt:MinimumMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember 2020-01-01 2020-12-31 0001142596 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0001142596 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-12-31 0001142596 us-gaap:ShippingAndHandlingMember 2018-01-01 2018-12-31 0001142596 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2020-01-01 2020-12-31 0001142596 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2019-01-01 2019-12-31 0001142596 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-01-01 2018-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001142596 nuva:StockOptionsAndESPPMember 2019-01-01 2019-12-31 0001142596 nuva:StockOptionsAndESPPMember 2018-01-01 2018-12-31 0001142596 nuva:RestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001142596 nuva:RestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001142596 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-12-31 0001142596 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-12-31 0001142596 nuva:StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001142596 nuva:StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001142596 nuva:StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001142596 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001142596 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001142596 us-gaap:WarrantMember 2018-01-01 2018-12-31 0001142596 us-gaap:ConvertibleDebtSecuritiesMember 2020-01-01 2020-12-31 0001142596 nuva:InstrumentSetsMember 2020-01-01 2020-12-31 0001142596 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2020-01-01 2020-12-31 0001142596 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 us-gaap:ComputerEquipmentMember srt:MinimumMember 2020-01-01 2020-12-31 0001142596 us-gaap:ComputerEquipmentMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2020-01-01 2020-12-31 0001142596 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2020-01-01 2020-12-31 0001142596 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 us-gaap:BuildingImprovementsMember srt:MinimumMember 2020-01-01 2020-12-31 0001142596 us-gaap:BuildingImprovementsMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 nuva:InstrumentSetsMember 2020-12-31 0001142596 nuva:InstrumentSetsMember 2019-12-31 0001142596 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001142596 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001142596 us-gaap:ComputerEquipmentMember 2020-12-31 0001142596 us-gaap:ComputerEquipmentMember 2019-12-31 0001142596 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001142596 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001142596 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001142596 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001142596 us-gaap:BuildingImprovementsMember 2020-12-31 0001142596 us-gaap:BuildingImprovementsMember 2019-12-31 0001142596 us-gaap:LandMember 2020-12-31 0001142596 us-gaap:LandMember 2019-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2020-01-01 2020-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2020-01-01 2020-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2020-01-01 2020-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2020-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2020-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2020-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2019-01-01 2019-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2019-01-01 2019-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2019-01-01 2019-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2019-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2019-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2019-12-31 0001142596 nuva:CorporateNotesMember 2020-12-31 0001142596 us-gaap:CommercialPaperMember 2020-12-31 0001142596 us-gaap:ForeignExchangeForwardMember 2020-12-31 0001142596 us-gaap:ForeignExchangeForwardMember 2019-12-31 0001142596 us-gaap:ForeignExchangeForwardMember 2018-12-31 0001142596 us-gaap:ForeignExchangeForwardMember us-gaap:OtherOperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001142596 us-gaap:ForeignExchangeForwardMember us-gaap:OtherOperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001142596 us-gaap:ForeignExchangeForwardMember us-gaap:OtherOperatingIncomeExpenseMember 2018-01-01 2018-12-31 0001142596 us-gaap:ForeignExchangeForwardMember nuva:OtherCurrentAssetsOrOtherCurrentLiabilitiesMember 2019-12-31 nuva:investment 0001142596 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2020-12-31 0001142596 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueMeasurementsRecurringMember nuva:CorporateNotesMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember nuva:CorporateNotesMember 2020-12-31 0001142596 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2019-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 xbrli:pure 0001142596 2020-09-09 0001142596 2020-09-10 0001142596 us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-01-01 2020-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyThreeMember 2020-01-01 2020-12-31 0001142596 us-gaap:MeasurementInputDiscountRateMember srt:MinimumMember us-gaap:FairValueInputsLevel3Member nuva:CommercialSaleMilestoneMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:MeasurementInputDiscountRateMember srt:MaximumMember us-gaap:FairValueInputsLevel3Member nuva:CommercialSaleMilestoneMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:MeasurementInputDiscountRateMember srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member nuva:CommercialSaleMilestoneMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember us-gaap:FairValueInputsLevel3Member nuva:CommercialSaleMilestoneMember us-gaap:FairValueMeasurementsRecurringMember 2020-01-01 2020-12-31 0001142596 us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member nuva:CommercialSaleMilestoneMember us-gaap:FairValueMeasurementsRecurringMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nuva:CommercialSaleMilestoneMember 2020-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2020-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2019-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2018-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2020-01-01 2020-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2019-01-01 2019-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2019-12-31 0001142596 nuva:OnePointZeroZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-12-31 0001142596 nuva:OnePointZeroZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2019-12-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2019-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodTwoMember nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember 2016-03-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodTwoMember nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember 2016-03-01 2016-03-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-01-01 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2019-01-01 2019-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2018-01-01 2018-12-31 utr:D 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember nuva:ScenarioOneMember srt:MinimumMember 2020-01-01 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember nuva:ScenarioOneMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember srt:MinimumMember 2020-01-01 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember nuva:ScenarioTwoMember 2020-01-01 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember srt:MaximumMember 2020-01-01 2020-12-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyOneMember 2016-03-01 2016-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyOneMember 2016-03-31 0001142596 us-gaap:AdditionalPaidInCapitalMember nuva:FairValueHedgingTwoThousandTwentyOneMember 2016-12-31 0001142596 us-gaap:CommonStockMember nuva:WarrantsTwoThousandTwentyOneMember srt:MaximumMember 2016-03-18 0001142596 nuva:WarrantsTwoThousandTwentyOneMember srt:MinimumMember 2016-03-01 2016-03-31 0001142596 nuva:WarrantsTwoThousandTwentyOneMember srt:MaximumMember 2016-03-01 2016-03-31 0001142596 nuva:WarrantsTwoThousandTwentyOneMember 2016-03-01 2016-03-31 0001142596 nuva:WarrantsTwoThousandTwentyOneMember 2016-03-31 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-01-01 2020-12-31 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember srt:MinimumMember nuva:ScenarioOneMember 2020-06-01 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember srt:MaximumMember nuva:ScenarioOneMember 2020-06-01 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember srt:MinimumMember 2020-06-01 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember nuva:ScenarioTwoMember 2020-06-01 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember srt:MaximumMember 2020-06-01 2020-06-01 0001142596 nuva:FairValueHedgingTwoThousandTwentyThreeMember 2020-06-01 2020-06-01 0001142596 nuva:FairValueHedgingTwoThousandTwentyThreeMember 2020-06-01 0001142596 us-gaap:CommonStockMember nuva:WarrantsTwoThousandTwentyThreeMember srt:MaximumMember 2020-12-31 0001142596 us-gaap:CommonStockMember nuva:WarrantsTwoThousandTwentyThreeMember 2020-06-01 0001142596 us-gaap:CommonStockMember nuva:WarrantsTwoThousandTwentyThreeMember nuva:TwoThousandTwentyThreeCounterpartiesMember 2020-09-11 0001142596 nuva:WarrantsTwoThousandTwentyThreeMember srt:MinimumMember 2020-06-01 2020-06-01 0001142596 nuva:WarrantsTwoThousandTwentyThreeMember srt:MaximumMember 2020-06-01 2020-06-01 0001142596 nuva:WarrantsTwoThousandTwentyThreeMember 2020-06-01 2020-06-01 0001142596 nuva:WarrantsTwoThousandTwentyThreeMember 2020-06-01 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-01 2020-03-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-01-01 2020-12-31 0001142596 nuva:ScenarioOneMember srt:MinimumMember us-gaap:DebtInstrumentRedemptionPeriodFourMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember 2020-03-01 2020-03-31 0001142596 nuva:ScenarioOneMember srt:MaximumMember us-gaap:DebtInstrumentRedemptionPeriodFourMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember 2020-03-01 2020-03-31 0001142596 srt:MinimumMember us-gaap:DebtInstrumentRedemptionPeriodFourMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember 2020-03-01 2020-03-31 0001142596 nuva:ScenarioTwoMember us-gaap:DebtInstrumentRedemptionPeriodFourMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember 2020-03-01 2020-03-31 0001142596 srt:MaximumMember us-gaap:DebtInstrumentRedemptionPeriodFourMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember 2020-03-01 2020-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyFiveMember 2020-03-31 0001142596 us-gaap:AdditionalPaidInCapitalMember nuva:FairValueHedgingTwoThousandTwentyFiveMember 2020-03-31 0001142596 us-gaap:CommonStockMember srt:MaximumMember nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-31 0001142596 srt:MinimumMember nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 srt:MaximumMember nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-31 0001142596 us-gaap:RevolvingCreditFacilityMember 2020-02-29 0001142596 nuva:MulticurrencyBorrowingsMember 2020-02-29 0001142596 us-gaap:StandbyLettersOfCreditMember 2020-02-29 0001142596 nuva:SwingLineLoansMember 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0001142596 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember srt:MinimumMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember srt:MaximumMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember srt:MinimumMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember srt:MaximumMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember srt:MinimumMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember srt:MaximumMember 2020-02-01 2020-02-29 0001142596 srt:MinimumMember 2020-12-31 0001142596 srt:MaximumMember 2020-12-31 0001142596 nuva:LicensingAndPurchasingAgreementsMember 2020-12-31 0001142596 nuva:ExecutiveSeverancePlansMember 2020-12-31 0001142596 srt:MaximumMember us-gaap:CommonStockMember 2017-10-31 0001142596 us-gaap:CommonStockMember 2017-10-01 2017-10-31 0001142596 us-gaap:CommonStockMember 2020-02-29 0001142596 us-gaap:CommonStockMember 2020-02-01 2020-02-29 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:CommonStockMember 2020-03-01 2020-03-31 0001142596 us-gaap:CommonStockMember 2020-09-09 0001142596 us-gaap:CommonStockMember 2020-09-10 0001142596 nuva:EquityIncentivePlan2014Member 2020-01-01 2020-12-31 0001142596 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001142596 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001142596 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0001142596 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001142596 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001142596 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-31 0001142596 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001142596 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001142596 us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001142596 us-gaap:EmployeeStockMember 2020-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2020-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember srt:MinimumMember 2020-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember srt:MaximumMember 2020-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2015-01-01 2015-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2019-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001142596 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001142596 us-gaap:EmployeeStockMember 2019-01-01 2019-12-31 0001142596 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001142596 nuva:RestrictedStockUnitsAndPerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001142596 nuva:AvailableForFutureGrantMember 2020-12-31 0001142596 nuva:SeniorConvertibleNotesDue2021Member 2020-12-31 0001142596 nuva:SeniorConvertibleWarrantsDue2021Member 2020-12-31 0001142596 nuva:SeniorConvertibleNotesDue2023Member 2020-12-31 0001142596 nuva:SeniorConvertibleWarrantsDue2023Member 2020-12-31 0001142596 nuva:SeniorConvertibleNotesDue2025Member 2020-12-31 0001142596 nuva:SeniorConvertibleWarrantsDue2025Member 2020-12-31 0001142596 nuva:AccountingStandardUpdate201616Member 2018-11-30 0001142596 us-gaap:DomesticCountryMember 2020-12-31 0001142596 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0001142596 us-gaap:ForeignCountryMember 2020-12-31 0001142596 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001142596 us-gaap:StateAndLocalJurisdictionMember 2020-01-01 2020-12-31 0001142596 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2020-12-31 0001142596 us-gaap:CaliforniaFranchiseTaxBoardMember us-gaap:ResearchMember 2020-12-31 0001142596 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2020-01-01 2020-12-31 0001142596 nuva:SpinalHardwareMember 2020-01-01 2020-12-31 0001142596 nuva:SpinalHardwareMember 2019-01-01 2019-12-31 0001142596 nuva:SpinalHardwareMember 2018-01-01 2018-12-31 0001142596 nuva:SurgicalSupportMember 2020-01-01 2020-12-31 0001142596 nuva:SurgicalSupportMember 2019-01-01 2019-12-31 0001142596 nuva:SurgicalSupportMember 2018-01-01 2018-12-31 0001142596 country:US 2020-01-01 2020-12-31 0001142596 us-gaap:NonUsMember 2020-01-01 2020-12-31 0001142596 country:US 2019-01-01 2019-12-31 0001142596 us-gaap:NonUsMember 2019-01-01 2019-12-31 0001142596 country:US 2018-01-01 2018-12-31 0001142596 us-gaap:NonUsMember 2018-01-01 2018-12-31 0001142596 country:US 2020-12-31 0001142596 us-gaap:NonUsMember 2020-12-31 0001142596 country:US 2019-12-31 0001142596 us-gaap:NonUsMember 2019-12-31 0001142596 nuva:MadsenMedicalIncLitigationMember 2018-01-01 2018-12-31 0001142596 us-gaap:SubsequentEventMember nuva:SimplifyMedicalPtyLimitedMember 2021-02-24 0001142596 us-gaap:SubsequentEventMember nuva:SimplifyMedicalPtyLimitedMember srt:MaximumMember 2021-02-24

fv 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-K

 (Mark One)

☒

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2020

OR

☐

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission file number: 000-50744

 

NUVASIVE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware

 

33-0768598

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

7475 Lusk Boulevard

 

 

92121

San Diego, California

(Address of principal executive offices)

 

(Zip Code)

(858) 909-1800

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.001 per share

NUVA

The Nasdaq Stock Market LLC

(Nasdaq Global Select Market)

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☑    No  ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes  ☐    No  ☑

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period than the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☑    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☑    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” a “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

☑

  

Accelerated filer

 

☐

 

 

 

 

Non-accelerated filer

 

☐  

  

Smaller reporting company

 

☐

Emerging growth company

 

☐  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☑ 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☑

The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $2.8 billion as of the last business day of the registrant’s most recently completed second fiscal quarter (June 30, 2020), based upon the closing sale price for the registrant’s common stock on that day as reported by the Nasdaq Global Select Market. Shares of common stock held by each officer and director on June 30, 2020 have been excluded in that such persons may be deemed to be affiliates.

As of February 23, 2021, there were 51,379,052 shares of the registrant’s common stock issued and outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Part III of this Form 10-K incorporates information by reference to portions of the definitive Proxy Statement for the registrant’s 2021 Annual Meeting of Stockholders, which will be filed with the U.S. Securities and Exchange Commission not- later than 120 days after December 31, 2020.

 

 

 

NuVasive, Inc.

Annual Report on Form 10-K for the Fiscal Year ended December 31, 2020

Table of Contents

 

PART I

Item 1.

  

Business

  

3

Item 1A.

  

Risk Factors

  

19

Item 1B.

  

Unresolved Staff Comments

  

46

Item 2.

  

Properties

  

46

Item 3.

  

Legal Proceedings

  

46

Item 4.

  

Mine Safety Disclosures

  

46

 

PART II

Item 5.

  

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

  

47

Item 6.

  

Selected Financial Data

  

49

Item 7.

  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

  

50

Item 7A.

  

Quantitative and Qualitative Disclosures About Market Risk

  

67

Item 8.

  

Financial Statements and Supplementary Data

  

68

Item 9.

  

Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

  

68

Item 9A.

  

Controls and Procedures

  

68

Item 9B.

  

Other Information

  

70

 

PART III

Item 10.

  

Directors, Executive Officers and Corporate Governance

  

70

Item 11.

  

Executive Compensation

  

70

Item 12.

  

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

  

71

Item 13.

  

Certain Relationships and Related Transactions, and Director Independence

  

71

Item 14.

  

Principal Accountant Fees and Services

  

71

 

PART IV

Item 15.

  

Exhibits, Financial Statement Schedules

  

72

Item 16.

  

Form 10-K Summary

  

80

SIGNATURES

  

81

Index to Consolidated Financial Statements

  

83

 

 

 

 

1

Table of Contents

 

PART I

This Annual Report on Form 10-K (“Annual Report”) contains forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause our results to differ from historical results or those expressed or implied by such forward-looking statements. In some cases, you can identify these forward-looking statements by words like “may”, “will”, “should”, “could”, “expect”, “plan”, “anticipate”, “believes”, “estimates”, “predicts”, “potential”, “intends”, or “continues” (or the negative of those words and other comparable words). Forward-looking statements include, but are not limited to, statements about:

 

•

the value proposition of our products and procedural solutions;

 

•

our intentions, beliefs and expectations regarding our net sales, expenses, operations and future financial performance;

 

•

our operating results;

 

•

our plans for future product development and enhancements of existing products;

 

•

anticipated growth and trends in our business;

 

•

third-party reimbursement policies and practices;

 

•

the timing of and our ability to maintain and obtain regulatory clearances or approvals;

 

•

our belief that our cash, cash equivalents and investments will be sufficient to satisfy our anticipated obligations;

 

•

the impact of global economic conditions and public health crises and epidemics, such as the COVID-19 pandemic, on our business;

 

•

our expectations regarding our customers and the adoption of our products and procedures;

 

•

our beliefs and expectations regarding our market penetration and expansion efforts;

 

•

our expectations regarding the benefits and integration of recently-acquired businesses and our ability to make future acquisitions and successfully integrate any such future-acquired businesses;

 

•

our anticipated trends, product pricing pressure, competitive tactics and other challenges in the markets in which we operate; and

 

•

our expectations and beliefs regarding and the impact of policy changes, investigations, claims and litigation.

These statements are not guarantees of future performance or events. Our actual results may differ materially from those discussed in this Annual Report and the documents incorporated by reference to this Annual Report. The potential risks and uncertainties that could cause actual results to differ materially include, but are not limited to, those set forth in Part I, Item 1A under the heading “Risk Factors”, Part II, Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere throughout this Annual Report and in any other documents incorporated by reference to this Annual Report. Readers are cautioned not to place undue reliance on such forward-looking statements. We assume no obligation to update any forward-looking statements to reflect new information, future events or circumstances or otherwise, except as required by law. This Annual Report and the documents incorporated by reference to this Annual Report also contain estimates, projections and other information concerning our industry, our business, and the markets for certain medical conditions and procedures. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market, and other data from reports, research surveys, studies, and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources.

This Annual Report and the documents incorporated by reference into this Annual Report refer to trademarks, such as Absolute Responsiveness®, Advanced Materials Science™, Acuity®, Affix®, Armada®, AttraX®, Back Pact®, Bendini®, Better Back Alliance®, Better Insight. Better Decisions. Better Medicine®, Brigade®, C360™, CerPass®, COALESCE®, COHERE®, CoRoent®, Creative Spine Technology®, DBR®, Embody™, Embrace™, ExtenSure®, Formagraft®, Gradient Plus®, Halo®, iGA®, ILIF®, InStim™, Lessray®, Leverage®, MAGEC®, MAGEC-EOS™, MAS®, Maxcess®, Modulus®, NeoDisc™, Nerve Avoidance Leader™, NuvaLine®, NuvaMap® O.R., NuvaPlanning™, NuVasive®, NVM5®, Osteocel®, Precept®, Precice®, PROPEL®, Pulse®, Radian®, Reline®, Speed of Innovation®, SpheRx®, Surgical Intelligence™, The Better Way Back®, Traverse®, Triad®, VuePoint®, X360™, X-Core®, and XLIF®, which are protected under applicable intellectual property laws and are our property or the property of our subsidiaries. Solely for convenience, our trademarks and tradenames referred to in this Annual Report may appear without the ® or ™ symbols, but such references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights to these trademarks and tradenames. This Annual Report also includes trademarks owned by other parties, and all other such trademarks mentioned in this Annual Report are the property of their respective owners.

 

2

Table of Contents

Item 1.Business

Overview

We are a global medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. We offer a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, we develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures. For the year ended December 31, 2020, we generated net sales of $1.05 billion, including sales in more than 50 countries.

Since our incorporation in 1997, we have grown from a small developer of specialty spinal implants into a leading medical technology company delivering procedurally integrated solutions for spine surgery. A key driver of our growth has been our focus on innovative products and technologies that drive reproducible outcomes for patients, surgeons and providers. In 2003, we introduced the eXtreme Lateral Interbody Fusion procedure, or XLIF, a lateral access spine surgery technique that is less-invasive than traditional, open surgical procedures and clinically proven to enable better patient outcomes. Building off the success of XLIF, we have continued to develop innovative, less-invasive techniques and technologies for spine surgery, and we have broadened our portfolio of solutions for traditional, open surgical procedures. Our comprehensive portfolio of solutions can be utilized in procedures for the cervical, thoracic and lumbar spine, supporting surgical approaches from the anterior, including lateral, and posterior. Our solutions are used to treat degenerative conditions and for complex spinal surgery, including adult and pediatric deformities, as well as trauma and tumors.

Underlying our procedurally integrated solutions for spine surgery are innovative technologies designed to enable better clinical, financial, and operational outcomes, including:

 

•

our differentiated surgical access instruments, including our Maxcess integrated split-blade retractor system, designed to enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery;

 

•

our neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and our intraoperative neuromonitoring, or IONM, services and support;

 

•

our Advanced Materials Science portfolio of specialized spinal implants, designed to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone, or PEEK;

 

•

our comprehensive Reline fixation system, designed to facilitate the preservation and restoration of patient alignment, while addressing a vast array of spinal pathologies from an open or less-invasive approach across all spinal procedures; and

 

•

our Integrated Global Alignment platform, or iGA, which is comprised of procedurally-based technologies that help increase the predictability of achieving global alignment in spinal procedures, including our Bendini spinal rod bending system that expedites manual rod manipulation for spinal fixation.

We have also invested in enabling technologies, including the development of capital equipment designed to further improve clinical, financial, and operational outcomes of spine surgery. Our capital equipment portfolio currently consists of Lessray and the Pulse platform. Lessray is an image enhancement platform designed to reduce radiation exposure in the operating room by allowing surgeons to take low-quality, low-dose images and improve them to look like conventional full-dose images. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for neuromonitoring, surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. Selling and leasing of capital equipment do not make up a material portion of our total net sales.

In addition to our procedurally integrated solutions for spine surgery, we also design and sell expandable growing rod implant systems that can be non-invasively lengthened following implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control, or MAGEC, which allows for the minimally invasive treatment of early-onset and adolescent scoliosis. This technology is also the basis for our Precice limb lengthening system, which allows for the correction of long bone limb length discrepancy, as well as other products for treating specialized orthopedic procedures.

We intend to continue development on a wide variety of innovation projects to advance our leadership position in less-invasive spine surgery, increase our product offerings and solutions for traditional spine surgery procedures, and further our enabling technologies portfolio. We expect to continue to invest in the Pulse platform to support a full global launch of the technology and to develop and expand its application offerings, including investments related to surgical automation and robotics. In addition, we expect to continue to pursue business and technology acquisition targets and strategic relationships to identify opportunities to broaden participation along the spine care continuum. Top priorities include opportunities that complement our technology leadership position in spine, targeted geographic expansion, technology that makes procedures even safer, as well as opportunities for surgical automation.

 

3

Table of Contents

Our corporate headquarters is located in San Diego, California and offers a state-of-the-art cadaver operating theatre and research and development labs designed to accommodate the training of spine surgeons through our Clinical Professional Development education programs. Our location in Amsterdam, the Netherlands, serves as our international headquarters. Our primary distribution and warehousing operations are located in our facility in Memphis, Tennessee, which due to its proximity to overnight third-party transporters, helps facilitate rapid delivery of our products and surgical instruments for surgeries. Additionally, our primary self-manufacturing facility, which produces spinal implants and fixation products, is located in West Carrollton, Ohio.

COVID-19 Impact on our Business

The COVID-19 pandemic materially impacted our business and results of operations in fiscal year 2020. Many government agencies in conjunction with hospitals and healthcare systems have, to varying degrees, deferred or suspended elective surgical procedures due to COVID-19. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, we have seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, we have experienced reductions in procedural volumes during 2020 and anticipate this trend may continue. Further discussion of the potential impacts on our business from the COVID-19 pandemic is provided under Part I, Item 1A – Risk Factors.

Despite the impact COVID-19 has had on our business, we continued to invest in research and development, invest in our people, improve operating processes, and take steps to position ourselves for long-term success. During 2020, we raised additional capital to solidify our financial foundation. We continued to train and educate surgeons on our products and less-invasive surgical techniques, while our Clinical Professional Development team developed virtual labs and created a Virtual Spine Conference series to enhance remote surgeon education and provide clinical insights. During 2020, we continued to focus on developing innovative solutions and enabling technologies to drive increased adoption of less-invasive surgery and improve clinical, financial and operational outcomes in furtherance of our strategy.

Our Strategy

We continue to pursue the following strategies in order to improve our competitive position and grow our business:

 

•

Advance our Position in Less-Invasive Spine Surgery. We believe that surgeons, providers and patients will continue to recognize the benefits of less-invasive surgical techniques and our procedurally integrated solutions will promote better clinical, financial, and operational outcomes. It has been demonstrated clinically that XLIF and other procedures facilitated by our procedurally integrated solutions decrease trauma and blood loss, and lead to faster overall patient recovery times compared to traditional, open spine surgery procedures. We believe our solutions have the potential to dramatically improve the clinical results of spine surgery and drive better reproducibility through enabling technologies. Because of this belief, we dedicate significant resources to researching clinical outcomes data as well as educating surgeons, providers and patients on the benefits of our products, and we intend to continue to capitalize on the growing demand for less-invasive surgical procedures.

 

•

Continue to Develop Innovative Solutions and Broaden our Portfolio of Offerings. One of our core competencies is our ability to rapidly develop and commercialize innovative spine surgery solutions to fulfill unmet clinical needs while improving clinical, financial, and operational outcomes. In the past several years, we have introduced a continual flow of new products and product enhancements, including a broader portfolio of offerings for traditional, open spine surgery procedures. With our comprehensive portfolio of product and service offerings, we can offer our customers procedural solutions for the cervical, thoracic and lumbar spine, and for various surgical approaches that distinguishes us from traditional spine implant companies. As part of this strategy, we must continue to vigorously protect and defend the intellectual property related to our innovative products.

 

4

Table of Contents

 

•

Strengthen Proceduralization Supported by Enabling Technologies and Surgeon Education. We intend to continue to build upon our procedural solutions with new and enhanced enabling technology offerings. We believe through continued innovation and a focus on providing comprehensive procedural solutions for our customers, we will simultaneously increase our market share and improve patient care. The opportunity to procedurally integrate enabling technologies such as neuromonitoring, iGA surgical planning, patient-specific rod bending, smart imaging, navigation and other smart tools into new and existing procedural solutions is key to our long-term strategy and represents a significant opportunity for the growth of our business. In 2019, we launched the X360 system, a comprehensive approach to lateral single-position surgery that leverages advanced techniques and technologies to deliver patient specific-care while enhancing operating room workflow and efficiency. In 2020, we launched the C360 system, a comprehensive portfolio to support anterior and posterior cervical spine surgery. These and other launches of procedural systems and enhancements to existing solutions which integrate enabling technologies expand the ability of surgeons to use our products in a variety of surgical approaches and procedures for the spine. We believe that our surgeon education and training program is a strategic differentiator for us, and our Clinical Professional Development team has developed comprehensive in-person training labs and virtual content to demonstrate the benefits of our innovative products and procedures. Education and training of surgeons will continue to be a focus as we advance our less-invasive solutions and launch new technologies like Lessray and the Pulse platform.

 

•

Expand the Reach of Our Sales Force and Drive Growth Globally. We believe there is significant opportunity for us to further penetrate existing markets and to enter new markets by increasing the size and geographic scope of our sales force both in the United States and internationally. In the United States, we have a sales force consisting of a mix of directly employed and independent sales representatives who are responsible for particular geographic regions of the country. Outside of the United States, our sales force consists of directly employed and independent sales representatives and distributors. We expect to increase the number of sales representatives in the United States to expand into new geographic territories and to deepen our penetration in existing territories. Internationally, we intend to make investments in infrastructure in order to better support existing markets and to drive expansion into new markets.

 

•

Selectively License or Acquire Complementary Products and Technologies. In addition to building our company through internal product development and global expansion efforts, we intend to selectively license or acquire complementary products and technologies and enter into strategic relationships intended to keep us on the forefront of innovation and to pursue opportunities that allow us to expand our presence in international markets. With the 2016 acquisition of Ellipse Technologies, we offer innovative products based on the MAGEC technology platform. With this acquisition, we accelerated our entry into the pediatric and idiopathic spine deformity segment and expanded our international presence. With the 2016 acquisition of the Lessray software technology suite, we are able to help surgeons and hospital staff manage radiation exposure, without compromising intraoperative images or visual accuracy. With the acquisition of Vertera Spine in 2017, we offer porous interbody technology across both PEEK and titanium materials, thereby addressing the spectrum of surgeons’ needs and preferences for spinal implants. In 2018, we entered into a Spine Precision Partnership with Siemens Healthineers to advance operating room workflow efficiency and provide increased precision in the delivery of minimally-disruptive spine surgery technologies through the integration of our Pulse platform with Siemens Healthineers’ mobile 3D C-arm, Cios Spin. By acquiring complementary products, entering into strategic relationships, and executing on domestic and international footprint expansion opportunities, we believe we can leverage our expertise of bringing new products to market that are intended to improve patient outcomes, simplify or better integrate techniques, reduce hospitalization and rehabilitation times across the globe, and, as a result, reduce overall costs to the healthcare system and continue to grow our global presence.

 

•

Provide Intraoperative Neuromonitoring Capabilities. Monitoring the health of the nervous system during spinal surgery has been a key component of our strategy of product differentiation since early in our development. Over time, surgeon and hospital demand for neuromonitoring has increased along with the advancement of technologies and techniques used in IONM. We believe our proprietary neuromonitoring platform is a differentiator in the market and is unique in its ability to provide information about the directionality and proximity of nerves. Through our NuVasive Clinical Services subsidiary, we have expanded the scale of our IONM services business and solidified our position as one of the largest providers of outsourced IONM services and are driving increased utilization of our neuromonitoring platform. We intend to continue to expand the utility of such platforms and advance our IONM product and services offerings to further our value to our customers and increase adoption and usage.

 

5

Table of Contents

Industry Background and Market

The spine is the core of the human skeleton and provides a crucial balance between structural support and flexibility. It consists of 33 separate bones called vertebrae that are connected together by connective tissue (defined as bone, muscle, or ligament) to form a column and to permit a normal range of motion. The spinal cord, the body’s central nerve system, is enclosed within the spinal column. Vertebrae are paired into what are called motion segments that move by means of three joints: two facet joints and one spine disc. The four major categories of spine disorders are degenerative conditions, deformities, trauma and tumors. The largest market and the focus of our business historically are degenerative conditions of the facet joints and the intervertebral disc space. These two conditions can result in instability and pressure on the nerve roots as they exit the spinal column, causing back or neck pain or radiating pain in the arms or legs.

The prescribed treatment for back or neck pain depends on the severity and duration of the disorder. Initially, physicians will prescribe non-operative, conservative procedures including bed rest, medication, lifestyle modification, exercise, physical therapy, chiropractic care and steroid injections. In many cases, non-operative treatment options are effective; however, some patients eventually require spine fusion surgery. The vast majority of spine fusion surgeries are performed using traditional open surgical techniques from either the anterior or posterior of the patient. These traditional open surgical approaches generally require a large incision in the patient’s abdomen or back in order to enable the surgeon to access and see the spine and surrounding area. These open procedures are invasive, lengthy and complex, and typically result in significant blood loss, extensive tissue damage and lengthy patient hospitalization and rehabilitation.

We believe the market for procedurally integrated spine surgery solutions will continue to grow over the long term, and we also believe our market share will increase, because of the following market dynamics:

 

•

Demand for Surgical Alternatives with Less Tissue Disruption. As has been demonstrated in other surgical markets, we anticipate the broader acceptance of less-invasive surgical treatments with reduced tissue disruption and patient trauma will result in increased demand.

 

•

Favorable Domestic Demographics. The population segment most likely to experience back pain is expected to increase as a result of aging “baby boomers” (people born between 1946 and 1965). This large population segment is expected to increasingly demand a quicker return to activities of daily living following surgery than prior generations.

 

•

Access to Care in Emerging Markets. Healthcare reforms in many emerging markets are expanding access to treatments to a greater proportion of their populations, which is expected to continue to drive strong increases in demand for healthcare-related product volumes. Increasing economic affluence in key developing regions will further drive demand for healthcare treatments.

 

•

Vendor/Hospital Consolidation. Given the continued economic pressures facing hospitals and healthcare systems, we anticipate broader consolidation of vendors in the spine space. We believe we are well-positioned to benefit from this vendor consolidation given our size and scale and the breadth of our portfolio.

Although the market for procedurally integrated spine surgery solutions should continue to grow over the long term, economic, political and regulatory influences are subjecting our industry to significant changes that may slow the growth rate of the spine surgery market.

Surgical Alternatives with Less Tissue Disruption

The benefits of less-invasive surgical procedures in other areas of orthopedics have significantly contributed to the strong and growing demand for surgical alternatives with less tissue disruption of the spine. Surgeons and hospitals seek spine procedures that result in fewer operative and postoperative complications and decreased patient hospitalization periods. Patients seek procedures that reduce trauma, allow for faster recovery times and result in more favorable and predictable clinical outcomes. Despite patient and doctor demands, the rate of adoption of alternative surgical procedures with less tissue disruption has been relatively slow with respect to the spine. Currently, the majority of spine surgery patients are treated with traditional open and invasive techniques.

A principal factor contributing to spine surgeons’ slow adoption of traditional “minimally invasive” spine procedure alternatives has been inconsistent outcomes driven by the limited or lack of direct access to and visibility of the surgical anatomy, and the associated complex instruments that have been required to perform these procedures. Most traditional minimally invasive spine surgery systems do not allow the surgeon to directly view the spine and the relevant pathology point and, as such, provide only restrictive visualization through a camera system or endoscope, while also requiring the use of complex surgical techniques. In addition, most traditional minimally invasive spine surgery systems use complex or highly customized surgical instruments that require special training and the completion of a large number of trial cases before the surgeon becomes proficient using the system, which is an impediment and/or deterrent to their adoption.

 

6

Table of Contents

Our Commercial Products

Our procedurally integrated spine surgery solutions are designed to allow surgeons to perform a wide range of less-invasive surgical procedures with less tissue disruption of the spine, in all regions of the spine and from various surgical approaches, while overcoming the shortcomings of traditional minimally invasive spine surgical techniques. Our solutions are designed to treat a wide range of spinal pathologies while accommodating a surgeon’s preferred surgical technique. We believe our solutions can improve clinical, financial, and operational outcomes of spine surgery and should continue to drive an expanded number of minimally disruptive procedures performed, lead the market away from open surgery, and make less-invasive techniques the standard of care in spine fusion and non-fusion surgery.

Our products and technology facilitate less-invasive applications of the following spine surgery procedures, among others:

 

•

Decompression, which is removal of a portion of bone or disc from over or under the nerve root to relieve impingement of the nerve;

 

•

Lumbar and thoracic fusion procedures in which the surgeon approaches the spine through the patient’s back (posterior), side (lateral) or abdomen (anterior);

 

•

Cervical fusion procedures for either the posterior occipito-cervico-thoracic region or the anterior cervical region; and

 

•

Complex cases involving adult and pediatric spinal deformity, trauma and tumor patients.

We offer a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, we develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.

Surgical Access Instruments

We have differentiated surgical access instruments that surgeons use to access the surgical site, including our Maxcess integrated split-blade retractor system, designed to minimize soft tissue disruption during spine surgery. Our Maxcess retractors have a split-blade design consisting of three blades that can be positioned to customize the surgical exposure in the shape and size specific to the surgical requirements rather than the more traditional fixed tube or two-blade designs of traditional minimally invasive spine surgical systems. This split-blade design also provides customizable access to the spine, which allows surgeons to perform surgical procedures using instruments that are similar to those used in open procedures but with a smaller incision and less tissue disruption. The ability to use familiar instruments reduces the learning curve for our procedures and facilitates the adoption of our products. Our system’s illumination of the operative corridor aids in providing surgeons with better direct visualization of the patient’s anatomy, without the need for additional technology or other special equipment such as endoscopes. Over the years, we have made improvements to our Maxcess systems, including incorporating enabling technologies and improving the blade systems. Our Maxcess products are used in the cervical spine for posterior application and anterior retraction, the lumbar spine for decompressions, transforaminal lumbar interbody fusions, or TLIFs, posterior lumbar interbody fusions, or PLIFs, the thoracolumbar spine for XLIFs, and the thoracic region for tumors and trauma, as well as in adult degenerative scoliosis procedures. Additionally, the Maxcess system is integrated into our X360 procedure which allows surgeons to conduct lateral single-position spine surgery without repositioning the patient, which enhances operating room workflow and efficiency and can reduce time under anesthesia and lower intraoperative risks for the patient.

Implants and Fixation Systems

We have many specialized implants and fixation products designed to be used as part of our procedurally integrated solutions. Our portfolio of spinal implants used for intervertebral disc height restoration include implants made from allograft, titanium, and PEEK. These spinal implants come in a variety of shapes, sizes, and lordosis options to accommodate specific approach, pathology, alignment restoration, and anatomical requirements of the patient and the particular fusion procedure. Our Advanced Materials Science portfolio of implants, designed to improve spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, includes our Modulus porous titanium implants and Cohere and Coalesce porous PEEK implants. Our implants are designed for insertion into the smallest possible space while maximizing surface area contact for fusion. Following our acquisition of Simplify Medical Pty Limited, or Simplify Medical, in February 2021, we also offer cervical artificial disc technology for cervical total disc replacement procedures. Our fixation products, including pedicle screws, rods and plates, have been uniquely designed and include a highly differentiated percutaneous minimally invasive solution with advanced guide technology, superior rod insertion options, and multiple reduction capabilities to be delivered through our procedures to provide stabilization of the spine. Our fixation offerings include our VuePoint, Armada, Precept and Reline posterior fixation portfolios. The Reline portfolio consists of innovative posterior fixation technology designed to preserve and restore spinal alignment, while addressing a wide range of spinal pathologies. Our Reline portfolio can be used in both traditional open procedures and less-invasive surgical procedures and includes fixation products for cervical, thoracic and lumbar spine, as well as Reline Trauma and Reline Small Stature for complex spinal surgery.

 

7

Table of Contents

Biologics

We offer a variety of biologics that are used to aid in the spinal fusion or bone healing process. The global biologics market in spine surgery consists of autograft (autologous human tissue), allograft (donated human tissue), and a varied offering of synthetic products and growth factors. Our allograft biologics product offerings include Osteocel Plus and Pro, a cellular bone matrix designed to mimic the biologic profile of autograft including mesenchymal stem cells and osteoprogenitor cells to aid in spinal fusion, and Propel DBM (highly moldable demineralized bone matrix putty and gel). Our synthetic biologics product offerings include Formagraft (collagen-based synthetic bone substitute) and AttraX (synthetic bone graft material delivered in putty and other forms).

Intraoperative Neuromonitoring Systems

Our intraoperative neuromonitoring systems utilize proprietary software hunting algorithms and graphical user interfaces to provide surgeons with an enhanced and intuitive nerve avoidance system. Our systems function by monitoring changes in electrical signals across muscle groups, which allows us to detect underlying changes in nerve activity. Through our neuromonitoring platforms, we give surgeons the option to connect their instruments to a computer system that provides discrete, real-time, surgeon directed and surgeon controlled feedback about the directionality and relative proximity of nerves during surgery. We believe our proprietary neuromonitoring platforms are a differentiator in the market and are unique in their ability to provide information about the directionality and proximity of nerves. Our systems analyze and then translate complex neurophysiologic data into simple, useful information to assist the surgeon’s clinical decision-making process. Surgeons can connect certain instruments to our neuromonitoring systems, thus creating an interactive set of instruments that better enable the safe navigation through the body’s nerve anatomy during surgery. The connection is accomplished using a clip that is attached to the instrument, effectively providing the benefits of our neuromonitoring systems through an instrument already familiar to the surgeon. Our proprietary software and easy to use graphical user interfaces allow the surgeon to make critical decisions in real time to help enable safer, faster, and more reproducible procedures to achieve improved patient outcomes.

Intraoperative Neuromonitoring Services

Through our NuVasive Clinical Services subsidiary, we provide onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. Monitoring the health of the nervous system during spinal surgery has been a key component of our strategy of product differentiation since early in our development. Over time, surgeon and hospital demand for neuromonitoring has increased along with the advancement of technologies and techniques used in IONM. Our neurophysiologists are present in the operating room during procedures and work in partnership with supervising physicians who remotely oversee and interpret neurophysiological data gathered via broadband transmission over the internet. Through this service, data can be analyzed in real-time by healthcare professionals for additional interpretation of intraoperative information and oversight, which we believe further improves the safety and reproducibility of the vast array of spine surgery procedures.

Integrated Global Alignment

Current and emerging data illustrates a direct correlation between proper spinal alignment and long-term clinical outcomes. To assist with surgical procedures, we offer a platform called Integrated Global Alignment, or iGA, which offers a global approach for assessing, preserving, and restoring spinal alignment in an effort to promote surgical effectiveness and efficiencies, lasting patient outcomes, and improved quality of life. We offer iGA for thoracolumbar and cervical procedures, which allows surgeons to use procedurally-based technologies to preoperatively calculate and evaluate alignment parameters and implant integration by accurately modeling surgery to create a reliable plan with clear results, and then conduct a real-time intraoperative assessment in order to correct the anterior and posterior column alignment in line with the surgical plan. Following a procedure, surgeons can use our iGA solutions to confirm the success of the procedure and effect on alignment by reviewing surgical results and easily comparing those results to the surgical plan. In addition to our software solutions, we also offer specific products that are designed to restore alignment, including our Bendini spinal rod bending system which is designed to provide rapid intraoperative alignment assessment and rod customization.

Imaging Technology

Our Lessray system is an image enhancement platform designed to help surgeons and hospital staff manage radiation exposure associated with x-ray and other imaging technology, without compromising intraoperative images or visual accuracy. This is achieved through digital imaging processing technology that generates high-resolution images of the surgical field from low-resolution fluoroscopy (or x-ray) images. We currently offer Lessray as a standalone product and the Lessray technology will also be incorporated into our Pulse platform.

 

8

Table of Contents

Integrated Surgical Automation Platform

The Pulse platform is our integrated technology platform designed to comprehensively address the unique clinical and operational challenges of spine surgery. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for neuromonitoring, iGA surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. We expect to continue to invest in the Pulse platform to support a full commercial launch of the technology and to develop and expand its application offerings, including investments related to surgical automation and robotics.

MAGEC Spinal Bracing and Distraction System

Our MAGEC system is designed to overcome the limitations of conventional adjustable rod treatments for early onset scoliosis, or EOS, and reduce the number of surgical procedures required throughout childhood. EOS refers to severely deformed curvatures of the spine diagnosed before the age of ten. EOS is a challenging health issue and can lead to more severe progressive deformities. Surgical treatments for EOS include the use of surgically adjustable expandable rods to control the spine deformity while still allowing the spine to grow until a child reaches an appropriate size or age for a more permanent solution, such as spinal fusion. Surgeries to adjust traditional growing rods are typically performed every six to nine months and are associated with scarring, elevated infection rates, postoperative pain, and impaired mobility as the child heals from surgery. Additionally, these surgeries involve repetitive exposure to general anesthesia, which can delay development and impair long-term cognitive function. Once our magnetically adjustable MAGEC growing rods are surgically implanted in a patient, they can be adjusted non-invasively using an external remote controller. The ability to adjust growing rods without surgical intervention means that EOS patients can be treated with fewer planned surgeries. Our non-invasive adjustment technology enables physicians to perform more frequent adjustments in a non-surgical outpatient setting, thereby improving deformity correction and allowing for optimal spinal growth.

Specialized Orthopedics

Through our NuVasive Specialized Orthopedics subsidiary, we develop and manufacture magnetically adjustable orthopedics products using the MAGEC technology. The Precice system is our primary specialized orthopedics product offering and is designed to treat and correct limb length discrepancies, or LLDs, caused by congenital deformity or injury resulting in one leg being shorter than the other. Large LLDs often require complex treatments including limb lengthening surgery to create equal limb length. The traditional limb lengthening surgical procedure includes the creation of a gap in the bone, or osteotomy, the attachment of wires or pins to the fractured bones, and the passing of the wires or pins through the skin to an external fixator, a scaffold-like frame that surrounds the limb. The external fixator distracts the bone when the patient or a family member manually turns the knobs on the fixator. These adjustments must be performed several times each day such that the bone is lengthened approximately one millimeter per day. Adjustments of the external fixator are very painful and associated with soft tissue disruption, disturbance of the wound healing process of the skin and soft tissue and high rates of pin site infection. In addition, traditional external fixation can result in significant psychosocial comorbidities that reduce quality of life for patients undergoing treatment, including anxiety, social disengagement, sleep disorders, depression and addiction to pain medication. The Precice system uses a specialized intramedullary nail that, once surgically implanted, is lengthened using the MAGEC technology, which enables non-invasive and painless adjustments using a pre-programmed external remote controller. As a result, Precice enables physicians to customize therapy to the needs of the patient over time without the need for surgical re-intervention and provides improved quality of life and satisfaction for patients in need of surgical limb lengthening.

Research and Development

Our research and development efforts are primarily focused on developing new technology platforms and further enhancing our existing products to improve and further integrate procedural solutions to address unmet clinical needs while improving clinical, economic, and operational outcomes. Our research and development group has extensive experience in developing products to treat spine pathologies. This group continues to work closely with clinical advisors and spine surgeons to design products and procedural solutions designed to improve patient outcomes, simplify techniques, and reduce patient trauma including subsequent hospitalization and rehabilitation times; and as a result reduce overall costs to patients and the healthcare system.

 

9

Table of Contents

International

As the spine market shifts towards less-invasive surgery and international access to healthcare increases, it should provide us with an opportunity for accelerated growth outside the United States. Because our procedurally integrated solutions and technologies treat similar pathologies around the world, we are focused on expanding our operations in select developed and emerging international markets. We are investing to tailor our products and technologies to meet varying international patient, surgeon and market requirements. We are also investing in our global infrastructure to adapt alternative distribution channels, to support differing language and customer service requirements, and to provide training and surgeon education in our surgical techniques, instruments, products and technologies to our international customers. We intend to continue to make targeted investments in select international markets in order to increase our commercial reach outside of the United States. Our international net sales, which exclude Puerto Rico, were $228.8 million or 22% of total net sales for the year ended December 31, 2020.

Sales and Marketing

In the United States, we currently sell our procedurally integrated solutions through a combination of exclusive and non-exclusive independent sales agents and directly-employed sales force. Each member of our United States sales force is responsible for a defined territory, with our independent sales agents acting as our sole representative in their respective territories. The determination of whether to engage a directly-employed sales representative or an independent sales agent is made on a territory–by-territory basis, with a focus on aligning the sales team with the best skills and experience with local surgeons’ needs. Our international sales force is comprised of directly-employed sales representatives, as well as exclusive distributors and independent sales agents. Directly-employed sales representatives make up the majority of our overall sales force.

Surgeon Training and Education

We devote significant resources to training and educating surgeons regarding the safety and reproducibility of our surgical techniques and our procedurally integrated solutions. Our surgeon education and training program is led by our Clinical Professional Development team, and integrates surgical training with professional development and enables us to introduce surgeons to our less-invasive approaches to spine surgery. At our corporate headquarters in San Diego, California, we maintain our West Coast Experience Center, including a state-of-the-art cadaver operating theatre and research and development labs to help educate and train surgeons. In February 2021, we announced plans to expand our Clinical Professional Development program with a new East Coast Experience Center in Englewood, New Jersey, scheduled to open later in 2021, where we will host competency-based courses and cadaveric trainings on our procedurally integrated solutions and showcase our Pulse platform in a dedicated demonstration lab. Additionally, we offer educational and training courses globally through in-person formats and via virtual content, including through virtual conferences, video and social channels, to demonstrate the benefits of our innovative products and procedures.

Manufacturing and Supply

A substantial portion of our implant products are self-manufactured in our facility in West Carrollton, Ohio. We also maintain a network of third-party suppliers for certain implant and instrument products. Our outsourcing strategy is targeted at companies that meet U.S. Food and Drug Administration, or FDA, International Organization for Standardization, or ISO, and quality standards supported by internal policies and procedures. Supplier performance is maintained and managed through a supplier qualification, performance management and corrective action program intended to ensure that all of our product requirements are met or exceeded.

Our products are inspected, packaged and labeled, as needed, at our qualified suppliers or at our facilities in San Diego, Memphis, West Carrollton, and Aliso Viejo. Under our existing contracts with third-party manufacturers, we reserve the right to inspect and assure conformance of each product and product component to our specifications.

We currently rely on several tissue banks as our suppliers of allograft tissue implants, including for our Osteocel Plus and Osteocel Pro product lines. Like our relationships with our device manufacturing suppliers, we subject our tissue processing suppliers to the same quality criteria in terms of selection, qualification, and verification of processed tissue quality upon receipt of goods, as well as hold them accountable to compliance with FDA regulations, state requirements, and as-voluntary industry standards (such as those put forward by the American Association of Tissue Banks).

We rely on two suppliers for PEEK, which comprises many of our partial vertebral body replacement and interbody product lines. We also work with a limited number of suppliers for certain components of our neuromonitoring platforms, and continue to develop redundancies for critical components within those supply chains.

 

10

Table of Contents

We, and our third-party manufacturers, are subject to the quality system regulations of the FDA, state regulations (such as the regulations promulgated by the California Department of Health Services), and regulations promulgated by foreign regulatory bodies (such as in the European Union). For tissue products, we are FDA registered and licensed in the States of California, New York, Florida, Maryland and Oregon. For our device implants and instruments, we are FDA registered, California licensed, CE marked and ISO certified. CE is an abbreviation for “Conformité Européenne” or European Conformity, and is the registration marking designating that a device can be commercially distributed throughout Europe. Our facilities and the facilities of our third-party manufacturers are subject to periodic announced and unannounced inspections by regulatory authorities, and may undergo compliance inspections conducted by the FDA, state, and/or international regulatory agencies.

Surgical Instrument, Implant Sets and Equipment Sales

For many of our customers, we provide surgical instrumentation sets, including both implants and instruments, as well as our neuromonitoring systems in a manner tailored to fulfill our customer’s obligations to meet surgery schedules. We do not generally receive separate economic value specific to the surgical instrument sets from the surgeons or hospitals that utilize them. In many cases, once the surgery is finished, the surgical instrument sets are returned to us, and we prepare them for shipment to meet future surgeries.

We complement this implant and instrument shipment model with field-based instrument assets. This hybrid strategy is designed to improve customer service, minimize backlogs, increase asset turns, optimize freight costs, and maximize cash flow. Our pool of surgical equipment we make available to hospitals continues to increase as we increase our product offering, expand our distribution channels and increase the market penetration of our products. These surgical instrumentation and implant sets are important to the growth of our business, and we anticipate additional investments in such assets going forward.

In certain cases, we will sell either surgical instruments, implant sets or both to our customers. While this does not constitute a material component of our business, as customer penetration and volume increases, these sales of sets allow our customers to increase the amount of surgical volume performed locally. Additionally, we offer flexibility to customers for our capital equipment by offering capital sales and leasing arrangements. We do not have a long history of selling, leasing or servicing capital equipment, and we have recently invested and intend to continue to invest in building resources and expertise in this area. Selling and leasing of capital equipment do not make up a material portion of our total net sales.

Intellectual Property

We rely on a combination of patent, trademark, copyright, trade secret and other intellectual property laws, nondisclosure agreements and other measures to protect our intellectual property rights. In order to have a competitive advantage, we must develop and maintain the proprietary aspects of our technologies. We require our employees, consultants and advisors to execute confidentiality agreements in connection with their employment, consulting or advisory relationships with us. We also require our employees, consultants and advisors who we expect to work on our products to agree to disclose and assign to us all inventions conceived using our property or which relate to our business. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or to obtain and use information that we regard as proprietary.

Patents

As of December 31, 2020, we had over 1,350 issued and pending patents world-wide, including over 650 U.S. issued patents. Our issued and pending patents cover, among other things:

 

•

Surgical access instrumentation and methodology, relating to our XLIF and X360 procedures and aspects thereof, as well as technologies and methods related to our C360 portfolio;

 

•

Neurophysiology enabled instrumentation and methodology, including pedicle screw test systems, software hunting algorithms, navigated guidance, rod bending and surgical access systems;

 

•

Spinal implants and related instrumentation and targeting systems;

 

•

Biologics, including Osteocel Plus and Osteocel Pro, Formagraft and AttraX;

 

•

Magnetic technology for non-invasive distraction of an implanted device, including the MAGEC technology platform;

 

•

Digital imaging processing technology that generates high resolution images of the surgical field from low resolution scans, including the Lessray technology platform;

 

•

Porous PEEK technology, included in our Cohere and Coalesce spinal implants; and

 

•

Surgical navigation and robotics technology.

Our issued patents began to expire in 2018. We do not believe that the expiration of any single patent is likely to significantly affect our intellectual property position.

 

11

Table of Contents

The medical device industry is characterized by the existence of a large number of patents and frequent litigation based on allegations of patent infringement. Patent litigation can involve complex factual and legal questions, can be expensive, and its outcome is uncertain. Our success will depend in part on our not infringing patents issued to others, including our competitors and potential competitors. As the number of entrants into our market increases, the possibility of future patent infringement claims against us grows. While we make extensive efforts to ensure that our products do not infringe other parties’ patents and proprietary rights, our products and methods may be covered by patents held by our competitors. There are numerous risks associated with our intellectual property. For a complete discussion of these risks, please see the “Risk Factors” section of this Annual Report.

Trademarks

As of December 31, 2020, we had over 320 trademark registrations in both domestic and foreign regions.

Competition

Competition within the industry is primarily based on technology, innovation, quality, reputation and customer service. Our significant competitors are Medtronic Sofamor Danek, or Medtronic, DePuy/Synthes, a Johnson & Johnson company, Stryker Spine, Globus Medical, and Zimmer Biomet Spine, which together represent a significant portion of the spine market. We also face competition from a significant number of smaller companies with more limited product offerings and geographic reach than our larger competitors. These companies, who represent intense competition in specific markets, include Orthofix International N.V., Alphatec Spine, SeaSpine Holdings Corporation, and others. With respect to our neuromonitoring systems, we primarily compete with Medtronic and Cadwell Industries. Our IONM services business competes with SpecialtyCare and numerous smaller and regional neuromonitoring companies as well as insourced neuromonitoring functions operated by hospitals.

The United States Government Regulation

Our products are medical devices and human tissue products subject to extensive regulation by the FDA and other regulatory bodies both inside and outside of the United States. Each of these agencies requires us to comply with laws and regulations governing the development, testing, manufacturing, storage, labeling, marketing and distribution of our products.

FDA’s Premarket Clearance and Approval Requirements

Unless an exemption applies, each medical device that we market and sell in the United States must first receive either premarket clearance (by submitting a 510(k) notification) or premarket approval (by filing a premarket approval application, or PMA) from the FDA. In addition, certain modifications to marketed devices may require 510(k) clearance or approval of a PMA supplement. The FDA will clear marketing of a medical device through the 510(k) process if it is demonstrated that the new product is substantially equivalent to other 510(k)-cleared products (referred to as a predicate device). The FDA’s 510(k) clearance process usually takes between three and six months from the date the application is completed, but may last longer. The process of obtaining PMA approval is much more costly, lengthy and uncertain than the 510(k) clearance process and generally takes between one and three years, or even longer, from the time the application is submitted to the FDA until any approval is obtained. In addition, a clinical trial is almost always required to support a PMA application and may be required for a 510(k) premarket notification.

In 2018, the FDA issued draft guidance and announced steps to modernize the 510(k) clearance pathway that, if finalized and implemented, could impact the ability of medical device manufacturers to obtain or maintain 510(k) clearance for devices. Among other initiatives, the FDA has proposed to “sunset” the use of older predicate devices for purposes of comparison in new device 510(k) clearance submissions. If we cannot establish that a new or modified product is substantially equivalent to a predicate device, we may be required to seek pre-market approval through the PMA process. There are numerous risks associated with the PMA process, which typically requires conducting clinical trials with high costs and uncertain outcomes. For a complete discussion of these risks, please see the “Risk Factors” section of this Annual Report.

Human Cell, Tissue, and Cellular and Tissue Based Products

Our allograft products, including our Triad and ExtenSure, and our Osteocel Plus and Osteocel Pro products, are regulated by the FDA as Human Cell, Tissue, and Cellular and Tissue Based Products. FDA regulations do not currently require these minimally manipulated human tissue-based products to be subjected to a premarket approval or pre-market notification process before they are marketed if they are deemed to meet the requirements of a “361” product under the Public Health Safety Act.

We are required to register with the FDA as a provider of such products and to list these products with the FDA and comply with its Current Good Tissue Practices for Human Cell, Tissue, and Cellular- and Tissue-Based Product Establishments. The FDA periodically inspects tissue facilities to determine compliance with these requirements. Entities that provide us with allograft bone tissue are responsible for performing donor recovery, donor screening, donor testing, processing, and packaging and our compliance with those aspects of the Current Good Tissue Practices regulations that regulate those functions are dependent upon the actions of these independent entities.

 

12

Table of Contents

The procurement and transplantation of allograft bone tissue is subject to United States federal law pursuant to the National Organ Transplant Act (NOTA), a criminal statute that prohibits the purchase and sale of human organs used in human transplantation - including bone and related tissue - for “valuable consideration” (as defined in the NOTA). The NOTA permits reasonable payments associated with the removal, transportation, processing, preservation, quality control, implantation and storage of human bone tissue. With the exception of removal and implantation, we provide services, directly or indirectly, in all of these areas. We make payments to vendors in consideration for the services they provide in connection with the recovery and screening of donors. Failure to comply with the requirements of NOTA could result in enforcement action against us.

The procurement of human tissue is also subject to state anatomical gift acts and some states have statutes similar to NOTA. In addition, some states require that tissue processors be licensed by that state. Failure to comply with state laws could also result in enforcement action against us.

Continuing FDA Regulation

After a device is placed on the market, numerous regulatory requirements continue to apply. These regulatory requirements include, but are not limited to, the following:

 

•

product listing and establishment registration;

 

•

adherence to the Quality System Regulation which requires stringent design, testing, control, documentation and other quality assurance procedures;

 

•

labeling requirements and FDA prohibitions against the promotion of off-label uses or indications;

 

•

adverse event reporting;

 

•

post-approval restrictions or conditions, including post-approval clinical trials or other required testing;

 

•

post-market surveillance requirements;

 

•

the FDA’s recall authority, whereby it can ask for, or require, the recall of products from the market; and

 

•

requirements relating to voluntary corrections or removals.

Failure to comply with applicable regulatory requirements can result in fines and other enforcement actions by the FDA, which could adversely impact our business.

We are also subject to announced and unannounced inspections by the FDA, the California Food and Drug Branch, American Association of Tissue Banking, as well as other regulatory agencies overseeing the implementation and adherence of applicable state and federal device and tissue licensing regulations. These inspections may include our manufacturing and subcontractors’ facilities.

Pursuant to FDA regulations, we can only market our products for cleared or approved uses. Although surgeons are permitted to use medical devices for indications other than those cleared or approved by the FDA based on their medical judgment, we are prohibited from promoting products for such “off-label” uses.

Healthcare Regulation and Commercial Compliance

The healthcare industry is highly regulated and changes in laws and regulations can be significant. The federal government and all states in which we currently operate regulate various aspects of our business. Changes in the law or new interpretation of existing laws can have a material effect on our permissible activities, the relative costs associated with doing business and the amount of reimbursement by government and other third-party payers.

Anti-Kickback Statute

We are subject to the federal Anti-Kickback Statute which, among other things, prohibits the knowing and willful solicitation, offer, payment or receipt of any remuneration, direct or indirect, in cash or in kind, in return for, or to induce the referral of patients for, items or services covered by Medicare, Medicaid and certain other governmental health programs. Under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (ACA), neither knowledge of the Anti-Kickback Statute nor the specific intent to violate the law is a requirement for being found in violation of such laws. Violation of the Anti-Kickback Statute may result in civil or criminal penalties and exclusion from Medicare, Medicaid and other federal healthcare programs, and now provides a basis for liability under the False Claims Act. Many states have enacted similar statutes, which are not limited to items and services paid for under Medicare or a federally funded healthcare program. We believe our operations materially comply with the anti-kickback laws; however, because these provisions are interpreted broadly by regulatory authorities, we cannot be assured that law enforcement officials or others will not challenge our operations under these statutes.

 

13

Table of Contents

Federal False Claims Act

The Federal False Claims Act (in particular its “qui tam” or “whistleblower” provisions) allows private individuals to bring actions in the name of the United States government alleging that a defendant has made false claims for payment from federal funds. In addition, various states are considering enacting or have enacted laws modeled after the Federal False Claims Act, penalizing false claims against state funds.

Health Insurance Portability and Accountability Act

Under the Health Insurance Portability and Accountability Act of 1996, as was amended in 2005 and in 2009, or HIPAA, a Covered Entity is required to adhere to certain requirements regarding the use, disclosure and security of protected health information, or PHI. In the past, HIPAA has generally affected us indirectly, as NuVasive is generally neither a Covered Entity nor a Business Associate, as further defined under HIPAA, to Covered Entities, except that our provision of IONM services through various subsidiaries may create a Business Associate relationship; additionally, we treat our Puerto Rico subsidiary as a Covered Entity. Regardless of Covered Entity status under HIPAA, in those cases where patient data is received, NuVasive is committed to maintaining the security and privacy of PHI. The potential for enforcement action against us is now greater, as the U.S. Department of Health and Human Services, or HHS, can take action directly against Business Associates. Thus, while we believe we are and will be in compliance with all required HIPAA standards, there is no guarantee that the government will agree. Enforcement actions can be costly and interrupt regular operations of our business.

Foreign Corrupt Practices Act

The United States and foreign government regulators have increased regulation, enforcement, inspections and governmental investigations of the medical device industry, including increased United States government oversight and enforcement of the Foreign Corrupt Practices Act, or FCPA. The FCPA and similar anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business. The FCPA also imposes accounting standards and requirements on publicly traded U.S. corporations and their foreign affiliates, which are intended to prevent the diversion of corporate funds to the payment of bribes and other improper payments. If the United States or another foreign governmental authority were to conclude that we are not in compliance with applicable laws or regulations, such governmental authority can impose fines, delay or suspend regulatory clearances, institute proceedings to detain or seize our products, issue a recall, impose operating restrictions, enjoin future violations and assess civil penalties against us or our officers or employees, and can recommend criminal prosecution to the DOJ. Moreover, governmental authorities can ban or request the recall, repair, replacement or refund of the cost of any device or product we manufacture or distribute. We are also potentially subject to the UK Bribery Act, which would also subject us to the imposition of civil and criminal fines. Any of the foregoing actions could result in decreased sales as a result of negative publicity and product liability claims, and could have a material adverse effect on our financial condition, results of operations and prospects.

Physician Payments Sunshine Act of 2009 (Sunshine Act)

The Sunshine Act was enacted into law in 2010 and requires public disclosure to the United States government of payments to physicians and teaching hospitals, including in-kind transfers of value such as free gifts or meals. The Act also provides penalties for non-compliance. The Sunshine Act requires that we file an annual report on March 31 of a calendar year for the transfers of value incurred for the prior calendar year. This law, along with various international and individual state reporting requirements, such as in Massachusetts and Vermont, increases the possibility that a healthcare company may run afoul of one or more of the requirements.

Compliance Program

A compliance program is a set of internal controls established by a company to prevent and/or detect any non-compliant activities and to address properly those issues that may be discovered. The United States government has recommended that healthcare companies, among others, develop and maintain an effective compliance program to reduce the likelihood of any such non-compliance by the company, its employees, agents and contractors. In addition, some states, such as Massachusetts and California, now require certain healthcare companies to have a formal compliance program in place in order to do business within the state. For years, we have maintained a compliance program structured to meet the requirements of the federal sentencing guidelines for an effective compliance program and the model compliance program guidance promulgated by HHS over the years. Our program includes, but is not limited to, a Code of Ethical Business Conduct, designation of a compliance officer, oversight by a designated committee of our Board of Directors, policies and procedures, a confidential disclosure method (a hotline), and conducting periodic compliance audits.

Foreign Government Regulation

Sales of medical devices outside the United States are subject to foreign government regulations, which vary substantially from country to country. The time required to obtain clearance or approval by a foreign country may be longer or shorter than that of the FDA, and the requirements may differ.

 

14

Table of Contents

The European Union has adopted numerous directives and standards regulating the design, manufacture, clinical trials, labeling, and adverse event reporting for medical devices. Additionally, certain countries (such as Switzerland), have voluntarily adopted laws and regulations that mirror those of the European Union with respect to medical devices. Devices that comply with the requirements of a relevant directive will be entitled to bear “CE” conformity marking, and, accordingly, can be commercially distributed throughout Europe. The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a “Notified Body”. This third-party assessment consists of an audit of the manufacturer’s quality system and technical review of the manufacturer’s product. We have now successfully passed several Notified Body audits since our original certification in 2001, granting us ISO certification and allowing the CE conformity marking to be applied to certain of our devices under the European Union Medical Device Directive.

In 2017, the European Union adopted the EU Medical Device Regulation (Council Regulations 2017/745) which imposes stricter requirements for the marketing and sale of medical devices, including new quality system and post-market surveillance requirements. In 2017, the European Union adopted the EU Medical Device Regulation (Council Regulations 2017/745) which will replace existing directives and impose stricter requirements for the marketing and sale of medical devices, including new clinical evaluation, quality system, and post-market surveillance requirements. The regulation initially provided for a three-year implementation period, with full application of the regulation to occur in May 2020, but this timeline has been delayed to May 2021 due to the COVID-19 pandemic. After May 2021, medical devices marketed in the European Union will require certification according to these new requirements, except that devices with valid CE certificates, issued pursuant to the Medical Device Directive before May 2021, may be placed on the market until May 2024. Complying with this new regulation will require us to incur significant costs and failure to meet the requirements of the regulation could adversely impact our business in the European Union and other countries that utilize or rely on European Union requirements for medical device registrations.

Following a national referendum and enactment of legislation by the government of the United Kingdom, or the UK, the UK formally withdrew from the European Union and ratified a trade and cooperation agreement governing its future relationship with the European Union. The agreement, which is being applied provisionally from January 1, 2021, until it is ratified by the European Parliament and the Council of the European Union, addresses trade, economic arrangements, law enforcement, judicial cooperation, and a governance framework, including procedures for dispute resolution, among other things. Because the agreement merely sets forth a framework in many respects and will require complex additional bilateral negotiations between the UK and the European Union, significant political and economic uncertainty remains about how the precise terms of the relationship between the parties will differ from the terms before withdrawal. Further, pursuant to guidance issued by the UK Government, the Medicines and Healthcare products Regulatory Agency (MHRA) became the standalone medicines and medical devices regulator for the UK as of January 1, 2021. A new mark referred to as “UKCA” (UK Conformity Assessed) has also been introduced and will replace the CE conformity mark. UK Approved Bodies designated by the MHRA will conduct conformity assessments against applicable requirements of the UKCA mark. Obtaining the UKCA conformity mark will be optional beginning in January 2021 and will become mandatory in July 2023. Although CE conformity marketing and certificates issued by Notified Bodies will continue to be recognized in the UK through June 2023, all medical devices must be registered with the MHRA as of January 1, 2021. Additionally, for manufacturers based outside of the UK, a single UK Responsible Person with a place of business in the UK must be established. Complying with this new regulatory framework will require us to invest in additional resources and could be expensive, time-consuming and disruptive to our existing operations in the UK.

In 2014, the Japanese government made revisions to the Pharmaceutical Affairs Law (now called PMD Act) that made significant changes to the preapproval regulatory systems. These changes have - in part - stipulated that, in addition to obtaining a manufacturing or import approval from the Ministry of Health, Labor and Welfare, certain low-risk medical devices can now be evaluated by third-party organizations. Based on the risk-based classification, manufacturers are provided three procedures for satisfying the PMD Act requirements prior to placing products on the market: Pre-market Submission, or Todokede; Pre-market Certification, or Ninsho; and Pre-market Approval, or Shonin. NuVasive markets devices in Japan that are assessed by both government entities and third-party organizations using all three procedures in place for manufacturers. The level of review and time line for medical device approval depends on the risk-based classification and subsequent regulatory procedure that the medical device is aligned based on assessment against the current PMD Law. Manufacturers must also obtain a manufacturing or import license from the prefectural government prior to importing medical devices. We also pursue authorizations required by the prefectural government as required.

Device and tissue premarket approval and/or registration and/or facility licensing requirements also exist in other markets where international NuVasive facilities are established and/or where we may conduct business, including, but not limited to, Southeast Asia, Australia, and Latin America. Such requirements vary by country and NuVasive has established procedures to drive its compliance with these requirements.

Data protection laws, including the EU General Data Protection Regulation, or GDPR, also apply to our international operations. The GDPR requires, among other things, obligations and restrictions on the ability to collect, analyze and transfer EU personal data and the prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances. These data protection regulations create a range of compliance obligations and permit substantial fines for noncompliance.

 

15

Table of Contents

Third-Party Reimbursement

Broadly speaking, payer pushback on spine surgery and IONM services in the United States has increased in the recent past, and we believe this has had an overall dampening effect on spine procedure volumes and prices.

We expect that sales volumes and prices of our products and services will continue to be largely dependent on the availability of reimbursement from third-party payers, such as governmental programs, for example, Medicare and Medicaid, private insurance plans, accountable care organizations and managed care programs. Reimbursement is contingent on established coding for a given procedure, coverage of the codes by the third-party payers, and adequate payment for the resources used.

Physician coding for procedures is established by the American Medical Association, or AMA. For coding related to spine surgery, the North American Spine Society, or NASS, is the primary liaison to the AMA. In July of 2006, NASS established the proper physician coding for the XLIF procedure by declaring it to be encompassed in existing codes that describe an anterolateral approach to the spine. This position was confirmed in a formal statement by NASS in January 2010. Hospital coding is established by the Centers for Medicare & Medicaid Services. XLIF is included in the nomenclature for hospital codes as an additional descriptor under long standing codes. All physician and hospital coding is subject to change which could impact reimbursement and physician practice behavior.

Independent of the coding status, third-party payers may deny coverage based on their own criteria, including if they feel that a device or procedure is not well established clinically, is not the most cost-effective treatment available, or is used for an unapproved indication. At various times in the past, certain insurance providers have adopted policies of not providing reimbursement for the XLIF procedure. We have worked with our surgeon customers and NASS who, in turn, have worked with these insurance providers to supply the information, explanation and clinical data they require to categorize the XLIF procedure as a procedure entitled to reimbursement under their policies. At present, most major health insurance companies in the United States provide reimbursement for XLIF procedures.

However, certain carriers, large and small, may have policies significantly limiting coverage of XLIF, Interlaminar Lumbar Interbody Fusion, or ILIF, Osteocel Plus and Osteocel Pro, cervical interbody implants, and/or other procedures, products or services that we offer. We will continue to provide resources to patients, surgeons, hospitals, and insurers in order to ensure optimum patient care and clarity regarding reimbursement and work to remove any and all non-coverage policies. National and regional coverage policy decisions are subject to unforeseeable change and have the potential to impact physician behavior and reimbursement for physician services. We cannot offer definitive time frames or final outcomes regarding reversal of the coverage-limiting policies, as the process is dictated by the third-party insurance providers. For a discussion of these risks, please see the “Risk Factors” section of this Annual Report.

Payment amounts are established by government and private payer programs and are subject to fluctuations, which could impact physician practice behavior. Third-party payers are increasingly challenging the prices charged for a wide range of medical products and services, including those in spine and intraoperative monitoring where we participate.

In international markets, reimbursement and healthcare payment systems vary significantly by country and many countries have instituted price ceilings on specific product lines. There can be no assurance that our products will be accepted by third-party payers, that reimbursement will be available, and/or that the third-party payers’ reimbursement policies (if available) will not adversely affect our ability to sell our products profitably.

In the United States, as a result of healthcare reform, third-party payers are increasingly required to demonstrate they can improve quality and reduce costs; we accordingly see an increase in pre-approval/prior authorizations and non-coverage policies citing higher levels of evidence required for medical therapies and technologies. In addition, insured individuals are facing increased premiums and higher out–of-pocket costs for medical coverage, which can lead a patient to delay medical treatment. An increasing number of insured individuals receive their medical care through managed care programs, which monitor and often require pre-approval of the services that a member will receive. The percentage of individuals covered by managed care programs is expected to grow in the United States over the next decade.

Overall escalating costs of medical products and services has led to, and is expected to continue to lead to, increased pressures on the healthcare industry to reduce the costs of products and services. There can be no assurance that third-party reimbursement and coverage will be available or adequate, or that future legislation, regulation, or reimbursement policies of third-party payers will not adversely affect the demand for our products and services or our ability to sell these products and services on a profitable basis. The unavailability or inadequacy of third-party payer coverage or reimbursement could have a material adverse effect on our business, operating results and financial condition. For a discussion of these risks, please see the “Risk Factors” section of this Annual Report.

 

16

Table of Contents

Human Capital Resources

Workforce Composition

As of December 31, 2020, we had approximately 2,700 employees worldwide. Approximately 2,200 employees were located within the U.S. and 500 employees were located outside of the U.S., primarily throughout Europe and Asia. None of our employees are represented by a labor union. Employees of our wholly-owned subsidiary, NuVasive Netherlands B.V., based in the Netherlands, are covered by a Works Council. In addition to our employees, we partner with independent sales representatives and independent distributors who sell our products in the United States and internationally.

In the United States, our sales force consists of directly employed sales representatives and independent sales representatives who are responsible for particular geographic regions of the country. Outside of the United States, our sales force consists of directly employed sales representatives, independent sales representatives and independent territory-based distributors. We operate in a highly competitive industry and it is essential that we attract and retain qualified personnel through competitive compensation and benefits and a rewarding work environment in order to achieve our strategic business objectives. In particular, competition for sales talent in the spine industry is significant. Our sales force provides a delivery and consultative service to our surgeon and hospital customers, and our sales representatives often develop long-lasting relationships with the customers they serve. Accordingly, recruiting sales representatives with appropriate expertise, retaining our talent, and incentivizing our sales force is important to our success. We also believe we attract and retain sales talent based on the breadth of our spine product and service offerings, our enabling technologies, our commitment to investing in research and development and our new product innovation pipeline, as well our world-class surgeon training and education program, all of which we believe makes NuVasive a destination of choice for top sales talent.

Compensation and Benefits

We offer competitive benefit packages, supporting our employees as they help to transform spine surgery. This includes encouraging a culture of health by providing cost-effective wellness programs to best serve our employees and their family members. Our comprehensive benefits package may include competitive pay, annual incentive awards and bonus opportunities, healthcare and retirement benefits, an Employee Stock Purchase Plan, paid time off and sick leave, flexible work schedules, remote working opportunities, and a wellness program.

Talent Development

We believe that success comes from investing in our people and ensuring our work force is aligned with our mission and values. To achieve this goal, we devote time and resources to ensure that throughout our organization, employees are familiar with our business, industry and product offerings. Training is offered to new employees which teaches the anatomy and pathologies of the spine and our surgical procedures, and our sales representatives receive additional comprehensive training on our various product offerings. In addition, a key driver of the Company’s future growth is our ability to develop leaders. We are committed to identifying and developing talent to help those employees accelerate their growth and achieve their career goals.

Employee Communication and Engagement

We value open and direct communication with our employees about their experiences. We use a variety of channels to obtain employee feedback, including employee surveys, open forums with leadership, and employee resource groups. Our annual employee survey provides us with actionable data for the overall Company and each department and also provides managers with upward feedback on how they are progressing against expectations. Each year, the input received through these mechanisms is used to help evolve our working environment and strengthen our culture.

Diversity and Inclusion

We recognize the value associated with fostering a work environment that is culturally diverse and inclusive. Our goal is to cultivate a respectful and professional environment where all voices are heard and valued. We have dedicated personnel focused on our diversity and inclusion vision and have established employee resource groups, which aim to highlight the value of diversity, inclusion and engagement, while providing professional development opportunities for employees of all genders, experience levels, and locations. As we seek to create a more diverse and inclusive workforce, we have begun to monitor voluntarily disclosed diversity data to review hiring, promotion and attrition overall at the company and at the department level. We also review performance data and promotion and compensation information to ensure fair and objective decision-making.

 

17

Table of Contents

Community

Our employees and sales representatives have a long history of providing support and care to our communities, donating time, resources and funds to local causes. Since 2009, we have leveraged our expertise in spine care to give back to local and global communities through the NuVasive Spine Foundation (“NSF”). NSF supports life-changing spine surgery for individuals around the world with limited access to high quality medical treatment by working with surgeons to advance the quality of spine care in disadvantaged communities. In addition, through our grants program, we support medical research and education, charitable and philanthropic endeavors. We believe in giving back, and we also believe it is important to operate our Company in a socially responsible manner.

Health, Safety, and Wellness

We are committed to the protection of our employees, customers, communities and the environment. Our operations require the use of hazardous materials that subject us to various federal, state, and local environmental and safety laws and regulations. Our key areas of focus include corporate compliance with responsible hazardous waste management, recycling, emergency preparedness, as well as various initiatives to improve our health and safety programs with the goal of reducing and ultimately eliminating serious injuries.

In response to the COVID-19 pandemic, we adopted a broad approach to increased safety, including work-at-home arrangements for employees who were able to do so, working shift adjustments to decrease the number of people in our manufacturing and distribution facilities, requirements for the wearing of masks and for physical distancing, increased cleaning between shifts, readily available hand sanitizing stations, widespread signage and messaging reminding employees of the importance of these measures and other steps.

Human Capital Governance

Our Board of Directors receives regular updates on topics related to talent development, retention and recruiting initiatives, our diversity and inclusion program, succession planning, employee engagement and the results from our annual employee survey. Management also works closely with the Compensation Committee to establish goals and objectives and metrics in connection with the design and funding of the annual bonus opportunity for our employees. Additionally, the Nominating, Corporate Governance and Compliance Committee and the Audit Committee share oversight responsibilities related to the Company’s Code of Ethical Business Conduct which establishes policies pertaining to, among other things, employee conduct in the workplace, workplace safety, confidentiality, conflicts of interest, accuracy of books, records and financial statements, securities trading, anti-corruption, competition laws, interactions with health care professionals and political and charitable activities.

Corporate Information

Our business was incorporated in Delaware in July 1997. Our principal executive offices are located at 7475 Lusk Boulevard, San Diego, California 92121, and our telephone number is (858) 909-1800. Our website is located at www.nuvasive.com.

We file our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K, and any amendments to those reports, electronically with the Securities and Exchange Commission, or the Commission. We make these reports available free of charge on our website under the investor relations page as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Commission. All such reports were made available in this fashion during 2020.

The public can also obtain any documents that we file with the Commission at http://www.sec.gov.

This report may refer to brand names, trademarks, service marks or trade names of other companies and organizations, and these brand names, trademarks, service marks and trade names are the property of their respective holders.

 

18

Table of Contents

Item 1A.Risk Factors

An investment in our common stock involves a high degree of risk. Risk factors that could cause actual results to differ from our expectations and that could negatively impact our financial condition and results of operations are summarized and set forth in detail below and elsewhere in this report. If any of these risks actually occur, our business, financial condition, results of operations and future growth prospects could be materially and adversely affected. Under these circumstances, the trading price of our common stock could decline, and you may lose all or part of your investment. Further, additional risks not currently known to us or that we currently believe are immaterial also may impair our business, operations, liquidity and stock price materially and adversely. You should consider carefully the risks and uncertainties summarized and set forth in detail below and elsewhere in this report before you decide to invest in our common stock.

Summary of Risk Factors

We are providing the following summary of the risk factors contained in this Annual Report on Form 10-K to enhance the readability and accessibility of our risk factor disclosures. This summary does not address all of the risks that we face. We encourage you to carefully review the full risk factors contained in this Annual Report on Form 10-K in their entirety for additional information regarding the material factors that make an investment in our securities speculative or risky. The primary categories by which we classify risks include those related to: (i) our business and industry, (ii) our commercial operations and plans for future growth, (iii) litigation and intellectual property, (iv) regulatory and compliance, (v) our financial results and financing needs, and (vi) the securities markets and ownership of our common stock. Set forth below within each of these categories is a summary of the principal factors that make an investment in our common stock speculative or risky.

Risks Related to Our Business and Industry

 

•

We are subject to risks associated with public health threats, including the ongoing COVID-19 pandemic, which has had, and we expect will continue to have, a material adverse effect on our business.

 

•

To be commercially successful, we must effectively demonstrate to surgeons and hospitals the value proposition of our products and procedural solutions compared to those of our competitors.

 

•

We operate in a highly competitive market segment that is subject to rapid change, and if we are unable to compete successfully, our sales and operating results may suffer.

 

•

Third-party reimbursement policies and practices, including non-coverage decisions, can negatively impact our ability to sell our products and services.

 

•

Pricing pressure from our competitors, hospital customers and insurance providers can negatively impact our ability to sell our products and services.

 

•

Quality or safety issues affecting our products could harm our reputation, result in liability and adversely impact our business.

 

•

Our IONM business exposes us to risks inherent with the sale of services.

Risks Related to our Commercial Operations and Plans for Future Growth

 

•

If we are unable to maintain and expand our network of direct and independent sales representatives, we may not be able to generate anticipated sales.

 

•

We may be unable to manage our future growth effectively, which could make it difficult to execute our business strategy.

 

•

Our reliance on a limited number of suppliers and manufacturers could limit our ability to meet demand for our products in a timely manner or within our budget.

 

•

Manufacturing risks may adversely affect our ability to manufacture products and could reduce our gross margins and negatively affect our operating results.

 

•

The loss of key employees, or our inability to recruit, hire and retain skilled and experienced personnel, could negatively impact our ability to effectively manage and expand our business.

 

•

Cybersecurity risks and the failure to maintain the confidentiality, integrity, and availability of our computer hardware, software, and Internet applications and related tools and functions could result in harm to our business and/or subject us to costs, fines or lawsuits.

 

19

Table of Contents

Risks Related to Litigation and Intellectual Property

 

•

Defending against litigation or other proceedings or third-party claims of intellectual property infringement could require us to spend significant time and money, and if we are unsuccessful, we may be obligated to pay damages and halt sales of our products.

 

•

We are currently, and may in the future be, subject to claims and lawsuits that could cause us to incur significant legal expenses and result in harm to our business.

 

•

Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain.

 

•

If we are unable to protect the confidentiality of our trade secrets, our business and competitive position could be harmed.

 

•

Third parties may assert ownership or commercial rights to inventions we develop.

 

•

If personal injury lawsuits are brought against us, our business may be harmed, and we may be required to pay damages that exceed our insurance coverage.

Risks Related to Regulatory and Compliance

 

•

We are subject to rigorous FDA and other governmental regulations regarding the development, manufacture, and sale of our products and we may incur significant expenses to comply with these regulations and develop products that satisfy these regulations.

 

•

Failure or alleged failure to comply with FDA and other governmental regulations can result in investigations and other regulatory proceedings, which are expensive and could divert management attention.

 

•

We are subject to federal, state and foreign fraud and abuse laws and health information privacy and security laws, which, if violated, could subject us to substantial penalties.

 

•

We may fail to obtain or maintain foreign regulatory approvals to market our products in other countries.

 

•

If we fail to obtain, or experience significant delays in obtaining, FDA clearances or approvals for our future products or product enhancements, our ability to commercially distribute and market our products could suffer.

 

•

The misuse or off-label use of our products may harm our reputation in the marketplace, result in injuries that lead to product liability suits or result in costly investigations, fines or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which could be costly to our business.

 

•

If we or our suppliers fail to comply with the FDA’s quality system regulations, ISO or other applicable regulations and standards, the manufacture and processing of our products could be delayed or interrupted and we may be subject to an enforcement action by the FDA or other government agencies.

 

•

Our relationships with physicians could be subject to additional scrutiny from regulatory enforcement authorities and could subject us to possible administrative, civil or criminal sanctions.

Risks Related to Our Financial Results and Need for Financing

 

•

We may be unable to grow our net sales or earnings as anticipated, which may have a material adverse effect on our future operating results.

 

•

We have a significant amount of outstanding indebtedness, and our financial condition and results of operations could be adversely affected if we do not effectively manage our liabilities.

 

•

We may need additional financing in the future to meet our capital needs or to make opportunistic acquisitions and such financing may not be available on favorable terms, if at all, and may be dilutive to existing stockholders.

Risks Related to the Securities Markets and Ownership of Our Common Stock

 

•

We expect that the price of our common stock will fluctuate substantially, potentially adversely affecting the ability of investors to sell their shares.

 

•

Anti-takeover provisions in our organizational documents and Delaware law may discourage or prevent a change of control, even if an acquisition would be beneficial to our stockholders, which could affect our stock price adversely and prevent attempts by our stockholders to replace or remove our current management.

 

•

We do not intend to pay cash dividends.

 

 

20

Table of Contents

 

Risk Factors

Risks Related to Our Business and Industry

We are subject to risks associated with public health threats, including the ongoing COVID-19 pandemic, which has had, and we expect will continue to have, a material adverse effect on our business.

The nature of our business and our interactions with healthcare systems, surgeons and patients expose us to substantial risks associated with public health threats, including widespread outbreaks of contagious diseases, epidemics, and pandemics such as COVID-19. To slow the proliferation of COVID-19, governments have implemented extraordinary measures, which include the mandatory closure of businesses, restrictions on travel and gatherings, and quarantine and physical distancing requirements. In addition, many government agencies in conjunction with hospitals and healthcare systems have to varying degrees deferred or suspended elective surgical procedures. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, we have seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, we experienced reductions in procedural volumes during 2020 and anticipate this trend may continue. In addition, restrictions on our ability to travel as well as the temporary closures of our facilities and the facilities of our suppliers adversely affected our business in 2020. Further, due to the travel restrictions and physical distancing requirements, we faced challenges in our ability to train and educate surgeons on our surgical techniques and products. These restrictions also impacted our manufacturing capabilities and distribution and warehousing operations. The cumulative effect of these disruptions had a significant impact on our business in 2020, and it is not possible for us to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures. The COVID-19 pandemic continues to rapidly evolve, and its impact on our business will depend on several factors that are highly uncertain and unpredictable, including, the efficacy and adoption of vaccines, future resurgences of the virus and its variants, the speed at which government restrictions are lifted, and the willingness and ability of patients to seek care and treatment due to safety concerns or financial hardship. We continue to believe that our overall business strategy and long-term future growth opportunities remain strong, and our priority is the health and well-being of our employees, customers, surgeons, and patients and the communities in which we operate.

The COVID-19 pandemic is straining healthcare systems worldwide, which will further impact our business, results of operations and liquidity.

Due to the COVID-19 pandemic, hospitals in the U.S. and globally have to varying degrees suspended and delayed elective surgeries in order to allocate and direct medical supplies and capacity to the COVID-19 response. Some hospitals have also limited access to their facilities or changed access protocols, which has made it difficult for us to support our surgeon customers. As a result, we experienced reductions in procedural volumes during 2020 and anticipate this trend may continue. We expect that hospitals and other facilities may face significant disruptions in their business and incur financial losses as they decrease elective procedures and increase spending on supplies and infrastructure in order to expand system capacity related to COVID-19 treatment. Potential patients may also cancel elective procedures or fail to seek needed care at hospitals which are involved in treating patients with COVID-19 due to the highly infectious nature of the disease. Additionally, the impact of the COVID-19 pandemic on the global economy and the financial markets could lead to a sustained period of economic turmoil and increased unemployment which may affect the ability of patients to seek care and treatment due to reduced health insurance coverage or the inability to pay premiums, deductibles, and copayments under health insurance plans. If the financial condition of hospitals deteriorate it could cause us to experience slower or impaired collections on accounts receivable, reductions in sales of our products and services, and increased price competition all of which could adversely impact our business, results of operations and liquidity. As of December 31, 2020, we had over $1.0 billion in cash, cash equivalents and short-term investments and the ability to draw $550.0 million under our 2020 Facility. However, our ability to borrow under the 2020 Facility is subject to remaining in compliance with underlying financial covenants which may be difficult to satisfy if the COVID-19 pandemic continues to adversely impact the healthcare system and our business. If the business interruptions caused by COVID-19 persist for a substantial period of time, we may need to seek other sources of liquidity and there can be no guarantee that additional liquidity will be readily available or available on favorable terms.

To the extent the COVID-19 pandemic adversely affects our operations and global economic conditions more generally, it may also have the effect of heightening many of the other risks described below.

 

21

Table of Contents

To be commercially successful, we must effectively demonstrate to surgeons and hospitals the value proposition of our products and procedural solutions compared to those of our competitors.

We focus on marketing our products and procedural solutions to surgeons, because of the role that they play in determining the course of patient treatment. However, hospitals are also becoming increasingly involved in the evaluation and acceptance of our products and procedural solutions. Surgeons and hospitals may not widely adopt our products and procedural solutions unless we are able to effectively educate them as to the distinctive characteristics, perceived benefits, safety and cost-effectiveness of our offerings as compared to those of our competitors. We believe that the most effective way to introduce and build market demand for our products and procedural solutions is by directly training surgeons in their use. If surgeons are not properly trained, they may misuse or ineffectively use our products and procedural solutions. This may also result in unsatisfactory patient outcomes, patient injury, negative publicity or lawsuits against us, any of which could have a significant adverse effect on our business, financial condition and results of operations.

Surgeons and hospitals may be hesitant to use and accept our products and procedural solutions for the following reasons, among others:

 

•

lack of experience with less invasive surgical products and procedures;

 

•

lack or perceived lack of evidence supporting additional patient benefits;

 

•

perceived liability risks generally associated with the use of new products and procedures;

 

•

existing relationships with competitors;

 

•

limited or lack of availability of coverage and reimbursement within healthcare payment systems;

 

•

higher pricing associated with new products and procedures;

 

•

increased competition in procedural offerings;

 

•

lack or perceived lack of differentiation among procedures;

 

•

costs associated with the purchase of new products and equipment; and

 

•

the time commitment that may be required for training.

If we are not able to effectively demonstrate to surgeons and hospitals the value proposition of our products and procedural solutions, or if surgeons and hospitals adopt competing products, our sales could significantly decrease or fail to increase, which could adversely impact our profitability and cash flow. In addition, we believe recommendations and support of our offerings by influential surgeons and other key opinion leaders are essential for market acceptance and adoption. If we are not successful in obtaining such support, surgeons may not use our products and procedural solutions, and we may not achieve expected sales or profitability.

Our future success depends on our strategy of rapidly developing innovative solutions and our ability to timely acquire, develop and introduce new products or product enhancements that will be accepted by the market.

An important part of our business strategy is to stay ahead of our competitors by rapidly developing and commercializing innovative surgical solutions to fulfill unmet clinical needs. As such, our success will depend in part on our ability to acquire, develop and introduce new products and enhancements to our existing products to keep pace with changes in technology and market demand, as well as physician, hospital and healthcare provider practices. The success of any new product offering or enhancement to an existing product will depend on numerous factors, including our ability to:

 

•

properly identify and anticipate surgeon and patient needs;

 

•

develop and introduce new products or product enhancements in a timely and cost-effective manner;

 

•

adequately protect our intellectual property and avoid infringing upon the intellectual property rights of third parties;

 

•

demonstrate the safety and efficacy of new products through clinical investigations or the collection of existing relevant clinical data;

 

•

qualify for adequate reimbursement from third-party payers; and

 

•

obtain the necessary regulatory clearances or approvals for new products or product enhancements.

 

22

Table of Contents

 

In addition, our research and development efforts may require a substantial investment of time and resources before we are adequately able to determine the commercial or technical viability of a new product, technology, or other innovation. Even if we are able to develop enhancements or new generation products successfully, these enhancements or new generation products may not generate sufficient demand or produce sales in excess of the costs of development, which would cause our results of operations to suffer. It is also important that we carefully manage our introduction of new and enhanced products. If potential customers delay purchases until new or enhanced products are available, it could negatively impact our sales. In addition, to the extent we have excess or obsolete inventory as we transition to new products, it would result in margin reducing write-offs and charges for obsolete inventory, and our results of operations may suffer.

Furthermore, our product development strategy is based on certain assumptions, including assumptions about various demographic trends and trends in the treatment of spine disorders, which could affect the demand for our products and procedural solutions. However, these trends are uncertain and actual demand for our products and procedural solutions could differ materially from projected demand if our assumptions regarding these trends prove to be incorrect or do not materialize, or if alternative treatments to those offered by our products gain widespread acceptance.

We operate in a highly competitive market segment that is subject to rapid change, and if we are unable to compete successfully, our sales and operating results may suffer.

The market for our surgical products and procedures is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants. Our ability to compete successfully will depend on our ability to develop proprietary products that reach the market in a timely manner, receive adequate reimbursement and are safer, less invasive and less expensive than those of our competitors. With respect to our neuromonitoring systems, we primarily compete with Medtronic and Cadwell Industries. Our IONM services business competes with Specialty Care and numerous smaller and regional neuromonitoring companies as well as insourced neuromonitoring functions operated by hospitals. With respect to our products and technologies for spine surgical procedures, our largest competitors are Medtronic, DePuy/Synthes, Stryker Spine, Globus Medical, and Zimmer Biomet Spine. We compete with many of the same companies with respect to our other products. We also compete with numerous smaller companies with respect to our implant products, many of whom have a significant regional market presence. At any time, these companies and other potential market entrants may develop alternative treatments, products or procedures for the treatment of spine disorders that compete directly or indirectly with our offerings. In addition, they may gain a market advantage by developing and patenting competitive products or processes earlier than we can or by obtaining regulatory clearances or market registrations more rapidly than we can.

Many of our competitors have greater resources than we have.

Many of our competitors are large medical device companies that have several competitive advantages over us, including:

 

•

significantly greater name recognition;

 

•

established relationships with a greater number of surgeons, hospitals, other healthcare providers and third-party payers;

 

•

larger and more well-established distribution networks domestically and/or internationally;

 

•

products supported by long-term clinical data;

 

•

greater experience in obtaining and maintaining FDA and other regulatory approvals or clearances for products and product enhancements;

 

•

greater experience in, and resources for, launching, marketing, distributing and selling products, including capital equipment;

 

•

greater ability to cross-sell their products or create bundled offerings to incentivize hospitals and surgeons to use their products;

 

•

more expansive portfolios of intellectual property rights; and

 

•

greater financial assets, cash flow, capital markets access and other resources for product research and development, sales and marketing, and litigation.

Because of the significant size of the potential market for spine surgery products and procedures, we anticipate that existing competitors will continue to dedicate substantial resources to developing competing products. If we are unable to compete effectively, our sales and operating results may suffer.

 

23

Table of Contents

Third-party reimbursement policies and practices, including non-coverage decisions, can negatively impact our ability to sell our products and services.

Sales of our products and procedural solutions depend on the availability of adequate reimbursement from third-party payers. Future third-party reimbursement for healthcare costs may be subject to changes in policies and practices, such as more restrictive criteria to qualify for surgery coverage or reduction in payment amounts to hospitals and surgeons for approved surgery and IONM services, both in the United States and internationally. Further, certain third-party payers have stated non-coverage decisions concerning our technologies and services. These actions could significantly alter our ability to sell our products and procedural solutions. The continuing efforts of governmental authorities, insurance companies, and other payers of healthcare costs to contain or reduce costs could lead to patients being unable to obtain approval for payment from these third-party payers. Changes in legislation, regulation or reimbursement policies of third-party payers may adversely affect the demand for our products and services as healthcare providers generally rely on third-party payers to reimburse all or part of the costs and fees associated with the procedures performed with these devices and services. Likewise, spine surgeons, neurophysiologists and their supervising physicians rely primarily on third-party reimbursement for the surgical or monitoring fees they earn. Spine surgeons are unlikely to use our products and services if they do not receive reimbursement adequate to cover the cost of their involvement in surgical procedures.

Further, as we continue to grow our international business, market acceptance of our products and procedural solutions in a particular international market may also depend, in part, upon the availability of coverage and reimbursement within the applicable healthcare payment system. Reimbursement and healthcare payment systems in international markets vary significantly by country. As in the United States, we may not be able to obtain coverage and reimbursement approvals in a timely manner, if at all, for our products and procedural solutions in a particular foreign market. In addition, even if we are able to obtain country-specific coverage and reimbursement approvals, the amount of such coverage and reimbursement may not be adequate and we could incur considerable expense in seeking such approvals. Our failure to obtain such coverage and approvals would negatively affect market acceptance of our products and procedural solutions in the international markets in which such failure occurs and the expenses incurred in connection with obtaining such coverage and approvals could outweigh the benefits of obtaining them.

Pricing pressure from our competitors, hospital customers and insurance providers can negatively impact our ability to sell our products and services.

The market for spine surgery products is large and has attracted numerous new companies and technologies. As some companies have sought to compete based on price, it has created pricing pressure, which we expect to continue in the future. Pricing pressure may also increase due to continued consolidation among healthcare providers, trends toward managed and value-based care, the shift toward governments becoming the primary payers of healthcare expenses, and reduction in reimbursement levels. As healthcare providers look to reduce costs, including by aggregating purchasing decisions and through industry consolidation, they are able to demand lower pricing and limit their number of suppliers. If competitive forces drive down the prices we are able to charge for our products, our profit margins will shrink, which will adversely affect our ability to maintain our profitability and to invest in and grow our business.

Quality or safety issues affecting our products could harm our reputation, result in liability and adversely impact our business.

In the course of conducting our business, we must adequately address quality and safety issues that may arise with our products, as well as defects in third-party components included in our products. Although we have established internal procedures to minimize risks that may arise from quality and safety issues, we may not be able to eliminate or mitigate occurrences of these issues and associated liabilities. Additionally, as we continue to launch more complex products and technologies, including products based on the MAGEC technology platform and products like Lessray and Pulse, risks related to quality and safety issues increase compared to our portfolio of spinal implants and fixation products. Manufacturing flaws, component failures, design defects, or inadequate disclosure of product-related information could result in an unsafe condition or the injury or death of a patient. These problems could lead to a recall of, or issuance of a safety alert relating to our products and result in significant costs and negative publicity. An adverse event, safety alert or recall involving one of our products could result in reduced market acceptance and demand for our products, and could harm our reputation and our ability to market our products in the future. In some circumstances, an adverse event, safety alert or recall could require costly design, engineering, and manufacturing changes, and result in the suspension or delay of regulatory reviews of our applications for new product approvals or clearances. Further, if we substitute, replace or exchange products to address an adverse event, safety alert or recall, or take other steps to address the needs or concerns of our customers and patients, it could disrupt our business and have an adverse effect on our results of operations and financial condition. We may also voluntarily undertake a recall of our products, initiate certain field actions, temporarily shut down production lines, or place products on a shipping hold based on internal safety, quality monitoring and testing data. If we take action to reduce a health risk posed by our products, or to remedy a violation of the Federal, Food, Drug and Cosmetic Act or other regulations caused by our products that may present a risk to health, such action may need to be reported to the FDA or equivalent governmental authority. If the FDA or equivalent governmental authority subsequently determines that a report was required for a quality or safety action related to our products that we did not believe required a report, we could be subject to enforcement actions.

 

24

Table of Contents

While we have a network of quality systems throughout our business lines and facilities, quality and safety issues may occur with respect to any of our products. A quality or safety issue may result in a public warning letter or consent decree from the FDA or an equivalent action by a governmental health authority in an international jurisdiction. In addition, we may be subject to product recalls or seizures, monetary sanctions, injunctions to halt manufacturing and distribution of products, civil or criminal sanctions, refusal of a government to grant clearances or approvals or delays in granting such clearances or approvals, import detentions of products made outside the United States, restrictions on operations or withdrawal or suspension of existing approvals. Any of the foregoing events could disrupt our business and have an adverse effect on our results of operations and financial condition.

The safety of many of our products is not yet supported by long-term clinical data and many of our products may therefore prove to be less safe and effective than initially thought.

As a consequence of our strategy to rapidly develop and commercialize new products and product enhancements, many of our products do not have a long history of use. Further, many of our products are subject to the FDA’s 510(k) premarket notification clearance process in the United States and similar regulatory processes in other countries, which may not require substantial clinical data. Accordingly, many of our products currently lack the breadth of published long-term clinical data supporting their safety and effectiveness. For these reasons, surgeons may be slow to adopt our products, we may not have comparative data that our competitors have or are generating, and we may be subject to greater regulatory and product liability risks. In particular, as we continue to launch more complex products and technologies, including products based on the MAGEC technology platform and products like Lessray and Pulse, we may have to conduct additional studies and gather additional data to support their safety and effectiveness.

Further, future patient studies or clinical experience may indicate that treatment with our products does not improve patient outcomes. Such results would reduce demand for our products, affect sustainable reimbursement from third-party payers, significantly reduce our ability to achieve expected sales and could prevent us from sustaining or increasing profitability. Moreover, if future results and experience indicate that our products cause unexpected or serious complications or other unforeseen negative effects, we could be subject to significant legal liability and harm to our business reputation. The spine medical device market has been particularly prone to potential product liability claims that are inherent in the testing, manufacture and sale of medical devices and products for spine surgery procedures.

As we expand our offerings to include capital equipment and invest in related resources and expertise, we are exposed to additional risks.

As we expand our procedural solutions offerings to include new technologies, including the Pulse platform, we expect that the selling and leasing of capital equipment will become a larger portion of our total net sales over time. We do not have a long history of selling, leasing or servicing capital equipment, and we intend to continue to invest in building resources and expertise in this area. We may not generate sufficient sales to offset the expenses associated with this investment. There can be no assurance that our capital equipment strategy will be successful and will not materially adversely affect our financial condition and operating results.

Approval processes of healthcare organizations for the purchase or lease of capital equipment can be lengthy, and such organizations may delay or accelerate system purchases or leases in conjunction with their internal budget timelines. Additionally, the introduction of new products by us or our competitors could adversely impact the sales cycle as healthcare organizations evaluate the benefits and costs of such products. As a result, it is difficult for us to predict the length of capital sales cycles and, therefore, the exact timing of capital sales, which may cause fluctuations in our financial results. Further, demand for capital equipment can be affected by changes in the budgets of healthcare organizations and conflicting spending priorities. Any such decreases in expenditures by these healthcare organizations and decreases in demand for our capital equipment could have an adverse effect on our results of operations and financial condition.

 

25

Table of Contents

We may engage in strategic transactions, including acquisitions, investments, joint development agreements or divestitures that may have an adverse effect on our business.

We may pursue transactions, including acquisitions of complementary businesses, technology licensing arrangements, strategic relationships, and joint development agreements to expand our product offerings and geographic presence as part of our business strategy, which could be material to our financial condition and results of operations. We may also consider divesting non-core product lines or out-licensing our technology. We may not complete transactions in a timely manner, on a cost-effective basis, or at all, and we may not realize the expected benefits of any acquisition, license arrangement, strategic relationship, joint development agreement or divestiture. Other companies may compete with us for these strategic opportunities. We also could experience negative effects on our results of operations and financial condition from charges related to acquisitions and investments, amortization of intangible assets and asset impairment charges, and other issues that could arise in connection with, or as a result of, the acquisition of an acquired company or business, including issues related to internal control over financial reporting, regulatory or compliance issues and potential adverse short-term effects on results of operations through increased costs or otherwise. Following our acquisition of Simplify Medical Pty Limited, or Simplify Medical, in February 2021, we also offer cervical artificial disc technology for cervical total disc replacement procedures. Pursuant to the terms of the definitive agreement, we agreed to make an upfront payment of $150.0 million at closing, subject to customary purchase price adjustments, plus additional future payments contingent upon milestones related to regulatory approval and net sales from products incorporating the Simplify Medical cervical artificial disc technology. The closing of the acquisition occurred on February 24, 2021, and Simplify Medical is now our wholly-owned subsidiary. Acquisitions, including the acquisition of Simplify Medical, involve numerous risks, including the following:

 

•

difficulties in finding suitable partners or acquisition candidates;

 

•

difficulties in obtaining financing on favorable terms, if at all;

 

•

difficulties in completing transactions on favorable terms, if at all;

 

•

the possibility that we will pay more than the value we derive from the acquisition, which could result in future non-cash impairment charges and/or a dilution of future earnings per share;

 

•

difficulties in integration of the operations, technologies, personnel, and products of acquired companies, which may require significant attention of our management team that otherwise would be available for the ongoing development of our business;

 

•

the applicability of additional laws, regulations and policies that have particular application to our acquisitions, including those relating to patient privacy, insurance fraud and abuse, false claims, prohibitions against self-referrals, anti-kickbacks, direct billing practices, HIPAA compliance, and prohibitions against the corporate practice of medicine and fee-splitting;

 

•

the assumption of certain known and unknown liabilities of acquired companies;

 

•

the incurrence of debt, contingent liabilities or future write-offs of intangible assets or goodwill;

 

•

difficulties in retaining key relationships with employees, customers, partners and suppliers of an acquired company; and

 

•

difficulties in operating in different business markets where we may not have historical experience.

Any of these factors could have a negative impact on our business, results of operations or financial position. Further, past and potential acquisitions entail risks, uncertainties and potential disruptions to our business, especially where we have limited experience as a company developing or marketing a particular product or technology. Following any acquisition, we must integrate the new business, which can be expensive, time-consuming and cause disruptions to our existing operations. Failure to timely and successfully integrate acquired businesses may result in non-compliance with regulatory or other requirements and may result in unexpected costs, including as a result of inadequate cost containment and failure to fully realize expected synergies. As a result of any of the foregoing, we may not realize the expected benefit from any acquisition or investment. If we cannot integrate acquired businesses, products or technologies, our business, financial conditions and results of operations could be materially and adversely affected.

In addition, we may face additional risks related to foreign acquisitions and investments. Foreign acquisitions and investments involve unique risks in addition to those mentioned above, including those related to integration of operations across different cultures and languages, currency risks and the particular economic, political and regulatory risks associated with specific countries.

Any divestitures may result in a dilutive impact to our future earnings, as well as significant write-offs, including those related to goodwill and other intangible assets, which could have a material adverse effect on our results of operations and financial condition. Divestitures could involve additional risks, including difficulties in the separation of operations, services, products and personnel, the diversion of management’s attention from other business concerns, the disruption of our business and the potential loss of key employees. We may not be successful in managing these or any other significant risks that we encounter in divesting a product or technology.

 

26

Table of Contents

Healthcare policy changes may have a material adverse effect on us.

Political, economic and regulatory influences are subjecting the healthcare industry to fundamental changes. For example, as a result of the Patient Protection and Affordable Care Act (“ACA”), the U.S. has implemented value-based payment methodologies and has created alternative payment models such as bundled payments to continue to drive improved value. The ACA also significantly altered Medicare and Medicaid reimbursements for medical services and medical devices. We anticipate that Congress, regulatory agencies and certain state legislatures will continue to review and assess alternative healthcare delivery systems and payment methods with an objective of ultimately reducing healthcare costs and expanding access. We cannot predict with certainty what healthcare initiatives, if any, will be implemented at the state level, or what ultimate effect federal healthcare reform or any future legislation or regulation may have on our customers’ purchasing decisions regarding our products and services. However, the implementation of new legislation and regulation may lower reimbursements for our products, reduce medical procedure volumes and adversely affect our business, possibly materially.

Our IONM business exposes us to risks inherent with the sale of services.

Our IONM services and support business exposes us to different risks than our other products and technologies. Through our NuVasive Clinical Services business, including the Biotronic NeuroNetwork business acquired in July 2016 and the SafePassage business acquired in January 2018, we provide onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. Our neurophysiologists are present in the operating room during procedures and work with supervising physicians who remotely oversee and interpret neurophysiological data gathered via broadband transmission over the Internet. Providing this service subjects us to malpractice exposure. In addition, given the reliance on technology, any disruption to our neuromonitoring equipment or the Internet could harm our service operations and our reputation among our customers. Further, any disruption to our information technology systems could adversely impact the performance of our neurophysiologists and oversight physicians.

In addition, IONM services are directly billed to Medicare and commercial payers, which brings with it additional risks associated with proper billing practice regulations, HIPAA compliance, corporate practice of medicine laws, and collections risk associated with third-party payers. Due to the breadth of many healthcare laws and regulations, our IONM business could also be subject to healthcare fraud regulation and enforcement by both the federal government and the states in which we conduct our business, including under the Anti-Kickback Statute, the federal false claims laws and state law equivalents. If our operations are found to be in violation of any of the laws described in the previous sentence or any other governmental regulations that apply to us, we may be subject to penalties, including civil and criminal penalties, damages, fines and the curtailment or restructuring of our operations. Any penalties, damages, fines, curtailment or restructuring of our operations could adversely affect our ability to operate our business and our financial results.

Our increased focus on specialized pediatric conditions exposes us to different risks.

In furtherance of our growth strategy, we have invested in, and expect to continue to invest in the pediatric spine and orthopedic segments, which exposes us to different risks than our other products and technologies. With the 2016 acquisition of Ellipse Technologies, we began to offer innovative products based on the MAGEC technology platform, which accelerated our entry into the pediatric spine segment. Our MAGEC growing rods are used to treat early-onset scoliosis (EOS) and, once surgically implanted in a patient, can be adjusted non-invasively using an external remote controller. We have further added to our pediatric portfolio with the launch of the Reline Small Stature system, designed as a deformity fixation solution for pediatric spine surgery, and products to support the adolescent deformity market. Designing and engineering specialized products for pediatric patients can be challenging, particularly as products need to accommodate growth in pediatric patients. If we are unable to design safe and effective products that meet the needs of pediatric patients, our ability to compete in the pediatric segment will be adversely impacted. Further, patients with EOS often have other risk factors and co-morbidities that can make surgeries more risky, which can lead to surgical and post-operative complications and potentially greater exposure for allegations of product liability.

In addition, if our pediatric products are the subject of safety concerns, whether actual or perceived, it would have an adverse impact on our business and results of operations. We have issued field safety notices regarding the MAGEC system in the past, and in April 2020, we agreed to voluntarily suspend sales of all MAGEC rods in non-essential cases in the United Kingdom and Ireland while local regulatory authorities conducted a market surveillance review of the MAGEC system. If we are unable to address the issues identified in the market surveillance review, we may need to conduct additional studies, gather additional data, or re-design or re-engineer the MAGEC system, which could be costly. Further, if our surgeon customers and their patients choose alternative treatments, it would negatively impact our pediatric business. If we are the subject of any claims or lawsuits related to the issues identified in the field safety notices, whether from impacted customers, distributors, surgeons or patients, it would have an adverse impact on our business and results of operations.

 

27

Table of Contents

Our employees, independent sales representatives, consultants, distributors and other commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements.

We are exposed to the risk that our employees, independent sales representatives, consultants, distributors and other commercial partners may engage in fraudulent or illegal activity. Misconduct by these parties could include intentional, reckless or negligent conduct or other unauthorized activities that violate the regulations of the FDA and non-U.S. regulators, including those laws requiring the reporting of true, complete and accurate information to such regulators, manufacturing standards, healthcare fraud and abuse laws and regulations in the United States and abroad or laws that require the true, complete and accurate reporting of financial information or data. In particular, sales, marketing and business arrangements in the healthcare industry, including the sale of medical devices, are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. It is not always possible to identify and deter misconduct by our employees or third parties, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us and we are not successful in defending ourselves or asserting our rights, those actions could result in the imposition of significant fines or other sanctions, including the imposition of civil, criminal and administrative penalties, damages, monetary fines, possible exclusion from participation in Medicare, Medicaid and other federal healthcare programs, contractual damages, reputational harm, diminished profits and future earnings and curtailment of operations, any of which could adversely affect our ability to operate our business and our results of operations. Whether or not we are successful in defending against such actions or investigations, we could incur substantial costs, including legal fees, and divert the attention of management in defending ourselves against any of these claims or investigations.

Risks Related to our Commercial Operations and Plans for Future Growth

If we are unable to maintain and expand our network of direct and independent sales representatives, we may not be able to generate anticipated sales.

In the United States, we sell our products primarily through a combination of independent sales representatives and directly-employed sales personnel. Our international sales force is comprised of independent sales agents, directly-employed sales personnel, as well as exclusive and non-exclusive independent third-party distributors. If our sales representatives and sales agents fail to adequately promote, market and sell our products, or fail to develop strong relationships with customers, our sales could significantly decrease or fail to increase. Further, the termination or transition of a sales representative could disrupt business and cause us to incur expenses related to such termination or transition, including contract termination fees or expenses associated with claims and lawsuits. Asserting or defending against these types of claims and lawsuits may result in significant legal fees and expenses, and if we are unsuccessful, we could be liable for damages.

We face significant challenges and risks in managing our geographically dispersed distribution network and retaining the individuals who make up that network. In the past, we have experienced departures of sales representatives, which have had a negative impact on our results. If sales representatives were to depart and be retained by one of our competitors, we may be unable to prevent them from helping competitors solicit business from our existing customers, which could further adversely affect our sales. In addition, as we expand into new markets, it may be difficult to find sales representatives with the appropriate expertise or it may take time for new sales representatives to reach full operational effectiveness and generate expected sales. Because of the intense competition for their services, we may be unable to recruit or retain sales representatives to work with us. Failure to hire or retain qualified sales representatives would prevent us from expanding our business and generating sales.

We may be unable to manage our future growth effectively, which could make it difficult to execute our business strategy.

We intend to grow our business operations and we may experience periods of rapid growth and expansion. This anticipated future growth could create a strain on our organizational, administrative and operational infrastructure, including manufacturing operations, quality control, information technology infrastructure, technical support and customer service, sales force management and general and financial administration. We may not be able to maintain the quality or delivery timelines of our products or satisfy customer demand as it grows. Our ability to manage our growth properly will require us to continue to improve our operational, financial and management controls, as well as our reporting systems and procedures.

If our commercial operations and sales volume grow, we will need to continue to increase our capacity for manufacturing, customer service, billing and general process improvements and expand our internal quality assurance program, among other things. We will also need to purchase additional equipment, some of which can take several months or more to procure, set up and validate, and increase our manufacturing, maintenance, and information technology systems capacity to meet increased demand, and further invest in our inventory. These increases in scale, expansion of personnel, purchases of equipment or process enhancements and investments in inventory can be costly and may not be successfully implemented, any of which could disrupt our business and have an adverse effect on our results of operations and financial condition.

 

28

Table of Contents

Our reliance on a limited number of suppliers and manufacturers could limit our ability to meet demand for our products in a timely manner or within our budget.

While we self-manufacture many of our products, we continue to rely on a limited number of third-party suppliers and manufacturers to supply and manufacture our products, and we may not be able to find replacements or immediately transition to alternative suppliers or manufacturers. Many of our key products are manufactured at single locations, with limited alternate facilities, and it could take considerable time and resources for us to replace the capacity of such vendors in the event of disruptions. In addition, if we are required to change the manufacturer of a critical component of our products, we will be required to verify that the new manufacturer maintains facilities, procedures and operations that comply with our quality and applicable regulatory requirements, which could further impede our ability to manufacture our products in a timely manner.

Further, for reasons of quality assurance or cost effectiveness, we purchase certain components and raw materials from sole suppliers. To be successful, we rely on our suppliers to provide us with products and components in substantial quantities, in compliance with regulatory requirements, in accordance with agreed upon specifications, at acceptable cost and on a timely basis. In the event we experience delays, shortages, or stoppages of supply with any supplier, we would be forced to identify a suitable alternative supplier which could take significant time and result in significant expense. In addition, our anticipated growth could strain the ability of suppliers to deliver an increasingly large supply of products, materials and components. If we are required to transition to new third-party suppliers for certain components of our products, the use of components or materials furnished by these alternative suppliers could require us to alter our operations. Any such interruption or alteration could harm our reputation, business, financial condition and results of operations. Transitioning to a new supplier could be time-consuming and expensive, may result in interruptions in our operations and product delivery, could affect the performance specifications of our products or could require that we modify the design of those systems.

Performance issues, service interruptions or price increases by our shipping carriers could adversely affect our business and harm our reputation and ability to provide our products and services on a timely basis.

Expedited, reliable shipping is essential to our operations. We rely heavily on providers of transport services for reliable and secure point-to-point transport of our products to our customers and for tracking of these shipments. Should a carrier encounter delivery performance issues such as loss, damage or destruction of any products, it could be costly to replace such products in a timely manner and such occurrences may damage our reputation and lead to decreased demand for our products and increased cost and expense to our business. In addition, any significant increase in shipping rates could adversely affect our operating margins and results of operations. Similarly, strikes, severe weather, natural disasters, public health threats, or other service interruptions affecting delivery services we use would adversely affect our ability to process and fulfill orders for our products on a timely basis.

 

29

Table of Contents

Manufacturing risks may adversely affect our ability to manufacture products and could reduce our gross margins and negatively affect our operating results.

As part of our business strategy, we intend to continue to expand our ability to manufacture our current and new products with exceptional quality and in sufficient quantities to meet demand, while complying with regulatory requirements and managing manufacturing costs. We are subject to numerous risks relating to our manufacturing capabilities, including both those of our own manufacturing facilities and those of our third-party suppliers, such as:

 

•

problems with quality control and assurance, including manufacturing nonconformances and product design defects;

 

•

defective raw materials or defects in product components that we source from third-party suppliers;

 

•

delays in obtaining components from third-party suppliers and component supply shortages;

 

•

failing to predict demand accurately, resulting in a failure to increase production of products to meet demand;

 

•

potential adverse effects on existing business relationships with current third-party suppliers as we expand our in-house manufacturing capabilities;

 

•

maintaining control over manufacturing expenses as production expands;

 

•

difficulties associated with compliance with local, state, federal and foreign regulatory requirements;

 

•

shortages of qualified personnel or workforce disruptions;

 

•

the inability to modify production lines to enable the efficient manufacture of new products or to quickly implement changes to current products in response to regulatory requirements;

 

•

disruptions caused by natural disasters such as hurricanes, tornadoes earthquakes or wildfires, and the impact of epidemics or pandemics, such as COVID-19; and

 

•

potential damage to or destruction of our, or our suppliers’ manufacturing equipment or manufacturing facilities.

These risks may be exacerbated by our limited experience with self- manufacturing processes and procedures. In addition, as we seek to expand our manufacturing capabilities, we will have to continue to invest additional resources to hire and train personnel and enhance our production processes. If we fail to increase our manufacturing capacity efficiently, our profit margins will shrink, which will negatively affect our operating results.

The loss of key employees, or our inability to recruit, hire and retain skilled and experienced personnel, could negatively impact our ability to effectively manage and expand our business.

Our success depends on the skills, experience and performance of the members of our executive management team and other key employees. Their individual and collective efforts will continue to be important as we continue to develop our products and as we expand our commercial activities. The loss or incapacity of existing members of our executive management team could negatively impact our operations, particularly if we experience difficulties in hiring qualified successors. We do not maintain key person life insurance with respect to any of our employees.

Our research and development programs and operations depend on our ability to attract and retain highly skilled engineers and technicians. We may not be able to attract or retain qualified managers, engineers and technicians in the future due to the competition for qualified personnel among medical device businesses. We also face competition from universities and public and private research institutions in recruiting and retaining highly qualified personnel. Recruiting and retention difficulties can limit our ability to support our commercial, manufacturing and research and development programs. All of our U.S. employees are employed on an at-will basis, which means that either we or the employee may terminate his or her employment at any time. The loss of key employees, the failure of any key employees to perform or our inability to attract and retain skilled employees, as needed, or an inability to effectively plan for and implement a succession plan for key employees could harm our business.

 

30

Table of Contents

We face risks associated with our international business.

During the year ended December 31, 2020, $228.8 million or approximately 22% of our net sales was attributable to our international customers (excluding Puerto Rico). We expect to continue to invest in international expansion with a focus on European, Asia-Pacific and Latin American markets. Our international business operations are subject to a variety of risks, including:

 

•

difficulties in staffing and managing foreign and geographically dispersed operations;

 

•

having to comply with various U.S. and international laws, including the FCPA and anti-money laundering laws;

 

•

having to comply with U.S. and foreign trade, import and export and customs regulations and laws, including, but not limited to, the Export Administration Regulations and trade sanctions against embargoed countries, which are administered by the Office of Foreign Assets Control within the Department of the Treasury, as well as the laws and regulations administered by the Department of Commerce;

 

•

differing complex regulatory requirements for obtaining clearances or approvals to market our products, including the EU Medical Device Regulation (Council Regulations 2017/745) and recent regulatory guidance issued by the UK Government in connection with the UK formally withdrawing from the European Union;

 

•

changes in, or uncertainties relating to, foreign rules and regulations that may impact our ability to sell our products, perform services or repatriate profits to the United States;

 

•

tariffs and trade barriers, export regulations and other regulatory and contractual limitations on our ability to sell our products in certain foreign markets;

 

•

fluctuations in foreign currency exchange rates;

 

•

limitations on or increase of withholding and other taxes on remittances and other payments by foreign subsidiaries or joint ventures;

 

•

differing multiple payer reimbursement regimes, government payers or patient self-pay systems;

 

•

differing labor laws and standards;

 

•

changes in, or uncertainties relating to foreign laws around value-added taxes or permanent establishment that may impact our international indirect and income tax expense and related compliance costs;

 

•

complex data privacy requirements, including the EU GDPR;

 

•

economic, political or social instability in foreign countries and regions;

 

•

an inability, or reduced ability, to protect our intellectual property, including any effect of compulsory licensing imposed by government action;

 

•

potential changes to U.S. trade policy, including new legislation that could restrict international trade, or protectionist or retaliatory measures taken by governments of other countries; and

 

•

availability of government subsidies or other incentives that benefit competitors in their local markets that are not available to us.

The FCPA and similar anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments for the purpose of obtaining or retaining business. The FCPA also imposes accounting standards and requirements on publicly traded U.S. corporations and their foreign affiliates, which are intended to prevent the diversion of corporate funds to the payment of bribes and other improper payments. Because of the predominance of government-sponsored healthcare systems around the world, many of our customer relationships outside of the United States are with governmental entities and are therefore subject to such anti-bribery laws. Our internal control policies and procedures may not always prevent or protect us from reckless or criminal acts committed by our employees, distributors or agents. In recent years, both the United States and foreign government regulators have increased regulation, enforcement, inspections and governmental investigations of the medical device industry, including increased United States government oversight and enforcement of the FCPA. Despite implementation of a comprehensive global healthcare compliance program, we may be subject to more regulation, enforcement, inspections and investigations by governmental authorities in the future.

 

31

Table of Contents

Any failure to comply with applicable legal and regulatory obligations in the United States or abroad could adversely affect us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments and restrictions on certain business activities, disgorgement and other remedial measures, disruptions of our operations, and significant management distraction. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our distribution and sales activities. Any reduction in international sales, or our failure to further develop our international markets, could have a material adverse effect on our business, results of operations and financial condition.

Our results may be impacted by changes in foreign currency exchange rates.

As we increasingly compete in markets outside of the United States, we are and will be exposed to foreign currency exchange risk related to our foreign operations. A significant portion of our foreign subsidiaries’ operating expenses are incurred in foreign currencies. If the U.S. dollar weakens, our consolidated operating expenses would increase. An increase in the value of the U.S. dollar relative to foreign currencies could require us to reduce our selling price or risk making our products less competitive in international markets or our costs could increase. Also, as our international sales continue to increase, we may enter into a greater number of transactions denominated in non-U.S. dollars, which could increase our exposure to foreign currency risks, including changes in currency exchange rates. If we are unable to address these risks and challenges effectively, our international operations may not be successful and our business could be harmed.

If we fail to properly manage our anticipated international growth, our business could suffer.

We have invested, and expect to increase our investment for the foreseeable future, in our expansion into international markets. To execute our anticipated growth in international markets we must:

 

•

manage the complexities associated with a larger, faster growing and more geographically diverse organization;

 

•

expand our clinical development resources to manage and execute increasingly global, larger and more complex clinical trials and studies;

 

•

manage our directly-employed sales personnel as well as independent distributors and sales agents operating in international markets often pursuant to laws, regulations and customs that may be different than those that are customary for our United States operations;

 

•

expand our sales and marketing presence in international markets generally to avoid concentration of sales in a small number of markets that would subject us to the risk of business disruption as a result of economic or political problems in concentrated locations;

 

•

upgrade our internal business processes and capabilities (e.g., information technology platform and systems, product distribution and tracking) to create scalability and properly handle the transaction volumes that our growing geographically diverse organization demands;

 

•

expend time and resources to receive product approvals and clearances to sell and promote products; and

 

•

incur significant costs to comply with new and complex regulatory requirements such as the EU Medical Device Regulation (Council Regulations 2017/745) and recent regulatory guidance issued by the UK Government in connection with the UK formally withdrawing from the European Union.

We expect that our operating expenses will continue to increase as we continue to expand into international markets. International markets may be slower than domestic markets in adopting our products and are expected, in many instances, to yield lower profit margins when compared to our domestic operations. We have only limited experience in expanding into international markets as well as marketing and operating our products and services in such markets.

Additionally, our international endeavors may involve significant risks and uncertainties, including distraction of management from domestic operations, insufficient sales to offset the expenses associated with our international strategy, and issues not discovered in our due diligence of new markets or ventures. Because expansion into international markets is inherently risky, no assurance can be given that such strategies and initiatives will be successful and will not materially adversely affect our financial condition and operating results. Even if our international expansion is successful, our expenses may increase at a greater pace than our net sales and our operating results could be harmed.

Further, our anticipated growth internationally will place additional strain on our suppliers and manufacturers, resulting in increased need for us to carefully monitor quality assurance. Any failure by us to manage our international growth effectively could have an adverse effect on our ability to achieve our development and commercialization goals.

 

32

Table of Contents

Cybersecurity risks and the failure to maintain the confidentiality, integrity, and availability of our computer hardware, software, and Internet applications and related tools and functions could result in harm to our business and/or subject us to costs, fines or lawsuits.

We rely on sophisticated information technology systems and network infrastructure to operate and manage our business. We also maintain personally identifiable information (PII) about our employees, and given the nature of our business, we have access to protected health information (PHI). Our business therefore depends on the continuous, effective, reliable, and secure operation of our computer hardware, software, networks, Internet servers, and related infrastructure. To the extent that our hardware or software malfunctions or access to our data by internal personnel, suppliers or customers through the Internet is interrupted or compromised, our business could suffer.

The integrity and protection of our customer, personnel, financial, research and development, and other confidential data is critical to our business, and our customers and employees have a high expectation that we will adequately protect their personal information. The regulatory environment governing information, security and privacy laws is increasingly demanding and continues to evolve and a number of states have adopted laws and regulations that may affect our privacy and data security practices regarding the use, disclosure and protection of PII. For example, California recently enacted legislation, the California Consumer Privacy Act, that, among other things, creates new individual privacy rights and imposes increased obligations on companies handling PII.

Although our computer and communications hardware is protected through physical and software safeguards, it is still vulnerable to system malfunction, computer viruses, malware and ransomware, and other cybersecurity threats such as phishing and social engineering attacks. These events could lead to the unauthorized access of our information technology systems and result in financial loss and the misappropriation or unauthorized disclosure of confidential information belonging to us, our employees, partners, customers, or our suppliers. The techniques used by criminal elements to attack computer systems are sophisticated, change frequently and may originate from less regulated and remote areas of the world. As a result, we may not be able to address these techniques proactively or implement adequate preventative measures. If our information technology systems are compromised we could be subject to fines, damages, litigation and enforcement actions, incur financial losses, suffer reputational damage, and lose trade secrets or other confidential information, each of which could significantly harm our business.

We rely on the performance of our information technology systems, the failure of which could have an adverse effect on our business and performance.

Our business requires the continued operation of sophisticated information technology systems and network infrastructure. These systems are vulnerable to interruption by fire, floods, earthquakes, power loss, system malfunction, computer viruses, security breaches, cybersecurity threats such as phishing and social engineering attacks and other events, which are beyond our control. Systems interruptions could reduce our ability to manufacture, deliver, and provide service for our products, and could have an adverse effect on our operations and financial performance. The level of protection and disaster-recovery capability varies from site to site, and there can be no guarantee that any such plans, to the extent they are in place, will be completely effective. Further, a greater number of our employees are working remotely in response to the COVID-19 pandemic and related government actions and may choose to continue to work remotely after the pandemic has ended, which could expose us to greater risks associated with cybersecurity threats and systems interruptions. Loss of data could interrupt our operations, including our ability to ship products, bill our customers, provide customer support services, conduct research and development activities, process and prepare company financial information, manage various general and administrative aspects of our business and damage our reputation, any of which could adversely affect our business.

Our operations are vulnerable to interruption or loss due to natural or other disasters, power loss, strikes and other events beyond our control.

We conduct a significant portion of our activities, including administration and data processing, at facilities located in Southern California, an area that has experienced major earthquakes, fires and other natural disasters. In addition, our primary self-manufacturing facility is located in West Carrollton, Ohio, an area that has experienced tornados, winter storms and other natural disasters. A major earthquake, fire, tornado or other disaster (such as a major flood, tsunami, storm or terrorist attack) affecting these or other NuVasive facilities, or those of our suppliers, could significantly disrupt our operations, and delay or prevent product shipment or installation during the time required to repair, rebuild or replace our facilities or those of our suppliers. These delays could be lengthy and costly. If our manufacturing facilities or any of our customers’ facilities are negatively impacted by a disaster, shipments of our products could be delayed. Additionally, customers may delay purchases of our products until operations return to normal. Even if we are able to quickly respond to a disaster, the ongoing effects of the disaster could create some uncertainty in the operations of our business. In addition, our facilities may be subject to a shortage of available electrical power and other energy supplies. Any shortages may increase our costs for power and energy supplies or could result in blackouts, which could disrupt the operations of our affected facilities and harm our business. In addition, concerns about terrorism, the effects of a terrorist attack, political turmoil or an outbreak of a widespread disease or other public health crisis, such as the COVID-19 pandemic, could have a negative effect on our operations, those of our suppliers and customers and the ability to travel, which could harm our business, financial condition and results of operations.

 

33

Table of Contents

Our insurance policies are expensive and protect us only from some business risks, which will leave us exposed to significant uninsured liabilities.

We do not carry insurance for all categories of risk that our business may encounter. Some of the policies we currently maintain include general liability, foreign liability, employee benefits liability, property, umbrella, workers’ compensation, products liability and directors’ and officers’ insurance. We do not know, however, if we will be able to maintain existing insurance with adequate levels of coverage. Any significant uninsured liability may require us to pay substantial amounts, which would adversely affect our cash position and results of operations.

We bear the risk of warranty claims on our products.

We bear the risk of express and implied warranty claims on products we supply, including equipment and component parts manufactured by third parties. We may not be successful in claiming recovery under any warranty or indemnity provided to us by our suppliers or vendors in the event of a successful warranty claim against us by a customer or that any recovery from such vendor or supplier would be adequate. In addition, warranty claims brought by our customers related to third-party components may arise after our ability to bring corresponding warranty claims against such suppliers expire, which could result in additional costs to us. There is a risk that warranty claims made against us will exceed our warranty reserve and our business, financial condition and results of operations could be harmed.

Risks Related to Litigation and Intellectual Property

Defending against litigation or other proceedings or third-party claims of intellectual property infringement could require us to spend significant time and money, and if we are unsuccessful, we may be obligated to pay damages and halt sales of our products.

Significant litigation regarding patent rights occurs in our industry and our commercial success depends in part on not infringing the patents or violating the proprietary rights of others. We have received in the past, and expect to receive in the future, claims from our competitors alleging infringement of their intellectual property rights as part of business strategies designed to impede our successful commercialization of updated and new products and entry into new markets. A patent infringement suit brought against us or any of our strategic partners or licensees may force us or such strategic partners or licensees to stop or delay developing, manufacturing or selling potential products that are claimed to infringe a third-party’s intellectual property, unless that party grants us or our strategic partners or licensees rights to use its intellectual property. In such cases, we may be required to obtain licenses to patents or proprietary rights of others in order to continue to commercialize our products. However, we may not be able to obtain any licenses required under any patents or proprietary rights of third parties on acceptable terms, or at all, and any licenses may require substantial royalties or other payments by us. Even if our strategic partners, licensees or we were able to obtain rights to the third-party’s intellectual property, these rights may be non-exclusive, thereby giving our competitors access to the same intellectual property. Ultimately, we may be unable to commercialize some of our potential products or may have to cease some of our business operations as a result of patent infringement claims, which could severely harm our business.

Moreover, we are currently and may become party to future adversarial proceedings regarding our patent portfolio or the patents of third parties. Such proceedings could include supplemental examination or contested post-grant proceedings such as inter partes review, reexamination, interference or derivation proceedings before the U.S. Patent and Trademark Office and challenges in U.S. District Court. Patents may be subjected to opposition, post-grant review or comparable proceedings lodged in various foreign, both national and regional, patent offices. The legal threshold for initiating litigation or contested proceedings may be low, so that even lawsuits or proceedings with a low probability of success might be initiated. Litigation and contested proceedings can also be expensive and time-consuming, and our adversaries in these proceedings may have the ability to dedicate substantially greater resources to prosecuting these legal actions than we can.

 

34

Table of Contents

Any lawsuits or claims relating to infringement of intellectual property or our patent portfolio could subject us to significant liability for damages and invalidate our proprietary rights. Any potential intellectual property litigation also could force us to do one or more of the following:

 

•

stop making, selling or using products or technologies that allegedly infringe the asserted intellectual property;

 

•

lose the opportunity to license our technology to others or to collect royalty payments based upon successful protection and assertion of our intellectual property rights against others;

 

•

incur significant legal expenses;

 

•

pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing;

 

•

pay the attorney’s fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing;

 

•

redesign those products that contain the allegedly infringing intellectual property, which could be costly, disruptive and/or infeasible; or

 

•

attempt to obtain a license to the relevant intellectual property from third parties, which may not be available on reasonable terms or at all.

Any litigation or claim against us, even those without merit, may cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business and harm our reputation. In addition, we generally indemnify our customers and distributors with respect to infringement by our products of the proprietary rights of third parties. If third parties assert infringement claims against our customers or distributors, we may be required to initiate or defend protracted and costly litigation on behalf of our customers or distributors, regardless of the merits of these claims. If any of these claims succeed or settle, we may be forced to pay damages or settlement payments on behalf of our customers or distributors or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products.

We are currently, and may in the future be, subject to claims and lawsuits that could cause us to incur significant legal expenses and result in harm to our business.

We are currently party to various commercial, personal injury, and intellectual property litigation and have previously been subject to a purported securities class action lawsuit, shareholder derivative litigation, and intellectual property infringement lawsuits, and we may be subject to additional claims and lawsuits in the future. In addition, we, as well as certain of our officers and sales representatives, are subject to claims or lawsuits from time to time. Regardless of the outcome, these lawsuits may result in significant legal fees and expenses and could divert management’s time and other resources. If the claims contained in these lawsuits are successfully asserted against us, we could be liable for damages and be required to alter or cease certain of our business practices or product lines. Any of these outcomes could cause our business, financial performance and cash position to be negatively impacted. Litigation may also harm our relationships with existing customers and subject us to negative publicity, each of which could harm our business and financial results.

Our ability to protect our intellectual property and proprietary technology through patents and other means is uncertain.

Our success depends significantly on our ability to protect our proprietary rights to the technologies used in our products and procedural solutions. We rely on patent protection, as well as a combination of copyright, trade secret and trademark laws, and nondisclosure, confidentiality and other contractual restrictions to protect our proprietary technology. However, these legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep any competitive advantage. If we do not adequately protect our intellectual property and proprietary technology, competitors may be able to use our technologies and erode or negate any competitive advantage we may have, which could harm our business and impact our profitability.

Our pending U.S. and foreign patent applications may not issue as patents at all or not in a form that will be advantageous to us or may issue and be subsequently successfully challenged by others and invalidated. Our existing patents and any patents issued in the future may not have claims with a scope sufficient to protect our products, any additional features we develop for our products or any new products. Both the patent application process and the process of managing patent disputes can be time consuming and expensive. Other parties may have developed technologies that may be related or competitive to our technology, may have filed or may file patent applications and may have received or may receive patents that overlap or conflict with our patent applications, either by claiming the same methods or devices or by claiming subject matter that could dominate our patent position. Further, competitors may also be able to design around our patents or develop products that provide outcomes that are comparable to our products but fall outside of the scope of our patent protection.

 

35

Table of Contents

We rely on our trademarks, trade names and brand names to distinguish our products from the products of our competitors, and have registered or applied to register many of these trademarks. We cannot assure you that our trademark applications will be approved. Third parties may also oppose our trademark applications, or otherwise challenge our use of the trademarks. In the event that our trademarks are successfully challenged, we could be forced to rebrand our products, which could result in loss of brand recognition, and could require us to devote resources to advertising and marketing new brands. Further, we cannot assure you that competitors will not infringe upon our trademarks, or that we will have adequate resources to enforce our trademarks.

If we seek to enforce our intellectual property rights through litigation or other proceedings, it could require us to spend significant time and money, with uncertain results.

In the event a competitor infringes upon our patent or other intellectual property rights, enforcing those rights may be costly, difficult and time consuming. We may not have sufficient resources to enforce our intellectual property rights or to defend our patents against a challenge. Our ability to enforce our patent rights depends on our ability to detect infringement. It may be difficult to detect infringers who do not advertise the components that are used in their products. Moreover, it may be difficult or impossible to obtain evidence of infringement in a competitor’s or potential competitor’s product. The medical device industry is characterized by the existence of a large number of patents and frequent litigation based on allegations of patent infringement. It is not unusual for parties to exchange letters surrounding allegations of intellectual property infringement and licensing arrangements. In addition, the patent positions of medical device companies, including our patent position, may involve complex legal and factual questions, and, therefore, the scope, validity and enforceability of any patent claims that we have or may obtain cannot be predicted with certainty.

If we are unable to protect the confidentiality of our trade secrets, our business and competitive position could be harmed.

We rely upon non-disclosure agreements and invention assignment agreements with our employees, consultants and third parties to protect our confidential and proprietary information and trade secrets. In addition to contractual measures, we try to protect the confidential nature of our proprietary information using physical and technological security measures. Such measures may not, for example, in the case of misappropriation of a trade secret by an employee or third party with authorized access, provide adequate protection for our proprietary information. Our security measures may not prevent an employee or consultant from misappropriating our trade secrets and providing them to a competitor, and recourse we take against such misconduct may not provide an adequate remedy to protect our interests fully. Unauthorized parties may also attempt to copy or reverse engineer certain aspects of our products that we consider proprietary. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret can be difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, trade secrets may be independently developed by others in a manner that could prevent legal recourse by us. If any of our confidential or proprietary information, such as our trade secrets, were to be disclosed or misappropriated, or if any such information was independently developed by a competitor, our business and competitive position could be harmed.

We may not be able to enforce our intellectual property rights throughout the world.

The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States. Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. This could make it difficult for us to stop infringement of our foreign patents, if obtained, or the misappropriation of our other intellectual property rights. For example, some foreign countries have compulsory licensing laws under which a patent owner must grant licenses to third parties. In addition, some countries limit the enforceability of patents against third parties, including government agencies or government contractors. In these countries, patents may provide limited or no benefit. Patent protection must ultimately be sought on a country-by-country basis, which is an expensive and time-consuming process with uncertain outcomes. Accordingly, we may choose not to seek patent protection in certain countries, and we will not have the benefit of patent protection in such countries.

Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. Accordingly, our efforts to protect our intellectual property rights in such countries may be inadequate. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our technology and the enforcement of our intellectual property.

Third parties may assert ownership or commercial rights to inventions we develop.

We enter into agreements with collaborators that provide for the ownership of intellectual property arising from our collaborations and product development initiatives. These collaborators and other third parties may in the future make claims challenging the inventorship or ownership of our intellectual property. In addition, we may face claims by third parties that our agreements with employees, contractors or consultants obligating them to assign intellectual property to us are ineffective or in conflict with prior or competing contractual obligations of assignment, which could result in ownership disputes regarding intellectual property we have developed or will develop and interfere with our ability to capture the commercial value of such intellectual property. Litigation may be necessary to resolve an ownership dispute, and if we are not successful, we may be precluded from using certain intellectual property or may lose our exclusive rights in that intellectual property. Either outcome could harm our business and competitive position.

 

36

Table of Contents

In addition, in certain instances we have agreed to pay consultants royalties, milestones and other payments in connection with their product development efforts. There can be no assurance that these consultants will not claim to be entitled to a royalty, milestone or other payment, even if we do not believe that it is warranted. Any such claim against us, even those without merit, may cause us to incur substantial costs, and could place a strain on our financial resources, divert the attention of management from our core business and harm our reputation.

Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets or are in breach of non-competition or non-solicitation agreements with our competitors.

We employ and contract with individuals who previously worked with other companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our personnel, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third party. In addition, we have been and may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement with a third party. Litigation may be necessary to defend against these claims. If we fail in defending any such claims or settling those claims, in addition to paying monetary damages or a settlement payment, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and/or be a distraction to management and other employees.

If personal injury lawsuits are brought against us, our business may be harmed, and we may be required to pay damages that exceed our insurance coverage.

Our business exposes us to potential product liability claims that are inherent in the testing, manufacture and sale of medical devices for surgical procedures, as well as potential malpractice claims that are inherent in the provision of IONM services. Surgical procedures using our products and services often involve significant risk of serious complications, including bleeding, nerve injury, paralysis and even death. We could become the subject of product liability lawsuits alleging that component failures, malfunctions, manufacturing flaws, design defects or inadequate disclosure of product-related risks or product-related information resulted in an unsafe condition or injury to patients. Furthermore, our biologics products may expose us to additional potential product liability claims, including due to the risk of transmitting disease to human recipients. Additionally, our IONM services business could become the subject of medical malpractice lawsuits alleging negligence on the part of our neurophysiologists and/or oversight physicians.

We have had, and continue to have, personal injury claims relating to our products and clinical services and in the future, we may be subject to additional claims, some of which may have a negative impact on our business, results of operations or financial position. Regardless of the merit or eventual outcome, these claims may result in:

 

•

decreased demand for our products;

 

•

injury to our reputation;

 

•

significant litigation costs;

 

•

substantial monetary awards to or costly settlements with patients;

 

•

product recalls;

 

•

material defense costs;

 

•

loss of net sales;

 

•

increased insurance costs;

 

•

the inability to commercialize new products or product candidates; and

 

•

diversion of management attention from pursuing our business strategy.

Our existing insurance coverage for personal injury claims may be inadequate to protect us from any liabilities we might incur. If a personal injury claim or series of claims is brought against us for uninsured liabilities or in excess of our insurance coverage, our business could suffer. In addition, we may not be able to maintain insurance coverage at a reasonable cost or in sufficient amounts or scope to protect us against losses. Any claims against us, regardless of their merit, could severely harm our financial condition, strain our management and other resources and adversely affect or eliminate the prospects for commercialization of our IONM business or sales of a product or product candidate that is the subject of any such claim.

 

37

Table of Contents

Risks Related to Regulatory and Compliance

We are subject to rigorous FDA and other governmental regulations regarding the development, manufacture, and sale of our products and we may incur significant expenses to comply with these regulations and develop products that satisfy these regulations.

The medical devices we manufacture and market are subject to rigorous regulation by the FDA and numerous other federal, state and foreign governmental authorities, including regulations that cover, among other things, the composition, labeling, testing, clinical study, manufacturing, packaging, marketing and distribution of our products.

We are required to register with the FDA as a device manufacturer and tissue bank. As a result, we are subject to periodic inspection by the FDA for compliance with the FDA’s Quality System Regulation (QSR) and Good Tissue Practices requirements, which require manufacturers of medical devices and tissue banks to adhere to certain regulations, including testing, quality control and documentation procedures. Our compliance with applicable regulatory requirements is subject to continual review and is rigorously monitored through periodic inspections by the FDA. In the European Community, we are required to maintain certain ISO certifications in order to sell our products, and are subject to periodic inspections by Notified Bodies to obtain and maintain these certifications. If we or our suppliers fail to adhere to QSR, ISO or other applicable regulations and standards, it could negatively impact product production and regulatory clearances and could result in fines. Further our products could be subject to field safety corrective actions or recall by the FDA or other regulatory bodies, or voluntarily by us, in the event of a material deficiency or defect in design, manufacture, labeling of a product or in the event that a product poses an unacceptable risk to health. For example, we have recently issued field safety notices for our MAGEC and Precice systems. If we are unable to resolve the issues identified in the field safety notices, we may need to re-design or re-engineer the affected systems, which could be costly. Further, if we are the subject of any claims or lawsuits related to the issues identified in the field safety notices, it could have a material adverse effect on our business and results of operations.

Most medical devices must receive FDA clearance or approval before they can be commercially marketed in the United States. In addition, the FDA may require testing and surveillance programs to monitor the effects of approved products that have been commercialized, and can prevent or limit further marketing of a product based upon the results of such post-marketing programs. In addition, the Federal Medical Device Reporting Regulations require us to provide information to the FDA whenever there is evidence that reasonably suggests that a device may have caused or contributed to a death or serious injury or, if a malfunction were to occur, that could cause or contribute to a death or serious injury. Furthermore, most major markets for medical devices outside the United States require clearance, approval or compliance with certain standards before a product can be commercially marketed. The process of obtaining regulatory approvals to market a medical device, particularly from the FDA and certain foreign governmental authorities, can be costly and time-consuming, and approvals may not be granted for future products or product improvements on a timely basis, if at all. Delays in receipt of, or failure to obtain, approvals for future products or product improvements could result in delayed realization of product sales or in substantial additional costs, which could have a material adverse effect on our business or results of operations or prospects. At any time after approval of a product, the FDA or other applicable regulator, including Notified Bodies, may conduct periodic inspections to determine compliance with our quality system and other laws and regulations governing the development, labeling, testing, manufacturing, packaging, marketing and distribution of our products. The results of these inspections can include observations, warning letters, or other forms of enforcement. If the FDA or another regulator were to conclude that we are not in compliance with applicable laws or regulations, or that any of our products are ineffective or pose an unreasonable health risk, they could ban such products, detain or seize adulterated or misbranded products, order a recall, repair, replacement, or refund of payment of such products, revoke existing product clearances or delay clearance of future products, refuse to provide certificates for exports, and/or require us to notify healthcare professionals and others that the products present unreasonable risks of substantial harm to the public health. The FDA or other regulators may also assess civil or criminal penalties against us, our officers or employees and impose operating restrictions on a company-wide basis.

Also, the procurement and transplantation of allograft bone tissue is subject to the criminal statute National Organ Transplant Act and state rules and regulations which govern, among other things, payments we make to vendors in consideration for the services they provide in connection with the recovery and screening of donors. Failure to comply with such laws could result in enforcement action against us and a disruption to these product lines (and the net sales associated therewith).

 

38

Table of Contents

Failure or alleged failure to comply with FDA and other governmental regulations can result in investigations and other regulatory proceedings, which are expensive and could divert management attention.

If the FDA or other governmental authorities in the United States or abroad believes we are not conducting our business in compliance with applicable laws or regulations, such governmental authority can initiate investigations or other regulatory proceedings. Responding to such investigations and proceedings may cause us to incur substantial costs, and could place a significant strain on our financial resources and divert the attention of management from our core business. We could be subject to proceedings to detain or seize our products, recall our products, or restrict our operations. Moreover, governmental authorities can ban or request the recall, repair, replacement or refund of the cost of any device or product we manufacture or distribute. Any of the foregoing actions could result in decreased sales as a result of negative publicity and product liability claims, and could have a material adverse effect on our financial condition, results of operations and prospects.

We are subject to federal, state and foreign fraud and abuse laws and health information privacy and security laws, which, if violated, could subject us to substantial penalties.

There are numerous U.S. federal and state, as well as foreign, laws pertaining to healthcare fraud and abuse, including anti-kickback, false claims and physician transparency laws. Our relationships with physicians, providers and hospitals are subject to scrutiny under these laws. We may also be subject to patient privacy regulation by both the federal government and the states and foreign jurisdictions in which we conduct our business.

Healthcare fraud and abuse laws are broad in scope and are subject to evolving interpretation, which could require us to incur substantial costs to monitor compliance or to alter our practices if they are found not to be in compliance. Violations of these laws may be punishable by criminal or civil sanctions, including substantial fines, imprisonment and exclusion from participation in governmental healthcare programs. Despite implementation of a comprehensive global healthcare compliance program, we cannot provide assurance that any of the healthcare fraud and abuse laws will not change or be interpreted in the future in a manner which restricts or adversely affects our business activities or relationships with healthcare professionals, nor can we make any assurances that authorities will not challenge or investigate our current or future activities under these laws.

Responding to government requests and investigations requires considerable resources, including the time and attention of management. If we were to become the subject of an enforcement action it could result in negative publicity, penalties, fines, the exclusion of our products from reimbursement under federally-funded programs and/or prohibitions on our ability to sell our products, which could have a material adverse effect on our results of operations, financial condition and liquidity.

We may fail to obtain or maintain foreign regulatory approvals to market our products in other countries.

We currently market our products internationally and intend to continue to expand our operations in select developed and emerging international markets. International jurisdictions require separate regulatory approvals and compliance with numerous and varying regulatory requirements. The approval procedures vary among countries and may involve requirements for additional studies and gathering of additional data. Clearance or approval by the FDA does not ensure approval or certification by regulatory authorities in other countries or jurisdictions, and approval or certification by one foreign regulatory authority does not ensure approval or certification by regulatory authorities in other foreign countries or by the FDA.

The European Union requires that manufacturers of medical devices obtain the right to bear the “CE” conformity marking which designates compliance with existing directives and standards regulating the design, manufacture and distribution of medical devices in member countries of the European Union. In 2017, the European Union adopted the EU Medical Device Regulation (Council Regulations 2017/745) which will replace existing directives and impose stricter requirements for the marketing and sale of medical devices, including new clinical evaluation, quality system, and post-market surveillance requirements. The regulation initially provided for a three-year implementation period, with full application of the regulation to occur in May 2020, but this timeline has been delayed to May 2021 due to the COVID-19 pandemic. After May 2021, medical devices marketed in the European Union will require certification according to these new requirements, except that devices with valid CE certificates, issued pursuant to the Medical Device Directive before May 2021, may be placed on the market until May 2024. Complying with this new regulation will require us to incur significant costs and failure to meet the requirements of the regulation could adversely impact our business in the European Union and other countries that utilize or rely on European Union requirements for medical device registrations.

Additionally, pursuant to guidance issued by the UK Government as a result of the UK formally withdrawing from the European Union, the Medicines and Healthcare products Regulatory Agency (MHRA) became the standalone medicines and medical devices regulator for the UK as of January 1, 2021. A new mark referred to as “UKCA” (UK Conformity Assessed) has also been introduced and will replace the CE conformity mark. Although CE conformity marketing and certificates issued by Notified Bodies will continue to be recognized in the UK through June 2023, all medical devices must be registered with the MHRA as of January 1, 2021. Complying with this new regulatory framework will require us to invest in additional resources and could be expensive, time-consuming and disruptive to our existing operations in the UK.

 

39

Table of Contents

The global regulatory environment is becoming increasingly complex and we expect the time and expense of obtaining and maintaining foreign regulatory approvals for our products to increase. We cannot be certain that we will receive necessary approvals or certifications to commercialize our products in foreign jurisdictions on a timely basis, or at all. If we fail to receive or maintain necessary approvals or certifications to commercialize our products in foreign jurisdictions our business, results of operations and financial condition could be adversely affected.

If we fail to obtain, or experience significant delays in obtaining, FDA clearances or approvals for our future products or product enhancements, our ability to commercially distribute and market our products could suffer.

The process of obtaining regulatory clearances or approvals to market a medical device, particularly from the FDA, can be costly and time consuming, and there can be no assurance that such clearances or approvals will be granted on a timely basis, if at all. In particular, the FDA permits commercial distribution of a new, non-exempt, non-Class I medical device only after the device has received clearance under Section 510(k) of the Federal Food, Drug and Cosmetic Act, or receives approval under the premarket approval application (PMA) process. If clinical trials of our current or future product candidates do not produce results necessary to support regulatory approval, we will be unable to commercialize these products, which could have a material adverse effect on our financial results.

The FDA will clear marketing of a medical device through the 510(k) process if it is demonstrated that the new product is substantially equivalent to other 510(k)-cleared products. The PMA process is more costly, lengthy and uncertain than the 510(k) clearance process. Additionally, any modification to a 510(k)-cleared device that could significantly affect its safety or efficacy, or that would constitute a major change in its intended use, requires a new 510(k) clearance or, possibly, a PMA. The FDA requires each manufacturer to make the determination of whether a modification requires a new 510(k) notification or PMA application in the first instance, but the FDA can review any such decision. If the FDA disagrees with our decisions regarding whether new clearances or approvals are necessary, the FDA may retroactively require us to seek 510(k) clearance or PMA approval. For device modifications that we conclude do not require a new regulatory clearance or approval, we may be required to recall and to stop marketing the modified devices if the FDA or other agency disagrees with our conclusion and requires new clearances or approvals for the modifications. Our failure to comply with such regulations could lead to the imposition of injunctions, suspensions or loss of regulatory approvals, product recalls, termination of distribution, or product seizures. In the most egregious cases, criminal sanctions or closure of our manufacturing facilities are possible.

Legislative or regulatory reforms in the United States may make it more difficult and costly for us to obtain regulatory clearances or approvals for our products or to produce, market or distribute our products after clearance or approval is obtained.

From time to time, legislation is drafted and introduced in Congress that could significantly change the statutory provisions governing the regulation of medical devices or the reimbursement thereof in the United States. In addition, the FDA regulations and guidance are often revised or reinterpreted by the FDA in ways that may significantly affect our business and our products. Any new statutes, regulations or revisions or reinterpretations of existing regulations may impose additional costs or lengthen review times of any future products or make it more difficult to manufacture, market or distribute our products or future products. We cannot determine what effect changes in regulations, statutes, legal interpretation or policies, when and if promulgated, enacted or adopted may have on our business in the future. Such changes could, among other things, require:

 

•

additional testing prior to obtaining clearance or approval;

 

•

changes to manufacturing methods;

 

•

recall, replacement or discontinuance of our products or future products; or

 

•

additional record keeping.

Any of these changes could require substantial time and cost and could harm our business and our financial results.

 

40

Table of Contents

The misuse or off-label use of our products may harm our reputation in the marketplace, result in injuries that lead to product liability suits or result in costly investigations, fines or sanctions by regulatory bodies if we are deemed to have engaged in the promotion of these uses, any of which could be costly to our business.

Pursuant to FDA regulations, medical devices may be promoted only for their cleared or approved indications and in accordance with the provisions of the cleared or approved label. Although physicians are permitted to use medical devices for indications other than those cleared or approved by the FDA based on their medical judgment, the FDA generally prohibits manufacturers and distributors of medical devices from promoting products for such off-label uses. We train our marketing personnel and independent sales representatives and distributors to not promote our products for uses outside of the FDA-cleared indications. Although we believe our marketing, promotional materials and training programs for physicians do not constitute promotion of unapproved uses of our products, if the FDA or any foreign regulatory body determines that our marketing, promotional materials or training programs constitute promotion of an off-label use, we could be subject to significant fines in addition to regulatory enforcement actions. It is also possible that other federal, state or foreign enforcement authorities might take action under other regulatory authority, such as false claims laws, if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but not limited to, criminal, civil and administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs and the curtailment of our operations.

In addition, there may be increased risk of injury to patients if physicians attempt to use our products off-label. Furthermore, the use of our products for indications other than those cleared by the FDA or approved by any foreign regulatory body may not effectively treat such conditions, which could harm our reputation in the marketplace among physicians and patients.

If we or our suppliers fail to comply with the FDA’s quality system regulations, ISO or other applicable regulations and standards, the manufacture and processing of our products could be delayed or interrupted and we may be subject to an enforcement action by the FDA or other government agencies.

We and our suppliers are required to comply with the QSR, ISO and other applicable regulations and standards, which cover the methods and documentation of the design, testing, production or processing, control, quality assurance, labeling, packaging, storage and shipping of our products. The FDA and other regulatory bodies enforce compliance with certain regulatory requirements and standards through periodic inspections. If we or one of our suppliers receive a warning letter or significant observed non-conformities are identified as a result of an inspection or if any corrective action plan is deemed not to be sufficient, the release of our products could be delayed. We have undergone inspections by the FDA and other regulatory bodies regarding our allograft business and regarding our medical device activities. In connection with these inspections, regulatory agencies have requested minor corrective actions, which we have implemented. The FDA and other regulatory agencies may impose additional inspections at any time and we may be required to take corrective actions in the future to address any findings.

Additionally, we are the legal manufacturer of record for the products that are distributed and labeled by us, regardless of whether the products are manufactured by us or our suppliers. Thus, a failure by us or our suppliers to comply with applicable regulatory requirements can result in enforcement action against us by the FDA, which may include any of the following sanctions:

 

•

fines, injunctions, and civil penalties;

 

•

recall or seizure of our products;

 

•

operating restrictions, partial suspension or total shutdown of production;

 

•

refusing our request for 510(k) clearance or premarket approval of new products;

 

•

withdrawing 510(k) clearance or premarket approvals that are already granted; and

 

•

criminal prosecution.

We or our suppliers may be the subject of claims for non-compliance with FDA regulations in connection with the processing or distribution of allograft products.

It is possible that allegations may be made against us or against donor recovery groups or tissue banks, including those with which we have a contractual relationship, claiming that the acquisition or processing of tissue for allograft products does not comply with applicable FDA regulations or other relevant statutes and regulations. Allegations like these could cause regulators or other authorities to take investigative or other action against us, or could cause negative publicity for us or our industry in general. These actions or any negative publicity could cause us to incur substantial costs, divert the attention of management from our business, harm our reputation and cause the market price of our shares to decline.

 

41

Table of Contents

As a U.S. federal government contractor, we are subject to a number of procurement rules and regulations.

Our contracts with the U.S. federal government are subject to specific procurement requirements including various import and export, security, contract pricing and cost, contract termination and adjustment, subcontracting, and audit requirements. These requirements, although customary in government contracts, increase our performance and compliance costs. In addition, failure to comply with these regulations and requirements could result in reductions of the value of contracts, contract modifications or termination, and the assessment of penalties and fines, which could negatively impact our results of operations and financial condition. Our failure to comply with these regulations and requirements could also lead to suspension or debarment, for cause, from government contracting or subcontracting for a period of time. Among the causes for debarment are violations of various statutes, including those related to product sourcing, product pricing, security regulations, employment practices and policies, and subcontracting requirements. The termination of a government contract as a result of any of these acts could have a negative impact on our results of operations and financial condition and could have a negative impact on our reputation and ability to procure other government contracts in the future.

Compliance with Commission regulations relating to “conflict minerals” may increase our costs and adversely affect our business.

We are subject to Commission regulations that require us to determine whether our products contain certain specified minerals, referred to under the regulations as “conflict minerals”, and, if so, to perform an extensive inquiry into our supply chain, in an effort to determine whether or not such conflict minerals originate from the Democratic Republic of Congo, or an adjoining country. Compliance with these requirements has been time-consuming for management and our supply chain personnel (as well as time-consuming for our suppliers), and we expect that compliance will continue to require the expenditure of resources by us and them. In addition, to the extent any of our disclosures are perceived by the market to be “negative,” it may cause customers to refuse to purchase our products. Further, if we determine to make any changes to products, processes, or sources of supply, it may result in additional costs, which may adversely affect our business.

Our relationships with physicians could be subject to additional scrutiny from regulatory enforcement authorities and could subject us to possible administrative, civil or criminal sanctions.

Federal and state laws and regulations impose restrictions on our relationships with physicians. We have entered into consulting agreements, license agreements and other agreements with physicians in which we provided equity awards or cash or both as compensation. Some of the physicians with which we have such consulting and other agreements are affiliated with some of our customers. Finally, we have other arrangements with physicians, including for research and development grants, education, training, and for other purposes as well.

We could be adversely affected if regulatory agencies were to interpret our financial relationships with these physicians, who may be in a position to influence the ordering of and use of our products for which governmental reimbursement may be available, as being in violation of applicable laws. If our relationships with physicians are found to be in violation of the laws and regulations that apply to us, we may be required to restructure the arrangements and could be subject to administrative, civil and criminal penalties, including exclusion from participation in government healthcare programs and the curtailment or restructuring of our operations, any of which could negatively impact our ability to operate our business and our results of operations.

Our business involves the use of hazardous materials and we and our third-party manufacturers must comply with environmental laws and regulations, which may be expensive and restrict how we do business.

Our third-party manufacturers’ activities and our own activities involve the controlled storage, use and disposal of hazardous materials or materials that can become hazardous as result of the manufacturing process. For example, we develop porous titanium implants using additive manufacturing technology, or 3D printing, which generates dust that is highly combustible. We and our manufacturers are subject to federal, state, local and foreign laws and regulations governing the use, generation, manufacture, storage, handling and disposal of these hazardous materials. We currently carry limited insurance covering environmental claims relating to the use of hazardous materials. Although we believe that our safety procedures for handling and disposing of these materials and waste products comply with the standards prescribed by these laws and regulations, we cannot eliminate the risk of accidental injury or contamination from the use, storage, handling or disposal of hazardous materials. In the event of an accident, state or federal or other applicable authorities may curtail our use of these materials and interrupt our business operations. In addition, if an accident or environmental discharge occurs, or if we discover contamination caused by prior operations, including by prior owners and operators of properties we acquire, we could be liable for cleanup obligations, damages and fines. If such unexpected costs are substantial, this could significantly harm our financial condition and results of operations.

 

42

Table of Contents

Risks Related to Our Financial Results and Need for Financing

We may be unable to grow our net sales or earnings as anticipated, which may have a material adverse effect on our future operating results.

We have experienced rapid growth since our inception, and have increased our net sales from $38.4 million in 2004, the year of our initial public offering, to $1.05 billion in 2020. Our ability to achieve future growth will depend upon, among other things, the effectiveness of our growth strategies, which we cannot assure will be successful. In addition, we may have more difficulty maintaining our prior rate of growth of net sales or recent levels of profitability and cash flow. Our future success will depend upon various factors, including the strength of our brand image, the market success of our current and future products, competitive conditions and our ability to manage increased sales, if any, or implement our growth strategy. In addition, we anticipate investing in and expanding our infrastructure and adding personnel in connection with our anticipated growth, which we expect will cause our selling, marketing and administrative expenses to increase. Because these expenses are generally fixed, particularly in the short-to-medium term, our operating and financial results may be adversely impacted if we do not achieve our anticipated growth.

We have a significant amount of outstanding indebtedness, and our financial condition and results of operations could be adversely affected if we do not effectively manage our liabilities.

As of December 31, 2020, we had outstanding $650.0 million aggregate principal amount of our 2.25% Convertible Senior Notes due 2021 (the “2021 Notes”), $450.0 million aggregate principal amount of our 1.00% Convertible Senior Notes due 2023 (the “2023 Notes”) and $450.0 million aggregate principal amount of our 0.375% Convertible Senior Notes due 2025 (the “2025 Notes”). This significant amount of debt has important risks to us and our investors, including:

 

•

requiring a portion of our cash flow from operations to make interest payments on this debt;

 

•

increasing our vulnerability to general adverse economic and industry conditions;

 

•

reducing the cash flow available to fund capital expenditures and other corporate purposes and to grow our business;

 

•

limiting our flexibility in planning for, or reacting to, changes in our business and the industry; and

 

•

limiting our ability to borrow additional funds as needed or take advantage of business opportunities as they arise.

In addition, to the extent we draw on our $550.0 million revolving senior credit facility (the “2020 Facility”) or otherwise incur additional indebtedness, the risks described above could increase. Further, if we increase our indebtedness, our actual cash requirements in the future may be greater than expected. Our cash flow from operations may not be sufficient to repay all of the outstanding debt as it becomes due, and we may not be able to borrow money, sell assets or otherwise raise funds on acceptable terms, or at all, to refinance our debt. Further, there are a large number of shares of common stock reserved for issuance upon the potential conversion of our 2021 Notes, 2023 Notes and 2025 Notes and the warrants that we issued as part of the related bond hedge transactions related to the 2021 Notes, 2023 Notes and 2025 Notes. If any of these shares are issued, the issuance of these shares may depress the market price of our common stock and our existing stockholders could experience dilution.

If we fail to comply with the covenants and other obligations under our credit facility, the lenders may be able to accelerate amounts owed under the facilities and may foreclose upon the assets securing our obligations.

In February 2020, we entered into a Second Amended and Restated Credit Agreement (the “2020 Credit Agreement”) with respect to the 2020 Facility, which replaced the previous Amended and Restated Credit Agreement we had entered into in April 2017. The 2020 Credit Agreement was further amended in May 2020 to, among other things, provide additional flexibility in determining the financial covenant leverage ratios for the second and third fiscal quarters of 2020 and to adjust certain margin and benchmark rates used to determine interest under the 2020 Facility. The 2020 Credit Agreement provides for secured revolving loans, multicurrency loan options and letters of credit in an aggregate amount of up to $550.0 million. The 2020 Credit Agreement also contains an expansion feature, which allows us to increase the aggregate principal amount of the 2020 Facility provided we remain in compliance with the underlying financial covenants on a pro forma basis, including but not limited to, compliance with the consolidated interest coverage ratio and certain consolidated net leverage ratios. All of our assets and the assets of our material domestic subsidiaries are pledged as collateral under the 2020 Facility (subject to customary exceptions) and each of our material domestic subsidiaries guarantee the 2020 Facility. The covenants set forth in the 2020 Credit Agreement impose limitations on, among other things, our ability to: create liens on assets, incur additional indebtedness, make investments, make acquisitions and other fundamental changes, sell and dispose of property or assets, pay dividends and other distributions, change the business conducted, engage in certain transactions with affiliates, enter into burdensome agreements, limit certain use of proceeds, amend organizational documents, change accounting policies or reporting practices, modify or terminate documents related to certain indebtedness, enter into sale and leaseback transactions, fund any person or business that is the subject of sanctions, and use proceeds for any breach of anti-corruption laws. If we fail to comply with the covenants and our other obligations under the 2020 Facility, the lenders would be able to accelerate the required repayment of amounts due under the 2020 Credit Agreement and, if they are not repaid, could foreclose upon our assets securing our obligations under the 2020 Facility.

 

43

Table of Contents

We may need additional financing in the future to meet our capital needs or to make opportunistic acquisitions and such financing may not be available on favorable terms, if at all, and may be dilutive to existing stockholders.

In furtherance of our growth strategy and global expansion efforts, we intend to continue to invest in our business, including through acquisitions and strategic transactions. These investments may be expensive, and we may need to seek additional financing in the future to meet our capital needs. As of December 31, 2020, we had $1.0 billion in cash, cash equivalents and short-term investments, and the ability to draw $550.0 million on our 2020 Facility. Additionally, as of December 31, 2020, we had outstanding $650.0 million aggregate principal amount of the 2021 Notes, which have a maturity date of March 15, 2021, $450.0 million aggregate principal amount of the 2023 Notes, which have a maturity date of June 1, 2023 and $450.0 million aggregate principal amount of the 2025 Notes, which have a maturity date of March 15, 2025. On February 23, 2021, we entered into a definitive agreement to acquire Simplify Medical for an upfront payment of $150.0 million at closing, subject to customary purchase price adjustments, plus additional future payments contingent upon milestones related to regulatory approval and net sales from products incorporating the Simplify Medical cervical artificial disc technology. The closing of the acquisition occurred on February 24, 2021, and Simplify Medical is now our wholly-owned subsidiary. In connection with the closing, the Company funded the $150.0 million upfront payment using available cash and investments on hand. We may seek to raise capital from public and private debt and equity offerings, borrowings under our existing or future credit facilities or other sources. We may be unable to obtain any desired additional financing on terms favorable to us, if at all. If adequate funds are not available on acceptable terms, we may be unable to fund our expansion, successfully develop or enhance products or respond to competitive pressures, any of which could negatively affect our business. If we raise additional funds through the issuance of equity securities, our stockholders will experience dilution of their ownership interest. If we raise additional funds by issuing debt, we may be subject to limitations on our operations due to restrictive covenants. Additionally, our ability to make scheduled payments or refinance our obligations will depend on our operating and financial performance, which in turn is subject to prevailing economic conditions and financial, business and other factors beyond our control.

We could be subject to changes in tax rates, the adoption, evolution or change of new and/or amended U.S. or international tax legislation or exposure to additional tax liabilities.

We are subject to taxes in the United States and numerous foreign jurisdictions, including the Netherlands, the location of our international headquarters. Significant judgment is required to determine and estimate our worldwide tax liabilities. Due to economic and political conditions, tax rates in various jurisdictions may be subject to significant change. Our effective income tax rates have been, and could in the future be, adversely affected by changes in tax laws or interpretations of those tax laws; by stock-based compensation and other non-deductible expenses; by changes in the mix of earnings in countries with differing statutory tax rates; or by changes in the valuation of our deferred tax assets and liabilities.

We have centralized international operations in the Netherlands and have entered into intercompany transfer pricing arrangements, including the licensing of intangibles. We continue to streamline our international operations to better align with and support our international business activities and markets through changes in how manage the development and use of our intangible property and how we structure our international procurement and customer service functions. There can be no assurance that the taxing authorities of the jurisdictions in which we operate, or will operate or to which we are otherwise deemed to have sufficient tax presence, will not challenge the tax benefits that we ultimately expect to realize as a result of our international structure. In addition, current and future changes to U.S. and non-U.S. tax laws, including recently enacted U.S. tax reform of international business and the continuing development of the Organization for Economic Cooperation and Development Base Erosion and Profit Shifting recommendations, could negatively impact the anticipated tax benefits of our international structure. Any long term benefits to our tax rate will also depend on our ability to achieve our anticipated international growth projections and to operate our business in a manner consistent with our international structure and intercompany transfer pricing arrangements. If we do not operate our business consistent with the structure and applicable tax provisions, we may fail to achieve the financial efficiencies that we anticipate as a result of the structure and our future operating results and financial condition may be negatively impacted.

Finally, we may be subject in the future to examination of our income tax returns by the Internal Revenue Service and other taxing authorities which may result in the assessment of additional income taxes. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes. There can be no assurance as to the outcome of these examinations. If our effective tax rates were to increase, particularly in the U.S. or the Netherlands or if the ultimate determination of our taxes owed is for an amount in excess of amounts previously accrued, our financial condition, cash flows or results of operations could be adversely affected.

 

44

Table of Contents

Risks Related to the Securities Markets and Ownership of Our Common Stock

We expect that the price of our common stock will fluctuate substantially, potentially adversely affecting the ability of investors to sell their shares.

The market price of our common stock may be subject to wide fluctuations, which may negatively affect the ability of investors to sell our shares at consistent prices. Fluctuation in the stock price may occur due to many factors, including, without limitation:

 

•

general market conditions and other factors related to the economy or otherwise, including factors unrelated to our operating performance or the operating performance of our competitors;

 

•

people’s expectations, favorable or unfavorable, as to the likely growth of the markets in which we participate;

 

•

negative publicity regarding spine surgeon’s practices or outcomes, whether warranted or not, that cast the sector in a negative light;

 

•

the introduction of new products or product enhancements by us or our competitors;

 

•

changes in the availability of third-party reimbursement in the United States or other countries;

 

•

disputes or other developments with respect to intellectual property rights or other potential legal actions;

 

•

our ability to develop, obtain regulatory clearance or approval for, and market new and enhanced products on a timely basis;

 

•

quarterly variations in our or our competitor’s results of operations;

 

•

sales of large blocks of our common stock, including sales by our executive officers and directors;

 

•

announcements of technological or medical innovations for the treatment of spine pathology;

 

•

changes in governmental regulations or in the status of our regulatory approvals, clearances or applications;

 

•

the acquisition or divestiture of businesses, products, assets or technology by us or by our competitors;

 

•

litigation (including intellectual property litigation) and any associated negative verdicts or ruling;

 

•

announcements of actions by the FDA or other regulatory agencies; and

 

•

changes in earnings or operating margin estimates or financial guidance provided by us or by reports or ratings by securities analysts.

Anti-takeover provisions in our organizational documents and Delaware law may discourage or prevent a change of control, even if an acquisition would be beneficial to our stockholders, which could affect our stock price adversely and prevent attempts by our stockholders to replace or remove our current management.

Our certificate of incorporation and bylaws contain provisions that could delay or prevent a change of control of our company or changes in our Board of Directors that our stockholders might consider favorable. Some of these provisions:

 

•

authorize the issuance of preferred stock which can be created and issued by the Board of Directors without prior stockholder approval, with rights senior to those of the common stock;

 

•

provide for a classified Board of Directors, with each director serving a staggered three-year term;

 

•

provide that our stockholders may remove our directors only for cause;

 

•

prohibit our stockholders from filling board vacancies, calling special stockholder meetings, or taking action by written consent;

 

•

prohibit our stockholders from making certain changes to our certificate of incorporation or bylaws except with 66 2/3% stockholder approval; and

 

•

require advance written notice of stockholder proposals and director nominations.

In addition, we are subject to the provisions of Section 203 of the Delaware General Corporation Law, which may prohibit certain business combinations with stockholders owning 15% or more of our outstanding voting stock. These and other provisions in our certificate of incorporation, our bylaws and Delaware law could make it more difficult for stockholders or potential acquirers to obtain control of our Board of Directors or initiate actions that are opposed by our then-current Board of Directors, including delay or impede a merger, tender offer, or proxy contest involving our company. Any delay or prevention of a change of control transaction or changes in our Board of Directors could cause the market price of our common stock to decline.

We do not intend to pay cash dividends.

We have never declared or paid cash dividends on our capital stock. We currently intend to retain all available funds and any future earnings for use in the operation and expansion of our business and do not anticipate paying any cash dividends in the foreseeable future. In addition, the terms of any future debt or credit facility may preclude us from paying any dividends. As a result, capital appreciation, if any, of our common stock will be our stockholders’ source of potential gain for the foreseeable future.

 

45

Table of Contents

Item 1B.           Unresolved Staff Comments

None.

Item 2.Properties

The following table sets forth our principal properties as of December 31, 2020, all of which are leased unless otherwise noted as owned:

Primary Use

Square Footage

 

 

Location

Corporate headquarters

 

252,000

 

 

San Diego, CA

Manufacturing facilities (1)

 

180,000

 

 

West Carrollton, OH

Fulfillment and warehouse operations (1)

 

100,000

 

 

Memphis, TN

Office facilities

 

42,000

 

 

Aliso Viejo, CA

Office facilities and warehouse

 

41,000

 

 

Japan

Office facilities and warehouse

 

22,000

 

 

Netherlands

Office facilities

 

21,000

 

 

Columbia, MD

Office facilities and warehouse

 

21,000

 

 

Australia

Office facilities and warehouse

 

15,000

 

 

Germany

Office facilities

 

7,000

 

 

Brazil

Office facilities

 

7,000

 

 

United Kingdom

 

 

 

 

 

 

(1) Owned by the Company

 

 

 

 

 

 

For a description of our material pending legal proceedings, refer to Note 12 “Contingencies” of the Notes to the Consolidated Financial Statements included in this Annual Report, which is incorporated herein by reference.

Item 4.Mine Safety Disclosures

Not applicable.

 

46

Table of Contents

PART II

Item 5.Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Common Stock Market Information

Our common stock is traded on the Nasdaq Global Select Market under the symbol “NUVA.”

We had approximately 71 stockholders of record as of January 31, 2021. The number of beneficial owners is substantially greater than the number of record holders because a large portion of our common stock is held of record through brokerage firms in “street name.”

Recent Sales of Unregistered Securities

There were no unregistered sales of equity securities which have not been previously disclosed in a Quarterly Report on Form 10-Q or a Current Report on Form 8-K during the year ended December 31, 2020.

Dividend Policy

We have never declared or paid any cash dividends on our capital stock. We currently intend to retain future earnings, if any, for development of our business and do not anticipate that we will declare or pay cash dividends on our capital stock in the foreseeable future.

 

47

Table of Contents

PERFORMANCE GRAPH

The following graph compares the cumulative total stockholder return data on our common stock with the cumulative return of (i) The Nasdaq Stock Market Composite Index, and (ii) Nasdaq Medical Equipment Index over the five-year period ending December 31, 2020. The graph assumes that $100 was invested on December 31, 2015 in our common stock and in each of the comparative indices, and the reinvestment of any dividends. The stock price performance on the following graph is not necessarily indicative of future stock price performance.

The following graph and related information shall not be deemed “soliciting material” or be deemed to be “filed” with the Commission, nor shall such information be incorporated by reference into any future filing, except to the extent that we specifically incorporate it by reference into such filing.

COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*

AMONG NUVASIVE, INC.,

THE NASDAQ COMPOSITE INDEX

AND THE NASDAQ MEDICAL EQUIPMENT INDEX

*$100 invested on December 31, 2015 in stock or index, including reinvestment of dividends.

 

 

48

Table of Contents

 

Purchases of Equity Securities

In October 2017, we announced that our Board of Directors had approved a share repurchase program authorizing the repurchase of up to $100 million of our common stock over a three-year period. Under this program, we are authorized to repurchase our shares in open market purchases, privately negotiated purchases or other transactions through October 2020. In February 2020, we announced that our Board of Directors increased the share repurchase authorization from $100 million to $150 million of our common stock through December 31, 2021. In March 2020, in connection with the issuance of our Convertible Senior Notes due 2025, we repurchased approximately 1,085,000 shares of our common stock for $75.0 million. As of December 31, 2020, $75.0 million remained authorized under the share repurchase program.

 

Item 6.Selected Financial Data

 

Part II, Item 6 is no longer required. The Company has adopted certain provisions within the amendments to Regulation S-K that eliminate Item 301.

 

 

 

49

Table of Contents

 

Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations

As noted earlier, this Annual Report, including the following discussion and analysis, may contain forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause our results to differ from historical results or those expressed or implied by such forward-looking statements. Please review this Annual Report and the following discussion and analysis in light of the forward-looking statements provisions outlined at the outset of Part I.

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with the Consolidated Financial Statements and the Notes to those statements included in this Annual Report.

Overview

We are a global medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. We offer a comprehensive portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, we develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures. For the year ended December 31, 2020, we generated net sales of $1.05 billion, including sales in more than 50 countries.

Since our incorporation in 1997, we have grown from a small developer of specialty spinal implants into a leading medical technology company delivering procedurally integrated solutions for spine surgery. A key driver of our growth has been our focus on innovative products and technologies that drive reproducible outcomes for patients, surgeons and providers. In 2003, we introduced the eXtreme Lateral Interbody Fusion procedure, or XLIF, a lateral access spine surgery technique that is less-invasive than traditional, open surgical procedures and clinically proven to enable better patient outcomes. Building off the success of XLIF, we have continued to develop innovative less-invasive techniques and technologies for spine surgery, and we have broadened our portfolio of solutions for traditional, open surgical procedures. Our comprehensive portfolio of solutions can be utilized in procedures for the cervical, thoracic and lumbar spine, supporting surgical approaches from the anterior, including lateral, and posterior. Our solutions are used to treat degenerative conditions and for complex spinal surgery, including adult and pediatric deformities, as well as trauma and tumors.

Underlying our procedurally integrated solutions for spine surgery are innovative technologies designed to enable better clinical, financial, and operational outcomes, including:

 

•

our differentiated surgical access instruments, including our Maxcess integrated split-blade retractor system, designed to enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery;

 

•

our neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and our intraoperative neuromonitoring, or IONM, services and support;

 

•

our Advanced Materials Science portfolio of specialized spinal implants, designed to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone, or PEEK;

 

•

our comprehensive Reline fixation system, designed to facilitate the preservation and restoration of patient alignment, while addressing a vast array of spinal pathologies from an open or less-invasive approach across all spinal procedures; and

 

•

our Integrated Global Alignment platform, or iGA, which is comprised of procedurally-based technologies that help increase the predictability of achieving global alignment in spinal procedures, including our Bendini spinal rod bending system that expedites manual rod manipulation for spinal fixation.

We have also invested in enabling technologies, including the development of capital equipment designed to further improve clinical, financial, and operational outcomes of spine surgery. Our capital equipment portfolio currently consists of Lessray and the Pulse platform. Lessray is an image enhancement platform designed to reduce radiation exposure in the operating room by allowing surgeons to take low-quality, low-dose images and improve them to look like conventional full-dose images. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for neuromonitoring, surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. Selling and leasing of capital equipment do not make up a material portion of our total net sales.

In addition to our procedurally integrated solutions for spine surgery, we also design and sell expandable growing rod implant systems that can be non-invasively lengthened following implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control, or MAGEC, which allows for the minimally invasive treatment of early-onset and adolescent scoliosis. This technology is also the basis for our Precice limb lengthening system, which allows for the correction of long bone limb length discrepancy, as well as other products for treating specialized orthopedic procedures.

 

50

Table of Contents

We intend to continue development on a wide variety of innovation projects to advance our leadership position in less-invasive spine surgery, increase our product offerings and solutions for traditional spine surgery procedures, and further our enabling technologies portfolio. We expect to continue to invest in the Pulse platform to support a full global launch of the technology and to develop and expand its application offerings, including investments related to surgical automation and robotics. In addition, we expect to continue to pursue business and technology acquisition targets and strategic relationships to identify opportunities to broaden participation along the spine care continuum. Top priorities include opportunities that complement our technology leadership position in spine, targeted geographic expansion, technology that makes procedures even safer, as well as opportunities for surgical automation.

In December 2019, a novel strain of coronavirus, which causes COVID-19, was identified. Due to the rapid and global spread of the virus, on March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. To slow the proliferation of COVID-19, governments have implemented extraordinary measures, which include the mandatory closure of businesses, restrictions on travel and gatherings, and quarantine and physical distancing requirements. In addition, many government agencies in conjunction with hospitals and healthcare systems have, to varying degrees, deferred or suspended elective surgical procedures. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, we have seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, we have experienced reductions in procedural volumes during 2020 and anticipate this trend may continue. The cumulative effect of these disruptions had a significant impact on our business in 2020 and it is not possible for us to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures. Further discussion of the potential impacts on our business from the COVID-19 pandemic is provided under Part I, Item 1A – Risk Factors.

Net Sales and Operations

The majority of our net sales are derived from the sale of implants and fixation products, biologics, disposables and IONM services and we expect this trend to continue for the foreseeable future. Our implants and fixation products, biologics, and disposables are currently sold and shipped from our distribution and warehousing operations. We generally recognize net sales from implants and fixation products, biologics and disposables upon notice that our products have been used in a surgical procedure or upon shipment to a third-party customer who has assumed control of the products. Net sales from IONM services is recognized in the period the service is performed for the amount of payment we expect to receive. We make available surgical access instrument sets and neuromonitoring systems to hospitals to facilitate surgeon access to the spine to perform restorative and fusion procedures using our implants and fixation products. We sell surgical instrument sets and our proprietary software-driven neuromonitoring systems, however this does not make up a material part of our business. Selling or leasing of capital equipment does not make up a material portion of our total net sales.

A substantial portion of our operations are located in the United States, and the majority of our net sales and cash generation have been made in the United States. We sell our products in the United States through a sales force comprised primarily of directly employed and independent sales representatives. Our sales force provides a delivery and consultative service to surgeon and hospital customers and is compensated based on sales and product placements in their territories. Sales force commissions are reflected in the selling, general and administrative operating expense line item within our Consolidated Statements of Operations. We continue to invest in international expansion with a focus on European, Asia-Pacific and Latin American markets. Our international sales force is comprised of directly-employed sales personnel, independent sales representatives, as well as exclusive and non-exclusive independent third-party distributors.

Critical Accounting Policies

Our discussion and analysis of our financial condition and results of operations is based upon our audited Consolidated Financial Statements, which have been prepared in accordance with generally accepted accounting principles in the United States (GAAP). The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses. On an ongoing basis, we evaluate our estimates including those related to revenue recognition, credit losses, inventories, valuation of financial instruments, goodwill, intangibles, property and equipment, contingent liabilities, stock-based compensation, income taxes, and legal proceedings. We base our estimates on historical experience and on various other assumptions we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities not readily apparent from other sources. Actual results may differ from these estimates.

The following accounting policies are critical to the judgments and estimates used in the preparation of our Consolidated Financial Statements.

 

51

Table of Contents

Revenue Recognition

In accordance with Accounting Standards Codification 606 Revenue from Contracts with Customers (“ASC 606”), we recognize revenue upon the transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. The principles in ASC 606 are applied using the following five steps: (i) identify the contract with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) we satisfy our performance obligation(s). Specifically, revenue from the sale of implants, fixation products and disposables is generally recognized at an amount that reflects the expected consideration upon notice that our products have been used in a surgical procedure or upon shipment to a third-party customer assuming control of the products. Revenue from IONM services is recognized in the period the service is performed for the amount of consideration expected to be received. Revenue from the sale of surgical instrument sets is generally recognized upon receipt of a purchase order and the subsequent shipment to a customer who assumes control. In certain cases, we offer the ability for customers to lease surgical instrumentation primarily on a non-sales type basis. Revenue from the sale or lease of capital equipment is recognized when we transfer control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Revenue from sales and leases of surgical instrument sets and capital equipment represent an immaterial amount of our total revenue in all periods presented. Revenue associated with products holding rights of return or trade-in are recognized when we conclude there is not a risk of significant revenue reversal in future periods for the expected consideration in the transaction. Our costs incurred associated with sales contracts with customers are deferred over the performance obligation period and recognized in the same period as the related revenue, with the exception of contracts that complete within one year or less, in which case the associated costs are expensed as incurred.

Allowance for Credit Losses and Sales Return and Pricing Reserves

We maintain an allowance for credit losses resulting from the inability of our customers, including hospitals, ambulatory surgery centers, and distributors, to make required payments. The allowance for credit losses is calculated quarterly, and is estimated on a region-by-region basis considering a number of factors including age of account balances, collection history, historical account write-offs, third party credit reports, identified trends, current economic conditions, and supportable forecasted economic expectations. The allowance is adjusted on a specific identification basis for certain accounts as well as pooling of accounts with similar characteristics. An increase in the provision for credit losses may be required when the financial condition of our customers or their collection experience deteriorates. An increase to the allowance for credit losses results in a corresponding charge to selling, general and administrative expenses. We have a diverse customer base and no single customer represented greater than ten percent of net sales or accounts receivable. Historically, our reserves have been adequate to cover credit losses.

Our exposure to credit losses may increase if our customers are adversely affected by changes in healthcare laws, coverage and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. It is possible that there could be a material adverse impact from potential adjustments of the carrying amount of trade receivables as customers’ cash flows are impacted by their response to the COVID-19 pandemic and the deferral of elective surgical procedures.

In addition, we establish a liability for estimated sales returns and a reserve for price adjustments that are recorded as a reduction to net sales. The liability and reserve are maintained to account for future product returns and price adjustments of products sold in the current period. This reserve is reviewed quarterly and is estimated based on an analysis of our historical experience and expected future trends. Historically, our reserves have been adequate to account for returns and pricing adjustments.

Inventory, net

Net inventory as of December 31, 2020 consisted of $285.4 million of finished goods, $7.3 million of work in progress and $7.9 million of raw materials. Net inventory as of December 31, 2019 consisted of $298.7 million of finished goods, $6.4 million of work in progress, and $7.3 million of raw materials.

Finished goods primarily consists of specialized implants, fixation products and disposables and are stated at the lower of cost or net realizable value determined by utilizing a standard cost method, which includes capitalized variances, which approximates the weighted average cost. Work in progress and raw materials represent the underlying material, and labor for work in progress, that ultimately yield finished goods upon completion and are subject to lower of cost or net realizable value. We review the components of inventory on a periodic basis for excess and obsolescence and adjust inventory to its net realizable value as necessary.

 

52

Table of Contents

We record an inventory reserve for estimated excess and obsolete inventory based upon historical turnover and assumptions about future demand for our products and market conditions. Our allograft products have shelf lives ranging from two to five years and are subject to demand fluctuations based on the availability and demand for alternative products. Our inventory, which consists primarily of disposables, specialized implants and fixation products, is at risk of obsolescence following the introduction and development of new or enhanced products. One of our strategic objectives is to continue to rapidly develop and commercialize new products and product enhancements which increases the risk that existing products will become obsolete prior to the end of their anticipated useful life. Our estimates and assumptions for excess and obsolete inventory are reviewed and updated on a quarterly basis. The estimates we use for demand are also used for near-term capacity planning and inventory purchasing and are consistent with our net sales forecasts. Increases in the reserve for excess and obsolete inventory result in a corresponding charge to cost of sales.

For the year ended December 31, 2020 and December 31, 2019, we recorded a reserve for excess and obsolete inventory of $48.9 million and $14.0 million, respectively. The increase is primarily attributable to updates to our estimates and assumptions about future product demand and product life cycles which have been affected by multiple factors, including the COVID-19 pandemic and general market conditions.

Fair Value of Financial Instruments

ASC Topic 820, Fair Value Measurements and Disclosures, defines fair value and requires us to establish a framework for measuring fair value and disclosure about fair value measurements. The framework requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed in one of the following three categories. Inputs to valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our market assumptions.

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available.

Carrying value of the financial instruments measured and classified within Level 1 is based on quoted prices.

The types of instruments that trade in markets that are not considered to be active, but are valued based on quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency are generally classified within Level 2 of the fair value hierarchy.

Certain contingent consideration liabilities are classified within Level 3 of the fair value hierarchy because they use unobservable inputs. For those liabilities, fair value is determined using a discounted cash flow model or probability simulation model. The significant inputs of such models that are not observable in the market include financial metric growth rates, volatility rates, projections associated with milestones, the discount rate, and the related probabilities and payment structure in the contingent consideration arrangement.

Valuation of Goodwill and Intangible Assets with Indefinite Lives

Our goodwill represents the excess of the cost over the fair value of net assets acquired from our business combinations. The determination of the value of goodwill and intangible assets arising from business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of the net tangible and intangible assets acquired, including capitalized in-process research and development, or IPR&D. Intangible assets acquired in a business combination that are used for IPR&D activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon commercialization of the relevant research and development project, we will amortize the acquired in-process research and development over its estimated useful life or expense the acquired in-process research and development should the research and development project be unsuccessful with no future alternative use.

Goodwill and IPR&D are not amortized; however, they are assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstance warrant such a review. The goodwill or IPR&D are considered to be impaired if we determine that the carrying value of the reporting unit or IPR&D exceeds its respective fair value.

 

53

Table of Contents

We perform our goodwill impairment analysis at the reporting unit level, which aligns with our reporting structure and availability of discrete financial information. We perform our annual impairment analysis by either doing a qualitative assessment of a reporting unit’s fair value from the last quantitative assessment to determine if there is potential impairment, or comparing a reporting unit’s estimated fair value to its carrying amount. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit’s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit’s operations that would significantly decrease its estimated fair value or significantly increase its net assets. If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections and/or use of a market approach by looking at market values of comparable companies. Key assumptions for these projections include net sales growth, future gross and operating margin growth, and its weighted cost of capital and terminal growth rates. The net sales and margin growth is based on increased sales of new and existing products as we maintain our investment in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including timing and probability of regulatory approvals for our products to be commercialized. Our market capitalization is also considered as a part of this analysis.

Our annual evaluation for impairment of goodwill consists of one reporting unit. In accordance with our policy, we completed our most recent annual evaluation for impairment as of October 1, 2020 using the qualitative method and determined that no impairment existed. In addition, no indicators of impairments were noted through December 31, 2020 and consequently, no impairment charge was recorded during the year.

Valuation of Intangible Assets

Our intangible assets are comprised primarily of purchased technology, customer relationships, manufacturing know-how and trade secrets, and trade name and trademarks. We make significant judgments in relation to the valuation of intangible assets resulting from business combinations and asset acquisitions.

Intangible assets are generally amortized on a straight-line basis over their estimated useful lives of 2 to 17 years. We base the useful lives and related amortization expense on the period of time we estimate the assets will generate net sales or otherwise be used. We also periodically review the lives assigned to our intangible assets to ensure that our initial estimates do not exceed any revised estimated periods from which we expect to realize cash flows from the technologies. If a change were to occur in any of the above-mentioned factors or estimates, the likelihood of a material change in our reported results would increase.

We evaluate our intangible assets with finite lives for indications of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include significant under-performance relative to expected historical or projected future operating results, significant changes in the manner of our use of the acquired assets or the strategy for our overall business or significant negative industry or economic trends. If this evaluation indicates that the value of the intangible asset may be impaired, we make an assessment of the recoverability of the net carrying value of the asset over its remaining useful life. If this assessment indicates that the intangible asset is not recoverable, based on the estimated undiscounted future cash flows of the technology over the remaining amortization period, we reduce the net carrying value of the related intangible asset to fair value and may adjust the remaining amortization period.

Significant judgment is required in the forecasts of future operating results that are used in the discounted cash flow valuation models. It is possible that plans may change and estimates used may prove to be inaccurate. If our actual results, or the plans and estimates used in future impairment analyses, are lower than the original estimates used to assess the recoverability of these assets, we could incur additional impairment charges.

Valuation of Stock-Based Compensation

Stock-based compensation expense for equity-classified awards, principally related to restricted stock units, or RSUs, and performance restricted stock units, or PRSUs, is measured at the grant date based on the estimated fair value of the award. The fair value of equity instruments that are expected to vest is recognized and amortized over the requisite service period. We have granted awards with up to five year graded or cliff vesting terms. No exercise price or other monetary payment is required for receipt of the shares issued in settlement of the respective award; instead, consideration is furnished in the form of the participant’s service.

The fair value of RSUs including PRSUs with pre-defined performance criteria is based on the stock price on the date of grant whereas the expense for PRSUs with pre-defined performance criteria is adjusted with the probability of achievement of such performance criteria at each period end. The fair value of the PRSUs that are earned based on the achievement of pre-defined market conditions for total shareholder return, is estimated on the date of grant using a Monte Carlo valuation model. The key assumptions in applying this model are an expected volatility and a risk-free interest rate.

 

54

Table of Contents

Stock-based compensation expense is adjusted from the grant date to exclude expense for awards that are expected to be forfeited. The forfeiture estimate is adjusted as necessary through the vesting date so that full compensation cost is recognized only for awards that vest. We assess the reasonableness of the estimated forfeiture rate at least annually, with any change to be made on a cumulative basis in the period the estimated forfeiture rates change. We considered our historical experience of pre-vesting forfeitures on awards by each homogenous group of employees as the basis to arrive at our estimated annual pre-vesting forfeiture rates.

We estimate the fair value of stock options issued under our equity incentive plans and shares issued to employees under our employee stock purchase plan, or ESPP, using a Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various assumptions including expected volatility, expected term and risk-free interest rates. The expected volatility is based on the historical volatility of our common stock over the most recent period commensurate with the estimated expected term of our stock options and ESPP offering period which is derived from historical experience. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. We have never declared or paid dividends and have no plans to do so in the foreseeable future.

Accounting for Income Taxes

The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Tax law and rate changes are reflected in income in the period such changes are enacted. We include interest and penalties related to income taxes, including unrecognized tax benefits, within income tax expense.

Our income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax regulations. We recognize liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While we believe we have appropriate support for the positions taken on our tax returns, we regularly assess the potential outcomes of examinations by tax authorities in determining the adequacy of our provision for income taxes. We continually assess the likelihood and amount of potential revisions and adjust the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known.

Significant judgment is required in determining our provision for income taxes, our deferred tax assets and liabilities and the valuation allowance recorded against our net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.

Based on our review, we concluded that it was more likely than not that we would be able to realize the future benefits of our domestic and foreign deferred tax assets, with the exceptions of California, Malta, Mexico, Brazil and Colombia. This conclusion was based on historical and projected operating performance, as well as our expectation that our operations will generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets well within the statutory carryover periods. Due to low state apportionment, large net operating losses and the generation of sizeable research credits in California, we concluded that it is not more likely than not that we will be able to utilize our California deferred tax assets. Therefore, we have maintained a full valuation allowance on our California deferred tax assets as of December 31, 2020. Due to a history of losses in Malta, Mexico, Brazil and Colombia, and the lack of alternative sources of future taxable income, we have established a full valuation allowance against these entities’ deferred tax assets as of December 31, 2020.

We will continue to assess the need for a valuation allowance on our deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.

 

55

Table of Contents

Legal Proceedings

We are involved in a number of legal actions and investigations arising out of the normal course of our business. The outcomes of these legal actions and investigations are not within our complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost net sales. In accordance with authoritative guidance, we disclose information regarding each claim where the likelihood of a material loss contingency is probable or reasonably possible. An estimated loss contingency is accrued in our financial statements if it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. If a loss is reasonably possible and can be reasonably estimated, the estimated loss or range of loss is disclosed in the notes to the Consolidated Financial Statements. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded. Our significant legal proceedings and investigations are discussed in Notes 12 to the Consolidated Financial Statements included in this Annual Report.

The above listing is not intended to be a comprehensive list of all of our accounting policies. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP. See our Consolidated Financial Statements and Notes thereto included in this Annual Report, which contain accounting policies and other disclosures required by GAAP.

Results of Operations

Net Sales

 

 

Year Ended December 31,

 

 

2019 to 2020

 

 

2018 to 2019

 

(in thousands, except %)

 

2020

 

 

2019

 

 

2018

 

 

$ Change

 

 

% Change

 

 

$ Change

 

 

% Change

 

Spinal hardware

 

$

783,510

 

 

$

851,440

 

 

$

788,649

 

 

$

(67,930

)

 

 

(8

)%

 

$

62,791

 

 

 

8

%

Surgical support

 

 

267,072

 

 

 

316,630

 

 

 

313,065

 

 

 

(49,558

)

 

 

(16

)%

 

 

3,565

 

 

 

1

%

Total net sales

 

$

1,050,582

 

 

$

1,168,070

 

 

$

1,101,714

 

 

$

(117,488

)

 

 

(10

)%

 

$

66,356

 

 

 

6

%

Our spinal hardware product line offerings include our implants and fixation products. Our surgical support product line offerings include IONM services, disposables and biologics, and our capital equipment, all of which are used to aid spine surgery.

 We expect continued adoption of our innovative minimally invasive procedures and deeper penetration into existing accounts and international markets as our sales force executes on our strategy of selling the full mix of our products and services. However, the continued consolidation and increased purchasing power of our hospital customers and group purchasing organizations, continued changes in the public and private insurance markets regarding reimbursement, and ongoing policy and legislative changes in the United States have created less predictability. Although the market for procedurally-integrated spine surgery solutions should continue to grow over the long term, economic, political and regulatory influences are subjecting our industry to significant changes that may slow the growth rate of the spine surgery market. Further, the COVID-19 pandemic has led to a significant reduction in procedural volumes in 2020, and it is not possible for us to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures.

Our total net sales decreased $117.5 million in 2020 compared to 2019, representing total net sales decline of 10%. In 2019 our total net sales increased $66.4 million compared to 2018, representing total net sales growth of 6%.

Net sales from our spinal hardware product line offerings decreased $67.9 million, or 8%, in 2020 compared to 2019. Product volume in spinal hardware decreased our net sales by approximately 7% in 2020 compared to 2019, primarily due to a reduction in elective surgeries as a result of the COVID-19 pandemic. Additionally, we experienced unfavorable pricing impacts of approximately 1% in 2020 compared to 2019. Foreign currency fluctuation from 2019 to 2020 did not have a material impact on spinal hardware net sales.

Net sales from our spinal hardware product line offerings increased $62.8 million, or 8%, in 2019 compared to 2018. Product volume for our spinal hardware business increased our net sales by approximately 11%, offset by unfavorable pricing impacts of approximately 2% in 2019, as compared to 2018. Foreign currency fluctuation decreased our spinal hardware net sales by approximately 1% in 2019 compared to 2018.

Net sales from our surgical support product line offerings decreased $49.6 million, or 16%, in 2020 compared to 2019. Product and service volume in surgical support decreased our net sales by approximately 15% in 2020 compared to 2019, primarily due to a reduction in elective surgeries as a result of the COVID-19 pandemic. Additionally, we experienced unfavorable pricing impacts of approximately 1% in 2020 compared to 2019. Foreign currency fluctuation from 2019 to 2020 did not have a material impact on surgical support net sales.

Net sales from our surgical support product line offerings increased $3.6 million, or 1%, in 2019 compared to 2018. Product and service volume for our surgical support business increased our net sales by approximately 2% in 2019, offset by unfavorable pricing impacts of approximately 1% in 2019, as compared to 2018. Foreign currency fluctuation from 2018 to 2019 did not have a material impact on surgical support net sales.

 

56

Table of Contents

Cost of Sales, Excluding Below Amortization of Intangible Assets

 

 

Year Ended December 31,

 

 

2019 to 2020

 

 

2018 to 2019

 

(in thousands, except %)

 

2020

 

 

2019

 

 

2018

 

 

$ Change

 

 

% Change

 

 

$ Change

 

 

% Change

 

Cost of sales

 

$

321,631

 

 

$

312,357

 

 

$

311,159

 

 

$

9,274

 

 

 

3

%

 

$

1,198

 

 

 

0

%

% of total net sales

 

 

31

%

 

 

27

%

 

 

28

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales consists primarily of purchased goods, raw materials, labor and overhead associated with product manufacturing, inventory-related costs and royalty expenses, as well as the cost of providing IONM services, which includes personnel and physician oversight costs. We primarily procure and manufacture our goods in the United States, and accordingly, foreign currency fluctuations have not materially impacted our cost of sales.

Cost of sales increased $9.3 million, or 3%, in 2020 compared to 2019. However, cost of sales as a percentage of net sales in 2020 increased by 4% compared to 2019. The increase in cost of sales in 2020 is due to an increase in the reserve for excess and obsolete inventory of $35.0 million, which is primarily attributable to updates to our estimates and assumptions about future demand for certain spinal hardware products associated with market conditions affected by the COVID-19 pandemic. Offsetting this increase is a proportional reduction in cost of sales associated with lower net sales due to a reduction in elective surgeries as a result of the COVID-19 pandemic.

Cost of sales increased $1.2 million during the year ended December 31, 2019, compared to 2018. Cost of sales for our business increased primarily due to growth in volume, changes in product mix, and shifts in production costs, offset by favorable manufacturing absorption from in-sourced products and improved throughput and plant efficiencies in 2019, compared to 2018.

Operating Expenses

 

 

Year Ended December 31,

 

 

2019 to 2020

 

 

2018 to 2019

 

(in thousands, except %)

 

2020

 

 

2019

 

 

2018

 

 

$ Change

 

 

% Change

 

 

$ Change

 

 

% Change

 

Selling, general and administrative

 

$

547,195

 

 

$

611,181

 

 

$

575,836

 

 

$

(63,986

)

 

 

(10

)%

 

$

35,345

 

 

 

6

%

% of total net sales

 

 

52

%

 

 

52

%

 

 

52

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

79,838

 

 

 

72,380

 

 

 

61,695

 

 

 

7,458

 

 

 

10

%

 

 

10,685

 

 

 

17

%

% of total net sales

 

 

8

%

 

 

6

%

 

 

6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization of intangibles

 

 

51,726

 

 

 

51,097

 

 

 

50,670

 

 

 

629

 

 

 

1

%

 

 

427

 

 

 

1

%

Purchase of in-process research and development

 

 

1,011

 

 

 

—

 

 

 

8,913

 

 

 

1,011

 

 

*

 

 

 

(8,913

)

 

 

(100

)%

Litigation liability loss

 

 

—

 

 

 

—

 

 

 

27,800

 

 

 

—

 

 

*

 

 

 

(27,800

)

 

 

(100

)%

Business transition costs

 

 

10,878

 

 

 

(1,995

)

 

 

11,473

 

 

 

12,873

 

 

 

645

%

 

 

(13,468

)

 

 

(117

)%

Selling, General and Administrative

Selling, general and administrative expenses consist primarily of compensation costs, commissions and training costs for our employees engaged in sales, marketing and customer support functions. The expense also includes commissions to sales representatives, freight expenses, surgeon training costs, depreciation expense for property and equipment such as surgical instrument sets, and administrative expenses for both employees and third-party service providers.

Selling, general and administrative expenses decreased by $64.0 million, or 10%, in 2020 compared to 2019. The decrease in 2020 is primarily due to impacts from the COVID-19 pandemic reducing compensation costs, including stock-based compensation subject to fair value adjustments for certain equity awards, as well as decreases in travel and consulting expenses, as compared to 2019. Additionally, during the year ended December 31, 2020, due to the impacts from the COVID-19 pandemic we implemented temporary actions to reduce expenses, including implementing compensation reductions for our Board of Directors and executive officers, and reducing discretionary spend across the organization.

Selling, general and administrative expenses increased by $35.3 million, or 6%, during the year ended December 31, 2019 as compared to 2018. The increase in 2019 is primarily due to increased employee compensation and expenses associated with increased headcount, as well as expenses that increased as a function of the increase in net sales and international expansion, such as equipment, freight, and facility related expenses, as compared to 2018. Stock-based compensation expense increased in 2019 as compared to 2018 due to higher fair value adjustments to certain equity awards that are subject to revaluation on a recurring basis based on stock price performance. These costs were partially offset by decreases in non-recurring consulting fees associated with the implementation of our state tax-planning strategy, which occurred during 2018. Additionally, during 2019 there was an increase in expenses associated with our compliance efforts with the EU Medical Device Regulation, and legal expenses.

 

57

Table of Contents

Research and Development

Research and development expense consists primarily of product research and development, clinical trial and study costs, regulatory and clinical functions, and compensation and other employee related expenses. In the last several years, we have introduced numerous new products and product enhancements that have significantly expanded our technology platforms and our comprehensive product portfolio. We have also acquired complementary and strategic assets and technology, particularly in the area of spinal hardware products. We continue to invest in research and development programs related to our core product portfolio, as well as in our capital equipment.

Research and development expense increased by $7.5 million, or 10%, in 2020 compared to 2019, and $10.7 million, or 17%, in 2019 compared to 2018. The increase in spending is primarily due to increased headcount and increased cost associated with further enhancement and functionality of our current and future product offerings, including capital equipment.

Amortization of Intangible Assets

Amortization of intangible assets relates to the amortization of finite-lived intangible assets acquired. Amortization expense remained relatively constant in 2020 compared to 2019 and in 2019 compared to 2018.

Purchase of In-Process Research and Development

During the year ended December 31, 2020 and December 31, 2018, we expensed $1.0 million and $8.9 million, respectively, for a purchased in-process research and development asset which had no future alternative use.

Litigation Liability Loss

During the year ended December 31, 2018, we settled all outstanding matters with Madsen Medical, Inc. for $27.8 million. We no longer have any remaining liability related to this matter.

Business Transition Costs

We incur certain costs related to acquisition, integration and business transition activities, which include severance, relocation, consulting, leasehold exit costs, third-party merger and acquisition costs, contingent consideration fair value adjustments and other costs directly associated with such activities. Contingent consideration is accrued based on the fair value of the expected payment, and such accruals are subject to increase or decrease based on the assessment of the likelihood that the contingent milestones will be achieved resulting in payment. If an accrual for contingent consideration decreases during a particular period, it results in a reduction of costs during such period.

During the year ended December 31, 2020, we recorded $10.9 million of costs related to acquisition, integration and business transition activities, which included $2.3 million of fair value adjustments on contingent consideration liabilities associated with our 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2019, we recorded a reduction of costs of $(2.0) million related to acquisition, integration and business transition activities, which included $(6.3) million of fair value adjustments on contingent consideration liabilities associated with our 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2018, we recorded $11.5 million of costs related to acquisition, integration and business transition activities, which included $(1.5) million of fair value adjustments on contingent consideration liabilities associated with our 2018, 2017 and 2016 acquisitions.

Interest and Other Expense, Net

 

 

Year Ended December 31,

 

 

2019 to 2020

 

 

2018 to 2019

 

(in thousands, except %)

 

2020

 

 

2019

 

 

2018

 

 

$ Change

 

 

% Change

 

 

$ Change

 

 

% Change

 

Interest income

 

$

1,472

 

 

$

1,917

 

 

$

586

 

 

$

(445

)

 

 

(23

)%

 

$

1,331

 

 

 

227

%

Interest expense

 

 

(70,466

)

 

 

(38,525

)

 

 

(37,857

)

 

 

(31,941

)

 

 

83

%

 

 

(668

)

 

 

2

%

Other (expense) income, net

 

 

(16,854

)

 

 

(5,925

)

 

 

(8,174

)

 

 

(10,929

)

 

 

184

%

 

 

2,249

 

 

 

(28

)%

Total interest and other expense, net

 

$

(85,848

)

 

$

(42,533

)

 

$

(45,445

)

 

$

(43,315

)

 

 

102

%

 

$

2,912

 

 

 

(6

)%

% of total net sales

 

 

8

%

 

 

4

%

 

 

4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total interest and other expense, net for the periods presented included gains and losses from strategic investments, gains and losses from changes in the fair value of derivatives, our pro rata allocation of net income or loss from our equity method investments, and net foreign currency exchange gains and losses. 

Total interest and other expense, net increased by $43.3 million in 2020 compared to 2019. The increase in 2020 is primarily due to a net loss of $12.3 million recognized for the change in fair value derivative assets and liabilities resulting from the Senior Convertible Notes due 2023 issued in June 2020, as well as an increase in interest expense associated with the Senior Convertible Notes due 2025 issued in March 2020 and Senior Convertible Notes due 2023 issued in June 2020.

 

58

Table of Contents

Income Tax (Benefit) Expense

 

 

Year Ended December 31,

 

 

2019 to 2020

 

 

2018 to 2019

 

(in thousands, except %)

 

2020

 

 

2019

 

 

2018

 

 

$ Change

 

 

% Change

 

 

$ Change

 

 

% Change

 

Income tax (benefit) expense

 

$

(10,392

)

 

$

15,283

 

 

$

(3,756

)

 

$

(25,675

)

 

 

(168

)%

 

$

19,039

 

 

 

507

%

Effective income tax rate

 

 

22

%

 

 

19

%

 

 

43

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The provision for income tax expense as a percentage of pre-tax loss from continuing operations reflected a tax benefit of 22% for the year ended December 31, 2020 compared with a tax expense of 19% on pre-tax income for the year ended December 31, 2019. Tax benefits contributing to the effective tax rate in 2020 were lower than those contributing to the effective tax rate in 2019 primarily due to higher foreign income inclusion, an increase in non-deductible officer’s compensation expense, increased contingent consideration adjustments, and increased valuation allowances, offset by increased tax reserve releases, decrease in state taxes, and increased deferred tax assets due to tax rate changes.

The provision for income tax expense as a percentage of pre-tax income from continuing operations reflected a tax expense of 19% for the year ended December 31, 2019 compared with a tax benefit of 43% on pre-tax income for the year ended December 31, 2018. Tax benefits contributing to the effective tax rate in 2019 were lower than those contributing to the effective tax rate in 2018 primarily due to reduced tax benefits from expiration of statute of limitations on uncertain tax positions, less favorable return to provision adjustments, and an increase in non-deductible officer’s compensation expense, offset by an increase in tax benefits associated with share-based payments, increase in research and development credit generation, and a decrease in valuation allowances.

We are subject to audits by federal, state, local, and foreign tax authorities. We believe that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. Should any issues addressed in our tax audits be resolved in a manner not consistent with our expectations, we could be required to adjust our provision for income taxes in the period such resolution occurs.

We continue to streamline our international operations, including procurement, logistics and customer service functions, in an effort to improve overall operational efficiencies. U.S. tax reform has lessened the tax benefit associated with foreign earnings due to a reduced federal corporate tax rate and the forced U.S. inclusion of certain foreign intangible related earnings. As international tax rules and regulations change, we may be subjected to higher taxes on foreign earnings.

Liquidity, Cash Flows and Capital Resources

Liquidity and Capital Resources

Our principal sources of liquidity are our existing cash, cash equivalents and marketable securities, cash generated from operations, proceeds from our convertible notes issuances, and access to our revolving line of credit. We expect that cash provided by operating activities may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, which include impacts from the COVID-19 pandemic, working capital requirements and capital deployment decisions. We have historically invested our cash primarily in U.S. treasuries and government agencies, corporate debt, and money market funds. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.

Our future capital requirements will depend on many factors including our growth rate in net sales, the timing and extent of spending to support development efforts, the expansion of selling, general and administrative activities, the timing of introductions of new products and enhancements to existing products, successful insourcing of our manufacturing process, the continuing market acceptance of our products, the expenditures associated with possible future acquisitions or other business combination transactions, the outcome of current and future litigation, international expansions of our business, and impacts from the COVID-19 pandemic. We expect our cash flows from operations to continue to fund the ongoing core business. As borrowings become due, we may be required to access the capital markets or draw upon our line of credit for additional funding. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to secure additional credit facilities, term loans, or other similar arrangements and access the capital markets in light of those earning levels and general financial market conditions.

 

59

Table of Contents

A substantial portion of our operations are located in the United States, and the majority of our net sales and cash generation have been made in the United States. Accordingly, we do not have material net cash flow exposures to foreign currency rate fluctuations. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the United States dollar and foreign currencies, primarily in the pound sterling, the euro, the Australian dollar, the Brazilian real, the Singapore dollar, and the yen, could adversely affect our financial results, including our net sales, growth rates in net sales, gross margins, income and losses as well as assets and liabilities. We enter into forward currency contracts to partially offset the impact from fluctuations of the foreign currency rates on our third-party and short-term intercompany receivables and payables between our domestic and international operations. We currently do not hedge future forecasted transactions but will continue to assess whether that strategy is appropriate. As of December 31, 2020, the cash balance held by our foreign subsidiaries with currencies other than the United States dollar was approximately $52.3 million and it is our intention to indefinitely reinvest all of our current foreign earnings to increase working capital within our international business and to expand our existing operations outside the United States. As of December 31, 2020, our account receivable balance held by our foreign subsidiaries with currencies other than the United States dollar was approximately $48.3 million. We have operations in markets in which there is governmental financial instability which could impact funds that flow into the medical reimbursement system. In addition, loss of financial stability within these markets could lead to delays in reimbursement or inability to remit payment due to currency controls. Specifically, we have operations and/or sales in Puerto Rico, Brazil and Argentina. We do not have any material financial exposure to one customer or one country that would significantly hinder our liquidity.

We are currently, and in the future could be, involved in legal actions and investigations arising out of the normal course of our business. Due to the inherent uncertainties associated with pending legal actions and investigations, we cannot predict the outcome, and, with respect to certain pending litigation or claims where no liability has been accrued, to make a meaningful estimate of the reasonably possible loss or range of loss that could result from an unfavorable outcome, other than those matters disclosed in this Annual Report. We have no material accruals for pending litigation or claims for which accrual amounts are not disclosed in our Consolidated Financial Statements. It is reasonably possible, however, that an unfavorable outcome that exceeds our accrual estimate for a particular legal proceeding or investigation could have a material adverse effect on our liquidity and access to capital resources. Additionally, it is possible that in connection with a legal proceeding or investigation we are required to pay fees and expenses of the other party or set aside funds in an escrow or purchase a performance bond, regardless of our assessment of the probability of a loss. These requirements to pay fees and expenses or escrow funding in connection with a legal proceeding or investigation could have an adverse impact on our liquidity or affect our access to additional capital resources. We have disclosed all material accruals for pending litigation or investigations in Note 12 of the Consolidated Financial Statements included in this Annual Report.

On September 12, 2016, we completed an acquisition of an imaging software and technology platform known as Lessray. In connection with the acquisition, we recorded a purchase accounting fair value estimate of $34.1 million for contingent consideration liabilities related to the achievement of certain regulatory and commercial milestones. In January 2018, we paid $9.0 million of the outstanding contingent consideration liabilities for the achievement of a commercial milestone. In July 2018, we paid $10.0 million of the outstanding contingent consideration liabilities for the achievement of a regulatory approval milestone. We anticipate the remaining sales-based milestones will become payable at varying times by 2024.

On September 7, 2017, we completed an acquisition of a medical device company that developed interbody implants for spinal fusion using patented porous PEEK technology. In connection with the acquisition, we recorded a purchase accounting fair value estimate of $31.4 million for contingent consideration liabilities related to the achievement of certain manufacturing and commercial milestones. In May 2020, we paid $7.5 million toward the successful achievement of a milestone. We anticipate the remaining milestones will become payable at varying times between 2021 and 2024, but are subject to change based on the achievement of those manufacturing and commercial milestones.

On February 24, 2021, we completed the acquisition of Simplify Medical Pty Limited, or Simplify Medical, a developer of cervical artificial disc technology for cervical total disc replacement procedures. Pursuant to the terms of the definitive agreement, we agreed to make an upfront payment of $150.0 million at closing, subject to customary purchase price adjustments, plus additional future payments contingent upon milestones related to regulatory approval and net sales from products incorporating the Simplify Medical cervical artificial disc technology. In connection with the closing, we funded the $150.0 million upfront payment using available cash and investments on hand. Upon achievement of the regulatory milestone, Simplify Medical will be entitled to a one-time payment of up to $45.9 million which could become due and payable at any time between 2021 and 2024. Additional milestone payments, which are contingent upon net sales from products incorporating the Simplify Medical cervical artificial disc technology, will become payable to Simplify Medical in calendar years 2023, 2024 and 2025.

 

60

Table of Contents

Cash, cash equivalents and short-term investments were $1.0 billion and $213.0 million at December 31, 2020 and December 31, 2019, respectively. While the unprecedented public health and governmental efforts to contain the spread of COVID-19 have created significant disruptions to the healthcare system and the global economy, as of the filing date of this report, we believe our existing cash, cash equivalents, short-term investments, projected future cash flows from operations and access to external financing sources are sufficient to satisfy our current and reasonably anticipated requirements for funds to conduct our operations in the ordinary course of our business and pay our obligation as they become due for the next twelve months. Given the impact the COVID-19 pandemic has had on demand for elective surgical procedures, we took temporary actions to reduce operating expenses and preserve liquidity such as reducing compensation for our directors and executive officers in 2020, limiting discretionary spend, and adjusting manufacturing capacity based upon demand. Additionally, we have varying needs for cash in connection with our Senior Convertible Notes and also as a result of certain acquisition-related obligations and milestone achievements. As of December 31, 2020, we had outstanding $650.0 million aggregate principal amount of unsecured senior convertible notes with a stated interest rate of 2.25% and a maturity date of March 15, 2021, which we refer to as the 2021 Notes. We anticipate that the 2021 Notes will be settled by satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of our common stock. Future litigation or requirements to escrow funds could also materially impact our liquidity and our ability to invest in and run our business on an ongoing basis. Although we have no cash borrowings under our existing revolving senior credit facility as of the date of this report, we expect to use our cash resources or cash borrowings under our senior credit facility to support our business within the context of prevailing market and economic conditions, which, given the COVID-19 crisis, could rapidly and materially deteriorate or otherwise change. During this time, we may seek other sources of liquidity through capital market or bank loan transactions to support our business needs. In addition, we may seek to further adjust or amend the terms of and/or expand the capacity of our existing senior credit facility, or enter into additional credit facilities, term loans, or other similar arrangements. However, with the uncertainty surrounding the COVID-19 crisis, our ability to engage in such transactions may be constrained by volatile financial market conditions, reduced investor and/or lender interest or capacity, as well as our liquidity, leverage, and general creditworthiness and we can provide no assurance as to successfully completing such transactions. Furthermore, our ability to borrow under our existing revolving senior credit facility is subject to remaining in compliance with underlying financial covenants which may be difficult to satisfy if the COVID-19 pandemic continues to adversely impact the healthcare system and our business. Further discussion of the potential impacts from the COVID-19 pandemic is provided under Part I, Item 1A – Risk Factors.

The increase in liquidity during the year ended December 31, 2020 of $817.0 million was mainly driven by cash inflows of $873.8 million related to the net issuance of our Senior Convertible Notes due 2023 and 2025 and $185.9 million in cash provided from operations, partially offset by $105.7 million in cash used for purchases of property and equipment, $80.7 million in cash used for treasury stock purchases, and $53.9 million net in cash used for the call spreads on the sales and purchases of our warrants and bond hedges issued in connection with the Senior Convertible Notes due 2023 and 2025. At December 31, 2020, we had cash totaling $1.5 million in restricted accounts which is not available to us to meet any ongoing capital requirements if and when needed.

Cash Flows

The following table summarizes our Consolidated Statements of Cash Flows:

 

 

 

Year Ended December 31,

 

 

2019 to 2020

 

 

2018 to 2019

 

(in thousands, except %)

 

2020

 

 

2019

 

 

2018

 

 

$ Change

 

 

% Change

 

 

$ Change

 

 

% Change

 

Cash provided by operating activities

 

$

185,911

 

 

$

235,290

 

 

$

219,183

 

 

$

(49,379

)

 

 

(21

)%

 

$

16,107

 

 

 

7

%

Cash used in investing activities

 

 

(281,934

)

 

 

(134,484

)

 

 

(161,285

)

 

 

(147,450

)

 

 

110

%

 

 

26,801

 

 

 

(17

)%

Cash provided by (used in) financing activities

 

 

736,656

 

 

 

(6,644

)

 

 

(14,578

)

 

 

743,300

 

 

 

11,188

%

 

 

7,934

 

 

 

(54

)%

Effect of exchange rate changes on cash

 

 

3,202

 

 

 

131

 

 

 

(1,283

)

 

 

3,071

 

 

 

2,344

%

 

 

1,414

 

 

 

(110

)%

Increase in cash, cash equivalents and restricted cash

 

$

643,835

 

 

$

94,293

 

 

$

42,037

 

 

$

549,542

 

 

 

583

%

 

$

52,256

 

 

 

124

%

Cash Flows from Operating Activities

Cash provided by operating activities was $185.9 million in 2020, compared to $235.3 million in 2019. The $49.4 million decrease in cash provided by operating activities was primarily due to decreased operational cash flows in 2020 related to lower net sales and cash receipts resulting from the impact of the COVID-19 pandemic, as well as an increase in payments for compensation related accruals and timing of spending.

Cash provided by operating activities was $235.3 million in 2019, compared to $219.2 million in 2018. The $16.1 million increase in cash provided by operating activities was primarily due to the comparable period’s payment of $27.8 million for the settlement of the Madsen litigation matter. This was partially offset by increased inventory purchases and general timing of cash receipts and disbursements in 2019.

 

61

Table of Contents

Cash Flows from Investing Activities

Cash used in investing activities was $281.9 million in 2020, compared to $134.5 million used in 2019. The $147.4 million increase in cash used in investing activities was primarily due to $173.5 million in cash used for the net purchases of marketable debt securities, offset by a decrease of $17.2 million in cash used for purchases of property and equipment, and a decrease of $8.9 million in cash used for acquisitions, strategic investments and intangible assets in 2020 compared to 2019.

Cash used in investing activities was $134.5 million in 2019, compared to $161.3 million used in 2018. The $26.8 million decrease in cash used in investing activities was primarily due to a decrease of $51.3 million in cash used for business combinations, strategic investments and intangible assets, offset by a $21.0 million increase in cash used for purchases of property and equipment in 2019 compared to 2018.

Cash Flows from Financing Activities

Cash provided by financing activities was $736.7 million in 2020, compared to $6.6 million cash used in 2019. The $743.3 million increase in cash provided by financing activities was primarily due to the net issuances of our Senior Convertible Notes due 2023 and 2025 of $873.8 million, offset by $53.9 million of net cash used for the call spreads on the sales and purchases of our warrants and bond hedges issued in connection with the Senior Convertible Notes due 2023 and 2025, and an increase in treasury stock purchases of $66.2 million in 2020 compared to 2019.

Cash used in financing activities was $6.6 million in 2019, compared to $14.6 million cash used in 2018. The $8.0 million decrease in cash used in financing activities was primarily due to decreased contingent consideration payments of $18.6 million, offset by increased treasury stock purchases of $11.6 million in 2019 compared to 2018.

Treasury stock purchases totaled $80.7 million during 2020, relating to our share repurchase program, the vesting of equity awards and stock option exercises. In March 2020, in connection with the issuance of the Senior Convertible Notes due 2025, we repurchased approximately 1,085,000 shares of our common stock for $75.0 million. We use net share settlement on stock issuances, which results in cash tax payments, as well as a decrease in the cash receipts from the issuance of common stock upon the exercising of stock options. Net share settlement is generally used in lieu of cash payments by employees for minimum tax withholding or exercise costs for equity awards. The net share settlement is accounted for as a treasury share repurchase transaction, with the cost of any deemed repurchased shares included in treasury stock and reported as a reduction in total equity at the time of settlement. Additionally, net share settlement for tax withholding requires us to fund a significant amount of cash for certain tax payment obligations from time-to-time with respect to the employee tax obligations for vested equity awards. We anticipate using cash generated from operating activities to fund such payments.

 

62

Table of Contents

Senior Convertible Notes

2.25% Senior Convertible Notes due 2021

In March 2016, we issued $650.0 million principal amount of unsecured senior convertible notes with a stated interest rate of 2.25% and a maturity date of March 15, 2021, which we refer to as the 2021 Notes. The net proceeds from the offering, after deducting initial purchasers' discounts and costs directly related to the offering, were approximately $634.1 million. Interest on the 2021 Notes began accruing upon issuance and is payable semi-annually. Prior to September 14, 2020, the 2021 Notes provided for settlement in cash, stock, or a combination thereof, solely at our discretion. As of September 14, 2020, combination settlement was deemed to have been elected by us and the 2021 Notes will be settled by satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of our common stock. The initial conversion rate of the 2021 Notes is 16.7158 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $59.82 per share, subject to adjustments. Prior to September 15, 2020, holders could have converted their 2021 Notes only under the following conditions: (a) during any calendar quarter beginning June 30, 2016, if the reported sale price of our common stock for at least 20 days out of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter was greater than 130% of the conversion price on each applicable trading day; (b) during the five business day period in which the trading price of the 2021 Notes fell below 98% of the product of (i) the last reported sale price of our common stock and (ii) the conversion rate on that date; and (c) upon the occurrence of specified corporate events, as defined in the 2021 Notes. From September 15, 2020 and until the close of business on the second scheduled trading day immediately preceding March 15, 2021, holders may convert their 2021 Notes at any time (regardless of the foregoing circumstances). The 2021 Notes can no longer be redeemed by us. We previously had the ability to redeem the 2021 Notes, at our option, in whole or in part beginning on March 20, 2019 until the close of business on the business day immediately preceding September 15, 2020 if the last reported sale price of our common stock had been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we deliver written notice of a redemption. No principal payments are due on the 2021 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2021 Notes do not contain any financial covenants and do not restrict us from paying dividends or issuing or repurchasing any of our other securities. As of September 15, 2020, holders may convert their 2021 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. The impact of the convertible feature will be dilutive to our earnings per share when our average stock price for the period is greater than the conversion price.

In connection with the offering of the 2021 Notes, we entered into transactions for convertible notes hedge, which we refer to as the 2021 Hedge, and warrants, which we refer to as the 2021 Warrants. The 2021 Hedge was entered into with the initial purchasers of the 2021 Notes and/or their affiliates, which we refer to as the 2021 Counterparties, entitling us to purchase up to 10,865,270 shares of our own common stock at an initial stock price of $59.82 per share, each of which is subject to adjustment. The cost of the 2021 Hedge was $111.2 million. The 2021 Hedge will expire on March 15, 2021. The 2021 Hedge is expected to reduce the potential equity dilution upon conversion of the 2021 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2021 Hedge. Our assumed exercise of the 2021 Hedge is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

In addition, we sold the 2021 Warrants to the 2021 Counterparties to acquire up to 10,865,270 common shares of our stock. The 2021 Warrants will expire on various dates from June 2021 through December 2021 and may be settled in cash or net shares. It is our current intent and policy to settle all conversions in shares of our common stock. We received $44.9 million in cash proceeds from the sale of the 2021 Warrants. The 2021 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2021 Warrants, which is $80.00 per share.

 

63

Table of Contents

1.00% Senior Convertible Notes due 2023

In June 2020, we issued $450.0 million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 1.00% and a maturity date of June 1, 2023, which we refer to as the 2023 Notes. The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $436.7 million. The 2023 Notes were initially required to be settled in cash as we did not have enough available shares and were unable to reserve the maximum number of shares issuable under the 2023 Notes (“sufficient reserved shares”). On September 10, 2020, we held a Special Meeting of Stockholders and received stockholder approval to amend our Restated Certificate of Incorporation to increase the number of shares of our common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares. As a result of the increase in the number of shares of our common stock authorized for issuance, we currently have sufficient reserved shares and therefore may settle conversions of the 2023 Notes in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of our common stock. The initial conversion rate of the 2023 Notes is 11.8778 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $84.19 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date or if we issue a notice of redemption, we will increase the conversion rate for a holder who elects to convert its 2023 Notes in connection with such a corporate event or in connection with such redemption in certain circumstances. Prior to February 1, 2023, holders may convert their 2023 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period, referred to as the measurement period, in which the trading price of the 2023 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on such trading day; (c) if we call any or all of the 2023 Notes for redemption, at any time prior to the close of business on the second scheduled trading day preceding the redemption date; or (d) upon the occurrence of specified corporate events, as defined in the 2023 Notes. On or after February 1, 2023, until the close of business on the second scheduled trading day immediately preceding June 1, 2023, holders may convert their 2023 Notes at any time, regardless of the foregoing conditions. We may not redeem the 2023 Notes prior to the maturity date. No principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2023 Notes do not contain any financial covenants and do not restrict us from conducting significant restructurings, paying dividends or issuing or repurchasing any of our other securities. As of December 31, 2020, we are unaware of any current events or market conditions that would allow holders to convert the 2023 Notes. The impact of the convertible feature will be dilutive to our earnings per share when our average stock price for the period is greater than the conversion price.

In connection with the sale of the 2023 Notes, we entered into transactions for convertible notes hedge, which we refer to as the 2023 Hedge, and warrants, which we refer to as the 2023 Warrants. The 2023 Hedge was entered into with certain dealers, which included affiliates of certain of the initial purchasers of the 2023 Notes and other financial institutions, which we refer to as the 2023 Counterparties, entitling us to purchase up to 5,345,010 shares of our own common stock at an initial stock price of $84.19 per share, each of which is subject to adjustment. The cost of the 2023 Hedge was $69.5 million. The 2023 Hedge will expire on the second scheduled trading day immediately preceding June 1, 2023. The 2023 Hedge is expected to reduce the potential equity dilution upon conversion of the 2023 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2023 Hedge. Our assumed exercise of the 2023 Hedge is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

In addition, we sold the 2023 Warrants to the 2023 Counterparties to acquire up to 5,345,010 common shares of our stock. The 2023 Warrants initially limited the amount of shares we were required to reserve for issuance under the 2023 Warrants to an aggregate of 3,093,500 shares of our common stock, subject to adjustment upon having a sufficient amount of authorized and unissued shares which are not reserved for other transactions. As a result of receiving stockholder approval to increase the number of shares of our common stock authorized for issuance on September 10, 2020, we subsequently entered into amendment agreements with each of the 2023 Counterparties to increase the number of authorized shares of our common stock required to be reserved under the 2023 Warrants to the aggregate amount of 6,948,512 shares. The 2023 Warrants will expire on various dates from September 2023 through November 2023 and may be settled in net shares or cash, subject to certain conditions. It is our current intent and policy to settle all conversions in shares of our common stock. We received $46.8 million in cash proceeds from the sale of the 2023 Warrants. The 2023 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2023 Warrants, which is $104.84 per share.

 

64

Table of Contents

0.375% Senior Convertible Notes due 2025

In March 2020, we issued $450.0 million principal amount of unsecured senior convertible notes with a stated interest rate of 0.375% and a maturity date of March 15, 2025, which we refer to as the 2025 Notes. The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $437.0 million. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. It is our current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of our common stock. The initial conversion rate of the 2025 Notes is 10.7198 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $93.29 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date or if we issue a notice of redemption, we will increase the conversion rate for a holder who elects to convert its 2025 Notes in connection with such a corporate event or in connection with such redemption in certain circumstances. Prior to September 15, 2024, holders may convert their 2025 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on June 30, 2020 (and only during such calendar quarter), if the last reported sale price of our common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period, referred to as the measurement period, in which the trading price of the 2025 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our common stock and the conversion rate on such trading day; (c) if we call any or all of the 2025 Notes for redemption, at any time prior to the close of business on the second scheduled trading day preceding the redemption date; or (d) upon the occurrence of specified corporate events, as defined in the 2025 Notes. On or after September 15, 2024, until the close of business on the second scheduled trading day immediately preceding March 15, 2025, holders may convert their 2025 Notes at any time, regardless of the foregoing conditions. We may not redeem the 2025 Notes prior to March 20, 2023. We may redeem the 2025 Notes, at our option, in whole or in part, on or after March 20, 2023 until the close of business on the business day immediately preceding September 15, 2024, if the last reported sale price of our common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which we deliver written notice of a redemption. The redemption price will be equal to 100% of the principal amount of such 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2025 Notes do not contain any financial covenants and do not restrict us from conducting significant restructurings, paying dividends or issuing or repurchasing any of our other securities. As of December 31, 2020, we are unaware of any current events or market conditions that would allow holders to convert the 2025 Notes. The impact of the convertible feature will be dilutive to our earnings per share when our average stock price for the period is greater than the conversion price.

In connection with the sale of the 2025 Notes, we entered into transactions for convertible notes hedge, which we refer to as the 2025 Hedge, and warrants, which we refer to as the 2025 Warrants. The 2025 Hedge was entered into with certain dealers, which included affiliates of certain of the initial purchasers of the 2025 Notes and other financial institutions, which we refer to as the 2025 Counterparties, entitling us to purchase up to 4,823,910 shares of our own common stock at an initial stock price of $93.29 per share, each of which is subject to adjustment. The cost of the 2025 Hedge was $78.3 million. The 2025 Hedge will expire on the second scheduled trading day immediately preceding March 15, 2025. The 2025 Hedge is expected to reduce the potential equity dilution upon conversion of the 2025 Notes if the daily volume-weighted average price per share of our common stock exceeds the strike price of the 2025 Hedge. Our assumed exercise of the 2025 Hedge is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

In addition, we sold the 2025 Warrants to the 2025 Counterparties to acquire up to 4,823,910 common shares of our stock. The 2025 Warrants will expire on various dates from June 2025 through October 2025 and may be settled in net shares or cash, subject to certain conditions. It is our current intent and policy to settle all conversions in shares of our common stock. We received $47.1 million in cash proceeds from the sale of the 2025 Warrants. The 2025 Warrants could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeds the strike price of the 2025 Warrants, which is $127.84 per share.

 

65

Table of Contents

Revolving Senior Credit Facility

In February 2020, we entered into a Second Amended and Restated Credit Agreement, or the 2020 Credit Agreement, for a revolving senior credit facility, referred to as the 2020 Facility, which replaced the previous Amended and Restated Credit Agreement we had entered into in April 2017. The 2020 Credit Agreement was further amended in May 2020 to, among other things, provide additional flexibility in determining the financial covenant leverage ratios for the second and third fiscal quarters of 2020 and to adjust certain margin and benchmark rates used to determine interest under the 2020 Facility. The 2020 Credit Agreement provides for secured revolving loans, multicurrency loan options and letters of credit in an aggregate amount of up to $550.0 million. The 2020 Credit Agreement also contains an expansion feature, which allows us to increase the aggregate principal amount of the 2020 Facility provided we remain in compliance with the underlying financial covenants on a pro forma basis, including but not limited to, compliance with the consolidated interest coverage ratio and certain consolidated leverage ratios. The 2020 Facility matures in February 2025 (subject to an earlier springing maturity date), and includes a sublimit of $50.0 million for standby letters of credit, a sublimit of $250.0 million for multicurrency borrowings, and a sublimit of $5.0 million for swingline loans. All of our assets including the assets of our material domestic subsidiaries continue to be pledged as collateral under the 2020 Facility (subject to customary exceptions) pursuant to the terms set forth in the Second Amended and Restated Security and Pledge Agreement executed in favor of the administrative agent. Each of our material domestic subsidiaries guarantee the 2020 Facility. In connection with the 2020 Facility, we incurred issuance costs which will be amortized over the term of the 2020 Facility. We did not carry any outstanding revolving loans under the 2020 Facility as of December 31, 2020 and 2019.

Borrowings under the 2020 Facility bear interest, at our option, at a rate equal to an applicable margin plus: (a) the applicable Eurocurrency Rate (as defined in the 2020 Credit Agreement), or (b) a base rate determined by reference to the highest of (1) the federal funds effective rate plus 0.50%, (2) the Bank of America prime rate, and (3) the Eurocurrency Rate for an interest period of one month plus 1.00%. The margin for the 2020 Facility ranges, based on our consolidated total net leverage ratio, from 0.50% to 1.25% in the case of base rate loans and from 1.50% to 2.25% in the case of Eurocurrency Rate loans. The 2020 Facility includes an unused line fee ranging, based on our consolidated total net leverage ratio, from 0.35% to 0.50% per annum on the revolving commitment.

The 2020 Credit Agreement contains affirmative, negative, permitted acquisition and financial covenants, and events of default customary for financings of this type. The financial covenants require us to maintain a consolidated interest coverage ratio and certain consolidated leverage ratios, which are measured on a quarterly basis. The 2020 Facility grants the lenders preferred first priority liens and security interests in capital stock, intercompany debt and all of our present and future property and assets including each guarantor. As of December 31, 2020, we are in compliance with the 2020 Credit Agreement covenants.

Contractual Obligations and Commitments

Contractual obligations and commitments represent future cash commitments and liabilities under agreements with third parties, including our Senior Convertible Notes, operating leases and other contractual obligations.

The following table summarizes our contractual obligations and commitments as of December 31, 2020:

 

 

 

 

 

 

Payments Due by Period

 

(in thousands)

 

Total

 

 

Less Than 1 Year

 

 

1 to 3 Years

 

 

4 to 5 Years

 

 

After 5 Years

 

Convertible Notes (1)

 

$

1,576,156

 

 

$

663,500

 

 

$

460,125

 

 

$

452,531

 

 

$

—

 

Operating leases

 

 

169,848

 

 

 

14,140

 

 

 

26,740

 

 

 

22,771

 

 

 

106,197

 

Finance leases

 

 

3,337

 

 

 

1,465

 

 

 

1,863

 

 

 

9

 

 

 

—

 

Other long-term obligations

 

 

13,750

 

 

 

5,080

 

 

 

4,194

 

 

 

1,476

 

 

 

3,000

 

Total

 

$

1,763,091

 

 

$

684,185

 

 

$

492,922

 

 

$

476,787

 

 

$

109,197

 

 

(1)

Senior Convertible Notes includes the expected coupon interest payments on the outstanding debt. See Note 6 to the Consolidated Financial Statements included in this Annual Report for further discussion of the terms of the Senior Convertible Notes.

Total contractual obligations and commitments listed in the table above excludes potential contingent consideration payments pursuant to certain merger, purchase, and product development agreements, other than achieved milestones. See Note 4 and 7 to the Consolidated Financial Statements included in this Annual Report for further discussion on the contingent consideration obligations and product development agreements, respectively.

The expected timing of payments of the obligations discussed above is estimated based on current information. Timing of payment and actual amounts paid may be different depending on the time of receipt of services or changes to agreed-upon amounts for some obligations.

 

66

Table of Contents

Off-Balance Sheet Arrangements

As of December 31, 2020, we did not have any off-balance sheet activities.

Item 7A.Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Sensitivity and Risk

Our exposure to interest rate risk at December 31, 2020 is related to our investment portfolio which consists largely of debt instruments of high quality corporate issuers. Due to the short-term nature of these investments, we have assessed that there is no material exposure to interest rate risk arising from our investments. Fixed rate investments and borrowings may have their fair market value adversely impacted from changes in interest rates. At December 31, 2020, we do not hold any material asset-backed investment securities and in 2020, we did not realize any losses related to asset-backed investment securities. Based upon our overall interest rate exposure as of December 31, 2020, a change of 10 percent in interest rates, assuming the amount of our investment portfolio and overall economic environment remains constant, would not have a material effect on interest income.

The primary objective of our investment activities is to preserve the principal while at the same time maximizing yields without significantly increasing the risk. To achieve this objective, we maintain our portfolio of cash equivalents and investments in instruments that meet high credit quality standards, as specified in our investment policy. None of our investments are held for trading purposes. Our policy also limits the amount of credit exposure to any one issue, issuer and type of instrument.

As of December 31, 2020, we only held investments in securities of a short-term nature classified as cash equivalents or short-term investments. During the periods presented, we did not hold any investments that were in a significant unrealized loss position and no impairment charges were recorded. Realized gains and losses and interest income related to marketable securities were immaterial during all periods presented.

Market Price Sensitive Instruments

In order to reduce the potential equity dilution, we entered into the 2021 Hedge, 2023 Hedge, and 2025 Hedge in connection with the issuances of the 2021 Notes, 2023 Notes, and 2025 Notes, respectively, entitling us to purchase our common stock. Upon conversion of our convertible notes, the 2021 Hedge, 2023 Hedge, and 2025 Hedge are expected to reduce the equity dilution if the daily volume-weighted average price per share of our common stock exceeds the strike price of the applicable hedge. We also entered into warrant transactions with the counterparties of the 2021 Hedge, 2023 Hedge, and 2025 Hedge entitling them to acquire shares of our common stock. The warrant transactions could have a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period (the quarter or year to date period) exceeds the strike price of the warrants. See Note 6 to the Consolidated Financial Statements included in this Annual Report for further discussion.

Foreign Currency Exchange Risk

A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in the United States dollars. Accordingly, we have assessed that we do not have any material net exposure to foreign currency rate fluctuations. However, as our business in markets outside of the United States continues to increase, we will be exposed to foreign currency exchange risk related to our foreign operations. Fluctuations in the rate of exchange between the United States dollar and foreign currencies, primarily the pound sterling, the euro, the Australian dollar, the Brazilian real, the Singapore dollar, and the yen, could adversely affect our financial results, including our net sales, net sales growth rates, gross margins, income and losses as well as assets and liabilities. In addition, loss of financial stability within these markets could lead to delays in reimbursement or inability to remit payment due to currency controls. Specifically, we have operations in Puerto Rico, Brazil, and Argentina that have financial instability or currency controls. We do not have any material financial exposure to one customer or one country that would significantly hinder our liquidity.

We translate the financial statements of our foreign subsidiaries with functional currencies other than the United States dollar into the United States dollar for consolidation using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. Net gains or losses resulting from the translation of foreign financial statements and the effect of exchange rate changes on intercompany receivables and payables of a long-term investment nature are recorded as a separate component of stockholders’ equity. These adjustments will affect net income only upon sale or liquidation of the underlying investment in foreign subsidiaries. Exchange rate fluctuations resulting from the translation of the short-term intercompany balances between domestic entities and our foreign subsidiaries are recorded as foreign currency transaction gains or losses and are included in other income (expense) in the Consolidated Statement of Operations. For those short-term intercompany balances, we enter into the foreign currency forward contracts to partially offset the impact from fluctuation of the foreign currency rates. The notional amount of the outstanding foreign currency forward contracts was $14.0 million as of December 31, 2020, which was settled in January 2021. During the year ended December 31, 2020, a loss of $(1.0) million was recognized in other (expense) income, net due to the change in the fair value of the derivative instruments, and the fair value of the hedge contracts we held was de minimis on our Consolidated Balance Sheet as of December 31, 2020. The notional principal amounts provide one measure of the transaction volume outstanding as of period end, but do not represent the amount of our exposure to market loss. The estimates of fair value are based on applicable and commonly used pricing models using prevailing financial market information. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. The financial exposures by exchange rate fluctuations are monitored and managed by us as an integral part of our overall risk management program, which recognizes the unpredictability of financial markets and seeks to reduce potentially adverse effects on our results.

 

67

Table of Contents

Item 8.Financial Statements and Supplementary Data

The Consolidated Financial Statements and supplementary data required by this item are set forth at the pages indicated in Item 15 of this Annual Report.

Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A.Controls and Procedures

Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports under the Securities Exchange Act of 1934, as amended (Exchange Act) is recorded, processed, summarized and reported within the timelines specified in the Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can only provide reasonable assurance of achieving the desired control objectives, and in reaching a reasonable level of assurance, management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, we carried out an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in SEC Rules 13a — 15(e) and 15d — 15(e) of the Exchange Act) as of December 31, 2020. Based on such evaluation, our management has concluded as of December 31, 2020, the Company’s disclosure controls and procedures are effective.

Management’s Report on Internal Control over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Internal control over financial reporting refers to the process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles.

Management has used the framework set forth in the report entitled Internal Control — Integrated Framework published by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) to evaluate the effectiveness of the Company’s internal control over financial reporting. On May 14, 2013, the Committee of Sponsoring Organizations of the Treadway Commission published a 2013 framework and related illustrative documents. We adopted the new framework during 2014. Management has concluded that the Company’s internal control over financial reporting was effective as of December 31, 2020, based on those criteria. Ernst & Young LLP, the Company’s independent registered public accounting firm, has issued an attestation report on the Company’s internal control over financial reporting which is included herein.

Changes in Internal Control over Financial Reporting

We are involved in ongoing evaluations of internal controls. In anticipation of the filing of this Form 10-K, our Chief Executive Officer and Chief Financial Officer, with the assistance of other members of our management, performed an evaluation of any change in internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal controls over financial reporting. There has been no change to our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

 

68

Table of Contents

 

Report of Independent Registered Public Accounting Firm

 

To the Stockholders and the Board of Directors of NuVasive, Inc.

 

Opinion on Internal Control over Financial Reporting

 

We have audited NuVasive, Inc.’s internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control—Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, NuVasive, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December 31, 2020, based on the COSO criteria.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of NuVasive, Inc. as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive (loss) income, equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes and our report dated February 25, 2021 expressed an unqualified opinion thereon.

 

Basis for Opinion

 

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management’s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.

 

Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

 

Definition and Limitations of Internal Control Over Financial Reporting

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

/s/ Ernst & Young LLP

 

San Diego, California

February 25, 2021

 

 

69

Table of Contents

Item 9B.Other Information

None.

PART III

Certain information required by Part III is omitted from this report because the Company will file a definitive proxy statement within 120 days after the end of its fiscal year pursuant to Regulation 14A (the Proxy Statement) for its 2021 annual meeting of stockholders, and certain information included in the Proxy Statement is incorporated herein by reference.

 

 

Item 10.Directors, Executive Officers and Corporate Governance

We have adopted a Code of Ethical Business Conduct for all officers, directors and employees. The Code of Ethical Business Conduct is available on our website, www.nuvasive.com. We intend to disclose future amendments to, or waivers from, provisions of our Code of Ethical Business Conduct that apply to our Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer, or Controller, or persons performing similar functions, within four business days of such amendment or waiver.

The other information required by this Item 10 will be set forth in the Proxy Statement and is incorporated in this report by reference.

 

Item 11.Executive Compensation

The information required by this item will be set forth in the Proxy Statement and is incorporated in this report by reference.

 

 

 

70

Table of Contents

Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

The information required by this item will be set forth in the Proxy Statement and is incorporated in this report by reference.

Equity Compensation Plan Information

The following table provides certain information with respect to all of our compensation plans in effect as of December 31, 2020:

Plan Category

 

(A)

Number of Securities to

be Issued Upon Exercise

of Outstanding Options,

Warrants and Rights

 

 

(B)

Weighted Average

Exercise Price of

Outstanding

Options, Warrants

and Rights

 

 

(C)

Number of Securities

Remaining Available for

Future Issuance Under

Equity Compensation

Plans (excluding

securities reflected in

column(A))

 

 

Equity Compensation Plans approved by stockholders

 

 

1,629,998

 

(1)

$

—

 

 

 

4,478,472

 

(2)(3)

Equity Compensation Plans not approved by stockholders

 

 

—

 

 

 

—

 

 

 

—

 

 

Total

 

 

1,629,998

 

 

$

—

 

 

 

4,478,472

 

 

 

(1)

Consists of shares subject to outstanding stock options, restricted stock units and performance restricted stock units under the NuVasive 2004 Amended and Restated Equity Incentive Plan, the NuVasive 2014 Equity Incentive Plan, and the Ellipse Technologies 2015 Incentive Award Plan, some of which are vested and some of which remain subject to the vesting and/or performance criteria of the respective equity award.

 

 

(2)

Consists of shares available for future issuance under the NuVasive 2014 Equity Incentive Plan, the Ellipse Technologies 2015 Incentive Award Plan, and the Amended and Restated 2004 Employee Stock Purchase Plan (ESPP). As of December 31, 2020, an aggregate of 3,056,803 shares of common stock were available for issuance under the NuVasive 2014 Equity Incentive Plan, 593,454 shares of common stock were available for issuance under the Ellipse Technologies 2015 Incentive Award Plan, and 828,215 shares of common stock were available for issuance under the 2004 Amended and Restated Employee Stock Purchase Plan.

 

 

(3)

The NuVasive 2004 Amended and Restated Equity Incentive Plan terminated in February 2014, upon the tenth anniversary of its effective date, and we are no longer granting awards under that plan. However, awards granted under the plan will remain outstanding until they are exercised, issued, terminated, cancelled or they expire. Pursuant to the terms of the plan, shares subject to awards granted under the NuVasive 2004 Amended and Restated Equity Incentive Plan may be utilized for future grants of awards under the NuVasive 2014 Equity Incentive Plan, to the extent such awards are terminated, cancelled or they expire, or shares subject thereto are withheld to cover taxes.

 

 

The information required by this item will be set forth in the Proxy Statement and is incorporated in this report by reference.

 

 

Item 14.Principal Accountant Fees and Services

The information required by this item will be set forth in the Proxy Statement and is incorporated in this report by reference.

 

71

Table of Contents

PART IV

 

 

Item 15.Exhibits, Financial Statement Schedules

 

(a)

The following documents are filed as a part of this report:

 

(1)

Report of Independent Registered Public Accounting Firm

Consolidated Balance Sheets as of December 31, 2020 and 2019

Consolidated Statements of Operations for the years ended December 31, 2020, 2019 and 2018

Consolidated Statements of Comprehensive Income for the years ended December 31, 2020, 2019 and 2018

Consolidated Statements of Equity for the years ended December 31, 2020, 2019 and 2018

Consolidated Statements of Cash Flows for the years ended December 31, 2020, 2019 and 2018

Notes to Consolidated Financial Statements

 

(2)

Financial Statement Schedules: Schedule II — Valuation Accounts

All other financial statement schedules have been omitted because they are not applicable, not required or the information required by such schedules is shown in the financial statements or the notes thereto.

 

(3)

Exhibits

See Item 15, subsection (b) below.

(b) The following exhibits are filed as part of this report:

 

Exhibit

Number

 

  

                                                                     Description

 

 

2.1†

  

Agreement and Plan of Merger, dated January 4, 2016, by and among the Company, Magneto Acquisition Corporation, a Delaware corporation and wholly-owned subsidiary of the Company, Ellipse Technologies, Inc., and Fortis Advisors LLC, a Delaware limited liability corporation, in its capacity as the equity holders’ representative  (incorporated by reference to our Current Report on Form 8-K filed with the Commission on February 11, 2016)

2.2

 

Agreement and Plan of Merger, dated June 6, 2016, by and among the Company, Bionic Acquisition Corporation, a Delaware corporation and wholly-owned subsidiary of the Company, BNN Holdings Corp., and GPP I-BNN, LLC, a Delaware limited liability corporation, in its capacity as the security holders’ agent to BNN Holdings Corp. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on July 5, 2016)

3.1

  

Restated Certificate of Incorporation (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on August 13, 2004)

3.2

  

Certificate of Amendment to the Restated Certificate of Incorporation (incorporated by reference to our Current Report on Form 8-K filed with the Commission on September 28, 2011)

3.3

 

Certificate of Amendment to the Restated Certificate of Incorporation (incorporated by reference to our Current Report on Form 8-K filed with the SEC on September 10, 2020)

3.4

  

Restated Bylaws (incorporated by reference to our Current Report on Form 8-K filed with the Commission on January 6, 2012)

3.5

 

Amendment No. 1 to the Restated Bylaws (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 19, 2014)

3.6

 

Amendment No. 2 to the Restated Bylaws (incorporated by reference to our Current Report on Form 8-K filed with the Commission on August 1, 2016)

 

72

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

4.1

  

Specimen Common Stock Certificate (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on March 15, 2006)

4.2

  

Certificate of Designations of Series A Participating Preferred Stock filed with the Delaware Secretary of State on June 28, 2011 (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 29, 2011)

4.3

  

Indenture, dated March 16, 2016, between the Company and Wilmington Trust, National Association, as Trustee (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

4.4

  

Form of 2.25% Convertible Senior Note due 2021 (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

4.5

 

Indenture, dated March 2, 2020, between the Company and Wilmington Trust, National Association, as Trustee (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

4.6

 

Form of 0.375% Convertible Senior Note due 2025 (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

4.7

 

Indenture, dated June 1, 2020, between the Company and Wilmington Trust, National Association, as Trustee (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

4.8

 

Form of 1.00% Convertible Senior Note due 2023 (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

4.9

 

Description of Registrant’s Securities (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.1#

  

2004 Amended and Restated Equity Incentive Plan (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on July 26, 2012)

10.2#

  

Amendment No. 1 to the 2004 Amended and Restated Equity Incentive Plan (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on March 3, 2014)

10.3#

  

Form of Stock Option Award Notice under the 2004 Amended and Restated Equity Incentive Plan (incorporated by reference to Amendment No. 1 to our Registration Statement on Form S-1 filed with the Commission on April 8, 2004)

10.4#

  

Form of Option Exercise and Stock Purchase Agreement under the 2004 Amended and Restated Equity Incentive Plan (incorporated by reference to Amendment No. 1 to our Registration Statement on Form S-1 filed with the Commission on April 8, 2004)

10.5#

  

Form of Restricted Stock Unit Award Agreement under the 2004 Amended and Restated Equity Incentive Plan (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 26, 2010)

10.6#

  

Form of Restricted Stock Grant Notice and Restricted Stock Agreement under the 2004 Amended and Restated Equity Incentive Plan (incorporated by reference to Amendment No. 1 to our Registration Statement on Form S-1 filed with the Commission on April 8, 2004)

10.7#

  

2004 Amended and Restated Employee Stock Purchase Plan of NuVasive, Inc. (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 30, 2014)

10.8#

  

Amendment No. 1 to 2004 Amended and Restated Employee Stock Purchase Plan of NuVasive, Inc. (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2019)

 

73

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

10.9#

  

2014 Equity Incentive Plan (incorporated by reference to Exhibit A to our Definitive Proxy Statement filed with the Commission on March 27, 2014)

10.10#

 

Form of Performance Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) under the 2014 Equity Incentive Plan (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 4, 2015)

10.11#

 

Form of Executive Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) under the 2014 Equity Incentive Plan (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 4, 2015)

10.12#

 

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) under the 2014 Equity Incentive Plan (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 4, 2015)

10.13#

  

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants after February 8, 2017 under the 2014 Equity Incentive Plan (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 9, 2017)

10.14#

  

Form of Executive Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants after February 8, 2017 under the 2014 Equity Incentive Plan (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 9, 2017)

10.15#

  

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) for grants after February 8, 2017 under the 2014 Equity Incentive Plan (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 9, 2017)

10.16#

  

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after April 30, 2018 (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 1, 2018)

10.17#

  

Form of Executive Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after April 30, 2018 (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 1, 2018)

10.18#

 

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) for grants on or after April 30, 2018 (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 1, 2018)

10.19#

 

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after March 1, 2019 (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.20#

 

Form of Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2019 (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.21#

 

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2019 (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.22#

 

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after March 1, 2020 (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 6, 2020)

 

74

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

10.23#

 

Form of Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2020 (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 6, 2020)

10.24#

 

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2020 (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 6, 2020)

10.25#

  

NuVasive, Inc. 2014 Executive Incentive Compensation Plan (incorporated by reference to Exhibit B to our Definitive Proxy Statement filed with the Commission on March 27, 2014)

10.26#

 

2015 Ellipse Technologies, Inc. Incentive Award Plan (incorporated by reference to our Registration Statement on Form S-8 filed with the Commission on February 11, 2016)

10.27#

  

Form of Indemnification Agreement between the Company and its directors and certain executives thereof (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 19, 2014)

10.28#

  

NuVasive, Inc. Amended and Restated Executive Severance Plan (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on July 27, 2017)

10.29#

 

Form of Change in Control Agreement between the Company and certain executives thereof (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 19, 2014)

10.30#

 

NuVasive, Inc. Deferred Compensation Plan (incorporated by reference to our Current Report on Form 8-K filed with the Commission on August 6, 2015)

10.31#

 

Employment Letter dated October 16, 2018 between the Company and J. Christopher Barry (incorporated by reference to our Current Report on Form 8-K filed with the Commission on October 19, 2018)

10.32#

 

Letter Agreement dated May 22, 2015 between the Company and Gregory T. Lucier (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 26, 2015)

10.33#

 

Amendment to Employment Letter effective October 16, 2018 between the Company and Gregory T. Lucier (incorporated by reference to our Current Report on Form 8-K filed with the Commission on October 19, 2018)

10.34#

 

General Consulting and Services Agreement effective October 16, 2018 between the Company and Gregory T. Lucier (incorporated by reference to our Current Report on form 8-K filed with the Commission on October 19, 2018)

10.35#

 

Assignment and Novation Agreement effective November 12, 2018 by and among Gregory T. Lucier, River Road Capital Partners, LLC and the Company (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2019)

10.36#

  

Amendment No. 1 to Proprietary Information, Inventions Assignment and Restrictive Covenant Agreement effective October 16, 2018 between the Company and Gregory T. Lucier (incorporated by reference to our Current Report on Form 8-K filed with the Commission on October 19, 2018)

10.37#

  

Notice of Grant of Share Purchase Matching Performance Restricted Stock Units and Award Agreement granted to Gregory T. Lucier on May 22, 2015 (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 26, 2015)

10.38#

 

Notice of Grant of “Inducement” Performance Restricted Stock Units and Award Agreement granted to Gregory T. Lucier on May 22, 2015 (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 26, 2015)

 

75

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

10.39#

 

Employment Letter Agreement dated October 13, 2020 between the Company and Matthew Link (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.40#

 

General Consulting and Services Agreement dated October 13, 2020 between the Company and Matthew Link (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.41#

 

Amendment No. 1 to Proprietary Information, Inventions Assignment and Restrictive Covenant Agreement dated October 13, 2020 between the Company and Matthew Link (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.42#

 

Separation Agreement and General Release dated January 28, 2021 between the Company and Matthew Link

10.43#

 

Notice of Grant of Performance Cash Award and Award Agreement granted to Matthew Link on December 3, 2018  (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2019)

10.44#

 

Employment Letter dated December 27, 2019 between the Company and Matthew K. Harbaugh (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.45#

 

Employment Letter dated October 14, 2020 between the Company and Massimo Calafiore (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.46#

 

Employment Letter dated October 13, 2020 between the Company and Brent Boucher (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.47#

 

Employment Letter dated June 19, 2018 between the Company and Nathaniel B. Sisitsky, Esq. (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.48#

 

Employment Letter dated January 1, 2019 between the Company and Lucas Vitale

10.49#

 

Employment Letter dated October 25, 2019 between the Company and Dale Wolf

10.50#

 

Employment Letter dated December 31, 2019 between the Company and Rajesh Asarpota (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.51#

 

General Consulting and Services Agreement dated December 31, 2019 between the Company and Rajesh Asarpota (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.52#

 

Separation Agreement and General Release dated as of May 4, 2020, between the Company and Rajesh J. Asarpota (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 6, 2020)

10.53#

 

Form of Temporary Reduction of Compensation Letter dated as of April 13, 2020 between the Company and its directors and executive officers (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on May 6, 2020)

10.54#

 

Non-Employee Director Cash Compensation Plan (incorporated by reference to our Annual Report on Form 10-K filed with the Commission on February 20, 2020)

10.55

  

Lease for Sorrento Summit, dated as of August 28, 2017, by and between HCPI/Sorrento, LLC and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on August 29, 2017)

10.56

  

Second Amended and Restated Credit Agreement, dated as of February 24, 2020, by and among the Company, certain material subsidiaries of the Company, as guarantors, Bank of America, N.A. and each of those additional Lenders that are a party to such agreement (incorporated by reference to our Current Report on Form 8-K filed with the Commission on February 26, 2020)

 

76

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

10.57

 

Amendment No. 1 to Credit Agreement, dated as of May 26, 2020, by and among NuVasive, Inc., Bank of America, N.A. and each of those additional Lenders that are a party to such agreement (incorporated by reference to our Current Report on Form 8-K filed with the Commission on May 26, 2020)

10.58

  

Second Amended and Restated Security Agreement, dated as of February 24, 2020, by and among the Company, certain material subsidiaries of the Company, as guarantors, and Bank of America, N.A. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on February 26, 2020)

10.59

  

Confirmation for base call option transaction, dated March 10, 2016, by and between the Company and Bank of America, N.A. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.60

  

Confirmation for additional call option transaction, dated March 11, 2016, by and between the Company and Bank of America, N.A. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.61

  

Confirmation for base call option transaction, dated March 10, 2016, by and between the Company and Goldman, Sachs & Co. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.62

  

Confirmation for additional call option transaction, dated March 11, 2016, by and between the Company and Goldman, Sachs & Co. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.63

  

Confirmation for base warrant transaction, dated March 10, 2016, by and between the Company and Bank of America, N.A. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.64

  

Confirmation for additional warrant transaction, dated March 11, 2016, by and between the Company and Bank of America, N.A. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.65

  

Confirmation for base warrant transaction, dated March 10, 2016, by and between the Company and Goldman, Sachs & Co. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.66

  

Confirmation for additional warrant transaction, dated March 11, 2016, by and between the Company and Goldman, Sachs & Co. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 16, 2016)

10.67

 

Confirmation for base call option transaction dated as of February 26, 2020, between Morgan Stanley & Co. International plc and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.68

 

Confirmation for base call option transaction dated as of February 26, 2020, between JPMorgan Chase Bank, National Association and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.69

 

Confirmation for base call option transaction dated as of February 26, 2020, between Royal Bank of Canada and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.70

 

Confirmation for base call option transaction dated as of February 26, 2020, between The Bank of Nova Scotia and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.71

 

Confirmation for base call option transaction dated as of February 26, 2020, between Barclays Bank PLC and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

 

77

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

10.72

 

Confirmation for base warrant transaction dated as of February 26, 2020, between Morgan Stanley & Co. International plc and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.73

 

Confirmation for base warrant transaction dated as of February 26, 2020, between JPMorgan Chase Bank, National Association and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.74

 

Confirmation for base warrant transaction dated as of February 26, 2020, between Royal Bank of Canada and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.75

 

Confirmation for base warrant transaction dated as of February 26, 2020, between The Bank of Nova Scotia and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.76

 

Confirmation for base warrant transaction dated as of February 26, 2020, between Barclays Bank PLC and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.77

 

Amendment Agreement, dated February 26, 2020, between the Company and Bank of America, N.A. (incorporated by reference to our Current Report on Form 8-K filed with the Commission on March 2, 2020)

10.78

 

Confirmation for base call option transaction dated as of May 27, 2020, between Morgan Stanley & Co. International plc and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.79

 

Confirmation for base call option transaction dated as of May 27, 2020, between Royal Bank of Canada and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.80

 

Confirmation for base call option transaction dated as of May 27, 2020, between Bank of America, N.A. and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.81

 

Confirmation for base call option transaction dated as of May 27, 2020, between Barclays Bank PLC and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.82

 

Confirmation for base warrant transaction dated as of May 27, 2020, between Morgan Stanley & Co. International plc and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.83

 

Confirmation for base warrant transaction dated as of May 27, 2020, between Royal Bank of Canada and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.84

 

Confirmation for base warrant transaction dated as of May 27, 2020, between Bank of America, N.A. and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.85

 

Confirmation for base warrant transaction dated as of May 27, 2020, between Barclays Bank PLC and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 1, 2020)

10.86

 

Confirmation for additional call option transaction dated as of June 2, 2020, between Morgan Stanley & Co. International plc and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

10.87

 

Confirmation for additional call option transaction dated as of June 2, 2020, between Royal Bank of Canada and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

10.88

 

Confirmation for additional call option transaction dated as of June 2, 2020, between Bank of America, N.A. and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

 

78

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

10.89

 

Confirmation for additional call option transaction dated as of June 2, 2020, between Barclays Bank PLC and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

10.90

 

Confirmation for additional warrant transaction dated as of June 2, 2020, between Morgan Stanley & Co. International plc and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

10.91

 

Confirmation for additional warrant transaction dated as of June 2, 2020, between Royal Bank of Canada and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

10.92

 

Confirmation for additional warrant transaction dated as of June 2, 2020, between Bank of America, N.A. and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

10.93

 

Confirmation for additional warrant transaction dated as of June 2, 2020, between Barclays Bank PLC and the Company (incorporated by reference to our Current Report on Form 8-K filed with the Commission on June 4, 2020)

10.94

 

Amendment Agreement dated as of October 26, 2020, between Morgan Stanley & Co. International plc and the Company (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.95

 

Amendment Agreement dated as of October 26, 2020, between Royal Bank of Canada and the Company (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.96

 

Amendment Agreement dated as of October 26, 2020, between Bank of America, N.A. and the Company (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

10.97

 

Amendment Agreement dated as of October 26, 2020, between Barclays Bank PLC and the Company (incorporated by reference to our Quarterly Report on Form 10-Q filed with the Commission on October 29, 2020)

21.1

  

List of subsidiaries of the Company

23.1

  

Consent of Independent Registered Public Accounting Firm

31.1

  

Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended

31.2

  

Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended

32.1*

 

Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. section 1350

 

79

Table of Contents

Exhibit

Number

 

  

                                                                     Description

 

 

101.INS

  

Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH

  

Inline XBRL Taxonomy Extension Schema Document

101.CAL

  

Inline XBRL Taxonomy Calculation Linkbase Document

101.DEF

 

Inline XBRL Taxonomy Definition Linkbase Document

101.LAB

  

Inline XBRL Taxonomy Label Linkbase Document

101.PRE

 

Inline XBRL Taxonomy Presentation Linkbase Document

104

 

Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibit 101.INS)

†

Certain confidential information contained in this exhibit was omitted by means of redacting a portion of the text and replacing it with an asterisk. We have filed separately with the Commission an unredacted copy of the exhibit.

#

Indicates management contract or compensatory plan.

*

These certifications are being furnished solely to accompany this annual report pursuant to 18 U.S.C. Section 1350, and are not being filed for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of NuVasive, Inc., whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Item 16.Form 10-K Summary

 

The Company has elected not to provide a summary.

 

 

80

Table of Contents

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

 

 

NUVASIVE, INC.

Date: February 25, 2021

 

 

 

By: /s/ J. Christopher Barry

 

 

 

J. Christopher Barry

Chief Executive Officer

(Principal Executive Officer)

 

 

81

Table of Contents

 

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints J. Christopher Barry and Matthew K. Harbaugh, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his or her substitute or substitutes may do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature

  

Title

 

Date

 

/s/    J. Christopher Barry

 

Chief Executive Officer and Director

 

February 25, 2021

 

J. Christopher Barry

 

(Principal Executive Officer)

 

 

 

 

 

 

 

 

 

/s/    Matthew K. Harbaugh

 

Executive Vice President and Chief Financial Officer

 

February 25, 2021

 

Matthew K. Harbaugh

 

(Principal Financial Officer and Principal Accounting Officer)

 

 

 

 

 

 

 

 

 

/s/    Vickie L. Capps

 

 

Director

 

February 25, 2021

 

Vickie L. Capps

 

 

 

 

 

 

 

 

 

 

 

/s/    John A. DeFord

 

Director

 

February 25, 2021

 

John A. DeFord, Ph.D.

 

 

 

 

 

 

 

 

 

 

 

/s/    Robert F. Friel

 

Director

 

February 25, 2021

 

Robert F. Friel

 

 

 

 

 

 

 

 

 

 

 

/s/    R. Scott Huennekens

 

Director

 

February 25, 2021

 

R. Scott Huennekens

 

 

 

 

 

 

 

Director

 

 

 

Siddhartha C. Kadia, Ph.D.

 

 

 

 

 

/s/    Gregory T. Lucier

 

Director

 

February 25, 2021

 

Gregory T. Lucier

 

 

 

 

 

 

 

 

 

 

 

/s/    Leslie V. Norwalk

 

Director

 

February 25, 2021

 

Leslie V. Norwalk, Esq.

 

 

 

 

 

 

 

 

 

 

 

/s/    Donald J. Rosenberg

 

Director

 

February 25, 2021

 

Donald J. Rosenberg

 

 

 

 

 

 

 

 

 

 

 

/s/    Daniel J. Wolterman

 

Director

 

February 25, 2021

 

Daniel J. Wolterman

 

 

 

 

 

 

 

 

82

Table of Contents

NUVASIVE, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

 

 

 

83

Table of Contents

 

Report of Independent Registered Public Accounting Firm

 

To the Stockholders and the Board of Directors of NuVasive, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of NuVasive, Inc. (the Company) as of December 31, 2020 and 2019, the related consolidated statements of operations, comprehensive (loss) income, equity and cash flows for each of the three years in the period ended December 31, 2020, and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2020, in conformity with U.S. generally accepted accounting principles.

 

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2020, based on criteria established in Internal Control — Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) and our report dated February 25, 2021 expressed an unqualified opinion thereon.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matter

The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

84

Table of Contents

Valuation of inventory

Description of the Matter

The Company's inventories totaled $300.6 million as of December 31, 2020. As explained in Note 1 to the consolidated financial statements, the Company reviews the components of its inventory on a periodic basis for excess and obsolescence and adjusts inventory to its net realizable value as necessary.

Auditing management's calculation of estimated excess and obsolete inventory involved subjective auditor judgment because the estimate was sensitive to changes in significant assumptions. In particular, such assumptions include product life cycle and revenue forecasts as well as specific product considerations such as timing of the introduction and development of new or enhanced products.

How We Addressed the Matter in Our Audit

We evaluated and tested the design and operating effectiveness of internal controls over the Company's excess and obsolete inventory valuation process, including controls over management's assessment of the assumptions and controls related to the completeness and accuracy of data, including calculations underlying the excess and obsolete inventory valuation.

Our substantive audit procedures included, among others, evaluating and testing the significant assumptions stated above and the accuracy and completeness of the underlying data used in management's excess and obsolete inventory valuation assessment. To test inventory excess and obsolescence assumptions, we compared the on-hand inventory quantities to revenue forecasts and historical sales and evaluated adjustments to revenue forecasts for specific product considerations, such as product life cycles and timing of the introduction and development of new or enhanced products. We also assessed the historical accuracy of management's estimate and performed sensitivity analyses over the significant assumptions to evaluate the impact of changes in the obsolete and excess inventory estimate that would result from changes in the underlying assumptions.

/s/ Ernst & Young LLP

 

We have served as the Company’s auditor since 2000.

 

San Diego, California

February 25, 2021

 

 

85

Table of Contents

 

NUVASIVE, INC.

CONSOLIDATED BALANCE SHEETS

(in thousands, except par value data)

 

 

 

December 31,

 

 

 

2020

 

 

2019

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

856,869

 

 

$

213,034

 

Short-term marketable securities

 

 

173,145

 

 

 

—

 

Accounts receivable, net of allowances of $20,631 and $17,019, respectively

 

 

207,071

 

 

 

211,532

 

Inventory, net

 

 

300,623

 

 

 

312,419

 

Prepaid income taxes

 

 

4,727

 

 

 

10,434

 

Prepaid expenses and other current assets

 

 

19,749

 

 

 

16,917

 

Total current assets

 

 

1,562,184

 

 

 

764,336

 

Property and equipment, net

 

 

286,369

 

 

 

266,318

 

Intangible assets, net

 

 

152,264

 

 

 

201,092

 

Goodwill

 

 

559,553

 

 

 

561,064

 

Operating lease right-of-use assets

 

 

102,270

 

 

 

66,932

 

Deferred tax assets

 

 

15,755

 

 

 

9,162

 

Restricted cash and investments

 

 

1,494

 

 

 

1,494

 

Other assets

 

 

13,193

 

 

 

14,892

 

Total assets

 

$

2,693,082

 

 

$

1,885,290

 

LIABILITIES AND EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

$

110,401

 

 

$

97,160

 

Contingent consideration liabilities

 

 

7,289

 

 

 

15,727

 

Accrued payroll and related expenses

 

 

63,421

 

 

 

86,458

 

Operating lease liabilities

 

 

7,875

 

 

 

5,567

 

Income tax liabilities

 

 

2,073

 

 

 

2,005

 

Senior convertible notes

 

 

645,303

 

 

 

—

 

Total current liabilities

 

 

836,362

 

 

 

206,917

 

Long-term senior convertible notes

 

 

766,226

 

 

 

623,298

 

Deferred tax liabilities

 

 

2,807

 

 

 

14,655

 

Operating lease liabilities

 

 

111,634

 

 

 

73,153

 

Other long-term liabilities

 

 

52,438

 

 

 

52,060

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Redeemable equity component of senior convertible notes

 

 

4,697

 

 

 

—

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value; 5,000 shares authorized, none outstanding

 

 

—

 

 

 

—

 

Common stock, $0.001 par value; 150,000 and 120,000 shares authorized at December 31, 2020 and December 31, 2019, respectively; 57,945 shares issued and 51,376 outstanding at December 31, 2020; 57,525 issued and 52,145 outstanding at December 31, 2019

 

 

62

 

 

 

62

 

Additional paid-in capital

 

 

1,550,001

 

 

 

1,429,854

 

Accumulated other comprehensive loss

 

 

(7,585

)

 

 

(9,418

)

Retained earnings

 

 

45,322

 

 

 

82,475

 

Treasury stock at cost; 6,569 shares and 5,380 shares at December 31, 2020 and December 31, 2019, respectively

 

 

(668,882

)

 

 

(587,766

)

Total equity

 

 

918,918

 

 

 

915,207

 

Total liabilities and equity

 

$

2,693,082

 

 

$

1,885,290

 

 

See accompanying notes to Consolidated Financial Statements.

 

 

 

86

Table of Contents

 

NUVASIVE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Net sales:

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

$

950,189

 

 

$

1,044,569

 

 

$

986,457

 

Services

 

 

100,393

 

 

 

123,501

 

 

 

115,257

 

Total net sales

 

 

1,050,582

 

 

 

1,168,070

 

 

 

1,101,714

 

Cost of sales (excluding below amortization of intangible assets):

 

 

 

 

 

 

 

 

 

 

 

 

Products

 

 

247,809

 

 

 

232,474

 

 

 

234,509

 

Services

 

 

73,822

 

 

 

79,883

 

 

 

76,650

 

Total cost of sales

 

 

321,631

 

 

 

312,357

 

 

 

311,159

 

Gross profit

 

 

728,951

 

 

 

855,713

 

 

 

790,555

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative

 

 

547,195

 

 

 

611,181

 

 

 

575,836

 

Research and development

 

 

79,838

 

 

 

72,380

 

 

 

61,695

 

Amortization of intangible assets

 

 

51,726

 

 

 

51,097

 

 

 

50,670

 

Purchase of in-process research and development

 

 

1,011

 

 

 

—

 

 

 

8,913

 

Litigation liability loss

 

 

—

 

 

 

—

 

 

 

27,800

 

Business transition costs

 

 

10,878

 

 

 

(1,995

)

 

 

11,473

 

Total operating expenses

 

 

690,648

 

 

 

732,663

 

 

 

736,387

 

Interest and other expense, net:

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

1,472

 

 

 

1,917

 

 

 

586

 

Interest expense

 

 

(70,466

)

 

 

(38,525

)

 

 

(37,857

)

Other (expense) income, net

 

 

(16,854

)

 

 

(5,925

)

 

 

(8,174

)

Total interest and other expense, net

 

 

(85,848

)

 

 

(42,533

)

 

 

(45,445

)

(Loss) income before income taxes

 

 

(47,545

)

 

 

80,517

 

 

 

8,723

 

Income tax benefit (expense)

 

 

10,392

 

 

 

(15,283

)

 

 

3,756

 

Consolidated net (loss) income

 

$

(37,153

)

 

$

65,234

 

 

$

12,479

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income per share:

 

 

 

 

 

 

 

 

 

 

 

 

   Basic

 

$

(0.72

)

 

$

1.26

 

 

$

0.24

 

   Diluted

 

$

(0.72

)

 

$

1.23

 

 

$

0.24

 

Weighted average shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

   Basic

 

 

51,416

 

 

 

51,956

 

 

 

51,382

 

   Diluted

 

 

51,416

 

 

 

53,160

 

 

 

52,355

 

See accompanying notes to Consolidated Financial Statements.

 

 

 

 

87

Table of Contents

 

NUVASIVE, INC.

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(in thousands)

 

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Consolidated net (loss) income

 

$

(37,153

)

 

$

65,234

 

 

$

12,479

 

Other comprehensive income (loss):

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized gain on marketable securities, net of tax

 

 

13

 

 

 

—

 

 

 

—

 

Translation adjustments, net of tax

 

 

1,820

 

 

 

(790

)

 

 

(1,695

)

Other comprehensive income (loss):

 

 

1,833

 

 

 

(790

)

 

 

(1,695

)

Total consolidated comprehensive (loss) income

 

$

(35,320

)

 

$

64,444

 

 

$

10,784

 

See accompanying notes to Consolidated Financial Statements.

 

88

Table of Contents

NUVASIVE, INC.

CONSOLIDATED STATEMENTS OF EQUITY

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NuVasive, Inc.

 

 

Non-

 

 

 

 

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

 

 

 

 

Treasury Stock

 

 

Stockholders'

 

 

Controlling

 

 

Total

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Loss

 

 

Retained Earnings

 

 

Shares

 

 

Amount

 

 

Equity

 

 

Interests

 

 

Equity

 

Balance at December 31, 2017

 

 

56,164

 

 

$

60

 

 

$

1,363,549

 

 

$

(6,933

)

 

$

4,762

 

 

 

(5,002

)

 

$

(565,867

)

 

$

795,571

 

 

$

3,845

 

 

$

799,416

 

Issuance of common stock under employee and director stock option and purchase plans

 

 

466

 

 

 

1

 

 

 

11,309

 

 

 

—

 

 

 

—

 

 

 

(114

)

 

 

(6,111

)

 

 

5,199

 

 

 

—

 

 

 

5,199

 

Stock-based compensation expense

 

 

—

 

 

 

—

 

 

 

27,353

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

27,353

 

 

 

—

 

 

 

27,353

 

Issuance of common stock in connection with royalty milestone achievement

 

 

18

 

 

 

—

 

 

 

4,719

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

4,719

 

 

 

—

 

 

 

4,719

 

Consolidated net income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

12,479

 

 

 

—

 

 

 

—

 

 

 

12,479

 

 

 

—

 

 

 

12,479

 

Consideration paid in excess of non-controlling interests

 

 

—

 

 

 

—

 

 

 

(9,101

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(9,101

)

 

 

—

 

 

 

(9,101

)

Non-controlling interests

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(3,845

)

 

 

(3,845

)

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,695

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,695

)

 

 

—

 

 

 

(1,695

)

Balance at December 31, 2018

 

 

56,648

 

 

$

61

 

 

$

1,397,829

 

 

$

(8,628

)

 

$

17,241

 

 

 

(5,116

)

 

$

(571,978

)

 

$

834,525

 

 

$

—

 

 

$

834,525

 

 

See accompanying notes to Consolidated Financial Statements.

 

 

89

Table of Contents

 

NUVASIVE, INC.

CONSOLIDATED STATEMENTS OF EQUITY – (Continued)

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

 

 

 

 

Treasury Stock

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Loss

 

 

Retained Earnings

 

 

Shares

 

 

Amount

 

 

Equity

 

Balance at December 31, 2018

 

 

56,648

 

 

$

61

 

 

$

1,397,829

 

 

$

(8,628

)

 

$

17,241

 

 

 

(5,116

)

 

$

(571,978

)

 

$

834,525

 

Issuance of common stock under employee and director stock option and purchase plans

 

 

805

 

 

 

1

 

 

 

7,724

 

 

 

—

 

 

 

—

 

 

 

(264

)

 

 

(15,788

)

 

 

(8,063

)

Stock-based compensation expense

 

 

—

 

 

 

—

 

 

 

24,096

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

24,096

 

Issuance of common stock in connection with royalty milestone achievement

 

 

72

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Consolidated net income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

65,234

 

 

 

—

 

 

 

—

 

 

 

65,234

 

Consideration paid in excess of non-controlling interests

 

 

—

 

 

 

—

 

 

 

205

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

205

 

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(790

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(790

)

Balance at December 31, 2019

 

 

57,525

 

 

$

62

 

 

$

1,429,854

 

 

$

(9,418

)

 

$

82,475

 

 

 

(5,380

)

 

$

(587,766

)

 

$

915,207

 

 

See accompanying notes to Consolidated Financial Statements.

 

90

Table of Contents

NUVASIVE, INC.

CONSOLIDATED STATEMENTS OF EQUITY – (Continued)

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accumulated

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Other

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

Common Stock

 

 

Paid-in

 

 

Comprehensive

 

 

 

 

 

 

Treasury Stock

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Loss

 

 

Retained Earnings

 

 

Shares

 

 

Amount

 

 

Equity

 

Balance at December 31, 2019

 

 

57,525

 

 

$

62

 

 

$

1,429,854

 

 

$

(9,418

)

 

$

82,475

 

 

 

(5,380

)

 

$

(587,766

)

 

$

915,207

 

Issuance of common stock under employee and director stock option and purchase plans

 

 

420

 

 

 

—

 

 

 

6,621

 

 

 

—

 

 

 

—

 

 

 

(104

)

 

 

(6,116

)

 

 

505

 

Stock-based compensation expense

 

 

—

 

 

 

—

 

 

 

25,778

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

25,778

 

Tax benefits related to convertible note issuance

 

 

—

 

 

 

—

 

 

 

484

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

484

 

Shares repurchased

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,085

)

 

 

(75,000

)

 

 

(75,000

)

Sale of warrants

 

 

—

 

 

 

—

 

 

 

93,915

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

93,915

 

Convertible note hedge

 

 

—

 

 

 

—

 

 

 

(115,592

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(115,592

)

Equity component of convertible note issuance

 

 

—

 

 

 

—

 

 

 

115,559

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

115,559

 

Debt issuance costs attributable to convertible feature

 

 

—

 

 

 

—

 

 

 

(1,921

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,921

)

Reclassification of redeemable equity component of senior convertible notes

 

 

—

 

 

 

—

 

 

 

(4,697

)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(4,697

)

Consolidated net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(37,153

)

 

 

—

 

 

 

—

 

 

 

(37,153

)

Other comprehensive income

 

 

—

 

 

 

—

 

 

 

—

 

 

 

1,833

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

1,833

 

Balance at December 31, 2020

 

 

57,945

 

 

$

62

 

 

$

1,550,001

 

 

$

(7,585

)

 

$

45,322

 

 

 

(6,569

)

 

$

(668,882

)

 

$

918,918

 

 

See accompanying notes to Consolidated Financial Statements.

 

 

 

 

91

Table of Contents

 

NUVASIVE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated net (loss) income

 

$

(37,153

)

 

$

65,234

 

 

$

12,479

 

Adjustments to reconcile net (loss) income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

140,937

 

 

 

135,593

 

 

 

129,765

 

Purchase of in-process research and development

 

 

1,011

 

 

 

—

 

 

 

8,913

 

Deferred income taxes

 

 

(18,007

)

 

 

5,844

 

 

 

(11,396

)

Amortization of non-cash interest

 

 

48,986

 

 

 

21,288

 

 

 

20,123

 

Stock-based compensation

 

 

18,145

 

 

 

30,297

 

 

 

25,673

 

Net loss on strategic investments

 

 

268

 

 

 

4,767

 

 

 

4,421

 

Net loss recognized on change in fair value of derivatives

 

 

12,301

 

 

 

—

 

 

 

—

 

Reserves on current assets

 

 

53,902

 

 

 

18,382

 

 

 

14,834

 

Other non-cash adjustments

 

 

16,876

 

 

 

5,650

 

 

 

22,186

 

Changes in operating assets and liabilities, net of effects from acquisitions:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

3,030

 

 

 

(16,407

)

 

 

4,562

 

Inventory

 

 

(40,765

)

 

 

(54,872

)

 

 

(38,646

)

Prepaid expenses and other current assets

 

 

(4,986

)

 

 

(4,622

)

 

 

(1,280

)

Accounts payable and accrued liabilities

 

 

8,756

 

 

 

(3,924

)

 

 

22,900

 

Accrued payroll and related expenses

 

 

(23,654

)

 

 

24,256

 

 

 

2,595

 

Income taxes

 

 

6,264

 

 

 

3,804

 

 

 

2,054

 

Net cash provided by operating activities

 

 

185,911

 

 

 

235,290

 

 

 

219,183

 

Investing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Acquisitions and investments

 

 

—

 

 

 

(4,100

)

 

 

(55,266

)

Proceeds from other investments

 

 

1,143

 

 

 

—

 

 

 

3,584

 

Purchases of intangible assets

 

 

(3,860

)

 

 

(7,501

)

 

 

(7,682

)

Purchases of property and equipment

 

 

(105,729

)

 

 

(122,883

)

 

 

(101,921

)

Purchases of marketable securities

 

 

(233,488

)

 

 

—

 

 

 

—

 

Proceeds from sales and maturities of marketable securities

 

 

60,000

 

 

 

—

 

 

 

—

 

Net cash used in investing activities

 

 

(281,934

)

 

 

(134,484

)

 

 

(161,285

)

Financing activities:

 

 

 

 

 

 

 

 

 

 

 

 

Proceeds from the issuance of common stock

 

 

6,170

 

 

 

6,415

 

 

 

8,127

 

Payment of contingent consideration

 

 

(7,053

)

 

 

(809

)

 

 

(19,450

)

Purchase of treasury stock

 

 

(80,665

)

 

 

(14,478

)

 

 

(2,928

)

Proceeds from issuance of convertible debt, net of issuance costs

 

 

873,848

 

 

 

—

 

 

 

—

 

Proceeds from sale of warrants

 

 

93,915

 

 

 

—

 

 

 

—

 

Purchases of convertible note hedges

 

 

(147,825

)

 

 

—

 

 

 

—

 

Proceeds from revolving line of credit

 

 

—

 

 

 

—

 

 

 

100,000

 

Repayments on revolving line of credit

 

 

—

 

 

 

—

 

 

 

(100,000

)

Other financing activities

 

 

(1,734

)

 

 

2,228

 

 

 

(327

)

Net cash provided by (used in) financing activities

 

 

736,656

 

 

 

(6,644

)

 

 

(14,578

)

Effect of exchange rate changes on cash

 

 

3,202

 

 

 

131

 

 

 

(1,283

)

Increase in cash, cash equivalents and restricted cash

 

 

643,835

 

 

 

94,293

 

 

 

42,037

 

Cash, cash equivalents and restricted cash at beginning of period

 

 

214,528

 

 

 

120,235

 

 

 

78,198

 

Cash, cash equivalents and restricted cash at end of period

 

$

858,363

 

 

$

214,528

 

 

$

120,235

 

Supplemental disclosure of non-cash transactions:

 

 

 

 

 

 

 

 

 

 

 

 

Issuance of common stock in connection with royalty milestone achievement

 

$

—

 

 

$

—

 

 

$

4,719

 

Supplemental cash flow information:

 

 

 

 

 

 

 

 

 

 

 

 

Interest paid

 

$

19,914

 

 

$

16,145

 

 

$

17,182

 

Income taxes paid

 

$

1,873

 

 

$

5,828

 

 

$

5,510

 

The following table provides a reconciliation of cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows for the periods presented:

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Cash and cash equivalents

 

$

856,869

 

 

$

213,034

 

 

$

117,840

 

Restricted cash

 

 

1,494

 

 

 

1,494

 

 

 

2,395

 

Total cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows

 

$

858,363

 

 

$

214,528

 

 

$

120,235

 

See accompanying notes to Consolidated Financial Statements.

 

92

Table of Contents

NUVASIVE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.    Organization and Significant Accounting Policies

Description of Business

NuVasive, Inc. (the “Company” or “NuVasive”) was incorporated in Delaware on July 21, 1997, and began commercializing its products in 2001. Since its incorporation in 1997, the Company has grown from a small developer of specialty spinal implants into a global medical technology company delivering procedurally integrated solutions for spine surgery. Underlying the Company’s procedurally integrated solutions for spine surgery are technologies designed to enable better clinical, financial, and operational outcomes, including:

 

•

its surgical access instruments, including its Maxcess integrated split-blade retractor system, designed to enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery;

 

•

its neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring (“IONM”) services and support;

 

•

its Advanced Materials Science portfolio of specialized spinal implants, designed to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone;

 

•

its Reline fixation system, designed to facilitate the preservation and restoration of patient alignment, while addressing a vast array of spinal pathologies from an open or less-invasive approach across all spinal procedures; and

 

•

its Integrated Global Alignment platform, which is comprised of procedurally based technologies that help increase the predictability of achieving global alignment in spinal procedures, including its Bendini spinal rod bending system that assist with manual rod manipulation for spinal fixation.

The Company has also invested in enabling technologies, including the development of capital equipment designed to further improve clinical, financial, and operational outcomes of spine surgery. The Company’s capital equipment portfolio currently consists of Lessray and the Pulse platform. Lessray is an image enhancement platform designed to reduce radiation exposure in the operating room by allowing surgeons to take low-quality, low-dose images and improve them to look like conventional full-dose images. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for neuromonitoring, surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. Selling and leasing of capital equipment do not make up a material portion of the Company’s total net sales.

In addition to the Company’s procedurally integrated solutions for spine surgery, it also designs and sells expandable growing rod implant systems that can be non-invasively lengthened following implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control (“MAGEC”), which allows for the minimally invasive treatment of early-onset and adolescent scoliosis. This technology is also the basis for the Company’s Precice limb lengthening system, which allows for the correction of long bone limb length discrepancy, as well as other products for treating specialized orthopedic procedures.

In December 2019, a novel strain of coronavirus, which causes COVID-19, was identified. Due to the rapid and global spread of the virus, on March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. To slow the proliferation of COVID-19, governments have implemented extraordinary measures, which include the mandatory closure of businesses, restrictions on travel and gatherings, and quarantine and physical distancing requirements. In addition, many government agencies in conjunction with hospitals and healthcare systems have, to varying degrees, deferred or suspended elective surgical procedures. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, the Company has seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, the Company has experienced reductions in procedural volumes during 2020 and anticipates this trend may continue. The cumulative effect of these disruptions had a significant impact on the Company’s business in 2020 and it is not possible to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures.

 

93

Table of Contents

Basis of Presentation and Principles of Consolidation

The accompanying Consolidated Financial Statements include the accounts of the Company and its majority-owned or controlled subsidiaries, collectively referred to as either NuVasive or the Company. The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. When there is a portion of equity in an acquired subsidiary not attributable, directly or indirectly, to the respective parent entity, the Company records the fair value of the non-controlling interest at the acquisition date and classifies the amounts attributable to non-controlling interest separately in equity in the Company's Consolidated Financial Statements. Any subsequent changes in a parent's ownership interest while the parent retains its controlling financial interest in its subsidiary are accounted for as equity transactions. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company has replaced the caption “Revenue” with “Net sales,” and the caption “Sales, marketing and administrative” with “Selling, general and administrative,” within the Consolidated Statements of Operations and corresponding changes have been made throughout this Annual Report to conform to this presentation. These updated captions have no impact on previously reported results of operations or financial position.

Use of Estimates

To prepare financial statements in conformity with generally accepted accounting principles (“GAAP”) accepted in the United States, management must make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Recent Accounting Pronouncements Not Yet Adopted

In January 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of the accounting for equity securities, investments accounted for under the equity method, and certain forward contracts and purchased options. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-01 on January 1, 2021, and does not expect a material impact to its Consolidated Financial Statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-06 on January 1, 2021, and will elect the modified transition method that allows for a cumulative-effect adjustment in the period of adoption and will not restate prior periods. As a result of the adoption, the Company will increase its convertible debt liabilities and retained earnings on January 1, 2021 by $115.4 million and $64.5 million, respectively, and decrease its deferred tax liabilities and additional paid-in capital by approximately $28.0 million and $151.9 million, respectively.

Recently Adopted Accounting Standards 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (“ASU 2016-13”), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The amendments in this update were adopted using a modified retrospective transition method as of January 1, 2020, which had no cumulative impact to retained earnings. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles – Goodwill and Other, which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted the amendments in this update on January 1, 2020, which will be applied using a prospective transition method. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.

 

94

Table of Contents

In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public companies will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. The Company adopted ASU 2018-13 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements. See Note 4 to the Consolidated Financial Statements for further discussion on fair value measurements.

In September 2018, the FASB issued Accounting Standards Update No. 2018-15, Intangible – Goodwill and Other – Internal-Use Software (“ASU 2018-15”), which requires a customer in a cloud computing arrangement to determine whether implementation costs should be capitalized as assets or expensed as incurred. Under the new guidance, capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. The amendments in this update will be applied using a prospective transition method to each period presented. The Company adopted ASU 2018-15 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which modifies Accounting Standard Codification 740 – Income Taxes (“ASC 740”). ASU 2019-12 enhances and simplifies various aspects of the income tax accounting guidance in ASC 740. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company elected to early adopt ASU 2019-12 in the quarter ended June 30, 2020. The Company applied the updated guidance for year-to-date losses in the Company’s interim period tax accounting on a prospective basis. The early adoption had no impact on the expected full year tax expense for 2020, but rather accelerated certain tax benefits to earlier quarters in 2020 that would otherwise have been limited under ASC 740.

In March 2020, the FASB issued Accounting Standards Update No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates. This update is effective upon issuance. The relief is temporary and generally cannot be applied to contract modifications that occur after December 31, 2022 or hedging relationships entered into or evaluated after that date. The adoption of ASU 2020-04 did not have a material impact on the Company’s Consolidated Financial Statements.

Revenue Recognition

In accordance with Accounting Standards Codification 606 Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue upon the transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. The principles in ASC 606 are applied using the following five steps: (i) identify the contract with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies its performance obligation(s). Specifically, revenue from the sale of implants, fixation products and disposables is generally recognized at an amount that reflects the expected consideration upon notice that the Company’s products have been used in a surgical procedure or upon shipment to a third-party customer assuming control of the products. Revenue from IONM services is recognized in the period the service is performed for the amount of consideration expected to be received. Revenue from the sale of surgical instrument sets is generally recognized upon receipt of a purchase order and the subsequent shipment to a customer who assumes control. In certain cases, the Company does offer the ability for customers to lease surgical instrumentation primarily on a non-sales type basis. Revenue from the sale or lease of capital equipment is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Selling and leasing of surgical instrument sets and capital equipment represents an immaterial amount of the Company’s total net sales in all periods presented. Revenue associated with products holding rights of return or trade-in are recognized when the Company concludes there is not a risk of significant revenue reversal in future periods for the expected consideration in the transaction. Costs incurred by the Company associated with sales contracts with customers are deferred over the performance obligation period and recognized in the same period as the related revenue, with the exception of contracts that complete within one year or less, in which case the associated costs are expensed as incurred.

 

95

Table of Contents

Accounts Receivable and Related Valuation Accounts

Accounts receivable in the accompanying Consolidated Balance Sheets are presented net of allowances for credit losses. The Company maintains an allowance for credit losses resulting from the inability of its customers, including hospitals, ambulatory surgery centers, and distributors, to make required payments. The allowance for credit losses is calculated quarterly, and is estimated on a region-by-region basis considering a number of factors including age of account balances, collection history, historical account write-offs, third party credit reports, identified trends, current economic conditions, and supportable forecasted economic expectations. The allowance is adjusted on a specific identification basis for certain accounts as well as pooling of accounts with similar characteristics. An increase in the provision for credit losses may be required when the financial condition of the Company’s customers or its collection experience deteriorates. An increase to the allowance for credit losses results in a corresponding charge to selling, general and administrative expenses. The Company has a diverse customer base and no single customer represented greater than ten percent of net sales or accounts receivable. Historically, the Company’s reserves have been adequate to cover credit losses.

The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. It is possible that there could be a material adverse impact from potential adjustments of the carrying amount of trade receivables as customers’ cash flows are impacted by their response to the COVID-19 pandemic and the deferral of elective surgical procedures.

The following table summarizes the changes in the allowance for credit losses:

 

(in thousands)

 

December 31, 2020

 

Allowance for credit losses at January 1, 2020

 

$

9,423

 

Current-period provision for expected losses

 

 

1,079

 

Write-offs charged against the allowance

 

 

(1,305

)

Recoveries of amounts previously written off

 

 

220

 

Changes resulting from foreign currency fluctuations

 

 

229

 

Allowance for credit losses at end of period

 

$

9,646

 

In addition, the Company establishes a liability for estimated sales returns and a reserve for price adjustments that are recorded as a reduction to net sales. The liability and reserve are maintained to account for the future product returns and price adjustments of products sold in the current period.

Concentration of Credit Risk and Significant Customers

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, marketable securities and accounts receivable. The Company limits its exposure to credit loss by placing its cash and investments with high credit quality financial institutions. Additionally, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has a diverse customer base and no single customer represented greater than ten percent of sales or accounts receivable for any of the periods presented.

Fair Value of Financial Instruments

The Company’s financial instruments consist principally of cash and cash equivalents, marketable securities, restricted investments, derivatives, contingent consideration liabilities, accounts receivable, accounts payable, accrued expenses, and Senior Convertible Notes.

The Company measures certain assets and liabilities in accordance with authoritative guidance which requires fair value measurements to be classified and disclosed in one of the following three categories:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available.

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.

 

96

Table of Contents

Cash and Cash Equivalents

The Company considers all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents.

Inventory, net

Net inventory as of December 31, 2020 consisted of $285.4 million of finished goods, $7.3 million of work in progress and $7.9 million of raw materials. Net inventory as of December 31, 2019 consisted of $298.7 million of finished goods, $6.4 million of work in progress and $7.3 million of raw materials.

Finished goods primarily consists of specialized implants, fixation products and disposables and are stated at the lower of cost or net realizable value determined by utilizing a standard cost method, which includes capitalized variances, which approximates the weighted average cost. Work in progress and raw materials represent the underlying material, and labor for work in progress, that ultimately yield finished goods upon completion and are subject to lower of cost or net realizable value. The Company reviews the components of its inventory on a periodic basis for excess and obsolescence and adjusts inventory to its net realizable value as necessary.

The Company records an inventory reserve for estimated excess and obsolete inventory based upon historical turnover and assumptions about future demand for its products and market conditions, such as product life cycles and timing of the introduction and development of new or enhanced products. The Company’s allograft products have shelf lives ranging from two to five years and are subject to demand fluctuations based on the availability and demand for alternative products. The Company’s inventory, which consists primarily of disposables, specialized implants and fixation products, is at risk of obsolescence following the introduction and development of new or enhanced products. One of the Company’s strategic objectives is to continue to rapidly develop and commercialize new products and product enhancements which increases the risk that products will become obsolete prior to the end of their anticipated useful life. The Company’s estimates and assumptions for excess and obsolete inventory are reviewed and updated on a quarterly basis. The estimates the Company uses for demand are also used for near-term capacity planning and inventory purchasing and are consistent with its revenue forecasts. Increases in the reserve for excess and obsolete inventory result in a corresponding charge to cost of sales.

For the year ended December 31, 2020 and 2019, the Company recorded a reserve for excess and obsolete inventory of $48.9 million and $14.0 million, respectively. The increase is primarily attributable to updates to the Company’s estimates and assumptions about future product demand and product life cycles which have been affected by multiple factors, including the COVID-19 pandemic and general market conditions.

Goodwill and Intangible Assets

The Company’s goodwill represents the excess of the cost over the fair value of net assets acquired from its business combinations. The determination of the value of goodwill and intangible assets arising from business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of the net tangible and intangible assets acquired, including capitalized in-process research and development (IPR&D). Intangible assets acquired in a business combination that are used for in-process research and development activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project, the Company will amortize the acquired IPR&D over its estimated useful life or expense the acquired in-process research and development should the research and development project be unsuccessful with no future alternative use.

Goodwill and IPR&D are not amortized; however, they are assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstance warrant such a review. The goodwill or IPR&D are considered to be impaired if the Company determines that the carrying value of the reporting unit or IPR&D exceeds its respective fair value.

 

97

Table of Contents

The Company performs its goodwill impairment analysis at the reporting unit level, which aligns with the Company’s reporting structure and availability of discrete financial information. The Company performs its annual impairment analysis by either comparing a reporting unit’s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit’s fair value from the last quantitative assessment to determine if there is potential impairment. The Company may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit’s estimated fair value was significantly in excess of the carrying value of its net assets and it does not believe there have been significant changes in the reporting unit’s operations that would significantly decrease its estimated fair value or significantly increase its net assets. If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections and/or use of a market approach by looking at market values of comparable companies. Key assumptions for these projections include net sales growth, future gross and operating margin growth, and its weighted cost of capital and terminal growth rates. The net sales and margin growth is based on increased sales of new and existing products as the Company maintains investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including timing and probability of regulatory approvals for Company products to be commercialized. The Company’s market capitalization is also considered as a part of its analysis.

The Company’s annual evaluation for impairment of goodwill consists of one reporting unit. In accordance with the Company’s policy, the Company completed its most recent annual evaluation for impairment as of October 1, 2020 using the qualitative assessment and determined that no impairment existed. In addition, no indicators of impairments were noted through December 31, 2020 and consequently, no impairment charge has been recorded during the year.

Intangible assets with a finite life, such as acquired technology, customer relationships, manufacturing know-how, licensed technology, supply agreements and certain trade names and trademarks, are amortized on a straight-line basis over their estimated useful life, ranging from 2 to 17 years. In determining the useful lives of intangible assets, the Company considers the expected use of the assets and the effects of obsolescence, demand, competition, anticipated technological advances, changes in surgical techniques, market influences and other economic factors. For technology based intangible assets, the Company considers the expected life cycles of products which incorporate the corresponding technology. Trademarks and trade names that are related to products are assigned lives consistent with the period in which the products bearing each brand are expected to be sold.

The Company evaluates its intangible assets with finite lives for indications of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include significant under-performance relative to expected historical or projected future operating results, significant changes in the manner of the Company’s use of the acquired assets or the strategy for the Company’s overall business or significant negative industry or economic trends. If this evaluation indicates that the value of the intangible asset may be impaired, the Company makes an assessment of the recoverability of the net carrying value of the asset over its remaining useful life. If this assessment indicates that the intangible asset is not recoverable, based on the estimated undiscounted future cash flows of the technology over the remaining amortization period, the Company reduces the net carrying value of the related intangible asset to fair value and may adjust the remaining amortization period.

See Note 2 to the Consolidated Financial Statements included in this Annual Report for further disclosure on goodwill and intangible assets.

Property and Equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from 2 to 20 years. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter. Leased property meeting certain financing lease criteria is capitalized under property and equipment, and the net present value of the related lease payments is recorded as a liability. Amortization of assets under financing leases is recorded using the straight-line method over the shorter of the estimated useful lives or the lease terms. Maintenance and repairs are expensed as incurred.

The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value.

Income Taxes

The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Tax law and rate changes are reflected in income in the period such changes are enacted. The Company includes interest and penalties related to income taxes, including unrecognized tax benefits, within income tax expense.

 

98

Table of Contents

The Company’s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known.

Significant judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.

Based on the Company’s review, it concluded that it was more likely than not that it would be able to realize the future benefits of its domestic and foreign deferred tax assets, with the exceptions of California, Malta, Mexico, Brazil and Colombia. This conclusion was based on historical and projected operating performance, as well as the Company’s expectation that its operations will generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets well within the statutory carryover periods. Due to low state apportionment, large net operating losses and the generation of sizeable research credits in California, the Company concluded that it is not more likely than not that it will be able to utilize its California deferred tax assets. Therefore, the Company has maintained a full valuation allowance on its California deferred tax assets as of December 31, 2020. Due to a history of losses in Malta, Brazil, Mexico and Colombia, and the lack of alternative sources of future taxable income, the Company has established a full valuation allowance against these entities’ deferred tax assets as of December 31, 2020.

The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.

See Note 10 to the Consolidated Financial Statements included in this Annual Report for further discussion on income taxes.

Loss Contingencies

An estimated loss contingency is accrued and disclosed in the Company’s financial statements if it is probable or disclosed if it is reasonably possible that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable and only discloses those matters it considers material to its overall financial position. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded.

The Company is involved in a number of legal actions arising in the normal course of business. The outcomes of these legal actions are not within the Company’s complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost net sales. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.

See Note 12 to the Consolidated Financial Statements included in this Annual Report for further discussion on legal proceedings and investigations.

Comprehensive Income

Comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income includes net of tax, unrealized gains or losses on the Company’s marketable debt securities and foreign currency translation adjustments. The cumulative translation adjustments included in accumulated other comprehensive loss were $7.6 million, $9.4 million, and $8.6 million at December 31, 2020, 2019, and 2018, respectively.

Research and Development

Research and development costs are expensed as incurred. To the extent the Company purchases research and development assets with a future alternative use the Company will capitalize and amortize the assets over its useful life.

 

99

Table of Contents

Product Shipment Costs

Product shipment costs, included in selling, general and administrative expense in the accompanying Consolidated Statements of Operations, were $27.4 million, $27.7 million, and $25.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The majority of the Company’s shipping costs are associated with providing instrument sets to hospitals for use in individual surgical procedures. Amounts billed to customers for shipping and handling of products are reflected in net sales and are not material for any period presented.

Business Transition Costs

The Company incurs certain costs related to acquisition, integration and business transition activities, which include severance, relocation, consulting, leasehold exit costs, third-party merger and acquisition costs, contingent consideration fair value adjustments and other costs directly associated with such activities. Contingent consideration is accrued based on the fair value of the expected payment, and such accruals are subject to increase or decrease based on the assessment of the likelihood that the contingent milestones will be achieved resulting in payment. If an accrual for contingent consideration decreases during a particular period, it results in a reduction of costs during such period.

During the year ended December 31, 2020, the Company recorded $10.9 million of costs related to acquisition, integration and business transition activities, which included $2.3 million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2019, the Company recorded a reduction of costs of $(2.0) million related to acquisition, integration and business transition activities, which included $(6.3) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2018, the Company recorded $11.5 million of costs related to acquisition, integration and business transition activities, which included $(1.5) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

Stock-based Compensation

Stock-based compensation expense for equity-classified awards, principally related to restricted stock units (“RSUs”) and performance restricted stock units (“PRSUs”), is measured at the grant date based on the estimated fair value of the award. The fair value of equity instruments that are expected to vest is recognized and amortized over the requisite service period. The Company has granted awards with up to five year graded or cliff vesting terms (in each case, with service through the date of vesting being required). No exercise price or other monetary payment is required for receipt of the shares issued in settlement of the respective award; instead, consideration is furnished in the form of the participant’s service to the Company.

The fair value of RSUs including PRSUs with pre-defined performance criteria is based on the stock price on the date of grant whereas the expense for PRSUs with pre-defined performance criteria is adjusted with the probability of achievement of such performance criteria at each period end. The fair value of the PRSUs that are earned based on the achievement of pre-defined market conditions for total shareholder return is estimated on the date of grant using a Monte Carlo valuation model. The key assumptions in applying this model are an expected volatility and a risk-free interest rate.

Stock-based compensation expense is adjusted from the grant date to exclude expense for awards that are expected to be forfeited. The forfeiture estimate is adjusted as necessary through the vesting date so that full compensation cost is recognized only for awards that vest. The Company assesses the reasonableness of the estimated forfeiture rate at least annually, with any change to be made on a cumulative basis in the period the estimated forfeiture rates change. The Company considered its historical experience of pre-vesting forfeitures on awards by each homogenous group of employees as the basis to arrive at its estimated annual pre-vesting forfeiture rates.

The Company estimates the fair value of stock options issued under its equity incentive plans and shares issued to employees under its employee stock purchase plan (“ESPP”) using a Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various assumptions including expected volatility, expected term and risk-free interest rates. The expected volatility is based on the historical volatility of the Company’s common stock over the most recent period commensurate with the estimated expected term of the Company’s stock options and ESPP offering period which is derived from historical experience. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future.

See Note 9 to the Consolidated Financial Statements included in this Annual Report for further discussion on stock-based compensation.

 

100

Table of Contents

Net (Loss) Income Per Share

The Company computes basic net income per share using the weighted-average number of common shares outstanding during the period. Diluted net income per share assumes the conversion, exercise or issuance of all potential common stock equivalents, unless the effect of inclusion would be anti-dilutive. For purposes of this calculation, common stock equivalents include the Company’s stock options, unvested RSUs, PRSUs (including those with performance and market conditions), warrants, and the shares to be issued upon the conversion of the Senior Convertible Notes. The contingently issuable shares are included in basic net income per share as of the date that all necessary conditions have been satisfied and are included in the denominator for dilutive calculation for the entire period if such shares would be issuable as of the end of the reporting period assuming the end of the reporting period was the end of the contingency period.

The following table sets forth the computation of basic and diluted consolidated net (loss) income per share:  

 

 

 

Year Ended December 31,

 

(in thousands, except per share data)

 

2020

 

 

2019

 

 

2018

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(37,153

)

 

$

65,234

 

 

$

12,479

 

Denominator for basic and diluted net (loss) income per

   share:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding for

   basic

 

 

51,416

 

 

 

51,956

 

 

 

51,382

 

Dilutive potential common stock outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and ESPP

 

 

—

 

 

 

15

 

 

 

36

 

RSUs and PRSUs

 

 

—

 

 

 

658

 

 

 

760

 

Senior Convertible Notes

 

 

—

 

 

 

531

 

 

 

177

 

Weighted average common shares outstanding for

   diluted

 

 

51,416

 

 

 

53,160

 

 

 

52,355

 

Basic net (loss) income per share

 

$

(0.72

)

 

$

1.26

 

 

$

0.24

 

Diluted net (loss) income per share

 

$

(0.72

)

 

$

1.23

 

 

$

0.24

 

The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Stock options, ESPP, RSUs and PRSUs

 

 

1,095

 

 

 

115

 

 

 

162

 

Warrants

 

 

21,034

 

 

 

10,865

 

 

 

10,865

 

Senior Convertible Notes

 

 

21,034

 

 

 

5,433

 

 

 

5,433

 

Total

 

 

43,163

 

 

 

16,413

 

 

 

16,460

 

 

 

 

 

 

101

Table of Contents

 

2.    Balance Sheet Details

Property and Equipment, net

Property and equipment, net, consisted of the following:

 

 

 

 

December 31,

 

(in thousands, except years)

Useful Life

 

2020

 

 

2019

 

Instrument sets

4

 

$

424,696

 

 

$

381,310

 

Machinery and equipment

5 to 7

 

 

71,616

 

 

 

66,482

 

Computer equipment and software

3 to 7

 

 

173,364

 

 

 

149,134

 

Leasehold improvements

2 to 15

 

 

35,372

 

 

 

29,542

 

Furniture and fixtures

3 to 7

 

 

9,916

 

 

 

8,931

 

Building and improvements

10 to 20

 

 

23,207

 

 

 

22,921

 

Land

—

 

 

1,277

 

 

 

1,277

 

 

 

 

 

739,448

 

 

 

659,597

 

Less: accumulated depreciation and amortization

 

 

 

(453,079

)

 

 

(393,279

)

 

 

 

$

286,369

 

 

$

266,318

 

 

Property and equipment mainly consisted of instrument sets, which are made available to surgeons and hospitals that purchase implants, biologics and disposables for use in individual surgical procedures.

Depreciation expense was $85.9 million, $80.8 million, and $75.4 million for the years ended December 31, 2020, 2019 and 2018, respectively. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter.

Capitalized software costs include only those direct costs associated with the actual development or acquisition of computer software. At December 31, 2020 and 2019, the Company had $57.6 million and $51.7 million in unamortized capitalized software costs, respectively. Amortization expense related to capitalized software costs was $10.4 million, $10.4 million and $10.6 million for the years ended December 31, 2020, 2019 and 2018, respectively.

Goodwill and Intangible Assets

Goodwill and intangible assets as of December 31, 2020 consisted of the following:

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Gross

 

 

Accumulated

 

 

Intangible

 

(in thousands, except years)

 

(in years)

 

Amount

 

 

Amortization

 

 

Assets, net

 

Intangible assets subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

8

 

$

271,748

 

 

$

(195,283

)

 

$

76,465

 

Manufacturing know-how and trade secrets

 

13

 

 

30,882

 

 

 

(22,720

)

 

 

8,162

 

Trade name and trademarks

 

9

 

 

25,500

 

 

 

(19,945

)

 

 

5,555

 

Customer relationships

 

9

 

 

156,436

 

 

 

(94,354

)

 

 

62,082

 

Total intangible assets subject to amortization

 

8

 

$

484,566

 

 

$

(332,302

)

 

$

152,264

 

Intangible assets not subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

 

 

 

 

 

 

 

 

 

 

559,553

 

Total goodwill and intangible assets, net

 

 

 

 

 

 

 

 

 

 

 

$

711,817

 

 

102

Table of Contents

 

Goodwill and intangible assets as of December 31, 2019 consisted of the following:

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Gross

 

 

Accumulated

 

 

Intangible

 

(in thousands, except years)

 

(in years)

 

Amount

 

 

Amortization

 

 

Assets, net

 

Intangible assets subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

8

 

$

271,748

 

 

$

(163,459

)

 

$

108,289

 

Manufacturing know-how and trade secrets

 

13

 

 

30,798

 

 

 

(20,333

)

 

 

10,465

 

Trade name and trademarks

 

9

 

 

25,500

 

 

 

(16,947

)

 

 

8,553

 

Customer relationships

 

9

 

 

150,744

 

 

 

(76,959

)

 

 

73,785

 

Total intangible assets subject to amortization

 

9

 

$

478,790

 

 

$

(277,698

)

 

$

201,092

 

Intangible assets not subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

 

 

 

 

 

 

 

 

 

 

561,064

 

Total goodwill and intangible assets, net

 

 

 

 

 

 

 

 

 

 

 

$

762,156

 

 

Total expense related to the amortization of intangible assets which is recorded in either cost of sales or operating expenses in the Consolidated Statements of Operations depending on the functional nature of the intangible, was $55.0 million, $54.8 million and $54.4 million for the years ended December 31, 2020, 2019 and 2018, respectively.

The changes to goodwill are comprised of the following:

(in thousands)

 

 

 

Gross goodwill

$

569,364

 

Accumulated impairment loss

 

(8,300

)

December 31, 2019

 

561,064

 

 

 

 

 

Changes to gross goodwill:

 

 

 

Changes resulting from foreign currency fluctuations

 

(1,511

)

 

 

(1,511

)

 

 

 

 

Gross goodwill

 

567,853

 

Accumulated impairment loss

 

(8,300

)

December 31, 2020

$

559,553

 

Total future amortization expense related to intangible assets subject to amortization at December 31, 2020 is set forth in the table below:

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

 

2021

 

 

 

$

51,876

 

2022

 

 

 

 

43,843

 

2023

 

 

 

 

18,697

 

2024

 

 

 

 

12,506

 

2025

 

 

 

 

11,705

 

Thereafter through 2031

 

 

 

 

13,637

 

Total future amortization expense

 

 

 

$

152,264

 

 

 

103

Table of Contents

 

Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

 

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

Accrued expenses

 

$

59,249

 

 

$

58,897

 

Accounts payable

 

 

17,386

 

 

 

11,827

 

Distributor commissions payable

 

 

9,891

 

 

 

7,983

 

Other taxes payable

 

 

6,425

 

 

 

6,501

 

Litigation liability

 

 

5,346

 

 

 

1,370

 

Debt interest payable

 

 

5,203

 

 

 

4,266

 

Royalties payable

 

 

4,495

 

 

 

4,994

 

Other

 

 

2,406

 

 

 

1,322

 

Accounts payable and accrued liabilities

 

$

110,401

 

 

$

97,160

 

 

3.    Marketable Securities

Short-Term Marketable Securities

The Company invests in available-for-sale marketable debt securities consisting of corporate notes and commercial paper. The Company has the ability, if necessary, to liquidate without penalty any of its marketable debt securities to meet its liquidity needs in the next 12 months. As such, those investments with contractual maturities greater than one year from the date of purchase are classified as short-term on the accompanying Consolidated Balance Sheets.

As of December 31, 2020, the Company’s outstanding marketable debt securities all have contractual maturities due within one year. The carrying value and amortized cost of the Company’s marketable debt securities, summarized by major security type, consisted of the following:

 

(in thousands)

 

Amortized Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities, available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate notes

 

$

54,197

 

 

$

6

 

 

$

(15

)

 

$

54,188

 

Commercial paper

 

 

118,932

 

 

 

25

 

 

 

—

 

 

 

118,957

 

Total debt securities, available for sale

 

$

173,129

 

 

$

31

 

 

$

(15

)

 

$

173,145

 

At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company’s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer’s industry, and any significant deterioration in economic conditions.

The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in interest income in the Consolidated Statement of Operations through an allowance for credit losses. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive loss. Unrealized losses on available-for-sale debt securities as of December 31, 2020 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, the Company has not recorded an allowance for credit losses with these investments.

 

 

104

Table of Contents

4.    Financial Instruments and Fair Value Measurements

Foreign Currency and Derivative Financial Instruments

The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities, and average exchange rates during each reporting period for results of operations.

Some of the Company’s reporting entities conduct a portion of their business in currencies other than the entity’s functional currency. These transactions give rise to receivables and payables that are denominated in currencies other than the entity’s functional currency. The value of these receivables and payables is subject to changes in currency exchange rates from the point at which the transactions are originated until the settlement in cash. Both realized and unrealized gains and losses in the value of these receivables and payables are included in the determination of net income. Net currency exchange losses, which include gains and losses from derivative instruments, were $4.2 million, $0.8 million and $3.7 million for the years ended December 31, 2020, 2019 and 2018, respectively, and are included in other (expense) income, net in the Consolidated Statements of Operations.

To manage foreign currency exposure risks, the Company uses derivatives for activities in entities that have short-term intercompany receivables and payables denominated in a currency other than the entity’s functional currency. The fair value is based on a quoted market price (Level 1). As of December 31, 2020, 2019, and 2018 a notional principal amount of $14.0 million, $26.9 million, and $26.8 million, respectively, was outstanding to hedge currency risk relative to foreign receivables and payables. Derivative instrument net (losses) gains on the Company’s forward exchange contracts were $(1.0) million, $0.4 million, and $0.5 million for the years ended December 31, 2020, 2019 and 2018, respectively, and are included in other (expense) income, net in the Consolidated Statements of Operations. The fair value of the forward contract exchange derivative instrument liability was de minimis as of December 31, 2020 and $0.1 million as of December 31, 2019. The derivative instruments are recorded in other current assets or other current liabilities in the Consolidated Balance Sheets commensurate with the nature of the instrument at period end.

Fair Value Measurements

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the periods presented.

The fair values of the Company’s assets and liabilities, including cash equivalents, marketable debt securities, derivatives, and contingent consideration are measured at fair value on a recurring basis. As of December 31, 2020 and December 31, 2019, the Company held investments in securities classified as cash equivalents. During the periods presented, the Company did not hold any such investments that were in a significant unrealized loss position and no impairment charges were recorded on such investments. Realized gains and losses and interest income related to marketable securities were immaterial during all periods presented. Cash equivalents and marketable debt securities are determined under the fair value categories as follows:

 

 

 

 

 

 

 

Quoted Price in

 

 

Significant Other

 

 

Significant

 

 

 

 

 

 

 

Active Market

 

 

Observable Inputs

 

 

Unobservable

 

(in thousands)

 

Total

 

 

(Level 1)

 

 

(Level 2)

 

 

Inputs (Level 3)

 

December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

725,108

 

 

$

725,108

 

 

$

—

 

 

$

—

 

Commercial paper

 

 

35,996

 

 

 

—

 

 

 

35,996

 

 

 

—

 

Total cash equivalents

 

 

761,104

 

 

 

725,108

 

 

 

35,996

 

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities, available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate notes

 

 

54,188

 

 

 

—

 

 

 

54,188

 

 

 

—

 

Commercial paper

 

 

118,957

 

 

 

—

 

 

 

118,957

 

 

 

—

 

Total debt securities, available for sale

 

 

173,145

 

 

 

—

 

 

 

173,145

 

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets measured at fair value

 

$

934,249

 

 

$

725,108

 

 

$

209,141

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

151,750

 

 

$

151,750

 

 

$

—

 

 

$

—

 

Total cash equivalents

 

$

151,750

 

 

$

151,750

 

 

$

—

 

 

$

—

 

 

 

105

Table of Contents

 

The carrying amounts of certain financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses, other current assets, accounts payable, accrued expenses, and other current liabilities as of December 31, 2020 and December 31, 2019 approximate their related fair values due to the short-term maturities of these instruments.

The fair value of certain financial instruments was measured and classified within Level 1 of the fair value hierarchy based on quoted prices. Certain financial instruments classified within Level 2 of the fair value hierarchy include the types of instruments that trade in markets that are not considered to be active, but are valued based on quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

Fair Value of Senior Convertible Notes

The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $650.0 million principal amount of Senior Convertible Notes due 2021 at December 31, 2020 and December 31, 2019 was approximately $651.6 million and $869.3 million, respectively. The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $450.0 million principal amount of Senior Convertible Notes due 2023 at December 31, 2020 was approximately $461.9 million. The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $450.0 million principal amount of Senior Convertible Notes due 2025 at December 31, 2020 was approximately $436.7 million. See Note 6 to the Consolidated Financial Statements included in this Annual Report for further discussion on the carrying value of the notes.

Fair Value of Convertible Note Hedge and Embedded Conversion Derivatives

On June 1, 2020, the Company issued $450.0 million principal amount of 1.00% Senior Convertible Notes due 2023 (the “2023 Notes”). The 2023 Notes were initially required to be settled in cash as the Company did not have enough available shares and was unable to reserve the maximum number of shares issuable under the 2023 Notes (“sufficient reserved shares”). On September 10, 2020, the Company held a Special Meeting of Stockholders and received stockholder approval to amend the Company’s Restated Certificate of Incorporation to increase the number of shares of its common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares. As a result of the increase in the number of shares of the Company’s common stock authorized for issuance, as of September 10, 2020 and as of December 31, 2020, the Company had sufficient reserved shares and therefore may settle conversions of the 2023 Notes in cash, stock, or a combination thereof, solely at the Company’s discretion. In accordance with authoritative guidance, the cash conversion feature of the 2023 Notes requires bifurcation from the 2023 Notes and was initially accounted for as a derivative liability (“Embedded Conversion Derivative”), which was included in long-term liabilities in the Company’s Consolidated Balance Sheet. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle conversions of the 2023 Notes in cash, stock, or a combination thereof, and in accordance with authoritative literature, the Embedded Conversion Derivative was marked to fair value and reclassified to stockholders’ equity.

In connection with the issuance of the 2023 Notes, the Company entered into convertible note hedge transactions (the “2023 Hedge”) entitling the Company to purchase up to 5,345,010 shares of the Company’s common stock at an initial stock price of $84.19 per share, each of which is subject to adjustment. The 2023 Hedge was initially required to be settled in cash as the Company did not have sufficient reserved shares with respect to the 2023 Notes. As a result, the 2023 Hedge was accounted for as a derivative asset (“Convertible Note Hedge Derivative”), which was included in long-term assets in the Company’s Consolidated Balance Sheet. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle the 2023 Notes, which therefore allows for the 2023 Hedge to be settled in cash, stock, or a combination thereof. In accordance with authoritative literature, the Convertible Note Hedge Derivative was marked to fair value and reclassified to stockholders’ equity.

Prior to their reclassification to stockholders’ equity on September 10, 2020, the Embedded Conversion Derivative and Convertible Note Hedge Derivative were classified as Level 3 of the fair value hierarchy as these derivative instruments were not actively traded and were valued using significant unobservable inputs.

The following tables set forth the changes in the estimated fair value for the Company’s derivative assets and liabilities measured using significant unobservable inputs (Level 3):

(in thousands)

 

2020

 

Assets:

 

 

 

 

Fair value measurement at January 1

 

$

—

 

Derivative assets recorded in connection with the 2023 Hedge

 

 

69,525

 

Change in fair value measurement

 

 

(32,233

)

Derivative asset reclassified to stockholders’ equity

 

 

(37,292

)

Fair value measurement at December 31

 

$

—

 

 

 

106

Table of Contents

 

(in thousands)

 

2020

 

Liabilities:

 

 

 

 

Fair value measurement at January 1

 

$

—

 

Derivative liability recorded in connection with the 2023 Notes

 

 

57,224

 

Change in fair value measurement

 

 

(19,932

)

Derivative liability reclassified to stockholders’ equity

 

 

(37,292

)

Fair value measurement at December 31

 

$

—

 

 

During 2020, the fair value measurement was determined utilizing a Black-Scholes valuation model. Key assumptions used in the valuation included risk-free interest rates, volatility, and expected term. The Company recorded the change in fair value measurement associated with its derivative assets and liabilities in other (expense) income, net in the Consolidated Statement of Operations.

Contingent Consideration Liabilities

The fair value of contingent consideration liabilities assumed in business combinations is recorded as part of the purchase price consideration of the acquisition, and is determined using a discounted cash flow model or probability simulation model. The significant inputs of such models are not observable in the market, such as certain financial metric growth rates, volatility rates, projections associated with the applicable milestone, the interest rate, and the related probabilities and payment structure in the contingent consideration arrangement. Fair value adjustments to contingent consideration liabilities are recorded through operating expenses in the Consolidated Statement of Operations. Contingent consideration arrangements assumed by an asset purchase will be measured and accrued when such contingency is resolved.

The recurring Level 3 fair value measurements of contingent consideration liabilities associated with commercial sales milestones include the following significant unobservable inputs as of December 31, 2020:

 

 

 

2020

 

Valuation Techniques

 

Discounted cash flow, Monte Carlo

 

Discount Rate Range

 

2.8% - 4.0%

 

Weighted Average Discount Rate

 

3.6%

 

Expected Years

 

2021 - 2024

 

Contingent consideration liabilities were $37.0 million and $42.6 million as of December 31, 2020 and December 31, 2019, respectively, and were recorded in the Consolidated Balance Sheet commensurate with the respective payment terms. The following table sets forth the changes in the estimated fair value of the Company’s liabilities measured on a recurring basis using significant unobservable inputs (Level 3):

 

 

 

 

 

(in thousands)

 

2020

 

 

2019

 

Fair value measurement at January 1

 

$

42,559

 

 

$

50,410

 

Change in fair value measurement

 

 

2,420

 

 

 

(6,297

)

Contingent consideration paid or settled

 

 

(7,938

)

 

 

(1,435

)

Changes resulting from foreign currency fluctuations

 

 

—

 

 

 

(119

)

Fair value measurement at December 31

 

$

37,041

 

 

$

42,559

 

 

Non-financial assets and liabilities measured on a nonrecurring basis

Certain non-financial assets and liabilities are measured at fair value, usually with Level 3 inputs including the discounted cash flow method or cost method, on a nonrecurring basis in accordance with authoritative guidance. These include items such as nonfinancial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets and property and equipment, are measured at fair value when there is an indication of impairment and are recorded at fair value only when any impairment is recognized. The carrying values of the Company’s financing lease obligations approximated their estimated fair value as of December 31, 2020 and 2019.

During the year ended December 31, 2019, the Company recorded a loss of $4.8 million on a strategic investment. The loss was recorded in other (expense) income, net in the Consolidated Statement of Operations included in this Annual Report.

 

107

Table of Contents

During the year ended December 31, 2018, the Company expensed $8.9 million for a purchased in-process research and development asset which had no future alternative use. The Company also recorded a net loss of $3.8 million on strategic investments during the year ended December 31, 2018. The net loss was recorded in other (expense) income, net in the Consolidated Statement of Operations included in this Annual Report.

5.    Business Combinations

The Company recognizes the assets acquired, liabilities assumed, and any non-controlling interest at fair value at the date of acquisition. Certain acquisitions contained contingent consideration arrangements that required the Company to assess the acquisition date fair value of the contingent consideration liabilities, which was recorded as part of the purchase price allocation of the acquisition, with subsequent fair value adjustments to the contingent consideration recorded in the Consolidated Statements of Operations. See Note 4 to the Consolidated Financial Statements included in this Annual Report for further discussion on contingent consideration liabilities.

Acquisitions

The Company has completed acquisitions that were not considered material, individually or collectively, to the overall Consolidated Financial Statements during the periods presented. These acquisitions have been included in the Consolidated Financial Statements from the respective dates of acquisition. The Company does not believe that collectively the acquisitions made during the periods presented are material to the overall financial statements.

The Company finalizes the purchase price allocation of the assets and liabilities subject to valuation obtained in business combinations within one year from the acquisition date. While the Company does not expect material changes from the initial outcome of the valuation, certain assumptions and findings made at the date of acquisition could result in changes in the purchase price allocation.

Variable Interest Entities

The Company provides IONM services through various subsidiaries, which conduct business as NuVasive Clinical Services. In providing IONM services to surgeons and healthcare facilities across the United States, the Company maintains contractual relationships with several physician practices (“PCs”). In accordance with authoritative guidance, the Company has determined that the PCs are variable interest entities and therefore, the accompanying Consolidated Financial Statements include the accounts of the PCs from the date of acquisition. During the periods presented, the results of the PCs were immaterial to the Company’s financial statements. The creditors of the PCs have claims only to the assets of the PCs, which are not material, and the assets of the PCs are not available to the Company.

 

6.     Indebtedness

The carrying values of the Company’s Senior Convertible Notes are as follows:

 

(in thousands)

 

December 31, 2020

 

 

December 31, 2019

 

2.25% Senior Convertible Notes due 2021:

 

 

 

 

 

 

 

 

Principal amount

 

$

650,000

 

 

$

650,000

 

Unamortized debt discount

 

 

(3,945

)

 

 

(22,501

)

Unamortized debt issuance costs

 

 

(752

)

 

 

(4,201

)

 

 

 

645,303

 

 

 

623,298

 

1.00% Senior Convertible Notes due 2023:

 

 

 

 

 

 

 

 

Principal amount

 

 

450,000

 

 

 

—

 

Unamortized debt discount

 

 

(46,837

)

 

 

—

 

Unamortized debt issuance costs

 

 

(11,049

)

 

 

—

 

 

 

 

392,114

 

 

 

—

 

0.375% Senior Convertible Notes due 2025:

 

 

 

 

 

 

 

 

Principal amount

 

 

450,000

 

 

 

—

 

Unamortized debt discount

 

 

(66,346

)

 

 

—

 

Unamortized debt issuance costs

 

 

(9,542

)

 

 

—

 

 

 

 

374,112

 

 

 

—

 

Total Senior Convertible Notes

 

$

1,411,529

 

 

$

623,298

 

 

 

 

 

 

 

 

 

 

Less: Current portion

 

 

(645,303

)

 

 

—

 

Long-term Senior Convertible Notes

 

$

766,226

 

 

$

623,298

 

 

 

108

Table of Contents

 

2.25% Senior Convertible Notes due 2021

In March 2016, the Company issued $650.0  million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 2.25% and a maturity date of March 15, 2021 (the “2021 Notes”). The net proceeds from the offering, after deducting initial purchasers' discounts and costs directly related to the offering, were approximately $634.1 million. Prior to September 14, 2020, the 2021 Notes provided for settlement in cash, stock, or a combination thereof, solely at the Company’s discretion. As of September 14, 2020, combination settlement was deemed to have been elected by the Company and the 2021 Notes will be settled by satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company's common stock. The initial conversion rate of the 2021 Notes is 16.7158  shares per $1,000  principal amount, which is equivalent to a conversion price of approximately $59.82  per share, subject to adjustments. The Company uses the treasury share method for assumed conversion of the 2021 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. The Company also entered into transactions for a convertible notes hedge (the “2021 Hedge”) and warrants (the “2021 Warrants”) concurrently with the issuance of the 2021 Notes.

The cash conversion feature of the 2021 Notes required bifurcation from the notes and was initially accounted for as an equity instrument classified to stockholders’ equity, which resulted in recognizing $84.8 million in additional paid-in-capital during 2016.

The interest expense recognized on the 2021 Notes during the year ended December 31, 2020 includes $14.6 million, $18.6 million and $3.4 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2021 Notes during the year ended December 31, 2019 includes $14.6 million, $17.6 million and $3.2 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2021 Notes during the year ended December 31, 2018 includes $14.6 million, $16.7 million and $2.9 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2021 Notes is 5.8%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2021 Notes began accruing upon issuance and is payable semi-annually.

Prior to September 15, 2020, holders could have converted their 2021 Notes only under the following conditions: (a) during any calendar quarter beginning June 30, 2016, if the reported sale price of the Company's common stock for at least 20 days out of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter was greater than 130% of the conversion price on each applicable trading day; (b) during the five business day period in which the trading price of the 2021 Notes fell below 98% of the product of (i) the last reported sale price of the Company's common stock and (ii) the conversion rate on that date; and (c) upon the occurrence of specified corporate events, as defined in the 2021 Notes. From September 15, 2020 and until the close of business on the second scheduled trading day immediately preceding March 15, 2021, holders may convert their 2021 Notes at any time (regardless of the foregoing circumstances). The 2021 Notes can no longer be redeemed by the Company. The Company previously had the ability to redeem the 2021 Notes, at its option, in whole or in part beginning on March 20, 2019 until the close of business on the business day immediately preceding September 15, 2020 if the last reported sale price of the Company’s common stock had been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company delivers written notice of a redemption. No principal payments are due on the 2021 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2021 Notes do not contain any financial covenants and do not restrict the Company from paying dividends or issuing or repurchasing any of its other securities. 

As of September 15, 2020, holders may convert their 2021 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. As a result, the 2021 Notes are considered redeemable as of December 31, 2020. A portion of the equity component that was recorded upon the issuance of the 2021 Notes was reclassified to temporary equity in the Consolidated Balance Sheet. Such amount was determined based on the cash consideration to be paid upon conversion and the carrying amount of the debt. The reclassification into temporary equity as of December 31, 2020 was $4.7 million based on the 2021 Notes principal of $650.0 million and the carrying value of $645.3 million.

2021 Hedge

In connection with the offering of the 2021 Notes, the Company entered into the hedge transaction with the initial purchasers of the 2021 Notes and/or their affiliates (the "2021 Counterparties") entitling the Company to purchase up to 10,865,270 shares of the Company's common stock at an initial stock price of $59.82 per share, each of which is subject to adjustment. The cost of the 2021 Hedge was $111.2 million and accounted for as an equity instrument by recognizing $111.2 million in additional paid-in-capital during 2016. The 2021 Hedge will expire on March 15, 2021. The 2021 Hedge is expected to reduce the potential equity dilution upon conversion of the 2021 Notes if the daily volume-weighted average price per share of the Company's common stock exceeds the strike price of the 2021 Hedge. An assumed exercise of the 2021 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

 

109

Table of Contents

2021 Warrants

The Company sold warrants to the 2021 Counterparties to acquire up to 10,865,270 shares of the Company’s common stock. The 2021 Warrants will expire on various dates from June 2021 through December 2021 and may be settled in cash or net shares. It is the Company's current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $44.9 million in cash proceeds from the sale of the 2021 Warrants, which was recorded in additional paid-in-capital. The 2021 Warrants could have a dilutive effect on the Company's earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2021 Warrants, which is $80.00 per share. The Company uses the treasury share method for assumed conversion of its 2021 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.

1.00% Senior Convertible Notes due 2023

In June 2020, the Company issued $450.0 million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 1.00% and a maturity date of June 1, 2023. The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $436.7 million. The 2023 Notes were initially required to be settled in cash as the Company did not have sufficient reserved shares. On September 10, 2020, the Company held a Special Meeting of Stockholders and received stockholder approval to amend the Company’s Restated Certificate of Incorporation to increase the number of shares of its common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares. As a result of the increase in the number of shares of the Company’s common stock authorized for issuance, as of September 10, 2020 and as of December 31, 2020, the Company had sufficient reserved shares and therefore may settle conversions of the 2023 Notes in cash, stock, or a combination thereof, solely at the Company’s discretion. It is the Company’s current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company’s common stock. The initial conversion rate of the 2023 Notes is 11.8778 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $84.19 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date, the Company will increase the conversion rate for a holder who elects to convert its 2023 Notes in connection with such a corporate event in certain circumstances. The Company also entered into transactions for a convertible notes hedge and warrants concurrently with the issuance of the 2023 Notes.

As discussed in Note 4, the Embedded Conversion Derivative requires bifurcation from the 2023 Notes and was initially accounted for as a liability, which was included in long-term liabilities in the Company’s Consolidated Balance Sheet. The fair value of the 2023 Notes Embedded Conversion Derivative at the time of issuance of the 2023 Notes was $57.2 million, and was recorded as the original debt discount for purposes of accounting for the debt component of the 2023 Notes. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle conversions of the 2023 Notes in cash, stock, or a combination thereof, and in accordance with authoritative literature, the Embedded Conversion Derivative was marked to fair value and reclassified to stockholders’ equity, which resulted in recognizing $37.3 million in additional paid-in-capital during the year ended December 31, 2020. The original discount will be recognized as interest expense using the effective interest method over the term of the 2023 Notes.

The interest expense recognized on the 2023 Notes during the year ended December 31, 2020 includes $2.6 million, $10.4 million and $2.2 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2023 Notes is 6.8%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually.

Prior to February 1, 2023, holders may convert their 2023 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price of the 2023 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on such trading day; or (c) upon the occurrence of specified corporate events, as defined in the 2023 Notes. On or after February 1, 2023, until the close of business on the second scheduled trading day immediately preceding June 1, 2023, holders may convert their 2023 Notes at any time, regardless of the foregoing conditions.

The Company may not redeem the 2023 Notes prior to the maturity date and no principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2023 Notes do not contain any financial covenants and do not restrict the Company from conducting significant restructurings, paying dividends or issuing or repurchasing any of its other securities. As of December 31, 2020, the Company is unaware of any current events or market conditions that would allow holders to convert the 2023 Notes.

 

110

Table of Contents

2023 Hedge

In connection with the sale of the 2023 Notes, the Company entered into privately negotiated call option transactions with certain dealers, which included affiliates of certain of the initial purchasers of the 2023 Notes and other financial institutions (the “2023 Counterparties”), entitling the Company to purchase up to 5,345,010 shares of the Company’s common stock at an initial stock price of $84.19 per share, each of which is subject to adjustment. The 2023 Hedge was initially required to be settled in cash as the Company did not have sufficient reserved shares with respect to the 2023 Notes. As a result, the 2023 Hedge was accounted for as a derivative asset, which was included in long-term assets in the Company’s Consolidated Balance Sheet. The cost of the 2023 Hedge was $69.5 million. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle the 2023 Notes, which therefore allows for the 2023 Hedge to be settled in cash, stock, or a combination thereof. In accordance with authoritative literature, the Convertible Note Hedge Derivative was marked to fair value and reclassified to stockholders’ equity, which resulted in recognizing a reduction of $37.3 million in additional paid-in-capital during the year ended December 31, 2020. The 2023 Hedge will expire on the second scheduled trading day immediately preceding June 1, 2023. The 2023 Hedge is expected to reduce the potential equity dilution upon conversion of the 2023 Notes if the daily volume-weighted average price per share of the Company’s common stock exceeds the strike price of the 2023 Hedge. An assumed exercise of the 2023 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

2023 Warrants

In connection with the sale of the 2023 Notes, the Company sold warrants to the 2023 Counterparties (the “2023 Warrants”) to acquire up to 5,345,010 shares of the Company’s common stock. The 2023 Warrants initially limited the amount of shares the Company was required to reserve for issuance under the 2023 Warrants to an aggregate of 3,093,500 shares of the Company’s common stock, subject to adjustment upon the Company having a sufficient amount of authorized and unissued shares which are not reserved for other transactions. As a result of the Company receiving stockholder approval to increase the number of shares of the Company’s common stock authorized for issuance on September 10, 2020, the Company subsequently entered into amendment agreements with each of the 2023 Counterparties to increase the number of authorized shares of the Company’s common stock required to be reserved under the 2023 Warrants to the aggregate amount of 6,948,512 shares. The 2023 Warrants will expire on various dates from September 2023 through November 2023 and may be settled in net shares or cash, subject to certain conditions. It is the Company’s current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $46.8 million in cash proceeds from the sale of the 2023 Warrants, which was recorded in additional paid-in-capital. The 2023 Warrants could have a dilutive effect on the Company’s earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2023 Warrants, which is $104.84 per share. The Company uses the treasury share method for assumed conversion of its 2023 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.

0.375% Senior Convertible Notes due 2025

In March 2020, the Company issued $450.0 million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 0.375% and a maturity date of March 15, 2025 (the “2025 Notes”). The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $437.0 million. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at the Company’s discretion. It is the Company's current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company’s common stock. The initial conversion rate of the 2025 Notes is 10.7198 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $93.29 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2025 Notes in connection with such a corporate event or in connection with such redemption in certain circumstances. The Company uses the treasury share method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. The Company also entered into transactions for a convertible notes hedge (the “2025 Hedge”) and warrants (the “2025 Warrants”) concurrently with the issuance of the 2025 Notes.

The cash conversion feature of the 2025 Notes required bifurcation from the notes and was initially accounted for as an equity instrument classified to stockholders’ equity, which resulted in recognizing $78.3 million in additional paid-in-capital during the year ended December 31, 2020.

The interest expense recognized on the 2025 Notes during the year ended December 31, 2020 includes $1.4 million, $11.9 million and $1.5 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2025 Notes is 4.9%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually.

 

111

Table of Contents

Prior to September 15, 2024, holders may convert their 2025 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price of the 2025 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on such trading day; (c) if the Company calls any or all of the 2025 Notes for redemption, at any time prior to the close of business on the second scheduled trading day preceding the redemption date; or (d) upon the occurrence of specified corporate events, as defined in the 2025 Notes. On or after September 15, 2024, until the close of business on the second scheduled trading day immediately preceding March 15, 2025, holders may convert their 2025 Notes at any time, regardless of the foregoing conditions.

The Company may not redeem the 2025 Notes prior to March 20, 2023. The Company may redeem the 2025 Notes, at its option, in whole or in part, on or after March 20, 2023 until the close of business on the business day immediately preceding September 15, 2024, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company delivers written notice of a redemption. The redemption price will be equal to 100% of the principal amount of such 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2025 Notes do not contain any financial covenants and do not restrict the Company from conducting significant restructurings, paying dividends or issuing or repurchasing any of its other securities. As of December 31, 2020, the Company is unaware of any current events or market conditions that would allow holders to convert the 2025 Notes.

2025 Hedge

In connection with the sale of the 2025 Notes, the Company entered into privately negotiated call option transactions with certain dealers, which included affiliates of certain of the initial purchasers of the 2025 Notes and other financial institutions (the “2025 Counterparties”), entitling the Company to purchase up to 4,823,910 shares of the Company’s common stock at an initial stock price of $93.29 per share, each of which is subject to adjustment. The cost of the 2025 Hedge was $78.3 million and accounted for as an equity instrument by recognizing $78.3 million in additional paid-in-capital during the year ended December 31, 2020. The 2025 Hedge will expire on the second scheduled trading day immediately preceding March 15, 2025. The 2025 Hedge is expected to reduce the potential equity dilution upon conversion of the 2025 Notes if the daily volume-weighted average price per share of the Company’s common stock exceeds the strike price of the 2025 Hedge. An assumed exercise of the 2025 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

2025 Warrants

The Company sold warrants to the 2025 Counterparties to acquire up to 4,823,910 shares of the Company’s common stock. The 2025 Warrants will expire on various dates from June 2025 through October 2025 and may be settled in net shares or cash, subject to certain conditions. It is the Company’s current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $47.1 million in cash proceeds from the sale of the 2025 Warrants, which was recorded in additional paid-in-capital. The 2025 Warrants could have a dilutive effect on the Company’s earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2025 Warrants, which is $127.84 per share. The Company uses the treasury share method for assumed conversion of its 2025 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.

 

112

Table of Contents

Revolving Senior Credit Facility

In February 2020, the Company entered into a Second Amended and Restated Credit Agreement (the “2020 Credit Agreement”) for a revolving senior credit facility (the “2020 Facility”), which replaced the previous Amended and Restated Credit Agreement the Company had entered into in April 2017. The 2020 Credit Agreement was further amended in May 2020 to, among other things, provide additional flexibility in determining the financial covenant leverage ratios for the second and third fiscal quarters of 2020 and to adjust certain margin and benchmark rates used to determine interest under the 2020 Facility. The 2020 Credit Agreement provides for secured revolving loans, multicurrency loan options and letters of credit in an aggregate amount of up to $550.0  million. The 2020 Credit Agreement also contains an expansion feature, which allows the Company to increase the aggregate principal amount of the 2020 Facility provided the Company remains in compliance with the underlying financial covenants on a pro forma basis, including but not limited to, compliance with the consolidated interest coverage ratio and certain consolidated leverage ratios. The 2020 Facility matures in February 2025 (subject to an earlier springing maturity date), and includes a sublimit of $50.0 million for standby letters of credit, a sublimit of $250.0 million for multicurrency borrowings, and a sublimit of $5.0 million for swingline loans. All assets of the Company and its material domestic subsidiaries continue to be pledged as collateral under the 2020 Facility (subject to customary exceptions) pursuant to the terms set forth in the Second Amended and Restated Security and Pledge Agreement executed in favor of the administrative agent by the Company. Each of the Company’s material domestic subsidiaries guarantee the 2020 Facility. In connection with the 2020 Facility, the Company incurred issuance costs which will be amortized over the term of the 2020 Facility. The Company did not carry any outstanding revolving loans under the 2020 Facility as of December 31, 2020 and 2019.

Any borrowings under the 2020 Facility are intended to be used by the Company to provide financing for working capital and other general corporate purposes, including potential mergers and acquisitions and to refinance indebtedness. Borrowings under the 2020 Facility bear interest, at the Company’s option, at a rate equal to an applicable margin plus: (a) the applicable Eurocurrency Rate (as defined in the 2020 Credit Agreement), or (b) a base rate determined by reference to the highest of (1) the federal funds effective rate plus 0.50%, (2) the Bank of America prime rate, and (3) the Eurocurrency Rate for an interest period of one month plus 1.00%. The margin for the 2020 Facility ranges, based on the Company’s consolidated total net leverage ratio, from 0.50% to 1.25% in the case of base rate loans and from 1.50% to 2.25% in the case of Eurocurrency Rate loans. The 2020 Facility includes an unused line fee ranging, based on the Company’s consolidated total net leverage ratio, from 0.35% to 0.50% per annum on the revolving commitment.

The 2020 Credit Agreement contains affirmative, negative, permitted acquisition and financial covenants, and events of default customary for financings of this type. The financial covenants require the Company to maintain a consolidated interest coverage ratio and certain consolidated leverage ratios, which are measured on a quarterly basis. The 2020 Facility grants the lenders preferred first priority liens and security interests in capital stock, intercompany debt and all of the present and future property and assets of the Company and each guarantor. The Company is currently in compliance with the 2020 Credit Agreement covenants.

 

7.    Commitments

Leases

At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company records the associated lease liability and corresponding right-of-use asset upon commencement of the lease using a discount rate based on a credit-adjusted secured borrowing rate commensurate with the term of the lease.

The Company records lease liabilities within current liabilities or long-term liabilities based upon the length of time associated with the lease payments. The Company records its operating lease right-of-use assets as long-term assets. Right-of-use assets for financing leases are recorded within property and equipment, net in the Consolidated Balance Sheet. Leases with an initial term of 12 months or less are not recorded in the Consolidated Balance Sheet. The Company recognizes lease expense on a straight-line basis over the lease term. In connection with certain operating leases, the Company has security deposits recorded and maintained as restricted cash totaling $1.5 million as of December 31, 2020 and December 31, 2019.

The Company leases office and storage facilities and equipment under various operating and financing lease agreements. The initial terms of these leases range from 1 to 17 years and generally provide for periodic rent increases, and renewal and termination options. The Company’s lease agreements do not contain any material variable lease payments, residual value guarantees or material restrictive covenants.

Certain leases require the Company to pay taxes, insurance and maintenance. Payments for the transfer of goods or services such as common area maintenance and utilities represent non-lease components. The Company elected the package of practical expedients and therefore does not separate non-lease components from lease components.

 

113

Table of Contents

The table below summarizes the Company’s right-of-use assets and lease liabilities:

(in thousands, except years and rates)

December 31, 2020

 

 

December 31, 2019

 

Assets

 

 

 

 

 

 

 

Operating

$

102,270

 

 

$

66,932

 

Financing

 

2,956

 

 

 

1,453

 

Total leased assets

$

105,226

 

 

$

68,385

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

Operating

$

7,875

 

 

$

5,567

 

Financing

 

1,355

 

 

 

672

 

Long-term:

 

 

 

 

 

 

 

Operating

 

111,634

 

 

 

73,153

 

Financing

 

1,812

 

 

 

905

 

Total lease liabilities

$

122,676

 

 

$

80,297

 

 

 

 

 

 

 

 

 

Supplemental non-cash information:

 

 

 

 

 

 

 

Weighted-average remaining lease term (years) - operating leases

 

12.8

 

 

 

12.4

 

Weighted-average remaining lease term (years) - finance leases

 

2.2

 

 

 

2.3

 

Weighted-average discount rate - operating leases

 

5.4

%

 

 

7.3

%

Weighted-average discount rate - finance leases

 

4.9

%

 

 

5.4

%

The table below summarizes the Company’s lease costs, cash payments, and operating lease liabilities arising from obtaining right-of-use assets under its operating and financing lease obligations:

 

(in thousands)

December 31, 2020

 

 

December 31, 2019

 

Lease expense:

 

 

 

 

 

 

 

Operating lease expense

$

15,316

 

 

$

11,859

 

Finance lease expense:

 

 

 

 

 

 

 

Depreciation of right-of-use assets

 

1,201

 

 

 

441

 

Interest expense on lease liabilities

 

124

 

 

 

56

 

Total lease expense

$

16,641

 

 

$

12,356

 

 

 

 

 

 

 

 

 

Consolidated Statements of Cash Flows information:

 

 

 

 

 

 

 

Operating cash flows used for operating leases

$

14,120

 

 

$

12,140

 

Operating cash flows used for financing leases

 

124

 

 

 

56

 

Financing cash flows used for financing leases

 

1,113

 

 

 

420

 

Total cash paid for amounts included in the measurement of lease liabilities

$

15,357

 

 

$

12,616

 

 

 

 

 

 

 

 

 

Supplemental non-cash information:

 

 

 

 

 

 

 

Operating lease liabilities arising from obtaining right-of-use assets

$

41,148

 

 

$

86,134

 

 

Rent expense, including costs directly associated with the facility leases, was approximately $12.8 million for the year ended December 31, 2018.

 

114

Table of Contents

The Company’s future minimum annual lease payments under operating and financing leases at December 31, 2020 are as follows:

 

 

Financing

 

 

Operating

 

(in thousands)

 

Leases

 

 

Leases

 

2021

 

$

1,465

 

 

$

14,140

 

2022

 

 

1,397

 

 

 

13,582

 

2023

 

 

466

 

 

 

13,158

 

2024

 

 

9

 

 

 

12,072

 

2025

 

 

—

 

 

 

10,699

 

Thereafter

 

 

—

 

 

 

106,197

 

Total minimum lease payments

 

$

3,337

 

 

$

169,848

 

Less: amount representing interest

 

 

(170

)

 

 

(50,339

)

Present value of obligations under leases

 

 

3,167

 

 

 

119,509

 

Less: current portion

 

 

(1,355

)

 

 

(7,875

)

Long-term lease obligations

 

$

1,812

 

 

$

111,634

 

Licensing and Purchasing Agreements

The Company has both minimum and contingent obligations to make payments of up to $50.4 million if specified future events occur or conditions are met as provided in certain net sales based, consulting, purchase and/or product development agreements. Not all of the respective agreements specify milestone payment timelines. Certain payments will be made in a combination of cash and the Company’s common shares as provided in the agreements. Any payments in satisfaction of these obligations are considered either a research and development expense or a cost of sales depending on the nature of the arrangement and are recognized ratably as and if milestones are achieved.

Executive Severance Plans

 The Company has employment contracts with key executives and maintains severance plans that provide for the payment of severance and other benefits if such executives are terminated for reasons other than cause, as defined in those agreements and plans. Certain agreements call for payments that are based on historical compensation, and accordingly, the amount of the contractual commitment will change over time commensurate with the executive’s applicable earnings. At December 31, 2020, future commitments for such key executives were approximately $20.1 million. In certain circumstances, the agreements call for the acceleration of equity vesting. Those figures are not reflected in the above information.

 

8.    Stockholders’ Equity

In October 2017, the Company announced that the Board of Directors approved a share repurchase program authorizing the repurchase of up to $100 million of the Company’s common stock over a three-year period. Under this program, the Company is authorized to repurchase common stock in open market purchases, privately negotiated purchases or other transactions through October 2020. In February 2020, the Company announced that the Board of Directors increased the share repurchase authorization from $100 million to $150 million of the Company’s common stock through December 31, 2021. In March 2020, in connection with the issuance of the 2025 Notes, the Company repurchased approximately 1,085,000 shares of its common stock for $75.0 million. As of December, 31 2020, $75.0 million remained authorized under the share repurchase program.

On September 10, 2020, upon obtaining stockholder approval, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock from 120,000,000 shares to 150,000,000 shares.

 

9.    Stock-Based Compensation

Common Stock

There were 150,000,000 and 120,000,000 shares of common stock authorized at December 31, 2020 and 2019, respectively.

Preferred Stock

There are 5,000,000 shares of preferred stock authorized and none issued or outstanding at December 31, 2020 and 2019.

 

115

Table of Contents

Stock-based Compensation

In March 2014, the Compensation Committee (the "Compensation Committee") of the Board of Directors of the Company adopted the 2014 Equity Incentive Plan of NuVasive, Inc. (the "2014 EIP"), replacing the 2004 Amended and Restated Equity Incentive Plan (the “2004 EIP”). No further awards may be granted under the 2004 EIP; however, that plan continues to govern all awards previously issued under it (of which awards remain outstanding). The 2014 EIP provides the Company with the ability to grant various types of equity awards to its workforce (including, without limitation, restricted stock units (“RSUs”), restricted stock awards, performance awards, and deferred stock awards). The 2014 EIP also provides for the issuance of performance RSUs (“PRSUs”) to be granted subject to time- and/or performance-based vesting requirements. In addition, the award agreements under the 2014 EIP generally provide for the acceleration of 50% of the unvested equity awards of all employees upon a change in control and the vesting of the remaining unvested equity awards for those employees that are involuntarily terminated within a year of the change in control.

Each of the 2004 EIP and the 2014 EIP allow for “net share settlement” of certain equity awards whereby, in lieu of (i) making cash payments in satisfaction of the exercise price owed respective to non-qualified stock option awards, or (ii) open market selling award shares to generate cash proceeds for use in satisfaction of statutory tax obligations respective to an award’s settlement or exercise, the company offsets the award shares being settled in a respective transaction by the number of shares of company stock with a value equal to the respective obligation, and, in the case of taxes, making a cash payment to the respective taxing authority on behalf of the employee using Company cash. The net share settlement is accounted for with the cost of any award shares that are net settled being included in treasury stock and reported as a reduction in total equity at the time of settlement.

In connection with the acquisition of Ellipse Technologies in February 2016, the Company assumed the Ellipse Technologies, Inc. 2015 Incentive Award Plan and the shares thereunder, subject to an equity exchange adjustment, for future awards by the Company.

The compensation cost that has been included in the Consolidated Statements of Operations for the Company’s stock-based compensation plans was as follows:

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Selling, general and administrative expense

 

$

12,622

 

 

$

25,968

 

 

$

22,190

 

Research and development expense

 

 

5,259

 

 

 

3,798

 

 

 

3,052

 

Cost of sales

 

 

264

 

 

 

531

 

 

 

431

 

Stock-based compensation expense before taxes

 

 

18,145

 

 

 

30,297

 

 

 

25,673

 

Related income tax benefits

 

 

(3,088

)

 

 

(6,191

)

 

 

(6,418

)

Stock-based compensation expense, net of taxes

 

$

15,057

 

 

$

24,106

 

 

$

19,255

 

As of December 31, 2020, there was $21.0 million and $16.1 million of unrecognized compensation expense for RSUs and PRSUs, respectively, which is expected to be recognized over a weighted-average period of approximately 1.7 years and 2.7 years, respectively. In addition, as of December 31, 2020, there was $1.0 million of unrecognized compensation expense for shares expected to be issued under the ESPP which is expected to be recognized through April 2021. There was no unamortized expense for stock options as of December 31, 2020.

Restricted Stock Units

The total fair value of RSUs that vested during the year ended December 31, 2020, 2019, and 2018 was $12.1 million, $21.5 million and $8.8 million, respectively.

Following is a summary of RSU activity for the year ended December 31, 2020:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

(in thousands, except per share amounts)

 

Shares

 

 

Fair Value

 

Outstanding at December 31, 2019

 

 

945

 

 

$

59.21

 

Granted

 

 

381

 

 

 

63.64

 

Vested

 

 

(209

)

 

 

68.67

 

Forfeited

 

 

(123

)

 

 

59.21

 

Outstanding at December 31, 2020

 

 

994

 

 

$

58.94

 

For the majority of RSUs, shares are issued on the vesting dates net of the amount of shares needed to satisfy statutory tax withholding requirements to be paid by the Company on behalf of the employees. The total shares withheld related to vested RSUs were approximately 71,000, 122,000, and 42,000 in 2020, 2019, and 2018, respectively, and were based on the value of the awards on their vesting dates as determined by the Company’s closing stock price. Total payments for the employees’ tax obligations to the taxing authorities related to vesting RSUs were $4.1 million, $7.2 million and $2.2 million in 2020, 2019 and 2018, respectively.

 

116

Table of Contents

Performance-Based Restricted Stock Units

The Company has granted PRSUs since 2012 for which the ultimate issuance amount is determined by the Company’s Compensation Committee upon its certification of Company performance against a pre-determined matrix, which have included targets for net sales, operating margin, earnings per share and total shareholder return over pre-determined periods of time. Share payout levels range from 0% to 200% depending on the respective terms of an award. Based upon the Company’s actual performance against the performance conditions, approximately 61,000, 276,000 and 21,000 shares of common stock vested pursuant to PRSUs in 2020, 2019 and 2018, respectively.

In 2015, the Company granted a PRSU award with a five-year cliff vesting term to its former Chief Executive Office, Gregory T. Lucier, in connection with his appointment to the Company, for which the performance criteria was not based on Company or market specific performance metrics, but rather stock price performance. As such, the Company recorded the award as a liability subject to recurring fair value adjustments that affect stock-based compensation expense. The minimum performance criteria for this award was not met, thus no shares were paid out and the entire liability was reversed during the year ended December 31, 2020.

The total fair value of PRSUs vested during 2020, 2019, 2018 and was $3.8 million, $19.9 million and $2.1 million, respectively.

Following is a summary of PRSU activity for the year ended December 31, 2020:

 

 

 

 

 

 

Maximum Number

 

 

 

 

 

(in thousands, except per share amounts)

 

Shares

 

 

of Shares Eligible

to be Issued

 

 

Average Grant

Date Fair Value

 

Outstanding at December 31, 2019

 

 

731

 

 

 

1,116

 

 

$

57.07

 

Awarded at target

 

 

172

 

 

 

248

 

 

 

69.72

 

Vested

 

 

(61

)

 

 

(61

)

 

 

73.20

 

Forfeited

 

 

(223

)

 

 

(453

)

 

 

56.48

 

Outstanding at December 31, 2020

 

 

619

 

 

 

850

 

 

$

57.38

 

For the majority of PRSUs, shares are issued on the vesting dates net of the amount of shares needed to satisfy statutory tax withholding requirements to be paid by the Company on behalf of the employees. The total shares withheld related to vesting PRSUs were approximately 25,000, 121,000 and 8,000 in 2020, 2019 and 2018 respectively, and were based on the value of the awards on their vesting dates as determined by the Company’s closing stock price. Total payments for the employees’ tax obligations to the taxing authorities related to vesting PRSUs were $1.6 million, $7.2 million, and $0.4 million in 2020, 2019, and 2018, respectively.

Stock Options

The Company has not granted any stock options since 2011. The stock options previously granted are exercisable for a period of up to ten years after the date of grant.

The aggregate intrinsic value of outstanding stock options at December 31, 2020 is based on the Company’s closing stock price on December 31, 2020 of $56.33. Stock option exercises during the years ended December 31, 2020 and 2019 were primarily all executed with net share settlements, for which the Company does not receive any cash proceeds. The Company received $1.3 million in proceeds from the exercise of stock options during the year ended December 31, 2018. The total intrinsic value of stock options exercised was $0.4 million, $1.0 million, and $2.5 million during the years ended December 31, 2020, 2019 and 2018, respectively. There were no stock options that vested during the years ended December 31, 2020, 2019 or 2018.

 

117

Table of Contents

Following is a summary of stock option activity for the year ended December 31, 2020 under all stock plans:

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

 

 

Avg. Exercise

 

 

Term

 

 

Intrinsic

 

(in thousands, except years and per share amounts)

 

Shares

 

 

Price

 

 

(Years)

 

 

Value

 

Outstanding at December 31, 2019

 

 

16

 

 

$

29.18

 

 

 

0.89

 

 

$

747

 

Exercised

 

 

(16

)

 

 

29.18

 

 

 

 

 

 

 

 

 

Cancelled

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

—

 

 

 

—

 

 

 

—

 

 

$

—

 

Exercisable at December 31, 2020

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 

Vested or expected to vest at December 31, 2020

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 

 For the majority of stock options, shares are issued on the exercise dates net of the amount of shares needed to satisfy each of the exercise price (in lieu of cash) and statutory tax withholding requirements, the latter to be paid by the Company on behalf of the employee. The total shares withheld related to exercised stock options were approximately 8,000, 21,000, and 65,000 in 2020, 2019, and 2018 respectively, and were based on the value of the stock options on their exercise dates as determined by the Company’s closing stock price. There were no cash payments for the employees’ tax obligations to the taxing authorities related to exercised stock options in 2020. Total cash payments for the employees’ tax obligations to the taxing authorities related to exercised stock options were $0.1 million and $0.4 million in 2019 and 2018, respectively.

Employee Stock Purchase Plan

The NuVasive, Inc. 2004 Amended and Restated Employee Stock Purchase Plan (the “ESPP”), provides eligible employees with a means of acquiring equity in the Company at a discounted purchase price using their own accumulated payroll deductions. Under the terms of the ESPP, employees can elect to have up to 15% of their annual compensation, up to a maximum of $21,250 per year, withheld to purchase shares of Company common stock for a purchase price equal to 85% of the lower of the fair market value per share (at closing) of Company common stock on (i) the commencement date of the six-month offering period or (ii) the respective purchase date. In the years ended December 31, 2020, 2019 and 2018, 136,000, 129,000, and 151,000 shares, respectively, were purchased under the ESPP.

The weighted average assumptions used to estimate the fair value of stock options granted and stock purchase rights under the ESPP are as follows:

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

ESPP

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

56

%

 

 

35

%

 

 

33

%

Expected term (years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

Risk free interest rate

 

 

0.5

%

 

 

2.3

%

 

 

1.8

%

Expected dividend yield

 

 

—

%

 

 

—

%

 

 

—

%

Common Stock Reserved for Future Issuance

The following table summarizes common shares reserved for issuance on exercise or conversion at December 31, 2020:

(in thousands)

 

 

 

 

Issued and outstanding RSUs and PRSUs

 

 

1,630

 

Available for issuance under the ESPP

 

 

828

 

Available for future grant

 

 

3,651

 

2021 Notes

 

 

14,396

 

2021 Warrants

 

 

25,207

 

2023 Notes

 

 

7,082

 

2023 Warrants

 

 

6,949

 

2025 Notes

 

 

6,512

 

2025 Warrants

 

 

6,271

 

Total shares reserved for future issuance

 

 

72,526

 

 

 

 

118

Table of Contents

 

10.    Income Taxes

Total (loss) income before income taxes summarized by region was as follows:

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

United States

 

$

(45,534

)

 

$

74,721

 

 

$

8,939

 

Foreign

 

 

(2,011

)

 

 

5,796

 

 

 

(216

)

Total (loss) income before income taxes

 

$

(47,545

)

 

$

80,517

 

 

$

8,723

 

The income tax (benefit) provision was as follows:

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(35

)

 

$

4,802

 

 

$

(4,188

)

State

 

 

2,309

 

 

 

4,638

 

 

 

2,043

 

Foreign

 

 

4,675

 

 

 

2,205

 

 

 

5,972

 

Total current provision

 

 

6,949

 

 

 

11,645

 

 

 

3,827

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

(13,800

)

 

 

5,873

 

 

 

(5,944

)

State

 

 

(8,315

)

 

 

(4,565

)

 

 

(7,092

)

Foreign

 

 

(3,849

)

 

 

(819

)

 

 

(98,795

)

Total deferred provision

 

 

(25,964

)

 

 

489

 

 

 

(111,831

)

Changes in tax rate

 

 

(579

)

 

 

606

 

 

 

258

 

Changes in valuation allowance

 

 

9,202

 

 

 

2,543

 

 

 

103,990

 

Total (benefit) provision

 

$

(10,392

)

 

$

15,283

 

 

$

(3,756

)

The differences between the income tax provision at the United States federal statutory tax rate and the Company’s effective tax rate were as follows:

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Tax (benefit) provision at federal statutory rate

 

$

(9,984

)

 

$

16,909

 

 

$

1,832

 

Income tax credits and incentives

 

 

(7,155

)

 

 

(7,209

)

 

 

(5,525

)

State income tax

 

 

(1,243

)

 

 

3,763

 

 

 

90

 

Valuation allowance

 

 

9,202

 

 

 

2,543

 

 

 

103,990

 

Net tax benefit on international restructuring

 

 

—

 

 

 

—

 

 

 

(97,028

)

Return to provision adjustments

 

 

(881

)

 

 

(2,323

)

 

 

(4,180

)

Acquisition related charges

 

 

687

 

 

 

(1,808

)

 

 

(221

)

Compensation expense

 

 

3,314

 

 

 

1,643

 

 

 

2,008

 

Income tax reserves

 

 

(4,217

)

 

 

(1,146

)

 

 

(6,717

)

Nondeductible meals and entertainment

 

 

351

 

 

 

717

 

 

 

769

 

Foreign tax rate differences from federal statutory rate

 

 

(1,215

)

 

 

716

 

 

 

576

 

Change in tax rates

 

 

(579

)

 

 

606

 

 

 

258

 

Other

 

 

1,328

 

 

 

872

 

 

 

392

 

Total (benefit) provision

 

$

(10,392

)

 

$

15,283

 

 

$

(3,756

)

 

 

119

Table of Contents

 

Significant components of the Company’s deferred tax assets and liabilities were as follows:

 

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Amortization

 

$

67,945

 

 

$

87,296

 

Net operating loss carryforwards

 

 

47,407

 

 

 

24,656

 

Inventory

 

 

35,763

 

 

 

24,069

 

General business and other credit carryforwards

 

 

26,542

 

 

 

23,168

 

Lease liability

 

 

28,356

 

 

 

17,636

 

Stock-based compensation

 

 

9,918

 

 

 

11,562

 

Original issue discount

 

 

3,735

 

 

 

1,840

 

Other

 

 

27,479

 

 

 

22,591

 

Gross deferred tax assets

 

 

247,145

 

 

 

212,818

 

Less valuation allowance

 

 

(130,434

)

 

 

(122,534

)

Net deferred tax assets

 

 

116,711

 

 

 

90,284

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Depreciation

 

 

(44,760

)

 

 

(37,045

)

Acquired intangibles

 

 

(27,544

)

 

 

(34,799

)

Right-of-use assets

 

 

(24,122

)

 

 

(14,891

)

Other

 

 

(5,176

)

 

 

(6,260

)

Total deferred tax liabilities

 

 

(101,602

)

 

 

(92,995

)

Net deferred tax assets (liabilities)

 

$

15,109

 

 

$

(2,711

)

 

The Company consolidates subsidiaries in foreign jurisdictions which use the local currency as their functional currency. Since income taxes for these subsidiaries are assessed in their local currency, deferred tax balances are translated into the Company’s reporting currency and adjusted for changes in the exchange rates over time through the cumulative translation account. Additionally, the Company established certain deferred taxes associated with the issuance of convertible debt in 2020 the benefit of which was recorded to equity. Accordingly, changes in the deferred tax balances associated with revaluations and convertible debt issuances are not reflected in income tax expense and create disparities between the changes in total deferred taxes for the year and deferred tax expense. In the year ended December 31, 2020, net decreases in deferred taxes of approximately $0.8 million and decreases in valuation allowances of approximately $1.3 million were recorded against equity and, therefore, not reflected in deferred tax expense.

The following table summarizes the activity related to the Company’s unrecognized tax benefits:

 

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Gross unrecognized tax benefits at January 1

 

$

20,328

 

 

$

19,545

 

 

$

25,356

 

Increases in tax positions for prior years

 

 

1,758

 

 

 

62

 

 

 

499

 

Decreases in tax positions for prior years

 

 

—

 

 

 

(112

)

 

 

(756

)

Increases in tax positions for current year relating to ongoing operations

 

 

2,159

 

 

 

2,073

 

 

 

1,913

 

Decreases in tax positions as a result of a lapse of statute of limitations

 

 

(5,929

)

 

 

(616

)

 

 

(6,446

)

Increases in tax positions for current year relating to acquisitions

 

 

—

 

 

 

—

 

 

 

169

 

Decreases in tax positions due to settlements with taxing authorities

 

 

—

 

 

 

(624

)

 

 

(1,190

)

Gross unrecognized tax benefits at December 31

 

$

18,316

 

 

$

20,328

 

 

$

19,545

 

At December 31, 2020, 2019, and 2018, $16.5 million, $18.7 million, and $18.1 million, respectively, of the Company’s total unrecognized tax benefits, if recognized, would impact the effective income tax rate.

In accordance with the disclosure requirements as described in ASC Topic 740, Income Taxes, the Company classified uncertain tax positions as non-current income tax liabilities unless expected to be paid in one year. The Company’s continuing practice is to recognize interest and/or penalties related to income tax matters in income tax expense. For the years ended December 31, 2020, 2019, and 2018, the Company recognized approximately $(0.1) million, $0.1 million, and $(0.5) million, respectively, in interest and penalties as income tax (benefit) expense in the Consolidated Statements of Operations. The Company had approximately $0.1 million for the payment of interest and penalties accrued at both December 31, 2020 and 2019 in the Consolidated Balance Sheets.

 

120

Table of Contents

The Company believes it is reasonably possible that approximately $2.4 million of its remaining unrecognized tax positions, primarily attributable to withholding obligations and the valuation of intercompany transactions, may decrease by the end of 2021 as we reach settlements with taxing authorities or certain statute of limitations expire.

In November 2018, the Company completed a reorganization of its international intellectual property company structure. This international restructuring generated a step-up in local tax basis, which under ASC Topic 740-10-25-20 as amended by ASU 2016-16, required the Company to record deferred tax assets of $100.8 million. Due to uncertainties surrounding the realization of a portion of these deferred tax assets, a valuation allowance of approximately $96.7 million was recorded.

The Company is subject to routine compliance reviews on various tax matters around the world in the ordinary course of business. Currently, the only active audit is with the U.S. Internal Revenue Service for 2014 – 2016 tax years. California is subject to examination in all years due to prior year net operating losses and research and development credits. Other major state and foreign jurisdictions remain subject to examination from 2016 and 2013 forward, respectively.

The Company made the accounting policy election to treat taxes due on U.S. inclusions in taxable income related to Global Intangible Low-Taxed Income as a current period expense when incurred (the "period cost method").

The Company has approximately $13.2 million of undistributed earnings attributable to operations in its controlled foreign corporations as of December 31, 2020. Due to recent tax reform in the United States and favorable treaties between the United States and countries in which its controlled foreign corporations operate, the Company has the ability to repatriate earnings without incurring additional tax liabilities. Accordingly, the Company has not recorded a liability for taxes associated with any future distributions of these undistributed earnings.

At December 31, 2020, the Company had $2.0 million, $50.9 million and $0.1 million of federal, state and foreign net operating loss carryforwards, respectively. Federal net operating loss carryforwards begin to expire in 2026, state net operating loss carryforwards begin to expire in 2021, and foreign net operating losses carry forward indefinitely.

The Company also has federal and California research and development income tax credit carryforwards of $11.4 million and $35.7 million, respectively. The federal credits will begin to expire in 2038, while the California credits can be carried forward indefinitely.

Due to the “change of ownership” provision of the Tax Reform Act of 1986, utilization of the Company’s net operating loss and credit carryforwards may be subject to an annual limitation against taxable income in future periods. As a result of any future ownership changes, the annual limitation of loss and credit carryforwards may cause them to expire before ultimately becoming available to reduce future income tax liabilities.

 

11.    Business Segment, Product and Geographic Information

The Company operates in one segment based upon the Company’s organizational structure, the way in which the operations and investments are managed and evaluated by the chief operating decision maker (“CODM”) as well as the lack of availability of discrete financial information at a lower level. The Company’s CODM reviews net sales at the product line offering level, and manufacturing, operating income and expenses, and net income at the Company-wide level to allocate resources and assess the Company’s overall performance. The Company shares common, centralized support functions, including finance, human resources, legal, information technology, and corporate marketing, all of which report directly to the CODM. Accordingly, decision-making regarding the Company’s overall operating performance and allocation of Company resources is assessed on a consolidated basis. The Company has disclosed the net sales for each of its product line offerings to provide the reader of the financial statements transparency into the operations of the Company.

The Company reports under two distinct product lines; spinal hardware and surgical support. The Company’s spinal hardware product line offerings include implants and fixation products. The Company’s surgical support product offerings include IONM services, disposables and biologics, and our capital equipment, all of which are used to aid spinal surgery.

 

121

Table of Contents

Net sales by product line was as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Spinal hardware

 

$

783,510

 

 

$

851,440

 

 

$

788,649

 

Surgical support

 

 

267,072

 

 

 

316,630

 

 

 

313,065

 

Total net sales

 

$

1,050,582

 

 

$

1,168,070

 

 

$

1,101,714

 

 

Net sales and property and equipment, net, by geographic area were as follows:

 

 

 

Net Sales

 

 

Property and Equipment, Net

 

 

 

Year Ended December 31,

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

 

2020

 

 

2019

 

United States

 

$

821,824

 

 

$

941,086

 

 

$

896,152

 

 

$

239,802

 

 

$

218,771

 

International (excludes Puerto Rico)

 

 

228,758

 

 

 

226,984

 

 

 

205,562

 

 

 

46,567

 

 

 

47,547

 

Total

 

$

1,050,582

 

 

$

1,168,070

 

 

$

1,101,714

 

 

$

286,369

 

 

$

266,318

 

 

12.    Contingencies

The Company is subject to potential liabilities under government regulations and various claims and legal actions that are pending or may be asserted from time-to-time. These matters arise in the ordinary course and conduct of the Company’s business and include, for example, commercial, intellectual property, environmental, securities and employment matters. The Company intends to continue to defend itself vigorously in such matters and when warranted, take legal action against others. Furthermore, the Company regularly assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in its financial statements.

During the year ended December 31, 2018, the Company settled all outstanding matters with Madsen Medical, Inc. for $27.8 million. The Company no longer has any remaining liability related to this matter.

An estimated loss contingency is accrued in the Company’s financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.

13.    Subsequent Events

On February 24, 2021, the Company completed the acquisition of Simplify Medical Pty Limited, or Simplify Medical, a developer of cervical artificial disc technology for cervical total disc replacement procedures. Pursuant to the terms of the definitive agreement, the Company agreed to make an upfront payment of $150.0 million at closing, subject to customary purchase price adjustments, plus additional future payments contingent upon milestones related to regulatory approval and net sales from products incorporating the Simplify Medical cervical artificial disc technology. In connection with the closing, the Company funded the $150.0 million upfront payment using available cash and investments on hand. Upon achievement of the regulatory milestone, Simplify Medical will be entitled to a one-time payment of up to $45.9 million which could become due and payable at any time between 2021 and 2024. Additional milestone payments, which are contingent upon net sales from products incorporating the Simplify Medical cervical artificial disc technology, will become payable in calendar years 2023, 2024 and 2025.

 

122

 EX-10.42 2 nuva-ex1042_270.htm EX-10.42 nuva-ex1042_270.htm

Exhibit 10.42

 

SEPARATION AGREEMENT
AND GENERAL RELEASE

THIS SEPARATION AGREEMENT AND GENERAL RELEASE (“Agreement”) is made and entered into by and between Matthew Link (“Executive”) and NuVasive, Inc. (the “Company”).

WHEREAS, the parties acknowledge and agree that Executive was employed by the Company as an at-will employee, and is an executive eligible for severance pay and benefits under the NuVasive, Inc. Amended and Restated Executive Severance Plan (the “Severance Plan”); and

WHEREAS, Executive’s employment has terminated on the separation date set forth on Appendix 1 attached hereto (“Separation Date”) and such termination is “involuntary” as defined in the Severance Plan, but not the result of a “Change in Control” as set forth in the Severance Plan; and

WHEREAS, the Parties entered into that certain letter agreement dated October 13, 2020 (the “Letter Agreement”);  and

WHEREAS, the Parties entered into that certain Amendment No. 1 to Proprietary Information, Inventions Assignment, and Restrictive Covenant Agreement dated October 13, 2020 (the “Amended PIIA”) that provides for, among other things, non-solicitation and non-competition obligations of Executive during the two-year period ending December 31, 2022; and

WHEREAS, the Parties entered into that certain General Consulting and Services Agreement effective as of October 13, 2020 (the “Consulting Agreement”), wherein Executive agreed to provide services to the Company as a consultant for the period January 1, 2021 through March 31, 2021; and

WHEREAS, in accordance with the terms of the Severance Plan and that certain Letter Agreement, Executive and the Company desire to enter into this Separation Agreement to provide for payment of certain severance pay and benefits conditioned on Executive providing a general release of claims and complying with the restrictive covenants and other conditions set out in this Agreement.

NOW, THEREFORE, in consideration of the mutual promises, agreements and valuable consideration contained herein, the sufficiency of which is hereby acknowledged, it is agreed as follows:

1.Severance Pay and Benefits.  In exchange for execution and non-revocation of this Agreement by Executive including the general release of claims herein, and only if Executive does not breach any of the provisions of this Agreement, including but not limited to Paragraph 3 (Return of Company Property), Paragraph 4 (Prohibited Conduct) and Paragraph 5 (Nondisclosure of Confidential Information):

 

 

(a)Severance Pay.  The Company will pay Executive severance pay in the aggregate amount set forth on Appendix 1 attached hereto (“Severance Pay”), which aggregate amount shall be paid in substantially equal installments over a period of one (1) year in accordance with the Company’s regular payroll practices beginning on the first regular payday after the Effective Date (as defined herein).  Executive acknowledges and agrees that this Severance Pay is fully taxable compensation subject to tax withholding and other required deductions.

(b)2020 Annual Bonus Eligibility. Executive will be eligible for an annual discretionary bonus for the year ended December 31, 2020, at the lesser of target or actual funding in an amount determined based on the Board-approved corporate funding level, and subject to the terms of the 2020 Annual Discretionary Bonus Plan (“Annual Discretionary Bonus”).  Such Annual Discretionary Bonus shall be paid in a lump sum cash payment no later than March 15, 2021.

(c)Outplacement Services.  The Company will provide outplacement assistance up to a total cost of $15,000.00) from a provider of the Company’s choosing.  Information about the outplacement service provider will be provided to Executive concurrent with the Effective Date. Executive may not receive cash or other severance benefits in lieu of outplacement service.

(d)Executive acknowledges that the right to receive some or all of the compensation and benefits provided by this Agreement is good and valuable consideration for the general release Executive is making in this Agreement and is in addition to any consideration to which he may already be entitled.  Further, Executive’s eligibility for the Severance Pay, Annual Discretionary Bonus, and other benefits herein are conditioned upon Executive’s compliance with the terms of this Agreement, the Letter Agreement, and the Amended PIIA.  Executive also acknowledges and agrees that neither the Company nor its attorneys have made any representations regarding the tax consequences, if any, of the Severance Pay and benefits provided in Paragraph 1.  Executive understands that to the extent additional taxes are found to be due and owing, the Executive will be solely responsible for payment of same.

(e)Executive and the Company agree that Executive has certain equity awards outstanding which are and shall remain subject to certain vesting conditions as of the Effective Date.  Except as otherwise set forth in the Letter Agreeement, Executive’s rights and interests under such equity awards will be determined pursuant to the terms of the relevant award agreements based on the terms and conditions thereof.  Except as otherwise set forth in the Letter Agreement, all long-term incentive awards subject to vesting after the Separation Date will terminate unvested and be forfeited in accordance with the terms of the relevant award agreements for such awards.

 

 

2.Release of Claims.

(a)General Release.  As a material inducement for the Company to enter this Agreement and as a condition to the right to receive Severance Pay, the Annual Discretionary Bonus and other benefits under the Severance Plan, Executive does hereby agree to release and forever discharge the Company, and all of its respective current and former parent corporations, subsidiaries, affiliates, predecessors, successors, divisions, other related entities, assigns, agents, attorneys, officers, directors, employees, benefit plans and fiduciaries thereof, and all of their respective current and former parent corporations, subsidiaries, affiliates, predecessors, successors, divisions, other related entities, assigns, agents, attorneys, officers, directors, employees, and heirs (referred to herein as “Releasees”) from any and all claims, complaints, liabilities or obligations of any kind whatsoever, whether known or unknown, arising in tort or contract, which Executive may have, now has, or has ever had arising from Executive’s employment with the Company or the termination thereof, or any other matter or event that may have occurred as of the Effective Date of this Agreement, including, but not limited to, unpaid wages, salary, overtime compensation, bonuses, commissions or other compensation of any sort or any benefits arising out of Executive’s employment (including but not limited to claims relating to stock and/or stock options); any other claims arising under any federal, state, or local laws and regulations relating to employment or employment discrimination; or for costs, fees or other expenses, including attorneys’ fees, incurred regarding these matters (“Released Claims”).  Executive understands and agrees that the Released Claims include, but are not limited to, any and all claims, complaints, liabilities or obligations under applicable federal, state or local statute, ordinance or common law, including, but not limited to, Title VII of the Civil Rights Act of 1964, as amended by the Civil Rights Act of 1991, 42 U.S.C. Section 1981, the Americans With Disabilities Act, Sections 503 and 504 of the Rehabilitation Act, the Age Discrimination in Employment Act (“ADEA”), the Older Workers’ Benefits Protection Act (“OWBPA”), the Executive Retirement Income Security Act, the Family and Medical Leave Act (“FMLA”), the Worker Adjustment and Retraining Notification Act (“WARN”), the Equal Pay Act,  the Uniform Services Employment and Reemployment Act of 1994, the Employee Retirement Income Security Act, the National Labor Relations Act (“NLRA”), the California Fair Employment and Housing Act (FEHA), the California Labor Code and the California Labor Code Private Attorneys General Act (PAGA). This release excludes claims for unemployment benefits, claims for worker’s compensation benefits, and any other claims, the release of which is prohibited by applicable state and/or federal law.

 

 

(b)No current claims, charges or unpaid wages.  Executive represents that as of the Effective Date of this Agreement, he has been paid all wages and/or salary earned and all accrued and unpaid vacation, and that he has accurately reported all hours worked, and is unaware of any pending lawsuit, claim, charge or complaint filed by him or on his behalf against the Releasees, or any of them.  Executive further represents that he (i) has reported to the Company any and all work-related injuries incurred during employment; (ii) the Company properly provided any leave of absence because of Executive or a family member’s health condition and Executive has not been subjected to any improper treatment, conduct or actions due to a request for or taking such leave; and (iii) Executive has provided the Company with written notice of any and all concerns regarding suspected bank fraud, wire fraud, mail fraud, securities fraud, any violation of a rule or regulation of the Securities and Exchange Commission (“SEC”), any violation of federal law, or any violation of the Company’s Code of Business Conduct, or any other ethical and compliance issues or violations on the part of the Company or any released person or entity.

(c)Release Includes Unknown Claims and Later Discovered Facts.  Executive understands that there is a risk that, subsequent to the execution of this Agreement, he may incur loss, damage or injury that he attributes to claims released herein.  Executive expressly assumes this risk.

(d)California General Release.  Executive acknowledges that he may discover facts different from or in addition to those which Executive now knows or believes to be true and that this Agreement shall be and remain effective in all respects notwithstanding such different or additional facts or the discovery thereof.   Executive hereby expressly waives any and all rights and benefits conferred upon him by the provisions of Section 1542 of the Civil Code of the State of California, and/or any analogous law of any other state.  Section 1542 states:

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.

Executive expressly agrees and understands that the release given by him pursuant to this Agreement applies to all unknown, unsuspected and unanticipated claims, liabilities and causes of action which Executive may have against the Company.

 

 

(e)Waiver of Right to Bring Released Claims.  Executive agrees not to bring or prosecute any Released Claims against the Releasees, either individually or collectively, whether acting on his own behalf or as part of a class or other group. Nothing in this Paragraph shall interfere with Executive’s right to file a charge with, or cooperate or participate in an investigation or proceeding conducted by, the Equal Employment Opportunity Commission (“EEOC”), or other state or federal agency, however, the consideration provided to Executive in this Agreement shall be the sole relief provided for the Released Claims and Executive will not be entitled to recover and Executive agrees to waive any monetary benefits or recovery, including any personal entitlement to reinstatement, back pay, or any other types of damages or injunctive relief in connection with any civil action brought on Executive’s behalf after his filing of any administrative charge against the Releasees in connection with any such charge or proceeding without regard to who has brought such charge or proceeding.

(f)Agreement as a Defense/Costs of Enforcement.  Executive agrees that if he asserts any claim, action, charge or suit against the Releasees, the Releasees, or any of them, may plead this Agreement as an absolute defense.  Executive further agrees that if Executive breaches this Agreement and brings a Released Claim against any of the Releasees or otherwise breaches this Agreement, Executive shall be liable for any and all expenses incurred by the person or entity who has to defend the action, including reasonable attorney’s fees; provided however, that this Paragraph 2(f) shall not apply to charges filed by Executive with the EEOC or other federal or state regulatory or law enforcement agency or to claims initiated by Executive to challenge the validity of the release of ADEA claims under this Agreement, including the knowing and voluntary nature of the ADEA release under the OWBPA.  

3.Return of Company Property.  Executive acknowledges that documents created during his affiliation with the Company are Company property, and that all such documents created or obtained by, or furnished to, Executive during the course of or in connection with his employment with the Company are the Company’s exclusive property.  Accordingly, Executive agrees that he will leave with the Company (or return to the Company) all originals and copies (whether paper or electronic) of such material in his possession by the close of business on the Separation Date, as well as any access keys, security codes, laptop, Company credit card(s), telephone card(s), and other Company property in his possession.  Executive promises that he has not and will not retain, distribute, or cause to be distributed, any original or duplicates of any Company property.  Executive further agrees that all personal charges to any corporate credit cards are the responsibility of Executive and will be paid by Executive to the credit card company in a timely manner.

 

 

4.Prohibited Conduct.  In the event that the Company, in its capacity as Plan Administrator of the Severance Plan, determines in its sole discretion that Executive has engaged in Prohibited Conduct, Executive shall (1) be disqualified from and cease to be eligible to participate in the Severance Plan, (2) forfeit all rights to any Severance Pay, Annual Discretionary Bonus or other benefits paid or payable pursuant to the Severance Plan and/or this Agreement, and (3) within thirty (30) days following written notice from the Company, pay to the Company an amount equal to the aggregate amount of Severance Pay, Annual Discretionary Bonus or benefits Executive received in cash pursuant to the Severance Plan and/or this Agreement.  For purposes of this Agreement, “Prohibited Conduct” means conduct in violation of the Amended PIIA.  Any determination of Prohibited Conduct shall be made by the Plan Administrator in accordance with the terms of the Severance Plan, and Executive shall have the right to pursue claims with respect thereto in accordance with the claims procedures set forth in the Severance Plan.  Notwithstanding anything contained herein to the contrary, Prohibited Conduct shall not include communication by Executive with any government agency, commission or regulator or participation by Executive in any investigation or proceeding that may be conducted by any government agency, commission or regulator, but only to the extent that such communication is required or permitted by law.

5.Non-Disclosure of Confidential Information.  Executive agrees to keep confidential all proprietary and Confidential Information regarding the Company or its parent corporation(s), subsidiaries, affiliates, or any Releasee, including, but not limited to, technical, research, business, development, and financial information, confidential information about employees, confidential information and material relating to any customer, vendor, licensee, or other party transacting business with the Company, and all other information disclosed to Executive, or to which Executive had access during the period of his employment with the Company, for which there is any reasonable basis to believe is, or which appears to be treated by the Company or relevant Releasee, as confidential information (“Confidential Information”). Executive further agrees not to release, use, or disclose Confidential Information except with the prior written permission of the Company.  The obligations in this paragraph supplement, and are in addition to any obligations Executive has under either a separate agreement concerning confidentiality and/or applicable law concerning the treatment of confidential information and/or trade secrets. Notwithstanding the obligations concerning confidentiality contained in this Agreement, the Company and Executive understand and agree that, pursuant to 18 USC § 1833(b), Executive shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made: (1) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney, and solely for the purpose of reporting or investigating a suspected violation of law; or (2) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  In addition, if Executive files a lawsuit for retaliation for reporting a suspected violation of law, Executive may disclose the trade secret to the Executive’s attorney and use the trade secret information in the court proceeding, provided that Executive files any document containing the trade secret under seal and does not disclose the trade secret, except pursuant to a court order.

 

 

6.Confidentiality of Terms of Agreement.  As an additional material inducement for the Company to enter this Agreement, Executive agrees to keep confidential any discussions with the Company concerning this Agreement, and will not disclose the provisions hereof to anyone except Executive’s spouse, attorney(s) and tax advisor(s) or except as required by law.  Executive agrees that in the event of disclosure to any of the above-referenced persons, Executive will advise such person(s) to whom the disclosure is made, in advance, of the obligation to preserve and maintain the confidentiality of the terms and conditions set forth herein.  Any further disclosure, other than as authorized above, shall constitute a breach of this Agreement.  If Executive breaches this provision, it would be impracticable or difficult to affix the actual damages to the Company, therefore Executive agrees that in the event of each and any such breach, Executive shall pay the Company as liquidated damages, and not as a penalty, the total sum of $5,000, which represents reasonable compensation for the loss incurred because of such breach, plus any attorneys’ fees and costs associated with the enforcement of this provision.

7.Whistleblower Activities Protected.  Notwithstanding any of the above, nothing in this Agreement shall interfere with Executive’s right to file a charge with, or cooperate or participate in an investigation or proceeding conducted by, the Department of Justice, Securities Exchange Commission, U.S. Congress, and any federal agency Inspector General, or any other disclosures that are protected under the whistleblower provisions of federal or state law or regulation.  Executive need not seek prior authorization from Company to make any such reports or disclosures, nor notify the Company that such reports or disclosures have been made.

8.

Knowing and Voluntary Execution.  Executive understands and agrees that he:

(a)May, but is not required to, take up to twenty-one (21) calendar days from the date he is presented this Agreement to consider whether or not he desires to execute this Agreement (with the understanding that to the extent, if any, changes are made to this Agreement at Executive’s request, such revisions do not re-start the twenty-one (21)-day consideration period);

(b)Knowingly and voluntarily agrees to all of the terms set forth in this Agreement and to be bound by this Agreement;

(c)Is hereby advised in writing to consult with an attorney and tax advisor of his choice prior to executing this Agreement and has had the opportunity and sufficient time to seek such advice;

(d)Agrees that some or all of the Severance Pay and benefits provided pursuant to this Agreement and the Severance Plan are in addition to any consideration to which he may already be entitled absent execution of this Agreement;

(e)Will not be entitled to a re-computation of any employment benefits based on amounts paid in lieu of notice and/or Severance Pay;

 

 

(f)Understands that rights or claims under the ADEA that may arise after the date this Agreement is executed are not waived; and

(g)May revoke this Agreement at any time during the seven (7) calendar day period immediately after Executive signs and delivers this Agreement to the Company. Executive also understands that any revocation of this Agreement must be made in writing and delivered to NuVasive, Inc. at 7475 Lusk Blvd., San Diego, CA 92121, attention Nathaniel Sisitsky, General Counsel, within the seven (7) day period. Executive understands that this Agreement is not effective, and Executive is not entitled to the Severance Pay and benefits provided herein, until the expiration of this seven (7) calendar day revocation period.  Executive understands that upon the expiration of such seven (7) day revocation period, this entire Agreement will be binding upon Executive and will be irrevocable.  The “Effective Date” of this Agreement shall be the eighth day after Executive has accepted this Agreement, provided the Agreement is not timely revoked.

9.Governing Law, Venue, and Jurisdiction.  Except to the extent preempted by the Employee Retirement Income Security Act of 1974, as amended, or other federal laws, this Agreement is governed by and construed in accordance with the laws of the State of Delaware, without regard to any conflict of laws rule or principle which might refer the governance or construction of this Agreement to the laws of another jurisdiction.  The Parties agree that any dispute relating to or arising out of this Agreement shall be heard and decided exclusively in a state or federal court of competent jurisdiction in the State of Delaware.  Executive also agrees and acknowledges that prior to filing any action to enforce any rights hereunder, Executive is required to exhaust Executive’s administrative remedies provided under the Severance Plan.  To the extent, if any, Executive’s agreement to have this Agreement so interpreted and enforced under Delaware law is found unlawful, this Agreement will be interpreted and enforced in accordance with the laws of the state(s) in which Executive reside(s)(d) at the time(s) relevant to the specific dispute.

10.Representations. The parties to this Agreement represent and acknowledge that in entering and executing this Agreement, they have not relied upon any representations or statements made by any other party to this Agreement, or by the agents, representatives, or attorneys of any other party, with regard to the subject matter, basis, or effect of this Agreement.

 

 

11.Agreement to Arbitrate All Claims.  In the event of any dispute arising under or including any provisions of this Agreement, Executive and Company agree to submit the dispute to binding arbitration before a mutually agreed upon arbitrator in accordance with the Federal Arbitration Act (“FAA”), 9 U.S.C., section 1, et seq.  The arbitration shall be conducted in San Diego, California by JAMS, Inc. (“JAMS”) or its successors, under JAMS’ then-applicable rules.  A neutral arbitrator shall be selected by both Executive and the Company, and shall: (1) have the authority to compel adequate discovery for the resolution of the dispute; (2) have the authority to award monetary damages and any and all other remedies that would be available in court, governed by the substantive Laws of the State of Delaware; and (c) issue a written arbitration decision including the arbitrators’ essential findings and conclusions and a statement of the award.  The Parties shall be entitled to all rights and remedies that either would be entitled to pursue in a court of law; provided, however, that either party may seek to obtain injunctive relief in court to prevent irreparable harm pending the conclusion of arbitration.  Each party will pay the fees for their own counsel, subject to any remedies to which that party may later be entitled under applicable law.  However, in all cases where required by applicable law, the Company will pay the arbitrator’s fees and arbitration costs.  If under applicable law the Company is not required to pay the arbitrator’s fees and costs, then such fees and costs will be apportioned equally between each set of adverse parties. The decision of the Arbitrator shall be final and binding on Executive and the Company.  

12.Entire Agreement.  This Agreement, the Amended PIIA and the Letter Agreement set forth the entire agreement between the parties hereto and fully supersedes any and all prior agreements or understandings, written or oral, between the parties hereto pertaining to the subject matter hereof.  However, Executive agrees to abide by the terms of the Amended PIIA and the Letter Agreement that Executive entered into with the Company in exchange for the consideration provided under this Agreement.  This Agreement cannot be amended or modified, unless such amendment or modification is in writing and signed by an authorized representative of the Company and the Executive.  Notwithstanding this paragraph, nothing in this Agreement is intended to reduce in any way Executive’s post-termination obligations, if any, contained in any separate agreement containing post-employment obligations or restrictions, including any restrictive covenants.  To the extent, if any, Executive violates the promises made in this Agreement, the Amended PIIA, or the Letter Agreement, the Company may cease making any further payments to Executive under this Agreement, and may pursue any other appropriate remedy against Executive, without limiting Executive’s release of claims contained herein.  

13.Representation by Independent Legal Counsel.   Executive represents and warrants that Executive has been individually represented by independent legal counsel, Bonnie Stokes, Esq., in negotiating the terms of this Agreement, including, but not limited to, the provisions relating to Governing Law, Venue and Jurisdiction.  Executive has engaged such legal counsel in accordance with California Labor Code Section 925 with the specific intent to designate the substantive laws of the State of Delaware as the choice of law to be applied to this Agreement and to designate the State of Delaware for venue and jurisdiction, in accordance with Section 9 of this Agreement.

 

 

14.Severability.  Should any court of competent jurisdiction declare any provision of this Agreement to be wholly or partially illegal, invalid, or unenforceable, the offending provision shall be stricken and all remaining provisions shall remain in full force and effect and shall be unaffected by such declaration.

15.No Admission of Liability.  This Agreement shall not in any way be construed as an admission by the Company of any improper actions or liability whatsoever as to Executive or any other person, and the Company specifically disclaims any liability to or improper actions against Executive or any other person, on the part of the Releasees.

16.Waiver of Breach.  The failure by either party to insist upon the performance of any one or more terms, covenants or conditions of this Agreement shall not be construed as a waiver or relinquishment of any right granted hereunder or of any future performance of any such term, covenant or condition, and the obligation of either party with respect hereto shall continue in full force and effect, unless such waiver shall be in writing and signed by the Company and Executive.

17.Not Aware of Violations.  Executive represents and agrees that he is not aware of any conduct by the Company or any other Releasees that may violate any federal, state or local law, rule or regulation.  

18.Notice and Cooperation.  Executive agrees that if he is solicited or contacted by any law firm or agent of any law firm regarding the Company or his employment with the Company, or if he is ordered or subpoenaed to testify or produce information in connection with any claim against the Company, he will immediately notify the Company by contacting the Company’s General Counsel.  Executive also agrees to make himself fully and reasonably available to assist the Company and its representatives with any investigation or with its prosecution and/or defense of any legal proceedings involving matters of which he may have relevant knowledge.

19.No Assignment. The Executive represents and warrants that he has made no assignment, and will make no assignment, of any claim, action, or right of any kind whatsoever, embodied in any of the matters referred to in this Agreement, and that no person or entity of any kind had or has any interest in any of the demands, obligations, actions, claims, debts, liabilities, rights, contracts, damages, attorneys’ fees, costs, expenses, losses, or claims referred to in this Agreement. By signing this Agreement, Executive has released all claims against the Releasees on behalf of Executive’s self, heirs, spouse, representatives, attorneys, advisors, family members, agents, or assigns.

20.No Rehire Rights.  Executive understands that as part of the consideration provided to Company under this Agreement, and to the extent permitted by law, he will not be eligible for hire or rehire by any of the Releasees and agrees that if he should apply for employment with any such entity, that entity may use this Agreement as the basis to withdraw any offer of employment and/or terminate the employment relationship.

 

 

21.Headings.  The headings in this Agreement are for convenience only and shall not be considered in interpreting the provisions hereof.

22.Assignment. Company may assign this Agreement to any successor, affiliate or third party without obtaining the consent of Executive.

23.Internal Revenue Code Section 409A.

(a)It is the intent of Executive and the Company that the termination of the employment of Executive pursuant to this Agreement constitute a “separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h).

(b)It is intended that this that the payments and benefits provided under this Agreement are exempt from or comply with the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (“Section 409A”), and this Agreement should be interpreted and construed in such a manner.

(c)If a payment obligation under this Plan arises on account of the Executive’s separation from service while the Executive is a “specified employee” (as defined under Section 409A and determined in good faith by the Compensation Committee), any payment of “deferred compensation” (as defined under Treasury Regulation Section 1.409A-1(b)(1), after giving effect to the exemptions in Treasury Regulation Sections 1.409A-1(b)(3) through (b)(12)) that is scheduled to be paid within six (6) months after such separation from service shall accrue with interest and shall be paid within 15 days after the end of the six-month period beginning on the date of such separation from service or, if earlier, within 15 days after the appointment of the personal representative or executor of the executive’s estate following his or her death. For purposes of the preceding sentence, interest shall accrue at the six (6)-month Libor rate.

(d)Each payment and benefit payable under this Agreement, and each other benefit required to be aggregated with the payment and benefits under this Agreement pursuant to Section 409A, is hereby designated as a separate payment, as provided in Treasury Regulation Section 1.409A-2(b)(2)(iii), and will not collectively be treated as a single payment.

(e)To the extent required to avoid accelerated taxation and/or tax penalties under Section 409A, amounts reimbursable to Executive under this Agreement shall be paid to Executive on or before the last day of the year following the year in which the expense was incurred, the amount of expenses eligible for reimbursement (and in-kind benefits provided to Executive) during one year may not affect amounts reimbursable or provided in any subsequent year, and the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.

 

 

(f)The Company makes no representation that any or all of the payments described in this Agreement will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment. Executive understands and agrees that Executive shall be solely responsible for the payment of any taxes, penalties, interest or other expenses incurred by Executive on account of non-compliance with Section 409A.

PLEASE READ CAREFULLY. THIS SEPARATION AGREEMENT AND GENERAL RELEASE INCLUDES THE RELEASE OF ALL CLAIMS AGAINST THE COMPANY, KNOWN OR UNKNOWN, THAT MAY HAVE OCCURRED AS OF THE DATE OF THIS AGREEMENT, INCLUDING CLAIMS BROUGHT UNDER THE AGE DISCRIMINATION IN EMPLOYMENT ACT.

IN WITNESS WHEREOF, the parties have entered into this Separation Agreement and General Release.

EXECUTIVE:

_/s/ Matthew Link__________________________
Printed Name: Matthew Link

 

Date:1/21/21

NUVASIVE, INC.

 

By:

_/s/ Lucas Vitale______            ___________
Lucas Vitale
Leader, Global Human Resources

Date:Jan 28, 2021

 

 

 

 

 

Appendix 1

 

Executive:

 

Matthew Link

Separation Date:

 

December 31, 2020

Severance Pay:

 

$575,934.00 , paid in substantially equal bi-weekly installments over a period of one (1) year in accordance with the Company’s regular payroll practices.

 

 

 

 

 

 

 

 

[Appendix 1 to Separation Agreement and General Release]

 

 EX-10.48 3 nuva-ex1048_269.htm EX-10.48 nuva-ex1048_269.htm

Exhibit 10.48

 

 

January 1, 2019

 

Lucas S. Vitale

XXX

XXX

Dear Lucas,

Congratulations on your promotion to the role of Leader, Global Human Resources. Your external / business card title is Chief Human Resources Officer. Your commitment and dedication to your work and the continued success of NuVasive sets an example for our Shareowners and is instrumental in our efforts to transform spine surgery and change lives. In this role you will report to me, Chris Barry, Chief Executive Officer. We would like for you to begin your role in this capacity on January 1, 2019.

 

I am pleased to present you with changes to your compensation package, effective January 1, 2019 and detailed below.

JOB TITLE, CAREER BAND & NEW COMPENSATION
Internal Job Title:  Leader, Global Human Resources
Career Band: P12

Compensation and 2019 Annual Bonus target percentage:

 

Current

New

Change

Annual Base Salary

(effective January 1, 2019)

$273,892

$340,000

24%

 

 

 

 

Annual Bonus Target %*

(effective January 1, 2019)

35%

60%

 

 

 

 

 

Annual Target Total Cash Opportunity

$369,754

$544,000

47%

* Above table is for illustrative purposes only. You are eligible for the discretionary annual corporate bonus plan which depends upon the Company’s successful achievement of its operational goals and your overall performance against your goals. This bonus requires that you be employed in good standing on the payout date (which is generally the first week of March, in the following year). Bonus target changes after April 1 of the plan year are adjusted to account for changes during the plan year.  Your Bonus Target amount shall equal the sum of your Eligible Earnings for the period of time in role multiplied by the respective Target Bonus Percentage for each bonus-eligible role you occupied during the plan year.

 

We expect to provide you with a 2019 annual LTI award that has a grant face value of $600,000, which is expected to be made in April 2019. The value and form of award is subject to approval by NuVasive’s Board of Directors or its delegate and will be governed by the terms of the applicable grant agreement(s).

 

Also, you will be eligible for an individual Change-in-Control Agreement (which requires a “double-trigger” of events before any respective severance benefits are payable) with a severance multiple of 1.5x.

 

 

 

 

 

I appreciate your contributions in taking NuVasive forward in 2019 and look forward to the work our team will do in helping NuVasive own the spine market. If you have any questions regarding your compensation, please don’t hesitate to reach out to me.

 

Keep up the great work and let’s crush it!

 

To an outstanding 2019,

 

/s/ Chris Barry

 

Chris Barry

Chief Executive Officer

 

Please sign below indicating your understanding and acceptance of this new role and return the fully executed letter to Karen Osgood. You should keep a copy of this letter for your records.

 

/s/ Lucas Vitale

1/2/2019

Lucas S. Vitale

Date

 

 

 EX-10.49 4 nuva-ex1049_268.htm EX-10.49 nuva-ex1049_268.htm

Exhibit 10.49

 

 

October 25, 2019

 

Dale A. Wolf

XXX

XXX

Dear Dale,

Congratulations on your promotion to the role of Leader, Global Operations with NuVasive, Inc. Your external / business card title is Senior Vice President, Global Operations. Your commitment and dedication to your work and the continued success of NuVasive sets an example for our Shareowners and is instrumental in our efforts to transform spine surgery and change lives. In this role you will be based in Denver, Colorado and continue to report to me. We would like for you to begin your role in this capacity on January 1, 2020.

 

I am pleased to present you with changes to your compensation package, effective January 1, 2020 and detailed below.

JOB TITLE, CAREER BAND & NEW COMPENSATION
Internal Job Title:  Leader, Global Operations
Career Band: P12

Compensation and 2020 Annual Bonus target percentage:

 

Current

New

Change

Annual Base Salary

(effective January 1, 2020)

$260,000

$340,000

31%

 

 

 

 

Annual Bonus Target %*

(effective January 1, 2020)

40%

60%

 

 

 

 

 

Annual Target Total Cash Opportunity

$364,000

$544,000

49%

* Above table is for illustrative purposes only. You are eligible for the discretionary annual corporate bonus plan which depends upon the Company’s successful achievement of its operational goals and your overall performance against your goals. This bonus requires that you be employed in good standing on the payout date (which is generally the first week of March, in the following year). Bonus target changes after April 1 of the plan year are adjusted to account for changes during the plan year.  Your Bonus Target amount shall equal the sum of your Eligible Earnings for the period of time in role multiplied by the respective Target Bonus Percentage for each bonus-eligible role you occupied during the plan year.

 

We expect to provide you with a 2020 annual LTI award that has a grant face value of $600,000, which is expected to be made in March 2020. The value and form of award is subject to approval by NuVasive’s Board of Directors or its delegate and will be governed by the terms of the applicable grant agreement(s).

 

Additionally, NuVasive will provide relocation assistance to assist in your move from Springboro, OH to Denver, Colorado and will be managed by the Company’s preferred vendor. The aggregate value of your relocation benefit will be subject to the Benefits Repayment Obligation explained below.

 

 

 

 

 

 

 

 

The Benefits Repayment Obligation means that, if within 24 months of your start date in the new role, you (a) voluntarily terminate your employment for any reason or (b) are terminated for “Cause” you will be required to repay to NuVasive the full gross amount of the payment or benefits received due and payable on the effective date of your termination of employment.

 

Benefits Repayment Obligation Schedule

Duration

Repayment Percentage

Within Months 0 - 24 of Start Date in New Role

100% of benefit received

After 24 Months of Start Date in New Role

0% of benefit received

 

 

For purposes of the Benefits Repayment Obligation, “cause” means theft, dishonesty or misconduct with respect to your employment or otherwise relating to the business of NuVasive; material neglect of duties; falsification of any employment or NuVasive’s records, improper use or disclosure of NuVasive’s trade secret or confidential information; violation of or failure to comply with NuVasive’s Code of Conduct; conviction or plea of nolo contendere to a felony if such conviction or plea is likely to harm the business or reputation of NuVasive; or other conduct that is likely to have an adverse effect on the name or public image of NuVasive.

 

I appreciate your contributions in taking NuVasive forward in 2020 and look forward to the work our team will do in helping NuVasive own the spine market. If you have any questions regarding your compensation, please don’t hesitate to reach out to me.

 

Keep up the great work!

 

To an outstanding 2020,

 

/s/ Chris Barry

 

Chris Barry

Chief Executive Officer

 

Please sign below indicating your understanding and acceptance of this new role and return the fully executed letter to Karen Osgood. You should keep a copy of this letter for your records.

 

/s/ Dale Wolf

28 – Oct - 2019

Dale A. Wolf

Date

 

 

 EX-21.1 5 nuva-ex211_19.htm EX-21.1 nuva-ex211_19.htm

Exhibit 21.1

 

Subsidiaries of NuVasive, Inc.

 

The following is a list of subsidiaries of the Company as of December 31, 2020, omitting subsidiaries which, considered in the aggregate, would not constitute a significant subsidiary as defined by Rule 1-02(w) of Regulation S-X.

 

Name

Jurisdiction of Incorporation

NuVasive Specialized Orthopedics, Inc.

Delaware

NuVasive Clinical Services Monitoring, Inc.

Delaware

NuVasive Technology International Limited

Malta

NuVasive Japan KK

Japan

 

 EX-23.1 6 nuva-ex231_7.htm EX-23.1 nuva-ex231_7.htm

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We consent to the incorporation by reference in the following Registration Statements:

 

(1) Registration Statement (Form S-3 Nos. 333-127634, 333-138047, and 333-140432) of NuVasive, Inc.,

 

(2) Registration Statement (Form S-8 No. 333-116546) pertaining to the 1998 Stock Option/Stock Issuance Plan, 2004 Equity Incentive Plan, and 2004 Employee Stock Purchase Plan of NuVasive, Inc.,

 

(3) Registration Statement (Form S-8 Nos. 333-149478, 333-172465, 333-186896 and 333-193705) pertaining to the 2004 Equity Incentive Plan, as amended and restated, and 2004 Employee Stock Purchase Plan of NuVasive, Inc.,

 

(4) Registration Statement (Form S-8 Nos. 333-196141 and 333-213476) pertaining to the 2014 Equity Incentive Plan of NuVasive, Inc., and

 

(5) Registration Statement (Form S-8 No. 333-209489) pertaining to the Ellipse Technologies, Inc. 2015 Incentive Award Plan;

 

of our reports dated February 25, 2021, with respect to the consolidated financial statements of NuVasive, Inc. and the effectiveness of internal control over financial reporting of NuVasive, Inc. included in this Annual Report (Form 10-K) of NuVasive, Inc. for the year ended December 31, 2020.

 

 

/s/ Ernst & Young LLP

 

San Diego, California

February 25, 2021

 

 EX-31.1 7 nuva-ex311_12.htm EX-31.1 nuva-ex311_12.htm

 

Exhibit 31.1

CERTIFICATION

I, J. Christopher Barry, certify that:

1.

I have reviewed this Annual Report on Form 10-K of NuVasive, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: February 25, 2021

 

/s/ J. Christopher Barry

 

 

J. Christopher Barry

 

 

Chief Executive Officer

 

 

 EX-31.2 8 nuva-ex312_18.htm EX-31.2 nuva-ex312_18.htm

 

Exhibit 31.2

CERTIFICATION

I, Matthew K. Harbaugh, certify that:

1.

I have reviewed this Annual Report on Form 10-K of NuVasive, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: February 25, 2021

 

/s/ Matthew K. Harbaugh

 

 

Matthew K. Harbaugh

 

 

Executive Vice President and Chief Financial Officer

 

 

 EX-32.1 9 nuva-ex321_17.htm EX-32.1 nuva-ex321_17.htm

 

Exhibit 32.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of NuVasive, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Annual Report”), I, J. Christopher Barry, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.      The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.      The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: February 25, 2021

 

/s/ J. Christopher Barry

 

 

J. Christopher Barry

 

 

Chief Executive Officer

 

In connection with the Annual Report, I, Matthew K. Harbaugh, Executive Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

1.      The Annual Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.      The information contained in the Annual Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: February 25, 2021

 

/s/ Matthew K. Harbaugh

 

 

Matthew K. Harbaugh

 

 

Executive Vice President and Chief Financial Officer

 

 

 GRAPHIC 10 gtolyqbxw5xl000001.jpg GRAPHIC begin 644 gtolyqbxw5xl000001.jpg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end GRAPHIC 11 gh5y20ivjrjj000001.jpg GRAPHIC begin 644 gh5y20ivjrjj000001.jpg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

,5[110!EZ!X+_%WXA^%M7^&>JZ=I>K07MU-=QV@CA895D=9&?!P3'A,!URI)&#Z ' >* M/B5%XA^,.FZO::?/J^F:9*L>FV*N\33R=G &X[C)M(^4%E1 1UJOXV^)]GXT MEL-9M]-_L77]'E26TF\T3B==V=I_=CYD8*RAOEP9.Y ;WOX8>"8?!/@ZUM7M MXTU2X02W\@ W-(23(CN M4'&'P"0P'1@#P-IXP5 .X\*^(;?Q7X7T_7+5=L=W$'*9)\MP<.F2!G:P89QS MC(XK8KPSX1OJ7P_\;ZA\.]=,9-V@O+.2(-Y;R; 6V$H"P*J
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�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end GRAPHIC 12 gmvdv5xtxrs3000001.jpg GRAPHIC begin 644 gmvdv5xtxrs3000001.jpg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end EX-101.SCH 13 nuva-20201231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Consolidated Statements of Comprehensive Income link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Consolidated Statements of Equity link:calculationLink link:presentationLink link:definitionLink 100060 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100070 - Statement - Consolidated Statements of Cash Flows (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Organization and Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Balance Sheet Details link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Marketable Securities link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Financial Instruments and Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Business Combinations link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Indebtedness link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Commitments link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Business Segment, Product, and Geographic Information link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Contingencies link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Organization and Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Organization and Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Balance Sheet Details (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Marketable Securities (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Indebtedness (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Commitments (Tables) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Business Segment, Product and Geographic Information (Tables) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Organization and Significant Accounting Policies (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Organization and Significant Accounting Policies - Summary of Changes in Allowance for Credit Losses (Details) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Organization and Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share (Details) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Balance Sheet Details - Property and Equipment Net (Details) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Balance Sheet Details (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Balance Sheet Details - Goodwill and Intangible Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Balance Sheet Details - Changes to Goodwill (Details) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Balance Sheet Details - Future Amortization Expense Related to Intangible Assets (Details) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Marketable Securities - Schedule of Carrying Value and Amortized Cost of Company's Marketable Debt Securities (Details) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Financial Instruments and Fair Value Measurements (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs (Details) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Recurring Fair Value Measurements of Contingent Consideration Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs (Details) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Indebtedness - Carrying Value of Senior Convertible Notes (Details) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Indebtedness - Carrying Value of Senior Convertible Notes (Details)2 link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Indebtedness - Carrying Value of Senior Convertible Notes (Parenthetical) (Details) link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Indebtedness (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Commitments (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100520 - Disclosure - Commitments - Right-of-use Assets and Lease Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100530 - Disclosure - Commitments - Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations (Details) link:calculationLink link:presentationLink link:definitionLink 100540 - Disclosure - Commitments - Future Minimum Annual Lease Payments under Capital, Operating and Financing Leases (Details) link:calculationLink link:presentationLink link:definitionLink 100550 - Disclosure - Commitments - Future Minimum Annual Lease Payments under Capital, Operating and Financing Leases (Details)2 link:calculationLink link:presentationLink link:definitionLink 100560 - Disclosure - Stockholders' Equity (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100570 - Disclosure - Stock-Based Compensation (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100580 - Disclosure - Stock-Based Compensation - Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements (Details) link:calculationLink link:presentationLink link:definitionLink 100590 - Disclosure - Stock-Based Compensation - Restricted Award Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100600 - Disclosure - Stock-Based Compensation - Performance-Based Restricted Stock Award Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100610 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details) link:calculationLink link:presentationLink link:definitionLink 100620 - Disclosure - Stock-Based Compensation - Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP (Details) link:calculationLink link:presentationLink link:definitionLink 100630 - Disclosure - Stock-Based Compensation - Stock Reserved for Future Issuance (Details) link:calculationLink link:presentationLink link:definitionLink 100640 - Disclosure - Income Taxes - Summary of Income Before Income Taxes By Region (Details) link:calculationLink link:presentationLink link:definitionLink 100650 - Disclosure - Income Taxes - Components of Income Tax Provision (Benefit) (Details) link:calculationLink link:presentationLink link:definitionLink 100660 - Disclosure - Income Taxes - Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate (Details) link:calculationLink link:presentationLink link:definitionLink 100670 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) link:calculationLink link:presentationLink link:definitionLink 100680 - Disclosure - Income Taxes (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100690 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details) link:calculationLink link:presentationLink link:definitionLink 100700 - Disclosure - Business Segment, Product and Geographic Information (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100710 - Disclosure - Business Segment, Product and Geographic Information - Schedule of Net Sales by Product Line (Details) link:calculationLink link:presentationLink link:definitionLink 100720 - Disclosure - Business Segment, Product and Geographic Information - Schedule of Net Sales and Net Property and Equipment by Geographical Area (Details) link:calculationLink link:presentationLink link:definitionLink 100730 - Disclosure - Contingencies (Details Textual) link:calculationLink link:presentationLink link:definitionLink 100740 - Disclosure - Subsequent Events (Details) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 14 nuva-20201231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 15 nuva-20201231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 16 nuva-20201231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Income tax reconciliation change in valuation allowance including accounting standard adjustments. Income tax reconciliation net tax benefit on international restructuring. Income tax reconciliation return to provision adjustments. Income tax reconciliation acquisition related charges. Income tax reconciliation tax reserve. Deferred tax assets amortization. Deferred tax assets tax credit carry forwards general business and other. Deferred tax assets lease liability. Deferred tax assets zero coupon notes. Deferred tax liabilities, depreciation. Deferred tax liabilities right-of-use assets. Cover [Abstract] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Entity Current Reporting Status Entity Current Reporting Status Document Type Document Type Document Period End Date Document Period End Date Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Current Fiscal Year End Date Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Well Known Seasoned Issuer Entity Voluntary Filers Entity Voluntary Filers Entity Filer Category Entity Filer Category ICFR Auditor Attestation Flag Icfr Auditor Attestation Flag Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Shell Company Entity Shell Company Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of 12(b) Security Security12b Title Entity Interactive Data Current Entity Interactive Data Current Security Exchange Name Security Exchange Name Entity Incorporation, State or Country Code Entity Incorporation State Country Code Document Annual Report Document Annual Report Document Transition Report Document Transition Report Entity Public Float Entity Public Float Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] Current assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Short-term marketable securities Available For Sale Securities Debt Securities Current Accounts receivable, net of allowances of $20,631 and $17,019, respectively Accounts Receivable Net Current Inventory, net Inventory Net Prepaid income taxes Prepaid Taxes Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Intangible assets, net Finite Lived Intangible Assets Net Goodwill Goodwill Operating lease right-of-use assets Operating Lease Right Of Use Asset Deferred tax assets Deferred Income Tax Assets Net Restricted cash and investments Restricted Cash And Investments Noncurrent Other assets Other Assets Noncurrent Total assets Assets LIABILITIES AND EQUITY Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable and accrued liabilities Accounts Payable And Accrued Liabilities Current Contingent consideration liabilities Business Combination Contingent Consideration Liability Current Accrued payroll and related expenses Employee Related Liabilities Current Operating lease liabilities Operating Lease Liability Current Income tax liabilities Taxes Payable Current Senior convertible notes Convertible Notes Payable Current Total current liabilities Liabilities Current Long-term senior convertible notes Convertible Long Term Notes Payable Deferred tax liabilities Deferred Income Tax Liabilities Net Operating lease liabilities Operating Lease Liability Noncurrent Other long-term liabilities Other Liabilities Noncurrent Commitments and contingencies Commitments And Contingencies Redeemable equity component of senior convertible notes Temporary Equity Carrying Amount Attributable To Parent Stockholders’ equity: Stockholders Equity [Abstract] Preferred stock, $0.001 par value; 5,000 shares authorized, none outstanding Preferred Stock Value Common stock, $0.001 par value; 150,000 and 120,000 shares authorized at December 31, 2020 and December 31, 2019, respectively; 57,945 shares issued and 51,376 outstanding at December 31, 2020; 57,525 issued and 52,145 outstanding at December 31, 2019 Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income Loss Net Of Tax Retained earnings Retained Earnings Accumulated Deficit Treasury stock at cost; 6,569 shares and 5,380 shares at December 31, 2020 and December 31, 2019, respectively Treasury Stock Value Total equity Stockholders Equity Including Portion Attributable To Noncontrolling Interest Total liabilities and equity Liabilities And Stockholders Equity Accounts receivable, allowances Allowance For Doubtful Accounts Receivable Current Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Treasury stock at cost, shares Treasury Stock Shares Amortization of intangible assets exclude cost of goods sold amortization. Purchase of in-process research and development. Business combination integration related costs (recoveries). Income Statement [Abstract] Statement [Table] Statement [Table] Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] Product [Member] Product [Member] Service [Member] Service [Member] Statement [Line Items] Statement [Line Items] Net sales: Revenues [Abstract] Net sales Revenue From Contract With Customer Excluding Assessed Tax Cost of sales (excluding below amortization of intangible assets): Cost Of Revenue [Abstract] Cost of sales Cost Of Goods And Services Sold Gross profit Gross Profit Operating expenses: Operating Expenses [Abstract] Selling, general and administrative Selling General And Administrative Expense Research and development Research And Development Expense Amortization of intangible assets Amortization Of Intangible Assets Exclude Cost Of Goods Sold Amortization Purchase of in-process research and development Purchase Of In Process Research And Development Litigation liability loss Gain Loss Related To Litigation Settlement Business transition costs Business Combination Integration Related Costs Recoveries Total operating expenses Operating Expenses Interest and other expense, net: Nonoperating Income Expense [Abstract] Interest income Investment Income Interest Interest expense Interest Expense Debt Other (expense) income, net Other Nonoperating Income Expense Total interest and other expense, net Nonoperating Income Expense (Loss) income before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax benefit (expense) Income Tax Expense Benefit Consolidated net (loss) income Net Income Loss Net (loss) income per share: Earnings Per Share [Abstract] Basic Earnings Per Share Basic Diluted Earnings Per Share Diluted Weighted average shares outstanding: Weighted Average Number Of Shares Outstanding [Abstract] Basic Weighted Average Number Of Shares Outstanding Basic Diluted Weighted Average Number Of Diluted Shares Outstanding Statement Of Income And Comprehensive Income [Abstract] Consolidated net (loss) income Profit Loss Other comprehensive income (loss): Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Unrealized gain on marketable securities, net of tax Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax Translation adjustments, net of tax Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax Other comprehensive income (loss): Other Comprehensive Income Loss Net Of Tax Total consolidated comprehensive (loss) income Comprehensive Income Net Of Tax Issuance of common stock in connection with royalty milestone achievement share. Issuance of common stock in connection with royalty milestone achievement value. Consideration paid in excess of non controlling interest. Adjustments to additional paid in capital convertible note hedge. Adjustments to additional paid in capital debt instrument convertible beneficial conversion feature. Adjustments to additional paid in capital reclassification of redeemable equity component of senior convertible notes. Stock issued during period value settlement of warrants. Convertible note settlement value. Equity component of convertible note settlement value. Statement Of Stockholders Equity [Abstract] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid In Capital [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income [Member] Retained Earnings (Accumulated Deficit) [Member] Retained Earnings [Member] Treasury Stock [Member] Treasury Stock [Member] Total Nuvasive, Inc. Stockholders' Equity [Member] Parent [Member] Non-controlling Interest [Member] Noncontrolling Interest [Member] Beginning Balance Beginning Balance, Shares Shares Issued Issuance of common stock under employee and director stock option and purchase plans Stock Issued During Period Value Share Based Compensation Issuance of common stock under employee and director equity option and purchase plans, Shares Stock Issued During Period Shares Share Based Compensation Stock-based compensation expense Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Tax benefits related to convertible note issuance Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Shares repurchased Stock Repurchased During Period Value Shares repurchased ,Shares Stock Repurchased During Period Shares Sale of warrants Adjustments To Additional Paid In Capital Warrant Issued Convertible note hedge Adjustments To Additional Paid In Capital Convertible Note Hedge Equity component of convertible note issuance Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Debt issuance costs attributable to convertible feature Adjustments To Additional Paid In Capital Debt Instrument Convertible Beneficial Conversion Feature Reclassification of redeemable equity component of senior convertible notes Adjustments To Additional Paid In Capital Reclassification Of Redeemable Equity Component Of Senior Convertible Notes Issuance of common stock in connection with royalty milestone achievement Issuance Of Common Stock In Connection With Royalty Milestone Achievement Value Issuance of common stock in connection with royalty milestone achievement, Shares Issuance Of Common Stock In Connection With Royalty Milestone Achievement Share Settlement of warrants Stock Issued During Period Value Settlement Of Warrants Stock issued during period shares settlement of warrants. Settlement of warrants, Shares Stock Issued During Period Shares Settlement Of Warrants Settlement of convertible note hedge Convertible Note Settlement Value Convertible note settlement shares. Settlement of convertible note hedge, Shares Convertible Note Settlement Shares Equity component of convertible note settlement Equity Component Of Convertible Note Settlement Value Equity component of convertible note settlement shares. Equity component of convertible note settlement, Shares Equity Component Of Convertible Note Settlement Shares Consolidated net income (loss) Consideration paid in excess of non-controlling interests Consideration Paid In Excess Of Non Controlling Interest Net loss attributable to non-controlling interests Net Income Loss Attributable To Nonredeemable Noncontrolling Interest Other comprehensive income (loss) Ending Balance Ending Balance, Shares Amortization of non-cash interest. Reserve on current asset. Payment of contingent consideration. Statement Of Cash Flows [Abstract] Operating activities: Net Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net (loss) income to net cash provided by operating activities: Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation Depletion And Amortization Purchase of in-process research and development Research And Development In Process Deferred income taxes Deferred Income Tax Expense Benefit Amortization of non-cash interest Amortization Of Non Cash Interest Stock-based compensation Share Based Compensation Net loss on strategic investments Gain Loss On Investments Net loss recognized on change in fair value of derivatives Derivative Gain Loss On Derivative Net Reserves on current assets Reserve On Current Asset Other non-cash adjustments Other Noncash Income Expense Changes in operating assets and liabilities, net of effects from acquisitions: Increase Decrease In Operating Capital [Abstract] Accounts receivable Increase Decrease In Accounts Receivable Inventory Increase Decrease In Inventories Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable and accrued liabilities Increase Decrease In Accounts Payable And Accrued Liabilities Accrued payroll and related expenses Increase Decrease In Employee Related Liabilities Income taxes Increase Decrease In Income Taxes Net cash provided by operating activities Net Cash Provided By Used In Operating Activities Investing activities: Net Cash Provided By Used In Investing Activities [Abstract] Acquisitions and investments Payments To Acquire Investments Proceeds from other investments Proceeds From Sale Of Other Investments Purchases of intangible assets Payments To Acquire Intangible Assets Purchases of property and equipment Payments To Acquire Property Plant And Equipment Purchases of marketable securities Payments To Acquire Available For Sale Securities Debt Proceeds from sales and maturities of marketable securities Proceeds From Sale And Maturity Of Marketable Securities Net cash used in investing activities Net Cash Provided By Used In Investing Activities Financing activities: Net Cash Provided By Used In Financing Activities [Abstract] Proceeds from the issuance of common stock Proceeds From Issuance Of Common Stock Payment of contingent consideration Payment Of Contingent Consideration Purchase of treasury stock Payments For Repurchase Of Common Stock Proceeds from issuance of convertible debt, net of issuance costs Proceeds From Convertible Debt Proceeds from sale of warrants Proceeds From Issuance Of Warrants Purchases of convertible note hedges Repayments Of Convertible Debt Proceeds from revolving line of credit Proceeds From Long Term Lines Of Credit Repayments on revolving line of credit Repayments Of Long Term Lines Of Credit Other financing activities Proceeds From Payments For Other Financing Activities Net cash provided by (used in) financing activities Net Cash Provided By Used In Financing Activities Effect of exchange rate changes on cash Effect Of Exchange Rate On Cash And Cash Equivalents Increase in cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents and restricted cash at beginning of period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of period Supplemental disclosure of non-cash transactions: Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract] Issuance of common stock in connection with royalty milestone achievement Stock Issued1 Supplemental cash flow information: Supplemental Cash Flow Information [Abstract] Interest paid Interest Paid Net Income taxes paid Income Taxes Paid Net Restricted cash Restricted Cash Noncurrent Total cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows Documents Incorporated by Reference Documents Incorporated By Reference [Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Organization and Significant Accounting Policies Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Balance Sheet Details Abstract Balance Sheet Details [Abstract] Balance Sheet Details Supplemental Balance Sheet Disclosures [Text Block] Investments Debt And Equity Securities [Abstract] Marketable Securities Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block] Financial Instruments and Fair Value Measurements Financial Instruments Disclosure [Text Block] Business Combination Description [Abstract] Business Combinations Business Combination Disclosure [Text Block] Debt Disclosure [Abstract] Indebtedness Debt Disclosure [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments Commitments Disclosure [Text Block] Stockholders Equity Note [Abstract] Stockholders' Equity Stockholders Equity Note Disclosure [Text Block] Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Stock-Based Compensation Disclosure Of Compensation Related Costs Share Based Payments [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Segment Reporting [Abstract] Business Segment, Product and Geographic Information Segment Reporting Disclosure [Text Block] Contingencies. Contingencies [Abstract] Contingencies Legal Matters And Contingencies [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Description of business. Organization, Consolidation and Presentation of Financial Statements [Abstract] Description of Business Description Of Business Policy [Text Block] Basis of Presentation and Principles of Consolidation Consolidation Policy [Text Block] Use of Estimates Use Of Estimates Recently Accounting Pronouncements Not Yet Adopted And Recently Adopted Accounting Standards New Accounting Pronouncements Policy Policy [Text Block] Revenue Recognition Revenue Recognition Policy [Text Block] Accounts Receivable and Related Valuation Accounts Receivables Policy [Text Block] Concentration of credit risk and significant customers. Concentration of Credit Risk and Significant Customers Concentration Of Credit Risk And Significant Customers Policy [Text Block] Fair Value of Financial Instruments Fair Value Of Financial Instruments Policy Cash and Cash Equivalents Cash And Cash Equivalents Policy [Text Block] Inventory, net Inventory Policy [Text Block] Goodwill and Intangible Assets Goodwill And Intangible Assets Policy [Text Block] Property and Equipment Property Plant And Equipment Policy [Text Block] Income Taxes Income Tax Policy [Text Block] Loss Contingencies Commitments And Contingencies Policy [Text Block] Comprehensive Income Stockholders Equity Policy [Text Block] Research and Development Research And Development Expense Policy Product shipment costs. Product Shipment Costs Product Shipment Costs Policy [Text Block] Business Transition Costs Business Combinations Policy Stock-based Compensation Share Based Compensation Option And Incentive Plans Policy Net Income Per Share Earnings Per Share Policy [Text Block] Summary of Changes in Allowance for Credit Losses Accounts Receivable Allowance For Credit Loss Table [Text Block] Computation of Basic and Diluted Earnings Per Share Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Property and Equipment Net Property Plant And Equipment [Text Block] Goodwill and Intangible Assets Schedule Of Intangible Assets And Goodwill Table [Text Block] Changes to Goodwill Schedule Of Goodwill [Text Block] Future Amortization Expense Related to Intangible Assets Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block] Accounts Payable and Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities Table [Text Block] Fair Value of Carrying Value and Amortized Cost of the Company's Marketable Securities. Schedule of Carrying Value and Amortized Cost of the Company's Marketable Debt Securities Fair Value Of Carrying Value And Amortized Cost Of Company S Marketable Securities Table [Text Block] Fair Value Disclosures [Abstract] Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block] Schedule of Estimated Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation Table [Text Block] Schedule of Inputs and Valuation Techniques Used in Recurring Level 3 Fair Value Measurements Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block] Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block] Carrying Value of Senior Convertible Notes Schedule Of Debt Instruments [Text Block] Lease liabilities and assets. Right-of-use Assets and Lease Liabilities Lease Liabilities And Assets Table [Text Block] Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations Lease Cost Table [Text Block] Future Minimum Annual Lease Payments under Operating and Financing Leases Contractual Obligation Fiscal Year Maturity Schedule Table [Text Block] Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Summary of Restricted Stock Units Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block] Schedule of Performance-Based Restricted Stock Units Schedule Of Nonvested Performance Based Units Activity Table [Text Block] Summary of Stock Option Activity under All Stock Plans Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP Schedule Of Share Based Payment Award Employee Stock Purchase Plan Valuation Assumptions Table [Text Block] Common stock reserved for future issuance. Common Stock Reserved for Future Issuance Common Stock Reserved For Future Issuance Table [Text Block] Summary of Income Before Income Taxes By Region Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block] Components of Income Tax Provision (Benefit) Schedule Of Components Of Income Tax Expense Benefit Table [Text Block] Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block] Significant Components of Deferred Tax Assets and Liabilities Schedule Of Deferred Tax Assets And Liabilities Table [Text Block] Summary of Unrecognized Tax Benefits Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block] Schedule of Net Sales by Product Line Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Text Block] Schedule of Net Sales and Net Property and Equipment by Geographical Area Schedule Of Revenues From External Customers And Long Lived Assets By Geographical Areas Table [Text Block] [Line Items] for Schedule of Organization and Significant Accounting Policies [Table] Schedule of organization and significant accounting policies. Schedule Of Organization And Significant Accounting Policies [Table] Schedule Of Organization And Significant Accounting Policies [Table] Cumulative Effect, Period of Adoption Cumulative Effect Period Of Adoption [Axis] Cumulative Effect, Period of Adoption Cumulative Effect Period Of Adoption [Domain] Cumulative Effect, Period of Adoption, Adjustment [Member] Cumulative Effect Period Of Adoption Adjustment [Member] Change in Accounting Principle, Type Adjustments For Change In Accounting Principle [Axis] Change in Accounting Principle, Type Change In Accounting Principle [Member] Accounting Standards Update 2020-06. ASU 2010-26 [Member] Accounting Standards Update202006 [Member] Subsequent Event Type Subsequent Event Type [Axis] Subsequent Event Type Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent Event [Member] ASU 2016-13 [Member] Accounting Standards Update201613 [Member] ASU 2017-04 [Member] Accounting Standards Update201704 [Member] ASU 2018-13 [Member] Accounting Standards Update201813 [Member] ASU 2018-15 [Member] Accounting Standards Update201815 [Member] ASU 2019-12 [Member] Accounting Standards Update201912 [Member] Accounting standards update twenty thousand twenty zero four. ASU 2020-04 [Member] Accounting Standards Update Twenty Thousand Twenty Zero Four [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Product Shipment [Member] Shipping And Handling [Member] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] 2017 and 2016 Acquisitions [Member] Series Of Individually Immaterial Business Acquisitions [Member] Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Performance-based restricted stock units. Performance Based Restricted Stock Units (PRSUs) [Member] Performance Based Restricted Stock Units [Member] Schedule Of Organization And Significant Accounting Policies [Line Items] Schedule Of Organization And Significant Accounting Policies [Line Items] Convertible debt liabilities Convertible Debt Deferred tax liabilities Deferred Tax Liabilities Additional paid-in capital Additional Paid In Capital Change in accounting principle, accounting standards update, adopted [true false] Change In Accounting Principle Accounting Standards Update Adopted Change in accounting principle, accounting standards update, adoption date Change In Accounting Principle Accounting Standards Update Adoption Date Change in accounting principle, accounting standards update, immaterial effect [true false] Change In Accounting Principle Accounting Standards Update Immaterial Effect Change in accounting principle, accounting standards update, early adoption [true false] Change In Accounting Principle Accounting Standards Update Early Adoption Allowance for doubtful accounts receivable increase (decrease) from foreign currency fluctuations. Allowance for credit loss at beginning of period Allowance For Doubtful Accounts Receivable Current-period provision for expected losses Provision For Doubtful Accounts Write-offs charged against the allowance Allowance For Doubtful Accounts Receivable Write Offs Recoveries of amounts previously written off Allowance For Doubtful Accounts Receivable Recoveries Changes resulting from foreign currency fluctuations Allowance For Doubtful Accounts Receivable Increase Decrease From Foreign Currency Fluctuations Allowance for credit losses at end of period Concentration risk number of customers. Customer represented greater than 10 percent Concentration Risk Number Of Customers Inventory, finished goods Inventory Finished Goods Inventory, work in progress Inventory Work In Process Inventory, raw materials Inventory Raw Materials Reserve for excess and obsolete inventory. Reserve for excess and obsolete inventory Reserve For Excess And Obsolete Inventory Number of Reportable Units Number Of Reporting Units Impairment of goodwill and intangible assets Goodwill And Intangible Asset Impairment Impairment charges related to goodwill Goodwill Impairment Loss Finite-Lived intangible assets, useful life Finite Lived Intangible Asset Useful Life Property and equipment, useful life Property Plant And Equipment Useful Life Translation Adjustment Functional to Reporting Currency, Net of Tax Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax Product shipment costs Business transition costs (recoveries) Vesting period for the award Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Earnings per share numerator. Earning per share. Earning per share. Earning Per Share [Table] Earning Per Share [Table] Stock options and ESPP. Stock Options and ESPP [Member] Stock Options And E S P P [Member] Restricted stock units and performance restricted stock units. RSUs and PRSUs [Member] Restricted Stock Units And Performance Restricted Stock Units [Member] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Senior Convertible Notes [Member] Convertible Debt Securities [Member] Earning Per Share [Line Items] Earning Per Share [Line Items] Numerator: Earnings Per Share Numerator [Abstract] Net (loss) income Denominator for basic and diluted net (loss) income per share: Weighted average common shares outstanding for basic Dilutive potential common stock outstanding: Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract] Incremental common shares from share based payments Incremental Common Shares Attributable To Share Based Payment Arrangements Weighted average common shares outstanding for diluted Basic net (loss) income per share Diluted net (loss) income per share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Stock options ESPP restricted stock units and performance restricted stock units. Stock options, ESPP, RSUs and PRSUs [Member] Stock Options E S P P Restricted Stock Units And Performance Restricted Stock Units [Member] Warrants [Member] Warrant [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Anti-dilutive securities excluded from computation of earnings per share Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Property Plant And Equipment [Abstract] Schedule Of Property Plant And Equipment [Table] Schedule Of Property Plant And Equipment [Table] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Instrument sets. Instrument sets [Member] Instrument Sets [Member] Machinery and equipment [Member] Machinery And Equipment [Member] Computer equipment and software [Member] Computer Equipment [Member] Leasehold improvements [Member] Leasehold Improvements [Member] Furniture and fixtures [Member] Furniture And Fixtures [Member] Building and improvements [Member] Building Improvements [Member] Land [Member] Land [Member] Property Plant And Equipment [Line Items] Property Plant And Equipment [Line Items] Property and equipment net Property Plant And Equipment Net By Type [Abstract] Property and equipment, gross Property Plant And Equipment Gross Less: accumulated depreciation and amortization Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Property and equipment, net Depreciation expense Depreciation Capitalized internal use software development costs Capitalized Computer Software Net Capitalized internal use software amortization Capitalized Computer Software Amortization1 Goodwill And Intangible Assets Disclosure [Abstract] Schedule Of Finite Lived Intangible Assets [Table] Schedule Of Finite Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Developed Technology [Member] Developed Technology Rights [Member] Manufacturing know-how and trade secrets. Manufacturing know-how and trade secrets [Member] Manufacturing Know How And Trade Secrets [Member] Trade name and trademarks. Trade name and trademarks [Member] Trade Name And Trademarks [Member] Customer relationships [Member] Customer Relationships [Member] Finite Lived Intangible Assets [Line Items] Finite Lived Intangible Assets [Line Items] Intangible assets subject to amortization: Finite Lived Intangible Assets Net [Abstract] Weighted Average Amortization Period Acquired Finite Lived Intangible Assets Weighted Average Useful Life Gross Amount Finite Lived Intangible Assets Gross Accumulated Amortization Finite Lived Intangible Assets Accumulated Amortization Intangible Assets, net Indefinite lived intangible assets. Intangible assets not subject to amortization: Indefinite Lived Intangible Assets [Abstract] Total goodwill and intangible assets, net Intangible Assets Net Including Goodwill Amortization expense related to intangible assets Amortization Of Intangible Assets Gross goodwill Goodwill Gross Accumulated impairment loss Goodwill Impaired Accumulated Impairment Loss Goodwill Changes to gross goodwill: Goodwill Translation And Purchase Accounting Adjustments [Abstract] Changes resulting from foreign currency fluctuations Goodwill Foreign Currency Translation Gain Loss Goodwill period increase (decrease) Goodwill Period Increase Decrease Future amortization expense related to intangible assets Finite Lived Intangible Assets Future Amortization Expense [Abstract] 2021 Finite Lived Intangible Assets Amortization Expense Next Twelve Months 2022 Finite Lived Intangible Assets Amortization Expense Year Two 2023 Finite Lived Intangible Assets Amortization Expense Year Three 2024 Finite Lived Intangible Assets Amortization Expense Year Four 2025 Finite Lived Intangible Assets Amortization Expense Year Five Thereafter through 2031 Finite Lived Intangible Assets Amortization Expense After Year Five Accrued other taxes current. Payables And Accruals [Abstract] Accounts payable and accrued liabilities Accounts Payable And Accrued Liabilities Current [Abstract] Accrued expenses Accrued Liabilities Current Accounts payable Accounts Payable Current Distributor commissions payable Accrued Sales Commission Current Other taxes payable Accrued Other Taxes Current Litigation liability Settlement Liabilities Current Debt interest payable Interest Payable Current Royalties payable Accrued Royalties Current Other Other Accrued Liabilities Current Accounts payable and accrued liabilities Debt Securities Available For Sale [Table] Debt Securities Available For Sale [Table] Cash and Cash Equivalents Cash And Cash Equivalents [Axis] Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member] Corporate notes. Corporate Notes [Member] Corporate Notes [Member] Commercial Paper [Member] Commercial Paper [Member] Schedule Of Available For Sale Securities [Line Items] Schedule Of Available For Sale Securities [Line Items] Amortized Cost Available For Sale Debt Securities Amortized Cost Basis Gross Unrealized Gains Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Gross Unrealized Losses Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Fair Value Available For Sale Securities Debt Securities Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Derivative Instrument Derivative Instrument Risk [Axis] Derivative Contract Derivative Contract Type [Domain] Foreign Exchange Forward [Member] Foreign Exchange Forward [Member] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Other (Expense) Income [Member] Other Operating Income Expense [Member] Balance Sheet Location Balance Sheet Location [Axis] Balance Sheet Location Balance Sheet Location [Domain] Other current assets or other current liabilities. Other Current Assets or Other Current Liabilities [Member] Other Current Assets Or Other Current Liabilities [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Quoted Price in Active Market (Level 1) [Member] Fair Value Inputs Level1 [Member] Debt Instrument, Redemption, Period Debt Instrument Redemption Period [Axis] Debt Instrument, Redemption, Period Debt Instrument Redemption Period [Domain] Convertible Notes due 2021 [Member] Debt Instrument Redemption Period Two [Member] Convertible Notes due 2023 [Member] Debt Instrument Redemption Period Three [Member] Convertible Notes due 2025 [Member] Debt Instrument Redemption Period Four [Member] Liability Class Fair Value By Liability Class [Axis] Fair Value by Liability Class Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain] Contingent consideration liabilities. Contingent Consideration Liabilities [Member] Contingent Consideration Liabilities [Member] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Net currency exchange losses from derivatives instruments Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax Notional principal amount Derivative Notional Amount Net (losses) gains recognized on derivative instruments Fair value of derivative instrument liability Derivative Assets Liabilities At Fair Value Net Unrealized loss position investment Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1 Impairment charges recorded for earnings Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value, Recurring [Member] Fair Value Measurements Recurring [Member] Significant Other Observable Inputs (Level 2) [Member] Fair Value Inputs Level2 [Member] Significant Unobservable Inputs (Level 3) [Member] Fair Value Inputs Level3 [Member] Asset Class Fair Value By Asset Class [Axis] Asset Class Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain] Money Market Funds [Member] Money Market Funds [Member] Cash Equivalents and Marketable Securities Assets Fair Value Disclosure [Abstract] Total cash equivalents Investments Fair Value Disclosure Total assets measured at fair value Assets Fair Value Disclosure Debt instrument, fair value disclosure Convertible Debt Fair Value Disclosures Senior convertible notes rate Derivative Variable Interest Rate Convertible note hedge transactions initial stock price per share. Convertible note hedge transactions purchase of common stock Debt Conversion Converted Instrument Shares Issued1 Convertible note hedge transactions initial stock price per share Convertible Note Hedge Transactions Initial Stock Price Per Share Fair value measurement with unobservable inputs reconciliation recurring basis asset derivative asset reclassified to stockholders equity. Hedging Relationship Derivative Instruments Gain Loss By Hedging Relationship [Axis] Hedging Relationship Hedging Relationship [Domain] Fair value hedging two thousand twenty three. 2023 Notes [Member] Fair Value Hedging Two Thousand Twenty Three [Member] Assets: Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation Calculation Roll Forward Fair value measurement at beginning of period Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value Derivative assets purchased Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases Change in fair value measurement Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 Derivative asset reclassified to stockholders’ equity Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Derivative Asset Reclassified To Stockholders Equity Fair value measurement at end of period Fair value measurement with unobservable inputs reconciliation recurring basis liability derivative liability reclassified to stockholders equity. Liabilities: Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation Roll Forward Fair value measurement at beginning of period Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value Derivative liability recorded in connection with the 2023 Notes Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases Change in fair value measurement Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings Derivative liability reclassified to stockholders’ equity Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Derivative Liability Reclassified To Stockholders Equity Fair value measurement at end of period Business combination contingent consideration liability expected years. Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table] Level 3 [Member] Financial Instrument Financial Instrument [Axis] Financial Instruments Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain] Commercial sale milestone. Commercial Sale Milestone [Member] Commercial Sale Milestone [Member] Measurement Input Type Measurement Input Type [Axis] Measurement Input Type Measurement Input Type [Domain] Discount Rate [Member] Measurement Input Discount Rate [Member] Expected Years [Member] Measurement Input Expected Term [Member] Weighted Average [Member] Weighted Average [Member] Weighted average measurement input Business Combination Contingent Consideration Liability Measurement Input Expected Years Business Combination Contingent Consideration Liability Expected Years Business Combination, Contingent Consideration, Liability, Valuation Technique [Extensible List] Business Combination Contingent Consideration Liability Valuation Technique Extensible List Contingent consideration liabilities Contingent consideration paid or settled Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements Changes resulting from foreign currency fluctuations Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net Net loss on strategic investments Realized Investment Gains Losses Purchased in-process research and development asset Debt Instrument [Table] Debt Instrument [Table] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Two point two five percent senior convertible notes. 2.25% Senior Convertible Notes [Member] Two Point Two Five Percent Senior Convertible Notes [Member] One point zero zero zero percent senior convertible notes. 1.00% Senior Convertible Notes [Member] One Point Zero Zero Zero Percent Senior Convertible Notes [Member] Zero point three seven five percent senior convertible notes. 0.375% Senior Convertible Notes [Member] Zero Point Three Seven Five Percent Senior Convertible Notes [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Principal amount Debt Instrument Face Amount Unamortized debt discount Debt Instrument Unamortized Discount Unamortized debt issuance costs Unamortized Debt Issuance Expense Total Senior Convertible Notes Convertible Notes Payable Less: Current portion Interest rate on convertible notes Debt Instrument Interest Rate Stated Percentage Base principal amount per note. Scenario Statement Scenario [Axis] Scenario Scenario Unspecified [Domain] Scenario one. Scenario One [Member] Scenario One [Member] Scenario two. Scenario Two [Member] Scenario Two [Member] Fair value hedging two thousand twenty one. 2021 Hedge [Member] Fair Value Hedging Two Thousand Twenty One [Member] Class of Warrant or Right Class Of Warrant Or Right [Axis] Class of Warrant or Right Class Of Warrant Or Right [Domain] Warrants 2021. 2021 Warrants [Member] Warrants Two Thousand Twenty One [Member] One point zero zero percent senior convertible notes. 1.00% Senior Convertible Notes [Member] One Point Zero Zero Percent Senior Convertible Notes [Member] 2023 Hedge [Member] Warrants two thousand twenty three. 2023 Warrants [Member] Warrants Two Thousand Twenty Three [Member] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] Two thousand twenty three counterparties. 2023 Counterparties [Member] Two Thousand Twenty Three Counterparties [Member] Fair value hedging two thousand twenty five. 2025 Hedge [Member] Fair Value Hedging Two Thousand Twenty Five [Member] Warrants two thousand twenty five. 2025 Warrants [Member] Warrants Two Thousand Twenty Five [Member] Credit Facility Credit Facility [Axis] Credit Facility Credit Facility [Domain] Revolving Senior Credit Facility [Member] Revolving Credit Facility [Member] Multicurrency borrowings. Multicurrency Borrowings [Member] Multicurrency Borrowings [Member] Standby Letters of Credit [Member] Standby Letters Of Credit [Member] Swing line loans. Swing Line Loans [Member] Swing Line Loans [Member] Variable Rate Variable Rate [Axis] Variable Rate Variable Rate [Domain] Federal Funds Effective Rate [Member] Federal Funds Effective Swap Rate [Member] Eurocurrency Rate [Member] Eurodollar [Member] Base Rate [Member] Base Rate [Member] Debt instrument, maturity date Debt Instrument Maturity Date Initial conversion rate adjustment, shares Debt Instrument Convertible Conversion Ratio1 Principal amount of debt considered for conversion rate Debt Instrument Convertible Principal Amount Of Debt Considered For Conversion Rate Initial conversion price of convertible notes Debt Instrument Convertible Conversion Price1 Amount reclassified to stockholders' equity Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity Contractual coupon interest expense Interest Expense Debt Excluding Amortization Amortization of debt discount (premium) Amortization Of Debt Discount Premium Amortization of debt issuance costs Amortization Of Financing Costs Effective interest rate Debt Instrument Interest Rate Effective Percentage Consecutive trading days considered for debt conversion Debt Instrument Convertible Threshold Consecutive Trading Days1 Percentage of conversion price Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger Debt redemption price percentage Debt Instrument Redemption Price Percentage Principal payments due Debt Instrument Annual Principal Payment Reclassification into temporary equity Carrying value Number of common stock to be purchased. Number of common stock to be purchased Number Of Securities Called By Convertible Note Hedge Transaction Stock price Share Price Cost of hedge transaction Derivative Amount Of Hedged Item Derivative, maturity date Derivative Maturity Dates Class of warrant or rights expiry month and year. Number of preferred or common stock into which the warrants is converted Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Class of warrant or rights expiry month and year Class Of Warrant Or Rights Expiry Month And Year Cash proceeds from the sale of warrants Warrant strike price Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Fair value of embedded conversion derivative Embedded Derivative Fair Value Of Embedded Derivative Liability Line of credit facility expiration month and year. Credit facility, maximum borrowing capacity Line Of Credit Facility Maximum Borrowing Capacity Credit facility, expiration date Line Of Credit Facility Expiration Month And Year Loan outstanding Line Of Credit Credit facility bear interest rate Debt Instrument Basis Spread On Variable Rate1 Unused line fee Line Of Credit Facility Unused Capacity Commitment Fee Percentage Commitments and contingencies disclosure. Commitments and contingencies disclosure. Commitments And Contingencies Disclosure [Table] Commitments And Contingencies Disclosure [Table] Other Commitments Other Commitments [Axis] Other Commitments Other Commitments [Domain] Licensing and purchasing agreements. Licensing and Purchasing Agreements [Member] Licensing And Purchasing Agreements [Member] Executive severance plans. Executive Severance Plans [Member] Executive Severance Plans [Member] Commitments And Contingencies Disclosure [Line Items] Commitments And Contingencies Disclosure [Line Items] Restricted cash for security deposit Security Deposit Liability Initial terms of lease Lessee Operating Lease Term Of Contract Lease, practical expedients, package Lease Practical Expedients Package Leased assets. Operating lease and finance lease right-of-use asset. Lease liabilities current. Lease Liabilities Long-term. Operating lease and finance lease liability. Assets Leased Assets [Abstract] Operating Financing Finance Lease Right Of Use Asset Total leased assets Operating Lease And Finance Lease Right Of Use Asset Current: Lease Liabilities Current [Abstract] Operating Financing Finance Lease Liability Current Long-term: Lease Liabilities Long Term [Abstract] Operating Financing Finance Lease Liability Noncurrent Total lease liabilities Operating Lease And Finance Lease Liability Weighted-average remaining lease term (years) - operating leases Operating Lease Weighted Average Remaining Lease Term1 Weighted-average remaining lease term (years) - finance leases Finance Lease Weighted Average Remaining Lease Term1 Weighted-average discount rate - operating leases Operating Lease Weighted Average Discount Rate Percent Weighted-average discount rate - finance leases Finance Lease Weighted Average Discount Rate Percent Cash paid for amounts included in measurement of lease liabilities. Finance lease expense. Lease expense: Lease Cost [Abstract] Operating lease expense Operating Lease Cost Finance lease expense: Finance Lease Expense [Abstract] Depreciation of right-of-use assets Finance Lease Right Of Use Asset Amortization Interest expense on lease liabilities Finance Lease Interest Expense Total lease expense Lease Cost Operating cash flows used for operating leases Operating Lease Payments Operating cash flows used for financing leases Finance Lease Interest Payment On Liability Financing cash flows used for financing leases Finance Lease Principal Payments Total cash paid for amounts included in the measurement of lease liabilities Cash Paid For Amounts Included In Measurement Of Lease Liabilities Operating lease liabilities arising from obtaining right-of-use assets Right Of Use Asset Obtained In Exchange For Operating Lease Liability Rent expense Operating Leases Rent Expense Net Financing Leases Finance Lease Liabilities Payments Due [Abstract] 2021 Finance Lease Liability Payments Due Next Twelve Months 2022 Finance Lease Liability Payments Due Year Two 2023 Finance Lease Liability Payments Due Year Three 2024 Finance Lease Liability Payments Due Year Four 2025 Finance Lease Liability Payments Due Year Five Thereafter Finance Lease Liability Payments Due After Year Five Total minimum lease payments Finance Lease Liability Payments Due Less: amount representing interest Finance Lease Liability Undiscounted Excess Amount Present value of obligations under leases Finance Lease Liability Less: current portion Long-term lease obligations Operating Leases Operating Lease Liabilities Payments Due [Abstract] 2021 Lessee Operating Lease Liability Payments Due Next Twelve Months 2022 Lessee Operating Lease Liability Payments Due Year Two 2023 Lessee Operating Lease Liability Payments Due Year Three 2024 Lessee Operating Lease Liability Payments Due Year Four 2025 Lessee Operating Lease Liability Payments Due Year Five Thereafter Lessee Operating Lease Liability Payments Due After Year Five Total minimum lease payments Lessee Operating Lease Liability Payments Due Less: amount representing interest Lessee Operating Lease Liability Undiscounted Excess Amount Present value of obligations under leases Operating Lease Liability Less: current portion Long-term lease obligations Other commitments Other Commitment Stock repurchase program expiration month and year. Class Of Treasury Stock [Table] Class Of Treasury Stock [Table] Convertible Notes due 2025 [Member] Equity Class Of Treasury Stock [Line Items] Equity Class Of Treasury Stock [Line Items] Share repurchase program, authorized amount Stock Repurchase Program Authorized Amount1 Share repurchase program, period in force Stock Repurchase Program Period In Force1 Share repurchase program, expiration month and year Stock Repurchase Program Expiration Month And Year Share repurchase program, expiration date Stock Repurchase Program Expiration Date Shares repurchased during period Treasury Stock Shares Acquired Shares repurchased during period, value Treasury Stock Value Acquired Cost Method Share repurchase program, remaining authorized amount Stock Repurchase Program Remaining Authorized Repurchase Amount1 Equity [Abstract] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Equity incentive plan 2014 [Member] 2014 Equity Incentive Plan [Member] Equity Incentive Plan2014 [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units R S U [Member] Stock Options [Member] Employee Stock Option [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] ESPP [Member] Employee Stock [Member] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Preferred stock, shares issued Preferred Stock Shares Issued Share-based compensation arrangement by share-based payment award accelerated Vesting percentage Percentage of acceleration of stock options in case of change in control Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Percentage Allocated share based compensation expense (benefit). Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Selling, General and Administrative Expense [Member] Selling General And Administrative Expenses [Member] Research and Development Expense [Member] Research And Development Expense [Member] Cost of Sales [Member] Cost Of Sales [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Stock-based compensation expense before taxes Allocated Share Based Compensation Expense Benefit Related income tax benefits Employee Service Share Based Compensation Tax Benefit From Compensation Expense Stock-based compensation expense, net of taxes Allocated Share Based Compensation Expense Net Of Tax Unrecognized cost related to share-based compensation Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted average contractual term Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Fair value of restricted stock units vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value Restricted Stock Units (RSUs) [Member] Restricted Stock Units Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward Number of shares outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of shares, Granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Number of shares, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Number of shares, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Number of shares outstanding, Ending balance Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward Weighted average grant date fair value outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Weighted average grant date fair value, Granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Weighted average grant date fair value, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Weighted average grant date fair value, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Weighted average grant date fair value outstanding, Ending balance Total shares withheld related to statutory tax Shares Paid For Tax Withholding For Share Based Compensation Payments of employees tax obligations Payments Related To Tax Withholding For Share Based Compensation Share based compensation arrangement by share based payment award equity instruments other than options percentage of target number of shares eligible to receive. Share payout levels Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Target Number Of Shares Eligible To Receive Vested during the period Vesting period for the awards Shares, Awarded at target Share-based compensation arrangement by share-based payment award equity instruments other than options maximum number of shares eligible to be issued grants in period. The number of equity-based payment instruments with performance vesting, excluding stock (or unit) options, that vested during the reporting period. Share-based compensation arrangement by share-based payment award equity instruments other than options maximum number of shares eligible to be issued forfeited in period. Maximum Number of Shares Eligible to be Issued, Outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Maximum Number of Shares Eligible to be Issued, Awarded at target Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Maximum Number Of Shares Eligible To Be Issued Grants In Period Maximum Number of Shares Eligible to be Issued, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments With Performance Measures Vested In Period Maximum Number of Shares Eligible to be Issued, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Maximum Number Of Shares Eligible To Be Issued Forfeited In Period Maximum Number of Shares Eligible to be Issued, Outstanding, Ending balance Share-based compensation arrangement by share-based payment award equity instruments other than options achieved in period weighted average grant date fair value. Average Grant Date Fair Value, Awarded at target Average Grant Date Fair Value, Vested Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Achieved In Period Weighted Average Grant Date Fair Value Average Grant Date Fair Value, Forfeited Closing price of stock Proceeds from exercise of stock options Proceeds From Stock Options Exercised Total intrinsic value Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Total stock options vested Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares Summary of stock option activity under all stock plans Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward Underlying shares outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Underlying shares, exercised Stock Issued During Period Shares Stock Options Exercised Underlying shares, cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Underlying shares outstanding, Ending balance Underlying shares exercisable, Ending balance Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Underlying shares vested or expected to vest, Ending balance Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Weighted average exercise price outstanding, Beginning balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted Average Exercise Price, cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Weighted Average Exercise Price outstanding, Ending balance Weighted Average Exercise Price option exercisable, Ending balance Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Weighted Average Exercise price vested or expected to vest, Ending balance Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Weighted Average Remaining Contractual Term outstanding, Beginning balance Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Weighted Average Remaining Contractual Term exercisable, Ending balance Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Weighted Average Remaining Contractual Term vested or expected to vest, Ending balance Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 Aggregate Intrinsic Value outstanding Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Aggregate intrinsic value exercisable Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Aggregate intrinsic value vested or expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value Maximum amount withheld to purchase shares of the company. Maximum percentage of annual compensation Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate Maximum amount withheld to purchase shares of the company Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Amount Percentage of issuance price of stock under the stock issuance program Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent ESPP offering period Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Number of share purchased under ESPP Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award Weighted average assumptions used to estimate fair value of stock options granted and stock purchase rights under ESPP Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract] Volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate Expected term (years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Risk free interest rate Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Expected dividend yield Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Common stock options. Senior convertible warrants due 2021. Senior Convertible Warrants Due 2021 [Member] Senior Convertible Warrants Due2021 [Member] Senior convertible warrants due 2023. Senior Convertible Warrants Due 2023 [Member] Senior Convertible Warrants Due2023 [Member] Senior convertible warrants due 2025. Senior Convertible Warrants Due 2025 [Member] Senior Convertible Warrants Due2025 [Member] Senior convertible notes. 2.25% Senior Convertible Notes due 2021 [Member] Senior Convertible Notes Due2021 [Member] Senior convertible notes due 2023. 1.00% Senior Convertible Notes due 2023 [Member] Senior Convertible Notes Due2023 [Member] Senior convertible notes due 2025. 0.375% Senior Convertible Notes due 2025 [Member] Senior Convertible Notes Due2025 [Member] Restricted stock units and performance based restricted stock units. Restricted Stock Units And Performance-Based Restricted Stock Units [Member] Restricted Stock Units And Performance Based Restricted Stock Units [Member] Available for future grant. Available for Future Grant [Member] Available For Future Grant [Member] Common stock options: Common Stock Options [Abstract] Shares reserved for future issuance Common Stock Capital Shares Reserved For Future Issuance Summarized details of income before income taxes by region Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments [Abstract] United States Income Loss From Continuing Operations Before Income Taxes Domestic Foreign Income Loss From Continuing Operations Before Income Taxes Foreign Current: Current Income Tax Expense Benefit Continuing Operations [Abstract] Federal Current Federal Tax Expense Benefit State Current State And Local Tax Expense Benefit Foreign Current Foreign Tax Expense Benefit Total current provision Current Income Tax Expense Benefit Deferred: Deferred Income Tax Expense Benefit Continuing Operations [Abstract] Federal Deferred Federal Income Tax Expense Benefit State Deferred State And Local Income Tax Expense Benefit Foreign Deferred Foreign Income Tax Expense Benefit Total deferred provision Deferred Income Taxes And Tax Credits Changes in tax rate Income Tax Reconciliation Change In Enacted Tax Rate Changes in valuation allowance Income Tax Reconciliation Change In Valuation Allowance Including Accounting Standard Adjustments Total (benefit) provision Tax (benefit) provision at federal statutory rate Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate Income tax credits and incentives Income Tax Reconciliation Tax Credits Research State income tax Income Tax Reconciliation State And Local Income Taxes Valuation allowance Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance Net tax benefit on international restructuring Income Tax Reconciliation Net Tax Benefit On International Restructuring Return to provision adjustments Income Tax Reconciliation Return To Provision Adjustments Acquisition related charges Income Tax Reconciliation Acquisition Related Charges Compensation expense Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost Income tax reserves Income Tax Reconciliation Tax Reserve Nondeductible meals and entertainment Income Tax Reconciliation Nondeductible Expense Meals And Entertainment Foreign tax rate differences from federal statutory rate Income Tax Reconciliation Foreign Income Tax Rate Differential Other Income Tax Reconciliation Other Adjustments Deferred tax assets: Components Of Deferred Tax Assets [Abstract] Amortization Deferred Tax Assets Amortization Net operating loss carryforwards Deferred Tax Assets Operating Loss Carryforwards Inventory Deferred Tax Assets Inventory General business and other credit carryforwards Deferred Tax Assets Tax Credit Carryforwards General Business And Other Lease liability Deferred Tax Assets Lease Liability Stock-based compensation Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Original issue discount Deferred Tax Assets Zero Coupon Notes Other Deferred Tax Assets Other Gross deferred tax assets Deferred Tax Assets Gross Less valuation allowance Deferred Tax Assets Valuation Allowance Net deferred tax assets Deferred Tax Assets Net Deferred tax liabilities: Components Of Deferred Tax Liabilities [Abstract] Depreciation Deferred Tax Liabilities Depreciation Acquired intangibles Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets Right-of-use assets Deferred Tax Liabilities Right Of Use Assets Other Deferred Tax Liabilities Other Total deferred tax liabilities Deferred Income Tax Liabilities Net deferred tax assets Deferred Tax Assets Liabilities Net Net deferred tax liabilities Income taxes. Income taxes. Income Taxes [Table] Income Taxes [Table] Accounting Standards Update Adjustments For New Accounting Pronouncements [Axis] Accounting Standards Update Type Of Adoption [Member] Accounting Standard Update 2016-16. ASU 2016-16 [Member] Accounting Standard Update201616 [Member] Income Tax Authority Income Tax Authority [Axis] Income Tax Authority Income Tax Authority [Domain] Federal Tax Authority [Member] Domestic Country [Member] State and Local Jurisdiction [Member] State And Local Jurisdiction [Member] Foreign Tax Authority [Member] Foreign Country [Member] Tax Credit Carryforward Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name Tax Credit Carryforward Name [Domain] Research and Development [Member] Research [Member] Income Tax Authority, Name Income Tax Authority Name [Axis] Income Tax Authority, Name Income Tax Authority Name [Domain] California Tax Authority [Member] California Franchise Tax Board [Member] Income Taxes [Line Items] Income Taxes [Line Items] Net decrease in deferred taxes Increase Decrease In Deferred Income Taxes Decrease in valuation allowance of deferred taxes Valuation Allowance Deferred Tax Asset Change In Amount Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns Roll Forward Gross unrecognized tax benefits at beginning of period Unrecognized Tax Benefits Increases in tax positions for prior years Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions Decreases in tax positions for prior years Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions Increases in tax positions for current year relating to ongoing operations Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions Decreases in tax positions as a result of a lapse of statute of limitations Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations Increases in tax positions for current year relating to acquisitions Unrecognized Tax Benefits Increases Resulting From Acquisition Decreases in tax positions due to settlements with taxing authorities Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities Gross unrecognized tax benefits period end Unrecognized tax benefits that would impact effective tax Unrecognized Tax Benefits That Would Impact Effective Tax Rate Income tax, penalties and interest (benefit) expense Unrecognized Tax Benefits Income Tax Penalties And Interest Expense Income tax, penalties and interest accrued Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Remaining unrecognized tax positions Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit Deferred tax assets Valuation allowance for deferred tax assets Undistributed earnings attributable to operations Foreign Income Tax Expense Benefit Continuing Operations Operating loss carry forwards expiration year. Net operating loss carryforwards Operating Loss Carryforwards Operating loss carryforwards expiration year Operating Loss Carry Forwards Expiration Year Federal tax credit carry forwards expiration year. Net research and development carryforwards Tax Credit Carryforward Amount Federal tax credit carryforwards, expiration year Federal Tax Credit Carryforwards Expiration Year Number of operating segments Number Of Operating Segments Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Table] Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Table] Spinal hardware. Spinal Hardware [Member] Spinal Hardware [Member] Surgical support. Surgical Support [Member] Surgical Support [Member] Entity Wide Information Revenue From External Customer [Line Items] Entity Wide Information Revenue From External Customer [Line Items] Schedule Of Revenues From External Customers And Long Lived Assets [Table] Schedule Of Revenues From External Customers And Long Lived Assets [Table] Geographical Statement Geographical [Axis] Geographical Segment Geographical [Domain] United States UNITED STATES International (excludes Puerto Rico) [Member] Non Us [Member] Revenues and Net Property and Equipment by Geographical Areas [Line Items] Revenues From External Customers And Long Lived Assets [Line Items] Net Sales Property and Equipment, Net Loss Contingencies [Table] Loss Contingencies [Table] Loss Contingency Nature Loss Contingencies By Nature Of Contingency [Axis] Loss Contingency, Nature Loss Contingency Nature [Domain] Madsen medical, Inc. litigation. Madsen Medical, Inc. Litigation [Member] Madsen Medical Inc Litigation [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Settlement agreement, consideration Litigation Settlement Amount Awarded To Other Party Business combination upfront payment liability. Business acquisition potential future milestone payment. Business combination upfront payment funded. Subsequent Event [Table] Subsequent Event [Table] Simplify Medical Pty Limited. Simplify Medical Pty Limited [Member] Simplify Medical Pty Limited [Member] Subsequent Event [Line Items] Subsequent Event [Line Items] Upfront payment Business Combination Upfront Payment Liability Upon achievement of the regulatory milestone, entitled to a one-time payment Business Acquisition Potential Future Milestone Payment Upfront payment funded Business Combination Upfront Payment Funded EX-101.PRE 17 nuva-20201231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 18 nuva-10k_20201231_htm.xml IDEA: XBRL DOCUMENT 0001142596 2020-01-01 2020-12-31 0001142596 2021-02-23 0001142596 2020-06-30 0001142596 2020-12-31 0001142596 2019-12-31 0001142596 us-gaap:ProductMember 2020-01-01 2020-12-31 0001142596 us-gaap:ProductMember 2019-01-01 2019-12-31 0001142596 us-gaap:ProductMember 2018-01-01 2018-12-31 0001142596 us-gaap:ServiceMember 2020-01-01 2020-12-31 0001142596 us-gaap:ServiceMember 2019-01-01 2019-12-31 0001142596 us-gaap:ServiceMember 2018-01-01 2018-12-31 0001142596 2019-01-01 2019-12-31 0001142596 2018-01-01 2018-12-31 0001142596 us-gaap:CommonStockMember 2017-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001142596 us-gaap:RetainedEarningsMember 2017-12-31 0001142596 us-gaap:TreasuryStockMember 2017-12-31 0001142596 us-gaap:ParentMember 2017-12-31 0001142596 us-gaap:NoncontrollingInterestMember 2017-12-31 0001142596 2017-12-31 0001142596 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001142596 us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0001142596 us-gaap:ParentMember 2018-01-01 2018-12-31 0001142596 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001142596 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001142596 us-gaap:CommonStockMember 2018-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001142596 us-gaap:RetainedEarningsMember 2018-12-31 0001142596 us-gaap:TreasuryStockMember 2018-12-31 0001142596 us-gaap:ParentMember 2018-12-31 0001142596 2018-12-31 0001142596 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001142596 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001142596 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001142596 us-gaap:CommonStockMember 2019-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001142596 us-gaap:RetainedEarningsMember 2019-12-31 0001142596 us-gaap:TreasuryStockMember 2019-12-31 0001142596 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001142596 us-gaap:TreasuryStockMember 2020-01-01 2020-12-31 0001142596 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-12-31 0001142596 us-gaap:CommonStockMember 2020-12-31 0001142596 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001142596 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001142596 us-gaap:RetainedEarningsMember 2020-12-31 0001142596 us-gaap:TreasuryStockMember 2020-12-31 0001142596 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember nuva:AccountingStandardsUpdate202006Member us-gaap:SubsequentEventMember 2021-01-01 0001142596 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember us-gaap:AccountingStandardsUpdate201613Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201613Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201704Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201813Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201815Member 2020-12-31 0001142596 us-gaap:AccountingStandardsUpdate201912Member 2020-12-31 0001142596 nuva:AccountingStandardsUpdateTwentyThousandTwentyZeroFourMember 2020-12-31 0001142596 2020-10-01 2020-10-01 0001142596 srt:MinimumMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember 2020-01-01 2020-12-31 0001142596 us-gaap:ShippingAndHandlingMember 2020-01-01 2020-12-31 0001142596 us-gaap:ShippingAndHandlingMember 2019-01-01 2019-12-31 0001142596 us-gaap:ShippingAndHandlingMember 2018-01-01 2018-12-31 0001142596 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2020-01-01 2020-12-31 0001142596 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2019-01-01 2019-12-31 0001142596 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2018-01-01 2018-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001142596 nuva:StockOptionsAndESPPMember 2019-01-01 2019-12-31 0001142596 nuva:StockOptionsAndESPPMember 2018-01-01 2018-12-31 0001142596 nuva:RestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001142596 nuva:RestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001142596 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-12-31 0001142596 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-12-31 0001142596 nuva:StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2020-01-01 2020-12-31 0001142596 nuva:StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001142596 nuva:StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001142596 us-gaap:WarrantMember 2020-01-01 2020-12-31 0001142596 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001142596 us-gaap:WarrantMember 2018-01-01 2018-12-31 0001142596 us-gaap:ConvertibleDebtSecuritiesMember 2020-01-01 2020-12-31 0001142596 nuva:InstrumentSetsMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember us-gaap:ComputerEquipmentMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember us-gaap:ComputerEquipmentMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember us-gaap:BuildingImprovementsMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember us-gaap:BuildingImprovementsMember 2020-01-01 2020-12-31 0001142596 nuva:InstrumentSetsMember 2020-12-31 0001142596 nuva:InstrumentSetsMember 2019-12-31 0001142596 us-gaap:MachineryAndEquipmentMember 2020-12-31 0001142596 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001142596 us-gaap:ComputerEquipmentMember 2020-12-31 0001142596 us-gaap:ComputerEquipmentMember 2019-12-31 0001142596 us-gaap:LeaseholdImprovementsMember 2020-12-31 0001142596 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001142596 us-gaap:FurnitureAndFixturesMember 2020-12-31 0001142596 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001142596 us-gaap:BuildingImprovementsMember 2020-12-31 0001142596 us-gaap:BuildingImprovementsMember 2019-12-31 0001142596 us-gaap:LandMember 2020-12-31 0001142596 us-gaap:LandMember 2019-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2020-01-01 2020-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2020-01-01 2020-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2020-01-01 2020-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2020-01-01 2020-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2020-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2020-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2020-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2020-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2019-01-01 2019-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2019-01-01 2019-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2019-01-01 2019-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2019-01-01 2019-12-31 0001142596 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0001142596 nuva:ManufacturingKnowHowAndTradeSecretsMember 2019-12-31 0001142596 nuva:TradeNameAndTrademarksMember 2019-12-31 0001142596 us-gaap:CustomerRelationshipsMember 2019-12-31 0001142596 nuva:CorporateNotesMember 2020-12-31 0001142596 us-gaap:CommercialPaperMember 2020-12-31 0001142596 us-gaap:ForeignExchangeForwardMember 2020-12-31 0001142596 us-gaap:ForeignExchangeForwardMember 2019-12-31 0001142596 us-gaap:ForeignExchangeForwardMember 2018-12-31 0001142596 us-gaap:ForeignExchangeForwardMember us-gaap:OtherOperatingIncomeExpenseMember 2020-01-01 2020-12-31 0001142596 us-gaap:ForeignExchangeForwardMember us-gaap:OtherOperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001142596 us-gaap:ForeignExchangeForwardMember us-gaap:OtherOperatingIncomeExpenseMember 2018-01-01 2018-12-31 0001142596 nuva:OtherCurrentAssetsOrOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2019-12-31 0001142596 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 nuva:CorporateNotesMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 nuva:CorporateNotesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001142596 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 0001142596 2020-09-09 0001142596 2020-09-10 0001142596 us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-01-01 2020-12-31 0001142596 us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyThreeMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nuva:CommercialSaleMilestoneMember us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0001142596 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nuva:CommercialSaleMilestoneMember us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0001142596 srt:WeightedAverageMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nuva:CommercialSaleMilestoneMember us-gaap:MeasurementInputDiscountRateMember 2020-12-31 0001142596 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nuva:CommercialSaleMilestoneMember us-gaap:MeasurementInputExpectedTermMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nuva:CommercialSaleMilestoneMember us-gaap:MeasurementInputExpectedTermMember 2020-01-01 2020-12-31 0001142596 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember nuva:CommercialSaleMilestoneMember 2020-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2020-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2019-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2018-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2020-01-01 2020-12-31 0001142596 nuva:ContingentConsiderationLiabilitiesMember 2019-01-01 2019-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2019-12-31 0001142596 nuva:OnePointZeroZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-12-31 0001142596 nuva:OnePointZeroZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2019-12-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2019-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2016-03-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2016-03-01 2016-03-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-01-01 2020-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2019-01-01 2019-12-31 0001142596 nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2018-01-01 2018-12-31 0001142596 srt:MinimumMember nuva:ScenarioOneMember nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember nuva:ScenarioOneMember nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-01-01 2020-12-31 0001142596 nuva:ScenarioTwoMember nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-01-01 2020-12-31 0001142596 srt:MaximumMember nuva:TwoPointTwoFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodTwoMember 2020-01-01 2020-12-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyOneMember 2016-03-01 2016-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyOneMember 2016-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyOneMember us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001142596 srt:MaximumMember nuva:WarrantsTwoThousandTwentyOneMember us-gaap:CommonStockMember 2016-03-18 0001142596 srt:MinimumMember nuva:WarrantsTwoThousandTwentyOneMember 2016-03-01 2016-03-31 0001142596 srt:MaximumMember nuva:WarrantsTwoThousandTwentyOneMember 2016-03-01 2016-03-31 0001142596 nuva:WarrantsTwoThousandTwentyOneMember 2016-03-01 2016-03-31 0001142596 nuva:WarrantsTwoThousandTwentyOneMember 2016-03-31 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 2020-06-01 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-01-01 2020-12-31 0001142596 nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-12-31 0001142596 srt:MinimumMember nuva:ScenarioOneMember nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 2020-06-01 0001142596 srt:MaximumMember nuva:ScenarioOneMember nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 2020-06-01 0001142596 srt:MinimumMember nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 2020-06-01 0001142596 nuva:ScenarioTwoMember nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 2020-06-01 0001142596 srt:MaximumMember nuva:OnePointZeroZeroPercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember 2020-06-01 2020-06-01 0001142596 nuva:FairValueHedgingTwoThousandTwentyThreeMember 2020-06-01 2020-06-01 0001142596 nuva:FairValueHedgingTwoThousandTwentyThreeMember 2020-06-01 0001142596 srt:MaximumMember nuva:WarrantsTwoThousandTwentyThreeMember us-gaap:CommonStockMember 2020-12-31 0001142596 nuva:WarrantsTwoThousandTwentyThreeMember us-gaap:CommonStockMember 2020-06-01 0001142596 nuva:TwoThousandTwentyThreeCounterpartiesMember nuva:WarrantsTwoThousandTwentyThreeMember us-gaap:CommonStockMember 2020-09-11 0001142596 srt:MinimumMember nuva:WarrantsTwoThousandTwentyThreeMember 2020-06-01 2020-06-01 0001142596 srt:MaximumMember nuva:WarrantsTwoThousandTwentyThreeMember 2020-06-01 2020-06-01 0001142596 nuva:WarrantsTwoThousandTwentyThreeMember 2020-06-01 2020-06-01 0001142596 nuva:WarrantsTwoThousandTwentyThreeMember 2020-06-01 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-01 2020-03-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-01-01 2020-12-31 0001142596 srt:MinimumMember nuva:ScenarioOneMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-01 2020-03-31 0001142596 srt:MaximumMember nuva:ScenarioOneMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-01 2020-03-31 0001142596 srt:MinimumMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-01 2020-03-31 0001142596 nuva:ScenarioTwoMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-01 2020-03-31 0001142596 srt:MaximumMember nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodFourMember 2020-03-01 2020-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyFiveMember 2020-03-31 0001142596 nuva:FairValueHedgingTwoThousandTwentyFiveMember us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001142596 srt:MaximumMember nuva:WarrantsTwoThousandTwentyFiveMember us-gaap:CommonStockMember 2020-03-31 0001142596 srt:MinimumMember nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 srt:MaximumMember nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-01 2020-03-31 0001142596 nuva:WarrantsTwoThousandTwentyFiveMember 2020-03-31 0001142596 us-gaap:RevolvingCreditFacilityMember 2020-02-29 0001142596 nuva:MulticurrencyBorrowingsMember 2020-02-29 0001142596 us-gaap:StandbyLettersOfCreditMember 2020-02-29 0001142596 nuva:SwingLineLoansMember 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember 2020-12-31 0001142596 us-gaap:RevolvingCreditFacilityMember 2019-12-31 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:FederalFundsEffectiveSwapRateMember 2020-02-01 2020-02-29 0001142596 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2020-02-01 2020-02-29 0001142596 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2020-02-01 2020-02-29 0001142596 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:BaseRateMember 2020-02-01 2020-02-29 0001142596 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2020-02-01 2020-02-29 0001142596 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2020-02-01 2020-02-29 0001142596 srt:MinimumMember us-gaap:RevolvingCreditFacilityMember 2020-02-01 2020-02-29 0001142596 srt:MaximumMember us-gaap:RevolvingCreditFacilityMember 2020-02-01 2020-02-29 0001142596 srt:MinimumMember 2020-12-31 0001142596 srt:MaximumMember 2020-12-31 0001142596 nuva:LicensingAndPurchasingAgreementsMember 2020-12-31 0001142596 nuva:ExecutiveSeverancePlansMember 2020-12-31 0001142596 srt:MaximumMember us-gaap:CommonStockMember 2017-10-31 0001142596 us-gaap:CommonStockMember 2017-10-01 2017-10-31 0001142596 us-gaap:CommonStockMember 2020-02-29 0001142596 us-gaap:CommonStockMember 2020-02-01 2020-02-29 0001142596 nuva:ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember us-gaap:DebtInstrumentRedemptionPeriodThreeMember us-gaap:CommonStockMember 2020-03-01 2020-03-31 0001142596 us-gaap:CommonStockMember 2020-09-09 0001142596 us-gaap:CommonStockMember 2020-09-10 0001142596 nuva:EquityIncentivePlan2014Member 2020-01-01 2020-12-31 0001142596 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2020-01-01 2020-12-31 0001142596 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001142596 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0001142596 us-gaap:ResearchAndDevelopmentExpenseMember 2020-01-01 2020-12-31 0001142596 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001142596 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-31 0001142596 us-gaap:CostOfSalesMember 2020-01-01 2020-12-31 0001142596 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001142596 us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001142596 us-gaap:EmployeeStockMember 2020-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2020-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001142596 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001142596 srt:MinimumMember nuva:PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001142596 srt:MaximumMember nuva:PerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2019-01-01 2019-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2018-01-01 2018-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2015-01-01 2015-12-31 0001142596 nuva:PerformanceBasedRestrictedStockUnitsMember 2019-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001142596 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001142596 us-gaap:EmployeeStockMember 2020-01-01 2020-12-31 0001142596 us-gaap:EmployeeStockMember 2019-01-01 2019-12-31 0001142596 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001142596 nuva:RestrictedStockUnitsAndPerformanceBasedRestrictedStockUnitsMember 2020-12-31 0001142596 nuva:AvailableForFutureGrantMember 2020-12-31 0001142596 nuva:SeniorConvertibleNotesDue2021Member 2020-12-31 0001142596 nuva:SeniorConvertibleWarrantsDue2021Member 2020-12-31 0001142596 nuva:SeniorConvertibleNotesDue2023Member 2020-12-31 0001142596 nuva:SeniorConvertibleWarrantsDue2023Member 2020-12-31 0001142596 nuva:SeniorConvertibleNotesDue2025Member 2020-12-31 0001142596 nuva:SeniorConvertibleWarrantsDue2025Member 2020-12-31 0001142596 nuva:AccountingStandardUpdate201616Member 2018-11-30 0001142596 us-gaap:DomesticCountryMember 2020-12-31 0001142596 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0001142596 us-gaap:ForeignCountryMember 2020-12-31 0001142596 us-gaap:DomesticCountryMember 2020-01-01 2020-12-31 0001142596 us-gaap:StateAndLocalJurisdictionMember 2020-01-01 2020-12-31 0001142596 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2020-12-31 0001142596 us-gaap:CaliforniaFranchiseTaxBoardMember us-gaap:ResearchMember 2020-12-31 0001142596 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2020-01-01 2020-12-31 0001142596 nuva:SpinalHardwareMember 2020-01-01 2020-12-31 0001142596 nuva:SpinalHardwareMember 2019-01-01 2019-12-31 0001142596 nuva:SpinalHardwareMember 2018-01-01 2018-12-31 0001142596 nuva:SurgicalSupportMember 2020-01-01 2020-12-31 0001142596 nuva:SurgicalSupportMember 2019-01-01 2019-12-31 0001142596 nuva:SurgicalSupportMember 2018-01-01 2018-12-31 0001142596 country:US 2020-01-01 2020-12-31 0001142596 us-gaap:NonUsMember 2020-01-01 2020-12-31 0001142596 country:US 2019-01-01 2019-12-31 0001142596 us-gaap:NonUsMember 2019-01-01 2019-12-31 0001142596 country:US 2018-01-01 2018-12-31 0001142596 us-gaap:NonUsMember 2018-01-01 2018-12-31 0001142596 country:US 2020-12-31 0001142596 us-gaap:NonUsMember 2020-12-31 0001142596 country:US 2019-12-31 0001142596 us-gaap:NonUsMember 2019-12-31 0001142596 nuva:MadsenMedicalIncLitigationMember 2018-01-01 2018-12-31 0001142596 nuva:SimplifyMedicalPtyLimitedMember us-gaap:SubsequentEventMember 2021-02-24 0001142596 srt:MaximumMember nuva:SimplifyMedicalPtyLimitedMember us-gaap:SubsequentEventMember 2021-02-24 shares iso4217:USD iso4217:USD shares nuva:Customer nuva:segment nuva:investment pure utr:D 0001142596 false 2020 FY --12-31 true true true true true true true true true true true true 2020 P3Y P5Y P6M P4Y P5Y P7Y P3Y P7Y P2Y P15Y P3Y P7Y P10Y P20Y P8Y P13Y P9Y P9Y P8Y P8Y P13Y P9Y P9Y P9Y 2021 0.028 0.040 us-gaap:ValuationTechniqueDiscountedCashFlowMember P12Y9M18D P12Y4M24D P2Y2M12D P2Y3M18D P10M20D P6M P6M P6M 10-K true 2020-12-31 false 000-50744 NUVASIVE, INC DE 33-0768598 7475 Lusk Boulevard 92121 San Diego CA (858) 909-1800 Common Stock, par value $0.001 per share NUVA NASDAQ Yes No Yes Yes Large Accelerated Filer false false true false 2800000000 51379052 <p style="text-align:justify;margin-bottom:0pt;margin-top:2pt;text-indent:4.54%;font-size:7.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Part III of this Form 10-K incorporates information by reference to portions of the definitive Proxy Statement for the registrant’s 2021 Annual Meeting of Stockholders, which will be filed with the U.S. Securities and Exchange Commission not- later than 120 days after December 31, 2020.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 856869000 213034000 173145000 20631000 17019000 207071000 211532000 300623000 312419000 4727000 10434000 19749000 16917000 1562184000 764336000 286369000 266318000 152264000 201092000 559553000 561064000 102270000 66932000 15755000 9162000 1494000 1494000 13193000 14892000 2693082000 1885290000 110401000 97160000 7289000 15727000 63421000 86458000 7875000 5567000 2073000 2005000 645303000 836362000 206917000 766226000 623298000 2807000 14655000 111634000 73153000 52438000 52060000 4697000 0.001 0.001 5000000 5000000 0 0 0.001 0.001 150000000 120000000 57945000 51376000 57525000 52145000 62000 62000 1550001000 1429854000 -7585000 -9418000 45322000 82475000 6569000 5380000 668882000 587766000 918918000 915207000 2693082000 1885290000 950189000 1044569000 986457000 100393000 123501000 115257000 1050582000 1168070000 1101714000 247809000 232474000 234509000 73822000 79883000 76650000 321631000 312357000 311159000 728951000 855713000 790555000 547195000 611181000 575836000 79838000 72380000 61695000 51726000 51097000 50670000 1011000 8913000 -27800000 10878000 -1995000 11473000 690648000 732663000 736387000 1472000 1917000 586000 70466000 38525000 37857000 -16854000 -5925000 -8174000 -85848000 -42533000 -45445000 -47545000 80517000 8723000 -10392000 15283000 -3756000 -37153000 65234000 12479000 -0.72 1.26 0.24 -0.72 1.23 0.24 51416000 51956000 51382000 51416000 53160000 52355000 -37153000 65234000 12479000 13000 1820000 -790000 -1695000 1833000 -790000 -1695000 -35320000 64444000 10784000 56164000 60000 1363549000 -6933000 4762000 -5002000 -565867000 795571000 3845000 799416000 466000 1000 11309000 -114000 -6111000 5199000 5199000 27353000 27353000 27353000 18000 4719000 4719000 4719000 12479000 12479000 12479000 9101000 9101000 9101000 3845000 3845000 -1695000 -1695000 -1695000 56648000 61000 1397829000 -8628000 17241000 -5116000 -571978000 834525000 834525000 56648000 61000 1397829000 -8628000 17241000 -5116000 -571978000 834525000 805000 1000 7724000 -264000 -15788000 -8063000 24096000 24096000 72000 65234000 65234000 -205000 -205000 -790000 -790000 57525000 62000 1429854000 -9418000 82475000 -5380000 -587766000 915207000 57525000 62000 1429854000 -9418000 82475000 -5380000 -587766000 915207000 420000 6621000 -104000 -6116000 505000 25778000 25778000 484000 484000 1085000 75000000 75000000 93915000 93915000 -115592000 -115592000 115559000 115559000 -1921000 -1921000 -4697000 -4697000 -37153000 -37153000 1833000 1833000 57945000 62000 1550001000 -7585000 45322000 -6569000 -668882000 918918000 -37153000 65234000 12479000 140937000 135593000 129765000 1011000 8913000 -18007000 5844000 -11396000 48986000 21288000 20123000 18145000 30297000 25673000 -268000 -4767000 -4421000 -12301000 53902000 18382000 14834000 -16876000 -5650000 -22186000 -3030000 16407000 -4562000 40765000 54872000 38646000 4986000 4622000 1280000 8756000 -3924000 22900000 -23654000 24256000 2595000 6264000 3804000 2054000 185911000 235290000 219183000 4100000 55266000 1143000 3584000 3860000 7501000 7682000 105729000 122883000 101921000 233488000 60000000 -281934000 -134484000 -161285000 6170000 6415000 8127000 7053000 809000 19450000 80665000 14478000 2928000 873848000 93915000 147825000 100000000 100000000 -1734000 2228000 -327000 736656000 -6644000 -14578000 3202000 131000 -1283000 643835000 94293000 42037000 214528000 120235000 78198000 858363000 214528000 120235000 4719000 19914000 16145000 17182000 1873000 5828000 5510000 856869000 213034000 117840000 1494000 1494000 2395000 858363000 214528000 120235000 <p style="text-align:justify;margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.    Organization and Significant Accounting Policies </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Description of Business</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">NuVasive, Inc. (the “Company” or “NuVasive”) was incorporated in Delaware on July 21, 1997, and began commercializing its products in 2001. </span>Since its incorporation in 1997, the Company has grown from a small developer of specialty spinal implants into a global medical technology company delivering procedurally integrated solutions for spine surgery. Underlying the Company’s procedurally integrated solutions for spine surgery are technologies designed to enable better clinical, financial, and operational outcomes, including:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its surgical access instruments, including its Maxcess integrated split-blade retractor system, designed to enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery;</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring (“IONM”) services and support;</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its Advanced Materials Science portfolio of specialized spinal implants, designed to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone;</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its Reline fixation system, designed to facilitate the preservation and restoration of patient alignment, while addressing a vast array of spinal pathologies from an open or less-invasive approach across all spinal procedures; and</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its Integrated Global Alignment platform, which is comprised of procedurally based technologies that help increase the predictability of achieving global alignment in spinal procedures, including its Bendini spinal rod bending system that assist with manual rod manipulation for spinal fixation.</p></td></tr></table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has also invested in enabling technologies, including the development of capital equipment designed to further improve clinical, financial, and operational outcomes of spine surgery. The Company’s capital equipment portfolio currently consists of Lessray and the Pulse platform. Lessray is an image enhancement platform designed to reduce radiation exposure in the operating room by allowing surgeons to take low-quality, low-dose images and improve them to look like conventional full-dose images. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for <span style="color:#000000;">neuromonitoring</span>, surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. <span style="color:#000000;">Selling and leasing of capital equipment do not make up a material portion of the Company’s total net sales.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the Company’s procedurally integrated solutions for spine surgery, it also designs and sells expandable growing rod implant systems that can be non-invasively lengthened following implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control (“MAGEC”), which allows for the minimally invasive treatment of early-onset and adolescent scoliosis. This technology is also the basis for the Company’s Precice limb lengthening system, which allows for the correction of long bone limb length discrepancy, as well as other products for treating specialized orthopedic procedures.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In December 2019, a novel strain of coronavirus, which causes COVID-19, was identified. Due to the rapid and global spread of the virus, on March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. To slow the proliferation of COVID-19, governments have implemented extraordinary measures, which include the mandatory closure of businesses, restrictions on travel and gatherings, and quarantine and physical distancing requirements. In addition, many government agencies in conjunction with hospitals and healthcare systems have, to varying degrees, deferred or suspended elective surgical procedures. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, the Company has seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, the Company has experienced reductions in procedural volumes during 2020 and anticipates this trend may continue. </span>The cumulative effect of these disruptions had a significant impact on the Company’s business in 2020 and it is not possible to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation and Principles of Consolidation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying Consolidated Financial Statements include the accounts of the Company and its majority-owned or controlled subsidiaries, collectively referred to as either NuVasive or the Company. The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. When there is a portion of equity in an acquired subsidiary not attributable, directly or indirectly, to the respective parent entity, the Company records the fair value of the non-controlling interest at the acquisition date and classifies the amounts attributable to non-controlling interest separately in equity in the Company's Consolidated Financial Statements. Any subsequent changes in a parent's ownership interest while the parent retains its controlling financial interest in its subsidiary are accounted for as equity transactions. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has replaced the caption “Revenue” with “Net sales,” and the caption “Sales, marketing and administrative” with “Selling, general and administrative,” within the Consolidated Statements of Operations and corresponding changes have been made throughout this Annual Report to conform to this presentation. These updated captions have no impact on previously reported results of operations or financial position.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To prepare financial statements in conformity with generally accepted accounting principles (“GAAP”) accepted in the United States, management must make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Recent Accounting Pronouncements Not Yet Adopted</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2020-01, <span style="font-style:italic;">Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force)</span>, which clarifies the interaction of the accounting for equity securities, investments accounted for under the equity method, and certain forward contracts and purchased options. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. <span style="Background-color:#FFFFFF;">The Company will adopt ASU 2020-01 on January 1, 2021, and does not expect a material impact to its Consolidated Financial Statements.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the FASB issued ASU No. 2020-06, <span style="font-style:italic;">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)</span> (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-06 on January 1, 2021, and will elect the modified transition method that allows for a cumulative-effect adjustment in the period of adoption and will not restate prior periods. As a result of the adoption, the Company will increase its convertible debt liabilities and retained earnings on January 1, 2021 by $<span style="Background-color:#FFFFFF;">115.4</span> million and $64.5 million, respectively, and decrease its deferred tax liabilities and additional paid-in capital by approximately $28.0 million and $151.9 million, respectively.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Recently Adopted Accounting Standards<span style="font-style:normal;"> </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, </span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments – Credit Losses</span><span style="Background-color:#FFFFFF;"> (“ASU 2016-13”), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination.</span> The amendments in this update were adopted using a modified retrospective transition method as of <span style="color:#000000;">January 1, 2020</span>, which had no cumulative impact to retained earnings. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2017, the FASB issued Accounting Standards Update No. 2017-04, <span style="font-style:italic;">Intangibles – Goodwill and Other</span>, which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted the amendments in this update on January 1, 2020, which will be applied using a prospective transition method. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued Accounting Standards Update No. 2018-13, <span style="font-style:italic;">Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement </span>(“ASU 2018-13”), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public companies will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. The Company adopted ASU 2018-13 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements. See Note 4 to the Consolidated Financial Statements for further discussion on fair value measurements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2018, the FASB issued Accounting Standards Update No. 2018-15, <span style="font-style:italic;">Intangible – Goodwill and Other – Internal-Use Software</span> (“ASU 2018-15”), which requires a customer in a cloud computing arrangement to determine whether implementation costs should be capitalized as assets or expensed as incurred. Under the new guidance, capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. The amendments in this update will be applied using a prospective transition method to each period presented. The Company adopted ASU 2018-15 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which modifies Accounting Standard Codification 740 – Income Taxes (“ASC 740”). ASU 2019-12 enhances and simplifies various aspects of the income tax accounting guidance in ASC 740. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company elected to early adopt ASU 2019-12 in the quarter ended June 30, 2020. The Company applied the updated guidance for year-to-date losses in the Company’s interim period tax accounting on a prospective basis. The early adoption had no impact on the expected full year tax expense for 2020, but rather accelerated certain tax benefits to earlier quarters in 2020 that would otherwise have been limited under ASC 740.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the FASB issued Accounting Standards Update No. 2020-04, <span style="font-style:italic;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span>(“ASU 2020-04”), which provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates. This update is effective upon issuance. The relief is temporary and generally cannot be applied to contract modifications that occur after December 31, 2022 or hedging relationships entered into or evaluated after that date. The adoption of ASU 2020-04 did not have a material impact on the Company’s Consolidated Financial Statements. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with Accounting Standards Codification 606 Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue upon the transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. The principles in ASC 606 are applied using the following five steps: (i) identify the contract with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies its performance obligation(s). Specifically, revenue from the sale of implants, fixation products and disposables is generally recognized at an amount that reflects the expected consideration upon notice that the Company’s products have been used in a surgical procedure or upon shipment to a third-party customer assuming control of the products. Revenue from IONM services is recognized in the period the service is performed for the amount of consideration expected to be received. Revenue from the sale of surgical instrument sets is generally recognized upon receipt of a purchase order and the subsequent shipment to a customer who assumes control. In certain cases, the Company does offer the ability for customers to lease surgical instrumentation primarily on a non-sales type basis. <span style="Background-color:#FFFFFF;">Revenue from the sale or lease of </span>capital equipment<span style="Background-color:#FFFFFF;"> is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement</span>. Selling and leasing of surgical instrument sets and capital equipment represents an immaterial amount of the Company’s total net sales in all periods presented. Revenue associated with products holding rights of return or trade-in are recognized when the Company concludes there is not a risk of significant revenue reversal in future periods for the expected consideration in the transaction. Costs incurred by the Company associated with sales contracts with customers are deferred over the performance obligation period and recognized in the same period as the related revenue, with the exception of contracts that complete within one year or less, in which case the associated costs are expensed as incurred.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounts Receivable and Related Valuation Accounts</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable in the accompanying Consolidated Balance Sheets are presented net of allowances for credit losses.<span style="font-style:italic;"> </span><span style="color:#000000;">The Company maintains an allowance for credit losses resulting from the inability of its customers, including hospitals, ambulatory surgery centers, and distributors, to make required payments. The allowance for credit losses is calculated quarterly, and is estimated on a region-by-region basis considering a number of factors including age of account balances, collection history, historical account write-offs, third party credit reports, identified trends, current economic conditions, and supportable forecasted economic expectations. The allowance is adjusted on a specific identification basis for certain accounts as well as pooling of accounts with similar characteristics. An increase in the provision for credit losses may be required when the financial condition of the Company’s customers or its collection experience deteriorates. An increase to the allowance for credit losses results in a corresponding charge to selling, general and administrative expenses. The Company has a diverse customer base and no single customer represented greater than ten percent of net sales or accounts receivable. </span><span style="Background-color:#FFFFFF;color:#000000;">Historically, the Company’s reserves have been adequate to cover credit losses.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. It is possible that there could be a material adverse impact from potential adjustments of the carrying amount of trade receivables as customers’ cash flows are impacted by their response to the COVID-19 pandemic and the deferral of elective surgical procedures.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes in the allowance for credit losses:</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.15%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> (in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses at January 1, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,423</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current-period provision for expected losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,079</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-offs charged against the allowance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,305</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recoveries of amounts previously written off</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes resulting from foreign currency fluctuations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses at end of period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,646</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company establishes a liability for estimated sales returns and a reserve for price adjustments that are recorded as a reduction to net sales. The liability and reserve are maintained to account for the future product returns and price adjustments of products sold in the current period. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Significant Customers</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, marketable securities and accounts receivable. The Company limits its exposure to credit loss by placing its cash and investments with high credit quality financial institutions. Additionally, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has a diverse customer base and no single customer represented greater than ten percent of sales or accounts receivable for any of the periods presented.<span style="font-style:italic;"> </span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s financial instruments consist principally of cash and cash equivalents, marketable securities, restricted investments, derivatives, contingent consideration liabilities, accounts receivable, accounts payable, accrued expenses, and Senior Convertible Notes.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company measures certain assets and liabilities in accordance with authoritative guidance which requires fair value measurements to be classified and disclosed in one of the following three categories: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3: Unobservable inputs are used when little or no market data is available. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Inventory, net</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net inventory as of December 31, 2020 consisted of $285.4 million of finished goods, $7.3 million of work in progress and $7.9 million of raw materials. Net inventory as of December 31, 2019 consisted of $298.7 million of finished goods, $6.4 million of work in progress and $7.3 million of raw materials. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods primarily consists of specialized implants, fixation products and disposables and are stated at the lower of cost or net realizable value determined by utilizing a standard cost method, which includes capitalized variances, which approximates the weighted average cost. Work in progress and raw materials represent the underlying material, and labor for work in progress, that ultimately yield finished goods upon completion and are subject to lower of cost or net realizable value. The Company reviews the components of its inventory on a periodic basis for excess and obsolescence and adjusts inventory to its net realizable value as necessary.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records an inventory reserve for estimated excess and obsolete inventory based upon historical turnover and assumptions about future demand for its products and market conditions, <span style="Background-color:#FFFFFF;">such as product life cycles and timing of the introduction and development of new or enhanced products</span>. The Company’s allograft products have shelf lives ranging from two to five years and are subject to demand fluctuations based on the availability and demand for alternative products. The Company’s inventory, which consists primarily of disposables, specialized implants and fixation products, is at risk of obsolescence following the introduction and development of new or enhanced products. <span style="Background-color:#FFFFFF;">One of the Company’s strategic objectives is to continue to rapidly develop and commercialize new products and product enhancements</span> which increases the risk that products will become obsolete prior to the end of their anticipated useful life. The Company’s estimates and assumptions for excess and obsolete inventory are reviewed and updated on a quarterly basis. The estimates the Company uses for demand are also used for near-term capacity planning and inventory purchasing and are consistent with its revenue forecasts. Increases in the reserve for excess and obsolete inventory result in a corresponding charge to cost of sales.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For the year ended December 31, 2020 and 2019, the Company recorded a reserve for excess and obsolete inventory of $48.9 million and $14.0 million, respectively. The increase is primarily attributable to updates </span><span style="color:#000000;">to the Company’s estimates and assumptions about future product demand and product life cycles which have been affected by multiple factors, including the COVID-19 pandemic and general market conditions</span>.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Goodwill and Intangible Assets</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s goodwill represents the excess of the cost over the fair value of net assets acquired from its business combinations. The determination of the value of goodwill and intangible assets arising from business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of the net tangible and intangible assets acquired, including <span style="Background-color:#FFFFFF;color:#000000;">capitalized</span> in-process research and development (IPR&amp;D). <span style="Background-color:#FFFFFF;color:#000000;">Intangible assets acquired in a business combination that are used for in-process research and development activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project, the Company will amortize the acquired IPR&amp;D over its estimated useful life or expense the acquired in-process research and development should the research and development project be unsuccessful with no future alternative use.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill and IPR&amp;D are not amortized; however, they are assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstance warrant such a review. <span style="Background-color:#FFFFFF;color:#000000;">The goodwill or IPR&amp;D are considered to be impaired if the Company determines that the carrying value of the reporting unit or IPR&amp;D exceeds its respective fair value.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company performs its goodwill impairment analysis at the reporting unit level, which aligns with the Company’s reporting structure and availability of discrete financial information. </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company performs its annual impairment analysis by either comparing a reporting unit’s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit’s fair value from the last quantitative assessment to determine if there is potential impairment. The Company may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit’s estimated fair value was significantly in excess of the carrying value of its net assets and it does not believe there have been significant changes in the reporting unit’s operations that would significantly decrease its estimated fair value or significantly increase its net assets. </span><span style="Background-color:#FFFFFF;">If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and/or use of a market approach by looking at market values of comparable companies</span><span style="Background-color:#FFFFFF;">. Key assumptions for these projections include </span><span style="Background-color:#FFFFFF;">net sales</span><span style="Background-color:#FFFFFF;"> growth, future gross and operating margin growth, and its weighted cost of capital and terminal growth rates. The </span><span style="Background-color:#FFFFFF;">net sales</span><span style="Background-color:#FFFFFF;"> and margin growth is based on increased sales of new and existing products as the Company maintains investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including timing and probability of regulatory approvals for Company products to be commercialized. The Company’s market capitalization is also considered as a part of its analysis.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s annual evaluation for impairment of goodwill consists of one reporting unit. <span style="Background-color:#FFFFFF;color:#000000;">In accordance with the Company’s policy, the Company completed its most recent annual evaluation for impairment as of October 1, 2020 using the qualitative assessment and determined that no impairment existed. In addition, no indicators of impairments were noted through </span>December 31, 2020<span style="Background-color:#FFFFFF;color:#000000;"> and consequently, no impairment charge has been recorded during the year.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets with a finite life, such as acquired technology, customer relationships, manufacturing know-how, licensed technology, supply agreements and certain trade names and trademarks, are amortized on a straight-line basis over their estimated useful life, ranging from 2 to 17 years. In determining the useful lives of intangible assets, the Company considers the expected use of the assets and the effects of obsolescence, demand, competition, anticipated technological advances, changes in surgical techniques, market influences and other economic factors. For technology based intangible assets, the Company considers the expected life cycles of products which incorporate the corresponding technology. Trademarks and trade names that are related to products are assigned lives consistent with the period in which the products bearing each brand are expected to be sold. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates its intangible assets with finite lives for indications of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include significant under-performance relative to expected historical or projected future operating results, significant changes in the manner of the Company’s use of the acquired assets or the strategy for the Company’s overall business or significant negative industry or economic trends. If this evaluation indicates that the value of the intangible asset may be impaired, the Company makes an assessment of the recoverability of the net carrying value of the asset over its remaining useful life. If this assessment indicates that the intangible asset is not recoverable, based on the estimated undiscounted future cash flows of the technology over the remaining amortization period, the Company reduces the net carrying value of the related intangible asset to fair value and may adjust the remaining amortization period. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 2 to the Consolidated Financial Statements included in this Annual Report for further disclosure<span style="color:#000000;"> on goodwill and intangible assets.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Property and Equipment</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from 2 to 20 years. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter. <span style="color:#000000;">Leased property meeting certain financing lease criteria is capitalized under property and equipment, and the net present value of the related lease payments is recorded as a liability. Amortization of assets under financing leases is recorded using the straight-line method over the shorter of the estimated useful lives or the lease terms. </span>Maintenance and repairs are expensed as incurred.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Tax law and rate changes are reflected in income in the period such changes are enacted. The Company includes interest and penalties related to income taxes, including unrecognized tax benefits, within income tax expense. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> income tax returns are based on calculations and</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the calculation of the Company’s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> tax liabilities involves dealing with uncertainties in the application of comp</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">lex tax regulations. The Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recognize</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> believe</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">appropriate support for the positions taken on its tax returns, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> continually assess</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">es</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the likelihood and amount of</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> potential revisions and adjusts</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the Company’s review, it concluded that it was more likely than not that it would be able to realize the future benefits of its domestic and foreign deferred tax assets, with the exceptions of California, Malta, Mexico, Brazil and Colombia. This conclusion was based on historical and projected operating performance, as well as the Company’s expectation that its operations will generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets well within the statutory carryover periods. Due to low state apportionment, large net operating losses and the generation of sizeable research credits in California, the Company concluded that it is not more likely than not that it will be able to utilize its California deferred tax assets. Therefore, the Company has maintained a full valuation allowance on its California deferred tax assets as of December 31, 2020. Due to a history of losses in Malta, Brazil, Mexico and Colombia, and the lack of alternative sources of future taxable income, the Company has established a full valuation allowance against these entities’ deferred tax assets as of December 31, 2020.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 10 to the Consolidated Financial Statements included in this Annual Report for further discussion on income taxes.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Loss Contingencies</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An estimated loss contingency is accrued and disclosed in the Company’s financial statements if it is probable or disclosed if it is reasonably possible that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable and only discloses those matters it considers material to its overall financial position. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is involved in a number of legal actions arising in the normal course of business. The outcomes of these legal actions are not within the Company’s complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost net sales. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 12 to the Consolidated Financial Statements included in this Annual Report for further discussion<span style="color:#000000;"> on legal proceedings and investigations.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Comprehensive Income</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income includes net of tax, unrealized gains or losses on the Company’s marketable debt securities and foreign currency translation adjustments. The cumulative translation adjustments included in accumulated other comprehensive loss were $7.6 million, $9.4 million, and $8.6 million at December 31, 2020, 2019, and 2018, respectively.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Research and Development</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development costs are expensed as incurred. To the extent the Company purchases research and development assets with a future alternative use the Company will capitalize and amortize the assets over its useful life.<span style="font-style:italic;"> </span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Product Shipment Costs</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product shipment costs, included in selling, general and administrative expense in the accompanying Consolidated Statements of Operations, were $27.4 million, $27.7 million, and $25.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The majority of the Company’s shipping costs are associated with providing instrument sets to hospitals for use in individual surgical procedures. Amounts billed to customers for shipping and handling of products are reflected in net sales and are not material for any period presented.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:inherit;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Business Transition Costs</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurs certain costs related to acquisition, integration and business transition activities, which include severance, relocation, consulting, leasehold exit costs, third-party merger and acquisition costs, contingent consideration fair value adjustments and other costs directly associated with such activities. Contingent consideration is accrued based on the fair value of the expected payment, and such accruals are subject to increase or decrease based on the assessment of the likelihood that the contingent milestones will be achieved resulting in payment. If an accrual for contingent consideration decreases during a particular period, it results in a reduction of costs during such period.<span style="color:#000000;"> </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2020, the Company recorded $10.9 million of costs related to acquisition, integration and business transition activities, which included $2.3 million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2019, the Company recorded a reduction of costs of $(2.0) million related to acquisition, integration and business transition activities, which included $(6.3) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2018, the Company recorded $11.5 million of costs related to acquisition, integration and business transition activities, which included $(1.5) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock-based Compensation</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense for equity-classified awards, principally related to restricted stock units (“RSUs”) and performance restricted stock units (“PRSUs”), is measured at the grant date based on the estimated fair value of the award. <span style="color:#000000;">The fair value of equity instruments that are expected to vest is recognized and amortized over the requisite service period. The Company has granted awards with up to five year graded or cliff vesting terms </span>(in each case, with service through the date of vesting being required)<span style="color:#000000;">. </span>No exercise price or other monetary payment is required for receipt of the shares issued in settlement of the respective award; instead, consideration is furnished in the form of the participant’s service to the Company.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of RSUs including PRSUs with <span style="color:#000000;">pre-defined performance criteria </span>is based on the stock price on the date of grant whereas the expense for PRSUs with <span style="color:#000000;">pre-defined performance criteria is adjusted with the probability of achievement of such performance criteria at each period end</span>. The fair value of the PRSUs that are earned based on the achievement of pre-defined market conditions for total shareholder return is estimated on the date of grant using a Monte Carlo valuation model. The key assumptions in applying this model are an expected volatility and a risk-free interest rate. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense is adjusted from the grant date to exclude expense for awards that are expected to be forfeited. The forfeiture estimate is adjusted as necessary through the vesting date so that full compensation cost is recognized only for awards that vest. <span style="color:#000000;">The Company assesses the reasonableness of the estimated forfeiture rate at least annually, with any change to be made on a cumulative basis in the period the estimated forfeiture rates change. The Company considered its historical experience of pre-vesting forfeitures on awards by each homogenous group of employees as the basis to arrive at its estimated annual pre-vesting forfeiture rates.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the fair value of stock options issued under its equity incentive plans and shares issued to employees under its employee stock purchase plan (“ESPP”) using a Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various assumptions including expected volatility, expected term and risk-free interest rates. The expected volatility is based on the historical volatility of the Company’s common stock over the most recent period commensurate with the estimated expected term of the Company’s stock options and ESPP offering period which is derived from historical experience. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future<span style="font-family:inherit;color:#000000;">. </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 9 to the Consolidated Financial Statements included in this Annual Report for further discussion <span style="color:#000000;">on stock-based compensation.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Net (Loss) Income Per Share</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company computes basic net income per share using the weighted-average number of common shares outstanding during the period. Diluted net income per share assumes the conversion, exercise or issuance of all potential common stock equivalents, unless the effect of inclusion would be anti-dilutive. For purposes of this calculation, common stock equivalents include the Company’s stock options, unvested RSUs, PRSUs (including those with performance and market conditions), warrants, and the shares to be issued upon the conversion of the Senior Convertible Notes. The contingently issuable shares are included in basic net income per share as of the date that all necessary conditions have been satisfied and are included in the denominator for dilutive calculation for the entire period if such shares would be issuable as of the end of the reporting period assuming the end of the reporting period was the end of the contingency period.</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the computation of basic and diluted consolidated net (loss) income per share:  </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except per share data</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net (loss) income</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,153</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,234</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,479</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net (loss) income per</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   share:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares outstanding for</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   basic</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,416</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,956</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,382</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilutive potential common stock outstanding:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and ESPP</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSUs and PRSUs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">760</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Convertible Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">531</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares outstanding for</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,416</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,355</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net (loss) income per share</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.72</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net (loss) income per share</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.72</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options, ESPP, RSUs and PRSUs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,095</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Convertible Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,413</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,460</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Description of Business</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">NuVasive, Inc. (the “Company” or “NuVasive”) was incorporated in Delaware on July 21, 1997, and began commercializing its products in 2001. </span>Since its incorporation in 1997, the Company has grown from a small developer of specialty spinal implants into a global medical technology company delivering procedurally integrated solutions for spine surgery. Underlying the Company’s procedurally integrated solutions for spine surgery are technologies designed to enable better clinical, financial, and operational outcomes, including:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its surgical access instruments, including its Maxcess integrated split-blade retractor system, designed to enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery;</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring (“IONM”) services and support;</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its Advanced Materials Science portfolio of specialized spinal implants, designed to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone;</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its Reline fixation system, designed to facilitate the preservation and restoration of patient alignment, while addressing a vast array of spinal pathologies from an open or less-invasive approach across all spinal procedures; and</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.54%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:6.67%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><span style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#000000;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"/><span style="font-size:10pt;font-family:'Times New Roman'">•</span></p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-weight:normal;font-style:normal;color:#000000;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:10pt;"><span style="Background-color:#auto;text-decoration:none;"/><span style="color:#000000;"/>its Integrated Global Alignment platform, which is comprised of procedurally based technologies that help increase the predictability of achieving global alignment in spinal procedures, including its Bendini spinal rod bending system that assist with manual rod manipulation for spinal fixation.</p></td></tr></table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has also invested in enabling technologies, including the development of capital equipment designed to further improve clinical, financial, and operational outcomes of spine surgery. The Company’s capital equipment portfolio currently consists of Lessray and the Pulse platform. Lessray is an image enhancement platform designed to reduce radiation exposure in the operating room by allowing surgeons to take low-quality, low-dose images and improve them to look like conventional full-dose images. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for <span style="color:#000000;">neuromonitoring</span>, surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. <span style="color:#000000;">Selling and leasing of capital equipment do not make up a material portion of the Company’s total net sales.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition to the Company’s procedurally integrated solutions for spine surgery, it also designs and sells expandable growing rod implant systems that can be non-invasively lengthened following implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control (“MAGEC”), which allows for the minimally invasive treatment of early-onset and adolescent scoliosis. This technology is also the basis for the Company’s Precice limb lengthening system, which allows for the correction of long bone limb length discrepancy, as well as other products for treating specialized orthopedic procedures.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In December 2019, a novel strain of coronavirus, which causes COVID-19, was identified. Due to the rapid and global spread of the virus, on March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. To slow the proliferation of COVID-19, governments have implemented extraordinary measures, which include the mandatory closure of businesses, restrictions on travel and gatherings, and quarantine and physical distancing requirements. In addition, many government agencies in conjunction with hospitals and healthcare systems have, to varying degrees, deferred or suspended elective surgical procedures. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, the Company has seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, the Company has experienced reductions in procedural volumes during 2020 and anticipates this trend may continue. </span>The cumulative effect of these disruptions had a significant impact on the Company’s business in 2020 and it is not possible to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Basis of Presentation and Principles of Consolidation</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying Consolidated Financial Statements include the accounts of the Company and its majority-owned or controlled subsidiaries, collectively referred to as either NuVasive or the Company. The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. When there is a portion of equity in an acquired subsidiary not attributable, directly or indirectly, to the respective parent entity, the Company records the fair value of the non-controlling interest at the acquisition date and classifies the amounts attributable to non-controlling interest separately in equity in the Company's Consolidated Financial Statements. Any subsequent changes in a parent's ownership interest while the parent retains its controlling financial interest in its subsidiary are accounted for as equity transactions. All significant intercompany balances and transactions have been eliminated in consolidation.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has replaced the caption “Revenue” with “Net sales,” and the caption “Sales, marketing and administrative” with “Selling, general and administrative,” within the Consolidated Statements of Operations and corresponding changes have been made throughout this Annual Report to conform to this presentation. These updated captions have no impact on previously reported results of operations or financial position.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To prepare financial statements in conformity with generally accepted accounting principles (“GAAP”) accepted in the United States, management must make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Recent Accounting Pronouncements Not Yet Adopted</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2020-01, <span style="font-style:italic;">Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force)</span>, which clarifies the interaction of the accounting for equity securities, investments accounted for under the equity method, and certain forward contracts and purchased options. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. <span style="Background-color:#FFFFFF;">The Company will adopt ASU 2020-01 on January 1, 2021, and does not expect a material impact to its Consolidated Financial Statements.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2020, the FASB issued ASU No. 2020-06, <span style="font-style:italic;">Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40)</span> (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-06 on January 1, 2021, and will elect the modified transition method that allows for a cumulative-effect adjustment in the period of adoption and will not restate prior periods. As a result of the adoption, the Company will increase its convertible debt liabilities and retained earnings on January 1, 2021 by $<span style="Background-color:#FFFFFF;">115.4</span> million and $64.5 million, respectively, and decrease its deferred tax liabilities and additional paid-in capital by approximately $28.0 million and $151.9 million, respectively.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Recently Adopted Accounting Standards<span style="font-style:normal;"> </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In June 2016, the FASB issued Accounting Standards Update No. 2016-13, </span><span style="font-style:italic;Background-color:#FFFFFF;">Financial Instruments – Credit Losses</span><span style="Background-color:#FFFFFF;"> (“ASU 2016-13”), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination.</span> The amendments in this update were adopted using a modified retrospective transition method as of <span style="color:#000000;">January 1, 2020</span>, which had no cumulative impact to retained earnings. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2017, the FASB issued Accounting Standards Update No. 2017-04, <span style="font-style:italic;">Intangibles – Goodwill and Other</span>, which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted the amendments in this update on January 1, 2020, which will be applied using a prospective transition method. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2018, the FASB issued Accounting Standards Update No. 2018-13, <span style="font-style:italic;">Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement </span>(“ASU 2018-13”), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public companies will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. The Company adopted ASU 2018-13 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements. See Note 4 to the Consolidated Financial Statements for further discussion on fair value measurements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In September 2018, the FASB issued Accounting Standards Update No. 2018-15, <span style="font-style:italic;">Intangible – Goodwill and Other – Internal-Use Software</span> (“ASU 2018-15”), which requires a customer in a cloud computing arrangement to determine whether implementation costs should be capitalized as assets or expensed as incurred. Under the new guidance, capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. The amendments in this update will be applied using a prospective transition method to each period presented. The Company adopted ASU 2018-15 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which modifies Accounting Standard Codification 740 – Income Taxes (“ASC 740”). ASU 2019-12 enhances and simplifies various aspects of the income tax accounting guidance in ASC 740. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company elected to early adopt ASU 2019-12 in the quarter ended June 30, 2020. The Company applied the updated guidance for year-to-date losses in the Company’s interim period tax accounting on a prospective basis. The early adoption had no impact on the expected full year tax expense for 2020, but rather accelerated certain tax benefits to earlier quarters in 2020 that would otherwise have been limited under ASC 740.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the FASB issued Accounting Standards Update No. 2020-04, <span style="font-style:italic;">Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span>(“ASU 2020-04”), which provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates. This update is effective upon issuance. The relief is temporary and generally cannot be applied to contract modifications that occur after December 31, 2022 or hedging relationships entered into or evaluated after that date. The adoption of ASU 2020-04 did not have a material impact on the Company’s Consolidated Financial Statements. </p> 115400000 64500000 28000000.0 151900000 2020-01-01 0 2020-01-01 2020-01-01 2020-01-01 2020-06-30 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with Accounting Standards Codification 606 Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue upon the transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. The principles in ASC 606 are applied using the following five steps: (i) identify the contract with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies its performance obligation(s). Specifically, revenue from the sale of implants, fixation products and disposables is generally recognized at an amount that reflects the expected consideration upon notice that the Company’s products have been used in a surgical procedure or upon shipment to a third-party customer assuming control of the products. Revenue from IONM services is recognized in the period the service is performed for the amount of consideration expected to be received. Revenue from the sale of surgical instrument sets is generally recognized upon receipt of a purchase order and the subsequent shipment to a customer who assumes control. In certain cases, the Company does offer the ability for customers to lease surgical instrumentation primarily on a non-sales type basis. <span style="Background-color:#FFFFFF;">Revenue from the sale or lease of </span>capital equipment<span style="Background-color:#FFFFFF;"> is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement</span>. Selling and leasing of surgical instrument sets and capital equipment represents an immaterial amount of the Company’s total net sales in all periods presented. Revenue associated with products holding rights of return or trade-in are recognized when the Company concludes there is not a risk of significant revenue reversal in future periods for the expected consideration in the transaction. Costs incurred by the Company associated with sales contracts with customers are deferred over the performance obligation period and recognized in the same period as the related revenue, with the exception of contracts that complete within one year or less, in which case the associated costs are expensed as incurred.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounts Receivable and Related Valuation Accounts</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable in the accompanying Consolidated Balance Sheets are presented net of allowances for credit losses.<span style="font-style:italic;"> </span><span style="color:#000000;">The Company maintains an allowance for credit losses resulting from the inability of its customers, including hospitals, ambulatory surgery centers, and distributors, to make required payments. The allowance for credit losses is calculated quarterly, and is estimated on a region-by-region basis considering a number of factors including age of account balances, collection history, historical account write-offs, third party credit reports, identified trends, current economic conditions, and supportable forecasted economic expectations. The allowance is adjusted on a specific identification basis for certain accounts as well as pooling of accounts with similar characteristics. An increase in the provision for credit losses may be required when the financial condition of the Company’s customers or its collection experience deteriorates. An increase to the allowance for credit losses results in a corresponding charge to selling, general and administrative expenses. The Company has a diverse customer base and no single customer represented greater than ten percent of net sales or accounts receivable. </span><span style="Background-color:#FFFFFF;color:#000000;">Historically, the Company’s reserves have been adequate to cover credit losses.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. It is possible that there could be a material adverse impact from potential adjustments of the carrying amount of trade receivables as customers’ cash flows are impacted by their response to the COVID-19 pandemic and the deferral of elective surgical procedures.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes in the allowance for credit losses:</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.15%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> (in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses at January 1, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,423</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current-period provision for expected losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,079</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-offs charged against the allowance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,305</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recoveries of amounts previously written off</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes resulting from foreign currency fluctuations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses at end of period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,646</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In addition, the Company establishes a liability for estimated sales returns and a reserve for price adjustments that are recorded as a reduction to net sales. The liability and reserve are maintained to account for the future product returns and price adjustments of products sold in the current period. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the changes in the allowance for credit losses:</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.15%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> (in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses at January 1, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,423</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current-period provision for expected losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,079</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Write-offs charged against the allowance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,305</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recoveries of amounts previously written off</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes resulting from foreign currency fluctuations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">229</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses at end of period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,646</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 9423000 1079000 1305000 220000 229000 9646000 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Significant Customers</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, marketable securities and accounts receivable. The Company limits its exposure to credit loss by placing its cash and investments with high credit quality financial institutions. Additionally, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has a diverse customer base and no single customer represented greater than ten percent of sales or accounts receivable for any of the periods presented.<span style="font-style:italic;"> </span></p> 0 0 0 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s financial instruments consist principally of cash and cash equivalents, marketable securities, restricted investments, derivatives, contingent consideration liabilities, accounts receivable, accounts payable, accrued expenses, and Senior Convertible Notes.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company measures certain assets and liabilities in accordance with authoritative guidance which requires fair value measurements to be classified and disclosed in one of the following three categories: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Level 3: Unobservable inputs are used when little or no market data is available. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Inventory, net</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net inventory as of December 31, 2020 consisted of $285.4 million of finished goods, $7.3 million of work in progress and $7.9 million of raw materials. Net inventory as of December 31, 2019 consisted of $298.7 million of finished goods, $6.4 million of work in progress and $7.3 million of raw materials. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods primarily consists of specialized implants, fixation products and disposables and are stated at the lower of cost or net realizable value determined by utilizing a standard cost method, which includes capitalized variances, which approximates the weighted average cost. Work in progress and raw materials represent the underlying material, and labor for work in progress, that ultimately yield finished goods upon completion and are subject to lower of cost or net realizable value. The Company reviews the components of its inventory on a periodic basis for excess and obsolescence and adjusts inventory to its net realizable value as necessary.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records an inventory reserve for estimated excess and obsolete inventory based upon historical turnover and assumptions about future demand for its products and market conditions, <span style="Background-color:#FFFFFF;">such as product life cycles and timing of the introduction and development of new or enhanced products</span>. The Company’s allograft products have shelf lives ranging from two to five years and are subject to demand fluctuations based on the availability and demand for alternative products. The Company’s inventory, which consists primarily of disposables, specialized implants and fixation products, is at risk of obsolescence following the introduction and development of new or enhanced products. <span style="Background-color:#FFFFFF;">One of the Company’s strategic objectives is to continue to rapidly develop and commercialize new products and product enhancements</span> which increases the risk that products will become obsolete prior to the end of their anticipated useful life. The Company’s estimates and assumptions for excess and obsolete inventory are reviewed and updated on a quarterly basis. The estimates the Company uses for demand are also used for near-term capacity planning and inventory purchasing and are consistent with its revenue forecasts. Increases in the reserve for excess and obsolete inventory result in a corresponding charge to cost of sales.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">For the year ended December 31, 2020 and 2019, the Company recorded a reserve for excess and obsolete inventory of $48.9 million and $14.0 million, respectively. The increase is primarily attributable to updates </span><span style="color:#000000;">to the Company’s estimates and assumptions about future product demand and product life cycles which have been affected by multiple factors, including the COVID-19 pandemic and general market conditions</span>.</p> 285400000 7300000 7900000 298700000 6400000 7300000 48900000 14000000.0 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Goodwill and Intangible Assets</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s goodwill represents the excess of the cost over the fair value of net assets acquired from its business combinations. The determination of the value of goodwill and intangible assets arising from business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of the net tangible and intangible assets acquired, including <span style="Background-color:#FFFFFF;color:#000000;">capitalized</span> in-process research and development (IPR&amp;D). <span style="Background-color:#FFFFFF;color:#000000;">Intangible assets acquired in a business combination that are used for in-process research and development activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project, the Company will amortize the acquired IPR&amp;D over its estimated useful life or expense the acquired in-process research and development should the research and development project be unsuccessful with no future alternative use.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill and IPR&amp;D are not amortized; however, they are assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstance warrant such a review. <span style="Background-color:#FFFFFF;color:#000000;">The goodwill or IPR&amp;D are considered to be impaired if the Company determines that the carrying value of the reporting unit or IPR&amp;D exceeds its respective fair value.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company performs its goodwill impairment analysis at the reporting unit level, which aligns with the Company’s reporting structure and availability of discrete financial information. </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company performs its annual impairment analysis by either comparing a reporting unit’s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit’s fair value from the last quantitative assessment to determine if there is potential impairment. The Company may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit’s estimated fair value was significantly in excess of the carrying value of its net assets and it does not believe there have been significant changes in the reporting unit’s operations that would significantly decrease its estimated fair value or significantly increase its net assets. </span><span style="Background-color:#FFFFFF;">If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections </span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and/or use of a market approach by looking at market values of comparable companies</span><span style="Background-color:#FFFFFF;">. Key assumptions for these projections include </span><span style="Background-color:#FFFFFF;">net sales</span><span style="Background-color:#FFFFFF;"> growth, future gross and operating margin growth, and its weighted cost of capital and terminal growth rates. The </span><span style="Background-color:#FFFFFF;">net sales</span><span style="Background-color:#FFFFFF;"> and margin growth is based on increased sales of new and existing products as the Company maintains investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including timing and probability of regulatory approvals for Company products to be commercialized. The Company’s market capitalization is also considered as a part of its analysis.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s annual evaluation for impairment of goodwill consists of one reporting unit. <span style="Background-color:#FFFFFF;color:#000000;">In accordance with the Company’s policy, the Company completed its most recent annual evaluation for impairment as of October 1, 2020 using the qualitative assessment and determined that no impairment existed. In addition, no indicators of impairments were noted through </span>December 31, 2020<span style="Background-color:#FFFFFF;color:#000000;"> and consequently, no impairment charge has been recorded during the year.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets with a finite life, such as acquired technology, customer relationships, manufacturing know-how, licensed technology, supply agreements and certain trade names and trademarks, are amortized on a straight-line basis over their estimated useful life, ranging from 2 to 17 years. In determining the useful lives of intangible assets, the Company considers the expected use of the assets and the effects of obsolescence, demand, competition, anticipated technological advances, changes in surgical techniques, market influences and other economic factors. For technology based intangible assets, the Company considers the expected life cycles of products which incorporate the corresponding technology. Trademarks and trade names that are related to products are assigned lives consistent with the period in which the products bearing each brand are expected to be sold. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company evaluates its intangible assets with finite lives for indications of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include significant under-performance relative to expected historical or projected future operating results, significant changes in the manner of the Company’s use of the acquired assets or the strategy for the Company’s overall business or significant negative industry or economic trends. If this evaluation indicates that the value of the intangible asset may be impaired, the Company makes an assessment of the recoverability of the net carrying value of the asset over its remaining useful life. If this assessment indicates that the intangible asset is not recoverable, based on the estimated undiscounted future cash flows of the technology over the remaining amortization period, the Company reduces the net carrying value of the related intangible asset to fair value and may adjust the remaining amortization period. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 2 to the Consolidated Financial Statements included in this Annual Report for further disclosure<span style="color:#000000;"> on goodwill and intangible assets.</span></p> 1 0 0 P2Y P17Y <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Property and Equipment</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from 2 to 20 years. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter. <span style="color:#000000;">Leased property meeting certain financing lease criteria is capitalized under property and equipment, and the net present value of the related lease payments is recorded as a liability. Amortization of assets under financing leases is recorded using the straight-line method over the shorter of the estimated useful lives or the lease terms. </span>Maintenance and repairs are expensed as incurred.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value. </p> P2Y P20Y <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Tax law and rate changes are reflected in income in the period such changes are enacted. The Company includes interest and penalties related to income taxes, including unrecognized tax benefits, within income tax expense. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> income tax returns are based on calculations and</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the calculation of the Company’s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> tax liabilities involves dealing with uncertainties in the application of comp</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">lex tax regulations. The Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> recognize</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> believe</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">it</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">has </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">appropriate support for the positions taken on its tax returns, </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">the Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> continually assess</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">es</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the likelihood and amount of</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> potential revisions and adjusts</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Based on the Company’s review, it concluded that it was more likely than not that it would be able to realize the future benefits of its domestic and foreign deferred tax assets, with the exceptions of California, Malta, Mexico, Brazil and Colombia. This conclusion was based on historical and projected operating performance, as well as the Company’s expectation that its operations will generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets well within the statutory carryover periods. Due to low state apportionment, large net operating losses and the generation of sizeable research credits in California, the Company concluded that it is not more likely than not that it will be able to utilize its California deferred tax assets. Therefore, the Company has maintained a full valuation allowance on its California deferred tax assets as of December 31, 2020. Due to a history of losses in Malta, Brazil, Mexico and Colombia, and the lack of alternative sources of future taxable income, the Company has established a full valuation allowance against these entities’ deferred tax assets as of December 31, 2020.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 10 to the Consolidated Financial Statements included in this Annual Report for further discussion on income taxes.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Loss Contingencies</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An estimated loss contingency is accrued and disclosed in the Company’s financial statements if it is probable or disclosed if it is reasonably possible that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable and only discloses those matters it considers material to its overall financial position. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is involved in a number of legal actions arising in the normal course of business. The outcomes of these legal actions are not within the Company’s complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost net sales. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 12 to the Consolidated Financial Statements included in this Annual Report for further discussion<span style="color:#000000;"> on legal proceedings and investigations.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Comprehensive Income</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income includes net of tax, unrealized gains or losses on the Company’s marketable debt securities and foreign currency translation adjustments. The cumulative translation adjustments included in accumulated other comprehensive loss were $7.6 million, $9.4 million, and $8.6 million at December 31, 2020, 2019, and 2018, respectively.</p> -7600000 -9400000 -8600000 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Research and Development</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development costs are expensed as incurred. To the extent the Company purchases research and development assets with a future alternative use the Company will capitalize and amortize the assets over its useful life.<span style="font-style:italic;"> </span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Product Shipment Costs</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Product shipment costs, included in selling, general and administrative expense in the accompanying Consolidated Statements of Operations, were $27.4 million, $27.7 million, and $25.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The majority of the Company’s shipping costs are associated with providing instrument sets to hospitals for use in individual surgical procedures. Amounts billed to customers for shipping and handling of products are reflected in net sales and are not material for any period presented.</p> 27400000 27700000 25400000 <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:inherit;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Business Transition Costs</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company incurs certain costs related to acquisition, integration and business transition activities, which include severance, relocation, consulting, leasehold exit costs, third-party merger and acquisition costs, contingent consideration fair value adjustments and other costs directly associated with such activities. Contingent consideration is accrued based on the fair value of the expected payment, and such accruals are subject to increase or decrease based on the assessment of the likelihood that the contingent milestones will be achieved resulting in payment. If an accrual for contingent consideration decreases during a particular period, it results in a reduction of costs during such period.<span style="color:#000000;"> </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2020, the Company recorded $10.9 million of costs related to acquisition, integration and business transition activities, which included $2.3 million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2019, the Company recorded a reduction of costs of $(2.0) million related to acquisition, integration and business transition activities, which included $(6.3) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2018, the Company recorded $11.5 million of costs related to acquisition, integration and business transition activities, which included $(1.5) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.</p> 10900000 2300000 -2000000.0 -6300000 11500000 -1500000 <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock-based Compensation</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense for equity-classified awards, principally related to restricted stock units (“RSUs”) and performance restricted stock units (“PRSUs”), is measured at the grant date based on the estimated fair value of the award. <span style="color:#000000;">The fair value of equity instruments that are expected to vest is recognized and amortized over the requisite service period. The Company has granted awards with up to five year graded or cliff vesting terms </span>(in each case, with service through the date of vesting being required)<span style="color:#000000;">. </span>No exercise price or other monetary payment is required for receipt of the shares issued in settlement of the respective award; instead, consideration is furnished in the form of the participant’s service to the Company.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of RSUs including PRSUs with <span style="color:#000000;">pre-defined performance criteria </span>is based on the stock price on the date of grant whereas the expense for PRSUs with <span style="color:#000000;">pre-defined performance criteria is adjusted with the probability of achievement of such performance criteria at each period end</span>. The fair value of the PRSUs that are earned based on the achievement of pre-defined market conditions for total shareholder return is estimated on the date of grant using a Monte Carlo valuation model. The key assumptions in applying this model are an expected volatility and a risk-free interest rate. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense is adjusted from the grant date to exclude expense for awards that are expected to be forfeited. The forfeiture estimate is adjusted as necessary through the vesting date so that full compensation cost is recognized only for awards that vest. <span style="color:#000000;">The Company assesses the reasonableness of the estimated forfeiture rate at least annually, with any change to be made on a cumulative basis in the period the estimated forfeiture rates change. The Company considered its historical experience of pre-vesting forfeitures on awards by each homogenous group of employees as the basis to arrive at its estimated annual pre-vesting forfeiture rates.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the fair value of stock options issued under its equity incentive plans and shares issued to employees under its employee stock purchase plan (“ESPP”) using a Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various assumptions including expected volatility, expected term and risk-free interest rates. The expected volatility is based on the historical volatility of the Company’s common stock over the most recent period commensurate with the estimated expected term of the Company’s stock options and ESPP offering period which is derived from historical experience. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future<span style="font-family:inherit;color:#000000;">. </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 9 to the Consolidated Financial Statements included in this Annual Report for further discussion <span style="color:#000000;">on stock-based compensation.</span></p> P5Y <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Net (Loss) Income Per Share</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company computes basic net income per share using the weighted-average number of common shares outstanding during the period. Diluted net income per share assumes the conversion, exercise or issuance of all potential common stock equivalents, unless the effect of inclusion would be anti-dilutive. For purposes of this calculation, common stock equivalents include the Company’s stock options, unvested RSUs, PRSUs (including those with performance and market conditions), warrants, and the shares to be issued upon the conversion of the Senior Convertible Notes. The contingently issuable shares are included in basic net income per share as of the date that all necessary conditions have been satisfied and are included in the denominator for dilutive calculation for the entire period if such shares would be issuable as of the end of the reporting period assuming the end of the reporting period was the end of the contingency period.</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the computation of basic and diluted consolidated net (loss) income per share:  </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except per share data</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net (loss) income</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,153</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,234</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,479</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net (loss) income per</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   share:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares outstanding for</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   basic</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,416</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,956</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,382</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilutive potential common stock outstanding:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and ESPP</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSUs and PRSUs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">760</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Convertible Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">531</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares outstanding for</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,416</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,355</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net (loss) income per share</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.72</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net (loss) income per share</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.72</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options, ESPP, RSUs and PRSUs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,095</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Convertible Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,413</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,460</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the computation of basic and diluted consolidated net (loss) income per share:  </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except per share data</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Numerator:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:20.5pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net (loss) income</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,153</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,234</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,479</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Denominator for basic and diluted net (loss) income per</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   share:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares outstanding for</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   basic</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,416</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,956</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,382</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dilutive potential common stock outstanding:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options and ESPP</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSUs and PRSUs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">760</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:34.2pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Convertible Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">531</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">177</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common shares outstanding for</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,416</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,355</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net (loss) income per share</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.72</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.26</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted net (loss) income per share</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.72</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.23</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.24</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options, ESPP, RSUs and PRSUs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,095</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Convertible Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,413</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,460</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> -37153000 65234000 12479000 51416000 51956000 51382000 15000 36000 658000 760000 531000 177000 51416000 53160000 52355000 -0.72 1.26 0.24 -0.72 1.23 0.24 <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive: </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options, ESPP, RSUs and PRSUs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,095</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">162</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,865</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior Convertible Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,034</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,433</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,163</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,413</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,460</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 1095000 115000 162000 21034000 10865000 10865000 21034000 5433000 5433000 43163000 16413000 16460000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2.    Balance Sheet Details </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Property and Equipment, net</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net, consisted of the following:<span style="font-style:italic;"> </span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful Life</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Instrument sets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">424,696</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">381,310</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Machinery and equipment</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 to 7</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,616</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,482</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 to 7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,364</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2 to 15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,372</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,542</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 to 7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,916</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,931</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building and improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 to 20</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,207</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,921</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Land</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,277</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,277</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">739,448</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">659,597</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: accumulated depreciation and amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(453,079</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(393,279</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">286,369</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,318</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment mainly consisted of instrument sets, <span style="letter-spacing:-0.1pt;">which</span> are made available to <span style="letter-spacing:-0.1pt;">surgeons and hospitals that purchase implants, biologics and disposables for use in individual surgical procedures.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation expense was $85.9 million, $80.8 million, and $75.4 million for the years ended December 31, 2020, 2019 and 2018, respectively. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capitalized software costs include only those direct costs associated with the actual development or acquisition of computer software. At December 31, 2020 and 2019, the Company had $57.6 million and $51.7 million in unamortized capitalized software costs, respectively. Amortization expense related to capitalized software costs was $10.4 million, $10.4 million and $10.6 million for the years ended December 31, 2020, 2019 and 2018, respectively. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Goodwill and Intangible Assets</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill and intangible assets as of December 31, 2020 consisted of the following:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technology</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000627">8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">271,748</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(195,283</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,465</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing know-how and trade secrets</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000628">13</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,882</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,720</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,162</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name and trademarks</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000629">9</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,945</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,555</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000630">9</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,436</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(94,354</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,082</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000631">8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">484,566</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(332,302</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,264</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets not subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">559,553</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total goodwill and intangible assets, net</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">711,817</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill and intangible assets as of December 31, 2019 consisted of the following: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technology</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000650">8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">271,748</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(163,459</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,289</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing know-how and trade secrets</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000651">13</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,798</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,333</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,465</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name and trademarks</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000652">9</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,947</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,553</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000653">9</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,744</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,959</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,785</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000654">9</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">478,790</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,698</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201,092</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets not subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">561,064</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total goodwill and intangible assets, net</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762,156</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total expense related to the amortization of intangible assets which is recorded in either cost of sales or operating expenses in the Consolidated Statements of Operations depending on the functional nature of the intangible, was $55.0 million, $54.8 million and $54.4 million for the years ended December 31, 2020, 2019 and 2018, respectively.</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes to goodwill are comprised of the following:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross goodwill</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">569,364</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated impairment loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">561,064</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes to gross goodwill:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes resulting from foreign currency fluctuations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,511</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,511</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross goodwill</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">567,853</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated impairment loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">559,553</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future amortization expense related to intangible assets subject to amortization at December 31, 2020 is set forth in the table below: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,876</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,843</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,697</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,506</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,705</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter through 2031</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.6%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future amortization expense</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,264</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounts Payable and Accrued Liabilities</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued liabilities consisted of the following:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.24%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,249</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,897</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,386</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Distributor commissions payable</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,891</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,983</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other taxes payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,425</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,501</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Litigation liability</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,346</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,370</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt interest payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,203</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,266</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties payable</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,495</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,994</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,322</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,401</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Property and Equipment, net</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net, consisted of the following:<span style="font-style:italic;"> </span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Useful Life</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Instrument sets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">424,696</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">381,310</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Machinery and equipment</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 to 7</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,616</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,482</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 to 7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,364</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">149,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2 to 15</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,372</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,542</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 to 7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,916</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,931</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Building and improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10 to 20</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,207</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,921</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Land</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,277</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,277</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">739,448</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">659,597</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: accumulated depreciation and amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(453,079</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(393,279</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:18.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">286,369</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.2%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,318</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> 424696000 381310000 71616000 66482000 173364000 149134000 35372000 29542000 9916000 8931000 23207000 22921000 1277000 1277000 739448000 659597000 453079000 393279000 286369000 266318000 85900000 80800000 75400000 57600000 51700000 10400000 10400000 10600000 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Goodwill and Intangible Assets</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill and intangible assets as of December 31, 2020 consisted of the following:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technology</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000627">8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">271,748</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(195,283</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,465</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing know-how and trade secrets</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000628">13</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,882</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,720</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,162</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name and trademarks</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000629">9</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,945</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,555</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000630">9</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,436</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(94,354</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,082</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000631">8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">484,566</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(332,302</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,264</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets not subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">559,553</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total goodwill and intangible assets, net</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">711,817</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill and intangible assets as of December 31, 2019 consisted of the following: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Accumulated</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intangible</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Assets, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Developed technology</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000650">8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">271,748</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(163,459</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108,289</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Manufacturing know-how and trade secrets</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000651">13</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,798</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(20,333</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,465</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade name and trademarks</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000652">9</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,500</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16,947</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,553</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer relationships</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000653">9</span></p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150,744</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(76,959</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,785</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total intangible assets subject to amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000654">9</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">478,790</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,698</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201,092</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.04%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Intangible assets not subject to amortization:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.28%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">561,064</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.04%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total goodwill and intangible assets, net</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.28%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">762,156</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;"> </p> 271748000 195283000 76465000 30882000 22720000 8162000 25500000 19945000 5555000 156436000 94354000 62082000 484566000 332302000 152264000 152264000 559553000 711817000 271748000 163459000 108289000 30798000 20333000 10465000 25500000 16947000 8553000 150744000 76959000 73785000 478790000 277698000 201092000 201092000 561064000 762156000 55000000.0 54800000 54400000 <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The changes to goodwill are comprised of the following:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross goodwill</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">569,364</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated impairment loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">561,064</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes to gross goodwill:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes resulting from foreign currency fluctuations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,511</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,511</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross goodwill</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">567,853</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated impairment loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.74%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">559,553</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 569364000 8300000 561064000 -1511000 -1511000 567853000 8300000 559553000 <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future amortization expense related to intangible assets subject to amortization at December 31, 2020 is set forth in the table below: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,876</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43,843</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,697</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,506</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,705</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter through 2031</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.6%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total future amortization expense</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,264</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 51876000 43843000 18697000 12506000 11705000 13637000 152264000 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Accounts Payable and Accrued Liabilities</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued liabilities consisted of the following:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:32.24%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59,249</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58,897</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,386</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,827</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Distributor commissions payable</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,891</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,983</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other taxes payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,425</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,501</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Litigation liability</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,346</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,370</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt interest payable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,203</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,266</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties payable</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,495</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,994</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,406</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,322</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:8.12%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,401</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,160</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 59249000 58897000 17386000 11827000 9891000 7983000 6425000 6501000 5346000 1370000 5203000 4266000 4495000 4994000 2406000 1322000 110401000 97160000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3.    Marketable Securities </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Short-Term Marketable Securities</p> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company invests in available-for-sale marketable debt securities consisting of corporate notes and commercial paper. </span><span style="color:#000000;">The Company has the ability, if necessary, to liquidate without penalty any of its marketable debt securities to meet its liquidity needs in the next 12 months. As such, those investments with contractual maturities greater than one year from the date of purchase are classified as short-term on the accompanying Consolidated Balance Sheets</span><span style="Background-color:#FFFFFF;">.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company’s outstanding <span style="Background-color:#FFFFFF;color:#212529;">marketable debt securities all have contractual maturities due within one year. The carrying value and amortized cost of the Company’s marketable debt securities, summarized by major security type, consisted of the following:</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt securities, available for sale:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,197</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,188</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,957</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt securities, available for sale</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,145</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company’s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer’s industry, and any significant deterioration in economic conditions.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in interest income in the Consolidated Statement of Operations through an allowance for credit losses. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive loss. <span style="Background-color:#FFFFFF;color:#212529;">Unrealized losses on available-for-sale debt securities as of December 31, 2020 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, the Company has not recorded an allowance for credit losses with these investments.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, the Company’s outstanding <span style="Background-color:#FFFFFF;color:#212529;">marketable debt securities all have contractual maturities due within one year. The carrying value and amortized cost of the Company’s marketable debt securities, summarized by major security type, consisted of the following:</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.82%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt securities, available for sale:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,197</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,188</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,957</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt securities, available for sale</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,145</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 54197000 6000 15000 54188000 118932000 25000 118957000 173129000 31000 15000 173145000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4.    Financial Instruments and Fair Value Measurements <span style="font-weight:normal;"> </span></p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Foreign Currency and Derivative Financial Instruments</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities, and average exchange rates during each reporting period for results of operations.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Some of the Company’s reporting entities conduct a portion of their business in currencies other than the entity’s functional currency. These transactions give rise to receivables and payables that are denominated in currencies other than the entity’s functional currency. The value of these receivables and payables is subject to changes in currency exchange rates from the point at which the transactions are originated until the settlement in cash. Both realized and unrealized gains and losses in the value of these receivables and payables are included in the determination of net income. Net currency exchange losses, which include gains and losses from derivative instruments, were $4.2 million, $0.8 million and $3.7 million for the years ended December 31, 2020, 2019 and 2018, respectively, and are included in other (expense) income, net in the Consolidated Statements of Operations.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">To manage foreign currency exposure risks, the Company uses derivatives for activities in entities that have short-term intercompany receivables and payables denominated in a currency other than the entity’s functional currency. </span>The fair value is based on a quoted market price (Level 1). As of December 31, 2020, 2019, and 2018 a notional principal amount of $14.0 million, $26.9 million, and $26.8 million, respectively, was outstanding to hedge currency risk relative to foreign receivables and payables. Derivative instrument net (losses) gains on the Company’s forward exchange contracts were $(1.0) million, $0.4 million, and $0.5 million for the years ended December 31, 2020, 2019 and 2018, respectively, and are included in other (expense) income, net in the Consolidated Statements of Operations. The fair value of the forward contract exchange derivative instrument liability was de minimis as of December 31, 2020 and $0.1 million as of December 31, 2019. The derivative instruments are recorded in other current assets or other current liabilities in the Consolidated Balance Sheets commensurate with the nature of the instrument at period end.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value Measurements</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the periods presented.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair values of the Company’s assets and liabilities, including cash equivalents, marketable debt securities, derivatives, and contingent consideration are measured at fair value on a recurring basis<span style="color:#000000;">. </span>As of <span style="color:#000000;">December 31, 2020</span> and <span style="color:#000000;">December 31, 2019</span>, the Company held investments in securities classified as cash equivalents. During the periods presented, the Company did not hold any such investments that were in a significant unrealized loss position and no impairment charges were recorded on such investments. Realized gains and losses and interest income related to marketable securities were immaterial during all periods presented.<span style="color:#000000;"> Cash equivalents and marketable debt securities are determined under the fair value categories as follows: </span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:6pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted Price in</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Active Market</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Observable Inputs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs (Level 3)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,996</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,996</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">761,104</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,996</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt securities, available for sale:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt securities, available for sale</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">934,249</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,141</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying amounts of certain financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses, other current assets, accounts payable, accrued expenses, and other current liabilities as of December 31, 2020 and December 31, 2019 approximate their related fair values due to the short-term maturities of these instruments.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The fair value of certain financial instruments was measured and classified within Level 1 of the fair value hierarchy based on quoted prices.</span> Certain financial instruments classified within Level 2 of the fair value hierarchy include the types of instruments that trade in markets that are not considered to be active, but are valued based on quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value of Senior Convertible Notes</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $650.0 million principal amount of Senior Convertible Notes due 2021 at December 31, 2020 and December 31, 2019 was approximately $651.6 million and $869.3 million, respectively. The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $450.0 million principal amount of Senior Convertible Notes due 2023 at December 31, 2020 was approximately $461.9 million. The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $450.0 million principal amount of Senior Convertible Notes due 2025 at December 31, 2020 was approximately $436.7 million. </span>See Note 6 to the Consolidated Financial Statements included in this Annual Report<span style="color:#000000;"> </span>for further discussion on the carrying value of the notes<span style="Background-color:#FFFFFF;">.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Fair Value of Convertible Note Hedge and Embedded Conversion Derivatives</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On June 1, 2020, the Company issued $450.0 million principal amount of 1.00% Senior Convertible Notes due 2023 (the “2023 Notes”). The 2023 Notes were initially required to be settled in cash as the Company did not have enough available shares and was unable to reserve the maximum number of shares issuable under the 2023 Notes (“sufficient reserved shares”). On September 10, 2020, the Company held a Special Meeting of Stockholders and received stockholder approval to amend the Company’s Restated Certificate of Incorporation to increase the number of shares of its common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares. As a result of the increase in the number of shares of the Company’s common stock authorized for issuance, as of September 10, 2020 and as of December 31, 2020, the Company had sufficient reserved shares and therefore may settle conversions of the 2023 Notes in cash, stock, or a combination thereof, solely at the Company’s discretion. In accordance with authoritative guidance, the cash conversion feature of the 2023 Notes requires bifurcation from the 2023 Notes and was initially accounted for as a derivative liability (“Embedded Conversion Derivative”), which was included in long-term liabilities in the Company’s Consolidated Balance Sheet. <span style="Background-color:#FFFFFF;">On September 10, 2020,</span> as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle conversions of the 2023 Notes in cash, stock, or a combination thereof,<span style="Background-color:#FFFFFF;"> and in accordance with authoritative literature, the </span>Embedded Conversion Derivative<span style="Background-color:#FFFFFF;"> was marked to fair value and reclassified to stockholders’ equity.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">In connection with the issuance of the 2023 Notes, the Company entered into convertible note hedge transactions (the “2023 Hedge”) entitling the Company</span> to purchase up to 5,345,010 shares of the Company’s common stock at an initial stock price of $84.19 per share, each of which is subject to adjustment. The 2023 Hedge was initially required to be settled in cash as the Company did not have sufficient reserved shares with respect to the 2023 Notes. As a result, the 2023 Hedge was accounted for as a derivative asset (“Convertible Note Hedge Derivative”), which was included in long-term assets in the Company’s Consolidated Balance Sheet<span style="Background-color:#FFFFFF;">. </span>On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle the 2023 Notes, which therefore allows for the 2023 Hedge to be settled in cash, stock, or a combination thereof. <span style="Background-color:#FFFFFF;">In accordance with authoritative literature, the </span>Convertible Note Hedge Derivative<span style="Background-color:#FFFFFF;"> was marked to fair value and reclassified to stockholders’ equity.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Prior to their reclassification to stockholders’ equity on September 10, 2020, </span>the Embedded Conversion Derivative and Convertible Note Hedge Derivative<span style="Background-color:#FFFFFF;"> were classified as Level 3 of the fair value hierarchy as these derivative instruments were not actively traded and were valued using significant unobservable inputs.</span></p> <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables set forth the changes in the estimated fair value for the Company’s derivative assets and liabilities measured using significant unobservable inputs (Level 3):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at January 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative assets recorded in connection with the 2023 Hedge</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,525</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value measurement</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,233</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative asset reclassified to stockholders’ equity</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,292</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at December 31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at January 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative liability recorded in connection with the 2023 Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,224</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value measurement</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative liability reclassified to stockholders’ equity</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,292</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at December 31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2020, the fair value measurement was determined utilizing a Black-Scholes valuation model. Key assumptions used in the valuation included risk-free interest rates, volatility, and expected term. <span style="Background-color:#FFFFFF;color:#000000;">The Company recorded the change in fair value measurement associated with its derivative assets and liabilities in other (expense) income, net in the Consolidated Statement of Operations.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Contingent Consideration Liabilities</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of contingent consideration liabilities assumed in business combinations is recorded as part of the purchase price consideration of the acquisition, and is determined using a discounted cash flow model or probability simulation model. The significant inputs of such models are not observable in the market, such as certain financial metric growth rates, volatility rates, projections associated with the applicable milestone, the interest rate, and the related probabilities and payment structure in the contingent consideration arrangement. Fair value adjustments to contingent consideration liabilities are recorded through operating expenses in the Consolidated Statement of Operations. Contingent consideration arrangements assumed by an asset purchase will be measured and accrued when such contingency is resolved.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The recurring Level 3 fair value measurements of contingent consideration liabilities associated with commercial sales milestones include the following significant unobservable inputs as of December 31, 2020:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation Techniques</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounted cash flow, Monte Carlo</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discount Rate Range</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8% - 4.0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Discount Rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.6%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected Years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021 - 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration liabilities were <span style="color:#000000;">$37.0 million </span>and $42.6 million as of <span style="color:#000000;">December 31, 2020</span> and <span style="color:#000000;">December 31, 2019</span>, respectively, and were recorded in the Consolidated Balance Sheet commensurate with the respective payment terms.<span style="color:#000000;"> The following table sets forth the changes in the estimated fair value of the Company’s liabilities measured on a recurring basis using significant unobservable inputs (Level 3):</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.86%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at January 1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,559</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value measurement</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,420</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration paid or settled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,938</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,435</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes resulting from foreign currency fluctuations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(119</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at December 31</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,041</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,559</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Non-financial assets and liabilities measured on a nonrecurring basis </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain non-financial assets and liabilities are measured at fair value, usually with Level 3 inputs including the discounted cash flow method or cost method, on a nonrecurring basis in accordance with authoritative guidance. These include items such as nonfinancial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets and property and equipment, are measured at fair value when there is an indication of impairment and are recorded at fair value only when any impairment is recognized. The carrying values of the Company’s financing lease obligations approximated their estimated fair value as of December 31, 2020 and 2019.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2019, the Company recorded a loss of $4.8 million on a strategic investment. The loss was recorded in other (expense) income, net in the Consolidated Statement of Operations included in this Annual Report.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2018, the Company expensed $8.9 million for a purchased in-process research and development asset which had no future alternative use. The Company also recorded a net loss of $3.8 million on strategic investments during the year ended December 31, 2018. The net loss was recorded in other (expense) income, net in the Consolidated Statement of Operations included in this Annual Report.</p> -4200000 -800000 -3700000 14000000.0 26900000 26800000 -1000000.0 400000 500000 100000 0 0 0 0 Cash equivalents and marketable debt securities are determined under the fair value categories as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Quoted Price in</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Significant</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Active Market</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Observable Inputs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unobservable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 1)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Level 2)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Inputs (Level 3)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020:</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,996</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,996</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">761,104</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,996</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt securities, available for sale:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118,957</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total debt securities, available for sale</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">173,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets measured at fair value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">934,249</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">725,108</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,141</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.9%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash equivalents:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:41.9%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash equivalents</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,750</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 725108000 725108000 35996000 35996000 761104000 725108000 35996000 54188000 54188000 118957000 118957000 173145000 173145000 934249000 725108000 209141000 151750000 151750000 151750000 151750000 650000000.0 650000000.0 651600000 869300000 450000000.0 461900000 450000000.0 436700000 450000000.0 0.0100 120000000 150000000 5345010 84.19 <p style="text-align:justify;margin-bottom:12pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following tables set forth the changes in the estimated fair value for the Company’s derivative assets and liabilities measured using significant unobservable inputs (Level 3):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at January 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative assets recorded in connection with the 2023 Hedge</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,525</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value measurement</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(32,233</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative asset reclassified to stockholders’ equity</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,292</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at December 31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Liabilities:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at January 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative liability recorded in connection with the 2023 Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57,224</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value measurement</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Derivative liability reclassified to stockholders’ equity</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,292</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at December 31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 69525000 -32233000 -37292000 57224000 -19932000 -37292000 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The recurring Level 3 fair value measurements of contingent consideration liabilities associated with commercial sales milestones include the following significant unobservable inputs as of December 31, 2020:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:69%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation Techniques</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discounted cash flow, Monte Carlo</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Discount Rate Range</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8% - 4.0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average Discount Rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.6%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:69%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected Years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:28.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021 - 2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 0.036 2024 37000000.0 42600000 The following table sets forth the changes in the estimated fair value of the Company’s liabilities measured on a recurring basis using significant unobservable inputs (Level 3): <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:37.86%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.36%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at January 1</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,559</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in fair value measurement</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,420</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:58.98%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contingent consideration paid or settled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,938</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.12%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,435</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes resulting from foreign currency fluctuations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(119</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:58.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value measurement at December 31</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,041</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.12%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.36%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,559</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 42559000 50410000 2420000 -6297000 7938000 1435000 -119000 37041000 42559000 -4800000 8900000 -3800000 <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5.    Business Combinations </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company recognizes the assets acquired, liabilities assumed, and any non-controlling interest at fair value at the date of acquisition. Certain acquisitions contained contingent consideration arrangements that required the Company to assess the acquisition date fair value of the contingent consideration liabilities, which was recorded as part of the purchase price allocation of the acquisition, with subsequent fair value adjustments to the contingent consideration recorded in the Consolidated Statements of Operations. </span>See Note 4 <span style="color:#000000;">to the Consolidated Financial Statements included in this Annual Report for further discussion on contingent consideration liabilities.</span></p> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Acquisitions</p> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company has completed acquisitions that were not considered material, individually or collectively, to the overall Consolidated Financial Statements during the periods presented. These acquisitions have been included in the Consolidated Financial Statements from the respective dates of acquisition. The Company does not believe that collectively the acquisitions made during the periods presented are material to the overall financial statements.</span></p> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company finalizes the purchase price allocation of the assets and liabilities subject to valuation obtained in business combinations within one year from the acquisition date. While the Company does not expect material changes from the initial outcome of the valuation, certain assumptions and findings made at the date of acquisition could result in changes in the purchase price allocation.</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#212529;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Variable Interest Entities</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company provides IONM services through various subsidiaries, which conduct business as NuVasive Clinical Services. In providing IONM services to surgeons and healthcare facilities across the United States, the Company maintains contractual relationships with several physician practices (“PCs”). In accordance with authoritative guidance, the Company has determined that the PCs are variable interest entities and therefore, the accompanying Consolidated Financial Statements include the accounts of the PCs from the date of acquisition. During the periods presented, the results of the PCs were immaterial to the Company’s financial statements. The creditors of the PCs have claims only to the assets of the PCs, which are not material, and the assets of the PCs are not available to the Company.</span></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6.     Indebtedness</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying values of the Company’s Senior Convertible Notes are as follow<span style="color:#000000;">s: </span></p> <p style="margin-top:0pt;margin-bottom:0pt;margin-left:6.67%;text-indent:3.33%;font-size:6pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.25% Senior Convertible Notes due 2021:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">650,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">650,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,501</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt issuance costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(752</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,201</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">645,303</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623,298</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.00% Senior Convertible Notes due 2023:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal amount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">450,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(46,837</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt issuance costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,049</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">392,114</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.375% Senior Convertible Notes due 2025:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">450,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,346</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt issuance costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,542</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">374,112</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Senior Convertible Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,411,529</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623,298</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Current portion</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(645,303</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term Senior Convertible Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">766,226</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623,298</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2.25% Senior Convertible Notes due 2021</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the Company issued $<span style="color:#000000;">650.0 </span> million principal amount of unsecured Senior Convertible Notes with a stated interest rate of <span style="color:#000000;">2.25</span>% and a maturity date of <span style="color:#000000;">March 15, 2021</span> (the “2021 Notes”). The net proceeds from the offering, after deducting initial purchasers' discounts and costs directly related to the offering, were approximately $<span style="color:#000000;">634.1</span> million. Prior to September 14, 2020, the 2021 Notes provided for settlement in cash, stock, or a combination thereof, solely at the Company’s discretion. As of September 14, 2020, combination settlement was deemed to have been elected by the Company and the 2021 Notes will be settled by satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company's common stock. The initial conversion rate of the 2021 Notes is <span style="color:#000000;">16.7158 </span> shares per $<span style="color:#000000;">1,000 </span> principal amount, which is equivalent to a conversion price of approximately $<span style="color:#000000;">59.82 </span> per share, subject to adjustments. The Company uses the treasury share method for assumed conversion of the 2021 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. The Company also entered into transactions for a convertible notes hedge (the “2021 Hedge”) and warrants (the “2021 Warrants”) concurrently with the issuance of the 2021 Notes.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The cash conversion feature of the 2021 Notes required bifurcation from the notes and was initially accounted for as an equity instrument classified to stockholders’ equity, which resulted in recognizing $84.8 million in additional paid-in-capital during 2016. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The interest expense recognized on the 2021 Notes during the year ended <span style="color:#000000;">December 31, 2020</span> includes $14.6 million, $18.6 million and $3.4 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2021 Notes during the year ended December 31, 2019 includes $14.6 million, $17.6 million and $3.2 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2021 Notes during the year ended December 31, 2018 includes $14.6 million, $16.7 million and $2.9 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2021 Notes is 5.8%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2021 Notes began accruing upon issuance and is payable semi-annually. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to September 15, 2020, holders could have converted their 2021 Notes only under the following conditions: (a) during any calendar quarter beginning June 30, 2016, if the reported sale price of the Company's common stock for at least 20 days out of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter was greater than 130% of the conversion price on each applicable trading day; (b) during the five business day period in which the trading price of the 2021 Notes fell below 98% of the product of (i) the last reported sale price of the Company's common stock and (ii) the conversion rate on that date; and (c) upon the occurrence of specified corporate events, as defined in the 2021 Notes. From September 15, 2020 and until the close of business on the second scheduled trading day immediately preceding March 15, 2021, holders may convert their 2021 Notes at any time (regardless of the foregoing circumstances). The 2021 Notes can no longer be redeemed by the Company. The Company previously had the ability to redeem the 2021 Notes, at its option, in whole or in part beginning on March 20, 2019 <span style="Background-color:#FFFFFF;">until the close of business on the business day immediately preceding September 15, 2020 if the last reported sale price of the Company’s common stock had been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company delivers written notice of a redemption. </span>No principal payments are due on the 2021 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2021 Notes do not contain any financial covenants and do not restrict the Company from paying dividends or issuing or repurchasing any of its other securities. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of September 15, 2020, holders may convert their 2021 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. As a result, the 2021 Notes are considered redeemable as of December 31, 2020. A portion of the equity component that was recorded upon the issuance of the 2021 Notes was reclassified to temporary equity in the Consolidated Balance Sheet. Such amount was determined based on the cash consideration to be paid upon conversion and the carrying amount of the debt. The reclassification into temporary equity as of December 31, 2020 was $4.7 million based on the 2021 Notes principal of $650.0 million and the carrying value of $645.3 million.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2021 Hedge</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the offering of the 2021 Notes, the Company entered into the hedge transaction with the initial purchasers of the 2021 Notes and/or their affiliates (the "2021 Counterparties") entitling the Company to purchase up to 10,865,270 shares of the Company's common stock at an initial stock price of $59.82 per share, each of which is subject to adjustment. The cost of the 2021 Hedge was $111.2 million and accounted for as an equity instrument by recognizing $111.2 million in additional paid-in-capital during 2016. The 2021 Hedge will expire on March 15, 2021. The 2021 Hedge is expected to reduce the potential equity dilution upon conversion of the 2021 Notes if the daily volume-weighted average price per share of the Company's common stock exceeds the strike price of the 2021 Hedge. An assumed exercise of the 2021 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2021 Warrants</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company sold warrants to the 2021 Counterparties to acquire up to 10,865,270 shares of the Company’s common stock. The 2021 Warrants will expire on various dates from June 2021 through December 2021 and may be settled in cash or net shares. It is the Company's current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $44.9 million in cash proceeds from the sale of the 2021 Warrants, which was recorded in additional paid-in-capital. The 2021 Warrants could have a dilutive effect on the Company's earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2021 Warrants, which is $80.00 per share. The Company uses the treasury share method for assumed conversion of its 2021 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">1.00% Senior Convertible Notes due 2023</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2020, the Company issued $450.0 million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 1.00% and a maturity date of June 1, 2023. The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $436.7 million. The 2023 Notes were initially required to be settled in cash as the Company did not have sufficient reserved shares. On September 10, 2020, the Company held a Special Meeting of Stockholders and received stockholder approval to amend the Company’s Restated Certificate of Incorporation to increase the number of shares of its common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares. As a result of the increase in the number of shares of the Company’s common stock authorized for issuance, as of September 10, 2020 and as of December 31, 2020, the Company had sufficient reserved shares and therefore may settle conversions of the 2023 Notes in cash, stock, or a combination thereof, solely at the Company’s discretion. It is the Company’s current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company’s common stock. The initial conversion rate of the 2023 Notes is 11.8778 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $84.19 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date, the Company will increase the conversion rate for a holder who elects to convert its 2023 Notes in connection with such a corporate event in certain circumstances. The Company also entered into transactions for a convertible notes hedge and warrants concurrently with the issuance of the 2023 Notes.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As discussed in Note 4, the Embedded Conversion Derivative requires bifurcation from the 2023 Notes and was initially accounted for as a liability, which was included in long-term liabilities in the Company’s Consolidated Balance Sheet. The fair value of the 2023 Notes Embedded Conversion Derivative at the time of issuance of the 2023 Notes was $57.2 million, and was recorded as the original debt discount for purposes of accounting for the debt component of the 2023 Notes. <span style="Background-color:#FFFFFF;">On September 10, 2020, </span>as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle conversions of the 2023 Notes in cash, stock, or a combination thereof, and<span style="Background-color:#FFFFFF;"> in accordance with authoritative literature, the </span>Embedded Conversion Derivative <span style="Background-color:#FFFFFF;">was marked to fair value and reclassified to stockholders’ equity, which resulted in recognizing $37.3 million in additional paid-in-capital during the year ended December 31, 2020.</span> The original discount will be recognized as interest expense using the effective interest method over the term of the 2023 Notes.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The interest expense recognized on the 2023 Notes during the year ended December 31, 2020 includes $2.6 million, $10.4 million and $2.2 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2023 Notes is 6.8%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to February 1, 2023, holders may convert their 2023 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price of the 2023 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on such trading day; or (c) upon the occurrence of specified corporate events, as defined in the 2023 Notes. On or after February 1, 2023, until the close of business on the second scheduled trading day immediately preceding June 1, 2023, holders may convert their 2023 Notes at any time, regardless of the foregoing conditions.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company may not redeem the 2023 Notes prior to the maturity date and no principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2023 Notes do not contain any financial covenants and do not restrict the Company from conducting significant restructurings, paying dividends or issuing or repurchasing any of its other securities. As of December 31, 2020, the Company is unaware of any current events or market conditions that would allow holders to convert the 2023 Notes.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2023 Hedge</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the sale of the 2023 Notes, the Company entered into privately negotiated call option transactions with certain dealers, which included affiliates of certain of the initial purchasers of the 2023 Notes and other financial institutions (the “2023 Counterparties”), entitling the Company to purchase up to 5,345,010 shares of the Company’s common stock at an initial stock price of $84.19 per share, each of which is subject to adjustment. The 2023 Hedge was initially required to be settled in cash as the Company did not have sufficient reserved shares with respect to the 2023 Notes. As a result, the 2023 Hedge was accounted for as a derivative asset, which was included in long-term assets in the Company’s Consolidated Balance Sheet. <span style="Background-color:#FFFFFF;">The cost of the 2023 Hedge was $69.5 million. </span>On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle the 2023 Notes, which therefore allows for the 2023 Hedge to be settled in cash, stock, or a combination thereof. <span style="Background-color:#FFFFFF;">In accordance with authoritative literature, the Convertible Note Hedge Derivative was marked to fair value and reclassified to stockholders’ equity, which resulted in recognizing a reduction of $37.3 million in additional paid-in-capital during the year ended December 31, 2020. The 2023 Hedge will expire on the second scheduled trading day immediately preceding June 1, 2023. The 2023 Hedge is expected to reduce the potential equity dilution upon conversion of the 2023 Notes if the daily volume-weighted average price per share of the Company’s common stock exceeds the strike price of the 2023 Hedge. An assumed exercise of the 2023 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2023 Warrants</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the sale of the 2023 Notes, the Company sold warrants to the 2023 Counterparties (the “2023 Warrants”) to acquire up to 5,345,010 shares of the Company’s common stock. The 2023 Warrants initially limited the amount of shares the Company was required to reserve for issuance under the 2023 Warrants to an aggregate of 3,093,500 shares of the Company’s common stock, subject to adjustment upon the Company having a sufficient amount of authorized and unissued shares which are not reserved for other transactions. As a result of the Company receiving stockholder approval to increase the number of shares of the Company’s common stock authorized for issuance on September 10, 2020, the Company subsequently entered into amendment agreements with each of the 2023 Counterparties to increase the number of authorized shares of the Company’s common stock required to be reserved under the 2023 Warrants to the aggregate amount of 6,948,512 shares. The 2023 Warrants will expire on various dates from September 2023 through November 2023 and may be settled in net shares or cash, subject to certain conditions. It is the Company’s current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $46.8 million in cash proceeds from the sale of the 2023 Warrants, which was recorded in additional paid-in-capital. The 2023 Warrants could have a dilutive effect on the Company’s earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2023 Warrants, which is $104.84 per share. The Company uses the treasury share method for assumed conversion of its 2023 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">0.375% Senior Convertible Notes due 2025</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2020, the Company issued $450.0 million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 0.375% and a maturity date of March 15, 2025 (the “2025 Notes”). The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $437.0 million. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at the Company’s discretion. It is the Company's current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company’s common stock. The initial conversion rate of the 2025 Notes is 10.7198 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $93.29 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2025 Notes in connection with such a corporate event or in connection with such redemption in certain circumstances. The Company uses the treasury share method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. The Company also entered into transactions for a convertible notes hedge (the “2025 Hedge”) and warrants (the “2025 Warrants”) concurrently with the issuance of the 2025 Notes.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The cash conversion feature of the 2025 Notes required bifurcation from the notes and was initially accounted for as an equity instrument classified to stockholders’ equity, which resulted in recognizing $78.3 million in additional paid-in-capital during the year ended December 31, 2020.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The interest expense recognized on the 2025 Notes during the year ended December 31, 2020 includes $1.4 million, $11.9 million and $1.5 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2025 Notes is 4.9%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to September 15, 2024, holders may convert their 2025 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price of the 2025 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on such trading day; (c) if the Company calls any or all of the 2025 Notes for redemption, at any time prior to the close of business on the second scheduled trading day preceding the redemption date; or (d) upon the occurrence of specified corporate events, as defined in the 2025 Notes. On or after September 15, 2024, until the close of business on the second scheduled trading day immediately preceding March 15, 2025, holders may convert their 2025 Notes at any time, regardless of the foregoing conditions.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company may not redeem the 2025 Notes prior to March 20, 2023. The Company may redeem the 2025 Notes, at its option, in whole or in part, on or after March 20, 2023 until the close of business on the business day immediately preceding September 15, 2024, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company delivers written notice of a redemption. The redemption price will be equal to 100% of the principal amount of such 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date</span>. No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2025 Notes do not contain any financial covenants and do not restrict the Company from conducting significant restructurings, paying dividends or issuing or repurchasing any of its other securities. As of December 31, 2020, the Company is unaware of any current events or market conditions that would allow holders to convert the 2025 Notes.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2025 Hedge</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the sale of the 2025 Notes, the Company entered into privately negotiated call option transactions with certain dealers, which included affiliates of certain of the initial purchasers of the 2025 Notes and other financial institutions (the “2025 Counterparties”), entitling the Company to purchase up to 4,823,910 shares of the Company’s common stock at an initial stock price of $93.29 per share, each of which is subject to adjustment. The cost of the 2025 Hedge was $78.3 million and accounted for as an equity instrument by recognizing $78.3 million in additional paid-in-capital during the year ended December 31, 2020. The 2025 Hedge will expire on the second scheduled trading day immediately preceding March 15, 2025. The 2025 Hedge is expected to reduce the potential equity dilution upon conversion of the 2025 Notes if the daily volume-weighted average price per share of the Company’s common stock exceeds the strike price of the 2025 Hedge. An assumed exercise of the 2025 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">2025 Warrants</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company sold warrants to the 2025 Counterparties to acquire up to 4,823,910 shares of the Company’s common stock. The 2025 Warrants will expire on various dates from June 2025 through October 2025 and may be settled in net shares or cash, subject to certain conditions. It is the Company’s current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $47.1 million in cash proceeds from the sale of the 2025 Warrants, which was recorded in additional paid-in-capital. The 2025 Warrants could have a dilutive effect on the Company’s earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2025 Warrants, which is $127.84 per share. The Company uses the treasury share method for assumed conversion of its 2025 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Revolving Senior Credit Facility</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2020, the Company entered into a Second Amended and Restated Credit Agreement (the “2020 Credit Agreement”) for a revolving senior credit facility (the “2020 Facility”), which replaced the previous Amended and Restated Credit Agreement the Company had entered into in April 2017. The 2020 Credit Agreement was further amended in May 2020 to, among other things, provide additional flexibility in determining the financial covenant leverage ratios for the second and third fiscal quarters of 2020 and to adjust certain margin and benchmark rates used to determine interest under the 2020 Facility. The 2020 Credit Agreement provides for secured revolving loans, multicurrency loan options and letters of credit in an aggregate amount of up to $<span style="color:#000000;">550.0 </span> million. The 2020 Credit Agreement also contains an expansion feature, which allows the Company to increase the aggregate principal amount of the 2020 Facility provided the Company remains in compliance with the underlying financial covenants on a pro forma basis, including but not limited to, compliance with the consolidated interest coverage ratio and certain consolidated leverage ratios. The 2020 Facility matures in February 2025 (subject to an earlier springing maturity date), <span style="Background-color:#FFFFFF;">and includes a sublimit of $50.0 million for standby letters of credit, a sublimit of $250.0 million for multicurrency borrowings, and a sublimit of $5.0 million for swingline loans. All assets of the Company and its material domestic subsidiaries continue to be pledged as collateral under the 2020 Facility (subject to customary exceptions) pursuant to the terms set forth in the Second Amended and Restated Security and Pledge Agreement executed in favor of the administrative agent by the Company. Each of the Company’s material domestic subsidiaries guarantee the 2020 Facility. In connection with the 2020 Facility, the Company incurred issuance costs which will be amortized over the term of the 2020 Facility. </span>The Company did not carry any outstanding revolving loans under the 2020 Facility as of December 31, 2020 and 2019.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Any borrowings under the 2020 Facility are intended to be used by the Company to provide financing for working capital and other general corporate purposes, including potential mergers and acquisitions and to refinance indebtedness. Borrowings under the 2020 Facility bear interest, at the Company’s option, at a rate equal to an applicable margin plus: (a) the applicable Eurocurrency Rate (as defined in the 2020 Credit Agreement), or (b) a base rate determined by reference to the highest of (1) the federal funds effective rate plus 0.50%, (2) the Bank of America prime rate, and (3) the Eurocurrency Rate for an interest period of one month plus 1.00%. The margin for the 2020 Facility ranges, based on the Company’s consolidated total net leverage ratio, from 0.50% to 1.25% in the case of base rate loans and from 1.50% to 2.25% in the case of Eurocurrency Rate loans. The 2020 Facility includes an unused line fee ranging, based on the Company’s consolidated total net leverage ratio, from 0.35% to 0.50% per annum on the revolving commitment.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2020 Credit Agreement contains affirmative, negative, permitted acquisition and financial covenants, and events of default customary for financings of this type. The financial covenants require the Company to maintain a consolidated interest coverage ratio and certain consolidated leverage ratios, which are measured on a quarterly basis. The 2020 Facility grants the lenders preferred first priority liens and security interests in capital stock, intercompany debt and all of the present and future property and assets of the Company and each guarantor. The Company is currently in compliance with the 2020 Credit Agreement covenants.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying values of the Company’s Senior Convertible Notes are as follow<span style="color:#000000;">s: </span></p> <p style="margin-top:0pt;margin-bottom:0pt;margin-left:6.67%;text-indent:3.33%;font-size:6pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> (<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.25% Senior Convertible Notes due 2021:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">650,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">650,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(22,501</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt issuance costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(752</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,201</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">645,303</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623,298</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.00% Senior Convertible Notes due 2023:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal amount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">450,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(46,837</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt issuance costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,049</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">392,114</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.375% Senior Convertible Notes due 2025:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">450,000</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt discount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(66,346</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized debt issuance costs</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,542</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">374,112</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Senior Convertible Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,411,529</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623,298</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.76%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Current portion</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(645,303</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.76%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term Senior Convertible Notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">766,226</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.02%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623,298</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 0.0225 0.0225 650000000 650000000 3945000 22501000 752000 4201000 645303000 623298000 0.0100 0.0100 450000000 46837000 11049000 392114000 0.00375 0.00375 450000000 66346000 9542000 374112000 1411529000 623298000 645303000 766226000 623298000 650000000.0 0.0225 2021-03-15 634100000 16.7158 1000 59.82 84800000 14600000 18600000 3400000 14600000 17600000 3200000 14600000 16700000 2900000 0.058 20 30 1.30 5 0.98 0 4700000 650000000.0 645300000 10865270 59.82 111200000 2021-03-15 10865270 2021-06 2021-12 44900000 80.00 450000000.0 0.0100 2023-06-01 436700000 120000000 150000000 11.8778 1000 84.19 57200000 37300000 2600000 10400000 2200000 0.068 20 30 1.30 5 1000 0.98 5345010 84.19 69500000 37300000 2023-06-01 5345010 3093500 6948512 2023-09 2023-11 46800000 104.84 450000000.0 0.00375 2025-03-15 437000000.0 10.7198 1000 93.29 78300000 1400000 11900000 1500000 0.049 20 30 1.30 5 1000 0.98 1.30 20 30 1 0 4823910 93.29 78300000 2025-03-15 4823910 2025-06 2025-10 47100000 127.84 550000000.0 2025-02 50000000.0 250000000.0 5000000.0 0 0 0.0050 0.0100 0.0050 0.0125 0.0150 0.0225 0.0035 0.0050 <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7.    Commitments </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Leases</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company records the associated lease liability and corresponding right-of-use asset upon commencement of the lease using a discount rate based on a credit-adjusted secured borrowing rate commensurate with the term of the lease.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records lease liabilities within current liabilities or long-term liabilities based upon the length of time associated with the lease payments. The Company records its operating lease right-of-use assets as long-term assets. Right-of-use assets for financing leases are recorded within property and equipment, net in the Consolidated Balance Sheet. Leases with an initial term of 12 months or less are not recorded in the Consolidated Balance Sheet. The Company recognizes lease expense on a straight-line basis over the lease term. In connection with certain operating leases, the Company has security deposits recorded and maintained as restricted cash totaling $1.5 million as of <span style="color:#000000;">December 31, 2020</span> and December 31, 2019.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases office and storage facilities and equipment under various operating and financing lease agreements. The initial terms of these leases range from 1 to 17 years <span style="color:#000000;">and generally provide for periodic rent increases, and renewal and termination options</span>. <span style="color:#000000;">The Company’s lease agreements do not contain any material variable lease payments, residual value guarantees or material restrictive covenants.</span> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain leases require the Company to pay taxes, insurance and maintenance. <span style="color:#000000;">Payments for the transfer of goods or services such as common area maintenance and utilities represent non-lease components. The Company elected the package of practical expedients and therefore does not separate non-lease components from lease components.</span></p> <p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below summarizes the Company’s right-of-use assets and lease liabilities:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> (in thousands, except years and rates)</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,270</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,956</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total leased assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,226</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,385</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,875</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,567</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,355</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">672</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,634</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,153</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">905</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,676</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,297</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental non-cash information:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (years) - operating leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000958">12.8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000959">12.4</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (years) - finance leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000960">2.2</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000961">2.3</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate - operating leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate - finance leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.9</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below summarizes the Company’s lease costs, cash payments, and operating lease liabilities arising from obtaining right-of-use assets under its operating and financing lease obligations:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> (in thousands)</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expense:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,316</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,859</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance lease expense:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation of right-of-use assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,201</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">441</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,641</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,356</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Cash Flows information:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows used for operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,120</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,140</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows used for financing leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing cash flows used for financing leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,113</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">420</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash paid for amounts included in the measurement of lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,357</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,616</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental non-cash information:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities arising from obtaining right-of-use assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,148</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Rent expense, including costs directly associated with the facility leases, was approximately $12.8 million for the year ended December 31, 2018.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s future minimum annual lease payments under operating and financing leases at <span style="color:#000000;">December 31, 2020</span> are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="color:#000000;"> </span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,465</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,140</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,397</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,582</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,158</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,072</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,699</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,197</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total minimum lease payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,337</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169,848</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: amount representing interest</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(170</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(50,339</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of obligations under leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,167</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,509</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: current portion</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,355</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,875</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,634</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">Licensing and Purchasing Agreements</span><span style="font-style:normal;color:#000000;"> </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has both minimum and contingent obligations to make payments of up to <span style="color:#000000;">$50.4 </span>million <span style="Background-color:#FFFFFF;">if specified future events occur or conditions are met </span>as provided in certain net sales based, consulting, purchase and/or product development agreements. Not all of the respective agreements<span style="Background-color:#FFFFFF;"> specify milestone payment timelines</span>. Certain payments will be made in a combination of cash and the Company’s common shares as provided in the agreements. Any payments in satisfaction of these obligations are considered either a research and development expense or a cost of sales depending on the nature of the arrangement and are recognized ratably as and if milestones are achieved.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Executive Severance Plans</p> <p style="text-align:justify;Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-weight:bold;color:#000000;font-size:1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> <span style="font-size:10pt;font-weight:normal;">The Company has employment contracts with key executives and maintains severance plans that provide for the payment of severance and other benefits if such executives are terminated for reasons other than cause, as defined in those agreements and plans. Certain agreements call for payments that are based on historical compensation, and accordingly, the amount of the contractual commitment will change over time commensurate with the executive’s applicable earnings. At December 31, 2020, future commitments for such key executives were approximately $20.1 million. In certain circumstances, the agreements call for the acceleration of equity vesting. Those figures are not reflected in the above information.</span></p> 1500000 1500000 P1Y P17Y <p style="text-align:justify;margin-bottom:12pt;margin-top:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below summarizes the Company’s right-of-use assets and lease liabilities:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> (in thousands, except years and rates)</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,270</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66,932</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,956</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total leased assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">105,226</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,385</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,875</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,567</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,355</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">672</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,634</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,153</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">905</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.78%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">122,676</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.24%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,297</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental non-cash information:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (years) - operating leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000958">12.8</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000959">12.4</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (years) - finance leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000960">2.2</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000961">2.3</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate - operating leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.78%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate - finance leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.9</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.24%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.48%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> 102270000 66932000 2956000 1453000 105226000 68385000 7875000 5567000 1355000 672000 111634000 73153000 1812000 905000 122676000 80297000 0.054 0.073 0.049 0.054 <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The table below summarizes the Company’s lease costs, cash payments, and operating lease liabilities arising from obtaining right-of-use assets under its operating and financing lease obligations:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> (in thousands)</p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:27.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease expense:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,316</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,859</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance lease expense:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation of right-of-use assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,201</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">441</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest expense on lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,641</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,356</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Consolidated Statements of Cash Flows information:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows used for operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,120</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,140</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows used for financing leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing cash flows used for financing leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,113</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">420</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:51.16%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total cash paid for amounts included in the measurement of lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,357</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,616</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental non-cash information:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:51.16%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease liabilities arising from obtaining right-of-use assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:26.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,148</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">86,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 15316000 11859000 1201000 441000 124000 56000 16641000 12356000 14120000 12140000 124000 56000 1113000 420000 15357000 12616000 41148000 86134000 12800000 <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s future minimum annual lease payments under operating and financing leases at <span style="color:#000000;">December 31, 2020</span> are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="color:#000000;"> </span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Financing</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-style:italic;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.92%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,465</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,140</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,397</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,582</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">466</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,158</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,072</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,699</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">106,197</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total minimum lease payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,337</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169,848</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: amount representing interest</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(170</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:double 2.5pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(50,339</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of obligations under leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:6.1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,167</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,509</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: current portion</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,355</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,875</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease obligations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:6.1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,812</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,634</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 1465000 14140000 1397000 13582000 466000 13158000 9000 12072000 10699000 106197000 3337000 169848000 170000 50339000 3167000 119509000 1355000 7875000 1812000 111634000 50400000 20100000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8.    Stockholders’ Equity </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2017, the Company announced that the Board of Directors approved a share repurchase program authorizing the repurchase of up to $100 million of the Company’s common stock over a <span style="-sec-ix-hidden:F_001008">three-year</span> period. Under this program, the Company is authorized to repurchase common stock in open market purchases, privately negotiated purchases or other transactions through October 2020. In February 2020, the Company announced that the Board of Directors increased the share repurchase authorization from $100 million to $150 million of the Company’s common stock through December 31, 2021. In March 2020, in connection with the issuance of the 2025 Notes, the Company repurchased approximately 1,085,000 shares of its common stock for $75.0 million. As of December, 31 2020, $75.0 million remained authorized under the share repurchase program.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On September 10, 2020, upon obtaining <span style="Background-color:#FFFFFF;">stockholder approval, </span>the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock from 120,000,000 shares to 150,000,000 shares.</p> 100000000 2020-10 150000000 2021-12-31 1085000 75000000.0 75000000.0 120000000 150000000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9.    Stock-Based Compensation </p> <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Common Stock</p> <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were 150,000,000 and 120,000,000 shares of common stock authorized <span style="color:#000000;">at December 31, 2020 and 2019, respectively.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Preferred Stock</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are 5,000,000 shares of preferred stock authorized and none issued or outstanding at December 31, 2020 and 2019.<span style="font-style:italic;"> </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock-based Compensation</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2014, the Compensation Committee (the "Compensation Committee") of the Board of Directors of the Company adopted the 2014 Equity Incentive Plan of NuVasive, Inc. (the "2014 EIP"), replacing the 2004 Amended and Restated Equity Incentive Plan (the “2004 EIP”). No further awards may be granted under the 2004 EIP; however, that plan continues to govern all awards previously issued under it (of which awards remain outstanding). The 2014 EIP provides the Company with the ability to grant various types of equity awards to its workforce (including, without limitation, restricted stock units (“RSUs”), restricted stock awards, performance awards, and deferred stock awards). The 2014 EIP also provides for the issuance of performance RSUs (“PRSUs”) to be granted subject to time- and/or performance-based vesting requirements. In addition, the award agreements under the 2014 EIP generally provide for the acceleration of 50% of the unvested equity awards of all employees upon a change in control and the vesting of the remaining unvested equity awards for those employees that are involuntarily terminated within a year of the change in control.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each of the 2004 EIP and the 2014 EIP allow for “net share settlement” of certain equity awards whereby, in lieu of (i) making cash payments in satisfaction of the exercise price owed respective to non-qualified stock option awards, or (ii) open market selling award shares to generate cash proceeds for use in satisfaction of statutory tax obligations respective to an award’s settlement or exercise, the company offsets the award shares being settled in a respective transaction by the number of shares of company stock with a value equal to the respective obligation, and, in the case of taxes, making a cash payment to the respective taxing authority on behalf of the employee using Company cash. The net share settlement is accounted for with the cost of any award shares that are net settled being included in treasury stock and reported as a reduction in total equity at the time of settlement.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the acquisition of Ellipse Technologies in February 2016, the Company assumed the Ellipse Technologies, Inc. 2015 Incentive Award Plan and the shares thereunder, subject to an equity exchange adjustment, for future awards by the Company.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation cost that has been included in the Consolidated Statements of Operations for the Company’s stock-based compensation plans was as follows:<span style="font-style:italic;"> </span></p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative expense</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,622</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,968</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,259</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,798</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,052</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of sales</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">264</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">531</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">431</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense before taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,673</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related income tax benefits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,088</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,191</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,418</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,057</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,106</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,255</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2020, there was $21.0 million and $16.1 million of unrecognized compensation expense for RSUs and PRSUs, respectively, which is expected to be recognized over a weighted-average period of approximately 1.7 years and 2.7 years, respectively. In addition, as of December 31, 2020, there was $1.0 million of unrecognized compensation expense for shares expected to be issued under the ESPP which is expected to be recognized through April 2021. There was no unamortized expense for stock options as of December 31, 2020.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Restricted Stock Units</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total fair value of RSUs that vested during the year ended December 31, 2020, 2019, and 2018 was $12.1 million, $21.5 million and $8.8 million, respectively. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is a summary of RSU activity for the year ended December 31, 2020: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except per share amounts</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">945</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.21</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">381</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63.64</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(209</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68.67</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(123</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.21</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.48%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">994</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.94</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the majority of RSUs, shares are issued on the vesting dates net of the amount of shares needed to satisfy statutory tax withholding requirements to be paid by the Company on <span style="font-family:inherit;">behalf of the employees. The total shares withheld related to vested RSUs were approximately 71,000, 122,000, and 42,000 in </span><span style="color:#000000;">2020</span>,<span style="font-family:inherit;"> </span><span style="color:#000000;">2019</span><span style="font-family:inherit;">, and </span><span style="color:#000000;">2018</span><span style="font-family:inherit;">, respectively, and were based on the value of the awards on their vesting dates as determined by the Company’s closing stock price. Total payments for the employees’ tax obligations to the taxing authorities related to vesting RSUs were $4.1 million, $7.2 million and $2.2 million in </span><span style="color:#000000;">2020</span><span style="font-family:inherit;">, </span><span style="color:#000000;">2019</span><span style="font-family:inherit;"> and </span><span style="color:#000000;">2018</span><span style="font-family:inherit;">, respectively. </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Performance-Based Restricted Stock Units</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has granted PRSUs since 2012 for which the ultimate issuance amount is determined by the Company’s Compensation Committee upon its certification of Company performance against a pre-determined matrix, which have included targets for net sales, operating margin, earnings per share and total shareholder return over pre-determined periods of time. Share payout levels range from 0% to 200% depending on the respective terms of an award.<span style="color:#000000;"> Based upon the Company’s actual performance against the performance conditions, approximately 61,000, 276,000 and 21,000 shares of common stock vested pursuant to PRSUs in 2020, 2019 and 2018, respectively.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2015, the Company granted a PRSU award with a <span style="-sec-ix-hidden:F_001074">five-year</span> cliff vesting term to its former Chief Executive Office, Gregory T. Lucier, in connection with his appointment to the Company, for which the performance criteria was not based on Company or market specific performance metrics, but rather stock price performance. As such, the Company recorded the award as a liability <span style="Background-color:#FFFFFF;color:#000000;">subject to recurring fair value adjustments that affect stock-based compensation expense.</span> The minimum performance criteria for this award was not met, thus no shares were paid out and the entire liability was reversed during the year ended December 31, 2020. </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The total fair value of PRSUs vested during 2020, 2019, 2018 and was $3.8 million, $19.9 million and $2.1 million, respectively.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is a summary of PRSU activity for the year ended December 31, 2020: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Maximum Number</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except per share amounts</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares Eligible</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">to be Issued</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average Grant</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">731</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,116</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.07</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Awarded at target</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69.72</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73.20</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(223</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(453</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.48</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">619</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">850</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.38</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the majority of PRSUs, shares are issued on the vesting dates net of the amount of shares needed to satisfy statutory tax withholding requirements to be paid by the Company on <span style="font-family:inherit;">behalf of the employees. The total shares withheld related to vesting PRSUs were approximately 25,000, 121,000 and 8,000 in </span><span style="color:#000000;">2020</span>,<span style="font-family:inherit;"> </span><span style="color:#000000;">2019</span><span style="font-family:inherit;"> and </span><span style="color:#000000;">2018</span><span style="font-family:inherit;"> respectively, and were based on the value of the awards on their vesting dates as determined by the Company’s closing stock price. Total payments for the employees’ tax obligations to the taxing authorities related to vesting PRSUs were $1.6 million, $7.2 million, and $0.4 million in </span><span style="color:#000000;">2020</span>,<span style="font-family:inherit;"> </span><span style="color:#000000;">2019</span><span style="font-family:inherit;">, and </span><span style="color:#000000;">2018</span>,<span style="font-family:inherit;"> respectively.</span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Stock Options</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has not granted any stock options since 2011. The stock options previously granted are exercisable for a period of up to ten years after the date of grant.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of outstanding stock options at December 31, 2020 is based on the Company’s closing stock price on December 31, 2020 of $56.33. Stock option exercises during the years ended December 31, 2020 and 2019 were primarily all executed with net share settlements, for which the Company does not receive any cash proceeds. The Company received $1.3 million in proceeds from the exercise of stock options during the year ended December 31, 2018. The total intrinsic value of stock options exercised was $0.4 million, $1.0 million, and $2.5 million during the years ended December 31, 2020, 2019 and 2018, respectively. There were no stock options that vested during the years ended December 31, 2020, 2019 or 2018. </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is a summary of stock option activity for the year ended December 31, 2020 under all stock plans:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Avg. Exercise</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years and per share amounts</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29.18</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001113">0.89</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">747</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29.18</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested or expected to vest at December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> <span style="color:#000000;font-size:10pt;">For the majority of stock options, shares are issued on the exercise dates net of the amount of shares needed to satisfy each of the exercise price (in lieu of cash) and statutory tax withholding requirements, the latter to be paid by the Company on </span><span style="color:#000000;font-family:inherit;font-size:10pt;">behalf of the employee. The total shares withheld related to exercised stock options were approximately 8,000, 21,000, and 65,000 in </span><span style="font-size:10pt;">2020</span><span style="color:#000000;font-family:inherit;font-size:10pt;">, </span><span style="font-size:10pt;">2019</span><span style="color:#000000;font-family:inherit;font-size:10pt;">, and </span><span style="font-size:10pt;">2018</span><span style="color:#000000;font-family:inherit;font-size:10pt;"> respectively, and were based on the value of the stock options on their exercise dates as determined by the Company’s closing stock price. There were no cash payments for the employees’ tax obligations to the taxing authorities related to exercised stock options in 2020. Total cash payments for the employees’ tax obligations to the taxing authorities related to exercised stock options were $0.1 million and $0.4 million in </span><span style="font-size:10pt;">2019</span><span style="color:#000000;font-family:inherit;font-size:10pt;"> and </span><span style="font-size:10pt;">2018</span><span style="color:#000000;font-family:inherit;font-size:10pt;">, respectively. </span></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Employee Stock Purchase Plan</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The NuVasive, Inc. 2004 Amended and Restated Employee Stock Purchase Plan (the “ESPP”), provides eligible employees with a means of acquiring equity in the Company at a discounted purchase price using their own accumulated payroll deductions. Under the terms of the ESPP, employees can elect to have up to 15% of their annual compensation, up to a maximum of $21,250 per year, withheld to purchase shares of Company common stock <span style="color:#000000;">for a purchase price equal to </span>85% of the lower of the fair market value per share (at closing) of Company common stock on (i) the commencement date of the <span style="-sec-ix-hidden:F_001124">six-month</span> offering period or (ii) the respective purchase date. In the years ended December 31, 2020, 2019 and 2018, 136,000, <span style="color:#000000;font-family:inherit;">129,000</span>, and 151,000 shares, respectively, were purchased under the ESPP.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average assumptions used to estimate the fair value of stock options granted and stock purchase rights under the ESPP are as follows: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.7%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001131">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001132">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001133">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.8</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:inherit;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Common Stock Reserved for Future Issuance</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:inherit;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes common shares reserved for issuance on exercise or conversion at <span style="font-family:Times New Roman;color:#000000;">December 31, 2020</span>:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issued and outstanding RSUs and PRSUs</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,630</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Available for issuance under the ESPP</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">828</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Available for future grant</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,651</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,396</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021 Warrants</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,207</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,082</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023 Warrants</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,949</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,512</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 Warrants</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,271</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares reserved for future issuance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,526</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 150000000 120000000 5000000 5000000 0 0 0 0 0.50 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The compensation cost that has been included in the Consolidated Statements of Operations for the Company’s stock-based compensation plans was as follows:<span style="font-style:italic;"> </span></p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:45.5%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.6%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Selling, general and administrative expense</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,622</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,968</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,259</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,798</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,052</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of sales</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">264</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">531</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">431</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:52.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense before taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,297</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,673</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related income tax benefits</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,088</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,191</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,418</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:52.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expense, net of taxes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,057</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,106</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.6%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,255</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 12622000 25968000 22190000 5259000 3798000 3052000 264000 531000 431000 18145000 30297000 25673000 3088000 6191000 6418000 15057000 24106000 19255000 21000000.0 16100000 P1Y8M12D P2Y8M12D 1000000.0 0 12100000 21500000 8800000 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is a summary of RSU activity for the year ended December 31, 2020: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except per share amounts</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">945</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.21</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">381</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63.64</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.48%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(209</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68.67</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.48%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(123</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.21</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.48%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">994</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">58.94</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 945000 59.21 381000 63.64 209000 68.67 123000 59.21 994000 58.94 71000 122000 42000 4100000 7200000 2200000 0 2 61000 276000 21000 3800000 19900000 2100000 <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is a summary of PRSU activity for the year ended December 31, 2020: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Maximum Number</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except per share amounts</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of Shares Eligible</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">to be Issued</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Average Grant</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">731</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,116</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.07</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Awarded at target</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">248</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69.72</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(61</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73.20</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(223</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(453</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.48</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">619</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">850</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.38</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 731000 1116000 57.07 172000 248000 69.72 61000 61000 73.20 223000 453000 56.48 619000 850000 57.38 25000 121000 8000 1600000 7200000 400000 56.33 0 0 1300000 400000 1000000.0 2500000 0 0 0 <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Following is a summary of stock option activity for the year ended December 31, 2020 under all stock plans:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Avg. Exercise</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands, except years and per share amounts</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.56%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29.18</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001113">0.89</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">747</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(16</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29.18</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.68%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercisable at December 31, 2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.68%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Vested or expected to vest at December 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.56%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 16000 29.18 747000 16000 29.18 8000 21000 65000 0 100000 400000 0.15 21250 0.85 136000 129000 151000 <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average assumptions used to estimate the fair value of stock options granted and stock purchase rights under the ESPP are as follows: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:41.7%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.84%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.44%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.26%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001131">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001132">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001133">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.8</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.84%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected dividend yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.44%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.26%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> 0.56 0.35 0.33 0.005 0.023 0.018 <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-style:italic;color:#000000;font-family:inherit;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Common Stock Reserved for Future Issuance</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:inherit;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes common shares reserved for issuance on exercise or conversion at <span style="font-family:Times New Roman;color:#000000;">December 31, 2020</span>:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Issued and outstanding RSUs and PRSUs</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,630</p></td> <td style="background-color:#CCF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Available for issuance under the ESPP</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">828</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Available for future grant</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,651</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,396</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021 Warrants</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,207</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,082</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023 Warrants</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,949</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:79.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,512</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2025 Warrants</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,271</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:79.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total shares reserved for future issuance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72,526</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 1630000 828000 3651000 14396000 25207000 7082000 6949000 6512000 6271000 72526000 <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10.    Income Taxes </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (loss) income before income taxes summarized by region was as follows: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(45,534</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74,721</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,939</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,011</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,796</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(216</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (loss) income before income taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,545</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,517</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,723</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income tax (benefit) provision was as follows:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:99.92%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,802</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,309</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,638</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,043</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,675</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,205</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,972</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current provision</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,949</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,827</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,800</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,873</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,944</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,315</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,565</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,092</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,849</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(819</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(98,795</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred provision</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,964</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">489</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(111,831</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in tax rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(579</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,202</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,543</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,990</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (benefit) provision</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,392</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,283</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,756</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The differences between the income tax provision at the United States federal statutory tax rate and the Company’s effective tax rate were as follows:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax (benefit) provision at federal statutory rate</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,984</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,909</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,832</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax credits and incentives</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,155</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,209</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,525</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State income tax</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,243</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,763</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,202</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,543</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,990</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net tax benefit on international restructuring</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,028</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Return to provision adjustments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(881</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,323</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,180</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisition related charges</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">687</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,808</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(221</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,314</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,643</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,008</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax reserves</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,217</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,146</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,717</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nondeductible meals and entertainment</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">351</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">717</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">769</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign tax rate differences from federal statutory rate</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,215</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">716</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">576</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in tax rates</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(579</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,328</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">872</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">392</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (benefit) provision</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,392</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,283</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,756</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant components of the Company’s deferred tax assets and liabilities were as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,945</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,296</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,407</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,656</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,763</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,069</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General business and other credit carryforwards</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,542</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,168</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,356</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,636</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,918</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,562</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Original issue discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,735</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,840</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,479</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,591</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross deferred tax assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">247,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212,818</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less valuation allowance</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(130,434</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(122,534</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,711</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44,760</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,045</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired intangibles</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,544</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(34,799</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,122</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,891</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,176</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,260</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(101,602</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,995</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets (liabilities)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,109</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,711</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company consolidates subsidiaries in foreign jurisdictions which use the local currency as their functional currency. Since income taxes for these subsidiaries are assessed in their local currency, deferred tax balances are translated into the Company’s reporting currency and adjusted for changes in the exchange rates over time through the cumulative translation account. Additionally, the Company established certain deferred taxes associated with the issuance of convertible debt in 2020 the benefit of which was recorded to equity. Accordingly, changes in the deferred tax balances associated with revaluations and convertible debt issuances are not reflected in income tax expense and create disparities between the changes in total deferred taxes for the year and deferred tax expense. In the year ended December 31, 2020, net decreases in deferred taxes of approximately $0.8 million and decreases in valuation allowances of approximately $1.3 million were recorded against equity and, therefore, not reflected in deferred tax expense.</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the activity related to the Company’s unrecognized tax benefits: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross unrecognized tax benefits at January 1</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,328</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,545</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,356</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases in tax positions for prior years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,758</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">499</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases in tax positions for prior years</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(756</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases in tax positions for current year relating to ongoing operations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,159</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,073</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,913</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases in tax positions as a result of a lapse of statute of limitations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(616</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,446</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases in tax positions for current year relating to acquisitions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases in tax positions due to settlements with taxing authorities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(624</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross unrecognized tax benefits at December 31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,316</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,328</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,545</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2020, 2019, and 2018, $16.5 million, $18.7 million, and $18.1 million, respectively, of the Company’s total unrecognized tax benefits, if recognized, would impact the effective income tax rate. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with the disclosure requirements as described in ASC Topic 740, Income Taxes, the Company classified uncertain tax positions as non-current income tax liabilities unless expected to be paid in one year. The Company’s continuing practice is to recognize interest and/or penalties related to income tax matters in income tax expense. For the years ended December 31, 2020, 2019, and 2018, the Company recognized approximately $(0.1) million, $0.1 million, and $(0.5) million, respectively, in interest and penalties as income tax (benefit) expense in the Consolidated Statements of Operations. The Company had approximately $0.1 million for the payment of interest and penalties accrued at both December 31, 2020 and 2019 in the Consolidated Balance Sheets.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company believes it is reasonably possible that approximately $2.4 million of its remaining unrecognized tax positions, primarily attributable to withholding obligations and the valuation of intercompany transactions, may decrease by the end of 2021 as we reach settlements with taxing authorities or certain statute of limitations expire.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2018, the Company completed a reorganization of its international intellectual property company structure. This international restructuring generated a step-up in local tax basis, which under <span style="font-style:italic;">ASC Topic 740-10-25-20 </span>as amended by <span style="font-style:italic;">ASU 2016-16, </span>required the Company to record deferred tax assets of $100.8 million. Due to uncertainties surrounding the realization of a portion of these deferred tax assets, a valuation allowance of approximately $96.7 million was recorded.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to routine compliance reviews on various tax matters around the world in the ordinary course of business. Currently, the only active audit is with the U.S. Internal Revenue Service for 2014 – 2016 tax years. California is subject to examination in all years due to prior year net operating losses and research and development credits. Other major state and foreign jurisdictions remain subject to examination from 2016 and 2013 forward, respectively.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company made the accounting policy election to treat taxes due on U.S. inclusions in taxable income related to Global Intangible Low-Taxed Income as a current period expense when incurred (the "period cost method").</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has approximately $13.2 million of undistributed earnings attributable to operations in its controlled foreign corporations as of December 31, 2020. Due to recent tax reform in the United States and favorable treaties between the United States and countries in which its controlled foreign corporations operate, the Company has the ability to repatriate earnings without incurring additional tax liabilities. Accordingly, the Company has not recorded a liability for taxes associated with any future distributions of these undistributed earnings.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">At December 31, 2020, the Company had $2.0 million, $50.9 million and $0.1 million of federal, state and foreign net operating loss carryforwards, respectively. Federal net operating loss carryforwards begin to expire in 2026, state net operating loss carryforwards begin to expire in 2021, and foreign net operating losses carry forward indefinitely. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also has federal and California research and development income tax credit carryforwards of $11.4 million and $35.7 million, respectively. The federal credits will begin to expire in 2038, while the California credits can be carried forward indefinitely. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Due to the “change of ownership” provision of the Tax Reform Act of 1986, utilization of the Company’s net operating loss and credit carryforwards may be subject to an annual limitation against taxable income in future periods. As a result of any future ownership changes, the annual limitation of loss and credit carryforwards may cause them to expire before ultimately becoming available to reduce future income tax liabilities.</p> <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (loss) income before income taxes summarized by region was as follows: </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(45,534</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74,721</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,939</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,011</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,796</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(216</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (loss) income before income taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,545</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,517</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,723</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> -45534000 74721000 8939000 -2011000 5796000 -216000 -47545000 80517000 8723000 <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The income tax (benefit) provision was as follows:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:99.92%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,802</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,309</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,638</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,043</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,675</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,205</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,972</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current provision</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,949</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,827</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,800</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,873</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,944</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,315</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,565</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,092</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,849</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(819</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(98,795</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred provision</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(25,964</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">489</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(111,831</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in tax rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(579</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Changes in valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,202</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,543</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,990</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (benefit) provision</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,392</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,283</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,756</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> -35000 4802000 -4188000 2309000 4638000 2043000 4675000 2205000 5972000 6949000 11645000 3827000 -13800000 5873000 -5944000 -8315000 -4565000 -7092000 -3849000 -819000 -98795000 -25964000 489000 -111831000 -579000 606000 258000 9202000 2543000 103990000 -10392000 15283000 -3756000 <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The differences between the income tax provision at the United States federal statutory tax rate and the Company’s effective tax rate were as follows:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax (benefit) provision at federal statutory rate</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,984</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,909</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,832</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax credits and incentives</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,155</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(7,209</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,525</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State income tax</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,243</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,763</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,202</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,543</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,990</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net tax benefit on international restructuring</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(97,028</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Return to provision adjustments</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(881</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,323</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,180</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquisition related charges</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">687</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,808</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(221</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,314</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,643</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,008</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax reserves</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,217</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,146</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,717</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Nondeductible meals and entertainment</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">351</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">717</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">769</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign tax rate differences from federal statutory rate</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,215</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">716</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">576</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in tax rates</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(579</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,328</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">872</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">392</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total (benefit) provision</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,392</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,283</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3,756</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> -9984000 16909000 1832000 7155000 7209000 5525000 -1243000 3763000 90000 9202000 2543000 103990000 97028000 -881000 -2323000 -4180000 687000 -1808000 -221000 3314000 1643000 2008000 -4217000 -1146000 -6717000 351000 717000 769000 -1215000 716000 576000 -579000 606000 258000 1328000 872000 392000 -10392000 15283000 -3756000 <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant components of the Company’s deferred tax assets and liabilities were as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.54%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets:</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,945</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,296</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,407</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,656</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35,763</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,069</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General business and other credit carryforwards</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,542</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,168</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,356</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,636</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,918</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,562</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Original issue discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,735</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,840</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,479</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">22,591</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross deferred tax assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">247,145</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212,818</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less valuation allowance</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(130,434</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(122,534</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">116,711</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90,284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities:</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44,760</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,045</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Acquired intangibles</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(27,544</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(34,799</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.7%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(24,122</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.72%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(14,891</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,176</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,260</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred tax liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(101,602</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(92,995</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.7%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets (liabilities)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,109</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.72%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,711</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> 67945000 87296000 47407000 24656000 35763000 24069000 26542000 23168000 28356000 17636000 9918000 11562000 3735000 1840000 27479000 22591000 247145000 212818000 130434000 122534000 116711000 90284000 44760000 37045000 27544000 34799000 24122000 14891000 5176000 6260000 101602000 92995000 15109000 2711000 -800000 -1300000 <p style="text-align:justify;margin-bottom:6pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the activity related to the Company’s unrecognized tax benefits: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross unrecognized tax benefits at January 1</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,328</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,545</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,356</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases in tax positions for prior years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,758</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">499</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases in tax positions for prior years</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(756</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases in tax positions for current year relating to ongoing operations</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,159</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,073</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,913</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases in tax positions as a result of a lapse of statute of limitations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(616</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6,446</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases in tax positions for current year relating to acquisitions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">169</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases in tax positions due to settlements with taxing authorities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(624</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,190</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross unrecognized tax benefits at December 31</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,316</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,328</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,545</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 20328000 19545000 25356000 1758000 62000 499000 112000 756000 2159000 2073000 1913000 5929000 616000 6446000 169000 624000 1190000 18316000 20328000 19545000 16500000 18700000 18100000 -100000 100000 -500000 100000 100000 2400000 100800000 96700000 13200000 2000000.0 50900000 100000 2026 2021 11400000 35700000 2038 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">11.    Business Segment, Product and Geographic Information </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in <span style="color:#000000;">one</span> segment based upon the Company’s organizational structure, the way in which the operations and investments are managed and evaluated by the chief operating decision maker (“CODM”) as well as the lack of availability of discrete financial information at a lower level. <span style="Background-color:#FFFFFF;">The Company’s CODM reviews net sales at the product line offering level, and manufacturing, operating income and expenses, and net income at the Company-wide level to allocate resources and assess the Company’s overall performance. The Company shares common, centralized support functions, including finance, human resources, legal, information technology, and corporate marketing, all of which report directly to the CODM. Accordingly, decision-making regarding the Company’s overall operating performance and allocation of Company resources is assessed on a consolidated basis. The Company has disclosed the net sales for each of its product line offerings to provide the reader of the financial statements transparency into the operations of the Company.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company reports under two distinct product lines; spinal hardware and surgical support. The Company’s spinal hardware product line offerings include implants and fixation products. The Company’s surgical support product offerings include IONM services, disposables and biologics, and our capital equipment, all of which are used to aid spinal surgery.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net sales</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> by product line was as follows:</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spinal hardware</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">783,510</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">851,440</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">788,649</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Surgical support</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267,072</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">316,630</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">313,065</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net sales</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,050,582</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,168,070</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,101,714</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net sales and property and equipment, net, by geographic area were as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Sales</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Property<span style="font-family:Calibri;"> </span>and Equipment, Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">821,824</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">941,086</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">896,152</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,802</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">218,771</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International (excludes Puerto Rico)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">228,758</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">226,984</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">205,562</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,567</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,547</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,050,582</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,168,070</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,101,714</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">286,369</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,318</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> 1 <span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net sales</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> by product line was as follows:</span> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.2%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Spinal hardware</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">783,510</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">851,440</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">788,649</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Surgical support</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267,072</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">316,630</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">313,065</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.2%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total net sales</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,050,582</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,168,070</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,101,714</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 783510000 851440000 788649000 267072000 316630000 313065000 1050582000 1168070000 1101714000 <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net sales and property and equipment, net, by geographic area were as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.14%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Net Sales</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Property<span style="font-family:Calibri;"> </span>and Equipment, Net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:31.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(<span style="font-style:italic;">in thousands</span>)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.94%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.5%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">821,824</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">941,086</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">896,152</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">239,802</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.14%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">218,771</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International (excludes Puerto Rico)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">228,758</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">226,984</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">205,562</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46,567</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47,547</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.5%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,050,582</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,168,070</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,101,714</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">286,369</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.14%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:7.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">266,318</p></td> <td style="background-color:#CFF0FA;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 821824000 941086000 896152000 239802000 218771000 228758000 226984000 205562000 46567000 47547000 1050582000 1168070000 1101714000 286369000 266318000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">12.    Contingencies </p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to potential liabilities under government regulations and various claims and legal actions that are pending or may be asserted from time-to-time. These matters arise in the ordinary course and conduct of the Company’s business and include, for example, commercial, intellectual property, environmental, securities and employment matters. The Company intends to continue to defend itself vigorously in such matters and when warranted, take legal action against others. Furthermore, the Company regularly assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in its financial statements.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">During the year ended December 31, 2018</span>, the Company settled all outstanding matters with Madsen Medical, Inc. for $27.8 million. The Company no longer has any remaining liability related to this matter. </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">An estimated loss contingency is accrued in the Company’s financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.</p> 27800000 <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13.    Subsequent Events</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.15%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 24, 2021, the Company completed the acquisition of Simplify Medical Pty Limited, or Simplify Medical, a developer of cervical artificial disc technology for cervical total disc replacement procedures. Pursuant to the terms of the definitive agreement, the Company agreed to make an upfront payment of $150.0 million at closing, subject to customary purchase price adjustments, plus additional future payments contingent upon milestones related to regulatory approval and net sales from products incorporating the Simplify Medical cervical artificial disc technology. In connection with the closing, the Company funded the $150.0 million upfront payment using available cash and investments on hand. Upon achievement of the regulatory milestone, Simplify Medical will be entitled to a one-time payment of up to $45.9 million which could become due and payable at any time between 2021 and 2024. Additional milestone payments, which are contingent upon net sales from products incorporating the Simplify Medical cervical artificial disc technology, will become payable in calendar years 2023, 2024 and 2025. </p> 150000000.0 150000000.0 45900000 XML 19 R1.htm IDEA: XBRL DOCUMENT v3.20.4
Document and Entity Information - USD ($)
$ in Billions
 12 Months Ended
Dec. 31, 2020
Feb. 23, 2021
Jun. 30, 2020
Cover [Abstract]      
Entity Registrant Name NUVASIVE, INC    
Entity Central Index Key 0001142596    
Entity Current Reporting Status Yes    
Document Type 10-K    
Document Period End Date Dec. 31, 2020    
Amendment Flag false    
Document Fiscal Year Focus 2020    
Document Fiscal Period Focus FY    
Trading Symbol NUVA    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Voluntary Filers No    
Entity Filer Category Large Accelerated Filer    
ICFR Auditor Attestation Flag true    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Common Stock, Shares Outstanding   51,379,052  
Entity Shell Company false    
Entity File Number 000-50744    
Entity Tax Identification Number 33-0768598    
Entity Address, Address Line One 7475 Lusk Boulevard    
Entity Address, City or Town San Diego    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 92121    
City Area Code (858)    
Local Phone Number 909-1800    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Entity Interactive Data Current Yes    
Security Exchange Name NASDAQ    
Entity Incorporation, State or Country Code DE    
Document Annual Report true    
Document Transition Report false    
Entity Public Float     $ 2.8
Documents Incorporated by Reference

Part III of this Form 10-K incorporates information by reference to portions of the definitive Proxy Statement for the registrant’s 2021 Annual Meeting of Stockholders, which will be filed with the U.S. Securities and Exchange Commission not- later than 120 days after December 31, 2020.

 

    

XML 20 R2.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 856,869 $ 213,034
Short-term marketable securities 173,145  
Accounts receivable, net of allowances of $20,631 and $17,019, respectively 207,071 211,532
Inventory, net 300,623 312,419
Prepaid income taxes 4,727 10,434
Prepaid expenses and other current assets 19,749 16,917
Total current assets 1,562,184 764,336
Property and equipment, net 286,369 266,318
Intangible assets, net 152,264 201,092
Goodwill 559,553 561,064
Operating lease right-of-use assets 102,270 66,932
Deferred tax assets 15,755 9,162
Restricted cash and investments 1,494 1,494
Other assets 13,193 14,892
Total assets 2,693,082 1,885,290
Current liabilities:    
Accounts payable and accrued liabilities 110,401 97,160
Contingent consideration liabilities 7,289 15,727
Accrued payroll and related expenses 63,421 86,458
Operating lease liabilities 7,875 5,567
Income tax liabilities 2,073 2,005
Senior convertible notes 645,303  
Total current liabilities 836,362 206,917
Long-term senior convertible notes 766,226 623,298
Deferred tax liabilities 2,807 14,655
Operating lease liabilities 111,634 73,153
Other long-term liabilities 52,438 52,060
Commitments and contingencies
Redeemable equity component of senior convertible notes 4,697  
Stockholders’ equity:    
Preferred stock, $0.001 par value; 5,000 shares authorized, none outstanding
Common stock, $0.001 par value; 150,000 and 120,000 shares authorized at December 31, 2020 and December 31, 2019, respectively; 57,945 shares issued and 51,376 outstanding at December 31, 2020; 57,525 issued and 52,145 outstanding at December 31, 2019 62 62
Additional paid-in capital 1,550,001 1,429,854
Accumulated other comprehensive loss (7,585) (9,418)
Retained earnings 45,322 82,475
Treasury stock at cost; 6,569 shares and 5,380 shares at December 31, 2020 and December 31, 2019, respectively (668,882) (587,766)
Total equity 918,918 915,207
Total liabilities and equity $ 2,693,082 $ 1,885,290
XML 21 R3.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Statement Of Financial Position [Abstract]    
Accounts receivable, allowances $ 20,631 $ 17,019
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 150,000,000 120,000,000
Common stock, shares issued 57,945,000 57,525,000
Common stock, shares outstanding 51,376,000 52,145,000
Treasury stock at cost, shares 6,569,000 5,380,000
XML 22 R4.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Net sales:      
Net sales $ 1,050,582 $ 1,168,070 $ 1,101,714
Cost of sales (excluding below amortization of intangible assets):      
Cost of sales 321,631 312,357 311,159
Gross profit 728,951 855,713 790,555
Operating expenses:      
Selling, general and administrative 547,195 611,181 575,836
Research and development 79,838 72,380 61,695
Amortization of intangible assets 51,726 51,097 50,670
Purchase of in-process research and development 1,011   8,913
Litigation liability loss     27,800
Business transition costs 10,878 (1,995) 11,473
Total operating expenses 690,648 732,663 736,387
Interest and other expense, net:      
Interest income 1,472 1,917 586
Interest expense (70,466) (38,525) (37,857)
Other (expense) income, net (16,854) (5,925) (8,174)
Total interest and other expense, net (85,848) (42,533) (45,445)
(Loss) income before income taxes (47,545) 80,517 8,723
Income tax benefit (expense) 10,392 (15,283) 3,756
Consolidated net (loss) income $ (37,153) $ 65,234 $ 12,479
Net (loss) income per share:      
Basic $ (0.72) $ 1.26 $ 0.24
Diluted $ (0.72) $ 1.23 $ 0.24
Weighted average shares outstanding:      
Basic 51,416 51,956 51,382
Diluted 51,416 53,160 52,355
Product [Member]      
Net sales:      
Net sales $ 950,189 $ 1,044,569 $ 986,457
Cost of sales (excluding below amortization of intangible assets):      
Cost of sales 247,809 232,474 234,509
Service [Member]      
Net sales:      
Net sales 100,393 123,501 115,257
Cost of sales (excluding below amortization of intangible assets):      
Cost of sales $ 73,822 $ 79,883 $ 76,650
XML 23 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement Of Income And Comprehensive Income [Abstract]      
Consolidated net (loss) income $ (37,153) $ 65,234 $ 12,479
Other comprehensive income (loss):      
Unrealized gain on marketable securities, net of tax 13    
Translation adjustments, net of tax 1,820 (790) (1,695)
Other comprehensive income (loss): 1,833 (790) (1,695)
Total consolidated comprehensive (loss) income $ (35,320) $ 64,444 $ 10,784
XML 24 R6.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings (Accumulated Deficit) [Member]
Treasury Stock [Member]
Total Nuvasive, Inc. Stockholders' Equity [Member]
Non-controlling Interest [Member]
Beginning Balance at Dec. 31, 2017 $ 799,416 $ 60 $ 1,363,549 $ (6,933) $ 4,762 $ (565,867) $ 795,571 $ 3,845
Beginning Balance, Shares at Dec. 31, 2017   56,164       (5,002)    
Issuance of common stock under employee and director stock option and purchase plans 5,199 $ 1 11,309     $ (6,111) 5,199  
Issuance of common stock under employee and director equity option and purchase plans, Shares   466       (114)    
Stock-based compensation expense 27,353   27,353       27,353  
Issuance of common stock in connection with royalty milestone achievement 4,719   4,719       4,719  
Issuance of common stock in connection with royalty milestone achievement, Shares   18            
Consolidated net income (loss) 12,479       12,479   12,479  
Consideration paid in excess of non-controlling interests (9,101)   (9,101)       (9,101)  
Net loss attributable to non-controlling interests (3,845)             $ (3,845)
Other comprehensive income (loss) (1,695)     (1,695)     (1,695)  
Ending Balance at Dec. 31, 2018 834,525 $ 61 1,397,829 (8,628) 17,241 $ (571,978) $ 834,525  
Ending Balance, Shares at Dec. 31, 2018   56,648       (5,116)    
Issuance of common stock under employee and director stock option and purchase plans (8,063) $ 1 7,724     $ (15,788)    
Issuance of common stock under employee and director equity option and purchase plans, Shares   805       (264)    
Stock-based compensation expense 24,096   24,096          
Issuance of common stock in connection with royalty milestone achievement, Shares   72            
Consolidated net income (loss) 65,234       65,234      
Consideration paid in excess of non-controlling interests 205   205          
Other comprehensive income (loss) (790)     (790)        
Ending Balance at Dec. 31, 2019 915,207 $ 62 1,429,854 (9,418) 82,475 $ (587,766)    
Ending Balance, Shares at Dec. 31, 2019   57,525       (5,380)    
Issuance of common stock under employee and director stock option and purchase plans 505   6,621     $ (6,116)    
Issuance of common stock under employee and director equity option and purchase plans, Shares   420       (104)    
Stock-based compensation expense 25,778   25,778          
Tax benefits related to convertible note issuance 484   484          
Shares repurchased (75,000)         $ (75,000)    
Shares repurchased ,Shares           (1,085)    
Sale of warrants 93,915   93,915          
Convertible note hedge (115,592)   (115,592)          
Equity component of convertible note issuance 115,559   115,559          
Debt issuance costs attributable to convertible feature (1,921)   (1,921)          
Reclassification of redeemable equity component of senior convertible notes (4,697)   (4,697)          
Consolidated net income (loss) (37,153)       (37,153)      
Other comprehensive income (loss) 1,833     1,833        
Ending Balance at Dec. 31, 2020 $ 918,918 $ 62 $ 1,550,001 $ (7,585) $ 45,322 $ (668,882)    
Ending Balance, Shares at Dec. 31, 2020   57,945       (6,569)    
XML 25 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating activities:      
Consolidated net (loss) income $ (37,153) $ 65,234 $ 12,479
Adjustments to reconcile net (loss) income to net cash provided by operating activities:      
Depreciation and amortization 140,937 135,593 129,765
Purchase of in-process research and development 1,011   8,913
Deferred income taxes (18,007) 5,844 (11,396)
Amortization of non-cash interest 48,986 21,288 20,123
Stock-based compensation 18,145 30,297 25,673
Net loss on strategic investments 268 4,767 4,421
Net loss recognized on change in fair value of derivatives 12,301    
Reserves on current assets 53,902 18,382 14,834
Other non-cash adjustments 16,876 5,650 22,186
Changes in operating assets and liabilities, net of effects from acquisitions:      
Accounts receivable 3,030 (16,407) 4,562
Inventory (40,765) (54,872) (38,646)
Prepaid expenses and other current assets (4,986) (4,622) (1,280)
Accounts payable and accrued liabilities 8,756 (3,924) 22,900
Accrued payroll and related expenses (23,654) 24,256 2,595
Income taxes 6,264 3,804 2,054
Net cash provided by operating activities 185,911 235,290 219,183
Investing activities:      
Acquisitions and investments   (4,100) (55,266)
Proceeds from other investments 1,143   3,584
Purchases of intangible assets (3,860) (7,501) (7,682)
Purchases of property and equipment (105,729) (122,883) (101,921)
Purchases of marketable securities (233,488)    
Proceeds from sales and maturities of marketable securities 60,000    
Net cash used in investing activities (281,934) (134,484) (161,285)
Financing activities:      
Proceeds from the issuance of common stock 6,170 6,415 8,127
Payment of contingent consideration (7,053) (809) (19,450)
Purchase of treasury stock (80,665) (14,478) (2,928)
Proceeds from issuance of convertible debt, net of issuance costs 873,848    
Proceeds from sale of warrants 93,915    
Purchases of convertible note hedges (147,825)    
Proceeds from revolving line of credit     100,000
Repayments on revolving line of credit     (100,000)
Other financing activities (1,734) 2,228 (327)
Net cash provided by (used in) financing activities 736,656 (6,644) (14,578)
Effect of exchange rate changes on cash 3,202 131 (1,283)
Increase in cash, cash equivalents and restricted cash 643,835 94,293 42,037
Cash, cash equivalents and restricted cash at beginning of period 214,528 120,235 78,198
Cash, cash equivalents and restricted cash at end of period 858,363 214,528 120,235
Supplemental disclosure of non-cash transactions:      
Issuance of common stock in connection with royalty milestone achievement     4,719
Supplemental cash flow information:      
Interest paid 19,914 16,145 17,182
Income taxes paid $ 1,873 $ 5,828 $ 5,510
XML 26 R8.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Statement Of Cash Flows [Abstract]      
Cash and cash equivalents $ 856,869 $ 213,034 $ 117,840
Restricted cash 1,494 1,494 2,395
Total cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows $ 858,363 $ 214,528 $ 120,235
XML 27 R9.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies
 12 Months Ended
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Organization and Significant Accounting Policies

1.    Organization and Significant Accounting Policies

Description of Business

NuVasive, Inc. (the “Company” or “NuVasive”) was incorporated in Delaware on July 21, 1997, and began commercializing its products in 2001. Since its incorporation in 1997, the Company has grown from a small developer of specialty spinal implants into a global medical technology company delivering procedurally integrated solutions for spine surgery. Underlying the Company’s procedurally integrated solutions for spine surgery are technologies designed to enable better clinical, financial, and operational outcomes, including:

 

•

its surgical access instruments, including its Maxcess integrated split-blade retractor system, designed to enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery;

 

•

its neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring (“IONM”) services and support;

 

•

its Advanced Materials Science portfolio of specialized spinal implants, designed to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone;

 

•

its Reline fixation system, designed to facilitate the preservation and restoration of patient alignment, while addressing a vast array of spinal pathologies from an open or less-invasive approach across all spinal procedures; and

 

•

its Integrated Global Alignment platform, which is comprised of procedurally based technologies that help increase the predictability of achieving global alignment in spinal procedures, including its Bendini spinal rod bending system that assist with manual rod manipulation for spinal fixation.

The Company has also invested in enabling technologies, including the development of capital equipment designed to further improve clinical, financial, and operational outcomes of spine surgery. The Company’s capital equipment portfolio currently consists of Lessray and the Pulse platform. Lessray is an image enhancement platform designed to reduce radiation exposure in the operating room by allowing surgeons to take low-quality, low-dose images and improve them to look like conventional full-dose images. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for neuromonitoring, surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. Selling and leasing of capital equipment do not make up a material portion of the Company’s total net sales.

In addition to the Company’s procedurally integrated solutions for spine surgery, it also designs and sells expandable growing rod implant systems that can be non-invasively lengthened following implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control (“MAGEC”), which allows for the minimally invasive treatment of early-onset and adolescent scoliosis. This technology is also the basis for the Company’s Precice limb lengthening system, which allows for the correction of long bone limb length discrepancy, as well as other products for treating specialized orthopedic procedures.

In December 2019, a novel strain of coronavirus, which causes COVID-19, was identified. Due to the rapid and global spread of the virus, on March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. To slow the proliferation of COVID-19, governments have implemented extraordinary measures, which include the mandatory closure of businesses, restrictions on travel and gatherings, and quarantine and physical distancing requirements. In addition, many government agencies in conjunction with hospitals and healthcare systems have, to varying degrees, deferred or suspended elective surgical procedures. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, the Company has seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, the Company has experienced reductions in procedural volumes during 2020 and anticipates this trend may continue. The cumulative effect of these disruptions had a significant impact on the Company’s business in 2020 and it is not possible to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures.

Basis of Presentation and Principles of Consolidation

The accompanying Consolidated Financial Statements include the accounts of the Company and its majority-owned or controlled subsidiaries, collectively referred to as either NuVasive or the Company. The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. When there is a portion of equity in an acquired subsidiary not attributable, directly or indirectly, to the respective parent entity, the Company records the fair value of the non-controlling interest at the acquisition date and classifies the amounts attributable to non-controlling interest separately in equity in the Company's Consolidated Financial Statements. Any subsequent changes in a parent's ownership interest while the parent retains its controlling financial interest in its subsidiary are accounted for as equity transactions. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company has replaced the caption “Revenue” with “Net sales,” and the caption “Sales, marketing and administrative” with “Selling, general and administrative,” within the Consolidated Statements of Operations and corresponding changes have been made throughout this Annual Report to conform to this presentation. These updated captions have no impact on previously reported results of operations or financial position.

Use of Estimates

To prepare financial statements in conformity with generally accepted accounting principles (“GAAP”) accepted in the United States, management must make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.

Recent Accounting Pronouncements Not Yet Adopted

In January 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of the accounting for equity securities, investments accounted for under the equity method, and certain forward contracts and purchased options. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-01 on January 1, 2021, and does not expect a material impact to its Consolidated Financial Statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-06 on January 1, 2021, and will elect the modified transition method that allows for a cumulative-effect adjustment in the period of adoption and will not restate prior periods. As a result of the adoption, the Company will increase its convertible debt liabilities and retained earnings on January 1, 2021 by $115.4 million and $64.5 million, respectively, and decrease its deferred tax liabilities and additional paid-in capital by approximately $28.0 million and $151.9 million, respectively.

Recently Adopted Accounting Standards 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (“ASU 2016-13”), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The amendments in this update were adopted using a modified retrospective transition method as of January 1, 2020, which had no cumulative impact to retained earnings. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles – Goodwill and Other, which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted the amendments in this update on January 1, 2020, which will be applied using a prospective transition method. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public companies will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. The Company adopted ASU 2018-13 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements. See Note 4 to the Consolidated Financial Statements for further discussion on fair value measurements.

In September 2018, the FASB issued Accounting Standards Update No. 2018-15, Intangible – Goodwill and Other – Internal-Use Software (“ASU 2018-15”), which requires a customer in a cloud computing arrangement to determine whether implementation costs should be capitalized as assets or expensed as incurred. Under the new guidance, capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. The amendments in this update will be applied using a prospective transition method to each period presented. The Company adopted ASU 2018-15 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which modifies Accounting Standard Codification 740 – Income Taxes (“ASC 740”). ASU 2019-12 enhances and simplifies various aspects of the income tax accounting guidance in ASC 740. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company elected to early adopt ASU 2019-12 in the quarter ended June 30, 2020. The Company applied the updated guidance for year-to-date losses in the Company’s interim period tax accounting on a prospective basis. The early adoption had no impact on the expected full year tax expense for 2020, but rather accelerated certain tax benefits to earlier quarters in 2020 that would otherwise have been limited under ASC 740.

In March 2020, the FASB issued Accounting Standards Update No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates. This update is effective upon issuance. The relief is temporary and generally cannot be applied to contract modifications that occur after December 31, 2022 or hedging relationships entered into or evaluated after that date. The adoption of ASU 2020-04 did not have a material impact on the Company’s Consolidated Financial Statements.

Revenue Recognition

In accordance with Accounting Standards Codification 606 Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue upon the transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. The principles in ASC 606 are applied using the following five steps: (i) identify the contract with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies its performance obligation(s). Specifically, revenue from the sale of implants, fixation products and disposables is generally recognized at an amount that reflects the expected consideration upon notice that the Company’s products have been used in a surgical procedure or upon shipment to a third-party customer assuming control of the products. Revenue from IONM services is recognized in the period the service is performed for the amount of consideration expected to be received. Revenue from the sale of surgical instrument sets is generally recognized upon receipt of a purchase order and the subsequent shipment to a customer who assumes control. In certain cases, the Company does offer the ability for customers to lease surgical instrumentation primarily on a non-sales type basis. Revenue from the sale or lease of capital equipment is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Selling and leasing of surgical instrument sets and capital equipment represents an immaterial amount of the Company’s total net sales in all periods presented. Revenue associated with products holding rights of return or trade-in are recognized when the Company concludes there is not a risk of significant revenue reversal in future periods for the expected consideration in the transaction. Costs incurred by the Company associated with sales contracts with customers are deferred over the performance obligation period and recognized in the same period as the related revenue, with the exception of contracts that complete within one year or less, in which case the associated costs are expensed as incurred.

Accounts Receivable and Related Valuation Accounts

Accounts receivable in the accompanying Consolidated Balance Sheets are presented net of allowances for credit losses. The Company maintains an allowance for credit losses resulting from the inability of its customers, including hospitals, ambulatory surgery centers, and distributors, to make required payments. The allowance for credit losses is calculated quarterly, and is estimated on a region-by-region basis considering a number of factors including age of account balances, collection history, historical account write-offs, third party credit reports, identified trends, current economic conditions, and supportable forecasted economic expectations. The allowance is adjusted on a specific identification basis for certain accounts as well as pooling of accounts with similar characteristics. An increase in the provision for credit losses may be required when the financial condition of the Company’s customers or its collection experience deteriorates. An increase to the allowance for credit losses results in a corresponding charge to selling, general and administrative expenses. The Company has a diverse customer base and no single customer represented greater than ten percent of net sales or accounts receivable. Historically, the Company’s reserves have been adequate to cover credit losses.

The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. It is possible that there could be a material adverse impact from potential adjustments of the carrying amount of trade receivables as customers’ cash flows are impacted by their response to the COVID-19 pandemic and the deferral of elective surgical procedures.

The following table summarizes the changes in the allowance for credit losses:

 

(in thousands)

 

December 31, 2020

 

Allowance for credit losses at January 1, 2020

 

$

9,423

 

Current-period provision for expected losses

 

 

1,079

 

Write-offs charged against the allowance

 

 

(1,305

)

Recoveries of amounts previously written off

 

 

220

 

Changes resulting from foreign currency fluctuations

 

 

229

 

Allowance for credit losses at end of period

 

$

9,646

 

In addition, the Company establishes a liability for estimated sales returns and a reserve for price adjustments that are recorded as a reduction to net sales. The liability and reserve are maintained to account for the future product returns and price adjustments of products sold in the current period.

Concentration of Credit Risk and Significant Customers

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, marketable securities and accounts receivable. The Company limits its exposure to credit loss by placing its cash and investments with high credit quality financial institutions. Additionally, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has a diverse customer base and no single customer represented greater than ten percent of sales or accounts receivable for any of the periods presented.

Fair Value of Financial Instruments

The Company’s financial instruments consist principally of cash and cash equivalents, marketable securities, restricted investments, derivatives, contingent consideration liabilities, accounts receivable, accounts payable, accrued expenses, and Senior Convertible Notes.

The Company measures certain assets and liabilities in accordance with authoritative guidance which requires fair value measurements to be classified and disclosed in one of the following three categories:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available.

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.

Cash and Cash Equivalents

The Company considers all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents.

Inventory, net

Net inventory as of December 31, 2020 consisted of $285.4 million of finished goods, $7.3 million of work in progress and $7.9 million of raw materials. Net inventory as of December 31, 2019 consisted of $298.7 million of finished goods, $6.4 million of work in progress and $7.3 million of raw materials.

Finished goods primarily consists of specialized implants, fixation products and disposables and are stated at the lower of cost or net realizable value determined by utilizing a standard cost method, which includes capitalized variances, which approximates the weighted average cost. Work in progress and raw materials represent the underlying material, and labor for work in progress, that ultimately yield finished goods upon completion and are subject to lower of cost or net realizable value. The Company reviews the components of its inventory on a periodic basis for excess and obsolescence and adjusts inventory to its net realizable value as necessary.

The Company records an inventory reserve for estimated excess and obsolete inventory based upon historical turnover and assumptions about future demand for its products and market conditions, such as product life cycles and timing of the introduction and development of new or enhanced products. The Company’s allograft products have shelf lives ranging from two to five years and are subject to demand fluctuations based on the availability and demand for alternative products. The Company’s inventory, which consists primarily of disposables, specialized implants and fixation products, is at risk of obsolescence following the introduction and development of new or enhanced products. One of the Company’s strategic objectives is to continue to rapidly develop and commercialize new products and product enhancements which increases the risk that products will become obsolete prior to the end of their anticipated useful life. The Company’s estimates and assumptions for excess and obsolete inventory are reviewed and updated on a quarterly basis. The estimates the Company uses for demand are also used for near-term capacity planning and inventory purchasing and are consistent with its revenue forecasts. Increases in the reserve for excess and obsolete inventory result in a corresponding charge to cost of sales.

For the year ended December 31, 2020 and 2019, the Company recorded a reserve for excess and obsolete inventory of $48.9 million and $14.0 million, respectively. The increase is primarily attributable to updates to the Company’s estimates and assumptions about future product demand and product life cycles which have been affected by multiple factors, including the COVID-19 pandemic and general market conditions.

Goodwill and Intangible Assets

The Company’s goodwill represents the excess of the cost over the fair value of net assets acquired from its business combinations. The determination of the value of goodwill and intangible assets arising from business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of the net tangible and intangible assets acquired, including capitalized in-process research and development (IPR&D). Intangible assets acquired in a business combination that are used for in-process research and development activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project, the Company will amortize the acquired IPR&D over its estimated useful life or expense the acquired in-process research and development should the research and development project be unsuccessful with no future alternative use.

Goodwill and IPR&D are not amortized; however, they are assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstance warrant such a review. The goodwill or IPR&D are considered to be impaired if the Company determines that the carrying value of the reporting unit or IPR&D exceeds its respective fair value.

The Company performs its goodwill impairment analysis at the reporting unit level, which aligns with the Company’s reporting structure and availability of discrete financial information. The Company performs its annual impairment analysis by either comparing a reporting unit’s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit’s fair value from the last quantitative assessment to determine if there is potential impairment. The Company may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit’s estimated fair value was significantly in excess of the carrying value of its net assets and it does not believe there have been significant changes in the reporting unit’s operations that would significantly decrease its estimated fair value or significantly increase its net assets. If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections and/or use of a market approach by looking at market values of comparable companies. Key assumptions for these projections include net sales growth, future gross and operating margin growth, and its weighted cost of capital and terminal growth rates. The net sales and margin growth is based on increased sales of new and existing products as the Company maintains investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including timing and probability of regulatory approvals for Company products to be commercialized. The Company’s market capitalization is also considered as a part of its analysis.

The Company’s annual evaluation for impairment of goodwill consists of one reporting unit. In accordance with the Company’s policy, the Company completed its most recent annual evaluation for impairment as of October 1, 2020 using the qualitative assessment and determined that no impairment existed. In addition, no indicators of impairments were noted through December 31, 2020 and consequently, no impairment charge has been recorded during the year.

Intangible assets with a finite life, such as acquired technology, customer relationships, manufacturing know-how, licensed technology, supply agreements and certain trade names and trademarks, are amortized on a straight-line basis over their estimated useful life, ranging from 2 to 17 years. In determining the useful lives of intangible assets, the Company considers the expected use of the assets and the effects of obsolescence, demand, competition, anticipated technological advances, changes in surgical techniques, market influences and other economic factors. For technology based intangible assets, the Company considers the expected life cycles of products which incorporate the corresponding technology. Trademarks and trade names that are related to products are assigned lives consistent with the period in which the products bearing each brand are expected to be sold.

The Company evaluates its intangible assets with finite lives for indications of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include significant under-performance relative to expected historical or projected future operating results, significant changes in the manner of the Company’s use of the acquired assets or the strategy for the Company’s overall business or significant negative industry or economic trends. If this evaluation indicates that the value of the intangible asset may be impaired, the Company makes an assessment of the recoverability of the net carrying value of the asset over its remaining useful life. If this assessment indicates that the intangible asset is not recoverable, based on the estimated undiscounted future cash flows of the technology over the remaining amortization period, the Company reduces the net carrying value of the related intangible asset to fair value and may adjust the remaining amortization period.

See Note 2 to the Consolidated Financial Statements included in this Annual Report for further disclosure on goodwill and intangible assets.

Property and Equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from 2 to 20 years. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter. Leased property meeting certain financing lease criteria is capitalized under property and equipment, and the net present value of the related lease payments is recorded as a liability. Amortization of assets under financing leases is recorded using the straight-line method over the shorter of the estimated useful lives or the lease terms. Maintenance and repairs are expensed as incurred.

The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value.

Income Taxes

The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Tax law and rate changes are reflected in income in the period such changes are enacted. The Company includes interest and penalties related to income taxes, including unrecognized tax benefits, within income tax expense.

The Company’s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known.

Significant judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.

Based on the Company’s review, it concluded that it was more likely than not that it would be able to realize the future benefits of its domestic and foreign deferred tax assets, with the exceptions of California, Malta, Mexico, Brazil and Colombia. This conclusion was based on historical and projected operating performance, as well as the Company’s expectation that its operations will generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets well within the statutory carryover periods. Due to low state apportionment, large net operating losses and the generation of sizeable research credits in California, the Company concluded that it is not more likely than not that it will be able to utilize its California deferred tax assets. Therefore, the Company has maintained a full valuation allowance on its California deferred tax assets as of December 31, 2020. Due to a history of losses in Malta, Brazil, Mexico and Colombia, and the lack of alternative sources of future taxable income, the Company has established a full valuation allowance against these entities’ deferred tax assets as of December 31, 2020.

The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.

See Note 10 to the Consolidated Financial Statements included in this Annual Report for further discussion on income taxes.

Loss Contingencies

An estimated loss contingency is accrued and disclosed in the Company’s financial statements if it is probable or disclosed if it is reasonably possible that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable and only discloses those matters it considers material to its overall financial position. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded.

The Company is involved in a number of legal actions arising in the normal course of business. The outcomes of these legal actions are not within the Company’s complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost net sales. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.

See Note 12 to the Consolidated Financial Statements included in this Annual Report for further discussion on legal proceedings and investigations.

Comprehensive Income

Comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income includes net of tax, unrealized gains or losses on the Company’s marketable debt securities and foreign currency translation adjustments. The cumulative translation adjustments included in accumulated other comprehensive loss were $7.6 million, $9.4 million, and $8.6 million at December 31, 2020, 2019, and 2018, respectively.

Research and Development

Research and development costs are expensed as incurred. To the extent the Company purchases research and development assets with a future alternative use the Company will capitalize and amortize the assets over its useful life.

Product Shipment Costs

Product shipment costs, included in selling, general and administrative expense in the accompanying Consolidated Statements of Operations, were $27.4 million, $27.7 million, and $25.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The majority of the Company’s shipping costs are associated with providing instrument sets to hospitals for use in individual surgical procedures. Amounts billed to customers for shipping and handling of products are reflected in net sales and are not material for any period presented.

Business Transition Costs

The Company incurs certain costs related to acquisition, integration and business transition activities, which include severance, relocation, consulting, leasehold exit costs, third-party merger and acquisition costs, contingent consideration fair value adjustments and other costs directly associated with such activities. Contingent consideration is accrued based on the fair value of the expected payment, and such accruals are subject to increase or decrease based on the assessment of the likelihood that the contingent milestones will be achieved resulting in payment. If an accrual for contingent consideration decreases during a particular period, it results in a reduction of costs during such period.

During the year ended December 31, 2020, the Company recorded $10.9 million of costs related to acquisition, integration and business transition activities, which included $2.3 million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2019, the Company recorded a reduction of costs of $(2.0) million related to acquisition, integration and business transition activities, which included $(6.3) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2018, the Company recorded $11.5 million of costs related to acquisition, integration and business transition activities, which included $(1.5) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

Stock-based Compensation

Stock-based compensation expense for equity-classified awards, principally related to restricted stock units (“RSUs”) and performance restricted stock units (“PRSUs”), is measured at the grant date based on the estimated fair value of the award. The fair value of equity instruments that are expected to vest is recognized and amortized over the requisite service period. The Company has granted awards with up to five year graded or cliff vesting terms (in each case, with service through the date of vesting being required). No exercise price or other monetary payment is required for receipt of the shares issued in settlement of the respective award; instead, consideration is furnished in the form of the participant’s service to the Company.

The fair value of RSUs including PRSUs with pre-defined performance criteria is based on the stock price on the date of grant whereas the expense for PRSUs with pre-defined performance criteria is adjusted with the probability of achievement of such performance criteria at each period end. The fair value of the PRSUs that are earned based on the achievement of pre-defined market conditions for total shareholder return is estimated on the date of grant using a Monte Carlo valuation model. The key assumptions in applying this model are an expected volatility and a risk-free interest rate.

Stock-based compensation expense is adjusted from the grant date to exclude expense for awards that are expected to be forfeited. The forfeiture estimate is adjusted as necessary through the vesting date so that full compensation cost is recognized only for awards that vest. The Company assesses the reasonableness of the estimated forfeiture rate at least annually, with any change to be made on a cumulative basis in the period the estimated forfeiture rates change. The Company considered its historical experience of pre-vesting forfeitures on awards by each homogenous group of employees as the basis to arrive at its estimated annual pre-vesting forfeiture rates.

The Company estimates the fair value of stock options issued under its equity incentive plans and shares issued to employees under its employee stock purchase plan (“ESPP”) using a Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various assumptions including expected volatility, expected term and risk-free interest rates. The expected volatility is based on the historical volatility of the Company’s common stock over the most recent period commensurate with the estimated expected term of the Company’s stock options and ESPP offering period which is derived from historical experience. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future.

See Note 9 to the Consolidated Financial Statements included in this Annual Report for further discussion on stock-based compensation.

Net (Loss) Income Per Share

The Company computes basic net income per share using the weighted-average number of common shares outstanding during the period. Diluted net income per share assumes the conversion, exercise or issuance of all potential common stock equivalents, unless the effect of inclusion would be anti-dilutive. For purposes of this calculation, common stock equivalents include the Company’s stock options, unvested RSUs, PRSUs (including those with performance and market conditions), warrants, and the shares to be issued upon the conversion of the Senior Convertible Notes. The contingently issuable shares are included in basic net income per share as of the date that all necessary conditions have been satisfied and are included in the denominator for dilutive calculation for the entire period if such shares would be issuable as of the end of the reporting period assuming the end of the reporting period was the end of the contingency period.

The following table sets forth the computation of basic and diluted consolidated net (loss) income per share:  

 

 

 

Year Ended December 31,

 

(in thousands, except per share data)

 

2020

 

 

2019

 

 

2018

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(37,153

)

 

$

65,234

 

 

$

12,479

 

Denominator for basic and diluted net (loss) income per

   share:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding for

   basic

 

 

51,416

 

 

 

51,956

 

 

 

51,382

 

Dilutive potential common stock outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and ESPP

 

 

—

 

 

 

15

 

 

 

36

 

RSUs and PRSUs

 

 

—

 

 

 

658

 

 

 

760

 

Senior Convertible Notes

 

 

—

 

 

 

531

 

 

 

177

 

Weighted average common shares outstanding for

   diluted

 

 

51,416

 

 

 

53,160

 

 

 

52,355

 

Basic net (loss) income per share

 

$

(0.72

)

 

$

1.26

 

 

$

0.24

 

Diluted net (loss) income per share

 

$

(0.72

)

 

$

1.23

 

 

$

0.24

 

The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Stock options, ESPP, RSUs and PRSUs

 

 

1,095

 

 

 

115

 

 

 

162

 

Warrants

 

 

21,034

 

 

 

10,865

 

 

 

10,865

 

Senior Convertible Notes

 

 

21,034

 

 

 

5,433

 

 

 

5,433

 

Total

 

 

43,163

 

 

 

16,413

 

 

 

16,460

 

 

 

 
XML 28 R10.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details
 12 Months Ended
Dec. 31, 2020
Balance Sheet Details [Abstract]  
Balance Sheet Details

2.    Balance Sheet Details

Property and Equipment, net

Property and equipment, net, consisted of the following:

 

 

 

 

December 31,

 

(in thousands, except years)

Useful Life

 

2020

 

 

2019

 

Instrument sets

4

 

$

424,696

 

 

$

381,310

 

Machinery and equipment

5 to 7

 

 

71,616

 

 

 

66,482

 

Computer equipment and software

3 to 7

 

 

173,364

 

 

 

149,134

 

Leasehold improvements

2 to 15

 

 

35,372

 

 

 

29,542

 

Furniture and fixtures

3 to 7

 

 

9,916

 

 

 

8,931

 

Building and improvements

10 to 20

 

 

23,207

 

 

 

22,921

 

Land

—

 

 

1,277

 

 

 

1,277

 

 

 

 

 

739,448

 

 

 

659,597

 

Less: accumulated depreciation and amortization

 

 

 

(453,079

)

 

 

(393,279

)

 

 

 

$

286,369

 

 

$

266,318

 

 

Property and equipment mainly consisted of instrument sets, which are made available to surgeons and hospitals that purchase implants, biologics and disposables for use in individual surgical procedures.

Depreciation expense was $85.9 million, $80.8 million, and $75.4 million for the years ended December 31, 2020, 2019 and 2018, respectively. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter.

Capitalized software costs include only those direct costs associated with the actual development or acquisition of computer software. At December 31, 2020 and 2019, the Company had $57.6 million and $51.7 million in unamortized capitalized software costs, respectively. Amortization expense related to capitalized software costs was $10.4 million, $10.4 million and $10.6 million for the years ended December 31, 2020, 2019 and 2018, respectively.

Goodwill and Intangible Assets

Goodwill and intangible assets as of December 31, 2020 consisted of the following:

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Gross

 

 

Accumulated

 

 

Intangible

 

(in thousands, except years)

 

(in years)

 

Amount

 

 

Amortization

 

 

Assets, net

 

Intangible assets subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

8

 

$

271,748

 

 

$

(195,283

)

 

$

76,465

 

Manufacturing know-how and trade secrets

 

13

 

 

30,882

 

 

 

(22,720

)

 

 

8,162

 

Trade name and trademarks

 

9

 

 

25,500

 

 

 

(19,945

)

 

 

5,555

 

Customer relationships

 

9

 

 

156,436

 

 

 

(94,354

)

 

 

62,082

 

Total intangible assets subject to amortization

 

8

 

$

484,566

 

 

$

(332,302

)

 

$

152,264

 

Intangible assets not subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

 

 

 

 

 

 

 

 

 

 

559,553

 

Total goodwill and intangible assets, net

 

 

 

 

 

 

 

 

 

 

 

$

711,817

 

 

Goodwill and intangible assets as of December 31, 2019 consisted of the following:

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Gross

 

 

Accumulated

 

 

Intangible

 

(in thousands, except years)

 

(in years)

 

Amount

 

 

Amortization

 

 

Assets, net

 

Intangible assets subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

8

 

$

271,748

 

 

$

(163,459

)

 

$

108,289

 

Manufacturing know-how and trade secrets

 

13

 

 

30,798

 

 

 

(20,333

)

 

 

10,465

 

Trade name and trademarks

 

9

 

 

25,500

 

 

 

(16,947

)

 

 

8,553

 

Customer relationships

 

9

 

 

150,744

 

 

 

(76,959

)

 

 

73,785

 

Total intangible assets subject to amortization

 

9

 

$

478,790

 

 

$

(277,698

)

 

$

201,092

 

Intangible assets not subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

 

 

 

 

 

 

 

 

 

 

561,064

 

Total goodwill and intangible assets, net

 

 

 

 

 

 

 

 

 

 

 

$

762,156

 

 

Total expense related to the amortization of intangible assets which is recorded in either cost of sales or operating expenses in the Consolidated Statements of Operations depending on the functional nature of the intangible, was $55.0 million, $54.8 million and $54.4 million for the years ended December 31, 2020, 2019 and 2018, respectively.

The changes to goodwill are comprised of the following:

(in thousands)

 

 

 

Gross goodwill

$

569,364

 

Accumulated impairment loss

 

(8,300

)

December 31, 2019

 

561,064

 

 

 

 

 

Changes to gross goodwill:

 

 

 

Changes resulting from foreign currency fluctuations

 

(1,511

)

 

 

(1,511

)

 

 

 

 

Gross goodwill

 

567,853

 

Accumulated impairment loss

 

(8,300

)

December 31, 2020

$

559,553

 

Total future amortization expense related to intangible assets subject to amortization at December 31, 2020 is set forth in the table below:

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

 

2021

 

 

 

$

51,876

 

2022

 

 

 

 

43,843

 

2023

 

 

 

 

18,697

 

2024

 

 

 

 

12,506

 

2025

 

 

 

 

11,705

 

Thereafter through 2031

 

 

 

 

13,637

 

Total future amortization expense

 

 

 

$

152,264

 

 

 

Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

 

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

Accrued expenses

 

$

59,249

 

 

$

58,897

 

Accounts payable

 

 

17,386

 

 

 

11,827

 

Distributor commissions payable

 

 

9,891

 

 

 

7,983

 

Other taxes payable

 

 

6,425

 

 

 

6,501

 

Litigation liability

 

 

5,346

 

 

 

1,370

 

Debt interest payable

 

 

5,203

 

 

 

4,266

 

Royalties payable

 

 

4,495

 

 

 

4,994

 

Other

 

 

2,406

 

 

 

1,322

 

Accounts payable and accrued liabilities

 

$

110,401

 

 

$

97,160

 

 
XML 29 R11.htm IDEA: XBRL DOCUMENT v3.20.4
Marketable Securities
 12 Months Ended
Dec. 31, 2020
Investments Debt And Equity Securities [Abstract]  
Marketable Securities

3.    Marketable Securities

Short-Term Marketable Securities

The Company invests in available-for-sale marketable debt securities consisting of corporate notes and commercial paper. The Company has the ability, if necessary, to liquidate without penalty any of its marketable debt securities to meet its liquidity needs in the next 12 months. As such, those investments with contractual maturities greater than one year from the date of purchase are classified as short-term on the accompanying Consolidated Balance Sheets.

As of December 31, 2020, the Company’s outstanding marketable debt securities all have contractual maturities due within one year. The carrying value and amortized cost of the Company’s marketable debt securities, summarized by major security type, consisted of the following:

 

(in thousands)

 

Amortized Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities, available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate notes

 

$

54,197

 

 

$

6

 

 

$

(15

)

 

$

54,188

 

Commercial paper

 

 

118,932

 

 

 

25

 

 

 

—

 

 

 

118,957

 

Total debt securities, available for sale

 

$

173,129

 

 

$

31

 

 

$

(15

)

 

$

173,145

 

At each reporting date, the Company performs an evaluation of impairment to determine if any unrealized losses are the result of credit losses. Impairment is assessed at the individual security level. Factors considered in determining whether a loss resulted from a credit loss or other factors include the Company’s intent and ability to hold the investment until the recovery of its amortized cost basis, the extent to which the fair value is less than the amortized cost basis, the length of time and extent to which fair value has been less than the cost basis, the financial condition of the issuer, any historical failure of the issuer to make scheduled interest or principal payments, any changes to the rating of the security by a rating agency, any adverse legal or regulatory events affecting the issuer or issuer’s industry, and any significant deterioration in economic conditions.

The credit-related portion of unrealized losses, and any subsequent improvements, are recorded in interest income in the Consolidated Statement of Operations through an allowance for credit losses. Unrealized gains and losses that are not credit-related are included in accumulated other comprehensive loss. Unrealized losses on available-for-sale debt securities as of December 31, 2020 were not significant and were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, the Company has not recorded an allowance for credit losses with these investments.
XML 30 R12.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments and Fair Value Measurements
 12 Months Ended
Dec. 31, 2020
Investments Debt And Equity Securities [Abstract]  
Financial Instruments and Fair Value Measurements

4.    Financial Instruments and Fair Value Measurements

Foreign Currency and Derivative Financial Instruments

The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities, and average exchange rates during each reporting period for results of operations.

Some of the Company’s reporting entities conduct a portion of their business in currencies other than the entity’s functional currency. These transactions give rise to receivables and payables that are denominated in currencies other than the entity’s functional currency. The value of these receivables and payables is subject to changes in currency exchange rates from the point at which the transactions are originated until the settlement in cash. Both realized and unrealized gains and losses in the value of these receivables and payables are included in the determination of net income. Net currency exchange losses, which include gains and losses from derivative instruments, were $4.2 million, $0.8 million and $3.7 million for the years ended December 31, 2020, 2019 and 2018, respectively, and are included in other (expense) income, net in the Consolidated Statements of Operations.

To manage foreign currency exposure risks, the Company uses derivatives for activities in entities that have short-term intercompany receivables and payables denominated in a currency other than the entity’s functional currency. The fair value is based on a quoted market price (Level 1). As of December 31, 2020, 2019, and 2018 a notional principal amount of $14.0 million, $26.9 million, and $26.8 million, respectively, was outstanding to hedge currency risk relative to foreign receivables and payables. Derivative instrument net (losses) gains on the Company’s forward exchange contracts were $(1.0) million, $0.4 million, and $0.5 million for the years ended December 31, 2020, 2019 and 2018, respectively, and are included in other (expense) income, net in the Consolidated Statements of Operations. The fair value of the forward contract exchange derivative instrument liability was de minimis as of December 31, 2020 and $0.1 million as of December 31, 2019. The derivative instruments are recorded in other current assets or other current liabilities in the Consolidated Balance Sheets commensurate with the nature of the instrument at period end.

Fair Value Measurements

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the periods presented.

The fair values of the Company’s assets and liabilities, including cash equivalents, marketable debt securities, derivatives, and contingent consideration are measured at fair value on a recurring basis. As of December 31, 2020 and December 31, 2019, the Company held investments in securities classified as cash equivalents. During the periods presented, the Company did not hold any such investments that were in a significant unrealized loss position and no impairment charges were recorded on such investments. Realized gains and losses and interest income related to marketable securities were immaterial during all periods presented. Cash equivalents and marketable debt securities are determined under the fair value categories as follows:

 

 

 

 

 

 

 

Quoted Price in

 

 

Significant Other

 

 

Significant

 

 

 

 

 

 

 

Active Market

 

 

Observable Inputs

 

 

Unobservable

 

(in thousands)

 

Total

 

 

(Level 1)

 

 

(Level 2)

 

 

Inputs (Level 3)

 

December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

725,108

 

 

$

725,108

 

 

$

—

 

 

$

—

 

Commercial paper

 

 

35,996

 

 

 

—

 

 

 

35,996

 

 

 

—

 

Total cash equivalents

 

 

761,104

 

 

 

725,108

 

 

 

35,996

 

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities, available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate notes

 

 

54,188

 

 

 

—

 

 

 

54,188

 

 

 

—

 

Commercial paper

 

 

118,957

 

 

 

—

 

 

 

118,957

 

 

 

—

 

Total debt securities, available for sale

 

 

173,145

 

 

 

—

 

 

 

173,145

 

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets measured at fair value

 

$

934,249

 

 

$

725,108

 

 

$

209,141

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

151,750

 

 

$

151,750

 

 

$

—

 

 

$

—

 

Total cash equivalents

 

$

151,750

 

 

$

151,750

 

 

$

—

 

 

$

—

 

 

 

The carrying amounts of certain financial instruments such as cash and cash equivalents, accounts receivable, prepaid expenses, other current assets, accounts payable, accrued expenses, and other current liabilities as of December 31, 2020 and December 31, 2019 approximate their related fair values due to the short-term maturities of these instruments.

The fair value of certain financial instruments was measured and classified within Level 1 of the fair value hierarchy based on quoted prices. Certain financial instruments classified within Level 2 of the fair value hierarchy include the types of instruments that trade in markets that are not considered to be active, but are valued based on quoted market prices, broker or dealer quotations, or alternative pricing sources with reasonable levels of price transparency.

Fair Value of Senior Convertible Notes

The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $650.0 million principal amount of Senior Convertible Notes due 2021 at December 31, 2020 and December 31, 2019 was approximately $651.6 million and $869.3 million, respectively. The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $450.0 million principal amount of Senior Convertible Notes due 2023 at December 31, 2020 was approximately $461.9 million. The fair value, based on a quoted market price (Level 1), of the Company’s outstanding $450.0 million principal amount of Senior Convertible Notes due 2025 at December 31, 2020 was approximately $436.7 million. See Note 6 to the Consolidated Financial Statements included in this Annual Report for further discussion on the carrying value of the notes.

Fair Value of Convertible Note Hedge and Embedded Conversion Derivatives

On June 1, 2020, the Company issued $450.0 million principal amount of 1.00% Senior Convertible Notes due 2023 (the “2023 Notes”). The 2023 Notes were initially required to be settled in cash as the Company did not have enough available shares and was unable to reserve the maximum number of shares issuable under the 2023 Notes (“sufficient reserved shares”). On September 10, 2020, the Company held a Special Meeting of Stockholders and received stockholder approval to amend the Company’s Restated Certificate of Incorporation to increase the number of shares of its common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares. As a result of the increase in the number of shares of the Company’s common stock authorized for issuance, as of September 10, 2020 and as of December 31, 2020, the Company had sufficient reserved shares and therefore may settle conversions of the 2023 Notes in cash, stock, or a combination thereof, solely at the Company’s discretion. In accordance with authoritative guidance, the cash conversion feature of the 2023 Notes requires bifurcation from the 2023 Notes and was initially accounted for as a derivative liability (“Embedded Conversion Derivative”), which was included in long-term liabilities in the Company’s Consolidated Balance Sheet. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle conversions of the 2023 Notes in cash, stock, or a combination thereof, and in accordance with authoritative literature, the Embedded Conversion Derivative was marked to fair value and reclassified to stockholders’ equity.

In connection with the issuance of the 2023 Notes, the Company entered into convertible note hedge transactions (the “2023 Hedge”) entitling the Company to purchase up to 5,345,010 shares of the Company’s common stock at an initial stock price of $84.19 per share, each of which is subject to adjustment. The 2023 Hedge was initially required to be settled in cash as the Company did not have sufficient reserved shares with respect to the 2023 Notes. As a result, the 2023 Hedge was accounted for as a derivative asset (“Convertible Note Hedge Derivative”), which was included in long-term assets in the Company’s Consolidated Balance Sheet. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle the 2023 Notes, which therefore allows for the 2023 Hedge to be settled in cash, stock, or a combination thereof. In accordance with authoritative literature, the Convertible Note Hedge Derivative was marked to fair value and reclassified to stockholders’ equity.

Prior to their reclassification to stockholders’ equity on September 10, 2020, the Embedded Conversion Derivative and Convertible Note Hedge Derivative were classified as Level 3 of the fair value hierarchy as these derivative instruments were not actively traded and were valued using significant unobservable inputs.

The following tables set forth the changes in the estimated fair value for the Company’s derivative assets and liabilities measured using significant unobservable inputs (Level 3):

(in thousands)

 

2020

 

Assets:

 

 

 

 

Fair value measurement at January 1

 

$

—

 

Derivative assets recorded in connection with the 2023 Hedge

 

 

69,525

 

Change in fair value measurement

 

 

(32,233

)

Derivative asset reclassified to stockholders’ equity

 

 

(37,292

)

Fair value measurement at December 31

 

$

—

 

 

 

(in thousands)

 

2020

 

Liabilities:

 

 

 

 

Fair value measurement at January 1

 

$

—

 

Derivative liability recorded in connection with the 2023 Notes

 

 

57,224

 

Change in fair value measurement

 

 

(19,932

)

Derivative liability reclassified to stockholders’ equity

 

 

(37,292

)

Fair value measurement at December 31

 

$

—

 

 

During 2020, the fair value measurement was determined utilizing a Black-Scholes valuation model. Key assumptions used in the valuation included risk-free interest rates, volatility, and expected term. The Company recorded the change in fair value measurement associated with its derivative assets and liabilities in other (expense) income, net in the Consolidated Statement of Operations.

Contingent Consideration Liabilities

The fair value of contingent consideration liabilities assumed in business combinations is recorded as part of the purchase price consideration of the acquisition, and is determined using a discounted cash flow model or probability simulation model. The significant inputs of such models are not observable in the market, such as certain financial metric growth rates, volatility rates, projections associated with the applicable milestone, the interest rate, and the related probabilities and payment structure in the contingent consideration arrangement. Fair value adjustments to contingent consideration liabilities are recorded through operating expenses in the Consolidated Statement of Operations. Contingent consideration arrangements assumed by an asset purchase will be measured and accrued when such contingency is resolved.

The recurring Level 3 fair value measurements of contingent consideration liabilities associated with commercial sales milestones include the following significant unobservable inputs as of December 31, 2020:

 

 

 

2020

 

Valuation Techniques

 

Discounted cash flow, Monte Carlo

 

Discount Rate Range

 

2.8% - 4.0%

 

Weighted Average Discount Rate

 

3.6%

 

Expected Years

 

2021 - 2024

 

Contingent consideration liabilities were $37.0 million and $42.6 million as of December 31, 2020 and December 31, 2019, respectively, and were recorded in the Consolidated Balance Sheet commensurate with the respective payment terms. The following table sets forth the changes in the estimated fair value of the Company’s liabilities measured on a recurring basis using significant unobservable inputs (Level 3):

 

 

 

 

 

(in thousands)

 

2020

 

 

2019

 

Fair value measurement at January 1

 

$

42,559

 

 

$

50,410

 

Change in fair value measurement

 

 

2,420

 

 

 

(6,297

)

Contingent consideration paid or settled

 

 

(7,938

)

 

 

(1,435

)

Changes resulting from foreign currency fluctuations

 

 

—

 

 

 

(119

)

Fair value measurement at December 31

 

$

37,041

 

 

$

42,559

 

 

Non-financial assets and liabilities measured on a nonrecurring basis

Certain non-financial assets and liabilities are measured at fair value, usually with Level 3 inputs including the discounted cash flow method or cost method, on a nonrecurring basis in accordance with authoritative guidance. These include items such as nonfinancial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets and property and equipment, are measured at fair value when there is an indication of impairment and are recorded at fair value only when any impairment is recognized. The carrying values of the Company’s financing lease obligations approximated their estimated fair value as of December 31, 2020 and 2019.

During the year ended December 31, 2019, the Company recorded a loss of $4.8 million on a strategic investment. The loss was recorded in other (expense) income, net in the Consolidated Statement of Operations included in this Annual Report.

During the year ended December 31, 2018, the Company expensed $8.9 million for a purchased in-process research and development asset which had no future alternative use. The Company also recorded a net loss of $3.8 million on strategic investments during the year ended December 31, 2018. The net loss was recorded in other (expense) income, net in the Consolidated Statement of Operations included in this Annual Report.
XML 31 R13.htm IDEA: XBRL DOCUMENT v3.20.4
Business Combinations
 12 Months Ended
Dec. 31, 2020
Business Combination Description [Abstract]  
Business Combinations

5.    Business Combinations

The Company recognizes the assets acquired, liabilities assumed, and any non-controlling interest at fair value at the date of acquisition. Certain acquisitions contained contingent consideration arrangements that required the Company to assess the acquisition date fair value of the contingent consideration liabilities, which was recorded as part of the purchase price allocation of the acquisition, with subsequent fair value adjustments to the contingent consideration recorded in the Consolidated Statements of Operations. See Note 4 to the Consolidated Financial Statements included in this Annual Report for further discussion on contingent consideration liabilities.

Acquisitions

The Company has completed acquisitions that were not considered material, individually or collectively, to the overall Consolidated Financial Statements during the periods presented. These acquisitions have been included in the Consolidated Financial Statements from the respective dates of acquisition. The Company does not believe that collectively the acquisitions made during the periods presented are material to the overall financial statements.

The Company finalizes the purchase price allocation of the assets and liabilities subject to valuation obtained in business combinations within one year from the acquisition date. While the Company does not expect material changes from the initial outcome of the valuation, certain assumptions and findings made at the date of acquisition could result in changes in the purchase price allocation.

Variable Interest Entities

The Company provides IONM services through various subsidiaries, which conduct business as NuVasive Clinical Services. In providing IONM services to surgeons and healthcare facilities across the United States, the Company maintains contractual relationships with several physician practices (“PCs”). In accordance with authoritative guidance, the Company has determined that the PCs are variable interest entities and therefore, the accompanying Consolidated Financial Statements include the accounts of the PCs from the date of acquisition. During the periods presented, the results of the PCs were immaterial to the Company’s financial statements. The creditors of the PCs have claims only to the assets of the PCs, which are not material, and the assets of the PCs are not available to the Company.
XML 32 R14.htm IDEA: XBRL DOCUMENT v3.20.4
Indebtedness
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Indebtedness

6.     Indebtedness

The carrying values of the Company’s Senior Convertible Notes are as follows:

 

(in thousands)

 

December 31, 2020

 

 

December 31, 2019

 

2.25% Senior Convertible Notes due 2021:

 

 

 

 

 

 

 

 

Principal amount

 

$

650,000

 

 

$

650,000

 

Unamortized debt discount

 

 

(3,945

)

 

 

(22,501

)

Unamortized debt issuance costs

 

 

(752

)

 

 

(4,201

)

 

 

 

645,303

 

 

 

623,298

 

1.00% Senior Convertible Notes due 2023:

 

 

 

 

 

 

 

 

Principal amount

 

 

450,000

 

 

 

—

 

Unamortized debt discount

 

 

(46,837

)

 

 

—

 

Unamortized debt issuance costs

 

 

(11,049

)

 

 

—

 

 

 

 

392,114

 

 

 

—

 

0.375% Senior Convertible Notes due 2025:

 

 

 

 

 

 

 

 

Principal amount

 

 

450,000

 

 

 

—

 

Unamortized debt discount

 

 

(66,346

)

 

 

—

 

Unamortized debt issuance costs

 

 

(9,542

)

 

 

—

 

 

 

 

374,112

 

 

 

—

 

Total Senior Convertible Notes

 

$

1,411,529

 

 

$

623,298

 

 

 

 

 

 

 

 

 

 

Less: Current portion

 

 

(645,303

)

 

 

—

 

Long-term Senior Convertible Notes

 

$

766,226

 

 

$

623,298

 

 

 

2.25% Senior Convertible Notes due 2021

In March 2016, the Company issued $650.0  million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 2.25% and a maturity date of March 15, 2021 (the “2021 Notes”). The net proceeds from the offering, after deducting initial purchasers' discounts and costs directly related to the offering, were approximately $634.1 million. Prior to September 14, 2020, the 2021 Notes provided for settlement in cash, stock, or a combination thereof, solely at the Company’s discretion. As of September 14, 2020, combination settlement was deemed to have been elected by the Company and the 2021 Notes will be settled by satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company's common stock. The initial conversion rate of the 2021 Notes is 16.7158  shares per $1,000  principal amount, which is equivalent to a conversion price of approximately $59.82  per share, subject to adjustments. The Company uses the treasury share method for assumed conversion of the 2021 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. The Company also entered into transactions for a convertible notes hedge (the “2021 Hedge”) and warrants (the “2021 Warrants”) concurrently with the issuance of the 2021 Notes.

The cash conversion feature of the 2021 Notes required bifurcation from the notes and was initially accounted for as an equity instrument classified to stockholders’ equity, which resulted in recognizing $84.8 million in additional paid-in-capital during 2016.

The interest expense recognized on the 2021 Notes during the year ended December 31, 2020 includes $14.6 million, $18.6 million and $3.4 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2021 Notes during the year ended December 31, 2019 includes $14.6 million, $17.6 million and $3.2 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The interest expense recognized on the 2021 Notes during the year ended December 31, 2018 includes $14.6 million, $16.7 million and $2.9 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2021 Notes is 5.8%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2021 Notes began accruing upon issuance and is payable semi-annually.

Prior to September 15, 2020, holders could have converted their 2021 Notes only under the following conditions: (a) during any calendar quarter beginning June 30, 2016, if the reported sale price of the Company's common stock for at least 20 days out of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter was greater than 130% of the conversion price on each applicable trading day; (b) during the five business day period in which the trading price of the 2021 Notes fell below 98% of the product of (i) the last reported sale price of the Company's common stock and (ii) the conversion rate on that date; and (c) upon the occurrence of specified corporate events, as defined in the 2021 Notes. From September 15, 2020 and until the close of business on the second scheduled trading day immediately preceding March 15, 2021, holders may convert their 2021 Notes at any time (regardless of the foregoing circumstances). The 2021 Notes can no longer be redeemed by the Company. The Company previously had the ability to redeem the 2021 Notes, at its option, in whole or in part beginning on March 20, 2019 until the close of business on the business day immediately preceding September 15, 2020 if the last reported sale price of the Company’s common stock had been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company delivers written notice of a redemption. No principal payments are due on the 2021 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2021 Notes do not contain any financial covenants and do not restrict the Company from paying dividends or issuing or repurchasing any of its other securities. 

As of September 15, 2020, holders may convert their 2021 Notes at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. As a result, the 2021 Notes are considered redeemable as of December 31, 2020. A portion of the equity component that was recorded upon the issuance of the 2021 Notes was reclassified to temporary equity in the Consolidated Balance Sheet. Such amount was determined based on the cash consideration to be paid upon conversion and the carrying amount of the debt. The reclassification into temporary equity as of December 31, 2020 was $4.7 million based on the 2021 Notes principal of $650.0 million and the carrying value of $645.3 million.

2021 Hedge

In connection with the offering of the 2021 Notes, the Company entered into the hedge transaction with the initial purchasers of the 2021 Notes and/or their affiliates (the "2021 Counterparties") entitling the Company to purchase up to 10,865,270 shares of the Company's common stock at an initial stock price of $59.82 per share, each of which is subject to adjustment. The cost of the 2021 Hedge was $111.2 million and accounted for as an equity instrument by recognizing $111.2 million in additional paid-in-capital during 2016. The 2021 Hedge will expire on March 15, 2021. The 2021 Hedge is expected to reduce the potential equity dilution upon conversion of the 2021 Notes if the daily volume-weighted average price per share of the Company's common stock exceeds the strike price of the 2021 Hedge. An assumed exercise of the 2021 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

2021 Warrants

The Company sold warrants to the 2021 Counterparties to acquire up to 10,865,270 shares of the Company’s common stock. The 2021 Warrants will expire on various dates from June 2021 through December 2021 and may be settled in cash or net shares. It is the Company's current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $44.9 million in cash proceeds from the sale of the 2021 Warrants, which was recorded in additional paid-in-capital. The 2021 Warrants could have a dilutive effect on the Company's earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2021 Warrants, which is $80.00 per share. The Company uses the treasury share method for assumed conversion of its 2021 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.

1.00% Senior Convertible Notes due 2023

In June 2020, the Company issued $450.0 million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 1.00% and a maturity date of June 1, 2023. The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $436.7 million. The 2023 Notes were initially required to be settled in cash as the Company did not have sufficient reserved shares. On September 10, 2020, the Company held a Special Meeting of Stockholders and received stockholder approval to amend the Company’s Restated Certificate of Incorporation to increase the number of shares of its common stock authorized for issuance from 120,000,000 shares to 150,000,000 shares. As a result of the increase in the number of shares of the Company’s common stock authorized for issuance, as of September 10, 2020 and as of December 31, 2020, the Company had sufficient reserved shares and therefore may settle conversions of the 2023 Notes in cash, stock, or a combination thereof, solely at the Company’s discretion. It is the Company’s current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company’s common stock. The initial conversion rate of the 2023 Notes is 11.8778 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $84.19 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date, the Company will increase the conversion rate for a holder who elects to convert its 2023 Notes in connection with such a corporate event in certain circumstances. The Company also entered into transactions for a convertible notes hedge and warrants concurrently with the issuance of the 2023 Notes.

As discussed in Note 4, the Embedded Conversion Derivative requires bifurcation from the 2023 Notes and was initially accounted for as a liability, which was included in long-term liabilities in the Company’s Consolidated Balance Sheet. The fair value of the 2023 Notes Embedded Conversion Derivative at the time of issuance of the 2023 Notes was $57.2 million, and was recorded as the original debt discount for purposes of accounting for the debt component of the 2023 Notes. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle conversions of the 2023 Notes in cash, stock, or a combination thereof, and in accordance with authoritative literature, the Embedded Conversion Derivative was marked to fair value and reclassified to stockholders’ equity, which resulted in recognizing $37.3 million in additional paid-in-capital during the year ended December 31, 2020. The original discount will be recognized as interest expense using the effective interest method over the term of the 2023 Notes.

The interest expense recognized on the 2023 Notes during the year ended December 31, 2020 includes $2.6 million, $10.4 million and $2.2 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2023 Notes is 6.8%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2023 Notes began accruing upon issuance and is payable semi-annually.

Prior to February 1, 2023, holders may convert their 2023 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price of the 2023 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on such trading day; or (c) upon the occurrence of specified corporate events, as defined in the 2023 Notes. On or after February 1, 2023, until the close of business on the second scheduled trading day immediately preceding June 1, 2023, holders may convert their 2023 Notes at any time, regardless of the foregoing conditions.

The Company may not redeem the 2023 Notes prior to the maturity date and no principal payments are due on the 2023 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2023 Notes do not contain any financial covenants and do not restrict the Company from conducting significant restructurings, paying dividends or issuing or repurchasing any of its other securities. As of December 31, 2020, the Company is unaware of any current events or market conditions that would allow holders to convert the 2023 Notes.

2023 Hedge

In connection with the sale of the 2023 Notes, the Company entered into privately negotiated call option transactions with certain dealers, which included affiliates of certain of the initial purchasers of the 2023 Notes and other financial institutions (the “2023 Counterparties”), entitling the Company to purchase up to 5,345,010 shares of the Company’s common stock at an initial stock price of $84.19 per share, each of which is subject to adjustment. The 2023 Hedge was initially required to be settled in cash as the Company did not have sufficient reserved shares with respect to the 2023 Notes. As a result, the 2023 Hedge was accounted for as a derivative asset, which was included in long-term assets in the Company’s Consolidated Balance Sheet. The cost of the 2023 Hedge was $69.5 million. On September 10, 2020, as a result of the increase in the number of shares of the Company’s common stock authorized for issuance, the Company had sufficient reserved shares to settle the 2023 Notes, which therefore allows for the 2023 Hedge to be settled in cash, stock, or a combination thereof. In accordance with authoritative literature, the Convertible Note Hedge Derivative was marked to fair value and reclassified to stockholders’ equity, which resulted in recognizing a reduction of $37.3 million in additional paid-in-capital during the year ended December 31, 2020. The 2023 Hedge will expire on the second scheduled trading day immediately preceding June 1, 2023. The 2023 Hedge is expected to reduce the potential equity dilution upon conversion of the 2023 Notes if the daily volume-weighted average price per share of the Company’s common stock exceeds the strike price of the 2023 Hedge. An assumed exercise of the 2023 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

2023 Warrants

In connection with the sale of the 2023 Notes, the Company sold warrants to the 2023 Counterparties (the “2023 Warrants”) to acquire up to 5,345,010 shares of the Company’s common stock. The 2023 Warrants initially limited the amount of shares the Company was required to reserve for issuance under the 2023 Warrants to an aggregate of 3,093,500 shares of the Company’s common stock, subject to adjustment upon the Company having a sufficient amount of authorized and unissued shares which are not reserved for other transactions. As a result of the Company receiving stockholder approval to increase the number of shares of the Company’s common stock authorized for issuance on September 10, 2020, the Company subsequently entered into amendment agreements with each of the 2023 Counterparties to increase the number of authorized shares of the Company’s common stock required to be reserved under the 2023 Warrants to the aggregate amount of 6,948,512 shares. The 2023 Warrants will expire on various dates from September 2023 through November 2023 and may be settled in net shares or cash, subject to certain conditions. It is the Company’s current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $46.8 million in cash proceeds from the sale of the 2023 Warrants, which was recorded in additional paid-in-capital. The 2023 Warrants could have a dilutive effect on the Company’s earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2023 Warrants, which is $104.84 per share. The Company uses the treasury share method for assumed conversion of its 2023 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.

0.375% Senior Convertible Notes due 2025

In March 2020, the Company issued $450.0 million principal amount of unsecured Senior Convertible Notes with a stated interest rate of 0.375% and a maturity date of March 15, 2025 (the “2025 Notes”). The net proceeds from the offering, after deducting initial purchasers’ discounts and costs directly related to the offering, were approximately $437.0 million. The 2025 Notes may be settled in cash, stock, or a combination thereof, solely at the Company’s discretion. It is the Company's current intent and policy to settle all conversions through combination settlement, which involves satisfying the principal amount outstanding with cash and any note conversion value over the principal amount in shares of the Company’s common stock. The initial conversion rate of the 2025 Notes is 10.7198 shares per $1,000 principal amount, which is equivalent to a conversion price of approximately $93.29 per share, subject to adjustments. In addition, following certain corporate events that occur prior to the maturity date or if the Company issues a notice of redemption, the Company will increase the conversion rate for a holder who elects to convert its 2025 Notes in connection with such a corporate event or in connection with such redemption in certain circumstances. The Company uses the treasury share method for assumed conversion of the 2025 Notes to compute the weighted average shares of common stock outstanding for diluted earnings per share. The Company also entered into transactions for a convertible notes hedge (the “2025 Hedge”) and warrants (the “2025 Warrants”) concurrently with the issuance of the 2025 Notes.

The cash conversion feature of the 2025 Notes required bifurcation from the notes and was initially accounted for as an equity instrument classified to stockholders’ equity, which resulted in recognizing $78.3 million in additional paid-in-capital during the year ended December 31, 2020.

The interest expense recognized on the 2025 Notes during the year ended December 31, 2020 includes $1.4 million, $11.9 million and $1.5 million for the contractual coupon interest, the accretion of the debt discount and the amortization of the debt issuance costs, respectively. The effective interest rate on the 2025 Notes is 4.9%, which includes the interest on the notes, amortization of the debt discount and debt issuance costs. Interest on the 2025 Notes began accruing upon issuance and is payable semi-annually.

Prior to September 15, 2024, holders may convert their 2025 Notes only under the following conditions: (a) during any calendar quarter commencing after the calendar quarter ending on June 30, 2020 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (b) during the five business day period after any five consecutive trading day period (the “measurement period”) in which the trading price of the 2025 Notes per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on such trading day; (c) if the Company calls any or all of the 2025 Notes for redemption, at any time prior to the close of business on the second scheduled trading day preceding the redemption date; or (d) upon the occurrence of specified corporate events, as defined in the 2025 Notes. On or after September 15, 2024, until the close of business on the second scheduled trading day immediately preceding March 15, 2025, holders may convert their 2025 Notes at any time, regardless of the foregoing conditions.

The Company may not redeem the 2025 Notes prior to March 20, 2023. The Company may redeem the 2025 Notes, at its option, in whole or in part, on or after March 20, 2023 until the close of business on the business day immediately preceding September 15, 2024, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading day period ending on, and including, the trading day immediately preceding the date on which the Company delivers written notice of a redemption. The redemption price will be equal to 100% of the principal amount of such 2025 Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date. No principal payments are due on the 2025 Notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the 2025 Notes do not contain any financial covenants and do not restrict the Company from conducting significant restructurings, paying dividends or issuing or repurchasing any of its other securities. As of December 31, 2020, the Company is unaware of any current events or market conditions that would allow holders to convert the 2025 Notes.

2025 Hedge

In connection with the sale of the 2025 Notes, the Company entered into privately negotiated call option transactions with certain dealers, which included affiliates of certain of the initial purchasers of the 2025 Notes and other financial institutions (the “2025 Counterparties”), entitling the Company to purchase up to 4,823,910 shares of the Company’s common stock at an initial stock price of $93.29 per share, each of which is subject to adjustment. The cost of the 2025 Hedge was $78.3 million and accounted for as an equity instrument by recognizing $78.3 million in additional paid-in-capital during the year ended December 31, 2020. The 2025 Hedge will expire on the second scheduled trading day immediately preceding March 15, 2025. The 2025 Hedge is expected to reduce the potential equity dilution upon conversion of the 2025 Notes if the daily volume-weighted average price per share of the Company’s common stock exceeds the strike price of the 2025 Hedge. An assumed exercise of the 2025 Hedge by the Company is considered anti-dilutive since the effect of the inclusion would always be anti-dilutive with respect to the calculation of diluted earnings per share.

2025 Warrants

The Company sold warrants to the 2025 Counterparties to acquire up to 4,823,910 shares of the Company’s common stock. The 2025 Warrants will expire on various dates from June 2025 through October 2025 and may be settled in net shares or cash, subject to certain conditions. It is the Company’s current intent and policy to settle all conversions in shares of the Company’s common stock. The Company received $47.1 million in cash proceeds from the sale of the 2025 Warrants, which was recorded in additional paid-in-capital. The 2025 Warrants could have a dilutive effect on the Company’s earnings per share to the extent that the price of the Company's common stock during a given measurement period exceeds the strike price of the 2025 Warrants, which is $127.84 per share. The Company uses the treasury share method for assumed conversion of its 2025 Warrants to compute the weighted average common shares outstanding for diluted earnings per share.

Revolving Senior Credit Facility

In February 2020, the Company entered into a Second Amended and Restated Credit Agreement (the “2020 Credit Agreement”) for a revolving senior credit facility (the “2020 Facility”), which replaced the previous Amended and Restated Credit Agreement the Company had entered into in April 2017. The 2020 Credit Agreement was further amended in May 2020 to, among other things, provide additional flexibility in determining the financial covenant leverage ratios for the second and third fiscal quarters of 2020 and to adjust certain margin and benchmark rates used to determine interest under the 2020 Facility. The 2020 Credit Agreement provides for secured revolving loans, multicurrency loan options and letters of credit in an aggregate amount of up to $550.0  million. The 2020 Credit Agreement also contains an expansion feature, which allows the Company to increase the aggregate principal amount of the 2020 Facility provided the Company remains in compliance with the underlying financial covenants on a pro forma basis, including but not limited to, compliance with the consolidated interest coverage ratio and certain consolidated leverage ratios. The 2020 Facility matures in February 2025 (subject to an earlier springing maturity date), and includes a sublimit of $50.0 million for standby letters of credit, a sublimit of $250.0 million for multicurrency borrowings, and a sublimit of $5.0 million for swingline loans. All assets of the Company and its material domestic subsidiaries continue to be pledged as collateral under the 2020 Facility (subject to customary exceptions) pursuant to the terms set forth in the Second Amended and Restated Security and Pledge Agreement executed in favor of the administrative agent by the Company. Each of the Company’s material domestic subsidiaries guarantee the 2020 Facility. In connection with the 2020 Facility, the Company incurred issuance costs which will be amortized over the term of the 2020 Facility. The Company did not carry any outstanding revolving loans under the 2020 Facility as of December 31, 2020 and 2019.

Any borrowings under the 2020 Facility are intended to be used by the Company to provide financing for working capital and other general corporate purposes, including potential mergers and acquisitions and to refinance indebtedness. Borrowings under the 2020 Facility bear interest, at the Company’s option, at a rate equal to an applicable margin plus: (a) the applicable Eurocurrency Rate (as defined in the 2020 Credit Agreement), or (b) a base rate determined by reference to the highest of (1) the federal funds effective rate plus 0.50%, (2) the Bank of America prime rate, and (3) the Eurocurrency Rate for an interest period of one month plus 1.00%. The margin for the 2020 Facility ranges, based on the Company’s consolidated total net leverage ratio, from 0.50% to 1.25% in the case of base rate loans and from 1.50% to 2.25% in the case of Eurocurrency Rate loans. The 2020 Facility includes an unused line fee ranging, based on the Company’s consolidated total net leverage ratio, from 0.35% to 0.50% per annum on the revolving commitment.

The 2020 Credit Agreement contains affirmative, negative, permitted acquisition and financial covenants, and events of default customary for financings of this type. The financial covenants require the Company to maintain a consolidated interest coverage ratio and certain consolidated leverage ratios, which are measured on a quarterly basis. The 2020 Facility grants the lenders preferred first priority liens and security interests in capital stock, intercompany debt and all of the present and future property and assets of the Company and each guarantor. The Company is currently in compliance with the 2020 Credit Agreement covenants.
XML 33 R15.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments
 12 Months Ended
Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]  
Commitments

 

7.    Commitments

Leases

At the inception of a contractual arrangement, the Company determines whether the contract contains a lease by assessing whether there is an identified asset and whether the contract conveys the right to control the use of the identified asset in exchange for consideration over a period of time. If both criteria are met, the Company records the associated lease liability and corresponding right-of-use asset upon commencement of the lease using a discount rate based on a credit-adjusted secured borrowing rate commensurate with the term of the lease.

The Company records lease liabilities within current liabilities or long-term liabilities based upon the length of time associated with the lease payments. The Company records its operating lease right-of-use assets as long-term assets. Right-of-use assets for financing leases are recorded within property and equipment, net in the Consolidated Balance Sheet. Leases with an initial term of 12 months or less are not recorded in the Consolidated Balance Sheet. The Company recognizes lease expense on a straight-line basis over the lease term. In connection with certain operating leases, the Company has security deposits recorded and maintained as restricted cash totaling $1.5 million as of December 31, 2020 and December 31, 2019.

The Company leases office and storage facilities and equipment under various operating and financing lease agreements. The initial terms of these leases range from 1 to 17 years and generally provide for periodic rent increases, and renewal and termination options. The Company’s lease agreements do not contain any material variable lease payments, residual value guarantees or material restrictive covenants.

Certain leases require the Company to pay taxes, insurance and maintenance. Payments for the transfer of goods or services such as common area maintenance and utilities represent non-lease components. The Company elected the package of practical expedients and therefore does not separate non-lease components from lease components.

The table below summarizes the Company’s right-of-use assets and lease liabilities:

(in thousands, except years and rates)

December 31, 2020

 

 

December 31, 2019

 

Assets

 

 

 

 

 

 

 

Operating

$

102,270

 

 

$

66,932

 

Financing

 

2,956

 

 

 

1,453

 

Total leased assets

$

105,226

 

 

$

68,385

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

Operating

$

7,875

 

 

$

5,567

 

Financing

 

1,355

 

 

 

672

 

Long-term:

 

 

 

 

 

 

 

Operating

 

111,634

 

 

 

73,153

 

Financing

 

1,812

 

 

 

905

 

Total lease liabilities

$

122,676

 

 

$

80,297

 

 

 

 

 

 

 

 

 

Supplemental non-cash information:

 

 

 

 

 

 

 

Weighted-average remaining lease term (years) - operating leases

 

12.8

 

 

 

12.4

 

Weighted-average remaining lease term (years) - finance leases

 

2.2

 

 

 

2.3

 

Weighted-average discount rate - operating leases

 

5.4

%

 

 

7.3

%

Weighted-average discount rate - finance leases

 

4.9

%

 

 

5.4

%

The table below summarizes the Company’s lease costs, cash payments, and operating lease liabilities arising from obtaining right-of-use assets under its operating and financing lease obligations:

 

(in thousands)

December 31, 2020

 

 

December 31, 2019

 

Lease expense:

 

 

 

 

 

 

 

Operating lease expense

$

15,316

 

 

$

11,859

 

Finance lease expense:

 

 

 

 

 

 

 

Depreciation of right-of-use assets

 

1,201

 

 

 

441

 

Interest expense on lease liabilities

 

124

 

 

 

56

 

Total lease expense

$

16,641

 

 

$

12,356

 

 

 

 

 

 

 

 

 

Consolidated Statements of Cash Flows information:

 

 

 

 

 

 

 

Operating cash flows used for operating leases

$

14,120

 

 

$

12,140

 

Operating cash flows used for financing leases

 

124

 

 

 

56

 

Financing cash flows used for financing leases

 

1,113

 

 

 

420

 

Total cash paid for amounts included in the measurement of lease liabilities

$

15,357

 

 

$

12,616

 

 

 

 

 

 

 

 

 

Supplemental non-cash information:

 

 

 

 

 

 

 

Operating lease liabilities arising from obtaining right-of-use assets

$

41,148

 

 

$

86,134

 

 

Rent expense, including costs directly associated with the facility leases, was approximately $12.8 million for the year ended December 31, 2018.

The Company’s future minimum annual lease payments under operating and financing leases at December 31, 2020 are as follows:

 

 

Financing

 

 

Operating

 

(in thousands)

 

Leases

 

 

Leases

 

2021

 

$

1,465

 

 

$

14,140

 

2022

 

 

1,397

 

 

 

13,582

 

2023

 

 

466

 

 

 

13,158

 

2024

 

 

9

 

 

 

12,072

 

2025

 

 

—

 

 

 

10,699

 

Thereafter

 

 

—

 

 

 

106,197

 

Total minimum lease payments

 

$

3,337

 

 

$

169,848

 

Less: amount representing interest

 

 

(170

)

 

 

(50,339

)

Present value of obligations under leases

 

 

3,167

 

 

 

119,509

 

Less: current portion

 

 

(1,355

)

 

 

(7,875

)

Long-term lease obligations

 

$

1,812

 

 

$

111,634

 

Licensing and Purchasing Agreements

The Company has both minimum and contingent obligations to make payments of up to $50.4 million if specified future events occur or conditions are met as provided in certain net sales based, consulting, purchase and/or product development agreements. Not all of the respective agreements specify milestone payment timelines. Certain payments will be made in a combination of cash and the Company’s common shares as provided in the agreements. Any payments in satisfaction of these obligations are considered either a research and development expense or a cost of sales depending on the nature of the arrangement and are recognized ratably as and if milestones are achieved.

Executive Severance Plans

 The Company has employment contracts with key executives and maintains severance plans that provide for the payment of severance and other benefits if such executives are terminated for reasons other than cause, as defined in those agreements and plans. Certain agreements call for payments that are based on historical compensation, and accordingly, the amount of the contractual commitment will change over time commensurate with the executive’s applicable earnings. At December 31, 2020, future commitments for such key executives were approximately $20.1 million. In certain circumstances, the agreements call for the acceleration of equity vesting. Those figures are not reflected in the above information.
XML 34 R16.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity
 12 Months Ended
Dec. 31, 2020
Stockholders Equity Note [Abstract]  
Stockholders' Equity

8.    Stockholders’ Equity

In October 2017, the Company announced that the Board of Directors approved a share repurchase program authorizing the repurchase of up to $100 million of the Company’s common stock over a three-year period. Under this program, the Company is authorized to repurchase common stock in open market purchases, privately negotiated purchases or other transactions through October 2020. In February 2020, the Company announced that the Board of Directors increased the share repurchase authorization from $100 million to $150 million of the Company’s common stock through December 31, 2021. In March 2020, in connection with the issuance of the 2025 Notes, the Company repurchased approximately 1,085,000 shares of its common stock for $75.0 million. As of December, 31 2020, $75.0 million remained authorized under the share repurchase program.

On September 10, 2020, upon obtaining stockholder approval, the Company filed a Certificate of Amendment to its Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of the Company’s common stock from 120,000,000 shares to 150,000,000 shares.
XML 35 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation
 12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation

9.    Stock-Based Compensation

Common Stock

There were 150,000,000 and 120,000,000 shares of common stock authorized at December 31, 2020 and 2019, respectively.

Preferred Stock

There are 5,000,000 shares of preferred stock authorized and none issued or outstanding at December 31, 2020 and 2019.

Stock-based Compensation

In March 2014, the Compensation Committee (the "Compensation Committee") of the Board of Directors of the Company adopted the 2014 Equity Incentive Plan of NuVasive, Inc. (the "2014 EIP"), replacing the 2004 Amended and Restated Equity Incentive Plan (the “2004 EIP”). No further awards may be granted under the 2004 EIP; however, that plan continues to govern all awards previously issued under it (of which awards remain outstanding). The 2014 EIP provides the Company with the ability to grant various types of equity awards to its workforce (including, without limitation, restricted stock units (“RSUs”), restricted stock awards, performance awards, and deferred stock awards). The 2014 EIP also provides for the issuance of performance RSUs (“PRSUs”) to be granted subject to time- and/or performance-based vesting requirements. In addition, the award agreements under the 2014 EIP generally provide for the acceleration of 50% of the unvested equity awards of all employees upon a change in control and the vesting of the remaining unvested equity awards for those employees that are involuntarily terminated within a year of the change in control.

Each of the 2004 EIP and the 2014 EIP allow for “net share settlement” of certain equity awards whereby, in lieu of (i) making cash payments in satisfaction of the exercise price owed respective to non-qualified stock option awards, or (ii) open market selling award shares to generate cash proceeds for use in satisfaction of statutory tax obligations respective to an award’s settlement or exercise, the company offsets the award shares being settled in a respective transaction by the number of shares of company stock with a value equal to the respective obligation, and, in the case of taxes, making a cash payment to the respective taxing authority on behalf of the employee using Company cash. The net share settlement is accounted for with the cost of any award shares that are net settled being included in treasury stock and reported as a reduction in total equity at the time of settlement.

In connection with the acquisition of Ellipse Technologies in February 2016, the Company assumed the Ellipse Technologies, Inc. 2015 Incentive Award Plan and the shares thereunder, subject to an equity exchange adjustment, for future awards by the Company.

The compensation cost that has been included in the Consolidated Statements of Operations for the Company’s stock-based compensation plans was as follows:

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Selling, general and administrative expense

 

$

12,622

 

 

$

25,968

 

 

$

22,190

 

Research and development expense

 

 

5,259

 

 

 

3,798

 

 

 

3,052

 

Cost of sales

 

 

264

 

 

 

531

 

 

 

431

 

Stock-based compensation expense before taxes

 

 

18,145

 

 

 

30,297

 

 

 

25,673

 

Related income tax benefits

 

 

(3,088

)

 

 

(6,191

)

 

 

(6,418

)

Stock-based compensation expense, net of taxes

 

$

15,057

 

 

$

24,106

 

 

$

19,255

 

As of December 31, 2020, there was $21.0 million and $16.1 million of unrecognized compensation expense for RSUs and PRSUs, respectively, which is expected to be recognized over a weighted-average period of approximately 1.7 years and 2.7 years, respectively. In addition, as of December 31, 2020, there was $1.0 million of unrecognized compensation expense for shares expected to be issued under the ESPP which is expected to be recognized through April 2021. There was no unamortized expense for stock options as of December 31, 2020.

Restricted Stock Units

The total fair value of RSUs that vested during the year ended December 31, 2020, 2019, and 2018 was $12.1 million, $21.5 million and $8.8 million, respectively.

Following is a summary of RSU activity for the year ended December 31, 2020:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

(in thousands, except per share amounts)

 

Shares

 

 

Fair Value

 

Outstanding at December 31, 2019

 

 

945

 

 

$

59.21

 

Granted

 

 

381

 

 

 

63.64

 

Vested

 

 

(209

)

 

 

68.67

 

Forfeited

 

 

(123

)

 

 

59.21

 

Outstanding at December 31, 2020

 

 

994

 

 

$

58.94

 

For the majority of RSUs, shares are issued on the vesting dates net of the amount of shares needed to satisfy statutory tax withholding requirements to be paid by the Company on behalf of the employees. The total shares withheld related to vested RSUs were approximately 71,000, 122,000, and 42,000 in 2020, 2019, and 2018, respectively, and were based on the value of the awards on their vesting dates as determined by the Company’s closing stock price. Total payments for the employees’ tax obligations to the taxing authorities related to vesting RSUs were $4.1 million, $7.2 million and $2.2 million in 2020, 2019 and 2018, respectively.

Performance-Based Restricted Stock Units

The Company has granted PRSUs since 2012 for which the ultimate issuance amount is determined by the Company’s Compensation Committee upon its certification of Company performance against a pre-determined matrix, which have included targets for net sales, operating margin, earnings per share and total shareholder return over pre-determined periods of time. Share payout levels range from 0% to 200% depending on the respective terms of an award. Based upon the Company’s actual performance against the performance conditions, approximately 61,000, 276,000 and 21,000 shares of common stock vested pursuant to PRSUs in 2020, 2019 and 2018, respectively.

In 2015, the Company granted a PRSU award with a five-year cliff vesting term to its former Chief Executive Office, Gregory T. Lucier, in connection with his appointment to the Company, for which the performance criteria was not based on Company or market specific performance metrics, but rather stock price performance. As such, the Company recorded the award as a liability subject to recurring fair value adjustments that affect stock-based compensation expense. The minimum performance criteria for this award was not met, thus no shares were paid out and the entire liability was reversed during the year ended December 31, 2020.

The total fair value of PRSUs vested during 2020, 2019, 2018 and was $3.8 million, $19.9 million and $2.1 million, respectively.

Following is a summary of PRSU activity for the year ended December 31, 2020:

 

 

 

 

 

 

Maximum Number

 

 

 

 

 

(in thousands, except per share amounts)

 

Shares

 

 

of Shares Eligible

to be Issued

 

 

Average Grant

Date Fair Value

 

Outstanding at December 31, 2019

 

 

731

 

 

 

1,116

 

 

$

57.07

 

Awarded at target

 

 

172

 

 

 

248

 

 

 

69.72

 

Vested

 

 

(61

)

 

 

(61

)

 

 

73.20

 

Forfeited

 

 

(223

)

 

 

(453

)

 

 

56.48

 

Outstanding at December 31, 2020

 

 

619

 

 

 

850

 

 

$

57.38

 

For the majority of PRSUs, shares are issued on the vesting dates net of the amount of shares needed to satisfy statutory tax withholding requirements to be paid by the Company on behalf of the employees. The total shares withheld related to vesting PRSUs were approximately 25,000, 121,000 and 8,000 in 2020, 2019 and 2018 respectively, and were based on the value of the awards on their vesting dates as determined by the Company’s closing stock price. Total payments for the employees’ tax obligations to the taxing authorities related to vesting PRSUs were $1.6 million, $7.2 million, and $0.4 million in 2020, 2019, and 2018, respectively.

Stock Options

The Company has not granted any stock options since 2011. The stock options previously granted are exercisable for a period of up to ten years after the date of grant.

The aggregate intrinsic value of outstanding stock options at December 31, 2020 is based on the Company’s closing stock price on December 31, 2020 of $56.33. Stock option exercises during the years ended December 31, 2020 and 2019 were primarily all executed with net share settlements, for which the Company does not receive any cash proceeds. The Company received $1.3 million in proceeds from the exercise of stock options during the year ended December 31, 2018. The total intrinsic value of stock options exercised was $0.4 million, $1.0 million, and $2.5 million during the years ended December 31, 2020, 2019 and 2018, respectively. There were no stock options that vested during the years ended December 31, 2020, 2019 or 2018.

Following is a summary of stock option activity for the year ended December 31, 2020 under all stock plans:

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

 

 

Avg. Exercise

 

 

Term

 

 

Intrinsic

 

(in thousands, except years and per share amounts)

 

Shares

 

 

Price

 

 

(Years)

 

 

Value

 

Outstanding at December 31, 2019

 

 

16

 

 

$

29.18

 

 

 

0.89

 

 

$

747

 

Exercised

 

 

(16

)

 

 

29.18

 

 

 

 

 

 

 

 

 

Cancelled

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

—

 

 

 

—

 

 

 

—

 

 

$

—

 

Exercisable at December 31, 2020

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 

Vested or expected to vest at December 31, 2020

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 

 For the majority of stock options, shares are issued on the exercise dates net of the amount of shares needed to satisfy each of the exercise price (in lieu of cash) and statutory tax withholding requirements, the latter to be paid by the Company on behalf of the employee. The total shares withheld related to exercised stock options were approximately 8,000, 21,000, and 65,000 in 2020, 2019, and 2018 respectively, and were based on the value of the stock options on their exercise dates as determined by the Company’s closing stock price. There were no cash payments for the employees’ tax obligations to the taxing authorities related to exercised stock options in 2020. Total cash payments for the employees’ tax obligations to the taxing authorities related to exercised stock options were $0.1 million and $0.4 million in 2019 and 2018, respectively.

Employee Stock Purchase Plan

The NuVasive, Inc. 2004 Amended and Restated Employee Stock Purchase Plan (the “ESPP”), provides eligible employees with a means of acquiring equity in the Company at a discounted purchase price using their own accumulated payroll deductions. Under the terms of the ESPP, employees can elect to have up to 15% of their annual compensation, up to a maximum of $21,250 per year, withheld to purchase shares of Company common stock for a purchase price equal to 85% of the lower of the fair market value per share (at closing) of Company common stock on (i) the commencement date of the six-month offering period or (ii) the respective purchase date. In the years ended December 31, 2020, 2019 and 2018, 136,000, 129,000, and 151,000 shares, respectively, were purchased under the ESPP.

The weighted average assumptions used to estimate the fair value of stock options granted and stock purchase rights under the ESPP are as follows:

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

ESPP

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

56

%

 

 

35

%

 

 

33

%

Expected term (years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

Risk free interest rate

 

 

0.5

%

 

 

2.3

%

 

 

1.8

%

Expected dividend yield

 

 

—

%

 

 

—

%

 

 

—

%

Common Stock Reserved for Future Issuance

The following table summarizes common shares reserved for issuance on exercise or conversion at December 31, 2020:

(in thousands)

 

 

 

 

Issued and outstanding RSUs and PRSUs

 

 

1,630

 

Available for issuance under the ESPP

 

 

828

 

Available for future grant

 

 

3,651

 

2021 Notes

 

 

14,396

 

2021 Warrants

 

 

25,207

 

2023 Notes

 

 

7,082

 

2023 Warrants

 

 

6,949

 

2025 Notes

 

 

6,512

 

2025 Warrants

 

 

6,271

 

Total shares reserved for future issuance

 

 

72,526

 

 

 

 
XML 36 R18.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes
 12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Income Taxes

10.    Income Taxes

Total (loss) income before income taxes summarized by region was as follows:

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

United States

 

$

(45,534

)

 

$

74,721

 

 

$

8,939

 

Foreign

 

 

(2,011

)

 

 

5,796

 

 

 

(216

)

Total (loss) income before income taxes

 

$

(47,545

)

 

$

80,517

 

 

$

8,723

 

The income tax (benefit) provision was as follows:

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(35

)

 

$

4,802

 

 

$

(4,188

)

State

 

 

2,309

 

 

 

4,638

 

 

 

2,043

 

Foreign

 

 

4,675

 

 

 

2,205

 

 

 

5,972

 

Total current provision

 

 

6,949

 

 

 

11,645

 

 

 

3,827

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

(13,800

)

 

 

5,873

 

 

 

(5,944

)

State

 

 

(8,315

)

 

 

(4,565

)

 

 

(7,092

)

Foreign

 

 

(3,849

)

 

 

(819

)

 

 

(98,795

)

Total deferred provision

 

 

(25,964

)

 

 

489

 

 

 

(111,831

)

Changes in tax rate

 

 

(579

)

 

 

606

 

 

 

258

 

Changes in valuation allowance

 

 

9,202

 

 

 

2,543

 

 

 

103,990

 

Total (benefit) provision

 

$

(10,392

)

 

$

15,283

 

 

$

(3,756

)

The differences between the income tax provision at the United States federal statutory tax rate and the Company’s effective tax rate were as follows:

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Tax (benefit) provision at federal statutory rate

 

$

(9,984

)

 

$

16,909

 

 

$

1,832

 

Income tax credits and incentives

 

 

(7,155

)

 

 

(7,209

)

 

 

(5,525

)

State income tax

 

 

(1,243

)

 

 

3,763

 

 

 

90

 

Valuation allowance

 

 

9,202

 

 

 

2,543

 

 

 

103,990

 

Net tax benefit on international restructuring

 

 

—

 

 

 

—

 

 

 

(97,028

)

Return to provision adjustments

 

 

(881

)

 

 

(2,323

)

 

 

(4,180

)

Acquisition related charges

 

 

687

 

 

 

(1,808

)

 

 

(221

)

Compensation expense

 

 

3,314

 

 

 

1,643

 

 

 

2,008

 

Income tax reserves

 

 

(4,217

)

 

 

(1,146

)

 

 

(6,717

)

Nondeductible meals and entertainment

 

 

351

 

 

 

717

 

 

 

769

 

Foreign tax rate differences from federal statutory rate

 

 

(1,215

)

 

 

716

 

 

 

576

 

Change in tax rates

 

 

(579

)

 

 

606

 

 

 

258

 

Other

 

 

1,328

 

 

 

872

 

 

 

392

 

Total (benefit) provision

 

$

(10,392

)

 

$

15,283

 

 

$

(3,756

)

 

 

Significant components of the Company’s deferred tax assets and liabilities were as follows:

 

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Amortization

 

$

67,945

 

 

$

87,296

 

Net operating loss carryforwards

 

 

47,407

 

 

 

24,656

 

Inventory

 

 

35,763

 

 

 

24,069

 

General business and other credit carryforwards

 

 

26,542

 

 

 

23,168

 

Lease liability

 

 

28,356

 

 

 

17,636

 

Stock-based compensation

 

 

9,918

 

 

 

11,562

 

Original issue discount

 

 

3,735

 

 

 

1,840

 

Other

 

 

27,479

 

 

 

22,591

 

Gross deferred tax assets

 

 

247,145

 

 

 

212,818

 

Less valuation allowance

 

 

(130,434

)

 

 

(122,534

)

Net deferred tax assets

 

 

116,711

 

 

 

90,284

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Depreciation

 

 

(44,760

)

 

 

(37,045

)

Acquired intangibles

 

 

(27,544

)

 

 

(34,799

)

Right-of-use assets

 

 

(24,122

)

 

 

(14,891

)

Other

 

 

(5,176

)

 

 

(6,260

)

Total deferred tax liabilities

 

 

(101,602

)

 

 

(92,995

)

Net deferred tax assets (liabilities)

 

$

15,109

 

 

$

(2,711

)

 

The Company consolidates subsidiaries in foreign jurisdictions which use the local currency as their functional currency. Since income taxes for these subsidiaries are assessed in their local currency, deferred tax balances are translated into the Company’s reporting currency and adjusted for changes in the exchange rates over time through the cumulative translation account. Additionally, the Company established certain deferred taxes associated with the issuance of convertible debt in 2020 the benefit of which was recorded to equity. Accordingly, changes in the deferred tax balances associated with revaluations and convertible debt issuances are not reflected in income tax expense and create disparities between the changes in total deferred taxes for the year and deferred tax expense. In the year ended December 31, 2020, net decreases in deferred taxes of approximately $0.8 million and decreases in valuation allowances of approximately $1.3 million were recorded against equity and, therefore, not reflected in deferred tax expense.

The following table summarizes the activity related to the Company’s unrecognized tax benefits:

 

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Gross unrecognized tax benefits at January 1

 

$

20,328

 

 

$

19,545

 

 

$

25,356

 

Increases in tax positions for prior years

 

 

1,758

 

 

 

62

 

 

 

499

 

Decreases in tax positions for prior years

 

 

—

 

 

 

(112

)

 

 

(756

)

Increases in tax positions for current year relating to ongoing operations

 

 

2,159

 

 

 

2,073

 

 

 

1,913

 

Decreases in tax positions as a result of a lapse of statute of limitations

 

 

(5,929

)

 

 

(616

)

 

 

(6,446

)

Increases in tax positions for current year relating to acquisitions

 

 

—

 

 

 

—

 

 

 

169

 

Decreases in tax positions due to settlements with taxing authorities

 

 

—

 

 

 

(624

)

 

 

(1,190

)

Gross unrecognized tax benefits at December 31

 

$

18,316

 

 

$

20,328

 

 

$

19,545

 

At December 31, 2020, 2019, and 2018, $16.5 million, $18.7 million, and $18.1 million, respectively, of the Company’s total unrecognized tax benefits, if recognized, would impact the effective income tax rate.

In accordance with the disclosure requirements as described in ASC Topic 740, Income Taxes, the Company classified uncertain tax positions as non-current income tax liabilities unless expected to be paid in one year. The Company’s continuing practice is to recognize interest and/or penalties related to income tax matters in income tax expense. For the years ended December 31, 2020, 2019, and 2018, the Company recognized approximately $(0.1) million, $0.1 million, and $(0.5) million, respectively, in interest and penalties as income tax (benefit) expense in the Consolidated Statements of Operations. The Company had approximately $0.1 million for the payment of interest and penalties accrued at both December 31, 2020 and 2019 in the Consolidated Balance Sheets.

The Company believes it is reasonably possible that approximately $2.4 million of its remaining unrecognized tax positions, primarily attributable to withholding obligations and the valuation of intercompany transactions, may decrease by the end of 2021 as we reach settlements with taxing authorities or certain statute of limitations expire.

In November 2018, the Company completed a reorganization of its international intellectual property company structure. This international restructuring generated a step-up in local tax basis, which under ASC Topic 740-10-25-20 as amended by ASU 2016-16, required the Company to record deferred tax assets of $100.8 million. Due to uncertainties surrounding the realization of a portion of these deferred tax assets, a valuation allowance of approximately $96.7 million was recorded.

The Company is subject to routine compliance reviews on various tax matters around the world in the ordinary course of business. Currently, the only active audit is with the U.S. Internal Revenue Service for 2014 – 2016 tax years. California is subject to examination in all years due to prior year net operating losses and research and development credits. Other major state and foreign jurisdictions remain subject to examination from 2016 and 2013 forward, respectively.

The Company made the accounting policy election to treat taxes due on U.S. inclusions in taxable income related to Global Intangible Low-Taxed Income as a current period expense when incurred (the "period cost method").

The Company has approximately $13.2 million of undistributed earnings attributable to operations in its controlled foreign corporations as of December 31, 2020. Due to recent tax reform in the United States and favorable treaties between the United States and countries in which its controlled foreign corporations operate, the Company has the ability to repatriate earnings without incurring additional tax liabilities. Accordingly, the Company has not recorded a liability for taxes associated with any future distributions of these undistributed earnings.

At December 31, 2020, the Company had $2.0 million, $50.9 million and $0.1 million of federal, state and foreign net operating loss carryforwards, respectively. Federal net operating loss carryforwards begin to expire in 2026, state net operating loss carryforwards begin to expire in 2021, and foreign net operating losses carry forward indefinitely.

The Company also has federal and California research and development income tax credit carryforwards of $11.4 million and $35.7 million, respectively. The federal credits will begin to expire in 2038, while the California credits can be carried forward indefinitely.

Due to the “change of ownership” provision of the Tax Reform Act of 1986, utilization of the Company’s net operating loss and credit carryforwards may be subject to an annual limitation against taxable income in future periods. As a result of any future ownership changes, the annual limitation of loss and credit carryforwards may cause them to expire before ultimately becoming available to reduce future income tax liabilities.
XML 37 R19.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segment, Product, and Geographic Information
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Business Segment, Product and Geographic Information

 

11.    Business Segment, Product and Geographic Information

The Company operates in one segment based upon the Company’s organizational structure, the way in which the operations and investments are managed and evaluated by the chief operating decision maker (“CODM”) as well as the lack of availability of discrete financial information at a lower level. The Company’s CODM reviews net sales at the product line offering level, and manufacturing, operating income and expenses, and net income at the Company-wide level to allocate resources and assess the Company’s overall performance. The Company shares common, centralized support functions, including finance, human resources, legal, information technology, and corporate marketing, all of which report directly to the CODM. Accordingly, decision-making regarding the Company’s overall operating performance and allocation of Company resources is assessed on a consolidated basis. The Company has disclosed the net sales for each of its product line offerings to provide the reader of the financial statements transparency into the operations of the Company.

The Company reports under two distinct product lines; spinal hardware and surgical support. The Company’s spinal hardware product line offerings include implants and fixation products. The Company’s surgical support product offerings include IONM services, disposables and biologics, and our capital equipment, all of which are used to aid spinal surgery.

Net sales by product line was as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Spinal hardware

 

$

783,510

 

 

$

851,440

 

 

$

788,649

 

Surgical support

 

 

267,072

 

 

 

316,630

 

 

 

313,065

 

Total net sales

 

$

1,050,582

 

 

$

1,168,070

 

 

$

1,101,714

 

 

Net sales and property and equipment, net, by geographic area were as follows:

 

 

 

Net Sales

 

 

Property and Equipment, Net

 

 

 

Year Ended December 31,

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

 

2020

 

 

2019

 

United States

 

$

821,824

 

 

$

941,086

 

 

$

896,152

 

 

$

239,802

 

 

$

218,771

 

International (excludes Puerto Rico)

 

 

228,758

 

 

 

226,984

 

 

 

205,562

 

 

 

46,567

 

 

 

47,547

 

Total

 

$

1,050,582

 

 

$

1,168,070

 

 

$

1,101,714

 

 

$

286,369

 

 

$

266,318

 

 
XML 38 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Contingencies
 12 Months Ended
Dec. 31, 2020
Contingencies [Abstract]  
Contingencies

12.    Contingencies

The Company is subject to potential liabilities under government regulations and various claims and legal actions that are pending or may be asserted from time-to-time. These matters arise in the ordinary course and conduct of the Company’s business and include, for example, commercial, intellectual property, environmental, securities and employment matters. The Company intends to continue to defend itself vigorously in such matters and when warranted, take legal action against others. Furthermore, the Company regularly assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in its financial statements.

During the year ended December 31, 2018, the Company settled all outstanding matters with Madsen Medical, Inc. for $27.8 million. The Company no longer has any remaining liability related to this matter.

An estimated loss contingency is accrued in the Company’s financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.
XML 39 R21.htm IDEA: XBRL DOCUMENT v3.20.4
Subsequent Events
 12 Months Ended
Dec. 31, 2020
Subsequent Events [Abstract]  
Subsequent Events

13.    Subsequent Events

On February 24, 2021, the Company completed the acquisition of Simplify Medical Pty Limited, or Simplify Medical, a developer of cervical artificial disc technology for cervical total disc replacement procedures. Pursuant to the terms of the definitive agreement, the Company agreed to make an upfront payment of $150.0 million at closing, subject to customary purchase price adjustments, plus additional future payments contingent upon milestones related to regulatory approval and net sales from products incorporating the Simplify Medical cervical artificial disc technology. In connection with the closing, the Company funded the $150.0 million upfront payment using available cash and investments on hand. Upon achievement of the regulatory milestone, Simplify Medical will be entitled to a one-time payment of up to $45.9 million which could become due and payable at any time between 2021 and 2024. Additional milestone payments, which are contingent upon net sales from products incorporating the Simplify Medical cervical artificial disc technology, will become payable in calendar years 2023, 2024 and 2025.

XML 40 R22.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Description of Business

Description of Business

NuVasive, Inc. (the “Company” or “NuVasive”) was incorporated in Delaware on July 21, 1997, and began commercializing its products in 2001. Since its incorporation in 1997, the Company has grown from a small developer of specialty spinal implants into a global medical technology company delivering procedurally integrated solutions for spine surgery. Underlying the Company’s procedurally integrated solutions for spine surgery are technologies designed to enable better clinical, financial, and operational outcomes, including:

 

•

its surgical access instruments, including its Maxcess integrated split-blade retractor system, designed to enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery;

 

•

its neuromonitoring systems, which use proprietary software-driven nerve detection and avoidance technology, and its intraoperative neuromonitoring (“IONM”) services and support;

 

•

its Advanced Materials Science portfolio of specialized spinal implants, designed to advance spinal fusion by enhancing the osseointegration and biomechanical properties of implant materials, including porous titanium and porous polyetheretherketone;

 

•

its Reline fixation system, designed to facilitate the preservation and restoration of patient alignment, while addressing a vast array of spinal pathologies from an open or less-invasive approach across all spinal procedures; and

 

•

its Integrated Global Alignment platform, which is comprised of procedurally based technologies that help increase the predictability of achieving global alignment in spinal procedures, including its Bendini spinal rod bending system that assist with manual rod manipulation for spinal fixation.

The Company has also invested in enabling technologies, including the development of capital equipment designed to further improve clinical, financial, and operational outcomes of spine surgery. The Company’s capital equipment portfolio currently consists of Lessray and the Pulse platform. Lessray is an image enhancement platform designed to reduce radiation exposure in the operating room by allowing surgeons to take low-quality, low-dose images and improve them to look like conventional full-dose images. Pulse integrates multiple enabling technologies within a single, expandable platform and is engineered to improve workflow, reduce variability, and increase the reproducibility of surgical outcomes. The Pulse platform’s modular architecture is designed to incorporate applications for neuromonitoring, surgical planning, patient-specific rod bending, smart imaging, navigation, and integration with robotics and other smart tools in the future. Selling and leasing of capital equipment do not make up a material portion of the Company’s total net sales.

In addition to the Company’s procedurally integrated solutions for spine surgery, it also designs and sells expandable growing rod implant systems that can be non-invasively lengthened following implantation with precise, incremental adjustments via an external remote controller using magnetic technology called MAGnetic External Control (“MAGEC”), which allows for the minimally invasive treatment of early-onset and adolescent scoliosis. This technology is also the basis for the Company’s Precice limb lengthening system, which allows for the correction of long bone limb length discrepancy, as well as other products for treating specialized orthopedic procedures.

In December 2019, a novel strain of coronavirus, which causes COVID-19, was identified. Due to the rapid and global spread of the virus, on March 11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic. To slow the proliferation of COVID-19, governments have implemented extraordinary measures, which include the mandatory closure of businesses, restrictions on travel and gatherings, and quarantine and physical distancing requirements. In addition, many government agencies in conjunction with hospitals and healthcare systems have, to varying degrees, deferred or suspended elective surgical procedures. While certain spine surgeries are deemed essential and certain surgeries, like in cases of trauma, cannot be delayed, the Company has seen and may continue to see a significant reduction in procedural volumes as hospital systems and/or patients elect to defer spine surgery procedures. As a result of these measures, the Company has experienced reductions in procedural volumes during 2020 and anticipates this trend may continue. The cumulative effect of these disruptions had a significant impact on the Company’s business in 2020 and it is not possible to accurately predict the length or severity of the COVID-19 pandemic or the timing for a broad and sustained resumption of elective surgical procedures.
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

The accompanying Consolidated Financial Statements include the accounts of the Company and its majority-owned or controlled subsidiaries, collectively referred to as either NuVasive or the Company. The Company translates the financial statements of its foreign subsidiaries using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. When there is a portion of equity in an acquired subsidiary not attributable, directly or indirectly, to the respective parent entity, the Company records the fair value of the non-controlling interest at the acquisition date and classifies the amounts attributable to non-controlling interest separately in equity in the Company's Consolidated Financial Statements. Any subsequent changes in a parent's ownership interest while the parent retains its controlling financial interest in its subsidiary are accounted for as equity transactions. All significant intercompany balances and transactions have been eliminated in consolidation.

The Company has replaced the caption “Revenue” with “Net sales,” and the caption “Sales, marketing and administrative” with “Selling, general and administrative,” within the Consolidated Statements of Operations and corresponding changes have been made throughout this Annual Report to conform to this presentation. These updated captions have no impact on previously reported results of operations or financial position.
Use of Estimates

Use of Estimates

To prepare financial statements in conformity with generally accepted accounting principles (“GAAP”) accepted in the United States, management must make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.
Recently Accounting Pronouncements Not Yet Adopted And Recently Adopted Accounting Standards

Recent Accounting Pronouncements Not Yet Adopted

In January 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2020-01, Investments—Equity Securities (Topic 321), Investments—Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)—Clarifying the Interactions between Topic 321, Topic 323, and Topic 815 (a consensus of the Emerging Issues Task Force), which clarifies the interaction of the accounting for equity securities, investments accounted for under the equity method, and certain forward contracts and purchased options. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-01 on January 1, 2021, and does not expect a material impact to its Consolidated Financial Statements.

In August 2020, the FASB issued ASU No. 2020-06, Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40) (“ASU 2020-06”), which simplifies the accounting for convertible instruments. The guidance removes certain accounting models that separate the embedded conversion features from the host contract for convertible instruments. ASU 2020-06 allows for a modified or full retrospective method of transition. This update is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, and early adoption is permitted. The Company will adopt ASU 2020-06 on January 1, 2021, and will elect the modified transition method that allows for a cumulative-effect adjustment in the period of adoption and will not restate prior periods. As a result of the adoption, the Company will increase its convertible debt liabilities and retained earnings on January 1, 2021 by $115.4 million and $64.5 million, respectively, and decrease its deferred tax liabilities and additional paid-in capital by approximately $28.0 million and $151.9 million, respectively.

Recently Adopted Accounting Standards 

In June 2016, the FASB issued Accounting Standards Update No. 2016-13, Financial Instruments – Credit Losses (“ASU 2016-13”), which changes the accounting for recognizing impairments of financial assets. Under the new guidance, credit losses for certain types of financial instruments will be estimated based on expected losses. The new guidance also modifies the impairment models for available-for-sale debt securities and for purchased financial assets with credit deterioration since their origination. The amendments in this update were adopted using a modified retrospective transition method as of January 1, 2020, which had no cumulative impact to retained earnings. The adoption of this guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued Accounting Standards Update No. 2017-04, Intangibles – Goodwill and Other, which eliminates the requirement to calculate the implied fair value of goodwill to measure a goodwill impairment charge. Instead, entities will record an impairment charge based on the excess of a reporting unit’s carrying amount over its fair value. The Company adopted the amendments in this update on January 1, 2020, which will be applied using a prospective transition method. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued Accounting Standards Update No. 2018-13, Fair Value Measurement: Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (“ASU 2018-13”), which adds and modifies certain disclosure requirements for fair value measurements. Under the new guidance, entities will no longer be required to disclose the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, or valuation processes for Level 3 fair value measurements. However, public companies will be required to disclose the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and related changes in unrealized gains and losses included in other comprehensive income. The Company adopted ASU 2018-13 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements. See Note 4 to the Consolidated Financial Statements for further discussion on fair value measurements.

In September 2018, the FASB issued Accounting Standards Update No. 2018-15, Intangible – Goodwill and Other – Internal-Use Software (“ASU 2018-15”), which requires a customer in a cloud computing arrangement to determine whether implementation costs should be capitalized as assets or expensed as incurred. Under the new guidance, capitalized implementation costs related to a hosting arrangement that is a service contract will be amortized over the term of the hosting arrangement, beginning when the module or component of the hosting arrangement is ready for its intended use. The amendments in this update will be applied using a prospective transition method to each period presented. The Company adopted ASU 2018-15 as of January 1, 2020. The adoption did not have a material impact on the Company’s Consolidated Financial Statements.

In December 2019, the FASB issued Accounting Standards Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (“ASU 2019-12”), which modifies Accounting Standard Codification 740 – Income Taxes (“ASC 740”). ASU 2019-12 enhances and simplifies various aspects of the income tax accounting guidance in ASC 740. This update is effective for fiscal years beginning after December 15, 2020, and interim periods within those fiscal years, and early adoption is permitted. The Company elected to early adopt ASU 2019-12 in the quarter ended June 30, 2020. The Company applied the updated guidance for year-to-date losses in the Company’s interim period tax accounting on a prospective basis. The early adoption had no impact on the expected full year tax expense for 2020, but rather accelerated certain tax benefits to earlier quarters in 2020 that would otherwise have been limited under ASC 740.

In March 2020, the FASB issued Accounting Standards Update No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting (“ASU 2020-04”), which provides temporary optional expedients and exceptions to the guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates. This update is effective upon issuance. The relief is temporary and generally cannot be applied to contract modifications that occur after December 31, 2022 or hedging relationships entered into or evaluated after that date. The adoption of ASU 2020-04 did not have a material impact on the Company’s Consolidated Financial Statements.

Revenue Recognition

Revenue Recognition

In accordance with Accounting Standards Codification 606 Revenue from Contracts with Customers (“ASC 606”), the Company recognizes revenue upon the transfer of goods or services to a customer at an amount that reflects the expected consideration to be received in exchange for those goods or services. The principles in ASC 606 are applied using the following five steps: (i) identify the contract with a customer; (ii) identify the performance obligation(s) in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligation(s) in the contract; and (v) recognize revenue when (or as) the Company satisfies its performance obligation(s). Specifically, revenue from the sale of implants, fixation products and disposables is generally recognized at an amount that reflects the expected consideration upon notice that the Company’s products have been used in a surgical procedure or upon shipment to a third-party customer assuming control of the products. Revenue from IONM services is recognized in the period the service is performed for the amount of consideration expected to be received. Revenue from the sale of surgical instrument sets is generally recognized upon receipt of a purchase order and the subsequent shipment to a customer who assumes control. In certain cases, the Company does offer the ability for customers to lease surgical instrumentation primarily on a non-sales type basis. Revenue from the sale or lease of capital equipment is recognized when the Company transfers control to the customer, which is generally at the point when acceptance occurs that indicates customer acknowledgment of delivery or installation, depending on the terms of the arrangement. Selling and leasing of surgical instrument sets and capital equipment represents an immaterial amount of the Company’s total net sales in all periods presented. Revenue associated with products holding rights of return or trade-in are recognized when the Company concludes there is not a risk of significant revenue reversal in future periods for the expected consideration in the transaction. Costs incurred by the Company associated with sales contracts with customers are deferred over the performance obligation period and recognized in the same period as the related revenue, with the exception of contracts that complete within one year or less, in which case the associated costs are expensed as incurred.
Accounts Receivable and Related Valuation Accounts

Accounts Receivable and Related Valuation Accounts

Accounts receivable in the accompanying Consolidated Balance Sheets are presented net of allowances for credit losses. The Company maintains an allowance for credit losses resulting from the inability of its customers, including hospitals, ambulatory surgery centers, and distributors, to make required payments. The allowance for credit losses is calculated quarterly, and is estimated on a region-by-region basis considering a number of factors including age of account balances, collection history, historical account write-offs, third party credit reports, identified trends, current economic conditions, and supportable forecasted economic expectations. The allowance is adjusted on a specific identification basis for certain accounts as well as pooling of accounts with similar characteristics. An increase in the provision for credit losses may be required when the financial condition of the Company’s customers or its collection experience deteriorates. An increase to the allowance for credit losses results in a corresponding charge to selling, general and administrative expenses. The Company has a diverse customer base and no single customer represented greater than ten percent of net sales or accounts receivable. Historically, the Company’s reserves have been adequate to cover credit losses.

The Company's exposure to credit losses may increase if its customers are adversely affected by changes in healthcare laws, coverage and reimbursement, economic pressures or uncertainty associated with local or global economic recessions, disruption associated with the current COVID-19 pandemic, or other customer-specific factors. It is possible that there could be a material adverse impact from potential adjustments of the carrying amount of trade receivables as customers’ cash flows are impacted by their response to the COVID-19 pandemic and the deferral of elective surgical procedures.

The following table summarizes the changes in the allowance for credit losses:

 

(in thousands)

 

December 31, 2020

 

Allowance for credit losses at January 1, 2020

 

$

9,423

 

Current-period provision for expected losses

 

 

1,079

 

Write-offs charged against the allowance

 

 

(1,305

)

Recoveries of amounts previously written off

 

 

220

 

Changes resulting from foreign currency fluctuations

 

 

229

 

Allowance for credit losses at end of period

 

$

9,646

 

In addition, the Company establishes a liability for estimated sales returns and a reserve for price adjustments that are recorded as a reduction to net sales. The liability and reserve are maintained to account for the future product returns and price adjustments of products sold in the current period.

Concentration of Credit Risk and Significant Customers

Concentration of Credit Risk and Significant Customers

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and cash equivalents, marketable securities and accounts receivable. The Company limits its exposure to credit loss by placing its cash and investments with high credit quality financial institutions. Additionally, the Company has established guidelines regarding diversification of its investments and their maturities, which are designed to maintain principal and maximize liquidity. The Company has a diverse customer base and no single customer represented greater than ten percent of sales or accounts receivable for any of the periods presented.

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company’s financial instruments consist principally of cash and cash equivalents, marketable securities, restricted investments, derivatives, contingent consideration liabilities, accounts receivable, accounts payable, accrued expenses, and Senior Convertible Notes.

The Company measures certain assets and liabilities in accordance with authoritative guidance which requires fair value measurements to be classified and disclosed in one of the following three categories:

Level 1: Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.

Level 2: Observable prices that are based on inputs not quoted on active markets, but corroborated by market data.

Level 3: Unobservable inputs are used when little or no market data is available.

Assets and liabilities are classified based on the lowest level of input that is significant to the fair value measurements. The Company reviews the fair value hierarchy classification on a quarterly basis. Changes in the ability to observe valuation inputs may result in a reclassification of levels for certain assets or liabilities within the fair value hierarchy. The Company did not have any transfers of assets and liabilities between the levels of the fair value measurement hierarchy during the years presented.
Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments that are readily convertible into cash and have an original maturity of three months or less at the time of purchase to be cash equivalents.
Inventory, net

Inventory, net

Net inventory as of December 31, 2020 consisted of $285.4 million of finished goods, $7.3 million of work in progress and $7.9 million of raw materials. Net inventory as of December 31, 2019 consisted of $298.7 million of finished goods, $6.4 million of work in progress and $7.3 million of raw materials.

Finished goods primarily consists of specialized implants, fixation products and disposables and are stated at the lower of cost or net realizable value determined by utilizing a standard cost method, which includes capitalized variances, which approximates the weighted average cost. Work in progress and raw materials represent the underlying material, and labor for work in progress, that ultimately yield finished goods upon completion and are subject to lower of cost or net realizable value. The Company reviews the components of its inventory on a periodic basis for excess and obsolescence and adjusts inventory to its net realizable value as necessary.

The Company records an inventory reserve for estimated excess and obsolete inventory based upon historical turnover and assumptions about future demand for its products and market conditions, such as product life cycles and timing of the introduction and development of new or enhanced products. The Company’s allograft products have shelf lives ranging from two to five years and are subject to demand fluctuations based on the availability and demand for alternative products. The Company’s inventory, which consists primarily of disposables, specialized implants and fixation products, is at risk of obsolescence following the introduction and development of new or enhanced products. One of the Company’s strategic objectives is to continue to rapidly develop and commercialize new products and product enhancements which increases the risk that products will become obsolete prior to the end of their anticipated useful life. The Company’s estimates and assumptions for excess and obsolete inventory are reviewed and updated on a quarterly basis. The estimates the Company uses for demand are also used for near-term capacity planning and inventory purchasing and are consistent with its revenue forecasts. Increases in the reserve for excess and obsolete inventory result in a corresponding charge to cost of sales.

For the year ended December 31, 2020 and 2019, the Company recorded a reserve for excess and obsolete inventory of $48.9 million and $14.0 million, respectively. The increase is primarily attributable to updates to the Company’s estimates and assumptions about future product demand and product life cycles which have been affected by multiple factors, including the COVID-19 pandemic and general market conditions.
Goodwill and Intangible Assets

Goodwill and Intangible Assets

The Company’s goodwill represents the excess of the cost over the fair value of net assets acquired from its business combinations. The determination of the value of goodwill and intangible assets arising from business combinations and asset acquisitions requires extensive use of accounting estimates and judgments to allocate the purchase price to the fair value of the net tangible and intangible assets acquired, including capitalized in-process research and development (IPR&D). Intangible assets acquired in a business combination that are used for in-process research and development activities are considered indefinite lived until the completion or abandonment of the associated research and development efforts. Upon reaching the end of the relevant research and development project, the Company will amortize the acquired IPR&D over its estimated useful life or expense the acquired in-process research and development should the research and development project be unsuccessful with no future alternative use.

Goodwill and IPR&D are not amortized; however, they are assessed for impairment using fair value measurement techniques on an annual basis or more frequently if facts and circumstance warrant such a review. The goodwill or IPR&D are considered to be impaired if the Company determines that the carrying value of the reporting unit or IPR&D exceeds its respective fair value.

The Company performs its goodwill impairment analysis at the reporting unit level, which aligns with the Company’s reporting structure and availability of discrete financial information. The Company performs its annual impairment analysis by either comparing a reporting unit’s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit’s fair value from the last quantitative assessment to determine if there is potential impairment. The Company may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit’s estimated fair value was significantly in excess of the carrying value of its net assets and it does not believe there have been significant changes in the reporting unit’s operations that would significantly decrease its estimated fair value or significantly increase its net assets. If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections and/or use of a market approach by looking at market values of comparable companies. Key assumptions for these projections include net sales growth, future gross and operating margin growth, and its weighted cost of capital and terminal growth rates. The net sales and margin growth is based on increased sales of new and existing products as the Company maintains investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including timing and probability of regulatory approvals for Company products to be commercialized. The Company’s market capitalization is also considered as a part of its analysis.

The Company’s annual evaluation for impairment of goodwill consists of one reporting unit. In accordance with the Company’s policy, the Company completed its most recent annual evaluation for impairment as of October 1, 2020 using the qualitative assessment and determined that no impairment existed. In addition, no indicators of impairments were noted through December 31, 2020 and consequently, no impairment charge has been recorded during the year.

Intangible assets with a finite life, such as acquired technology, customer relationships, manufacturing know-how, licensed technology, supply agreements and certain trade names and trademarks, are amortized on a straight-line basis over their estimated useful life, ranging from 2 to 17 years. In determining the useful lives of intangible assets, the Company considers the expected use of the assets and the effects of obsolescence, demand, competition, anticipated technological advances, changes in surgical techniques, market influences and other economic factors. For technology based intangible assets, the Company considers the expected life cycles of products which incorporate the corresponding technology. Trademarks and trade names that are related to products are assigned lives consistent with the period in which the products bearing each brand are expected to be sold.

The Company evaluates its intangible assets with finite lives for indications of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors that could trigger an impairment review include significant under-performance relative to expected historical or projected future operating results, significant changes in the manner of the Company’s use of the acquired assets or the strategy for the Company’s overall business or significant negative industry or economic trends. If this evaluation indicates that the value of the intangible asset may be impaired, the Company makes an assessment of the recoverability of the net carrying value of the asset over its remaining useful life. If this assessment indicates that the intangible asset is not recoverable, based on the estimated undiscounted future cash flows of the technology over the remaining amortization period, the Company reduces the net carrying value of the related intangible asset to fair value and may adjust the remaining amortization period.

See Note 2 to the Consolidated Financial Statements included in this Annual Report for further disclosure on goodwill and intangible assets.
Property and Equipment

Property and Equipment

Property and equipment are carried at cost less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from 2 to 20 years. The Company depreciates leasehold improvements over their estimated useful lives or the term of the applicable lease, whichever is shorter. Leased property meeting certain financing lease criteria is capitalized under property and equipment, and the net present value of the related lease payments is recorded as a liability. Amortization of assets under financing leases is recorded using the straight-line method over the shorter of the estimated useful lives or the lease terms. Maintenance and repairs are expensed as incurred.

The Company reviews property, plant and equipment for impairment whenever events or changes in circumstances indicate that the carrying value of an asset may not be recoverable. An impairment loss would be recognized when estimated future undiscounted cash flows relating to the asset are less than its carrying amount. An impairment loss is measured as the amount by which the carrying amount of an asset exceeds its fair value.

Income Taxes

Income Taxes

The asset and liability approach is used to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Tax law and rate changes are reflected in income in the period such changes are enacted. The Company includes interest and penalties related to income taxes, including unrecognized tax benefits, within income tax expense.

The Company’s income tax returns are based on calculations and assumptions that are subject to examination by the Internal Revenue Service and other tax authorities. In addition, the calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax regulations. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While the Company believes it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcomes of examinations by tax authorities in determining the adequacy of its provision for income taxes. The Company continually assesses the likelihood and amount of potential revisions and adjusts the income tax provision, income taxes payable and deferred taxes in the period in which the facts that give rise to a revision become known.

Significant judgment is required in determining the Company’s provision for income taxes, deferred tax assets and liabilities and the valuation allowance recorded against net deferred tax assets. Deferred tax assets and liabilities are determined using the enacted tax rates in effect for the years in which those tax assets are expected to be realized. A valuation allowance is established when it is more likely than not the future realization of all or some of the deferred tax assets will not be achieved. The evaluation of the need for a valuation allowance is performed on a jurisdiction-by-jurisdiction basis, and includes a review of all available positive and negative evidence. Factors reviewed include projections of pre-tax book income for the foreseeable future, determination of cumulative pre-tax book income after permanent differences, earnings history, and reliability of forecasting.

Based on the Company’s review, it concluded that it was more likely than not that it would be able to realize the future benefits of its domestic and foreign deferred tax assets, with the exceptions of California, Malta, Mexico, Brazil and Colombia. This conclusion was based on historical and projected operating performance, as well as the Company’s expectation that its operations will generate sufficient taxable income in future periods to realize the tax benefits associated with the deferred tax assets well within the statutory carryover periods. Due to low state apportionment, large net operating losses and the generation of sizeable research credits in California, the Company concluded that it is not more likely than not that it will be able to utilize its California deferred tax assets. Therefore, the Company has maintained a full valuation allowance on its California deferred tax assets as of December 31, 2020. Due to a history of losses in Malta, Brazil, Mexico and Colombia, and the lack of alternative sources of future taxable income, the Company has established a full valuation allowance against these entities’ deferred tax assets as of December 31, 2020.

The Company will continue to assess the need for a valuation allowance on its deferred tax assets by evaluating both positive and negative evidence that may exist. Any adjustment to the net deferred tax asset valuation allowance would be recorded in the statement of operations for the period that the adjustment is determined to be required.

See Note 10 to the Consolidated Financial Statements included in this Annual Report for further discussion on income taxes.
Loss Contingencies

Loss Contingencies

An estimated loss contingency is accrued and disclosed in the Company’s financial statements if it is probable or disclosed if it is reasonably possible that a liability has been incurred and the amount of the loss can be reasonably estimated. Based on the Company’s assessment, it has adequately accrued an amount for contingent liabilities currently in existence. The Company does not accrue amounts for liabilities that it does not believe are probable and only discloses those matters it considers material to its overall financial position. In most cases, significant judgment is required to estimate the amount and timing of a loss to be recorded.

The Company is involved in a number of legal actions arising in the normal course of business. The outcomes of these legal actions are not within the Company’s complete control and may not be known for prolonged periods of time. In some actions, the claimants seek damages as well as other relief, including injunctions barring the sale of products that are the subject of the lawsuit, that could require significant expenditures or result in lost net sales. Litigation is inherently unpredictable, and unfavorable resolutions could occur. As a result, assessing contingencies is highly subjective and requires judgment about future events. The amount of ultimate loss may exceed the Company’s current accruals, and it is possible that its cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies.

See Note 12 to the Consolidated Financial Statements included in this Annual Report for further discussion on legal proceedings and investigations.
Comprehensive Income

Comprehensive Income

Comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. Comprehensive income includes net of tax, unrealized gains or losses on the Company’s marketable debt securities and foreign currency translation adjustments. The cumulative translation adjustments included in accumulated other comprehensive loss were $7.6 million, $9.4 million, and $8.6 million at December 31, 2020, 2019, and 2018, respectively.
Research and Development

Research and Development

Research and development costs are expensed as incurred. To the extent the Company purchases research and development assets with a future alternative use the Company will capitalize and amortize the assets over its useful life.

Product Shipment Costs

Product Shipment Costs

Product shipment costs, included in selling, general and administrative expense in the accompanying Consolidated Statements of Operations, were $27.4 million, $27.7 million, and $25.4 million for the years ended December 31, 2020, 2019, and 2018, respectively. The majority of the Company’s shipping costs are associated with providing instrument sets to hospitals for use in individual surgical procedures. Amounts billed to customers for shipping and handling of products are reflected in net sales and are not material for any period presented.
Business Transition Costs

Business Transition Costs

The Company incurs certain costs related to acquisition, integration and business transition activities, which include severance, relocation, consulting, leasehold exit costs, third-party merger and acquisition costs, contingent consideration fair value adjustments and other costs directly associated with such activities. Contingent consideration is accrued based on the fair value of the expected payment, and such accruals are subject to increase or decrease based on the assessment of the likelihood that the contingent milestones will be achieved resulting in payment. If an accrual for contingent consideration decreases during a particular period, it results in a reduction of costs during such period.

During the year ended December 31, 2020, the Company recorded $10.9 million of costs related to acquisition, integration and business transition activities, which included $2.3 million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2019, the Company recorded a reduction of costs of $(2.0) million related to acquisition, integration and business transition activities, which included $(6.3) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.

During the year ended December 31, 2018, the Company recorded $11.5 million of costs related to acquisition, integration and business transition activities, which included $(1.5) million of fair value adjustments on contingent consideration liabilities associated with the Company’s 2018, 2017 and 2016 acquisitions.
Stock-based Compensation

Stock-based Compensation

Stock-based compensation expense for equity-classified awards, principally related to restricted stock units (“RSUs”) and performance restricted stock units (“PRSUs”), is measured at the grant date based on the estimated fair value of the award. The fair value of equity instruments that are expected to vest is recognized and amortized over the requisite service period. The Company has granted awards with up to five year graded or cliff vesting terms (in each case, with service through the date of vesting being required). No exercise price or other monetary payment is required for receipt of the shares issued in settlement of the respective award; instead, consideration is furnished in the form of the participant’s service to the Company.

The fair value of RSUs including PRSUs with pre-defined performance criteria is based on the stock price on the date of grant whereas the expense for PRSUs with pre-defined performance criteria is adjusted with the probability of achievement of such performance criteria at each period end. The fair value of the PRSUs that are earned based on the achievement of pre-defined market conditions for total shareholder return is estimated on the date of grant using a Monte Carlo valuation model. The key assumptions in applying this model are an expected volatility and a risk-free interest rate.

Stock-based compensation expense is adjusted from the grant date to exclude expense for awards that are expected to be forfeited. The forfeiture estimate is adjusted as necessary through the vesting date so that full compensation cost is recognized only for awards that vest. The Company assesses the reasonableness of the estimated forfeiture rate at least annually, with any change to be made on a cumulative basis in the period the estimated forfeiture rates change. The Company considered its historical experience of pre-vesting forfeitures on awards by each homogenous group of employees as the basis to arrive at its estimated annual pre-vesting forfeiture rates.

The Company estimates the fair value of stock options issued under its equity incentive plans and shares issued to employees under its employee stock purchase plan (“ESPP”) using a Black-Scholes option-pricing model on the date of grant. The Black-Scholes option-pricing model incorporates various assumptions including expected volatility, expected term and risk-free interest rates. The expected volatility is based on the historical volatility of the Company’s common stock over the most recent period commensurate with the estimated expected term of the Company’s stock options and ESPP offering period which is derived from historical experience. The risk-free interest rate for periods within the contractual life of the option is based on the U.S. Treasury yield in effect at the time of grant. The Company has never declared or paid dividends and has no plans to do so in the foreseeable future.

See Note 9 to the Consolidated Financial Statements included in this Annual Report for further discussion on stock-based compensation.
Net Income Per Share

Net (Loss) Income Per Share

The Company computes basic net income per share using the weighted-average number of common shares outstanding during the period. Diluted net income per share assumes the conversion, exercise or issuance of all potential common stock equivalents, unless the effect of inclusion would be anti-dilutive. For purposes of this calculation, common stock equivalents include the Company’s stock options, unvested RSUs, PRSUs (including those with performance and market conditions), warrants, and the shares to be issued upon the conversion of the Senior Convertible Notes. The contingently issuable shares are included in basic net income per share as of the date that all necessary conditions have been satisfied and are included in the denominator for dilutive calculation for the entire period if such shares would be issuable as of the end of the reporting period assuming the end of the reporting period was the end of the contingency period.

The following table sets forth the computation of basic and diluted consolidated net (loss) income per share:  

 

 

 

Year Ended December 31,

 

(in thousands, except per share data)

 

2020

 

 

2019

 

 

2018

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(37,153

)

 

$

65,234

 

 

$

12,479

 

Denominator for basic and diluted net (loss) income per

   share:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding for

   basic

 

 

51,416

 

 

 

51,956

 

 

 

51,382

 

Dilutive potential common stock outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and ESPP

 

 

—

 

 

 

15

 

 

 

36

 

RSUs and PRSUs

 

 

—

 

 

 

658

 

 

 

760

 

Senior Convertible Notes

 

 

—

 

 

 

531

 

 

 

177

 

Weighted average common shares outstanding for

   diluted

 

 

51,416

 

 

 

53,160

 

 

 

52,355

 

Basic net (loss) income per share

 

$

(0.72

)

 

$

1.26

 

 

$

0.24

 

Diluted net (loss) income per share

 

$

(0.72

)

 

$

1.23

 

 

$

0.24

 

The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Stock options, ESPP, RSUs and PRSUs

 

 

1,095

 

 

 

115

 

 

 

162

 

Warrants

 

 

21,034

 

 

 

10,865

 

 

 

10,865

 

Senior Convertible Notes

 

 

21,034

 

 

 

5,433

 

 

 

5,433

 

Total

 

 

43,163

 

 

 

16,413

 

 

 

16,460

 

 

 

 
XML 41 R23.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Summary of Changes in Allowance for Credit Losses

The following table summarizes the changes in the allowance for credit losses:

 

(in thousands)

 

December 31, 2020

 

Allowance for credit losses at January 1, 2020

 

$

9,423

 

Current-period provision for expected losses

 

 

1,079

 

Write-offs charged against the allowance

 

 

(1,305

)

Recoveries of amounts previously written off

 

 

220

 

Changes resulting from foreign currency fluctuations

 

 

229

 

Allowance for credit losses at end of period

 

$

9,646

 
Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted consolidated net (loss) income per share:  

 

 

 

Year Ended December 31,

 

(in thousands, except per share data)

 

2020

 

 

2019

 

 

2018

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net (loss) income

 

$

(37,153

)

 

$

65,234

 

 

$

12,479

 

Denominator for basic and diluted net (loss) income per

   share:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding for

   basic

 

 

51,416

 

 

 

51,956

 

 

 

51,382

 

Dilutive potential common stock outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

Stock options and ESPP

 

 

—

 

 

 

15

 

 

 

36

 

RSUs and PRSUs

 

 

—

 

 

 

658

 

 

 

760

 

Senior Convertible Notes

 

 

—

 

 

 

531

 

 

 

177

 

Weighted average common shares outstanding for

   diluted

 

 

51,416

 

 

 

53,160

 

 

 

52,355

 

Basic net (loss) income per share

 

$

(0.72

)

 

$

1.26

 

 

$

0.24

 

Diluted net (loss) income per share

 

$

(0.72

)

 

$

1.23

 

 

$

0.24

 

The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Stock options, ESPP, RSUs and PRSUs

 

 

1,095

 

 

 

115

 

 

 

162

 

Warrants

 

 

21,034

 

 

 

10,865

 

 

 

10,865

 

Senior Convertible Notes

 

 

21,034

 

 

 

5,433

 

 

 

5,433

 

Total

 

 

43,163

 

 

 

16,413

 

 

 

16,460

 

 

 

 
Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share

The following weighted outstanding common stock equivalents were not included in the calculation of net (loss) income per diluted share because their effects were anti-dilutive:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Stock options, ESPP, RSUs and PRSUs

 

 

1,095

 

 

 

115

 

 

 

162

 

Warrants

 

 

21,034

 

 

 

10,865

 

 

 

10,865

 

Senior Convertible Notes

 

 

21,034

 

 

 

5,433

 

 

 

5,433

 

Total

 

 

43,163

 

 

 

16,413

 

 

 

16,460

 

 
XML 42 R24.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details (Tables)
 12 Months Ended
Dec. 31, 2020
Balance Sheet Details [Abstract]  
Property and Equipment Net

Property and Equipment, net

Property and equipment, net, consisted of the following:

 

 

 

 

December 31,

 

(in thousands, except years)

Useful Life

 

2020

 

 

2019

 

Instrument sets

4

 

$

424,696

 

 

$

381,310

 

Machinery and equipment

5 to 7

 

 

71,616

 

 

 

66,482

 

Computer equipment and software

3 to 7

 

 

173,364

 

 

 

149,134

 

Leasehold improvements

2 to 15

 

 

35,372

 

 

 

29,542

 

Furniture and fixtures

3 to 7

 

 

9,916

 

 

 

8,931

 

Building and improvements

10 to 20

 

 

23,207

 

 

 

22,921

 

Land

—

 

 

1,277

 

 

 

1,277

 

 

 

 

 

739,448

 

 

 

659,597

 

Less: accumulated depreciation and amortization

 

 

 

(453,079

)

 

 

(393,279

)

 

 

 

$

286,369

 

 

$

266,318

 

 
Goodwill and Intangible Assets

Goodwill and Intangible Assets

Goodwill and intangible assets as of December 31, 2020 consisted of the following:

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Gross

 

 

Accumulated

 

 

Intangible

 

(in thousands, except years)

 

(in years)

 

Amount

 

 

Amortization

 

 

Assets, net

 

Intangible assets subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

8

 

$

271,748

 

 

$

(195,283

)

 

$

76,465

 

Manufacturing know-how and trade secrets

 

13

 

 

30,882

 

 

 

(22,720

)

 

 

8,162

 

Trade name and trademarks

 

9

 

 

25,500

 

 

 

(19,945

)

 

 

5,555

 

Customer relationships

 

9

 

 

156,436

 

 

 

(94,354

)

 

 

62,082

 

Total intangible assets subject to amortization

 

8

 

$

484,566

 

 

$

(332,302

)

 

$

152,264

 

Intangible assets not subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

 

 

 

 

 

 

 

 

 

 

559,553

 

Total goodwill and intangible assets, net

 

 

 

 

 

 

 

 

 

 

 

$

711,817

 

Goodwill and intangible assets as of December 31, 2019 consisted of the following:

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Amortization

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Period

 

Gross

 

 

Accumulated

 

 

Intangible

 

(in thousands, except years)

 

(in years)

 

Amount

 

 

Amortization

 

 

Assets, net

 

Intangible assets subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed technology

 

8

 

$

271,748

 

 

$

(163,459

)

 

$

108,289

 

Manufacturing know-how and trade secrets

 

13

 

 

30,798

 

 

 

(20,333

)

 

 

10,465

 

Trade name and trademarks

 

9

 

 

25,500

 

 

 

(16,947

)

 

 

8,553

 

Customer relationships

 

9

 

 

150,744

 

 

 

(76,959

)

 

 

73,785

 

Total intangible assets subject to amortization

 

9

 

$

478,790

 

 

$

(277,698

)

 

$

201,092

 

Intangible assets not subject to amortization:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

 

 

 

 

 

 

 

 

 

 

561,064

 

Total goodwill and intangible assets, net

 

 

 

 

 

 

 

 

 

 

 

$

762,156

 

 
Changes to Goodwill

The changes to goodwill are comprised of the following:

(in thousands)

 

 

 

Gross goodwill

$

569,364

 

Accumulated impairment loss

 

(8,300

)

December 31, 2019

 

561,064

 

 

 

 

 

Changes to gross goodwill:

 

 

 

Changes resulting from foreign currency fluctuations

 

(1,511

)

 

 

(1,511

)

 

 

 

 

Gross goodwill

 

567,853

 

Accumulated impairment loss

 

(8,300

)

December 31, 2020

$

559,553

 
Future Amortization Expense Related to Intangible Assets

Total future amortization expense related to intangible assets subject to amortization at December 31, 2020 is set forth in the table below:

 

 

 

 

 

 

 

(in thousands)

 

 

 

 

 

 

2021

 

 

 

$

51,876

 

2022

 

 

 

 

43,843

 

2023

 

 

 

 

18,697

 

2024

 

 

 

 

12,506

 

2025

 

 

 

 

11,705

 

Thereafter through 2031

 

 

 

 

13,637

 

Total future amortization expense

 

 

 

$

152,264

 

 

 
Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

 

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

Accrued expenses

 

$

59,249

 

 

$

58,897

 

Accounts payable

 

 

17,386

 

 

 

11,827

 

Distributor commissions payable

 

 

9,891

 

 

 

7,983

 

Other taxes payable

 

 

6,425

 

 

 

6,501

 

Litigation liability

 

 

5,346

 

 

 

1,370

 

Debt interest payable

 

 

5,203

 

 

 

4,266

 

Royalties payable

 

 

4,495

 

 

 

4,994

 

Other

 

 

2,406

 

 

 

1,322

 

Accounts payable and accrued liabilities

 

$

110,401

 

 

$

97,160

 

 
XML 43 R25.htm IDEA: XBRL DOCUMENT v3.20.4
Marketable Securities (Tables)
 12 Months Ended
Dec. 31, 2020
Investments Debt And Equity Securities [Abstract]  
Schedule of Carrying Value and Amortized Cost of the Company's Marketable Debt Securities

As of December 31, 2020, the Company’s outstanding marketable debt securities all have contractual maturities due within one year. The carrying value and amortized cost of the Company’s marketable debt securities, summarized by major security type, consisted of the following:

 

(in thousands)

 

Amortized Cost

 

 

Gross

Unrealized

Gains

 

 

Gross

Unrealized

Losses

 

 

Fair Value

 

December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities, available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate notes

 

$

54,197

 

 

$

6

 

 

$

(15

)

 

$

54,188

 

Commercial paper

 

 

118,932

 

 

 

25

 

 

 

—

 

 

 

118,957

 

Total debt securities, available for sale

 

$

173,129

 

 

$

31

 

 

$

(15

)

 

$

173,145

 
XML 44 R26.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments and Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis Cash equivalents and marketable debt securities are determined under the fair value categories as follows:

 

 

 

 

 

 

Quoted Price in

 

 

Significant Other

 

 

Significant

 

 

 

 

 

 

 

Active Market

 

 

Observable Inputs

 

 

Unobservable

 

(in thousands)

 

Total

 

 

(Level 1)

 

 

(Level 2)

 

 

Inputs (Level 3)

 

December 31, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

725,108

 

 

$

725,108

 

 

$

—

 

 

$

—

 

Commercial paper

 

 

35,996

 

 

 

—

 

 

 

35,996

 

 

 

—

 

Total cash equivalents

 

 

761,104

 

 

 

725,108

 

 

 

35,996

 

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt securities, available for sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate notes

 

 

54,188

 

 

 

—

 

 

 

54,188

 

 

 

—

 

Commercial paper

 

 

118,957

 

 

 

—

 

 

 

118,957

 

 

 

—

 

Total debt securities, available for sale

 

 

173,145

 

 

 

—

 

 

 

173,145

 

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total assets measured at fair value

 

$

934,249

 

 

$

725,108

 

 

$

209,141

 

 

$

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

December 31, 2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds

 

$

151,750

 

 

$

151,750

 

 

$

—

 

 

$

—

 

Total cash equivalents

 

$

151,750

 

 

$

151,750

 

 

$

—

 

 

$

—

 

 

 
Schedule of Estimated Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs

The following tables set forth the changes in the estimated fair value for the Company’s derivative assets and liabilities measured using significant unobservable inputs (Level 3):

(in thousands)

 

2020

 

Assets:

 

 

 

 

Fair value measurement at January 1

 

$

—

 

Derivative assets recorded in connection with the 2023 Hedge

 

 

69,525

 

Change in fair value measurement

 

 

(32,233

)

Derivative asset reclassified to stockholders’ equity

 

 

(37,292

)

Fair value measurement at December 31

 

$

—

 

 

 

(in thousands)

 

2020

 

Liabilities:

 

 

 

 

Fair value measurement at January 1

 

$

—

 

Derivative liability recorded in connection with the 2023 Notes

 

 

57,224

 

Change in fair value measurement

 

 

(19,932

)

Derivative liability reclassified to stockholders’ equity

 

 

(37,292

)

Fair value measurement at December 31

 

$

—

 
Schedule of Inputs and Valuation Techniques Used in Recurring Level 3 Fair Value Measurements

The recurring Level 3 fair value measurements of contingent consideration liabilities associated with commercial sales milestones include the following significant unobservable inputs as of December 31, 2020:

 

 

 

2020

 

Valuation Techniques

 

Discounted cash flow, Monte Carlo

 

Discount Rate Range

 

2.8% - 4.0%

 

Weighted Average Discount Rate

 

3.6%

 

Expected Years

 

2021 - 2024

 
Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs The following table sets forth the changes in the estimated fair value of the Company’s liabilities measured on a recurring basis using significant unobservable inputs (Level 3):

 

 

 

 

 

(in thousands)

 

2020

 

 

2019

 

Fair value measurement at January 1

 

$

42,559

 

 

$

50,410

 

Change in fair value measurement

 

 

2,420

 

 

 

(6,297

)

Contingent consideration paid or settled

 

 

(7,938

)

 

 

(1,435

)

Changes resulting from foreign currency fluctuations

 

 

—

 

 

 

(119

)

Fair value measurement at December 31

 

$

37,041

 

 

$

42,559

 

 
XML 45 R27.htm IDEA: XBRL DOCUMENT v3.20.4
Indebtedness (Tables)
 12 Months Ended
Dec. 31, 2020
Debt Disclosure [Abstract]  
Carrying Value of Senior Convertible Notes

The carrying values of the Company’s Senior Convertible Notes are as follows:

 

(in thousands)

 

December 31, 2020

 

 

December 31, 2019

 

2.25% Senior Convertible Notes due 2021:

 

 

 

 

 

 

 

 

Principal amount

 

$

650,000

 

 

$

650,000

 

Unamortized debt discount

 

 

(3,945

)

 

 

(22,501

)

Unamortized debt issuance costs

 

 

(752

)

 

 

(4,201

)

 

 

 

645,303

 

 

 

623,298

 

1.00% Senior Convertible Notes due 2023:

 

 

 

 

 

 

 

 

Principal amount

 

 

450,000

 

 

 

—

 

Unamortized debt discount

 

 

(46,837

)

 

 

—

 

Unamortized debt issuance costs

 

 

(11,049

)

 

 

—

 

 

 

 

392,114

 

 

 

—

 

0.375% Senior Convertible Notes due 2025:

 

 

 

 

 

 

 

 

Principal amount

 

 

450,000

 

 

 

—

 

Unamortized debt discount

 

 

(66,346

)

 

 

—

 

Unamortized debt issuance costs

 

 

(9,542

)

 

 

—

 

 

 

 

374,112

 

 

 

—

 

Total Senior Convertible Notes

 

$

1,411,529

 

 

$

623,298

 

 

 

 

 

 

 

 

 

 

Less: Current portion

 

 

(645,303

)

 

 

—

 

Long-term Senior Convertible Notes

 

$

766,226

 

 

$

623,298

 
XML 46 R28.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments (Tables)
 12 Months Ended
Dec. 31, 2020
Commitments And Contingencies Disclosure [Abstract]  
Right-of-use Assets and Lease Liabilities

The table below summarizes the Company’s right-of-use assets and lease liabilities:

(in thousands, except years and rates)

December 31, 2020

 

 

December 31, 2019

 

Assets

 

 

 

 

 

 

 

Operating

$

102,270

 

 

$

66,932

 

Financing

 

2,956

 

 

 

1,453

 

Total leased assets

$

105,226

 

 

$

68,385

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

Current:

 

 

 

 

 

 

 

Operating

$

7,875

 

 

$

5,567

 

Financing

 

1,355

 

 

 

672

 

Long-term:

 

 

 

 

 

 

 

Operating

 

111,634

 

 

 

73,153

 

Financing

 

1,812

 

 

 

905

 

Total lease liabilities

$

122,676

 

 

$

80,297

 

 

 

 

 

 

 

 

 

Supplemental non-cash information:

 

 

 

 

 

 

 

Weighted-average remaining lease term (years) - operating leases

 

12.8

 

 

 

12.4

 

Weighted-average remaining lease term (years) - finance leases

 

2.2

 

 

 

2.3

 

Weighted-average discount rate - operating leases

 

5.4

%

 

 

7.3

%

Weighted-average discount rate - finance leases

 

4.9

%

 

 

5.4

%
Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations

The table below summarizes the Company’s lease costs, cash payments, and operating lease liabilities arising from obtaining right-of-use assets under its operating and financing lease obligations:

 

(in thousands)

December 31, 2020

 

 

December 31, 2019

 

Lease expense:

 

 

 

 

 

 

 

Operating lease expense

$

15,316

 

 

$

11,859

 

Finance lease expense:

 

 

 

 

 

 

 

Depreciation of right-of-use assets

 

1,201

 

 

 

441

 

Interest expense on lease liabilities

 

124

 

 

 

56

 

Total lease expense

$

16,641

 

 

$

12,356

 

 

 

 

 

 

 

 

 

Consolidated Statements of Cash Flows information:

 

 

 

 

 

 

 

Operating cash flows used for operating leases

$

14,120

 

 

$

12,140

 

Operating cash flows used for financing leases

 

124

 

 

 

56

 

Financing cash flows used for financing leases

 

1,113

 

 

 

420

 

Total cash paid for amounts included in the measurement of lease liabilities

$

15,357

 

 

$

12,616

 

 

 

 

 

 

 

 

 

Supplemental non-cash information:

 

 

 

 

 

 

 

Operating lease liabilities arising from obtaining right-of-use assets

$

41,148

 

 

$

86,134

 
Future Minimum Annual Lease Payments under Operating and Financing Leases

The Company’s future minimum annual lease payments under operating and financing leases at December 31, 2020 are as follows:

 

 

Financing

 

 

Operating

 

(in thousands)

 

Leases

 

 

Leases

 

2021

 

$

1,465

 

 

$

14,140

 

2022

 

 

1,397

 

 

 

13,582

 

2023

 

 

466

 

 

 

13,158

 

2024

 

 

9

 

 

 

12,072

 

2025

 

 

—

 

 

 

10,699

 

Thereafter

 

 

—

 

 

 

106,197

 

Total minimum lease payments

 

$

3,337

 

 

$

169,848

 

Less: amount representing interest

 

 

(170

)

 

 

(50,339

)

Present value of obligations under leases

 

 

3,167

 

 

 

119,509

 

Less: current portion

 

 

(1,355

)

 

 

(7,875

)

Long-term lease obligations

 

$

1,812

 

 

$

111,634

 
XML 47 R29.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements

The compensation cost that has been included in the Consolidated Statements of Operations for the Company’s stock-based compensation plans was as follows:

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Selling, general and administrative expense

 

$

12,622

 

 

$

25,968

 

 

$

22,190

 

Research and development expense

 

 

5,259

 

 

 

3,798

 

 

 

3,052

 

Cost of sales

 

 

264

 

 

 

531

 

 

 

431

 

Stock-based compensation expense before taxes

 

 

18,145

 

 

 

30,297

 

 

 

25,673

 

Related income tax benefits

 

 

(3,088

)

 

 

(6,191

)

 

 

(6,418

)

Stock-based compensation expense, net of taxes

 

$

15,057

 

 

$

24,106

 

 

$

19,255

 
Summary of Restricted Stock Units

Following is a summary of RSU activity for the year ended December 31, 2020:

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant Date

 

(in thousands, except per share amounts)

 

Shares

 

 

Fair Value

 

Outstanding at December 31, 2019

 

 

945

 

 

$

59.21

 

Granted

 

 

381

 

 

 

63.64

 

Vested

 

 

(209

)

 

 

68.67

 

Forfeited

 

 

(123

)

 

 

59.21

 

Outstanding at December 31, 2020

 

 

994

 

 

$

58.94

 
Schedule of Performance-Based Restricted Stock Units

Following is a summary of PRSU activity for the year ended December 31, 2020:

 

 

 

 

 

 

Maximum Number

 

 

 

 

 

(in thousands, except per share amounts)

 

Shares

 

 

of Shares Eligible

to be Issued

 

 

Average Grant

Date Fair Value

 

Outstanding at December 31, 2019

 

 

731

 

 

 

1,116

 

 

$

57.07

 

Awarded at target

 

 

172

 

 

 

248

 

 

 

69.72

 

Vested

 

 

(61

)

 

 

(61

)

 

 

73.20

 

Forfeited

 

 

(223

)

 

 

(453

)

 

 

56.48

 

Outstanding at December 31, 2020

 

 

619

 

 

 

850

 

 

$

57.38

 
Summary of Stock Option Activity under All Stock Plans

Following is a summary of stock option activity for the year ended December 31, 2020 under all stock plans:

 

 

 

 

 

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

Contractual

 

 

Aggregate

 

 

 

 

 

 

 

Avg. Exercise

 

 

Term

 

 

Intrinsic

 

(in thousands, except years and per share amounts)

 

Shares

 

 

Price

 

 

(Years)

 

 

Value

 

Outstanding at December 31, 2019

 

 

16

 

 

$

29.18

 

 

 

0.89

 

 

$

747

 

Exercised

 

 

(16

)

 

 

29.18

 

 

 

 

 

 

 

 

 

Cancelled

 

 

—

 

 

 

—

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

—

 

 

 

—

 

 

 

—

 

 

$

—

 

Exercisable at December 31, 2020

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 

Vested or expected to vest at December 31, 2020

 

 

—

 

 

$

—

 

 

 

—

 

 

$

—

 
Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP

The weighted average assumptions used to estimate the fair value of stock options granted and stock purchase rights under the ESPP are as follows:

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

ESPP

 

 

 

 

 

 

 

 

 

 

 

 

Volatility

 

 

56

%

 

 

35

%

 

 

33

%

Expected term (years)

 

 

0.5

 

 

 

0.5

 

 

 

0.5

 

Risk free interest rate

 

 

0.5

%

 

 

2.3

%

 

 

1.8

%

Expected dividend yield

 

 

—

%

 

 

—

%

 

 

—

%
Common Stock Reserved for Future Issuance

Common Stock Reserved for Future Issuance

The following table summarizes common shares reserved for issuance on exercise or conversion at December 31, 2020:

(in thousands)

 

 

 

 

Issued and outstanding RSUs and PRSUs

 

 

1,630

 

Available for issuance under the ESPP

 

 

828

 

Available for future grant

 

 

3,651

 

2021 Notes

 

 

14,396

 

2021 Warrants

 

 

25,207

 

2023 Notes

 

 

7,082

 

2023 Warrants

 

 

6,949

 

2025 Notes

 

 

6,512

 

2025 Warrants

 

 

6,271

 

Total shares reserved for future issuance

 

 

72,526

 

 
XML 48 R30.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2020
Income Tax Disclosure [Abstract]  
Summary of Income Before Income Taxes By Region

Total (loss) income before income taxes summarized by region was as follows:

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

United States

 

$

(45,534

)

 

$

74,721

 

 

$

8,939

 

Foreign

 

 

(2,011

)

 

 

5,796

 

 

 

(216

)

Total (loss) income before income taxes

 

$

(47,545

)

 

$

80,517

 

 

$

8,723

 
Components of Income Tax Provision (Benefit)

The income tax (benefit) provision was as follows:

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(35

)

 

$

4,802

 

 

$

(4,188

)

State

 

 

2,309

 

 

 

4,638

 

 

 

2,043

 

Foreign

 

 

4,675

 

 

 

2,205

 

 

 

5,972

 

Total current provision

 

 

6,949

 

 

 

11,645

 

 

 

3,827

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

(13,800

)

 

 

5,873

 

 

 

(5,944

)

State

 

 

(8,315

)

 

 

(4,565

)

 

 

(7,092

)

Foreign

 

 

(3,849

)

 

 

(819

)

 

 

(98,795

)

Total deferred provision

 

 

(25,964

)

 

 

489

 

 

 

(111,831

)

Changes in tax rate

 

 

(579

)

 

 

606

 

 

 

258

 

Changes in valuation allowance

 

 

9,202

 

 

 

2,543

 

 

 

103,990

 

Total (benefit) provision

 

$

(10,392

)

 

$

15,283

 

 

$

(3,756

)
Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate

The differences between the income tax provision at the United States federal statutory tax rate and the Company’s effective tax rate were as follows:

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Tax (benefit) provision at federal statutory rate

 

$

(9,984

)

 

$

16,909

 

 

$

1,832

 

Income tax credits and incentives

 

 

(7,155

)

 

 

(7,209

)

 

 

(5,525

)

State income tax

 

 

(1,243

)

 

 

3,763

 

 

 

90

 

Valuation allowance

 

 

9,202

 

 

 

2,543

 

 

 

103,990

 

Net tax benefit on international restructuring

 

 

—

 

 

 

—

 

 

 

(97,028

)

Return to provision adjustments

 

 

(881

)

 

 

(2,323

)

 

 

(4,180

)

Acquisition related charges

 

 

687

 

 

 

(1,808

)

 

 

(221

)

Compensation expense

 

 

3,314

 

 

 

1,643

 

 

 

2,008

 

Income tax reserves

 

 

(4,217

)

 

 

(1,146

)

 

 

(6,717

)

Nondeductible meals and entertainment

 

 

351

 

 

 

717

 

 

 

769

 

Foreign tax rate differences from federal statutory rate

 

 

(1,215

)

 

 

716

 

 

 

576

 

Change in tax rates

 

 

(579

)

 

 

606

 

 

 

258

 

Other

 

 

1,328

 

 

 

872

 

 

 

392

 

Total (benefit) provision

 

$

(10,392

)

 

$

15,283

 

 

$

(3,756

)

 

 
Significant Components of Deferred Tax Assets and Liabilities

Significant components of the Company’s deferred tax assets and liabilities were as follows:

 

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Amortization

 

$

67,945

 

 

$

87,296

 

Net operating loss carryforwards

 

 

47,407

 

 

 

24,656

 

Inventory

 

 

35,763

 

 

 

24,069

 

General business and other credit carryforwards

 

 

26,542

 

 

 

23,168

 

Lease liability

 

 

28,356

 

 

 

17,636

 

Stock-based compensation

 

 

9,918

 

 

 

11,562

 

Original issue discount

 

 

3,735

 

 

 

1,840

 

Other

 

 

27,479

 

 

 

22,591

 

Gross deferred tax assets

 

 

247,145

 

 

 

212,818

 

Less valuation allowance

 

 

(130,434

)

 

 

(122,534

)

Net deferred tax assets

 

 

116,711

 

 

 

90,284

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Depreciation

 

 

(44,760

)

 

 

(37,045

)

Acquired intangibles

 

 

(27,544

)

 

 

(34,799

)

Right-of-use assets

 

 

(24,122

)

 

 

(14,891

)

Other

 

 

(5,176

)

 

 

(6,260

)

Total deferred tax liabilities

 

 

(101,602

)

 

 

(92,995

)

Net deferred tax assets (liabilities)

 

$

15,109

 

 

$

(2,711

)
Summary of Unrecognized Tax Benefits

The following table summarizes the activity related to the Company’s unrecognized tax benefits:

 

  

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Gross unrecognized tax benefits at January 1

 

$

20,328

 

 

$

19,545

 

 

$

25,356

 

Increases in tax positions for prior years

 

 

1,758

 

 

 

62

 

 

 

499

 

Decreases in tax positions for prior years

 

 

—

 

 

 

(112

)

 

 

(756

)

Increases in tax positions for current year relating to ongoing operations

 

 

2,159

 

 

 

2,073

 

 

 

1,913

 

Decreases in tax positions as a result of a lapse of statute of limitations

 

 

(5,929

)

 

 

(616

)

 

 

(6,446

)

Increases in tax positions for current year relating to acquisitions

 

 

—

 

 

 

—

 

 

 

169

 

Decreases in tax positions due to settlements with taxing authorities

 

 

—

 

 

 

(624

)

 

 

(1,190

)

Gross unrecognized tax benefits at December 31

 

$

18,316

 

 

$

20,328

 

 

$

19,545

 
XML 49 R31.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segment, Product and Geographic Information (Tables)
 12 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Schedule of Net Sales by Product Line Net sales by product line was as follows:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

Spinal hardware

 

$

783,510

 

 

$

851,440

 

 

$

788,649

 

Surgical support

 

 

267,072

 

 

 

316,630

 

 

 

313,065

 

Total net sales

 

$

1,050,582

 

 

$

1,168,070

 

 

$

1,101,714

 

 
Schedule of Net Sales and Net Property and Equipment by Geographical Area

Net sales and property and equipment, net, by geographic area were as follows:

 

 

 

Net Sales

 

 

Property and Equipment, Net

 

 

 

Year Ended December 31,

 

 

December 31,

 

(in thousands)

 

2020

 

 

2019

 

 

2018

 

 

2020

 

 

2019

 

United States

 

$

821,824

 

 

$

941,086

 

 

$

896,152

 

 

$

239,802

 

 

$

218,771

 

International (excludes Puerto Rico)

 

 

228,758

 

 

 

226,984

 

 

 

205,562

 

 

 

46,567

 

 

 

47,547

 

Total

 

$

1,050,582

 

 

$

1,168,070

 

 

$

1,101,714

 

 

$

286,369

 

 

$

266,318

 
XML 50 R32.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies (Details Textual)
 12 Months Ended
Oct. 01, 2020
USD ($)
Dec. 31, 2020
USD ($)
Customer
segment
Dec. 31, 2019
USD ($)
Customer
Dec. 31, 2018
USD ($)
Customer
Dec. 31, 2015
Jan. 01, 2021
USD ($)
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Retained earnings   $ 45,322,000 $ 82,475,000      
Deferred tax liabilities     $ 2,711,000      
Customer represented greater than 10 percent | Customer   0 0 0    
Inventory, finished goods   $ 285,400,000 $ 298,700,000      
Inventory, work in progress   7,300,000 6,400,000      
Inventory, raw materials   7,900,000 7,300,000      
Reserve for excess and obsolete inventory   $ 48,900,000 14,000,000.0      
Number of Reportable Units | segment   1        
Impairment of goodwill and intangible assets $ 0          
Impairment charges related to goodwill   $ 0        
Translation Adjustment Functional to Reporting Currency, Net of Tax   7,600,000 9,400,000 $ 8,600,000    
Product shipment costs   321,631,000 312,357,000 311,159,000    
Business transition costs (recoveries)   $ 10,878,000 (1,995,000) 11,473,000    
Performance Based Restricted Stock Units (PRSUs) [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Vesting period for the award   5 years     5 years  
2017 and 2016 Acquisitions [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Business transition costs (recoveries)   $ 2,300,000 (6,300,000) (1,500,000)    
Product Shipment [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Product shipment costs   $ 27,400,000 $ 27,700,000 $ 25,400,000    
Minimum [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Finite-Lived intangible assets, useful life   2 years        
Property and equipment, useful life   2 years        
Maximum [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Finite-Lived intangible assets, useful life   17 years        
Property and equipment, useful life   20 years        
ASU 2016-13 [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Change in accounting principle, accounting standards update, adopted [true false]   true        
Change in accounting principle, accounting standards update, adoption date   Jan. 01, 2020        
Change in accounting principle, accounting standards update, immaterial effect [true false]   true        
ASU 2017-04 [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Change in accounting principle, accounting standards update, adopted [true false]   true        
Change in accounting principle, accounting standards update, adoption date   Jan. 01, 2020        
Change in accounting principle, accounting standards update, immaterial effect [true false]   true        
ASU 2018-13 [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Change in accounting principle, accounting standards update, adopted [true false]   true        
Change in accounting principle, accounting standards update, adoption date   Jan. 01, 2020        
Change in accounting principle, accounting standards update, immaterial effect [true false]   true        
ASU 2018-15 [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Change in accounting principle, accounting standards update, adopted [true false]   true        
Change in accounting principle, accounting standards update, adoption date   Jan. 01, 2020        
Change in accounting principle, accounting standards update, immaterial effect [true false]   true        
ASU 2019-12 [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Change in accounting principle, accounting standards update, adoption date   Jun. 30, 2020        
Change in accounting principle, accounting standards update, immaterial effect [true false]   true        
Change in accounting principle, accounting standards update, early adoption [true false]   true        
ASU 2020-04 [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Change in accounting principle, accounting standards update, immaterial effect [true false]   true        
Cumulative Effect, Period of Adoption, Adjustment [Member] | ASU 2010-26 [Member] | Subsequent Event [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Retained earnings           $ 115,400,000
Convertible debt liabilities           64,500,000
Deferred tax liabilities           28,000,000.0
Additional paid-in capital           $ 151,900,000
Cumulative Effect, Period of Adoption, Adjustment [Member] | ASU 2016-13 [Member]            
Schedule Of Organization And Significant Accounting Policies [Line Items]            
Retained earnings   $ 0        
XML 51 R33.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies - Summary of Changes in Allowance for Credit Losses (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
USD ($)
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Allowance for credit loss at beginning of period $ 9,423
Current-period provision for expected losses 1,079
Write-offs charged against the allowance (1,305)
Recoveries of amounts previously written off 220
Changes resulting from foreign currency fluctuations 229
Allowance for credit losses at end of period $ 9,646
XML 52 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Numerator:      
Net (loss) income $ (37,153) $ 65,234 $ 12,479
Denominator for basic and diluted net (loss) income per share:      
Weighted average common shares outstanding for basic 51,416 51,956 51,382
Dilutive potential common stock outstanding:      
Weighted average common shares outstanding for diluted 51,416 53,160 52,355
Basic net (loss) income per share $ (0.72) $ 1.26 $ 0.24
Diluted net (loss) income per share $ (0.72) $ 1.23 $ 0.24
Senior Convertible Notes [Member]      
Dilutive potential common stock outstanding:      
Incremental common shares from share based payments   531 177
Stock Options and ESPP [Member]      
Dilutive potential common stock outstanding:      
Incremental common shares from share based payments   15 36
RSUs and PRSUs [Member]      
Dilutive potential common stock outstanding:      
Incremental common shares from share based payments   658 760
XML 53 R35.htm IDEA: XBRL DOCUMENT v3.20.4
Organization and Significant Accounting Policies - Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share (Details) - shares
shares in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share 43,163 16,413 16,460
Stock options, ESPP, RSUs and PRSUs [Member]      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share 1,095 115 162
Warrants [Member]      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share 21,034 10,865 10,865
Senior Convertible Notes [Member]      
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]      
Anti-dilutive securities excluded from computation of earnings per share 21,034 5,433 5,433
XML 54 R36.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details - Property and Equipment Net (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Property and equipment net    
Property and equipment, gross $ 739,448 $ 659,597
Less: accumulated depreciation and amortization (453,079) (393,279)
Property and equipment, net $ 286,369 266,318
Minimum [Member]    
Property and equipment net    
Property and equipment, useful life 2 years  
Maximum [Member]    
Property and equipment net    
Property and equipment, useful life 20 years  
Instrument sets [Member]    
Property and equipment net    
Property and equipment, useful life 4 years  
Property and equipment, gross $ 424,696 381,310
Machinery and equipment [Member]    
Property and equipment net    
Property and equipment, gross $ 71,616 66,482
Machinery and equipment [Member] | Minimum [Member]    
Property and equipment net    
Property and equipment, useful life 5 years  
Machinery and equipment [Member] | Maximum [Member]    
Property and equipment net    
Property and equipment, useful life 7 years  
Computer equipment and software [Member]    
Property and equipment net    
Property and equipment, gross $ 173,364 149,134
Computer equipment and software [Member] | Minimum [Member]    
Property and equipment net    
Property and equipment, useful life 3 years  
Computer equipment and software [Member] | Maximum [Member]    
Property and equipment net    
Property and equipment, useful life 7 years  
Leasehold improvements [Member]    
Property and equipment net    
Property and equipment, gross $ 35,372 29,542
Leasehold improvements [Member] | Minimum [Member]    
Property and equipment net    
Property and equipment, useful life 2 years  
Leasehold improvements [Member] | Maximum [Member]    
Property and equipment net    
Property and equipment, useful life 15 years  
Furniture and fixtures [Member]    
Property and equipment net    
Property and equipment, gross $ 9,916 8,931
Furniture and fixtures [Member] | Minimum [Member]    
Property and equipment net    
Property and equipment, useful life 3 years  
Furniture and fixtures [Member] | Maximum [Member]    
Property and equipment net    
Property and equipment, useful life 7 years  
Building and improvements [Member]    
Property and equipment net    
Property and equipment, gross $ 23,207 22,921
Building and improvements [Member] | Minimum [Member]    
Property and equipment net    
Property and equipment, useful life 10 years  
Building and improvements [Member] | Maximum [Member]    
Property and equipment net    
Property and equipment, useful life 20 years  
Land [Member]    
Property and equipment net    
Property and equipment, gross $ 1,277 $ 1,277
XML 55 R37.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details (Details Textual) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Balance Sheet Details [Abstract]      
Depreciation expense $ 85.9 $ 80.8 $ 75.4
Capitalized internal use software development costs 57.6 51.7  
Capitalized internal use software amortization 10.4 10.4 10.6
Amortization expense related to intangible assets $ 55.0 $ 54.8 $ 54.4
XML 56 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details - Goodwill and Intangible Assets (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Intangible assets subject to amortization:    
Weighted Average Amortization Period 8 years 9 years
Gross Amount $ 484,566 $ 478,790
Accumulated Amortization (332,302) (277,698)
Intangible Assets, net 152,264 201,092
Intangible assets not subject to amortization:    
Goodwill 559,553 561,064
Total goodwill and intangible assets, net $ 711,817 $ 762,156
Developed Technology [Member]    
Intangible assets subject to amortization:    
Weighted Average Amortization Period 8 years 8 years
Gross Amount $ 271,748 $ 271,748
Accumulated Amortization (195,283) (163,459)
Intangible Assets, net $ 76,465 $ 108,289
Manufacturing know-how and trade secrets [Member]    
Intangible assets subject to amortization:    
Weighted Average Amortization Period 13 years 13 years
Gross Amount $ 30,882 $ 30,798
Accumulated Amortization (22,720) (20,333)
Intangible Assets, net $ 8,162 $ 10,465
Trade name and trademarks [Member]    
Intangible assets subject to amortization:    
Weighted Average Amortization Period 9 years 9 years
Gross Amount $ 25,500 $ 25,500
Accumulated Amortization (19,945) (16,947)
Intangible Assets, net $ 5,555 $ 8,553
Customer relationships [Member]    
Intangible assets subject to amortization:    
Weighted Average Amortization Period 9 years 9 years
Gross Amount $ 156,436 $ 150,744
Accumulated Amortization (94,354) (76,959)
Intangible Assets, net $ 62,082 $ 73,785
XML 57 R39.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details - Changes to Goodwill (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Goodwill And Intangible Assets Disclosure [Abstract]    
Gross goodwill $ 567,853 $ 569,364
Accumulated impairment loss (8,300) (8,300)
Goodwill 559,553 $ 561,064
Changes to gross goodwill:    
Changes resulting from foreign currency fluctuations (1,511)  
Goodwill period increase (decrease) $ (1,511)  
XML 58 R40.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details - Future Amortization Expense Related to Intangible Assets (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Future amortization expense related to intangible assets    
2021 $ 51,876  
2022 43,843  
2023 18,697  
2024 12,506  
2025 11,705  
Thereafter through 2031 13,637  
Intangible Assets, net $ 152,264 $ 201,092
XML 59 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Accounts payable and accrued liabilities    
Accrued expenses $ 59,249 $ 58,897
Accounts payable 17,386 11,827
Distributor commissions payable 9,891 7,983
Other taxes payable 6,425 6,501
Litigation liability 5,346 1,370
Debt interest payable 5,203 4,266
Royalties payable 4,495 4,994
Other 2,406 1,322
Accounts payable and accrued liabilities $ 110,401 $ 97,160
XML 60 R42.htm IDEA: XBRL DOCUMENT v3.20.4
Marketable Securities - Schedule of Carrying Value and Amortized Cost of Company's Marketable Debt Securities (Details)
$ in Thousands
Dec. 31, 2020
USD ($)
Schedule Of Available For Sale Securities [Line Items]  
Amortized Cost $ 173,129
Gross Unrealized Gains 31
Gross Unrealized Losses (15)
Fair Value 173,145
Corporate Notes [Member]  
Schedule Of Available For Sale Securities [Line Items]  
Amortized Cost 54,197
Gross Unrealized Gains 6
Gross Unrealized Losses (15)
Fair Value 54,188
Commercial Paper [Member]  
Schedule Of Available For Sale Securities [Line Items]  
Amortized Cost 118,932
Gross Unrealized Gains 25
Fair Value $ 118,957
XML 61 R43.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments and Fair Value Measurements (Details Textual)
 12 Months Ended
Dec. 31, 2020
USD ($)
investment
$ / shares
shares
Dec. 31, 2019
USD ($)
investment
shares
Dec. 31, 2018
USD ($)
Sep. 10, 2020
shares
Sep. 09, 2020
shares
Jun. 01, 2020
USD ($)
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Net currency exchange losses from derivatives instruments $ 4,200,000 $ 800,000 $ 3,700,000      
Net (losses) gains recognized on derivative instruments $ (12,301,000)          
Unrealized loss position investment | investment 0 0        
Impairment charges recorded for earnings $ 0 $ 0        
Common stock, shares authorized | shares 150,000,000 120,000,000   150,000,000 120,000,000  
Contingent consideration liabilities $ 7,289,000 $ 15,727,000        
Net loss on strategic investments   4,800,000 3,800,000      
Purchased in-process research and development asset 1,011,000   8,913,000      
Contingent Consideration Liabilities [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Contingent consideration liabilities $ 37,000,000.0 42,600,000        
Convertible Notes due 2023 [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Notional principal amount           $ 450,000,000.0
Senior convertible notes rate           1.00%
Convertible note hedge transactions purchase of common stock | shares 5,345,010          
Convertible note hedge transactions initial stock price per share | $ / shares $ 84.19          
Quoted Price in Active Market (Level 1) [Member] | Convertible Notes due 2021 [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Notional principal amount $ 650,000,000.0 650,000,000.0        
Debt instrument, fair value disclosure 651,600,000 869,300,000        
Quoted Price in Active Market (Level 1) [Member] | Convertible Notes due 2023 [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Notional principal amount 450,000,000.0          
Debt instrument, fair value disclosure 461,900,000          
Quoted Price in Active Market (Level 1) [Member] | Convertible Notes due 2025 [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Notional principal amount 450,000,000.0          
Debt instrument, fair value disclosure 436,700,000          
Foreign Exchange Forward [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Notional principal amount 14,000,000.0 26,900,000 26,800,000      
Foreign Exchange Forward [Member] | Other Current Assets or Other Current Liabilities [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Fair value of derivative instrument liability   100,000        
Foreign Exchange Forward [Member] | Other (Expense) Income [Member]            
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]            
Net (losses) gains recognized on derivative instruments $ (1,000,000.0) $ 400,000 $ 500,000      
XML 62 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Cash Equivalents and Marketable Securities    
Fair Value $ 173,145  
Commercial Paper [Member]    
Cash Equivalents and Marketable Securities    
Fair Value 118,957  
Corporate Notes [Member]    
Cash Equivalents and Marketable Securities    
Fair Value 54,188  
Fair Value, Recurring [Member]    
Cash Equivalents and Marketable Securities    
Total cash equivalents 761,104 $ 151,750
Fair Value 173,145  
Total assets measured at fair value 934,249  
Fair Value, Recurring [Member] | Commercial Paper [Member]    
Cash Equivalents and Marketable Securities    
Total cash equivalents 35,996  
Fair Value 118,957  
Fair Value, Recurring [Member] | Corporate Notes [Member]    
Cash Equivalents and Marketable Securities    
Fair Value 54,188  
Fair Value, Recurring [Member] | Money Market Funds [Member]    
Cash Equivalents and Marketable Securities    
Total cash equivalents 725,108 151,750
Fair Value, Recurring [Member] | Quoted Price in Active Market (Level 1) [Member]    
Cash Equivalents and Marketable Securities    
Total cash equivalents 725,108 151,750
Total assets measured at fair value 725,108  
Fair Value, Recurring [Member] | Quoted Price in Active Market (Level 1) [Member] | Money Market Funds [Member]    
Cash Equivalents and Marketable Securities    
Total cash equivalents 725,108 $ 151,750
Fair Value, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member]    
Cash Equivalents and Marketable Securities    
Total cash equivalents 35,996  
Fair Value 173,145  
Total assets measured at fair value 209,141  
Fair Value, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member] | Commercial Paper [Member]    
Cash Equivalents and Marketable Securities    
Total cash equivalents 35,996  
Fair Value 118,957  
Fair Value, Recurring [Member] | Significant Other Observable Inputs (Level 2) [Member] | Corporate Notes [Member]    
Cash Equivalents and Marketable Securities    
Fair Value $ 54,188  
XML 63 R45.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs (Details)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
USD ($)
Assets:  
Derivative assets purchased $ 69,525
Change in fair value measurement (32,233)
Derivative asset reclassified to stockholders’ equity (37,292)
Liabilities:  
Change in fair value measurement (19,932)
Derivative liability reclassified to stockholders’ equity (37,292)
2023 Notes [Member]  
Liabilities:  
Derivative liability recorded in connection with the 2023 Notes $ 57,224
XML 64 R46.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments and Fair Value Measurements - Schedule of Recurring Fair Value Measurements of Contingent Consideration Liabilities (Details) - Level 3 [Member] - Commercial Sale Milestone [Member] - Fair Value, Recurring [Member]
 12 Months Ended
Dec. 31, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Business Combination, Contingent Consideration, Liability, Valuation Technique [Extensible List] us-gaap:ValuationTechniqueDiscountedCashFlowMember
Discount Rate [Member] | Minimum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Weighted average measurement input 0.028
Discount Rate [Member] | Maximum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Weighted average measurement input 0.040
Discount Rate [Member] | Weighted Average [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Weighted average measurement input 0.036
Expected Years [Member] | Minimum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Expected Years 2021
Expected Years [Member] | Maximum [Member]  
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]  
Expected Years 2024
XML 65 R47.htm IDEA: XBRL DOCUMENT v3.20.4
Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Change in fair value measurement $ (19,932)  
Contingent Consideration Liabilities [Member]    
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]    
Fair value measurement at beginning of period 42,559 $ 50,410
Change in fair value measurement 2,420 (6,297)
Contingent consideration paid or settled (7,938) (1,435)
Changes resulting from foreign currency fluctuations   (119)
Fair value measurement at end of period $ 37,041 $ 42,559
XML 66 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Indebtedness - Carrying Value of Senior Convertible Notes (Details) - USD ($)
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2016
Debt Instrument [Line Items]        
Total Senior Convertible Notes $ 1,411,529,000   $ 623,298,000  
Less: Current portion (645,303,000)      
Long-term senior convertible notes 766,226,000   623,298,000  
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member]        
Debt Instrument [Line Items]        
Principal amount 650,000,000   650,000,000 $ 650,000,000.0
Unamortized debt discount (3,945,000)   (22,501,000)  
Unamortized debt issuance costs (752,000)   (4,201,000)  
Total Senior Convertible Notes 645,303,000   $ 623,298,000  
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member]        
Debt Instrument [Line Items]        
Principal amount 450,000,000      
Unamortized debt discount (46,837,000)      
Unamortized debt issuance costs (11,049,000)      
Total Senior Convertible Notes 392,114,000      
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member]        
Debt Instrument [Line Items]        
Principal amount 450,000,000 $ 450,000,000.0    
Unamortized debt discount (66,346,000)      
Unamortized debt issuance costs (9,542,000)      
Total Senior Convertible Notes $ 374,112,000      
XML 67 R49.htm IDEA: XBRL DOCUMENT v3.20.4
Indebtedness - Carrying Value of Senior Convertible Notes (Parenthetical) (Details)
Dec. 31, 2020
Mar. 31, 2020
Dec. 31, 2019
Mar. 31, 2016
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member]        
Debt Instrument [Line Items]        
Interest rate on convertible notes 2.25%   2.25% 2.25%
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member]        
Debt Instrument [Line Items]        
Interest rate on convertible notes 1.00%   1.00%  
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member]        
Debt Instrument [Line Items]        
Interest rate on convertible notes 0.375% 0.375% 0.375%  
XML 68 R50.htm IDEA: XBRL DOCUMENT v3.20.4
Indebtedness (Details Textual)
 1 Months Ended 12 Months Ended
Jun. 01, 2020
USD ($)
d
$ / shares
shares
Mar. 31, 2020
USD ($)
d
$ / shares
shares
Feb. 29, 2020
USD ($)
Mar. 31, 2016
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
d
$ / shares
shares
Dec. 31, 2019
USD ($)
shares
Dec. 31, 2018
USD ($)
Dec. 31, 2016
USD ($)
Sep. 11, 2020
shares
Sep. 10, 2020
shares
Sep. 09, 2020
shares
Mar. 18, 2016
shares
Debt Instrument [Line Items]                        
Proceeds from issuance of convertible debt, net of issuance costs         $ 873,848,000              
Reclassification into temporary equity         4,697,000              
Carrying value         $ 1,411,529,000 $ 623,298,000            
Stock price | $ / shares         $ 56.33              
Cash proceeds from the sale of warrants         $ 93,915,000              
Common stock, shares authorized | shares         150,000,000 120,000,000       150,000,000 120,000,000  
Revolving Senior Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Credit facility, maximum borrowing capacity     $ 550,000,000.0                  
Credit facility, expiration date     2025-02                  
Loan outstanding         $ 0 $ 0            
Revolving Senior Credit Facility [Member] | Federal Funds Effective Rate [Member]                        
Debt Instrument [Line Items]                        
Credit facility bear interest rate     0.50%                  
Revolving Senior Credit Facility [Member] | Eurocurrency Rate [Member]                        
Debt Instrument [Line Items]                        
Credit facility bear interest rate     1.00%                  
Multicurrency Borrowings [Member]                        
Debt Instrument [Line Items]                        
Credit facility, maximum borrowing capacity     $ 250,000,000.0                  
Standby Letters of Credit [Member]                        
Debt Instrument [Line Items]                        
Credit facility, maximum borrowing capacity     50,000,000.0                  
Swing Line Loans [Member]                        
Debt Instrument [Line Items]                        
Credit facility, maximum borrowing capacity     $ 5,000,000.0                  
2021 Warrants [Member]                        
Debt Instrument [Line Items]                        
Cash proceeds from the sale of warrants       $ 44,900,000                
Warrant strike price | $ / shares       $ 80.00                
2023 Warrants [Member]                        
Debt Instrument [Line Items]                        
Cash proceeds from the sale of warrants $ 46,800,000                      
Warrant strike price | $ / shares $ 104.84                      
2025 Warrants [Member]                        
Debt Instrument [Line Items]                        
Cash proceeds from the sale of warrants   $ 47,100,000                    
Warrant strike price | $ / shares   $ 127.84                    
2021 Hedge [Member]                        
Debt Instrument [Line Items]                        
Number of common stock to be purchased | shares       10,865,270                
Stock price | $ / shares       $ 59.82                
Derivative, maturity date       Mar. 15, 2021                
2023 Hedge [Member]                        
Debt Instrument [Line Items]                        
Amount reclassified to stockholders' equity         $ 37,300,000              
Number of common stock to be purchased | shares 5,345,010                      
Stock price | $ / shares $ 84.19                      
Cost of hedge transaction $ 69,500,000                      
Derivative, maturity date Jun. 01, 2023                      
2025 Hedge [Member]                        
Debt Instrument [Line Items]                        
Number of common stock to be purchased | shares   4,823,910                    
Stock price | $ / shares   $ 93.29                    
Derivative, maturity date   Mar. 15, 2025                    
Minimum [Member] | Revolving Senior Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Unused line fee     0.35%                  
Minimum [Member] | Revolving Senior Credit Facility [Member] | Eurocurrency Rate [Member]                        
Debt Instrument [Line Items]                        
Credit facility bear interest rate     1.50%                  
Minimum [Member] | Revolving Senior Credit Facility [Member] | Base Rate [Member]                        
Debt Instrument [Line Items]                        
Credit facility bear interest rate     0.50%                  
Minimum [Member] | 2021 Warrants [Member]                        
Debt Instrument [Line Items]                        
Class of warrant or rights expiry month and year       2021-06                
Minimum [Member] | 2023 Warrants [Member]                        
Debt Instrument [Line Items]                        
Class of warrant or rights expiry month and year 2023-09                      
Minimum [Member] | 2025 Warrants [Member]                        
Debt Instrument [Line Items]                        
Class of warrant or rights expiry month and year   2025-06                    
Maximum [Member] | Revolving Senior Credit Facility [Member]                        
Debt Instrument [Line Items]                        
Unused line fee     0.50%                  
Maximum [Member] | Revolving Senior Credit Facility [Member] | Eurocurrency Rate [Member]                        
Debt Instrument [Line Items]                        
Credit facility bear interest rate     2.25%                  
Maximum [Member] | Revolving Senior Credit Facility [Member] | Base Rate [Member]                        
Debt Instrument [Line Items]                        
Credit facility bear interest rate     1.25%                  
Maximum [Member] | 2021 Warrants [Member]                        
Debt Instrument [Line Items]                        
Class of warrant or rights expiry month and year       2021-12                
Maximum [Member] | 2023 Warrants [Member]                        
Debt Instrument [Line Items]                        
Class of warrant or rights expiry month and year 2023-11                      
Maximum [Member] | 2025 Warrants [Member]                        
Debt Instrument [Line Items]                        
Class of warrant or rights expiry month and year   2025-10                    
Additional Paid-in Capital [Member] | 2021 Hedge [Member]                        
Debt Instrument [Line Items]                        
Cost of hedge transaction               $ 111,200,000        
Additional Paid-in Capital [Member] | 2025 Hedge [Member]                        
Debt Instrument [Line Items]                        
Cost of hedge transaction   $ 78,300,000                    
Common Stock [Member]                        
Debt Instrument [Line Items]                        
Common stock, shares authorized | shares                   150,000,000 120,000,000  
Common Stock [Member] | 2023 Warrants [Member]                        
Debt Instrument [Line Items]                        
Number of preferred or common stock into which the warrants is converted | shares 3,093,500                      
Common Stock [Member] | 2023 Warrants [Member] | 2023 Counterparties [Member]                        
Debt Instrument [Line Items]                        
Number of preferred or common stock into which the warrants is converted | shares                 6,948,512      
Common Stock [Member] | Maximum [Member] | 2021 Warrants [Member]                        
Debt Instrument [Line Items]                        
Number of preferred or common stock into which the warrants is converted | shares                       10,865,270
Common Stock [Member] | Maximum [Member] | 2023 Warrants [Member]                        
Debt Instrument [Line Items]                        
Number of preferred or common stock into which the warrants is converted | shares         5,345,010              
Common Stock [Member] | Maximum [Member] | 2025 Warrants [Member]                        
Debt Instrument [Line Items]                        
Number of preferred or common stock into which the warrants is converted | shares   4,823,910                    
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member]                        
Debt Instrument [Line Items]                        
Principal amount       $ 650,000,000.0 $ 650,000,000 $ 650,000,000            
Proceeds from issuance of convertible debt, net of issuance costs       $ 634,100,000                
Interest rate on convertible notes       2.25% 2.25% 2.25%            
Debt instrument, maturity date       Mar. 15, 2021                
Initial conversion rate adjustment, shares       16.7158                
Principal amount of debt considered for conversion rate       $ 1,000                
Initial conversion price of convertible notes | $ / shares       $ 59.82                
Contractual coupon interest expense         $ 14,600,000 $ 14,600,000 $ 14,600,000          
Amortization of debt discount (premium)         18,600,000 17,600,000 16,700,000          
Amortization of debt issuance costs         $ 3,400,000 3,200,000 $ 2,900,000          
Effective interest rate         5.80%              
Principal payments due         $ 0              
Reclassification into temporary equity         4,700,000              
Carrying value         $ 645,303,000 $ 623,298,000            
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member] | Scenario Two [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d         5              
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member] | Minimum [Member]                        
Debt Instrument [Line Items]                        
Percentage of conversion price         130.00%              
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member] | Minimum [Member] | Scenario One [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d         20              
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member] | Maximum [Member]                        
Debt Instrument [Line Items]                        
Percentage of conversion price         98.00%              
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member] | Maximum [Member] | Scenario One [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d         30              
2.25% Senior Convertible Notes [Member] | Convertible Notes due 2021 [Member] | Additional Paid-in Capital [Member]                        
Debt Instrument [Line Items]                        
Amount reclassified to stockholders' equity               $ 84,800,000        
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member]                        
Debt Instrument [Line Items]                        
Principal amount $ 450,000,000.0                      
Proceeds from issuance of convertible debt, net of issuance costs $ 436,700,000                      
Interest rate on convertible notes 1.00%                      
Debt instrument, maturity date Jun. 01, 2023                      
Initial conversion rate adjustment, shares 11.8778                      
Principal amount of debt considered for conversion rate $ 1,000                      
Initial conversion price of convertible notes | $ / shares $ 84.19                      
Contractual coupon interest expense         $ 2,600,000              
Amortization of debt discount (premium)         10,400,000              
Amortization of debt issuance costs         $ 2,200,000              
Effective interest rate         6.80%              
Fair value of embedded conversion derivative $ 57,200,000                      
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member] | Scenario Two [Member]                        
Debt Instrument [Line Items]                        
Principal amount of debt considered for conversion rate $ 1,000                      
Consecutive trading days considered for debt conversion | d 5                      
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member] | Minimum [Member]                        
Debt Instrument [Line Items]                        
Percentage of conversion price 130.00%                      
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member] | Minimum [Member] | Scenario One [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d 20                      
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member] | Maximum [Member]                        
Debt Instrument [Line Items]                        
Percentage of conversion price 98.00%                      
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member] | Maximum [Member] | Scenario One [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d 30                      
1.00% Senior Convertible Notes [Member] | Convertible Notes due 2023 [Member] | Additional Paid-in Capital [Member]                        
Debt Instrument [Line Items]                        
Amount reclassified to stockholders' equity         $ 37,300,000              
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member]                        
Debt Instrument [Line Items]                        
Principal amount   $ 450,000,000.0     $ 450,000,000              
Proceeds from issuance of convertible debt, net of issuance costs   $ 437,000,000.0                    
Interest rate on convertible notes   0.375%     0.375% 0.375%            
Debt instrument, maturity date   Mar. 15, 2025                    
Initial conversion rate adjustment, shares   10.7198                    
Principal amount of debt considered for conversion rate   $ 1,000                    
Initial conversion price of convertible notes | $ / shares   $ 93.29                    
Contractual coupon interest expense         $ 1,400,000              
Amortization of debt discount (premium)         11,900,000              
Amortization of debt issuance costs         $ 1,500,000              
Effective interest rate         4.90%              
Percentage of conversion price   130.00%                    
Debt redemption price percentage   100.00%                    
Principal payments due   $ 0                    
Carrying value         $ 374,112,000              
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member] | Scenario Two [Member]                        
Debt Instrument [Line Items]                        
Principal amount of debt considered for conversion rate   $ 1,000                    
Consecutive trading days considered for debt conversion | d   5                    
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member] | Minimum [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d   20                    
Percentage of conversion price   130.00%                    
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member] | Minimum [Member] | Scenario One [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d   20                    
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member] | Maximum [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d   30                    
Percentage of conversion price   98.00%                    
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member] | Maximum [Member] | Scenario One [Member]                        
Debt Instrument [Line Items]                        
Consecutive trading days considered for debt conversion | d   30                    
0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member] | Additional Paid-in Capital [Member]                        
Debt Instrument [Line Items]                        
Amount reclassified to stockholders' equity         $ 78,300,000              
XML 69 R51.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments (Details Textual) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2018
Dec. 31, 2019
Commitments And Contingencies Disclosure [Line Items]      
Restricted cash for security deposit $ 1.5   $ 1.5
Lease, practical expedients, package true    
Rent expense   $ 12.8  
Licensing and Purchasing Agreements [Member]      
Commitments And Contingencies Disclosure [Line Items]      
Other commitments $ 50.4    
Executive Severance Plans [Member]      
Commitments And Contingencies Disclosure [Line Items]      
Other commitments $ 20.1    
Minimum [Member]      
Commitments And Contingencies Disclosure [Line Items]      
Initial terms of lease 1 year    
Maximum [Member]      
Commitments And Contingencies Disclosure [Line Items]      
Initial terms of lease 17 years    
XML 70 R52.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments - Right-of-use Assets and Lease Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Assets    
Operating $ 102,270 $ 66,932
Financing 2,956 1,453
Total leased assets 105,226 68,385
Current:    
Operating 7,875 5,567
Financing 1,355 672
Long-term:    
Operating 111,634 73,153
Financing 1,812 905
Total lease liabilities $ 122,676 $ 80,297
Weighted-average remaining lease term (years) - operating leases 12 years 9 months 18 days 12 years 4 months 24 days
Weighted-average remaining lease term (years) - finance leases 2 years 2 months 12 days 2 years 3 months 18 days
Weighted-average discount rate - operating leases 5.40% 7.30%
Weighted-average discount rate - finance leases 4.90% 5.40%
XML 71 R53.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments - Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Lease expense:    
Operating lease expense $ 15,316 $ 11,859
Finance lease expense:    
Depreciation of right-of-use assets 1,201 441
Interest expense on lease liabilities 124 56
Total lease expense 16,641 12,356
Operating cash flows used for operating leases 14,120 12,140
Operating cash flows used for financing leases 124 56
Financing cash flows used for financing leases 1,113 420
Total cash paid for amounts included in the measurement of lease liabilities 15,357 12,616
Operating lease liabilities arising from obtaining right-of-use assets $ 41,148 $ 86,134
XML 72 R54.htm IDEA: XBRL DOCUMENT v3.20.4
Commitments - Future Minimum Annual Lease Payments under Capital, Operating and Financing Leases (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Financing Leases    
2021 $ 1,465  
2022 1,397  
2023 466  
2024 9  
Total minimum lease payments 3,337  
Less: amount representing interest (170)  
Present value of obligations under leases 3,167  
Less: current portion (1,355) $ (672)
Long-term lease obligations 1,812 905
Operating Leases    
2021 14,140  
2022 13,582  
2023 13,158  
2024 12,072  
2025 10,699  
Thereafter 106,197  
Total minimum lease payments 169,848  
Less: amount representing interest (50,339)  
Present value of obligations under leases 119,509  
Less: current portion (7,875) (5,567)
Long-term lease obligations $ 111,634 $ 73,153
XML 73 R55.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity (Details Textual) - USD ($)
 1 Months Ended
Mar. 31, 2020
Feb. 29, 2020
Oct. 31, 2017
Dec. 31, 2020
Sep. 10, 2020
Sep. 09, 2020
Dec. 31, 2019
Equity Class Of Treasury Stock [Line Items]              
Common stock, shares authorized       150,000,000 150,000,000 120,000,000 120,000,000
Common Stock [Member]              
Equity Class Of Treasury Stock [Line Items]              
Share repurchase program, authorized amount   $ 150,000,000          
Share repurchase program, period in force     3 years        
Share repurchase program, expiration month and year     2020-10        
Share repurchase program, expiration date   Dec. 31, 2021          
Share repurchase program, remaining authorized amount       $ 75,000,000.0      
Common stock, shares authorized         150,000,000 120,000,000  
Common Stock [Member] | 0.375% Senior Convertible Notes [Member] | Convertible Notes due 2025 [Member]              
Equity Class Of Treasury Stock [Line Items]              
Shares repurchased during period 1,085,000            
Shares repurchased during period, value $ 75,000,000.0            
Common Stock [Member] | Maximum [Member]              
Equity Class Of Treasury Stock [Line Items]              
Share repurchase program, authorized amount     $ 100,000,000        
XML 74 R56.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation (Details Textual) - USD ($)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2015
Sep. 10, 2020
Sep. 09, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock, shares authorized 150,000,000 120,000,000     150,000,000 120,000,000
Preferred stock, shares authorized 5,000,000 5,000,000        
Preferred stock, shares issued 0 0        
Preferred stock, shares outstanding 0 0        
Closing price of stock $ 56.33          
Proceeds from exercise of stock options $ 0 $ 0 $ 1,300,000      
Total intrinsic value $ 400,000 $ 1,000,000.0 $ 2,500,000      
Total stock options vested 0 0 0      
ESPP [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Unrecognized cost related to share-based compensation $ 1,000,000.0          
Maximum percentage of annual compensation 15.00%          
Maximum amount withheld to purchase shares of the company $ 21,250          
Percentage of issuance price of stock under the stock issuance program 85.00%          
ESPP offering period 6 months          
Number of share purchased under ESPP 136,000 129,000 151,000      
2014 Equity Incentive Plan [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Percentage of acceleration of stock options in case of change in control 50.00%          
Restricted Stock Units (RSUs) [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Unrecognized cost related to share-based compensation $ 21,000,000.0          
Weighted average contractual term 1 year 8 months 12 days          
Fair value of restricted stock units vested $ 12,100,000 $ 21,500,000 $ 8,800,000      
Total shares withheld related to statutory tax 71,000 122,000 42,000      
Payments of employees tax obligations $ 4,100,000 $ 7,200,000 $ 2,200,000      
Vested during the period 209,000          
Performance Based Restricted Stock Units (PRSUs) [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Unrecognized cost related to share-based compensation $ 16,100,000          
Weighted average contractual term 2 years 8 months 12 days          
Fair value of restricted stock units vested $ 3,800,000 $ 19,900,000 $ 2,100,000      
Total shares withheld related to statutory tax 25,000 121,000 8,000      
Payments of employees tax obligations $ 1,600,000 $ 7,200,000 $ 400,000      
Vested during the period 61,000 276,000 21,000      
Vesting period for the awards 5 years     5 years    
Performance Based Restricted Stock Units (PRSUs) [Member] | Minimum [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Share payout levels 0.00%          
Performance Based Restricted Stock Units (PRSUs) [Member] | Maximum [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Share payout levels 200.00%          
Stock Options [Member]            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Unrecognized cost related to share-based compensation $ 0          
Total shares withheld related to statutory tax 8,000 21,000 65,000      
Payments of employees tax obligations $ 0 $ 100,000 $ 400,000      
XML 75 R57.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense before taxes $ 18,145 $ 30,297 $ 25,673
Related income tax benefits (3,088) (6,191) (6,418)
Stock-based compensation expense, net of taxes 15,057 24,106 19,255
Selling, General and Administrative Expense [Member]      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense before taxes 12,622 25,968 22,190
Research and Development Expense [Member]      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense before taxes 5,259 3,798 3,052
Cost of Sales [Member]      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense before taxes $ 264 $ 531 $ 431
XML 76 R58.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Restricted Award Activity (Details) - Restricted Stock Units (RSUs) [Member]
shares in Thousands
 12 Months Ended
Dec. 31, 2020
$ / shares
shares
Restricted Stock Units  
Number of shares outstanding, Beginning balance | shares 945
Number of shares, Granted | shares 381
Number of shares, Vested | shares (209)
Number of shares, Forfeited | shares (123)
Number of shares outstanding, Ending balance | shares 994
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]  
Weighted average grant date fair value outstanding, Beginning balance | $ / shares $ 59.21
Weighted average grant date fair value, Granted | $ / shares 63.64
Weighted average grant date fair value, Vested | $ / shares 68.67
Weighted average grant date fair value, Forfeited | $ / shares 59.21
Weighted average grant date fair value outstanding, Ending balance | $ / shares $ 58.94
XML 77 R59.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Performance-Based Restricted Stock Award Activity (Details) - Performance Based Restricted Stock Units (PRSUs) [Member] - $ / shares
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]      
Number of shares outstanding, Beginning balance 731,000    
Shares, Awarded at target 172,000    
Number of shares, Vested (61,000) (276,000) (21,000)
Number of shares, Forfeited (223,000)    
Number of shares outstanding, Ending balance 619,000 731,000  
Maximum Number of Shares Eligible to be Issued, Outstanding, Beginning balance 1,116,000    
Maximum Number of Shares Eligible to be Issued, Awarded at target 248,000    
Maximum Number of Shares Eligible to be Issued, Vested (61,000)    
Maximum Number of Shares Eligible to be Issued, Forfeited (453,000)    
Maximum Number of Shares Eligible to be Issued, Outstanding, Ending balance 850,000 1,116,000  
Weighted average grant date fair value outstanding, Beginning balance $ 57.07    
Average Grant Date Fair Value, Awarded at target 69.72    
Average Grant Date Fair Value, Vested 73.20    
Average Grant Date Fair Value, Forfeited 56.48    
Weighted average grant date fair value outstanding, Ending balance $ 57.38 $ 57.07  
XML 78 R60.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Stock Options Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Summary of stock option activity under all stock plans    
Underlying shares outstanding, Beginning balance 16  
Underlying shares, exercised (16)  
Underlying shares outstanding, Ending balance   16
Weighted average exercise price outstanding, Beginning balance $ 29.18  
Weighted Average Exercise Price, exercised $ 29.18  
Weighted Average Exercise Price outstanding, Ending balance   $ 29.18
Weighted Average Remaining Contractual Term outstanding, Beginning balance   10 months 20 days
Aggregate Intrinsic Value outstanding   $ 747
XML 79 R61.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP (Details) - ESPP [Member]
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Weighted average assumptions used to estimate fair value of stock options granted and stock purchase rights under ESPP      
Volatility 56.00% 35.00% 33.00%
Expected term (years) 6 months 6 months 6 months
Risk free interest rate 0.50% 2.30% 1.80%
XML 80 R62.htm IDEA: XBRL DOCUMENT v3.20.4
Stock-Based Compensation - Stock Reserved for Future Issuance (Details)
shares in Thousands
Dec. 31, 2020
shares
Common stock options:  
Shares reserved for future issuance 72,526
Restricted Stock Units And Performance-Based Restricted Stock Units [Member]  
Common stock options:  
Shares reserved for future issuance 1,630
Available for Future Grant [Member]  
Common stock options:  
Shares reserved for future issuance 3,651
ESPP [Member]  
Common stock options:  
Shares reserved for future issuance 828
2.25% Senior Convertible Notes due 2021 [Member]  
Common stock options:  
Shares reserved for future issuance 14,396
1.00% Senior Convertible Notes due 2023 [Member]  
Common stock options:  
Shares reserved for future issuance 7,082
0.375% Senior Convertible Notes due 2025 [Member]  
Common stock options:  
Shares reserved for future issuance 6,512
Senior Convertible Warrants Due 2021 [Member]  
Common stock options:  
Shares reserved for future issuance 25,207
Senior Convertible Warrants Due 2023 [Member]  
Common stock options:  
Shares reserved for future issuance 6,949
Senior Convertible Warrants Due 2025 [Member]  
Common stock options:  
Shares reserved for future issuance 6,271
XML 81 R63.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Summary of Income Before Income Taxes By Region (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Summarized details of income before income taxes by region      
United States $ (45,534) $ 74,721 $ 8,939
Foreign (2,011) 5,796 (216)
(Loss) income before income taxes $ (47,545) $ 80,517 $ 8,723
XML 82 R64.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Components of Income Tax Provision (Benefit) (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Current:      
Federal $ (35) $ 4,802 $ (4,188)
State 2,309 4,638 2,043
Foreign 4,675 2,205 5,972
Total current provision 6,949 11,645 3,827
Deferred:      
Federal (13,800) 5,873 (5,944)
State (8,315) (4,565) (7,092)
Foreign (3,849) (819) (98,795)
Total deferred provision (25,964) 489 (111,831)
Changes in tax rate (579) 606 258
Changes in valuation allowance 9,202 2,543 103,990
Total (benefit) provision $ (10,392) $ 15,283 $ (3,756)
XML 83 R65.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]      
Tax (benefit) provision at federal statutory rate $ (9,984) $ 16,909 $ 1,832
Income tax credits and incentives (7,155) (7,209) (5,525)
State income tax (1,243) 3,763 90
Valuation allowance 9,202 2,543 103,990
Net tax benefit on international restructuring     (97,028)
Return to provision adjustments (881) (2,323) (4,180)
Acquisition related charges 687 (1,808) (221)
Compensation expense 3,314 1,643 2,008
Income tax reserves (4,217) (1,146) (6,717)
Nondeductible meals and entertainment 351 717 769
Foreign tax rate differences from federal statutory rate (1,215) 716 576
Changes in tax rate (579) 606 258
Other 1,328 872 392
Total (benefit) provision $ (10,392) $ 15,283 $ (3,756)
XML 84 R66.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Deferred tax assets:    
Amortization $ 67,945 $ 87,296
Net operating loss carryforwards 47,407 24,656
Inventory 35,763 24,069
General business and other credit carryforwards 26,542 23,168
Lease liability 28,356 17,636
Stock-based compensation 9,918 11,562
Original issue discount 3,735 1,840
Other 27,479 22,591
Gross deferred tax assets 247,145 212,818
Less valuation allowance (130,434) (122,534)
Net deferred tax assets 116,711 90,284
Deferred tax liabilities:    
Depreciation (44,760) (37,045)
Acquired intangibles (27,544) (34,799)
Right-of-use assets (24,122) (14,891)
Other (5,176) (6,260)
Total deferred tax liabilities (101,602) (92,995)
Net deferred tax assets $ 15,109  
Net deferred tax liabilities   $ (2,711)
XML 85 R67.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes (Details Textual) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Nov. 30, 2018
Income Taxes [Line Items]        
Net decrease in deferred taxes $ 800      
Decrease in valuation allowance of deferred taxes 1,300      
Unrecognized tax benefits that would impact effective tax 16,500 $ 18,700 $ 18,100  
Income tax, penalties and interest (benefit) expense (100) 100 $ (500)  
Income tax, penalties and interest accrued 100 100    
Remaining unrecognized tax positions 2,400      
Deferred tax assets 247,145 212,818    
Valuation allowance for deferred tax assets 130,434 $ 122,534    
Undistributed earnings attributable to operations 13,200      
Research and Development [Member] | California Tax Authority [Member]        
Income Taxes [Line Items]        
Net research and development carryforwards 35,700      
Federal Tax Authority [Member]        
Income Taxes [Line Items]        
Net operating loss carryforwards $ 2,000      
Operating loss carryforwards expiration year 2026      
Federal Tax Authority [Member] | Research and Development [Member]        
Income Taxes [Line Items]        
Net research and development carryforwards $ 11,400      
Federal tax credit carryforwards, expiration year 2038      
State and Local Jurisdiction [Member]        
Income Taxes [Line Items]        
Net operating loss carryforwards $ 50,900      
Operating loss carryforwards expiration year 2021      
Foreign Tax Authority [Member]        
Income Taxes [Line Items]        
Net operating loss carryforwards $ 100      
ASU 2016-16 [Member]        
Income Taxes [Line Items]        
Deferred tax assets       $ 100,800
Valuation allowance for deferred tax assets       $ 96,700
XML 86 R68.htm IDEA: XBRL DOCUMENT v3.20.4
Income Taxes - Summary of Unrecognized Tax Benefits (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns Roll Forward      
Gross unrecognized tax benefits at beginning of period $ 20,328 $ 19,545 $ 25,356
Increases in tax positions for prior years 1,758 62 499
Decreases in tax positions for prior years   (112) (756)
Increases in tax positions for current year relating to ongoing operations 2,159 2,073 1,913
Decreases in tax positions as a result of a lapse of statute of limitations (5,929) (616) (6,446)
Increases in tax positions for current year relating to acquisitions     169
Decreases in tax positions due to settlements with taxing authorities   (624) (1,190)
Gross unrecognized tax benefits period end $ 18,316 $ 20,328 $ 19,545
XML 87 R69.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segment, Product and Geographic Information (Details Textual)
 12 Months Ended
Dec. 31, 2020
segment
Segment Reporting [Abstract]  
Number of operating segments 1
XML 88 R70.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segment, Product and Geographic Information - Schedule of Net Sales by Product Line (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Entity Wide Information Revenue From External Customer [Line Items]      
Net sales $ 1,050,582 $ 1,168,070 $ 1,101,714
Spinal Hardware [Member]      
Entity Wide Information Revenue From External Customer [Line Items]      
Net sales 783,510 851,440 788,649
Surgical Support [Member]      
Entity Wide Information Revenue From External Customer [Line Items]      
Net sales $ 267,072 $ 316,630 $ 313,065
XML 89 R71.htm IDEA: XBRL DOCUMENT v3.20.4
Business Segment, Product and Geographic Information - Schedule of Net Sales and Net Property and Equipment by Geographical Area (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Revenues and Net Property and Equipment by Geographical Areas [Line Items]      
Net Sales $ 1,050,582 $ 1,168,070 $ 1,101,714
Property and Equipment, Net 286,369 266,318  
United States      
Revenues and Net Property and Equipment by Geographical Areas [Line Items]      
Net Sales 821,824 941,086 896,152
Property and Equipment, Net 239,802 218,771  
International (excludes Puerto Rico) [Member]      
Revenues and Net Property and Equipment by Geographical Areas [Line Items]      
Net Sales 228,758 226,984 $ 205,562
Property and Equipment, Net $ 46,567 $ 47,547  
XML 90 R72.htm IDEA: XBRL DOCUMENT v3.20.4
Contingencies (Details Textual)
$ in Millions
 12 Months Ended
Dec. 31, 2018
USD ($)
Madsen Medical, Inc. Litigation [Member]  
Loss Contingencies [Line Items]  
Settlement agreement, consideration $ 27.8
XML 91 R73.htm IDEA: XBRL DOCUMENT v3.20.4
Subsequent Events (Details) - Subsequent Event [Member] - Simplify Medical Pty Limited [Member]
$ in Millions
Feb. 24, 2021
USD ($)
Subsequent Event [Line Items]  
Upfront payment $ 150.0
Upfront payment funded 150.0
Maximum [Member]  
Subsequent Event [Line Items]  
Upon achievement of the regulatory milestone, entitled to a one-time payment $ 45.9
EXCEL 92 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 93 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 94 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 95 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.4 html 323 551 1 false 106 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations Sheet http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Equity Sheet http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity Consolidated Statements of Equity Statements 6 false false R7.htm 100060 - Statement - Consolidated Statements of Cash Flows Sheet http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 100070 - Statement - Consolidated Statements of Cash Flows (Parenthetical) Sheet http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical Consolidated Statements of Cash Flows (Parenthetical) Statements 8 false false R9.htm 100080 - Disclosure - Organization and Significant Accounting Policies Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPolicies Organization and Significant Accounting Policies Notes 9 false false R10.htm 100090 - Disclosure - Balance Sheet Details Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetails Balance Sheet Details Notes 10 false false R11.htm 100100 - Disclosure - Marketable Securities Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 11 false false R12.htm 100110 - Disclosure - Financial Instruments and Fair Value Measurements Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurements Financial Instruments and Fair Value Measurements Notes 12 false false R13.htm 100120 - Disclosure - Business Combinations Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessCombinations Business Combinations Notes 13 false false R14.htm 100130 - Disclosure - Indebtedness Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtedness Indebtedness Notes 14 false false R15.htm 100140 - Disclosure - Commitments Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitments Commitments Notes 15 false false R16.htm 100150 - Disclosure - Stockholders' Equity Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 16 false false R17.htm 100160 - Disclosure - Stock-Based Compensation Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 17 false false R18.htm 100170 - Disclosure - Income Taxes Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 18 false false R19.htm 100180 - Disclosure - Business Segment, Product, and Geographic Information Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformation Business Segment, Product, and Geographic Information Notes 19 false false R20.htm 100190 - Disclosure - Contingencies Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingencies Contingencies Notes 20 false false R21.htm 100200 - Disclosure - Subsequent Events Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 21 false false R22.htm 100210 - Disclosure - Organization and Significant Accounting Policies (Policies) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies Organization and Significant Accounting Policies (Policies) Policies http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPolicies 22 false false R23.htm 100220 - Disclosure - Organization and Significant Accounting Policies (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesTables Organization and Significant Accounting Policies (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPolicies 23 false false R24.htm 100230 - Disclosure - Balance Sheet Details (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables Balance Sheet Details (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetails 24 false false R25.htm 100240 - Disclosure - Marketable Securities (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecurities 25 false false R26.htm 100250 - Disclosure - Financial Instruments and Fair Value Measurements (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables Financial Instruments and Fair Value Measurements (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurements 26 false false R27.htm 100260 - Disclosure - Indebtedness (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessTables Indebtedness (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtedness 27 false false R28.htm 100270 - Disclosure - Commitments (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsTables Commitments (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitments 28 false false R29.htm 100280 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensation 29 false false R30.htm 100290 - Disclosure - Income Taxes (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxes 30 false false R31.htm 100300 - Disclosure - Business Segment, Product and Geographic Information (Tables) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationTables Business Segment, Product and Geographic Information (Tables) Tables 31 false false R32.htm 100310 - Disclosure - Organization and Significant Accounting Policies (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual Organization and Significant Accounting Policies (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesTables 32 false false R33.htm 100320 - Disclosure - Organization and Significant Accounting Policies - Summary of Changes in Allowance for Credit Losses (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesSummaryOfChangesInAllowanceForCreditLossesDetails Organization and Significant Accounting Policies - Summary of Changes in Allowance for Credit Losses (Details) Details 33 false false R34.htm 100330 - Disclosure - Organization and Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails Organization and Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) Details 34 false false R35.htm 100340 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails Organization and Significant Accounting Policies - Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share (Details) Details 35 false false R36.htm 100350 - Disclosure - Balance Sheet Details - Property and Equipment Net (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails Balance Sheet Details - Property and Equipment Net (Details) Details 36 false false R37.htm 100360 - Disclosure - Balance Sheet Details (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsDetailsTextual Balance Sheet Details (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables 37 false false R38.htm 100370 - Disclosure - Balance Sheet Details - Goodwill and Intangible Assets (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails Balance Sheet Details - Goodwill and Intangible Assets (Details) Details 38 false false R39.htm 100380 - Disclosure - Balance Sheet Details - Changes to Goodwill (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails Balance Sheet Details - Changes to Goodwill (Details) Details 39 false false R40.htm 100390 - Disclosure - Balance Sheet Details - Future Amortization Expense Related to Intangible Assets (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails Balance Sheet Details - Future Amortization Expense Related to Intangible Assets (Details) Details 40 false false R41.htm 100400 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details) Details 41 false false R42.htm 100410 - Disclosure - Marketable Securities - Schedule of Carrying Value and Amortized Cost of Company's Marketable Debt Securities (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails Marketable Securities - Schedule of Carrying Value and Amortized Cost of Company's Marketable Debt Securities (Details) Details 42 false false R43.htm 100420 - Disclosure - Financial Instruments and Fair Value Measurements (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual Financial Instruments and Fair Value Measurements (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables 43 false false R44.htm 100430 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis (Details) Details 44 false false R45.htm 100440 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs (Details) Details 45 false false R46.htm 100450 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Recurring Fair Value Measurements of Contingent Consideration Liabilities (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails Financial Instruments and Fair Value Measurements - Schedule of Recurring Fair Value Measurements of Contingent Consideration Liabilities (Details) Details 46 false false R47.htm 100460 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs (Details) Details 47 false false R48.htm 100470 - Disclosure - Indebtedness - Carrying Value of Senior Convertible Notes (Details) Notes http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails Indebtedness - Carrying Value of Senior Convertible Notes (Details) Details 48 false false R49.htm 100490 - Disclosure - Indebtedness - Carrying Value of Senior Convertible Notes (Parenthetical) (Details) Notes http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails Indebtedness - Carrying Value of Senior Convertible Notes (Parenthetical) (Details) Details 49 false false R50.htm 100500 - Disclosure - Indebtedness (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual Indebtedness (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessTables 50 false false R51.htm 100510 - Disclosure - Commitments (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual Commitments (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsTables 51 false false R52.htm 100520 - Disclosure - Commitments - Right-of-use Assets and Lease Liabilities (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails Commitments - Right-of-use Assets and Lease Liabilities (Details) Details 52 false false R53.htm 100530 - Disclosure - Commitments - Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails Commitments - Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations (Details) Details 53 false false R54.htm 100540 - Disclosure - Commitments - Future Minimum Annual Lease Payments under Capital, Operating and Financing Leases (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails Commitments - Future Minimum Annual Lease Payments under Capital, Operating and Financing Leases (Details) Details 54 false false R55.htm 100560 - Disclosure - Stockholders' Equity (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual Stockholders' Equity (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquity 55 false false R56.htm 100570 - Disclosure - Stock-Based Compensation (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual Stock-Based Compensation (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables 56 false false R57.htm 100580 - Disclosure - Stock-Based Compensation - Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails Stock-Based Compensation - Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements (Details) Details 57 false false R58.htm 100590 - Disclosure - Stock-Based Compensation - Restricted Award Activity (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails Stock-Based Compensation - Restricted Award Activity (Details) Details 58 false false R59.htm 100600 - Disclosure - Stock-Based Compensation - Performance-Based Restricted Stock Award Activity (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails Stock-Based Compensation - Performance-Based Restricted Stock Award Activity (Details) Details 59 false false R60.htm 100610 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails Stock-Based Compensation - Stock Options Activity (Details) Details 60 false false R61.htm 100620 - Disclosure - Stock-Based Compensation - Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails Stock-Based Compensation - Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP (Details) Details 61 false false R62.htm 100630 - Disclosure - Stock-Based Compensation - Stock Reserved for Future Issuance (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails Stock-Based Compensation - Stock Reserved for Future Issuance (Details) Details 62 false false R63.htm 100640 - Disclosure - Income Taxes - Summary of Income Before Income Taxes By Region (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails Income Taxes - Summary of Income Before Income Taxes By Region (Details) Details 63 false false R64.htm 100650 - Disclosure - Income Taxes - Components of Income Tax Provision (Benefit) (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails Income Taxes - Components of Income Tax Provision (Benefit) (Details) Details 64 false false R65.htm 100660 - Disclosure - Income Taxes - Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails Income Taxes - Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate (Details) Details 65 false false R66.htm 100670 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details) Details 66 false false R67.htm 100680 - Disclosure - Income Taxes (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual Income Taxes (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables 67 false false R68.htm 100690 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails Income Taxes - Summary of Unrecognized Tax Benefits (Details) Details 68 false false R69.htm 100700 - Disclosure - Business Segment, Product and Geographic Information (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationDetailsTextual Business Segment, Product and Geographic Information (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationTables 69 false false R70.htm 100710 - Disclosure - Business Segment, Product and Geographic Information - Schedule of Net Sales by Product Line (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails Business Segment, Product and Geographic Information - Schedule of Net Sales by Product Line (Details) Details 70 false false R71.htm 100720 - Disclosure - Business Segment, Product and Geographic Information - Schedule of Net Sales and Net Property and Equipment by Geographical Area (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails Business Segment, Product and Geographic Information - Schedule of Net Sales and Net Property and Equipment by Geographical Area (Details) Details 71 false false R72.htm 100730 - Disclosure - Contingencies (Details Textual) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual Contingencies (Details Textual) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingencies 72 false false R73.htm 100740 - Disclosure - Subsequent Events (Details) Sheet http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) Details http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEvents 73 false false All Reports Book All Reports nuva-10k_20201231.htm nuva-20201231.xsd nuva-20201231_cal.xml nuva-20201231_def.xml nuva-20201231_lab.xml nuva-20201231_pre.xml nuva-ex1042_270.htm nuva-ex1048_269.htm nuva-ex1049_268.htm nuva-ex211_19.htm nuva-ex231_7.htm nuva-ex311_12.htm nuva-ex312_18.htm nuva-ex321_17.htm gh5y20ivjrjj000001.jpg http://xbrl.sec.gov/dei/2020-01-31 http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/country/2020-01-31 true true JSON 98 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nuva-10k_20201231.htm": { "axisCustom": 0, "axisStandard": 37, "contextCount": 323, "dts": { "calculationLink": { "local": [ "nuva-20201231_cal.xml" ] }, "definitionLink": { "local": [ "nuva-20201231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "nuva-10k_20201231.htm" ] }, "labelLink": { "local": [ "nuva-20201231_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-doc-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "nuva-20201231_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-ref-2020-01-31.xml", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml" ] }, "schema": { "local": [ "nuva-20201231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd" ] } }, "elementCount": 797, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2020-01-31": 51, "http://www.nuvasive.com/20201231": 1, "http://xbrl.sec.gov/dei/2020-01-31": 6, "total": 58 }, "keyCustom": 58, "keyStandard": 493, "memberCustom": 44, "memberStandard": 62, "nsprefix": "nuva", "nsuri": "http://www.nuvasive.com/20201231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Balance Sheet Details", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetails", "shortName": "Balance Sheet Details", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Marketable Securities", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecurities", "shortName": "Marketable Securities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Financial Instruments and Fair Value Measurements", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurements", "shortName": "Financial Instruments and Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancialInstrumentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Business Combinations", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessCombinations", "shortName": "Business Combinations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Indebtedness", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtedness", "shortName": "Indebtedness", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Commitments", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitments", "shortName": "Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Stockholders' Equity", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquity", "shortName": "Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Stock-Based Compensation", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Income Taxes", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Business Segment, Product, and Geographic Information", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformation", "shortName": "Business Segment, Product, and Geographic Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Consolidated Balance Sheets", "role": "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Contingencies", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingencies", "shortName": "Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LegalMattersAndContingenciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Subsequent Events", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "nuva:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Organization and Significant Accounting Policies (Policies)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies", "shortName": "Organization and Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "nuva:DescriptionOfBusinessPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:ReceivablesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Organization and Significant Accounting Policies (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesTables", "shortName": "Organization and Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ReceivablesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Balance Sheet Details (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables", "shortName": "Balance Sheet Details (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "nuva:FairValueOfCarryingValueAndAmortizedCostOfCompanySMarketableSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Marketable Securities (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesTables", "shortName": "Marketable Securities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "nuva:FairValueOfCarryingValueAndAmortizedCostOfCompanySMarketableSecuritiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Financial Instruments and Fair Value Measurements (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables", "shortName": "Financial Instruments and Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Indebtedness (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessTables", "shortName": "Indebtedness (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "nuva:LeaseLiabilitiesAndAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Commitments (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsTables", "shortName": "Commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "nuva:LeaseLiabilitiesAndAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Income Taxes (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Business Segment, Product and Geographic Information (Tables)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationTables", "shortName": "Business Segment, Product and Geographic Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RetainedEarningsAccumulatedDeficit", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Organization and Significant Accounting Policies (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "shortName": "Organization and Significant Accounting Policies (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "nuva:ConcentrationOfCreditRiskAndSignificantCustomersPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "INF", "lang": null, "name": "nuva:ConcentrationRiskNumberOfCustomers", "reportCount": 1, "unique": true, "unitRef": "U_nuvaCustomer", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Organization and Significant Accounting Policies - Summary of Changes in Allowance for Credit Losses (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesSummaryOfChangesInAllowanceForCreditLossesDetails", "shortName": "Organization and Significant Accounting Policies - Summary of Changes in Allowance for Credit Losses (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock", "us-gaap:ReceivablesPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Organization and Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "shortName": "Organization and Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaapConvertibleDebtSecuritiesMember_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Organization and Significant Accounting Policies - Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails", "shortName": "Organization and Significant Accounting Policies - Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Balance Sheet Details - Property and Equipment Net (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails", "shortName": "Balance Sheet Details - Property and Equipment Net (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Balance Sheet Details (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsDetailsTextual", "shortName": "Balance Sheet Details (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Balance Sheet Details - Goodwill and Intangible Assets (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails", "shortName": "Balance Sheet Details - Goodwill and Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GoodwillGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Balance Sheet Details - Changes to Goodwill (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails", "shortName": "Balance Sheet Details - Changes to Goodwill (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfGoodwillTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:GoodwillGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Consolidated Statements of Operations", "role": "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Balance Sheet Details - Future Amortization Expense Related to Intangible Assets (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails", "shortName": "Balance Sheet Details - Future Amortization Expense Related to Intangible Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails", "shortName": "Balance Sheet Details - Accounts Payable and Accrued Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccruedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nuva:FairValueOfCarryingValueAndAmortizedCostOfCompanySMarketableSecuritiesTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Marketable Securities - Schedule of Carrying Value and Amortized Cost of Company's Marketable Debt Securities (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails", "shortName": "Marketable Securities - Schedule of Carrying Value and Amortized Cost of Company's Marketable Debt Securities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nuva:FairValueOfCarryingValueAndAmortizedCostOfCompanySMarketableSecuritiesTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Financial Instruments and Fair Value Measurements (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "shortName": "Financial Instruments and Fair Value Measurements (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nuva:FairValueOfCarryingValueAndAmortizedCostOfCompanySMarketableSecuritiesTableTextBlock", "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtSecurities", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "shortName": "Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:FinancialInstrumentsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "shortName": "Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_srtRangeAxis_srtWeightedAverageMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapFinancialInstrumentAxis_nuvaCommercialSaleMilestoneMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputDiscountRateMember_20201231", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Recurring Fair Value Measurements of Contingent Consideration Liabilities (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails", "shortName": "Financial Instruments and Fair Value Measurements - Schedule of Recurring Fair Value Measurements of Contingent Consideration Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_srtRangeAxis_srtWeightedAverageMember_us-gaapFairValueByFairValueHierarchyLevelAxis_us-gaapFairValueInputsLevel3Member_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_us-gaapFinancialInstrumentAxis_nuvaCommercialSaleMilestoneMember_us-gaapMeasurementInputTypeAxis_us-gaapMeasurementInputDiscountRateMember_20201231", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails", "shortName": "Financial Instruments and Fair Value Measurements - Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapFairValueByLiabilityClassAxis_nuvaContingentConsiderationLiabilitiesMember_20181231", "decimals": "-3", "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ConvertibleNotesPayable", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Indebtedness - Carrying Value of Senior Convertible Notes (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "shortName": "Indebtedness - Carrying Value of Senior Convertible Notes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapDebtInstrumentAxis_nuvaTwoPointTwoFivePercentSeniorConvertibleNotesMember_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentUnamortizedDiscount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapDebtInstrumentAxis_nuvaTwoPointTwoFivePercentSeniorConvertibleNotesMember_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodTwoMember_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Indebtedness - Carrying Value of Senior Convertible Notes (Parenthetical) (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "shortName": "Indebtedness - Carrying Value of Senior Convertible Notes (Parenthetical) (Details)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtInstrumentsTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapDebtInstrumentAxis_nuvaOnePointZeroZeroZeroPercentSeniorConvertibleNotesMember_us-gaapDebtInstrumentRedemptionPeriodAxis_us-gaapDebtInstrumentRedemptionPeriodThreeMember_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Consolidated Statements of Comprehensive Income", "role": "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome", "shortName": "Consolidated Statements of Comprehensive Income", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromConvertibleDebt", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Indebtedness (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "shortName": "Indebtedness (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapCreditFacilityAxis_us-gaapRevolvingCreditFacilityMember_20200229", "decimals": "INF", "lang": null, "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "us-gaap:SecurityDepositLiability", "p", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SecurityDepositLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Commitments (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual", "shortName": "Commitments (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:SecurityDepositLiability", "p", "us-gaap:CommitmentsDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:SecurityDepositLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Commitments - Right-of-use Assets and Lease Liabilities (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails", "shortName": "Commitments - Right-of-use Assets and Lease Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nuva:LeaseLiabilitiesAndAssetsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:FinanceLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Commitments - Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails", "shortName": "Commitments - Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Commitments - Future Minimum Annual Lease Payments under Capital, Operating and Financing Leases (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails", "shortName": "Commitments - Future Minimum Annual Lease Payments under Capital, Operating and Financing Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Stockholders' Equity (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "shortName": "Stockholders' Equity (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapStatementEquityComponentsAxis_us-gaapCommonStockMember_20200229", "decimals": "INF", "lang": null, "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Stock-Based Compensation (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "shortName": "Stock-Based Compensation (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "nuva:AllocatedShareBasedCompensationExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100580 - Disclosure - Stock-Based Compensation - Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails", "shortName": "Stock-Based Compensation - Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "nuva:AllocatedShareBasedCompensationExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Stock-Based Compensation - Restricted Award Activity (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails", "shortName": "Stock-Based Compensation - Restricted Award Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapAwardTypeAxis_nuvaPerformanceBasedRestrictedStockUnitsMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - Stock-Based Compensation - Performance-Based Restricted Stock Award Activity (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "shortName": "Stock-Based Compensation - Performance-Based Restricted Stock Award Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapAwardTypeAxis_nuvaPerformanceBasedRestrictedStockUnitsMember_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20171231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Consolidated Statements of Equity", "role": "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity", "shortName": "Consolidated Statements of Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20171231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - Stock-Based Compensation - Stock Options Activity (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails", "shortName": "Stock-Based Compensation - Stock Options Activity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - Stock-Based Compensation - Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails", "shortName": "Stock-Based Compensation - Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapSubsidiarySaleOfStockAxis_us-gaapEmployeeStockMember_20200101_20201231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Stock-Based Compensation - Stock Reserved for Future Issuance (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails", "shortName": "Stock-Based Compensation - Stock Reserved for Future Issuance (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Income Taxes - Summary of Income Before Income Taxes By Region (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails", "shortName": "Income Taxes - Summary of Income Before Income Taxes By Region (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - Income Taxes - Components of Income Tax Provision (Benefit) (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails", "shortName": "Income Taxes - Components of Income Tax Provision (Benefit) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Income Taxes - Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails", "shortName": "Income Taxes - Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "nuva:DeferredTaxAssetsAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "Income Taxes - Significant Components of Deferred Tax Assets and Liabilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "nuva:DeferredTaxAssetsAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncreaseDecreaseInDeferredIncomeTaxes", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - Income Taxes (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual", "shortName": "Income Taxes (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:IncreaseDecreaseInDeferredIncomeTaxes", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100690 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails", "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20171231", "decimals": "-3", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "U_nuvasegment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100700 - Disclosure - Business Segment, Product and Geographic Information (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationDetailsTextual", "shortName": "Business Segment, Product and Geographic Information (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfOperatingSegments", "reportCount": 1, "unique": true, "unitRef": "U_nuvasegment", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100060 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Business Segment, Product and Geographic Information - Schedule of Net Sales by Product Line (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails", "shortName": "Business Segment, Product and Geographic Information - Schedule of Net Sales by Product Line (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_srtProductOrServiceAxis_nuvaSpinalHardwareMember_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Business Segment, Product and Geographic Information - Schedule of Net Sales and Net Property and Equipment by Geographical Area (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails", "shortName": "Business Segment, Product and Geographic Information - Schedule of Net Sales and Net Property and Equipment by Geographical Area (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_srtStatementGeographicalAxis_countryUS_20200101_20201231", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapLossContingenciesByNatureOfContingencyAxis_nuvaMadsenMedicalIncLitigationMember_20180101_20181231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100730 - Disclosure - Contingencies (Details Textual)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual", "shortName": "Contingencies (Details Textual)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:LegalMattersAndContingenciesTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapLossContingenciesByNatureOfContingencyAxis_nuvaMadsenMedicalIncLitigationMember_20180101_20181231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:LitigationSettlementAmountAwardedToOtherParty", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapBusinessAcquisitionAxis_nuvaSimplifyMedicalPtyLimitedMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210224", "decimals": "-5", "first": true, "lang": null, "name": "nuva:BusinessCombinationUpfrontPaymentLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Subsequent Events (Details)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_us-gaapBusinessAcquisitionAxis_nuvaSimplifyMedicalPtyLimitedMember_us-gaapSubsequentEventTypeAxis_us-gaapSubsequentEventMember_20210224", "decimals": "-5", "first": true, "lang": null, "name": "nuva:BusinessCombinationUpfrontPaymentLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20201231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100070 - Statement - Consolidated Statements of Cash Flows (Parenthetical)", "role": "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical", "shortName": "Consolidated Statements of Cash Flows (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20181231", "decimals": "-3", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Organization and Significant Accounting Policies", "role": "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPolicies", "shortName": "Organization and Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nuva-10k_20201231.htm", "contextRef": "C_0001142596_20200101_20201231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 106, "tag": { "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r654", "r655", "r656" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "verboseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r652" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "verboseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "verboseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "verboseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "verboseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r660" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "verboseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r658" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r654", "r655", "r656" ], "lang": { "en-us": { "role": { "label": "Icfr Auditor Attestation Flag", "terseLabel": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r651" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r653" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "nuva_AccountingStandardUpdate201616Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Standard Update 2016-16.", "label": "Accounting Standard Update201616 [Member]", "terseLabel": "ASU 2016-16 [Member]" } } }, "localname": "AccountingStandardUpdate201616Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_AccountingStandardsUpdate202006Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2020-06.", "label": "Accounting Standards Update202006 [Member]", "terseLabel": "ASU 2010-26 [Member]" } } }, "localname": "AccountingStandardsUpdate202006Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_AccountingStandardsUpdateTwentyThousandTwentyZeroFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accounting standards update twenty thousand twenty zero four.", "label": "Accounting Standards Update Twenty Thousand Twenty Zero Four [Member]", "terseLabel": "ASU 2020-04 [Member]" } } }, "localname": "AccountingStandardsUpdateTwentyThousandTwentyZeroFourMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_AccruedOtherTaxesCurrent": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10040.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued other taxes current.", "label": "Accrued Other Taxes Current", "verboseLabel": "Other taxes payable" } } }, "localname": "AccruedOtherTaxesCurrent", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_AdjustmentsToAdditionalPaidInCapitalConvertibleNoteHedge": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital convertible note hedge.", "label": "Adjustments To Additional Paid In Capital Convertible Note Hedge", "terseLabel": "Convertible note hedge" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleNoteHedge", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_AdjustmentsToAdditionalPaidInCapitalDebtInstrumentConvertibleBeneficialConversionFeature": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital debt instrument convertible beneficial conversion feature.", "label": "Adjustments To Additional Paid In Capital Debt Instrument Convertible Beneficial Conversion Feature", "terseLabel": "Debt issuance costs attributable to convertible feature" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalDebtInstrumentConvertibleBeneficialConversionFeature", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_AdjustmentsToAdditionalPaidInCapitalReclassificationOfRedeemableEquityComponentOfSeniorConvertibleNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital reclassification of redeemable equity component of senior convertible notes.", "label": "Adjustments To Additional Paid In Capital Reclassification Of Redeemable Equity Component Of Senior Convertible Notes", "terseLabel": "Reclassification of redeemable equity component of senior convertible notes" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfRedeemableEquityComponentOfSeniorConvertibleNotes", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_AllocatedShareBasedCompensationExpenseBenefit": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails": { "order": 10010.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Allocated share based compensation expense (benefit).", "label": "Allocated Share Based Compensation Expense Benefit", "terseLabel": "Stock-based compensation expense before taxes" } } }, "localname": "AllocatedShareBasedCompensationExpenseBenefit", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "nuva_AllowanceForDoubtfulAccountsReceivableIncreaseDecreaseFromForeignCurrencyFluctuations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Allowance for doubtful accounts receivable increase (decrease) from foreign currency fluctuations.", "label": "Allowance For Doubtful Accounts Receivable Increase Decrease From Foreign Currency Fluctuations", "terseLabel": "Changes resulting from foreign currency fluctuations" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableIncreaseDecreaseFromForeignCurrencyFluctuations", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesSummaryOfChangesInAllowanceForCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_AmortizationOfIntangibleAssetsExcludeCostOfGoodsSoldAmortization": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10110.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of intangible assets exclude cost of goods sold amortization.", "label": "Amortization Of Intangible Assets Exclude Cost Of Goods Sold Amortization", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssetsExcludeCostOfGoodsSoldAmortization", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "nuva_AmortizationOfNonCashInterest": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10240.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of non-cash interest.", "label": "Amortization Of Non Cash Interest", "terseLabel": "Amortization of non-cash interest" } } }, "localname": "AmortizationOfNonCashInterest", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nuva_AvailableForFutureGrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Available for future grant.", "label": "Available For Future Grant [Member]", "terseLabel": "Available for Future Grant [Member]" } } }, "localname": "AvailableForFutureGrantMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_BalanceSheetDetailsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Balance Sheet Details Abstract", "label": "Balance Sheet Details [Abstract]" } } }, "localname": "BalanceSheetDetailsAbstract", "nsuri": "http://www.nuvasive.com/20201231", "xbrltype": "stringItemType" }, "nuva_BusinessAcquisitionPotentialFutureMilestonePayment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business acquisition potential future milestone payment.", "label": "Business Acquisition Potential Future Milestone Payment", "terseLabel": "Upon achievement of the regulatory milestone, entitled to a one-time payment" } } }, "localname": "BusinessAcquisitionPotentialFutureMilestonePayment", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "nuva_BusinessCombinationContingentConsiderationLiabilityExpectedYears": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination contingent consideration liability expected years.", "label": "Business Combination Contingent Consideration Liability Expected Years", "terseLabel": "Expected Years" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityExpectedYears", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "gYearItemType" }, "nuva_BusinessCombinationIntegrationRelatedCostsRecoveries": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10140.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business combination integration related costs (recoveries).", "label": "Business Combination Integration Related Costs Recoveries", "terseLabel": "Business transition costs", "verboseLabel": "Business transition costs (recoveries)" } } }, "localname": "BusinessCombinationIntegrationRelatedCostsRecoveries", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "nuva_BusinessCombinationUpfrontPaymentFunded": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination upfront payment funded.", "label": "Business Combination Upfront Payment Funded", "terseLabel": "Upfront payment funded" } } }, "localname": "BusinessCombinationUpfrontPaymentFunded", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "nuva_BusinessCombinationUpfrontPaymentLiability": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination upfront payment liability.", "label": "Business Combination Upfront Payment Liability", "terseLabel": "Upfront payment" } } }, "localname": "BusinessCombinationUpfrontPaymentLiability", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "nuva_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for amounts included in measurement of lease liabilities.", "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities", "totalLabel": "Total cash paid for amounts included in the measurement of lease liabilities" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "nuva_ClassOfWarrantOrRightsExpiryMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or rights expiry month and year.", "label": "Class Of Warrant Or Rights Expiry Month And Year", "terseLabel": "Class of warrant or rights expiry month and year" } } }, "localname": "ClassOfWarrantOrRightsExpiryMonthAndYear", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "gYearMonthItemType" }, "nuva_CommercialSaleMilestoneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commercial sale milestone.", "label": "Commercial Sale Milestone [Member]", "terseLabel": "Commercial Sale Milestone [Member]" } } }, "localname": "CommercialSaleMilestoneMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "nuva_CommitmentsAndContingenciesDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies disclosure.", "label": "Commitments And Contingencies Disclosure [Line Items]", "terseLabel": "Commitments And Contingencies Disclosure [Line Items]" } } }, "localname": "CommitmentsAndContingenciesDisclosureLineItems", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "stringItemType" }, "nuva_CommitmentsAndContingenciesDisclosureTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitments and contingencies disclosure.", "label": "Commitments And Contingencies Disclosure [Table]", "terseLabel": "Commitments And Contingencies Disclosure [Table]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTable", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "stringItemType" }, "nuva_CommonStockOptionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock options.", "label": "Common Stock Options [Abstract]", "terseLabel": "Common stock options:" } } }, "localname": "CommonStockOptionsAbstract", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "stringItemType" }, "nuva_CommonStockReservedForFutureIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock reserved for future issuance.", "label": "Common Stock Reserved For Future Issuance Table [Text Block]", "terseLabel": "Common Stock Reserved for Future Issuance" } } }, "localname": "CommonStockReservedForFutureIssuanceTableTextBlock", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "nuva_ConcentrationOfCreditRiskAndSignificantCustomersPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Concentration of credit risk and significant customers.", "label": "Concentration Of Credit Risk And Significant Customers Policy [Text Block]", "terseLabel": "Concentration of Credit Risk and Significant Customers" } } }, "localname": "ConcentrationOfCreditRiskAndSignificantCustomersPolicyTextBlock", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nuva_ConcentrationRiskNumberOfCustomers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Concentration risk number of customers.", "label": "Concentration Risk Number Of Customers", "terseLabel": "Customer represented greater than 10 percent" } } }, "localname": "ConcentrationRiskNumberOfCustomers", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "integerItemType" }, "nuva_ConsiderationPaidInExcessOfNonControllingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Consideration paid in excess of non controlling interest.", "label": "Consideration Paid In Excess Of Non Controlling Interest", "negatedLabel": "Consideration paid in excess of non-controlling interests" } } }, "localname": "ConsiderationPaidInExcessOfNonControllingInterest", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_ContingenciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingencies.", "label": "Contingencies [Abstract]" } } }, "localname": "ContingenciesAbstract", "nsuri": "http://www.nuvasive.com/20201231", "xbrltype": "stringItemType" }, "nuva_ContingentConsiderationLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contingent consideration liabilities.", "label": "Contingent Consideration Liabilities [Member]", "terseLabel": "Contingent Consideration Liabilities [Member]" } } }, "localname": "ContingentConsiderationLiabilitiesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "nuva_ConvertibleNoteHedgeTransactionsInitialStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible note hedge transactions initial stock price per share.", "label": "Convertible Note Hedge Transactions Initial Stock Price Per Share", "terseLabel": "Convertible note hedge transactions initial stock price per share" } } }, "localname": "ConvertibleNoteHedgeTransactionsInitialStockPricePerShare", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "perShareItemType" }, "nuva_ConvertibleNoteSettlementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible note settlement shares.", "label": "Convertible Note Settlement Shares", "negatedLabel": "Settlement of convertible note hedge, Shares" } } }, "localname": "ConvertibleNoteSettlementShares", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "nuva_ConvertibleNoteSettlementValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible note settlement value.", "label": "Convertible Note Settlement Value", "terseLabel": "Settlement of convertible note hedge" } } }, "localname": "ConvertibleNoteSettlementValue", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_CorporateNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Corporate notes.", "label": "Corporate Notes [Member]", "terseLabel": "Corporate Notes [Member]" } } }, "localname": "CorporateNotesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "nuva_DebtInstrumentConvertiblePrincipalAmountOfDebtConsideredForConversionRate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Base principal amount per note.", "label": "Debt Instrument Convertible Principal Amount Of Debt Considered For Conversion Rate", "terseLabel": "Principal amount of debt considered for conversion rate" } } }, "localname": "DebtInstrumentConvertiblePrincipalAmountOfDebtConsideredForConversionRate", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "nuva_DeferredTaxAssetsAmortization": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10110.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets amortization.", "label": "Deferred Tax Assets Amortization", "terseLabel": "Amortization" } } }, "localname": "DeferredTaxAssetsAmortization", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_DeferredTaxAssetsLeaseLiability": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10150.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets lease liability.", "label": "Deferred Tax Assets Lease Liability", "terseLabel": "Lease liability" } } }, "localname": "DeferredTaxAssetsLeaseLiability", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusinessAndOther": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10140.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets tax credit carry forwards general business and other.", "label": "Deferred Tax Assets Tax Credit Carryforwards General Business And Other", "terseLabel": "General business and other credit carryforwards" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusinessAndOther", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_DeferredTaxAssetsZeroCouponNotes": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10170.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets zero coupon notes.", "label": "Deferred Tax Assets Zero Coupon Notes", "terseLabel": "Original issue discount" } } }, "localname": "DeferredTaxAssetsZeroCouponNotes", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_DeferredTaxLiabilitiesDepreciation": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10050.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities, depreciation.", "label": "Deferred Tax Liabilities Depreciation", "negatedLabel": "Depreciation" } } }, "localname": "DeferredTaxLiabilitiesDepreciation", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_DeferredTaxLiabilitiesRightOfUseAssets": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10070.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities right-of-use assets.", "label": "Deferred Tax Liabilities Right Of Use Assets", "negatedLabel": "Right-of-use assets" } } }, "localname": "DeferredTaxLiabilitiesRightOfUseAssets", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_DescriptionOfBusinessPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of business.", "label": "Description Of Business Policy [Text Block]", "terseLabel": "Description of Business" } } }, "localname": "DescriptionOfBusinessPolicyTextBlock", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nuva_EarningPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earning per share.", "label": "Earning Per Share [Line Items]", "terseLabel": "Earning Per Share [Line Items]" } } }, "localname": "EarningPerShareLineItems", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "nuva_EarningPerShareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earning per share.", "label": "Earning Per Share [Table]", "terseLabel": "Earning Per Share [Table]" } } }, "localname": "EarningPerShareTable", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "nuva_EarningsPerShareNumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings per share numerator.", "label": "Earnings Per Share Numerator [Abstract]", "verboseLabel": "Numerator:" } } }, "localname": "EarningsPerShareNumeratorAbstract", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "nuva_EquityComponentOfConvertibleNoteSettlementShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity component of convertible note settlement shares.", "label": "Equity Component Of Convertible Note Settlement Shares", "terseLabel": "Equity component of convertible note settlement, Shares" } } }, "localname": "EquityComponentOfConvertibleNoteSettlementShares", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "nuva_EquityComponentOfConvertibleNoteSettlementValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity component of convertible note settlement value.", "label": "Equity Component Of Convertible Note Settlement Value", "terseLabel": "Equity component of convertible note settlement" } } }, "localname": "EquityComponentOfConvertibleNoteSettlementValue", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_EquityIncentivePlan2014Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity incentive plan 2014 [Member]", "label": "Equity Incentive Plan2014 [Member]", "terseLabel": "2014 Equity Incentive Plan [Member]" } } }, "localname": "EquityIncentivePlan2014Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_ExecutiveSeverancePlansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Executive severance plans.", "label": "Executive Severance Plans [Member]", "terseLabel": "Executive Severance Plans [Member]" } } }, "localname": "ExecutiveSeverancePlansMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_FairValueHedgingTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value hedging two thousand twenty five.", "label": "Fair Value Hedging Two Thousand Twenty Five [Member]", "terseLabel": "2025 Hedge [Member]" } } }, "localname": "FairValueHedgingTwoThousandTwentyFiveMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_FairValueHedgingTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value hedging two thousand twenty one.", "label": "Fair Value Hedging Two Thousand Twenty One [Member]", "terseLabel": "2021 Hedge [Member]" } } }, "localname": "FairValueHedgingTwoThousandTwentyOneMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_FairValueHedgingTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair value hedging two thousand twenty three.", "label": "Fair Value Hedging Two Thousand Twenty Three [Member]", "terseLabel": "2023 Hedge [Member]", "verboseLabel": "2023 Notes [Member]" } } }, "localname": "FairValueHedgingTwoThousandTwentyThreeMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetDerivativeAssetReclassifiedToStockholdersEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis asset derivative asset reclassified to stockholders equity.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Derivative Asset Reclassified To Stockholders Equity", "terseLabel": "Derivative asset reclassified to stockholders\u2019 equity" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetDerivativeAssetReclassifiedToStockholdersEquity", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "nuva_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityDerivativeLiabilityReclassifiedToStockholdersEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value measurement with unobservable inputs reconciliation recurring basis liability derivative liability reclassified to stockholders equity.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Derivative Liability Reclassified To Stockholders Equity", "terseLabel": "Derivative liability reclassified to stockholders\u2019 equity" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityDerivativeLiabilityReclassifiedToStockholdersEquity", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "nuva_FairValueOfCarryingValueAndAmortizedCostOfCompanySMarketableSecuritiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair Value of Carrying Value and Amortized Cost of the Company's Marketable Securities.", "label": "Fair Value Of Carrying Value And Amortized Cost Of Company S Marketable Securities Table [Text Block]", "terseLabel": "Schedule of Carrying Value and Amortized Cost of the Company's Marketable Debt Securities" } } }, "localname": "FairValueOfCarryingValueAndAmortizedCostOfCompanySMarketableSecuritiesTableTextBlock", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "nuva_FederalTaxCreditCarryforwardsExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Federal tax credit carry forwards expiration year.", "label": "Federal Tax Credit Carryforwards Expiration Year", "terseLabel": "Federal tax credit carryforwards, expiration year" } } }, "localname": "FederalTaxCreditCarryforwardsExpirationYear", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "gYearItemType" }, "nuva_FinanceLeaseExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Finance lease expense.", "label": "Finance Lease Expense [Abstract]", "terseLabel": "Finance lease expense:" } } }, "localname": "FinanceLeaseExpenseAbstract", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "stringItemType" }, "nuva_IncomeTaxReconciliationAcquisitionRelatedCharges": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10070.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation acquisition related charges.", "label": "Income Tax Reconciliation Acquisition Related Charges", "terseLabel": "Acquisition related charges" } } }, "localname": "IncomeTaxReconciliationAcquisitionRelatedCharges", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nuva_IncomeTaxReconciliationChangeInValuationAllowanceIncludingAccountingStandardAdjustments": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10040.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation change in valuation allowance including accounting standard adjustments.", "label": "Income Tax Reconciliation Change In Valuation Allowance Including Accounting Standard Adjustments", "terseLabel": "Changes in valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInValuationAllowanceIncludingAccountingStandardAdjustments", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "nuva_IncomeTaxReconciliationNetTaxBenefitOnInternationalRestructuring": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10050.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation net tax benefit on international restructuring.", "label": "Income Tax Reconciliation Net Tax Benefit On International Restructuring", "negatedLabel": "Net tax benefit on international restructuring" } } }, "localname": "IncomeTaxReconciliationNetTaxBenefitOnInternationalRestructuring", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nuva_IncomeTaxReconciliationReturnToProvisionAdjustments": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10060.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation return to provision adjustments.", "label": "Income Tax Reconciliation Return To Provision Adjustments", "terseLabel": "Return to provision adjustments" } } }, "localname": "IncomeTaxReconciliationReturnToProvisionAdjustments", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nuva_IncomeTaxReconciliationTaxReserve": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10090.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Income tax reconciliation tax reserve.", "label": "Income Tax Reconciliation Tax Reserve", "terseLabel": "Income tax reserves" } } }, "localname": "IncomeTaxReconciliationTaxReserve", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "nuva_IncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income taxes.", "label": "Income Taxes [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "localname": "IncomeTaxesLineItems", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "nuva_IncomeTaxesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Income taxes.", "label": "Income Taxes [Table]", "terseLabel": "Income Taxes [Table]" } } }, "localname": "IncomeTaxesTable", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "nuva_IndefiniteLivedIntangibleAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indefinite lived intangible assets.", "label": "Indefinite Lived Intangible Assets [Abstract]", "terseLabel": "Intangible assets not subject to amortization:" } } }, "localname": "IndefiniteLivedIntangibleAssetsAbstract", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "nuva_InstrumentSetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Instrument sets.", "label": "Instrument Sets [Member]", "terseLabel": "Instrument sets [Member]" } } }, "localname": "InstrumentSetsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "nuva_IssuanceOfCommonStockInConnectionWithRoyaltyMilestoneAchievementShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with royalty milestone achievement share.", "label": "Issuance Of Common Stock In Connection With Royalty Milestone Achievement Share", "terseLabel": "Issuance of common stock in connection with royalty milestone achievement, Shares" } } }, "localname": "IssuanceOfCommonStockInConnectionWithRoyaltyMilestoneAchievementShare", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "nuva_IssuanceOfCommonStockInConnectionWithRoyaltyMilestoneAchievementValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with royalty milestone achievement value.", "label": "Issuance Of Common Stock In Connection With Royalty Milestone Achievement Value", "terseLabel": "Issuance of common stock in connection with royalty milestone achievement" } } }, "localname": "IssuanceOfCommonStockInConnectionWithRoyaltyMilestoneAchievementValue", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_LeaseLiabilitiesAndAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease liabilities and assets.", "label": "Lease Liabilities And Assets Table [Text Block]", "terseLabel": "Right-of-use Assets and Lease Liabilities" } } }, "localname": "LeaseLiabilitiesAndAssetsTableTextBlock", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "nuva_LeaseLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease liabilities current.", "label": "Lease Liabilities Current [Abstract]", "terseLabel": "Current:" } } }, "localname": "LeaseLiabilitiesCurrentAbstract", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "nuva_LeaseLiabilitiesLongTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease Liabilities Long-term.", "label": "Lease Liabilities Long Term [Abstract]", "terseLabel": "Long-term:" } } }, "localname": "LeaseLiabilitiesLongTermAbstract", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "nuva_LeasedAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Leased assets.", "label": "Leased Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "LeasedAssetsAbstract", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "nuva_LicensingAndPurchasingAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Licensing and purchasing agreements.", "label": "Licensing And Purchasing Agreements [Member]", "terseLabel": "Licensing and Purchasing Agreements [Member]" } } }, "localname": "LicensingAndPurchasingAgreementsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_LineOfCreditFacilityExpirationMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of credit facility expiration month and year.", "label": "Line Of Credit Facility Expiration Month And Year", "terseLabel": "Credit facility, expiration date" } } }, "localname": "LineOfCreditFacilityExpirationMonthAndYear", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "gYearMonthItemType" }, "nuva_MadsenMedicalIncLitigationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Madsen medical, Inc. litigation.", "label": "Madsen Medical Inc Litigation [Member]", "terseLabel": "Madsen Medical, Inc. Litigation [Member]" } } }, "localname": "MadsenMedicalIncLitigationMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_ManufacturingKnowHowAndTradeSecretsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Manufacturing know-how and trade secrets.", "label": "Manufacturing Know How And Trade Secrets [Member]", "terseLabel": "Manufacturing know-how and trade secrets [Member]" } } }, "localname": "ManufacturingKnowHowAndTradeSecretsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "nuva_MulticurrencyBorrowingsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Multicurrency borrowings.", "label": "Multicurrency Borrowings [Member]", "terseLabel": "Multicurrency Borrowings [Member]" } } }, "localname": "MulticurrencyBorrowingsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_NumberOfSecuritiesCalledByConvertibleNoteHedgeTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common stock to be purchased.", "label": "Number Of Securities Called By Convertible Note Hedge Transaction", "terseLabel": "Number of common stock to be purchased" } } }, "localname": "NumberOfSecuritiesCalledByConvertibleNoteHedgeTransaction", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "sharesItemType" }, "nuva_OnePointZeroZeroPercentSeniorConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One point zero zero percent senior convertible notes.", "label": "One Point Zero Zero Percent Senior Convertible Notes [Member]", "terseLabel": "1.00% Senior Convertible Notes [Member]" } } }, "localname": "OnePointZeroZeroPercentSeniorConvertibleNotesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_OnePointZeroZeroZeroPercentSeniorConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One point zero zero zero percent senior convertible notes.", "label": "One Point Zero Zero Zero Percent Senior Convertible Notes [Member]", "terseLabel": "1.00% Senior Convertible Notes [Member]" } } }, "localname": "OnePointZeroZeroZeroPercentSeniorConvertibleNotesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails" ], "xbrltype": "domainItemType" }, "nuva_OperatingLeaseAndFinanceLeaseLiability": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease and finance lease liability.", "label": "Operating Lease And Finance Lease Liability", "totalLabel": "Total lease liabilities" } } }, "localname": "OperatingLeaseAndFinanceLeaseLiability", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_OperatingLeaseAndFinanceLeaseRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease and finance lease right-of-use asset.", "label": "Operating Lease And Finance Lease Right Of Use Asset", "totalLabel": "Total leased assets" } } }, "localname": "OperatingLeaseAndFinanceLeaseRightOfUseAsset", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "nuva_OperatingLossCarryForwardsExpirationYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carry forwards expiration year.", "label": "Operating Loss Carry Forwards Expiration Year", "terseLabel": "Operating loss carryforwards expiration year" } } }, "localname": "OperatingLossCarryForwardsExpirationYear", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "gYearItemType" }, "nuva_OtherCurrentAssetsOrOtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other current assets or other current liabilities.", "label": "Other Current Assets Or Other Current Liabilities [Member]", "terseLabel": "Other Current Assets or Other Current Liabilities [Member]" } } }, "localname": "OtherCurrentAssetsOrOtherCurrentLiabilitiesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_PaymentOfContingentConsideration": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of contingent consideration.", "label": "Payment Of Contingent Consideration", "negatedLabel": "Payment of contingent consideration" } } }, "localname": "PaymentOfContingentConsideration", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nuva_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance-based restricted stock units.", "label": "Performance Based Restricted Stock Units [Member]", "terseLabel": "Performance Based Restricted Stock Units (PRSUs) [Member]" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails" ], "xbrltype": "domainItemType" }, "nuva_ProductShipmentCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product shipment costs.", "label": "Product Shipment Costs Policy [Text Block]", "terseLabel": "Product Shipment Costs" } } }, "localname": "ProductShipmentCostsPolicyTextBlock", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nuva_PurchaseOfInProcessResearchAndDevelopment": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10120.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Purchase of in-process research and development.", "label": "Purchase Of In Process Research And Development", "terseLabel": "Purchase of in-process research and development" } } }, "localname": "PurchaseOfInProcessResearchAndDevelopment", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "nuva_ReserveForExcessAndObsoleteInventory": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Reserve for excess and obsolete inventory.", "label": "Reserve For Excess And Obsolete Inventory", "terseLabel": "Reserve for excess and obsolete inventory" } } }, "localname": "ReserveForExcessAndObsoleteInventory", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "nuva_ReserveOnCurrentAsset": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10280.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Reserve on current asset.", "label": "Reserve On Current Asset", "terseLabel": "Reserves on current assets" } } }, "localname": "ReserveOnCurrentAsset", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nuva_RestrictedStockUnitsAndPerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock units and performance based restricted stock units.", "label": "Restricted Stock Units And Performance Based Restricted Stock Units [Member]", "terseLabel": "Restricted Stock Units And Performance-Based Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsAndPerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_RestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock units and performance restricted stock units.", "label": "Restricted Stock Units And Performance Restricted Stock Units [Member]", "terseLabel": "RSUs and PRSUs [Member]" } } }, "localname": "RestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "nuva_ScenarioOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scenario one.", "label": "Scenario One [Member]", "terseLabel": "Scenario One [Member]" } } }, "localname": "ScenarioOneMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_ScenarioTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Scenario two.", "label": "Scenario Two [Member]", "terseLabel": "Scenario Two [Member]" } } }, "localname": "ScenarioTwoMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_ScheduleOfOrganizationAndSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "[Line Items] for Schedule of Organization and Significant Accounting Policies [Table]", "label": "Schedule Of Organization And Significant Accounting Policies [Line Items]", "terseLabel": "Schedule Of Organization And Significant Accounting Policies [Line Items]" } } }, "localname": "ScheduleOfOrganizationAndSignificantAccountingPoliciesLineItems", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "stringItemType" }, "nuva_ScheduleOfOrganizationAndSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of organization and significant accounting policies.", "label": "Schedule Of Organization And Significant Accounting Policies [Table]", "terseLabel": "Schedule Of Organization And Significant Accounting Policies [Table]" } } }, "localname": "ScheduleOfOrganizationAndSignificantAccountingPoliciesTable", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "stringItemType" }, "nuva_SeniorConvertibleNotesDue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior convertible notes.", "label": "Senior Convertible Notes Due2021 [Member]", "terseLabel": "2.25% Senior Convertible Notes due 2021 [Member]" } } }, "localname": "SeniorConvertibleNotesDue2021Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_SeniorConvertibleNotesDue2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior convertible notes due 2023.", "label": "Senior Convertible Notes Due2023 [Member]", "terseLabel": "1.00% Senior Convertible Notes due 2023 [Member]" } } }, "localname": "SeniorConvertibleNotesDue2023Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_SeniorConvertibleNotesDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior convertible notes due 2025.", "label": "Senior Convertible Notes Due2025 [Member]", "terseLabel": "0.375% Senior Convertible Notes due 2025 [Member]" } } }, "localname": "SeniorConvertibleNotesDue2025Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_SeniorConvertibleWarrantsDue2021Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior convertible warrants due 2021.", "label": "Senior Convertible Warrants Due2021 [Member]", "terseLabel": "Senior Convertible Warrants Due 2021 [Member]" } } }, "localname": "SeniorConvertibleWarrantsDue2021Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_SeniorConvertibleWarrantsDue2023Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior convertible warrants due 2023.", "label": "Senior Convertible Warrants Due2023 [Member]", "terseLabel": "Senior Convertible Warrants Due 2023 [Member]" } } }, "localname": "SeniorConvertibleWarrantsDue2023Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_SeniorConvertibleWarrantsDue2025Member": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Senior convertible warrants due 2025.", "label": "Senior Convertible Warrants Due2025 [Member]", "terseLabel": "Senior Convertible Warrants Due 2025 [Member]" } } }, "localname": "SeniorConvertibleWarrantsDue2025Member", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "nuva_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award accelerated Vesting percentage", "label": "Share Based Compensation Arrangement By Share Based Payment Award Accelerated Vesting Percentage", "terseLabel": "Percentage of acceleration of stock options in case of change in control" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedVestingPercentage", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "percentItemType" }, "nuva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAchievedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award equity instruments other than options achieved in period weighted average grant date fair value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Achieved In Period Weighted Average Grant Date Fair Value", "verboseLabel": "Average Grant Date Fair Value, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAchievedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails" ], "xbrltype": "perShareItemType" }, "nuva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumNumberOfSharesEligibleToBeIssuedForfeitedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award equity instruments other than options maximum number of shares eligible to be issued forfeited in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Maximum Number Of Shares Eligible To Be Issued Forfeited In Period", "negatedLabel": "Maximum Number of Shares Eligible to be Issued, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumNumberOfSharesEligibleToBeIssuedForfeitedInPeriod", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "nuva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumNumberOfSharesEligibleToBeIssuedGrantsInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award equity instruments other than options maximum number of shares eligible to be issued grants in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Maximum Number Of Shares Eligible To Be Issued Grants In Period", "verboseLabel": "Maximum Number of Shares Eligible to be Issued, Awarded at target" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsMaximumNumberOfSharesEligibleToBeIssuedGrantsInPeriod", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "nuva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfTargetNumberOfSharesEligibleToReceive": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options percentage of target number of shares eligible to receive.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Percentage Of Target Number Of Shares Eligible To Receive", "terseLabel": "Share payout levels" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPercentageOfTargetNumberOfSharesEligibleToReceive", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "percentItemType" }, "nuva_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWithPerformanceMeasuresVestedInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments with performance vesting, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments With Performance Measures Vested In Period", "negatedLabel": "Maximum Number of Shares Eligible to be Issued, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWithPerformanceMeasuresVestedInPeriod", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "nuva_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum amount withheld to purchase shares of the company.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Amount", "terseLabel": "Maximum amount withheld to purchase shares of the company" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionAmount", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "monetaryItemType" }, "nuva_SimplifyMedicalPtyLimitedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Simplify Medical Pty Limited.", "label": "Simplify Medical Pty Limited [Member]", "terseLabel": "Simplify Medical Pty Limited [Member]" } } }, "localname": "SimplifyMedicalPtyLimitedMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "nuva_SpinalHardwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Spinal hardware.", "label": "Spinal Hardware [Member]", "terseLabel": "Spinal Hardware [Member]" } } }, "localname": "SpinalHardwareMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails" ], "xbrltype": "domainItemType" }, "nuva_StockIssuedDuringPeriodSharesSettlementOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares settlement of warrants.", "label": "Stock Issued During Period Shares Settlement Of Warrants", "terseLabel": "Settlement of warrants, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesSettlementOfWarrants", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "nuva_StockIssuedDuringPeriodValueSettlementOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value settlement of warrants.", "label": "Stock Issued During Period Value Settlement Of Warrants", "terseLabel": "Settlement of warrants" } } }, "localname": "StockIssuedDuringPeriodValueSettlementOfWarrants", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "nuva_StockOptionsAndESPPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock options and ESPP.", "label": "Stock Options And E S P P [Member]", "terseLabel": "Stock Options and ESPP [Member]" } } }, "localname": "StockOptionsAndESPPMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "nuva_StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock options ESPP restricted stock units and performance restricted stock units.", "label": "Stock Options E S P P Restricted Stock Units And Performance Restricted Stock Units [Member]", "terseLabel": "Stock options, ESPP, RSUs and PRSUs [Member]" } } }, "localname": "StockOptionsESPPRestrictedStockUnitsAndPerformanceRestrictedStockUnitsMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails" ], "xbrltype": "domainItemType" }, "nuva_StockRepurchaseProgramExpirationMonthAndYear": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock repurchase program expiration month and year.", "label": "Stock Repurchase Program Expiration Month And Year", "terseLabel": "Share repurchase program, expiration month and year" } } }, "localname": "StockRepurchaseProgramExpirationMonthAndYear", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "gYearMonthItemType" }, "nuva_SurgicalSupportMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Surgical support.", "label": "Surgical Support [Member]", "terseLabel": "Surgical Support [Member]" } } }, "localname": "SurgicalSupportMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails" ], "xbrltype": "domainItemType" }, "nuva_SwingLineLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Swing line loans.", "label": "Swing Line Loans [Member]", "terseLabel": "Swing Line Loans [Member]" } } }, "localname": "SwingLineLoansMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_TradeNameAndTrademarksMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade name and trademarks.", "label": "Trade Name And Trademarks [Member]", "terseLabel": "Trade name and trademarks [Member]" } } }, "localname": "TradeNameAndTrademarksMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "nuva_TwoPointTwoFivePercentSeniorConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two point two five percent senior convertible notes.", "label": "Two Point Two Five Percent Senior Convertible Notes [Member]", "terseLabel": "2.25% Senior Convertible Notes [Member]" } } }, "localname": "TwoPointTwoFivePercentSeniorConvertibleNotesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_TwoThousandTwentyThreeCounterpartiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two thousand twenty three counterparties.", "label": "Two Thousand Twenty Three Counterparties [Member]", "terseLabel": "2023 Counterparties [Member]" } } }, "localname": "TwoThousandTwentyThreeCounterpartiesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_WarrantsTwoThousandTwentyFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants two thousand twenty five.", "label": "Warrants Two Thousand Twenty Five [Member]", "terseLabel": "2025 Warrants [Member]" } } }, "localname": "WarrantsTwoThousandTwentyFiveMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_WarrantsTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants 2021.", "label": "Warrants Two Thousand Twenty One [Member]", "terseLabel": "2021 Warrants [Member]" } } }, "localname": "WarrantsTwoThousandTwentyOneMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_WarrantsTwoThousandTwentyThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants two thousand twenty three.", "label": "Warrants Two Thousand Twenty Three [Member]", "terseLabel": "2023 Warrants [Member]" } } }, "localname": "WarrantsTwoThousandTwentyThreeMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "nuva_ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Zero point three seven five percent senior convertible notes.", "label": "Zero Point Three Seven Five Percent Senior Convertible Notes [Member]", "terseLabel": "0.375% Senior Convertible Notes [Member]" } } }, "localname": "ZeroPointThreeSevenFivePercentSeniorConvertibleNotesMember", "nsuri": "http://www.nuvasive.com/20201231", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r659" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation Fiscal Year Maturity Schedule Table [Text Block]", "terseLabel": "Future Minimum Annual Lease Payments under Operating and Financing Leases" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r58", "r128", "r663" ], "lang": { "en-us": { "role": { "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": { "auth_ref": [ "r137", "r145", "r231", "r378", "r379", "r380", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Increase (decrease) to financial statements for cumulative-effect adjustment in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect Period Of Adoption Adjustment [Member]", "terseLabel": "Cumulative Effect, Period of Adoption, Adjustment [Member]" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_CumulativeEffectPeriodOfAdoptionAxis": { "auth_ref": [ "r137", "r145", "r231", "r378", "r379", "r380", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Information by cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect Period Of Adoption [Axis]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "stringItemType" }, "srt_CumulativeEffectPeriodOfAdoptionDomain": { "auth_ref": [ "r137", "r145", "r231", "r378", "r379", "r380", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Cumulative-effect adjustment to financial statements in period of adoption of amendment to accounting standards.", "label": "Cumulative Effect Period Of Adoption [Domain]", "terseLabel": "Cumulative Effect, Period of Adoption" } } }, "localname": "CumulativeEffectPeriodOfAdoptionDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [ "r333", "r336", "r542", "r543", "r544", "r545", "r546", "r547", "r566", "r611", "r614" ], "lang": { "en-us": { "role": { "documentation": "Upper limit of the provided range.", "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r333", "r336", "r542", "r543", "r544", "r545", "r546", "r547", "r566", "r611", "r614" ], "lang": { "en-us": { "role": { "documentation": "Lower limit of the provided range.", "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r197", "r320", "r321", "r567", "r610", "r612" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product Or Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r197", "r320", "r321", "r567", "r610", "r612" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Products And Services [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r323", "r333", "r336", "r542", "r543", "r544", "r545", "r546", "r547", "r566", "r611", "r614" ], "lang": { "en-us": { "role": { "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r323", "r333", "r336", "r542", "r543", "r544", "r545", "r546", "r547", "r566", "r611", "r614" ], "lang": { "en-us": { "role": { "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median.", "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution.", "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r334" ], "lang": { "en-us": { "role": { "documentation": "Scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Scenario Unspecified [Domain]", "terseLabel": "Scenario" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r198", "r199", "r320", "r322", "r613", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r198", "r199", "r320", "r322", "r613", "r630", "r638", "r639", "r640", "r641", "r642", "r643", "r644", "r645", "r646", "r661", "r662" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r286", "r334", "r534" ], "lang": { "en-us": { "role": { "documentation": "Information by scenario reported, distinguishing information from actual fact. Includes, but is not limited to, pro forma and forecast. Excludes actual facts.", "label": "Statement Scenario [Axis]", "terseLabel": "Scenario" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "stringItemType" }, "srt_WeightedAverageMember": { "auth_ref": [ "r542", "r544", "r547" ], "lang": { "en-us": { "role": { "documentation": "Average of a range of values, calculated with consideration of proportional relevance.", "label": "Weighted Average [Member]", "terseLabel": "Weighted Average [Member]" } } }, "localname": "WeightedAverageMember", "nsuri": "http://fasb.org/srt/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201613Member": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2016-13 Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.", "label": "Accounting Standards Update201613 [Member]", "terseLabel": "ASU 2016-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201613Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201704Member": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2017-04 Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment.", "label": "Accounting Standards Update201704 [Member]", "terseLabel": "ASU 2017-04 [Member]" } } }, "localname": "AccountingStandardsUpdate201704Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201813Member": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2018-13 Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.", "label": "Accounting Standards Update201813 [Member]", "terseLabel": "ASU 2018-13 [Member]" } } }, "localname": "AccountingStandardsUpdate201813Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201815Member": { "auth_ref": [ "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2018-15 Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract (a consensus of the FASB Emerging Issues Task Force).", "label": "Accounting Standards Update201815 [Member]", "terseLabel": "ASU 2018-15 [Member]" } } }, "localname": "AccountingStandardsUpdate201815Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201912Member": { "auth_ref": [ "r424", "r425", "r426", "r427" ], "lang": { "en-us": { "role": { "documentation": "Accounting Standards Update 2019-12 Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes.", "label": "Accounting Standards Update201912 [Member]", "terseLabel": "ASU 2019-12 [Member]" } } }, "localname": "AccountingStandardsUpdate201912Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10150.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable And Accrued Liabilities Current", "terseLabel": "Accounts payable and accrued liabilities", "totalLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounts Payable And Accrued Liabilities Current [Abstract]", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r38" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10020.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": { "auth_ref": [ "r242" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.", "label": "Accounts Receivable Allowance For Credit Loss Table [Text Block]", "terseLabel": "Summary of Changes in Allowance for Credit Losses" } } }, "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r4", "r25", "r203", "r204" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10310.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Net Current", "terseLabel": "Accounts receivable, net of allowances of $20,631 and $17,019, respectively" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10010.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRoyaltiesCurrent": { "auth_ref": [ "r10", "r11", "r41" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10070.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for royalties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Royalties Current", "terseLabel": "Royalties payable" } } }, "localname": "AccruedRoyaltiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r10", "r11", "r41" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10030.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Sales Commission Current", "terseLabel": "Distributor commissions payable" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r36", "r281" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails": { "order": 10860.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedLabel": "Less: accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax": { "auth_ref": [ "r60", "r64", "r65", "r66", "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated adjustment, net of tax, that results from the process of translating subsidiary financial statements and foreign equity investments into the reporting currency from the functional currency of the reporting entity, net of reclassification of realized foreign currency translation gains or losses.", "label": "Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax", "negatedLabel": "Translation Adjustment Functional to Reporting Currency, Net of Tax" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r28", "r64", "r65", "r66", "r597", "r622", "r626" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10120.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r63", "r66", "r67", "r134", "r135", "r136", "r457", "r617", "r618" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r269" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite Lived Intangible Assets Weighted Average Useful Life", "terseLabel": "Weighted Average Amortization Period" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r26", "r381" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid In Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r26" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10110.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r134", "r135", "r136", "r378", "r379", "r380" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": { "auth_ref": [ "r139", "r140", "r141", "r142" ], "lang": { "en-us": { "role": { "documentation": "Information by type of change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Adjustments For Change In Accounting Principle [Axis]", "terseLabel": "Change in Accounting Principle, Type" } } }, "localname": "AdjustmentsForChangeInAccountingPrincipleAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r139", "r140", "r141", "r142", "r228", "r229", "r230", "r231", "r233", "r234", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r424", "r425", "r426", "r427", "r569", "r570", "r571", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626" ], "lang": { "en-us": { "role": { "documentation": "Information by amendment to accounting standards.", "label": "Adjustments For New Accounting Pronouncements [Axis]", "terseLabel": "Accounting Standards Update" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "auth_ref": [ "r306", "r312", "r423" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.", "label": "Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature", "terseLabel": "Tax benefits related to convertible note issuance" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt": { "auth_ref": [ "r300" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital.", "label": "Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt", "terseLabel": "Equity component of convertible note issuance" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r337", "r339", "r384", "r385" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r299", "r306", "r312" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Adjustments To Additional Paid In Capital Warrant Issued", "terseLabel": "Sale of warrants" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net (loss) income to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of expense for award under share-based payment arrangement.", "label": "Allocated Share Based Compensation Expense Net Of Tax", "totalLabel": "Stock-based compensation expense, net of taxes" } } }, "localname": "AllocatedShareBasedCompensationExpenseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r206", "r235", "r237", "r241" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance For Doubtful Accounts Receivable", "periodEndLabel": "Allowance for credit losses at end of period", "periodStartLabel": "Allowance for credit loss at beginning of period" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesSummaryOfChangesInAllowanceForCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r30", "r206", "r235" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance For Doubtful Accounts Receivable Current", "terseLabel": "Accounts receivable, allowances" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": { "auth_ref": [ "r240" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery.", "label": "Allowance For Doubtful Accounts Receivable Recoveries", "terseLabel": "Recoveries of amounts previously written off" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesSummaryOfChangesInAllowanceForCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": { "auth_ref": [ "r239" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.", "label": "Allowance For Doubtful Accounts Receivable Write Offs", "negatedLabel": "Write-offs charged against the allowance" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesSummaryOfChangesInAllowanceForCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r92", "r112", "r508" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount Premium", "terseLabel": "Amortization of debt discount (premium)" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r83", "r112", "r510" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization Of Financing Costs", "terseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r112", "r267", "r274" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization Of Intangible Assets", "terseLabel": "Amortization expense related to intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "verboseLabel": "Anti-dilutive securities excluded from computation of earnings per share" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r126", "r184", "r188", "r193", "r222", "r452", "r458", "r497", "r576", "r594" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r6", "r8", "r57", "r126", "r222", "r452", "r458", "r497" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10210.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r480" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Fair Value Disclosure", "terseLabel": "Total assets measured at fair value" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Fair Value Disclosure [Abstract]", "terseLabel": "Cash Equivalents and Marketable Securities" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r216" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails": { "order": 10010.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax", "terseLabel": "Gross Unrealized Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r217" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails": { "order": 10020.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax", "negatedLabel": "Gross Unrealized Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r214", "r246" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Amortized Cost Basis", "totalLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r210", "r215", "r246", "r581" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails": { "order": 10030.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Securities Debt Securities", "terseLabel": "Fair Value" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r212", "r246" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10300.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Available For Sale Securities Debt Securities Current", "terseLabel": "Short-term marketable securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Number of investment positions in available-for-sale investments in a continuous unrealized loss position for which an other-than-temporary impairment (OTTI) has not been recognized in the income statement.", "label": "Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions1", "terseLabel": "Unrealized loss position investment" } } }, "localname": "AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositions1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "integerItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r341", "r372" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r468", "r473" ], "lang": { "en-us": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_BaseRateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum rate investor will accept.", "label": "Base Rate [Member]", "terseLabel": "Base Rate [Member]" } } }, "localname": "BaseRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_BuildingImprovementsMember": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.", "label": "Building Improvements [Member]", "terseLabel": "Building and improvements [Member]" } } }, "localname": "BuildingImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r332", "r335" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r332", "r335", "r441", "r442" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityCurrent": { "auth_ref": [ "r445", "r446" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10160.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled within one year or the normal operating cycle, if longer.", "label": "Business Combination Contingent Consideration Liability Current", "terseLabel": "Contingent consideration liabilities", "verboseLabel": "Contingent consideration liabilities" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityMeasurementInput": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure contingent consideration liability from business combination.", "label": "Business Combination Contingent Consideration Liability Measurement Input", "terseLabel": "Weighted average measurement input" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiabilityValuationTechniqueExtensibleList": { "auth_ref": [ "r484" ], "lang": { "en-us": { "role": { "documentation": "Indicates valuation technique for measuring business combination contingent consideration liability.", "label": "Business Combination Contingent Consideration Liability Valuation Technique Extensible List", "terseLabel": "Business Combination, Contingent Consideration, Liability, Valuation Technique [Extensible List]" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityValuationTechniqueExtensibleList", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "extensibleListItemType" }, "us-gaap_BusinessCombinationDescriptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination Description [Abstract]" } } }, "localname": "BusinessCombinationDescriptionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combinations" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessCombinations" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r122", "r440" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations Policy", "terseLabel": "Business Transition Costs" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CaliforniaFranchiseTaxBoardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government of the state of California.", "label": "California Franchise Tax Board [Member]", "terseLabel": "California Tax Authority [Member]" } } }, "localname": "CaliforniaFranchiseTaxBoardMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalizedComputerSoftwareAmortization1": { "auth_ref": [ "r648", "r650" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for amortization of capitalized computer software costs.", "label": "Capitalized Computer Software Amortization1", "terseLabel": "Capitalized internal use software amortization" } } }, "localname": "CapitalizedComputerSoftwareAmortization1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r647" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Capitalized Computer Software Net", "terseLabel": "Capitalized internal use software development costs" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r33", "r114" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10290.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash And Cash Equivalents [Axis]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r14", "r115", "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash And Cash Equivalents Policy [Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r108", "r114", "r120" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of period", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of period", "totalLabel": "Total cash, cash equivalents and restricted cash reported in the Consolidated Statements of Cash Flows" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r108", "r499" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flow Noncash Investing And Financing Activities Disclosure [Abstract]", "terseLabel": "Supplemental disclosure of non-cash transactions:" } } }, "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": { "auth_ref": [ "r138", "r224", "r225", "r226", "r228", "r229", "r374", "r375", "r376", "r424", "r479", "r498", "r515", "r569", "r570", "r615", "r616" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether accounting standards update was adopted.", "label": "Change In Accounting Principle Accounting Standards Update Adopted", "terseLabel": "Change in accounting principle, accounting standards update, adopted [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": { "auth_ref": [ "r145", "r224", "r225", "r226", "r228", "r229", "r374", "r375", "r376", "r424", "r479", "r498", "r515", "r569", "r570", "r615", "r616" ], "lang": { "en-us": { "role": { "documentation": "Date accounting standards update was adopted, in CCYY-MM-DD format.", "label": "Change In Accounting Principle Accounting Standards Update Adoption Date", "terseLabel": "Change in accounting principle, accounting standards update, adoption date" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "dateItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption": { "auth_ref": [ "r138", "r224", "r227", "r230", "r377", "r425", "r479", "r498", "r515", "r571", "r615", "r616", "r635" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether accounting standards update was early adopted.", "label": "Change In Accounting Principle Accounting Standards Update Early Adoption", "terseLabel": "Change in accounting principle, accounting standards update, early adoption [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateEarlyAdoption", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": { "auth_ref": [ "r139", "r151", "r232", "r381", "r428" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.", "label": "Change In Accounting Principle Accounting Standards Update Immaterial Effect", "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect [true false]" } } }, "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "booleanItemType" }, "us-gaap_ChangeInAccountingPrincipleMember": { "auth_ref": [ "r139", "r140", "r141", "r142" ], "lang": { "en-us": { "role": { "documentation": "Change in accounting principle. Excludes change from amendment to accounting standards.", "label": "Change In Accounting Principle [Member]", "terseLabel": "Change in Accounting Principle, Type" } } }, "localname": "ChangeInAccountingPrincipleMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfTreasuryStockTable": { "auth_ref": [ "r313", "r314", "r315", "r316" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about treasury stock, including, but not limited to, average cost per share, description of share repurchase program, shares repurchased, shares held for each class of treasury stock.", "label": "Class Of Treasury Stock [Table]", "terseLabel": "Class Of Treasury Stock [Table]" } } }, "localname": "ClassOfTreasuryStockTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r317", "r338" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class Of Warrant Or Right [Axis]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class Of Warrant Or Right [Domain]", "terseLabel": "Class of Warrant or Right" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1", "terseLabel": "Warrant strike price" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r307" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights", "terseLabel": "Number of preferred or common stock into which the warrants is converted" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r298" ], "lang": { "en-us": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial Paper [Member]" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r48", "r285", "r582", "r601" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10060.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r122", "r296", "r632", "r633" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments And Contingencies Policy [Text Block]", "terseLabel": "Loss Contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsDisclosureTextBlock": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.", "label": "Commitments Disclosure [Text Block]", "terseLabel": "Commitments" } } }, "localname": "CommitmentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance", "terseLabel": "Shares reserved for future issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r134", "r135" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r24", "r306" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r24" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10100.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common stock, $0.001 par value; 150,000 and 120,000 shares authorized at December 31, 2020 and December 31, 2019, respectively; 57,945 shares issued and 51,376 outstanding at December 31, 2020; 57,525 issued and 52,145 outstanding at December 31, 2019" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components Of Deferred Tax Assets [Abstract]", "terseLabel": "Deferred tax assets:" } } }, "localname": "ComponentsOfDeferredTaxAssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Components Of Deferred Tax Liabilities [Abstract]", "terseLabel": "Deferred tax liabilities:" } } }, "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r70", "r72", "r73", "r80", "r586", "r605" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Total consolidated comprehensive (loss) income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r122", "r454" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Consolidation Policy [Text Block]", "terseLabel": "Basis of Presentation and Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r20", "r579", "r596" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible debt liabilities" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtFairValueDisclosures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.", "label": "Convertible Debt Fair Value Disclosures", "terseLabel": "Debt instrument, fair value disclosure" } } }, "localname": "ConvertibleDebtFairValueDisclosures", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "terseLabel": "Senior Convertible Notes [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleLongTermNotesPayable": { "auth_ref": [ "r46" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails2": { "order": 10020.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Long Term Notes Payable", "terseLabel": "Long-term senior convertible notes" } } }, "localname": "ConvertibleLongTermNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayable": { "auth_ref": [ "r20", "r579", "r595", "r628" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable", "terseLabel": "Carrying value", "totalLabel": "Total Senior Convertible Notes" } } }, "localname": "ConvertibleNotesPayable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails2": { "order": 10010.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10200.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.", "label": "Convertible Notes Payable Current", "negatedLabel": "Less: Current portion", "terseLabel": "Senior convertible notes" } } }, "localname": "ConvertibleNotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r87", "r567" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10160.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost Of Goods And Services Sold", "terseLabel": "Cost of sales", "verboseLabel": "Product shipment costs" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost Of Revenue [Abstract]", "terseLabel": "Cost of sales (excluding below amortization of intangible assets):" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost Of Sales [Member]", "terseLabel": "Cost of Sales [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r127", "r419", "r431" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10080.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense Benefit", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r132", "r419" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10100.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense Benefit", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r419", "r431", "r433" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense Benefit", "totalLabel": "Total current provision" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r127", "r419", "r431" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10090.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State And Local Tax Expense Benefit", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r443" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r117", "r119" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion Converted Instrument Shares Issued1", "terseLabel": "Convertible note hedge transactions purchase of common stock" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Indebtedness" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtedness" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAnnualPrincipalPayment": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the total principal payments made during the annual reporting period.", "label": "Debt Instrument Annual Principal Payment", "terseLabel": "Principal payments due" } } }, "localname": "DebtInstrumentAnnualPrincipalPayment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r18", "r19", "r20", "r577", "r579", "r593" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.", "label": "Debt Instrument Basis Spread On Variable Rate1", "terseLabel": "Credit facility bear interest rate" } } }, "localname": "DebtInstrumentBasisSpreadOnVariableRate1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument Convertible Conversion Price1", "terseLabel": "Initial conversion price of convertible notes" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleConversionRatio1": { "auth_ref": [ "r45", "r307", "r308", "r310" ], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.", "label": "Debt Instrument Convertible Conversion Ratio1", "terseLabel": "Initial conversion rate adjustment, shares" } } }, "localname": "DebtInstrumentConvertibleConversionRatio1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "pureItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument Convertible Threshold Consecutive Trading Days1", "terseLabel": "Consecutive trading days considered for debt conversion" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger", "terseLabel": "Percentage of conversion price" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r509", "r511" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails": { "order": 10010.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r43", "r302", "r509" ], "lang": { "en-us": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "terseLabel": "Effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "terseLabel": "Interest rate on convertible notes" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r44", "r485" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument Maturity Date", "terseLabel": "Debt instrument, maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodAxis": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Information about timing of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period [Axis]", "terseLabel": "Debt Instrument, Redemption, Period" } } }, "localname": "DebtInstrumentRedemptionPeriodAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodDomain": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Period as defined under terms of the debt agreement for debt redemption features.", "label": "Debt Instrument Redemption Period [Domain]", "terseLabel": "Debt Instrument, Redemption, Period" } } }, "localname": "DebtInstrumentRedemptionPeriodDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodFourMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Four [Member]", "terseLabel": "Convertible Notes due 2025 [Member]" } } }, "localname": "DebtInstrumentRedemptionPeriodFourMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Three [Member]", "terseLabel": "Convertible Notes due 2023 [Member]", "verboseLabel": "Convertible Notes due 2025 [Member]" } } }, "localname": "DebtInstrumentRedemptionPeriodThreeMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.", "label": "Debt Instrument Redemption Period Two [Member]", "terseLabel": "Convertible Notes due 2021 [Member]" } } }, "localname": "DebtInstrumentRedemptionPeriodTwoMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r590" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument Redemption Price Percentage", "terseLabel": "Debt redemption price percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r46", "r129", "r307", "r309", "r310", "r311", "r508", "r509", "r511", "r591" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesParentheticalDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r508", "r511" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails": { "order": 10020.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument Unamortized Discount", "negatedLabel": "Unamortized debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTable": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities Available For Sale [Table]", "terseLabel": "Debt Securities Available For Sale [Table]" } } }, "localname": "DebtSecuritiesAvailableForSaleTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r420", "r431" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10050.0, "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense Benefit", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r420", "r431" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10070.0, "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense Benefit", "terseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r392", "r393" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10260.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets Net", "terseLabel": "Deferred tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r112", "r127", "r420", "r431", "r432", "r433" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10230.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense Benefit", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r21", "r22", "r409", "r578", "r592" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10040.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Income Tax Liabilities", "negatedTotalLabel": "Total deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r392", "r393" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10030.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxesAndTaxCredits": { "auth_ref": [ "r113" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.", "label": "Deferred Income Taxes And Tax Credits", "totalLabel": "Total deferred provision" } } }, "localname": "DeferredIncomeTaxesAndTaxCredits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r420", "r431" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10060.0, "parentTag": "us-gaap_DeferredIncomeTaxesAndTaxCredits", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State And Local Income Tax Expense Benefit", "terseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r410" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10090.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Gross", "terseLabel": "Deferred tax assets", "totalLabel": "Gross deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r417", "r418" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10130.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Deferred Tax Assets Inventory", "terseLabel": "Inventory" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r412" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets Liabilities Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r412" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10030.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r417", "r418" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10120.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r417", "r418" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10180.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r417", "r418" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10160.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r411" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10100.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets Valuation Allowance", "negatedLabel": "Less valuation allowance", "terseLabel": "Valuation allowance for deferred tax assets" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r393", "r412" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "negatedTotalLabel": "Net deferred tax liabilities", "terseLabel": "Deferred tax liabilities" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r417", "r418" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10060.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets", "negatedLabel": "Acquired intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesOther": { "auth_ref": [ "r417", "r418" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10080.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.", "label": "Deferred Tax Liabilities Other", "negatedLabel": "Other" } } }, "localname": "DeferredTaxLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r112", "r279" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "verboseLabel": "Depreciation expense" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r112", "r182" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation Depletion And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAmountOfHedgedItem": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amount of hedged item in hedging relationship. Excludes hedged asset or liability.", "label": "Derivative Amount Of Hedged Item", "terseLabel": "Cost of hedge transaction" } } }, "localname": "DerivativeAmountOfHedgedItem", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r464" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative Assets Liabilities At Fair Value Net", "terseLabel": "Fair value of derivative instrument liability" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract Type [Domain]", "terseLabel": "Derivative Contract" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r470" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10270.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative Gain Loss On Derivative Net", "negatedLabel": "Net loss recognized on change in fair value of derivatives", "terseLabel": "Net (losses) gains recognized on derivative instruments" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r469", "r472", "r474", "r476" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument Risk [Axis]", "terseLabel": "Derivative Instrument" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r467", "r469", "r474" ], "lang": { "en-us": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Derivative Instruments Gain Loss By Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeMaturityDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the derivative contract matures, in CCYY-MM-DD format.", "label": "Derivative Maturity Dates", "terseLabel": "Derivative, maturity date" } } }, "localname": "DerivativeMaturityDates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "dateItemType" }, "us-gaap_DerivativeNotionalAmount": { "auth_ref": [ "r465", "r466" ], "lang": { "en-us": { "role": { "documentation": "Nominal or face amount used to calculate payment on derivative.", "label": "Derivative Notional Amount", "terseLabel": "Notional principal amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeVariableInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.", "label": "Derivative Variable Interest Rate", "terseLabel": "Senior convertible notes rate" } } }, "localname": "DerivativeVariableInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r444" ], "lang": { "en-us": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed Technology [Member]" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Disclosure Of Compensation Related Costs Share Based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]", "terseLabel": "Federal Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Net (loss) income per share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r81", "r143", "r144", "r145", "r146", "r147", "r152", "r154", "r159", "r160", "r161", "r164", "r165", "r587", "r606" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share Basic", "terseLabel": "Basic", "verboseLabel": "Basic net (loss) income per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r81", "r143", "r144", "r145", "r146", "r147", "r154", "r159", "r160", "r161", "r164", "r165", "r587", "r606" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Diluted", "terseLabel": "Diluted", "verboseLabel": "Diluted net (loss) income per share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r122", "r162", "r163" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share Policy [Text Block]", "terseLabel": "Net Income Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r499" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10040.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect Of Exchange Rate On Cash And Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": { "auth_ref": [ "r471" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.", "label": "Embedded Derivative Fair Value Of Embedded Derivative Liability", "terseLabel": "Fair value of embedded conversion derivative" } } }, "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity": { "auth_ref": [ "r477" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the liability for the conversion option reclassified to stockholders' equity when the embedded option no longer required separation from the host instrument.", "label": "Embedded Derivative No Longer Bifurcated Amount Reclassified To Stockholders Equity", "terseLabel": "Amount reclassified to stockholders' equity" } } }, "localname": "EmbeddedDerivativeNoLongerBifurcatedAmountReclassifiedToStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10170.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Accrued payroll and related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": { "auth_ref": [ "r371" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized", "terseLabel": "Unrecognized cost related to share-based compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Weighted average contractual term" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": { "auth_ref": [ "r370" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails": { "order": 10020.0, "parentTag": "us-gaap_AllocatedShareBasedCompensationExpenseNetOfTax", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Tax Benefit From Compensation Expense", "negatedLabel": "Related income tax benefits" } } }, "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "ESPP [Member]" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r368" ], "lang": { "en-us": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_EntityWideInformationRevenueFromExternalCustomerLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Wide Information Revenue From External Customer [Line Items]", "terseLabel": "Entity Wide Information Revenue From External Customer [Line Items]" } } }, "localname": "EntityWideInformationRevenueFromExternalCustomerLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityClassOfTreasuryStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Equity Class Of Treasury Stock [Line Items]", "terseLabel": "Equity Class Of Treasury Stock [Line Items]" } } }, "localname": "EquityClassOfTreasuryStockLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r134", "r135", "r136", "r140", "r148", "r150", "r167", "r231", "r306", "r312", "r378", "r379", "r380", "r426", "r427", "r500", "r501", "r502", "r503", "r504", "r506", "r617", "r618", "r619" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_EurodollarMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate based on U.S. dollar denominated deposits at foreign banks or foreign branches of U.S. banks.", "label": "Eurodollar [Member]", "terseLabel": "Eurocurrency Rate [Member]" } } }, "localname": "EurodollarMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r480", "r481", "r482", "r491" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis Valuation Techniques Table [Text Block]", "terseLabel": "Schedule of Inputs and Valuation Techniques Used in Recurring Level 3 Fair Value Measurements" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation By Asset Class [Domain]", "terseLabel": "Asset Class" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value Assets Measured On Recurring Basis Unobservable Input Reconciliation Calculation Roll Forward", "terseLabel": "Assets:" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r480", "r491" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Fair Value By Asset Class [Axis]", "terseLabel": "Asset Class" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r481", "r539", "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByLiabilityClassAxis": { "auth_ref": [ "r489", "r491" ], "lang": { "en-us": { "role": { "documentation": "Information by class of liability.", "label": "Fair Value By Liability Class [Axis]", "terseLabel": "Liability Class" } } }, "localname": "FairValueByLiabilityClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r480", "r481", "r484", "r485", "r492" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Fair Value By Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r324", "r325", "r330", "r331", "r481", "r539" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Quoted Price in Active Market (Level 1) [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r324", "r325", "r330", "r331", "r481", "r540" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Significant Other Observable Inputs (Level 2) [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r481", "r541" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level3 [Member]", "terseLabel": "Significant Unobservable Inputs (Level 3) [Member]", "verboseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "Represents classes of liabilities measured and disclosed at fair value.", "label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation By Liability Class [Domain]", "terseLabel": "Fair Value by Liability Class" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation Calculation Roll Forward", "terseLabel": "Liabilities:" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r486", "r491" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.", "label": "Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Text Block]", "terseLabel": "Schedule of Fair Value of Liabilities Measured on Recurring Basis Using Unobservable Inputs" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r487" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1", "terseLabel": "Change in fair value measurement" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "auth_ref": [ "r488" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases", "terseLabel": "Derivative assets purchased" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r486" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value", "periodEndLabel": "Fair value measurement at end of period", "periodStartLabel": "Fair value measurement at beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": { "auth_ref": [ "r487" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings", "terseLabel": "Change in fair value measurement" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": { "auth_ref": [ "r488" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases", "terseLabel": "Derivative liability recorded in connection with the 2023 Notes" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r488" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements", "negatedLabel": "Contingent consideration paid or settled" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as a liability into (out of) level 3 of the fair value hierarchy.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net", "terseLabel": "Changes resulting from foreign currency fluctuations" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r486" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value", "periodEndLabel": "Fair value measurement at end of period", "periodStartLabel": "Fair value measurement at beginning of period" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfLiabilitiesMeasuredOnRecurringBasisUsingUnobservableInputsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r539", "r540", "r541" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r489", "r492" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r486", "r490" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Input Reconciliation Table [Text Block]", "terseLabel": "Schedule of Estimated Fair Value of Derivative Assets and Liabilities Measured Using Significant Unobservable Inputs" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r122", "r493", "r496" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value Of Financial Instruments Policy", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FederalFundsEffectiveSwapRateMember": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Fixed rate on U.S. dollar, constant-notional interest rate swap having its variable-rate leg referenced to Federal Funds effective rate with no additional spread over Federal Funds effective rate on that variable-rate leg.", "label": "Federal Funds Effective Swap Rate [Member]", "terseLabel": "Federal Funds Effective Rate [Member]" } } }, "localname": "FederalFundsEffectiveSwapRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r518", "r523", "r531" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": 10060.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease Interest Expense", "terseLabel": "Interest expense on lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseInterestPaymentOnLiability": { "auth_ref": [ "r520", "r525" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": 10020.0, "parentTag": "nuva_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest paid on finance lease liability.", "label": "Finance Lease Interest Payment On Liability", "terseLabel": "Operating cash flows used for financing leases" } } }, "localname": "FinanceLeaseInterestPaymentOnLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finance Lease Liabilities Payments Due [Abstract]", "terseLabel": "Financing Leases" } } }, "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r517", "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails2": { "order": 10040.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease Liability", "totalLabel": "Present value of obligations under leases" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r517" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10090.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": 10020.0, "parentTag": "nuva_OperatingLeaseAndFinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease Liability Current", "negatedLabel": "Less: current portion", "terseLabel": "Financing" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r517" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10100.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": 10040.0, "parentTag": "nuva_OperatingLeaseAndFinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease Liability Noncurrent", "terseLabel": "Long-term lease obligations", "verboseLabel": "Financing" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease Liability Payments Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10160.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due After Year Five", "terseLabel": "Thereafter" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10110.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Next Twelve Months", "terseLabel": "2021" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10150.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Five", "terseLabel": "2025" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10140.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Four", "terseLabel": "2024" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10130.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Three", "terseLabel": "2023" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10120.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Two", "terseLabel": "2022" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails2": { "order": 10030.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: amount representing interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r519", "r525" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": 10030.0, "parentTag": "nuva_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease Principal Payments", "terseLabel": "Financing cash flows used for financing leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r516" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": 10060.0, "parentTag": "nuva_OperatingLeaseAndFinanceLeaseRightOfUseAsset", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease Right Of Use Asset", "terseLabel": "Financing" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r518", "r523", "r531" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": 10050.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease Right Of Use Asset Amortization", "terseLabel": "Depreciation of right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r528", "r531" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted-average discount rate - finance leases" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r527", "r531" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted-average remaining lease term (years) - finance leases" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r218", "r219", "r236", "r242", "r243", "r244", "r245", "r247", "r248", "r249", "r250", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]", "terseLabel": "Financial Instrument" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financial instruments. This disclosure includes, but is not limited to, fair value measurements of short and long term marketable securities, international currencies forward contracts, and auction rate securities. Financial instruments may include hedging and non-hedging currency exchange instruments, derivatives, securitizations and securities available for sale at fair value. Also included are investment results, realized and unrealized gains and losses as well as impairments and risk management disclosures.", "label": "Financial Instruments Disclosure [Text Block]", "terseLabel": "Financial Instruments and Fair Value Measurements" } } }, "localname": "FinancialInstrumentsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite Lived Intangible Asset Useful Life", "terseLabel": "Finite-Lived intangible assets, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r273" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails": { "order": 10040.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails": { "order": 10060.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense After Year Five", "terseLabel": "Thereafter through 2031" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r275" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails": { "order": 10010.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Next Twelve Months", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r275" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails": { "order": 10050.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Five", "terseLabel": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r275" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails": { "order": 10040.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Four", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r275" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails": { "order": 10030.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Three", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r275" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails": { "order": 10020.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finite Lived Intangible Assets Amortization Expense Year Two", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r268", "r270", "r273", "r276", "r568", "r572" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Future Amortization Expense [Abstract]", "terseLabel": "Future amortization expense related to intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsFutureAmortizationExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r273", "r572" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails": { "order": 10030.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Gross Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite Lived Intangible Assets [Line Items]", "terseLabel": "Finite Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r268", "r272" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r273", "r568" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails": { "order": 10010.0, "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10230.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Net", "terseLabel": "Intangible assets, net", "totalLabel": "Intangible Assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsFutureAmortizationExpenseRelatedToIntangibleAssetsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Finite Lived Intangible Assets Net [Abstract]", "terseLabel": "Intangible assets subject to amortization:" } } }, "localname": "FiniteLivedIntangibleAssetsNetAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Country [Member]", "terseLabel": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeForwardMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.", "label": "Foreign Exchange Forward [Member]", "terseLabel": "Foreign Exchange Forward [Member]" } } }, "localname": "ForeignExchangeForwardMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r131" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred foreign income tax expense (benefit) attributable to income (loss) from continuing operations.", "label": "Foreign Income Tax Expense Benefit Continuing Operations", "terseLabel": "Undistributed earnings attributable to operations" } } }, "localname": "ForeignIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture And Fixtures [Member]", "terseLabel": "Furniture and fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r90", "r112", "r213" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10260.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Gain Loss On Investments", "negatedLabel": "Net loss on strategic investments" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossRelatedToLitigationSettlement": { "auth_ref": [ "r285" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10130.0, "parentTag": "us-gaap_OperatingExpenses", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process.", "label": "Gain Loss Related To Litigation Settlement", "negatedLabel": "Litigation liability loss" } } }, "localname": "GainLossRelatedToLitigationSettlement", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r256", "r258", "r575" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails": { "order": 10020.0, "parentTag": "us-gaap_IntangibleAssetsNetIncludingGoodwill", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10240.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill", "totalLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetImpairment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.", "label": "Goodwill And Intangible Asset Impairment", "terseLabel": "Impairment of goodwill and intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetImpairment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r122", "r263", "r271" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill And Intangible Assets Policy [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillForeignCurrencyTranslationGainLoss": { "auth_ref": [ "r261" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails": { "order": 10010.0, "parentTag": "us-gaap_GoodwillPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of foreign currency translation gain (loss) which increases (decreases) an asset representing future economic benefits from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Foreign Currency Translation Gain Loss", "terseLabel": "Changes resulting from foreign currency fluctuations" } } }, "localname": "GoodwillForeignCurrencyTranslationGainLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillGross": { "auth_ref": [ "r259", "r262" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails": { "order": 10020.0, "parentTag": "us-gaap_Goodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Gross", "terseLabel": "Gross goodwill" } } }, "localname": "GoodwillGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairedAccumulatedImpairmentLoss": { "auth_ref": [ "r259", "r262" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails": { "order": 10030.0, "parentTag": "us-gaap_Goodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Impaired Accumulated Impairment Loss", "negatedLabel": "Accumulated impairment loss" } } }, "localname": "GoodwillImpairedAccumulatedImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r112", "r257", "r260", "r264" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Impairment Loss", "terseLabel": "Impairment charges related to goodwill" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillPeriodIncreaseDecrease": { "auth_ref": [ "r263" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill Period Increase Decrease", "totalLabel": "Goodwill period increase (decrease)" } } }, "localname": "GoodwillPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill Translation And Purchase Accounting Adjustments [Abstract]", "terseLabel": "Changes to gross goodwill:" } } }, "localname": "GoodwillTranslationAndPurchaseAccountingAdjustmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsChangesToGoodwillDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r85", "r126", "r184", "r187", "r189", "r192", "r195", "r222", "r497" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10030.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfDerivativeAssetsAndLiabilitiesMeasuredUsingSignificantUnobservableInputsDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r130", "r434" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income Loss From Continuing Operations Before Income Taxes Domestic", "terseLabel": "United States" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r77", "r184", "r187", "r189", "r192", "r195", "r573", "r583", "r588", "r607" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10010.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "totalLabel": "(Loss) income before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r130", "r434" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income Loss From Continuing Operations Before Income Taxes Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments [Abstract]", "terseLabel": "Summarized details of income before income taxes by region" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfIncomeBeforeIncomeTaxesByRegionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r283" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority Name [Axis]", "terseLabel": "Income Tax Authority, Name" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority Name [Domain]", "terseLabel": "Income Tax Authority, Name" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r396", "r407", "r414", "r429", "r435", "r437", "r438", "r439" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r127", "r149", "r150", "r183", "r394", "r430", "r436", "r608" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10020.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "negatedLabel": "Income tax benefit (expense)", "totalLabel": "Total (benefit) provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r74", "r122", "r390", "r391", "r407", "r408", "r413", "r421", "r634" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax Policy [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10040.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.", "label": "Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance", "verboseLabel": "Valuation allowance" } } }, "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r389", "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails": { "order": 10030.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10120.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.", "label": "Income Tax Reconciliation Change In Enacted Tax Rate", "terseLabel": "Changes in tax rate" } } }, "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesComponentsOfIncomeTaxProvisionBenefitDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10110.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).", "label": "Income Tax Reconciliation Foreign Income Tax Rate Differential", "terseLabel": "Foreign tax rate differences from federal statutory rate" } } }, "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate", "terseLabel": "Tax (benefit) provision at federal statutory rate" } } }, "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10100.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible meals and entertainment expense.", "label": "Income Tax Reconciliation Nondeductible Expense Meals And Entertainment", "terseLabel": "Nondeductible meals and entertainment" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10080.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost", "terseLabel": "Compensation expense" } } }, "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationOtherAdjustments": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10130.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Income Tax Reconciliation Other Adjustments", "terseLabel": "Other" } } }, "localname": "IncomeTaxReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10030.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).", "label": "Income Tax Reconciliation State And Local Income Taxes", "terseLabel": "State income tax" } } }, "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": { "auth_ref": [ "r395" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.", "label": "Income Tax Reconciliation Tax Credits Research", "negatedLabel": "Income tax credits and incentives" } } }, "localname": "IncomeTaxReconciliationTaxCreditsResearch", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesReconciliationOfIncomeTaxFromStatutoryTaxRateToEffectiveIncomeTaxRateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid Net", "terseLabel": "Income taxes paid" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r111" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10330.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase Decrease In Accounts Payable And Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r111" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10300.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase Decrease In Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": { "auth_ref": [ "r111" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.", "label": "Increase Decrease In Deferred Income Taxes", "negatedLabel": "Net decrease in deferred taxes" } } }, "localname": "IncreaseDecreaseInDeferredIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "auth_ref": [ "r111" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10340.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Increase Decrease In Employee Related Liabilities", "terseLabel": "Accrued payroll and related expenses" } } }, "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIncomeTaxes": { "auth_ref": [ "r111" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10350.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes, and in deferred and other tax liabilities and assets.", "label": "Increase Decrease In Income Taxes", "terseLabel": "Income taxes" } } }, "localname": "IncreaseDecreaseInIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r111" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10310.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities, net of effects from acquisitions:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r111" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10320.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r155", "r156", "r157", "r161" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails": { "order": 10020.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable To Share Based Payment Arrangements", "terseLabel": "Incremental common shares from share based payments" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets Net Including Goodwill", "totalLabel": "Total goodwill and intangible assets, net" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r92", "r303" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10070.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense Debt", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense Debt Excluding Amortization", "terseLabel": "Contractual coupon interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r106", "r109", "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid Net", "terseLabel": "Interest paid" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r11", "r12", "r41" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10060.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable Current", "terseLabel": "Debt interest payable" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r52" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Inventory Finished Goods", "terseLabel": "Inventory, finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r55" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10320.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventory, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r13", "r56", "r122", "r166", "r251", "r252", "r253" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory Policy [Text Block]", "terseLabel": "Inventory, net" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterials": { "auth_ref": [ "r54" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Raw Materials", "terseLabel": "Inventory, raw materials" } } }, "localname": "InventoryRawMaterials", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Inventory Work In Process", "terseLabel": "Inventory, work in progress" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r89", "r181" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10060.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments Debt And Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r480" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments Fair Value Disclosure", "terseLabel": "Total cash equivalents" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": { "auth_ref": [ "r221", "r574", "r589", "r629" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for investments in certain debt and equity securities.", "label": "Investments In Debt And Marketable Equity Securities And Certain Trading Assets Disclosure [Text Block]", "terseLabel": "Marketable Securities" } } }, "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r529", "r531" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease Cost", "totalLabel": "Total lease expense" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Cost [Abstract]", "terseLabel": "Lease expense:" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r529" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease Cost Table [Text Block]", "terseLabel": "Lease Costs, Cash Payments and Operating Lease Liabilities Arising From Obtaining Right-of-use Assets under Operating and Financing Lease Obligations" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasePracticalExpedientsPackage": { "auth_ref": [ "r513", "r514" ], "lang": { "en-us": { "role": { "documentation": "Indicates (true false) whether practical expedients are elected for not reassessing whether any expired or existing contract is or contains lease, lease classification for expired or existing lease, and initial direct cost for any existing lease.", "label": "Lease Practical Expedients Package", "terseLabel": "Lease, practical expedients, package" } } }, "localname": "LeasePracticalExpedientsPackage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "booleanItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LegalMattersAndContingenciesTextBlock": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.", "label": "Legal Matters And Contingencies [Text Block]", "terseLabel": "Contingencies" } } }, "localname": "LegalMattersAndContingenciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total minimum lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10080.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due After Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10030.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10070.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10060.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10050.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10040.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r530" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails2": { "order": 10010.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: amount representing interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r522" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract", "terseLabel": "Initial terms of lease" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "durationItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r29", "r126", "r222", "r497", "r580", "r599" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "LIABILITIES AND EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r42", "r126", "r222", "r453", "r458", "r459", "r497" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCredit": { "auth_ref": [ "r20", "r579", "r593" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.", "label": "Line Of Credit", "terseLabel": "Loan outstanding" } } }, "localname": "LineOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r39" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line Of Credit Facility Maximum Borrowing Capacity", "terseLabel": "Credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.", "label": "Line Of Credit Facility Unused Capacity Commitment Fee Percentage", "terseLabel": "Unused line fee" } } }, "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_LitigationSettlementAmountAwardedToOtherParty": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount awarded to other party in judgment or settlement of litigation.", "label": "Litigation Settlement Amount Awarded To Other Party", "terseLabel": "Settlement agreement, consideration" } } }, "localname": "LitigationSettlementAmountAwardedToOtherParty", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingencies By Nature Of Contingency [Axis]", "terseLabel": "Loss Contingency Nature" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r285", "r286", "r287", "r288", "r289", "r290", "r291", "r294", "r295" ], "lang": { "en-us": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency Nature [Domain]", "terseLabel": "Loss Contingency, Nature" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureContingenciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery And Equipment [Member]", "terseLabel": "Machinery and equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input Discount Rate [Member]", "terseLabel": "Discount Rate [Member]" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input Expected Term [Member]", "terseLabel": "Expected Years [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r483" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]", "terseLabel": "Measurement Input Type" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r324" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r108" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r108" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Investing activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r108", "r110", "r113" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r0", "r68", "r71", "r78", "r113", "r126", "r139", "r143", "r144", "r145", "r146", "r149", "r150", "r158", "r184", "r187", "r189", "r192", "r195", "r222", "r497", "r584", "r603" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net (loss) income", "totalLabel": "Consolidated net (loss) income", "verboseLabel": "Consolidated net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNonredeemableNoncontrollingInterest": { "auth_ref": [ "r86" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Portion of net income (loss) attributable to nonredeemable noncontrolling interest.", "label": "Net Income Loss Attributable To Nonredeemable Noncontrolling Interest", "negatedLabel": "Net loss attributable to non-controlling interests" } } }, "localname": "NetIncomeLossAttributableToNonredeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "Recently Accounting Pronouncements Not Yet Adopted And Recently Adopted Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non Us [Member]", "verboseLabel": "International (excludes Puerto Rico) [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r134", "r135", "r136", "r312", "r449" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r91" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10050.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income Expense", "totalLabel": "Total interest and other expense, net" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income Expense [Abstract]", "terseLabel": "Interest and other expense, net:" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [ "r176" ], "lang": { "en-us": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number Of Operating Segments", "terseLabel": "Number of operating segments" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationDetailsTextual" ], "xbrltype": "integerItemType" }, "us-gaap_NumberOfReportingUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.", "label": "Number Of Reporting Units", "terseLabel": "Number of Reportable Units" } } }, "localname": "NumberOfReportingUnits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10040.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r524", "r531" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": 10040.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost", "terseLabel": "Operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Lease Liabilities Payments Due [Abstract]", "terseLabel": "Operating Leases" } } }, "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r517" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails2": { "order": 10020.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "totalLabel": "Present value of obligations under leases" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r517" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10010.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": 10010.0, "parentTag": "nuva_OperatingLeaseAndFinanceLeaseLiability", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10180.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "negatedLabel": "Less: current portion", "terseLabel": "Operating", "verboseLabel": "Operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r517" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails": { "order": 10020.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": 10030.0, "parentTag": "nuva_OperatingLeaseAndFinanceLeaseLiability", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10040.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "positiveTerseLabel": "Operating lease liabilities", "terseLabel": "Long-term lease obligations", "verboseLabel": "Operating" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsFutureMinimumAnnualLeasePaymentsUnderCapitalOperatingAndFinancingLeasesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r521", "r525" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails": { "order": 10010.0, "parentTag": "nuva_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments", "terseLabel": "Operating cash flows used for operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r516" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails": { "order": 10050.0, "parentTag": "nuva_OperatingLeaseAndFinanceLeaseRightOfUseAsset", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10250.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Operating", "verboseLabel": "Operating lease right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r528", "r531" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted-average discount rate - operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r527", "r531" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted-average remaining lease term (years) - operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsRightOfUseAssetsAndLeaseLiabilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesRentExpenseNet": { "auth_ref": [ "r512" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.", "label": "Operating Leases Rent Expense Net", "terseLabel": "Rent expense" } } }, "localname": "OperatingLeasesRentExpenseNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r415" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r463" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization and Significant Accounting Policies" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r10", "r11", "r12", "r41" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10080.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10280.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions.", "label": "Other Commitment", "terseLabel": "Other commitments" } } }, "localname": "OtherCommitment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of other commitment.", "label": "Other Commitments [Axis]", "terseLabel": "Other Commitments" } } }, "localname": "OtherCommitmentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other future obligation.", "label": "Other Commitments [Domain]", "terseLabel": "Other Commitments" } } }, "localname": "OtherCommitmentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r60" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 10040.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax", "terseLabel": "Translation adjustments, net of tax" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r69", "r72", "r75", "r79", "r306", "r500", "r505", "r506", "r585", "r604" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]", "terseLabel": "Other comprehensive income (loss):" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r62", "r64" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 10030.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.", "label": "Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax", "terseLabel": "Unrealized gain on marketable securities, net of tax" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10050.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashIncomeExpense": { "auth_ref": [ "r113" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10290.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.", "label": "Other Noncash Income Expense", "negatedLabel": "Other non-cash adjustments" } } }, "localname": "OtherNoncashIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r93" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10080.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "terseLabel": "Other (expense) income, net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherOperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing other operating income (expense).", "label": "Other Operating Income Expense [Member]", "terseLabel": "Other (Expense) Income [Member]" } } }, "localname": "OtherOperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of other than temporary impairment (OTTI) losses on equity securities, OTTI related to credit losses on debt securities, and OTTI losses on debt securities when the entity intends to sell the securities or it is more likely than not that the entity will be required to sell the securities before recovery of its amortized cost basis. Additionally, this item includes OTTI losses recognized during the period on investments accounted for under the cost method of accounting.", "label": "Other Than Temporary Impairment Losses Investments Portion Recognized In Earnings Net", "terseLabel": "Impairment charges recorded for earnings" } } }, "localname": "OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Nuvasive, Inc. Stockholders' Equity [Member]" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables And Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r103" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments For Repurchase Of Common Stock", "negatedLabel": "Purchase of treasury stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payments Related To Tax Withholding For Share Based Compensation", "terseLabel": "Payments of employees tax obligations" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r95", "r97", "r211" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments To Acquire Available For Sale Securities Debt", "negatedLabel": "Purchases of marketable securities" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r98" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments To Acquire Intangible Assets", "negatedLabel": "Purchases of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r99" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments To Acquire Investments", "negatedLabel": "Acquisitions and investments" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r98" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r23" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10090.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred stock, $0.001 par value; 5,000 shares authorized, none outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r6", "r31", "r32" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10340.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidTaxes": { "auth_ref": [ "r5", "r7", "r254", "r255" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10330.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for income and other taxes that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Taxes", "terseLabel": "Prepaid income taxes" } } }, "localname": "PrepaidTaxes", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r101" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds From Convertible Debt", "terseLabel": "Proceeds from issuance of convertible debt, net of issuance costs" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r100" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds From Issuance Of Common Stock", "terseLabel": "Proceeds from the issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r100" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds From Issuance Of Warrants", "terseLabel": "Proceeds from sale of warrants", "verboseLabel": "Cash proceeds from the sale of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLongTermLinesOfCredit": { "auth_ref": [ "r101" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Proceeds From Long Term Lines Of Credit", "terseLabel": "Proceeds from revolving line of credit" } } }, "localname": "ProceedsFromLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r102", "r105", "r133" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds From Payments For Other Financing Activities", "terseLabel": "Other financing activities" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds From Sale And Maturity Of Marketable Securities", "terseLabel": "Proceeds from sales and maturities of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherInvestments": { "auth_ref": [ "r96" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale of investments classified as other.", "label": "Proceeds From Sale Of Other Investments", "terseLabel": "Proceeds from other investments" } } }, "localname": "ProceedsFromSaleOfOtherInvestments", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromStockOptionsExercised": { "auth_ref": [ "r100", "r373" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.", "label": "Proceeds From Stock Options Exercised", "terseLabel": "Proceeds from exercise of stock options" } } }, "localname": "ProceedsFromStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r0", "r68", "r71", "r107", "r126", "r139", "r149", "r150", "r184", "r187", "r189", "r192", "r195", "r222", "r451", "r455", "r456", "r461", "r462", "r497", "r588" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "terseLabel": "Consolidated net (loss) income" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property Plant And Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r36", "r282" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r35", "r280" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails": { "order": 10850.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property Plant And Equipment [Line Items]", "terseLabel": "Property Plant And Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r15", "r16", "r282", "r600" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10220.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net", "verboseLabel": "Property and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNetByTypeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property Plant And Equipment Net By Type [Abstract]", "terseLabel": "Property and equipment net" } } }, "localname": "PropertyPlantAndEquipmentNetByTypeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r34", "r122", "r282", "r636", "r637" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property Plant And Equipment Policy [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r15", "r282" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property Plant And Equipment [Text Block]", "terseLabel": "Property and Equipment Net" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r15", "r280" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property Plant And Equipment Useful Life", "terseLabel": "Property and equipment, useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r82", "r238" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision For Doubtful Accounts", "terseLabel": "Current-period provision for expected losses" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesSummaryOfChangesInAllowanceForCreditLossesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RealizedInvestmentGainsLosses": { "auth_ref": [ "r609" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment.", "label": "Realized Investment Gains Losses", "negatedLabel": "Net loss on strategic investments" } } }, "localname": "RealizedInvestmentGainsLosses", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesPolicyTextBlock": { "auth_ref": [ "r122", "r205", "r207", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.", "label": "Receivables Policy [Text Block]", "terseLabel": "Accounts Receivable and Related Valuation Accounts" } } }, "localname": "ReceivablesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Reconciliation Of Unrecognized Tax Benefits Excluding Amounts Pertaining To Examined Tax Returns Roll Forward" } } }, "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_RepaymentsOfConvertibleDebt": { "auth_ref": [ "r104" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Repayments Of Convertible Debt", "negatedLabel": "Purchases of convertible note hedges" } } }, "localname": "RepaymentsOfConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfLongTermLinesOfCredit": { "auth_ref": [ "r104" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.", "label": "Repayments Of Long Term Lines Of Credit", "negatedLabel": "Repayments on revolving line of credit" } } }, "localname": "RepaymentsOfLongTermLinesOfCredit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r387", "r649" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10100.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and Development Expense [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r122", "r387" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research And Development Expense Policy", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentInProcess": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.", "label": "Research And Development In Process", "terseLabel": "Purchase of in-process research and development", "verboseLabel": "Purchased in-process research and development asset" } } }, "localname": "ResearchAndDevelopmentInProcess", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research [Member]", "terseLabel": "Research and Development [Member]" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfFairValueOfAssetsAndLiabilitiesMeasuredOnRecurringBasisDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndInvestmentsNoncurrent": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10270.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The noncurrent cash, cash equivalents and investments that is restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits classified as long-term; that is not expected to be released from such existing restrictions within one year of the balance sheet date or operating cycle, whichever is longer. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. Includes noncurrent cash equivalents and investments that are similarly restricted as to withdrawal, usage or disposal.", "label": "Restricted Cash And Investments Noncurrent", "terseLabel": "Restricted cash and investments" } } }, "localname": "RestrictedCashAndInvestmentsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashNoncurrent": { "auth_ref": [ "r9", "r17", "r120", "r631" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.", "label": "Restricted Cash Noncurrent", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashNoncurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "Restricted Stock Units (RSUs) [Member]", "verboseLabel": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r27", "r312", "r381", "r598", "r621", "r626" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10130.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r134", "r135", "r136", "r140", "r148", "r150", "r231", "r378", "r379", "r380", "r426", "r427", "r617", "r619" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings (Accumulated Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r179", "r180", "r186", "r190", "r191", "r197", "r198", "r201", "r319", "r320", "r567" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10150.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Net sales", "verboseLabel": "Net Sales" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r123", "r124" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition Policy [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Net sales:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenues From External Customers And Long Lived Assets [Line Items]", "terseLabel": "Revenues and Net Property and Equipment by Geographical Areas [Line Items]" } } }, "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Senior Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r526", "r531" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability", "terseLabel": "Operating lease liabilities arising from obtaining right-of-use assets" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsLeaseCostsCashPaymentsAndOperatingLeaseLiabilitiesArisingFromObtainingRightOfUseAssetsUnderOperatingAndFinancingLeaseObligationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale Of Stock Name Of Transaction [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "Schedule Of Accounts Payable And Accrued Liabilities Table [Text Block]", "terseLabel": "Accounts Payable and Accrued Liabilities" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r162" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]", "terseLabel": "Anti-dilutive Common Stock Equivalents Not Included in Calculation of Net Income Per Diluted Share" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule Of Available For Sale Securities [Line Items]", "terseLabel": "Schedule Of Available For Sale Securities [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCarryingValueAndAmortizedCostOfCompanySMarketableDebtSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]", "terseLabel": "Components of Income Tax Provision (Benefit)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtInstrumentsTextBlock": { "auth_ref": [ "r46", "r129", "r307", "r309", "r310", "r311", "r508", "r509", "r511", "r591" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.", "label": "Schedule Of Debt Instruments [Text Block]", "terseLabel": "Carrying Value of Senior Convertible Notes" } } }, "localname": "ScheduleOfDebtInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r412" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "Schedule Of Deferred Tax Assets And Liabilities Table [Text Block]", "terseLabel": "Significant Components of Deferred Tax Assets and Liabilities" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]", "terseLabel": "Computation of Basic and Diluted Earnings Per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r395" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]", "terseLabel": "Reconciliation of Income Tax from Statutory Tax Rate to Effective Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r339", "r369", "r383" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r339", "r369", "r383" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]", "terseLabel": "Compensation Costs Included in Consolidated Statement of Operations for All Stock-based Compensation Arrangements" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Tabular presentation of the description and amount of revenues from a product or service, or a group of similar products or similar services, reported from external customers during the period, if the information is not provided as part of the reportable operating segment information.", "label": "Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Table]", "terseLabel": "Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Table]" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesByProductLineDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.", "label": "Schedule Of Entity Wide Information Revenue From External Customers By Products And Services [Text Block]", "terseLabel": "Schedule of Net Sales by Product Line" } } }, "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r480", "r481" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule Of Fair Value Assets And Liabilities Measured On Recurring Basis Table [Text Block]", "terseLabel": "Schedule of Fair Value of Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r268", "r272", "r568" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule Of Finite Lived Intangible Assets [Table]", "terseLabel": "Schedule Of Finite Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsGoodwillAndIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r263", "r265" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule Of Goodwill [Text Block]", "terseLabel": "Changes to Goodwill" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r130" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]", "terseLabel": "Summary of Income Before Income Taxes By Region" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r263" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule Of Intangible Assets And Goodwill Table [Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested performance-based units.", "label": "Schedule Of Nonvested Performance Based Units Activity Table [Text Block]", "terseLabel": "Schedule of Performance-Based Restricted Stock Units" } } }, "localname": "ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "auth_ref": [ "r353" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.", "label": "Schedule Of Nonvested Restricted Stock Units Activity Table [Text Block]", "terseLabel": "Summary of Restricted Stock Units" } } }, "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r36", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule Of Property Plant And Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsPropertyAndEquipmentNetDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock": { "auth_ref": [ "r84", "r200" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule Of Revenues From External Customers And Long Lived Assets By Geographical Areas Table [Text Block]", "terseLabel": "Schedule of Net Sales and Net Property and Equipment by Geographical Area" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": { "auth_ref": [ "r76", "r200" ], "lang": { "en-us": { "role": { "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.", "label": "Schedule Of Revenues From External Customers And Long Lived Assets [Table]", "terseLabel": "Schedule Of Revenues From External Customers And Long Lived Assets [Table]" } } }, "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformationScheduleOfNetSalesAndNetPropertyAndEquipmentByGeographicalAreaDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r341", "r372" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r346", "r358", "r361" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of Stock Option Activity under All Stock Plans" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": { "auth_ref": [ "r363" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule Of Share Based Payment Award Employee Stock Purchase Plan Valuation Assumptions Table [Text Block]", "terseLabel": "Weighted Average Assumptions Used to Estimate Fair Value of Stock Options Granted and Stock Purchase Rights under ESPP" } } }, "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r406", "r422" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]", "terseLabel": "Summary of Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Scheduleof Finite Lived Intangible Assets Future Amortization Expense Table [Text Block]", "terseLabel": "Future Amortization Expense Related to Intangible Assets" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecurityDepositLiability": { "auth_ref": [ "r602" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This element represents money paid in advance to protect the provider of a product or service, such as a lessor, against damage or nonpayment by the buyer or tenant (lessee) during the term of the agreement. Such damages may include physical damage to the property, theft of property, and other contractual breaches. Security deposits held may be interest or noninterest bearing.", "label": "Security Deposit Liability", "terseLabel": "Restricted cash for security deposit" } } }, "localname": "SecurityDepositLiability", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureCommitmentsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r175", "r177", "r178", "r184", "r185", "r189", "r193", "r194", "r195", "r196", "r197", "r200", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Business Segment, Product and Geographic Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBusinessSegmentProductAndGeographicInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r88" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations": { "order": 10090.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling General And Administrative Expense", "terseLabel": "Selling, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling General And Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative Expense [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationCompensationCostsIncludedInConsolidatedStatementOfOperationsForAllStockBasedCompensationArrangementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r442" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series Of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "2017 and 2016 Acquisitions [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service [Member]" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_SettlementLiabilitiesCurrent": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails": { "order": 10050.0, "parentTag": "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amounts payable for money transfers, money orders, and consumer payment service arrangements. Settlement liabilities include amounts payable to intermediaries for global payment transfers.", "label": "Settlement Liabilities Current", "terseLabel": "Litigation liability" } } }, "localname": "SettlementLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetailsAccountsPayableAndAccruedLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r111" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10250.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r342" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Vesting period for the award", "verboseLabel": "Vesting period for the awards" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r351" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period", "negatedLabel": "Number of shares, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r357" ], "lang": { "en-us": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, Forfeited", "verboseLabel": "Average Grant Date Fair Value, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Number of shares, Granted", "verboseLabel": "Shares, Awarded at target" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r355" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, Granted", "verboseLabel": "Average Grant Date Fair Value, Awarded at target" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number", "periodEndLabel": "Number of shares outstanding, Ending balance", "periodStartLabel": "Number of shares outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Roll Forward", "terseLabel": "Restricted Stock Units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r354" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted average grant date fair value outstanding, Ending balance", "periodStartLabel": "Weighted average grant date fair value outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Roll Forward", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period", "negatedLabel": "Number of shares, Vested", "terseLabel": "Vested during the period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": { "auth_ref": [ "r360" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value", "terseLabel": "Fair value of restricted stock units vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r356" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted average grant date fair value, Vested" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions And Methodology [Abstract]", "terseLabel": "Weighted average assumptions used to estimate fair value of stock options granted and stock purchase rights under ESPP" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": { "auth_ref": [ "r365" ], "lang": { "en-us": { "role": { "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate", "terseLabel": "Maximum percentage of annual compensation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant", "periodEndLabel": "Maximum Number of Shares Eligible to be Issued, Outstanding, Ending balance", "periodStartLabel": "Maximum Number of Shares Eligible to be Issued, Outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number", "terseLabel": "Underlying shares exercisable, Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r349" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price option exercisable, Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r360" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value", "terseLabel": "Total intrinsic value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period", "negatedLabel": "Underlying shares, cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value", "terseLabel": "Aggregate Intrinsic Value outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r348", "r372" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Underlying shares outstanding, Ending balance", "periodStartLabel": "Underlying shares outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward", "terseLabel": "Summary of stock option activity under all stock plans" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r347" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price outstanding, Ending balance", "periodStartLabel": "Weighted average exercise price outstanding, Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r361" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value", "terseLabel": "Aggregate intrinsic value vested or expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number", "terseLabel": "Underlying shares vested or expected to vest, Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise price vested or expected to vest, Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r338", "r372" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award", "terseLabel": "Number of share purchased under ESPP" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r338", "r344" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationPerformanceBasedRestrictedStockAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationRestrictedAwardActivityDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r122", "r341", "r345" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share Based Compensation Option And Incentive Plans Policy", "terseLabel": "Stock-based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Stock price", "verboseLabel": "Closing price of stock" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period", "terseLabel": "ESPP offering period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r364", "r382" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "verboseLabel": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r372" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1", "terseLabel": "Aggregate intrinsic value exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1", "terseLabel": "Weighted Average Remaining Contractual Term exercisable, Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2", "terseLabel": "Weighted Average Remaining Contractual Term outstanding, Beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r362" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1", "terseLabel": "Weighted Average Remaining Contractual Term vested or expected to vest, Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares", "terseLabel": "Total stock options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "Percentage of issuance price of stock under the stock issuance program" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "percentItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Shares Issued", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance, Shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Shares Paid For Tax Withholding For Share Based Compensation", "terseLabel": "Total shares withheld related to statutory tax" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_ShippingAndHandlingMember": { "auth_ref": [ "r321" ], "lang": { "en-us": { "role": { "documentation": "Packing and transport of product.", "label": "Shipping And Handling [Member]", "terseLabel": "Product Shipment [Member]" } } }, "localname": "ShippingAndHandlingMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit": { "auth_ref": [ "r398" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the unrecognized tax benefit of a position taken for which it is reasonably possible that the total amount thereof will significantly increase or decrease within twelve months of the balance sheet date.", "label": "Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit", "terseLabel": "Remaining unrecognized tax positions" } } }, "localname": "SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandbyLettersOfCreditMember": { "auth_ref": [ "r293", "r297", "r448", "r627" ], "lang": { "en-us": { "role": { "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.", "label": "Standby Letters Of Credit [Member]", "terseLabel": "Standby Letters of Credit [Member]" } } }, "localname": "StandbyLettersOfCreditMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State And Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r51", "r134", "r135", "r136", "r140", "r148", "r150", "r167", "r231", "r306", "r312", "r378", "r379", "r380", "r426", "r427", "r500", "r501", "r502", "r503", "r504", "r506", "r617", "r618", "r619" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Income And Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r134", "r135", "r136", "r167", "r567" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r117", "r118", "r119" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued1", "terseLabel": "Issuance of common stock in connection with royalty milestone achievement" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r23", "r24", "r306", "r312" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Stock Issued During Period Shares Share Based Compensation", "terseLabel": "Issuance of common stock under employee and director equity option and purchase plans, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r23", "r24", "r306", "r312", "r350" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Underlying shares, exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockOptionsActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r23", "r24", "r312", "r340", "r359" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Stock Issued During Period Value Share Based Compensation", "terseLabel": "Issuance of common stock under employee and director stock option and purchase plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramAuthorizedAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stock repurchase plan authorized.", "label": "Stock Repurchase Program Authorized Amount1", "terseLabel": "Share repurchase program, authorized amount" } } }, "localname": "StockRepurchaseProgramAuthorizedAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchaseProgramExpirationDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date for the purchase of an entity's own shares under a stock repurchase plan, in the CCYY-MM-DD format.", "label": "Stock Repurchase Program Expiration Date", "terseLabel": "Share repurchase program, expiration date" } } }, "localname": "StockRepurchaseProgramExpirationDate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "dateItemType" }, "us-gaap_StockRepurchaseProgramPeriodInForce1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Stock Repurchase Program Period In Force1", "terseLabel": "Share repurchase program, period in force" } } }, "localname": "StockRepurchaseProgramPeriodInForce1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "durationItemType" }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount remaining of a stock repurchase plan authorized.", "label": "Stock Repurchase Program Remaining Authorized Repurchase Amount1", "terseLabel": "Share repurchase program, remaining authorized amount" } } }, "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r23", "r24", "r306", "r312" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period Shares", "negatedLabel": "Shares repurchased ,Shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r23", "r24", "r306", "r312" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period Value", "negatedLabel": "Shares repurchased" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Stockholders\u2019 equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r126", "r134", "r135", "r136", "r140", "r148", "r222", "r231", "r312", "r378", "r379", "r380", "r426", "r427", "r449", "r450", "r460", "r497", "r500", "r501", "r506", "r618", "r619" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10080.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r125", "r312", "r318" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders Equity Note Disclosure [Text Block]", "terseLabel": "Stockholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityPolicyTextBlock": { "auth_ref": [ "r121", "r122", "r305" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.", "label": "Stockholders Equity Policy [Text Block]", "terseLabel": "Comprehensive Income" } } }, "localname": "StockholdersEquityPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]", "terseLabel": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r507", "r533" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r507", "r533" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]", "terseLabel": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r507", "r533" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r507", "r533" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r532", "r535" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureSubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Subsidiary Sale Of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationStockReservedForFutureIssuanceDetails", "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockBasedCompensationWeightedAverageAssumptionsUsedToEstimateFairValueOfStockOptionsGrantedAndStockPurchaseRightsUnderESPPDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Details" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureBalanceSheetDetails" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental cash flow information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r415" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward Amount", "terseLabel": "Net research and development carryforwards" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_TaxesPayableCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10190.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Taxes Payable Current", "terseLabel": "Income tax liabilities" } } }, "localname": "TaxesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10070.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity Carrying Amount Attributable To Parent", "terseLabel": "Redeemable equity component of senior convertible notes", "verboseLabel": "Reclassification into temporary equity" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r218", "r219", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r565" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.", "label": "Transfers And Servicing Of Financial Instruments Types Of Financial Instruments [Domain]", "terseLabel": "Financial Instruments" } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsScheduleOfRecurringFairValueMeasurementsOfContingentConsiderationLiabilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": { "auth_ref": [ "r61", "r475" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.", "label": "Translation Adjustment For Net Investment Hedge Increase Decrease Net Of Tax", "negatedLabel": "Net currency exchange losses from derivatives instruments" } } }, "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureFinancialInstrumentsAndFairValueMeasurementsDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r50", "r313" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r50", "r313" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury Stock Shares", "terseLabel": "Treasury stock at cost, shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockSharesAcquired": { "auth_ref": [ "r24", "r306", "r312" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.", "label": "Treasury Stock Shares Acquired", "terseLabel": "Shares repurchased during period" } } }, "localname": "TreasuryStockSharesAcquired", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r50", "r313", "r316" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10140.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock Value", "negatedLabel": "Treasury stock at cost; 6,569 shares and 5,380 shares at December 31, 2020 and December 31, 2019, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockValueAcquiredCostMethod": { "auth_ref": [ "r306", "r312", "r313" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.", "label": "Treasury Stock Value Acquired Cost Method", "terseLabel": "Shares repurchased during period, value" } } }, "localname": "TreasuryStockValueAcquiredCostMethod", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureStockholdersEquityDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [ "r139", "r140", "r141", "r142", "r228", "r229", "r230", "r231", "r233", "r234", "r374", "r375", "r376", "r377", "r378", "r379", "r380", "r381", "r424", "r425", "r426", "r427", "r569", "r570", "r571", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626" ], "lang": { "en-us": { "role": { "documentation": "Amendment to accounting standards.", "label": "Type Of Adoption [Member]", "terseLabel": "Accounting Standards Update" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [ "r37" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails": { "order": 10030.0, "parentTag": "us-gaap_ConvertibleNotesPayable", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "negatedLabel": "Unamortized debt issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessCarryingValueOfSeniorConvertibleNotesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r388", "r400" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Gross unrecognized tax benefits period end", "periodStartLabel": "Gross unrecognized tax benefits at beginning of period" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r401" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions", "negatedLabel": "Decreases in tax positions for prior years" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities": { "auth_ref": [ "r403" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from settlements with taxing authorities.", "label": "Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities", "negatedLabel": "Decreases in tax positions due to settlements with taxing authorities" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r397" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued", "terseLabel": "Income tax, penalties and interest accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r397" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Expense", "terseLabel": "Income tax, penalties and interest (benefit) expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from acquisitions.", "label": "Unrecognized Tax Benefits Increases Resulting From Acquisition", "terseLabel": "Increases in tax positions for current year relating to acquisitions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r402" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions", "terseLabel": "Increases in tax positions for current year relating to ongoing operations" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r401" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions", "terseLabel": "Increases in tax positions for prior years" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": { "auth_ref": [ "r404" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.", "label": "Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations", "negatedLabel": "Decreases in tax positions as a result of a lapse of statute of limitations" } } }, "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": { "auth_ref": [ "r405" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.", "label": "Unrecognized Tax Benefits That Would Impact Effective Tax Rate", "terseLabel": "Unrecognized tax benefits that would impact effective tax" } } }, "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r168", "r169", "r170", "r171", "r172", "r173", "r174" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r412" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance Deferred Tax Asset Change In Amount", "negatedLabel": "Decrease in valuation allowance of deferred taxes" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIncomeTaxesDetailsTextual" ], "xbrltype": "monetaryItemType" }, "us-gaap_VariableRateAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of variable rate.", "label": "Variable Rate [Axis]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateAxis", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "stringItemType" }, "us-gaap_VariableRateDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.", "label": "Variable Rate [Domain]", "terseLabel": "Variable Rate" } } }, "localname": "VariableRateDomain", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureIndebtednessDetailsTextual" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrants [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesAntiDilutiveCommonStockEquivalentsNotIncludedInCalculationOfNetIncomePerDilutedShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number Diluted Shares Outstanding Adjustment [Abstract]", "verboseLabel": "Dilutive potential common stock outstanding:" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r153", "r161" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number Of Diluted Shares Outstanding", "terseLabel": "Diluted", "totalLabel": "Weighted average common shares outstanding for diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number Of Shares Outstanding [Abstract]", "terseLabel": "Weighted average shares outstanding:", "verboseLabel": "Denominator for basic and diluted net (loss) income per share:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r152", "r161" ], "calculation": { "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails": { "order": 10010.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number Of Shares Outstanding Basic", "terseLabel": "Basic", "verboseLabel": "Weighted average common shares outstanding for basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2020-01-31", "presentation": [ "http://www.nuvasive.com/20201231/taxonomy/role/DisclosureOrganizationAndSignificantAccountingPoliciesComputationOfBasicAndDilutedEarningsPerShareDetails", "http://www.nuvasive.com/20201231/taxonomy/role/StatementConsolidatedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3000-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(4)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=112272810&loc=d3e31010-122693" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599" }, "r202": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26610-111562" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26853-111562" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121553693&loc=d3e26626-111562" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27405-111563" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27161-111563" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27290-111563" }, "r221": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL82887624-210437" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL120254519-210437" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL120320025-210437" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121558606&loc=SL82898722-210454" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r253": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "http://asc.fasb.org/topic&trid=2126998" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=121329188&loc=SL108377954-173880" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=120431994&loc=SL118172731-207502" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r284": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r292": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=121596127&loc=d3e12803-110250" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109126253&loc=d3e4724-112606" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=51819886&loc=SL6014347-161799" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031898-161870" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870" }, "r304": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21459-112644" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23309-112656" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r318": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)-(4)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907" }, "r386": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32059-109318" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(4)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e34017-109320" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "740" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r439": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "b", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478" }, "r447": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r463": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=117331979&loc=d3e41228-113958" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998896-113959" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "15", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=35708913&loc=d3e50896-113970" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121607252&loc=SL5864739-113975" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117817908&loc=SL117819236-161440" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=116690757&loc=SL116692626-108610" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=120240428&loc=SL120254526-165497" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=121573735&loc=d3e41499-112717" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL120154346-209984" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r535": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "926", "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r574": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "940", "URI": "http://asc.fasb.org/subtopic&trid=2176304" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r589": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/subtopic&trid=2209399" }, "r59": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.3(a))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r629": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "320", "Topic": "946", "URI": "http://asc.fasb.org/subtopic&trid=2324412" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491354&loc=d3e6052-115624" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120520240&loc=SL120174030-210619" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756" }, "r651": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r652": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r653": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r654": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r655": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r656": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r657": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r658": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r659": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580" }, "r660": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r661": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r662": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r663": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(m)", "Publisher": "SEC", "Section": "4", "Subparagraph": "(1)(iii)", "Subsection": "08" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3151-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585" } }, "version": "2.1" } ZIP 99 0001564590-21-008934-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-21-008934-xbrl.zip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

    3(0=@R>@^# M:YP>C9DC')PH<%+"42@K!@\<@*#P: B_Z\4ANZ<-U7(6P8V]E3="@6XQ0C' MX*Q2XVI,8&X'89

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�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end

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�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